{"meta":{"query_hash":"ee89edce7903","filters":{"venue":"Clinical Pharmacology & Therapeutics"},"cohort_total":490,"direct_labels_cover":3,"predictions_cover":490,"exported":490,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/ee89edce7903","api":"https://metacan.xera.ac/api/v1/cohort?venue=Clinical+Pharmacology+%26+Therapeutics"},"results":[{"id":"W1486887573","doi":"10.1016/s0009-9236(03)90393-6b","title":"Perspective of canadian pediatricians on barriers to drug investigation in children in Canada","year":2003,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Western University","funders":"","keywords":"Perspective (graphical); Medicine; Drug; Family medicine; Pharmacology; Computer science","score_opus":0.07613562687481412,"score_gpt":0.4110212150575115,"score_spread":0.33488558818269737,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1486887573","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93519545,0.00056812685,4.904588e-7,0.05982896,0.0005450393,0.00058831304,0.00001945196,0.000005701231,0.0032484517],"genre_scores_gemma":[0.82903636,0.0011949443,0.000058501897,0.1695338,0.00010985494,0.00001454144,0.0000022108122,0.000012353801,0.00003744567],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981551,0.00047142664,0.0005196505,0.00029463234,0.00016324966,0.00039591032],"domain_scores_gemma":[0.9981557,0.0008058799,0.00009999443,0.00011516545,0.00009544512,0.0007278135],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00068186613,0.00014461027,0.00039694895,0.00031700425,0.000053710148,0.0000027963863,0.00011249581,0.000094036186,0.00025255728],"category_scores_gemma":[0.0003628722,0.00013391342,0.000056529498,0.0008727071,0.00012313908,0.000031700616,0.00001687168,0.0007448069,0.00001064454],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003136363,0.00012066579,0.98962826,0.000006398295,0.00021731161,0.000039419625,0.0006552704,0.00014735106,0.00013750904,0.00015377943,0.008096601,0.00048377746],"study_design_scores_gemma":[0.0043482757,0.00046086876,0.92665964,0.000023529545,0.0005199281,0.00000819605,0.0021833447,0.00014487503,0.0017678468,0.00030524924,0.06332251,0.00025572325],"about_ca_topic_score_codex":0.88753706,"about_ca_topic_score_gemma":0.96981984,"teacher_disagreement_score":0.109704845,"about_ca_system_score_codex":0.0010084996,"about_ca_system_score_gemma":0.004033365,"threshold_uncertainty_score":0.71550167},"labels":[],"label_agreement":null},{"id":"W1586266234","doi":"10.1002/cpt.176","title":"Human Ontogeny of Drug Transporters: Review and Recommendations of the Pediatric Transporter Working Group","year":2015,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":180,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Center for Advancing Translational Sciences; Indiana Clinical and Translational Sciences Institute; National Institute of Environmental Health Sciences; National Institute of Child Health and Human Development; National Institute of General Medical Sciences; National Institutes of Health","keywords":"Transporter; Ontogeny; Drug; Pharmacology; Medicine; Computational biology; Chemistry; Biology; Biochemistry; Internal medicine; Gene","score_opus":0.19333240478759608,"score_gpt":0.47056720107202,"score_spread":0.27723479628442393,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1586266234","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00028552924,0.9936748,0.000027041428,0.0019289274,0.001668251,0.0021313257,0.00009961425,0.000029386407,0.0001551139],"genre_scores_gemma":[0.0004174612,0.9923501,0.00023482995,0.005754176,0.00051246746,0.00006667985,0.000116543095,0.00007455448,0.00047318722],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9957038,0.00050160906,0.0027106314,0.00048940984,0.00028634744,0.0003082119],"domain_scores_gemma":[0.9974827,0.0002512309,0.0013296928,0.00051881844,0.00021959473,0.00019795724],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0017173173,0.00045550993,0.0035220217,0.00012066583,0.00008015101,0.0000029236828,0.00046169054,0.00050094497,0.00015437766],"category_scores_gemma":[0.000004763165,0.00028442603,0.0013552022,0.00039264935,0.00050619926,0.000031667914,0.00002728384,0.0012278415,0.000002813302],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001884715,0.0033213794,0.006115649,0.18110855,0.007241677,0.000053607455,0.00070036505,1.880742e-7,0.000039790462,0.00010372835,0.01951582,0.7816108],"study_design_scores_gemma":[0.0014249706,0.00018641562,0.00042557516,0.010102566,0.0799847,0.00001466939,0.00002069683,3.0889413e-7,0.0000036463457,0.000045389297,0.90755093,0.00024012558],"about_ca_topic_score_codex":0.0000025289135,"about_ca_topic_score_gemma":0.000013504078,"teacher_disagreement_score":0.8880351,"about_ca_system_score_codex":0.000040592757,"about_ca_system_score_gemma":0.0003915413,"threshold_uncertainty_score":0.9999608},"labels":[],"label_agreement":null},{"id":"W1598794013","doi":"10.1002/cpt.167","title":"Children: Are We Doing Enough?","year":2015,"lang":"en","type":"letter","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Pediatric research; Medicine; Population; Psychology; Environmental health; Pediatrics","score_opus":0.293640376953571,"score_gpt":0.5088611963876836,"score_spread":0.2152208194341126,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1598794013","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0013391511,0.025372254,0.000026651915,0.9606262,0.007463521,0.0010529087,0.00010011816,0.0002502742,0.0037689134],"genre_scores_gemma":[0.0007712168,0.0473791,0.0004199009,0.902895,0.04518374,0.000050189916,0.00016178977,0.0001474476,0.0029916333],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9948172,0.0010693113,0.0013240066,0.0010242737,0.00067864207,0.0010865557],"domain_scores_gemma":[0.9949341,0.0027190126,0.0008876722,0.00057599193,0.00042227167,0.00046094172],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity","insufficient_payload"],"category_scores_codex":[0.0012478934,0.0007394438,0.001864884,0.00011728732,0.0002434548,0.000045327124,0.0005776752,0.0022573418,0.0011103791],"category_scores_gemma":[0.00006809851,0.0005904964,0.000718165,0.00026688984,0.0009532727,0.0000980391,0.00038602034,0.010357186,0.00088526506],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00065259915,0.00054794643,0.0038195811,0.00015029853,0.0057418267,0.0011865918,0.00005994113,0.0000013546163,0.000045592613,6.4200935e-7,0.9758034,0.011990227],"study_design_scores_gemma":[0.004462049,0.00079681945,0.00094373815,0.00011032705,0.0105356295,0.00023228879,0.00002726553,0.000068971014,0.00007097732,0.00007911631,0.98209983,0.00057297177],"about_ca_topic_score_codex":0.000005493188,"about_ca_topic_score_gemma":0.0000010506217,"teacher_disagreement_score":0.057731226,"about_ca_system_score_codex":0.00018252232,"about_ca_system_score_gemma":0.00041967246,"threshold_uncertainty_score":0.99989265},"labels":[],"label_agreement":null},{"id":"W1859537116","doi":"10.1002/cpt.158","title":"Risks of congenital malformations in offspring exposed to valproic acid <i>in utero</i>: A systematic review and cumulative meta‐analysis","year":2015,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacological Effects and Toxicity Studies","field":"Medicine","cited_by":80,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; McMaster University; University of Toronto","funders":"","keywords":"In utero; Offspring; Valproic Acid; Meta-analysis; Medicine; Congenital malformations; Pregnancy; Obstetrics; Physiology; Internal medicine; Epilepsy; Biology; Fetus; Genetics; Psychiatry","score_opus":0.58865317533237,"score_gpt":0.578545360180645,"score_spread":0.010107815151725097,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1859537116","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00063260976,0.99061143,0.00003608364,0.00095944764,0.00017347527,0.0073896917,0.00009119753,0.00002988591,0.00007615632],"genre_scores_gemma":[0.0032995583,0.9783425,0.0002011295,0.01692561,0.00005814312,0.0010651577,0.000025248484,0.000034008815,0.000048696973],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9928452,0.0025315026,0.0032967897,0.0006038291,0.0002864003,0.00043632163],"domain_scores_gemma":[0.9952909,0.0027464551,0.001037422,0.00036869195,0.00024599207,0.00031057157],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0036663078,0.0005966035,0.012679889,0.0005936875,0.00004164128,0.000009736027,0.00031551844,0.00043649902,0.00008420716],"category_scores_gemma":[0.00025467481,0.00038614948,0.0018728386,0.0015230128,0.00031569257,0.0000711287,0.0002949356,0.0012206122,0.000027288792],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015279424,0.0015295122,0.00010003524,0.6265226,0.36411706,0.00020118644,0.00032725232,0.000015249794,0.000015976313,0.0000064444753,0.0002904266,0.0067214565],"study_design_scores_gemma":[0.0017433884,0.0007007294,0.00006282535,0.016264832,0.9659844,0.000026141392,0.000028768325,0.00020498701,0.000009698103,0.000013611743,0.014585092,0.00037553767],"about_ca_topic_score_codex":0.0000074888244,"about_ca_topic_score_gemma":0.00001660346,"teacher_disagreement_score":0.6102578,"about_ca_system_score_codex":0.00013303518,"about_ca_system_score_gemma":0.00020848797,"threshold_uncertainty_score":0.99985904},"labels":[],"label_agreement":null},{"id":"W1886211687","doi":"10.1002/cpt.284","title":"Emerging monoclonal antibodies as targeted innovative therapeutic approaches to asthma","year":2015,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Asthma and respiratory diseases","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Omalizumab; Asthma; Immunology; Medicine; Monoclonal antibody; Immunoglobulin E; Cytokine; Mepolizumab; Antibody; Allergy; Eosinophil","score_opus":0.4073594702037661,"score_gpt":0.5071271919195822,"score_spread":0.0997677217158161,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1886211687","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00083373697,0.99003434,0.00008810425,0.0024966577,0.0025370987,0.0026320335,0.000099187375,0.00023761575,0.0010411948],"genre_scores_gemma":[0.00018512401,0.9427136,0.00050219824,0.05190524,0.002829103,0.0002757021,0.000258551,0.00022352894,0.0011069191],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9937702,0.0014180592,0.0021324614,0.0012216126,0.00056412455,0.0008935807],"domain_scores_gemma":[0.9962614,0.000860308,0.0007992154,0.00064545916,0.00057091186,0.0008627143],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0012795853,0.0010679848,0.004142578,0.0004882546,0.00020431803,0.00003740925,0.0006389329,0.0011353473,0.000452359],"category_scores_gemma":[0.000077142206,0.0007740689,0.0011726498,0.0013330439,0.0008672107,0.00008060494,0.00035248196,0.0021453784,0.0010421128],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00050878664,0.001190048,0.00030052432,0.0020134253,0.004472799,0.00022543114,0.00016960397,0.0000030630288,0.000013412837,0.000045059696,0.013007664,0.9780502],"study_design_scores_gemma":[0.0015565776,0.0016104026,0.00021022608,0.0011207238,0.0066919057,0.00009763012,0.00012199425,0.000039221955,0.000015850319,0.00007866042,0.987726,0.000730824],"about_ca_topic_score_codex":0.0000015626549,"about_ca_topic_score_gemma":4.5018257e-7,"teacher_disagreement_score":0.97731936,"about_ca_system_score_codex":0.00022164811,"about_ca_system_score_gemma":0.0029937671,"threshold_uncertainty_score":0.9997357},"labels":[],"label_agreement":null},{"id":"W1919247819","doi":"10.1016/j.clpt.2005.12.124","title":"OV-A-3Genetic determinants of the hepatic expression of the phase II conjugating UGT1A3 enzyme","year":2006,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Enzyme; Chemistry; Phase (matter); Biochemistry; Pharmacology; Medicine; Organic chemistry","score_opus":0.16431138991915625,"score_gpt":0.5032590767554878,"score_spread":0.3389476868363315,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1919247819","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9842836,0.003777336,0.00004617815,0.0016421739,0.008359363,0.0011128183,0.00015719981,0.00004496435,0.00057633675],"genre_scores_gemma":[0.98015,0.0010299816,0.00018142168,0.017054686,0.0009314363,0.000060422157,0.000005684777,0.00006244448,0.00052396435],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9930461,0.0029944074,0.0022083619,0.00056193693,0.00043537913,0.00075379974],"domain_scores_gemma":[0.99536556,0.0018283727,0.0015703471,0.00071054464,0.00032534622,0.00019983182],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0019030861,0.0004777634,0.0009401242,0.00008716196,0.0007395875,0.000010006321,0.0016797129,0.00066257117,0.00068702316],"category_scores_gemma":[0.00008382619,0.0003066006,0.00073340064,0.00052325276,0.0022326028,0.00006714457,0.00086155446,0.001596104,0.000017621462],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006231856,0.0035487209,0.07365469,0.0000853142,0.00032919212,0.000007166689,0.00041991883,0.00090167474,0.90075856,0.00004815831,0.005408853,0.014214567],"study_design_scores_gemma":[0.008250563,0.00039879052,0.01834903,0.000053266525,0.002118582,0.00001430322,0.00004741376,0.008053745,0.89441174,0.00072414335,0.06725529,0.00032310913],"about_ca_topic_score_codex":0.000020384785,"about_ca_topic_score_gemma":0.000012856925,"teacher_disagreement_score":0.061846435,"about_ca_system_score_codex":0.00004036417,"about_ca_system_score_gemma":0.00033997482,"threshold_uncertainty_score":0.9999386},"labels":[],"label_agreement":null},{"id":"W1921586980","doi":"10.1002/cpt.203","title":"Structured Frameworks to Increase the Transparency of the Assessment of Benefits and Risks of Medicines: Current Status and Possible Future Directions","year":2015,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Canada","funders":"","keywords":"Transparency (behavior); Risk analysis (engineering); Business; Risk assessment; Regulatory science; Drug development; Process management; Medicine; Drug; Pharmacology; Computer science; Computer security","score_opus":0.6491720548327571,"score_gpt":0.6195767082772885,"score_spread":0.029595346555468582,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1921586980","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.009662436,0.9743136,0.00008481811,0.009270279,0.0034294056,0.001764557,0.0014123565,0.000008379417,0.000054175725],"genre_scores_gemma":[0.0026910566,0.9899399,0.0003383447,0.0062638796,0.0006126869,0.00009252111,0.00002207846,0.000030821517,0.00000867175],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9919225,0.0016228363,0.0055756825,0.00047275715,0.00012817788,0.0002780699],"domain_scores_gemma":[0.99075603,0.0038344893,0.0044175955,0.0005515466,0.00019968898,0.00024065637],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008889504,0.00030281232,0.003009653,0.00018220488,0.00011592204,0.000010747351,0.0004795305,0.00065412844,0.000073532035],"category_scores_gemma":[0.00038447665,0.00020823185,0.0003200107,0.00035524438,0.00059656077,0.000053757456,0.00013206578,0.0012794794,0.0000025745755],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007010688,0.0007997515,0.06317025,0.015075529,0.003138796,2.856763e-7,0.0031453772,0.00009041955,5.130488e-7,0.0045746523,0.011110094,0.8988242],"study_design_scores_gemma":[0.0008032799,0.0002406206,0.025753006,0.0013340944,0.0014855376,0.0000026221094,0.00021063977,0.0001886704,2.4075953e-7,0.0012996001,0.96847904,0.00020262206],"about_ca_topic_score_codex":0.00011300036,"about_ca_topic_score_gemma":0.000058125774,"teacher_disagreement_score":0.95736897,"about_ca_system_score_codex":0.00012813561,"about_ca_system_score_gemma":0.0007893515,"threshold_uncertainty_score":0.8491449},"labels":[],"label_agreement":null},{"id":"W1950615881","doi":"10.1002/cpt.201","title":"Schizophrenia and the influence of male gender","year":2015,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Sex and Gender in Healthcare","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mental Health Research Canada; University of Toronto; Centre for Addiction and Mental Health","funders":"Canadian Institutes of Health Research","keywords":"Schizophrenia (object-oriented programming); Psychiatry; Psychology; Medicine; Clinical psychology","score_opus":0.25729247375135267,"score_gpt":0.48338880913043497,"score_spread":0.2260963353790823,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1950615881","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9826973,0.0032885917,0.00001812832,0.011109062,0.00046016983,0.00036325384,0.000002057407,0.000027232298,0.002034209],"genre_scores_gemma":[0.9356001,0.0009434289,0.00046973824,0.062036954,0.00030631723,0.000011013863,0.0000010612592,0.000017993709,0.00061341043],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99876326,0.00033653405,0.00040642975,0.00019810957,0.00012996446,0.00016570615],"domain_scores_gemma":[0.99867684,0.0006490401,0.000105396044,0.00022403235,0.0001586497,0.00018604533],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00097184116,0.00009449657,0.00032522195,0.000028694238,0.000033991204,0.0000027251092,0.00011106729,0.00014785831,0.00011305192],"category_scores_gemma":[0.000058836467,0.000058198886,0.00006984106,0.00009352924,0.0010300654,0.0000178962,0.000062446925,0.00036681807,0.000037163984],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.023312634,0.0011664467,0.8680715,0.0003097492,0.0031973387,0.000110976915,0.004644438,0.00011858127,0.004361403,0.0019523323,0.036910467,0.055844165],"study_design_scores_gemma":[0.056842666,0.0017647125,0.71282476,0.000040217787,0.0029038803,0.00045940606,0.0011726388,0.0015392693,0.0014021768,0.0062072747,0.21450305,0.00033992203],"about_ca_topic_score_codex":0.00000679899,"about_ca_topic_score_gemma":0.0000010440239,"teacher_disagreement_score":0.17759259,"about_ca_system_score_codex":0.000009745303,"about_ca_system_score_gemma":0.00017710352,"threshold_uncertainty_score":0.3795319},"labels":[],"label_agreement":null},{"id":"W1954522611","doi":"10.1016/j.clpt.2003.11.009","title":"Probing opioid effects in major depression hydromorphone (HM) challenge","year":2004,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Treatment of Major Depression","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"","keywords":"Placebo; Opioid; Major depressive disorder; Depression (economics); Medicine; Internal medicine; Hamd; Psychology; Hydromorphone; Anesthesia; Mood; Psychiatry; Significant difference; Receptor","score_opus":0.06385215346772229,"score_gpt":0.4052982068413665,"score_spread":0.34144605337364425,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1954522611","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98099333,0.0049354862,0.00024495486,0.009532868,0.0019223476,0.0015825123,0.0000028023792,0.00020929711,0.00057639566],"genre_scores_gemma":[0.9761727,0.0020428437,0.0020539267,0.018726118,0.000596679,0.00014728609,0.000022296594,0.000069545036,0.00016862966],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9974782,0.00032003396,0.00074059755,0.00064376084,0.00027706436,0.0005403395],"domain_scores_gemma":[0.99841464,0.000668993,0.0001953529,0.0003866574,0.000056996792,0.0002773767],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00048208586,0.00032393003,0.00071478373,0.00015250169,0.000093735216,0.000009542853,0.00021889611,0.0004995321,0.00014464652],"category_scores_gemma":[0.000033380264,0.00026115405,0.00021792368,0.00021171104,0.00026789441,0.00009151649,0.00014975492,0.0010270609,0.00023584113],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0100076925,0.032736186,0.28896627,0.0009549,0.0029329606,0.006954649,0.00217463,0.0003860671,0.54009664,0.00006640674,0.0048024687,0.109921105],"study_design_scores_gemma":[0.17470768,0.009626778,0.44172028,0.0022548654,0.0059076515,0.00045035977,0.00011057105,0.0011044379,0.32054427,0.004781395,0.03733252,0.0014592091],"about_ca_topic_score_codex":0.000010876082,"about_ca_topic_score_gemma":0.000008084183,"teacher_disagreement_score":0.2195524,"about_ca_system_score_codex":0.0002066497,"about_ca_system_score_gemma":0.00018190798,"threshold_uncertainty_score":0.9999841},"labels":[],"label_agreement":null},{"id":"W1964333742","doi":"10.1038/clpt.2012.154","title":"Epigenetic Chemical Probes","year":2012,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Structural Genomics Consortium","funders":"Canadian Institutes of Health Research; Wellcome Trust","keywords":"Epigenetics; Histone; DNA methylation; Gene expression; Computational biology; Methylation; Regulation of gene expression; Biology; DNA; Gene; Genetics","score_opus":0.19702409534672538,"score_gpt":0.4766277423614126,"score_spread":0.2796036470146872,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1964333742","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00012680389,0.99509114,0.00012239553,0.0002329894,0.00300908,0.0009559744,0.000032909953,0.000043622298,0.00038506466],"genre_scores_gemma":[0.00008084589,0.9856956,0.00041837094,0.0069414014,0.0052224696,0.000208539,0.00041270684,0.00011249183,0.0009075754],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9966471,0.0007610906,0.0011693193,0.0007041785,0.00015238547,0.00056590594],"domain_scores_gemma":[0.99845797,0.00014900122,0.0004802407,0.0005395239,0.000092071656,0.00028118814],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00060447055,0.0005407449,0.001210411,0.00006421893,0.00007607417,0.000019956728,0.0006969695,0.0014940994,0.00024668625],"category_scores_gemma":[0.000025909225,0.00044484367,0.0009225143,0.000145491,0.00049852475,0.0000035856024,0.000336384,0.00085783965,0.00039621146],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000038871967,0.00053765625,0.000023046672,0.00095277926,0.0012885212,0.000003507857,0.0000050340077,1.2712425e-7,0.0019698816,0.000007946558,0.01955575,0.9756169],"study_design_scores_gemma":[0.00044163887,0.00020801854,0.0000026482162,0.00016627515,0.0030631996,0.000025629606,0.0000019012369,0.0000018781112,0.004003894,0.000011479108,0.99159974,0.0004737273],"about_ca_topic_score_codex":3.7361042e-7,"about_ca_topic_score_gemma":3.1756247e-7,"teacher_disagreement_score":0.97514313,"about_ca_system_score_codex":0.00003330564,"about_ca_system_score_gemma":0.0003739295,"threshold_uncertainty_score":0.9998022},"labels":[],"label_agreement":null},{"id":"W1964612294","doi":"10.1016/j.clpt.2003.11.094","title":"Fluvoxamine (LUVOX™) use in pregnancy","year":2004,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Maternal Mental Health During Pregnancy and Postpartum","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Fluvoxamine; Medicine; Pregnancy; Depression (economics); Obstetrics; Clinical pharmacology; Serotonin reuptake inhibitor; Birth weight; Prospective cohort study; Fluoxetine; Pediatrics; Internal medicine; Antidepressant; Serotonin; Pharmacology","score_opus":0.16347744935869693,"score_gpt":0.45778079357164003,"score_spread":0.29430334421294313,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1964612294","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98417366,0.0022377116,0.00004216216,0.009915743,0.0023556591,0.00078681,0.00000888914,0.00009742586,0.00038193233],"genre_scores_gemma":[0.91405964,0.004273062,0.001004776,0.079036504,0.0003879615,0.000058647103,0.000013744133,0.000037775877,0.0011278965],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99797195,0.00019581981,0.0008142821,0.00037539416,0.00015710443,0.00048544773],"domain_scores_gemma":[0.99892986,0.00036380824,0.00013091393,0.00026139722,0.00005486573,0.0002591525],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030661942,0.0002037011,0.0004706115,0.00009195581,0.00006040425,0.000009813049,0.00014838566,0.00026720893,0.00020696384],"category_scores_gemma":[0.00002056229,0.00017710615,0.00013783948,0.00016717202,0.00023642507,0.00010377085,0.00006532431,0.0008080665,0.00021060326],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0066828276,0.00923294,0.95578706,0.0020338902,0.00078755367,0.0029413817,0.0007478129,0.00009425922,0.008208881,0.00042107035,0.00079998956,0.012262356],"study_design_scores_gemma":[0.02375034,0.0030581553,0.92177767,0.004330618,0.0007084581,0.00021548624,0.00002646403,0.00010946457,0.0194976,0.0009767776,0.025093652,0.00045530353],"about_ca_topic_score_codex":0.000025465119,"about_ca_topic_score_gemma":0.000017365028,"teacher_disagreement_score":0.07011403,"about_ca_system_score_codex":0.00011427498,"about_ca_system_score_gemma":0.0001695625,"threshold_uncertainty_score":0.7222179},"labels":[],"label_agreement":null},{"id":"W1965717563","doi":"10.1002/cpt.59","title":"From adaptive licensing to adaptive pathways: Delivering a flexible life‐span approach to bring new drugs to patients","year":2015,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":187,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institut National d'Excellence en Santé et en Services Sociaux; Canadian Agency for Drugs and Technologies in Health; Health Canada","funders":"European Federation of Pharmaceutical Industries and Associations","keywords":"Risk analysis (engineering); Sustainability; Business; Drug development; Life span; Adaptive strategies; New product development; Medicine; Drug; Marketing; Gerontology; Pharmacology","score_opus":0.696669527203476,"score_gpt":0.5022952081605061,"score_spread":0.19437431904296987,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1965717563","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8826619,0.00060832035,0.07786708,0.029393597,0.0039836545,0.0023244324,0.00029861217,0.00018068797,0.002681758],"genre_scores_gemma":[0.46703672,0.000062311585,0.06564954,0.4633859,0.003294712,0.00009128523,0.000032938773,0.000115851915,0.00033072504],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99294525,0.00073914474,0.00399199,0.0012871304,0.00018598432,0.00085050054],"domain_scores_gemma":[0.9940641,0.0017793213,0.0011236161,0.0005508096,0.00030135972,0.0021807824],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0067241034,0.000403071,0.0015170625,0.00036619438,0.00016959573,0.00008837734,0.00069366733,0.00033926847,0.00010126255],"category_scores_gemma":[0.0010670874,0.00052018143,0.00021740577,0.00046678088,0.00008433702,0.00030834775,0.00041718173,0.000559114,0.0064943223],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0048868596,0.0050224205,0.10169453,0.00010899444,0.0042778193,0.000008471131,0.14914593,0.058296435,0.00015487029,0.0035127136,0.6548702,0.01802076],"study_design_scores_gemma":[0.020486424,0.0072136233,0.10110105,0.0003989251,0.00068806566,0.0000036934746,0.017708693,0.1622939,0.00033167575,0.010897679,0.67432207,0.0045542205],"about_ca_topic_score_codex":0.0018663785,"about_ca_topic_score_gemma":0.000041723943,"teacher_disagreement_score":0.43399233,"about_ca_system_score_codex":0.0009005607,"about_ca_system_score_gemma":0.0005779593,"threshold_uncertainty_score":0.999725},"labels":[],"label_agreement":null},{"id":"W1966308229","doi":"10.1038/clpt.2013.42","title":"System, Crowd, and Communal Innovation: Can the Monks Solve the Elephant?","year":2013,"lang":"en","type":"editorial","venue":"Clinical Pharmacology & Therapeutics","topic":"Evolutionary Game Theory and Cooperation","field":"Social Sciences","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; SickKids Foundation; Hospital for Sick Children","funders":"","keywords":"Construct (python library); Computer science; Data science; Complex system; Artificial intelligence","score_opus":0.0659278245362619,"score_gpt":0.42742740838631677,"score_spread":0.3614995838500549,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1966308229","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0085877925,0.0038354911,0.0001228802,0.046890426,0.93470573,0.0015166097,0.00009225947,0.00017994404,0.0040688594],"genre_scores_gemma":[0.068896115,0.0075255823,0.00003932951,0.030046165,0.8889276,0.0002649145,0.00013332683,0.000052848973,0.004114112],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9937387,0.0038877171,0.000939702,0.00039320943,0.00057893567,0.00046173806],"domain_scores_gemma":[0.9890066,0.008992743,0.000555244,0.00041687005,0.00093557476,0.00009299836],"candidate_categories":["sts","research_integrity"],"consensus_categories":["sts"],"category_scores_codex":[0.0055471146,0.00030067354,0.00045915056,0.00005609275,0.002601652,0.00018960825,0.0012136861,0.0012700761,0.00025105843],"category_scores_gemma":[0.0002433543,0.00018354961,0.00013321018,0.00044105086,0.0037015143,0.00012637113,0.00021987727,0.0027187977,0.00008934903],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012285379,0.000102623606,0.00008175275,0.000018222452,0.0004908449,0.0000027338094,0.0028284832,0.0000071819313,0.000036046175,0.012331219,0.98159957,0.0023784614],"study_design_scores_gemma":[0.0006208579,0.00015082605,0.000111129724,0.000026820215,0.00065470365,0.0000015536438,0.0020241647,0.00019998197,0.0000072270755,0.0018164135,0.994163,0.00022331877],"about_ca_topic_score_codex":0.00026308378,"about_ca_topic_score_gemma":0.0003376224,"teacher_disagreement_score":0.06030832,"about_ca_system_score_codex":0.00016474724,"about_ca_system_score_gemma":0.0011271967,"threshold_uncertainty_score":0.999582},"labels":[],"label_agreement":null},{"id":"W1967478796","doi":"10.1038/clpt.2014.92","title":"Genetic Markers of Cisplatin-Induced Hearing Loss in Children","year":2014,"lang":"en","type":"letter","venue":"Clinical Pharmacology & Therapeutics","topic":"Hearing, Cochlea, Tinnitus, Genetics","field":"Neuroscience","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Heart Institute; Université de Montréal; Child and Family Research Institute; BC Children's Hospital; University of British Columbia","funders":"Canadian Institutes of Health Research","keywords":"Clinical pharmacology; Cisplatin; Hearing loss; Medicine; Audiology; Psychology; Pharmacology; Internal medicine; Chemotherapy","score_opus":0.1521319106897729,"score_gpt":0.41366531784897154,"score_spread":0.26153340715919865,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1967478796","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.87989193,0.0001404412,0.00009690959,0.115075305,0.0030201504,0.0011896903,0.00002801199,0.00011239153,0.0004451939],"genre_scores_gemma":[0.3460227,0.000773867,0.00038563905,0.64940995,0.003001027,0.000028957164,0.000010737243,0.00016110997,0.00020603115],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99136204,0.0027845022,0.0023745543,0.0015427162,0.00065154704,0.0012846186],"domain_scores_gemma":[0.99382395,0.0037923504,0.0010193529,0.0010391467,0.00012111537,0.0002040732],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0012571785,0.0007242557,0.0014782033,0.00039353577,0.00011739367,0.0000384619,0.0017325793,0.0023241045,0.00029449436],"category_scores_gemma":[0.0002686363,0.00076677196,0.00046938265,0.0005286564,0.0011565505,0.000050115523,0.0005387888,0.0064170538,0.00024187719],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007665649,0.0011009203,0.421879,0.0003735932,0.00079497154,0.00096758624,0.00023563538,0.00045133065,0.14596656,0.00000575786,0.41212627,0.015331814],"study_design_scores_gemma":[0.009534206,0.0023736695,0.41829574,0.0002797203,0.002138763,0.0004496952,0.000007036617,0.006028667,0.056247625,0.00047877818,0.5013855,0.0027806044],"about_ca_topic_score_codex":0.00003462595,"about_ca_topic_score_gemma":0.0000042528154,"teacher_disagreement_score":0.5343346,"about_ca_system_score_codex":0.00012789905,"about_ca_system_score_gemma":0.00041273344,"threshold_uncertainty_score":0.99947834},"labels":[],"label_agreement":null},{"id":"W1967851981","doi":"10.1016/j.clpt.2004.12.068","title":"Effects of infant formula, cow milk and human milk on drug metabolizing enzymes","year":2005,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Breastfeeding Practices and Influences","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Pregnane X receptor; Aryl hydrocarbon receptor; Infant formula; CYP3A4; Chemistry; Pharmacology; Breast milk; Receptor; Endocrinology; Internal medicine; Cytochrome P450; Biology; Enzyme; Medicine; Nuclear receptor; Biochemistry; Transcription factor; Gene","score_opus":0.056908851156162996,"score_gpt":0.427783864006138,"score_spread":0.370875012849975,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1967851981","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96969146,0.007596138,0.000008155594,0.020936353,0.0006971609,0.00042365133,0.0000032856358,0.000050785507,0.0005929995],"genre_scores_gemma":[0.9358829,0.0030761864,0.00064691534,0.05919711,0.0009206004,0.000015060409,0.000002584176,0.000023996705,0.00023463808],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9982839,0.00022266989,0.00067229,0.00032183516,0.00019527452,0.0003040304],"domain_scores_gemma":[0.99731743,0.0019049427,0.0003209154,0.00016663247,0.00010605992,0.00018403461],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007228711,0.0002071788,0.0006428487,0.00008831985,0.00011859693,0.000012073696,0.00014658066,0.00019339244,0.00009768494],"category_scores_gemma":[0.000049771876,0.0001587651,0.00017375148,0.00010593592,0.00047660782,0.00014113431,0.000068188994,0.00064775924,0.000020667421],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006454394,0.007345228,0.16754971,0.0010649622,0.0070832674,0.00012065925,0.0026020526,0.00004625742,0.51979834,0.002593869,0.029529402,0.25581184],"study_design_scores_gemma":[0.012103128,0.0023803597,0.32633656,0.00018438092,0.005363772,0.000056200905,0.00007364407,0.0005843726,0.2273191,0.00019128076,0.42504022,0.00036698382],"about_ca_topic_score_codex":0.00001847653,"about_ca_topic_score_gemma":0.0000052065816,"teacher_disagreement_score":0.39551082,"about_ca_system_score_codex":0.000018253835,"about_ca_system_score_gemma":0.000059097205,"threshold_uncertainty_score":0.6474253},"labels":[],"label_agreement":null},{"id":"W1970738061","doi":"10.1038/sj.clpt.6100359","title":"The Morally Uncomfortable Global Drug Gap","year":2007,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Essential medicines; Population; Human rights; Consumption (sociology); Quality (philosophy); Economic growth; Medicine; Business; Development economics; Public relations; Law and economics; Political science; Law; Health care; Economics; Sociology; Environmental health; Social science","score_opus":0.17917928466033714,"score_gpt":0.4357705111054546,"score_spread":0.25659122644511745,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1970738061","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6694574,0.017684886,0.0032310144,0.111534074,0.02148343,0.001154318,0.00035768814,0.00029296827,0.17480426],"genre_scores_gemma":[0.7605448,0.0060601346,0.00039117786,0.22902218,0.0018718439,0.00002040087,0.000009685961,0.00004651816,0.002033305],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.9967376,0.000081731036,0.0016685727,0.00051874516,0.00004559081,0.00094774464],"domain_scores_gemma":[0.9975604,0.0011009139,0.0005031915,0.00041920433,0.000051682688,0.00036461538],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.003934658,0.00025999462,0.0005455152,0.000051212704,0.00040563088,0.000092655646,0.00085180375,0.00023771918,0.00052263745],"category_scores_gemma":[0.00003632337,0.00023138129,0.0003547163,0.000273506,0.00065909297,0.00012591326,0.00019102196,0.00068004994,0.0016258394],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009083705,0.0011703641,0.33724707,0.000023999892,0.0021621322,0.000047080186,0.00019431218,0.00016905514,0.000090831374,0.34012854,0.29127252,0.026585707],"study_design_scores_gemma":[0.0014903964,0.00008512961,0.01680743,0.0000017731725,0.000074766154,0.0000059829117,0.000023822462,0.0021754089,0.00010156659,0.08081648,0.8981309,0.00028632712],"about_ca_topic_score_codex":0.000036275735,"about_ca_topic_score_gemma":0.000072799055,"teacher_disagreement_score":0.6068584,"about_ca_system_score_codex":0.00018797476,"about_ca_system_score_gemma":0.00008595106,"threshold_uncertainty_score":0.9991515},"labels":[],"label_agreement":null},{"id":"W1971306812","doi":"10.1038/clpt.2011.249","title":"Induction of CYP2C19 and CYP3A Activity Following Repeated Administration of Efavirenz in Healthy Volunteers","year":2012,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Center for Research Resources; National Institute of General Medical Sciences; Canadian Institutes of Health Research; Bristol-Myers Squibb","keywords":"Omeprazole; Efavirenz; CYP2C19; CYP3A; Pharmacology; Pharmacokinetics; Chemistry; CYP3A4; CYP2B6; Oral administration; Drug interaction; Metabolism; Medicine; Cytochrome P450; Biochemistry; Immunology","score_opus":0.09949900459842544,"score_gpt":0.4534612111092563,"score_spread":0.3539622065108309,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1971306812","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936126,0.00044523567,0.00002977627,0.004697402,0.0007051332,0.00038094967,0.0000027866938,0.000017846101,0.00010828127],"genre_scores_gemma":[0.99739164,0.00053476857,0.0004348849,0.0013357854,0.00011300996,0.000012867924,0.000013027747,0.000012156302,0.000151842],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986551,0.00023706672,0.0005894276,0.00017946845,0.00012522447,0.00021374803],"domain_scores_gemma":[0.9992376,0.00028205392,0.00020155511,0.000109804976,0.00004934277,0.0001196344],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007501736,0.00012105746,0.0004519918,0.000100695324,0.000028659351,0.0000014576963,0.000038004655,0.00019593033,0.000028280178],"category_scores_gemma":[0.00002492881,0.00010594467,0.00010219209,0.00017846852,0.00016156585,0.00008941448,0.00002325569,0.0002885029,0.0000037238965],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004797972,0.0031020092,0.9268383,0.00008516258,0.0009233756,0.000015291886,0.00093367626,0.0000011544172,0.04515218,0.000009693143,0.00028696455,0.01785425],"study_design_scores_gemma":[0.0103704985,0.0019472346,0.9220134,0.00007476627,0.0015371885,0.000024556022,0.00023285566,0.00028137676,0.06023777,0.000023854716,0.0030813708,0.00017514598],"about_ca_topic_score_codex":0.000007713183,"about_ca_topic_score_gemma":0.0000061068044,"teacher_disagreement_score":0.017679103,"about_ca_system_score_codex":0.00006350486,"about_ca_system_score_gemma":0.00017077365,"threshold_uncertainty_score":0.43202984},"labels":[],"label_agreement":null},{"id":"W1971946342","doi":"10.1038/clpt.2013.103","title":"Clinical Pharmacogenetics Implementation Consortium Guidelines for HLA-B Genotype and Carbamazepine Dosing","year":2013,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Drug-Induced Adverse Reactions","field":"Medicine","cited_by":329,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"National Institute of General Medical Sciences; National Institute of Mental Health; National Institutes of Health; National Heart, Lung, and Blood Institute; U.S. Department of Veterans Affairs; National Institute for Health and Care Research; St. Jude Children's Research Hospital","keywords":"Pharmacogenetics; Dosing; Carbamazepine; Medicine; Genotype; Pharmacology; Human leukocyte antigen; Immunology; Biology; Genetics; Epilepsy; Psychiatry; Gene; Antigen","score_opus":0.30556172178049124,"score_gpt":0.5670369111085714,"score_spread":0.2614751893280801,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1971946342","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94782364,0.001385491,0.0019079349,0.040192842,0.0051456867,0.0029132008,0.00005196857,0.00017905828,0.00040015357],"genre_scores_gemma":[0.76042676,0.010104066,0.022617903,0.2003814,0.0052796337,0.00029433874,0.0001385747,0.00013182919,0.0006255263],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9966048,0.00029576058,0.0018011095,0.000595244,0.00018697603,0.00051612634],"domain_scores_gemma":[0.99629194,0.0014417389,0.00041038767,0.00027943906,0.0011360155,0.00044046165],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00092067214,0.00029743343,0.00071023224,0.00010036491,0.00017749805,0.000029067718,0.00014450551,0.0003487762,0.00023744906],"category_scores_gemma":[0.00014338558,0.0002666058,0.00032281983,0.00015597806,0.00052081526,0.00011204202,0.00009686939,0.00062448526,0.000101084064],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027281643,0.0010583341,0.07080421,0.00009715499,0.0028954647,0.000017000208,0.00010928611,0.000017303459,0.17025109,0.000028177365,0.04415649,0.7102927],"study_design_scores_gemma":[0.018218264,0.00080913375,0.2040745,0.000034525256,0.006982169,0.00009988892,0.00041670608,0.0095040165,0.009066663,0.00031880478,0.74994415,0.00053116056],"about_ca_topic_score_codex":0.00002064186,"about_ca_topic_score_gemma":0.0000058626165,"teacher_disagreement_score":0.7097615,"about_ca_system_score_codex":0.00006574909,"about_ca_system_score_gemma":0.00032943414,"threshold_uncertainty_score":0.9999786},"labels":[],"label_agreement":null},{"id":"W1971983191","doi":"10.1038/clpt.2013.219","title":"Role of TPMT and COMT genetic variation in cisplatin-induced ototoxicity","year":2013,"lang":"en","type":"letter","venue":"Clinical Pharmacology & Therapeutics","topic":"Hearing, Cochlea, Tinnitus, Genetics","field":"Neuroscience","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Heart Institute; Université de Montréal; Child and Family Research Institute; BC Children's Hospital; University of British Columbia","funders":"Canadian Institutes of Health Research","keywords":"Columbia university; Medicine; Research centre; University hospital; Library science; Family medicine; Media studies; Sociology","score_opus":0.13018917291056392,"score_gpt":0.39944532819208234,"score_spread":0.2692561552815184,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1971983191","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92307353,0.00021577546,0.000058800866,0.07321362,0.0016817831,0.0013540073,0.000032203876,0.00006759546,0.00030271438],"genre_scores_gemma":[0.3610394,0.0010536476,0.00060619717,0.6354129,0.0015592333,0.000060357645,0.0000068699683,0.00009128051,0.00017012608],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9939459,0.0020566531,0.0017353066,0.0010802657,0.00043724995,0.0007446143],"domain_scores_gemma":[0.9945563,0.0036785193,0.0008752918,0.00059445493,0.00014562337,0.00014977316],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0007176373,0.00049575284,0.0010211479,0.00025558058,0.00009684319,0.000043652824,0.00079212815,0.0019568857,0.00030777883],"category_scores_gemma":[0.00023796892,0.00051090214,0.00018109095,0.000340049,0.00070149894,0.00007094347,0.00037799886,0.0039424133,0.00012655828],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010250399,0.00044846768,0.006698063,0.00011789689,0.00013368911,0.00008840573,0.00037240636,0.00004309523,0.94823354,0.000006907041,0.037999105,0.0057559446],"study_design_scores_gemma":[0.008067285,0.0024467788,0.32267392,0.00015924232,0.0016844263,0.00010165427,0.000028050883,0.031606674,0.21889162,0.0039475416,0.40818635,0.0022064687],"about_ca_topic_score_codex":0.00004682538,"about_ca_topic_score_gemma":0.0000074101563,"teacher_disagreement_score":0.72934186,"about_ca_system_score_codex":0.00008238397,"about_ca_system_score_gemma":0.00027944255,"threshold_uncertainty_score":0.9997343},"labels":[],"label_agreement":null},{"id":"W1975055422","doi":"10.1016/j.clpt.2003.08.003","title":"Use of nicotine patches in breast-feeding mothers: transfer of nicotine and cotinine into human milk","year":2003,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Smoking Behavior and Cessation","field":"Medicine","cited_by":82,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Cotinine; Nicotine; Medicine; Nicotine patch; Breast milk; Smoking cessation; Physiology; Breast feeding; Animal science; Anesthesia; Obstetrics; Internal medicine; Pediatrics; Chemistry; Biology","score_opus":0.14969422178743427,"score_gpt":0.42517178511759673,"score_spread":0.2754775633301625,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1975055422","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99740136,0.00022335773,0.00007171433,0.0015635174,0.00033291735,0.00032540763,0.000009331115,0.000024270277,0.000048106063],"genre_scores_gemma":[0.99537635,0.00059831515,0.00026663378,0.0035494585,0.00009521063,0.000008566611,0.0000121648145,0.00003283729,0.000060445684],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980256,0.00028851457,0.0009915981,0.00029124648,0.00017596419,0.0002270916],"domain_scores_gemma":[0.99883974,0.0005598037,0.00016147878,0.00018074142,0.00015293827,0.00010527645],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008025143,0.00018381196,0.00065452966,0.0001356623,0.00003468935,0.000004840822,0.00008749382,0.00028394518,0.00025932497],"category_scores_gemma":[0.00003012111,0.00016311948,0.00013352458,0.00022785447,0.00052886555,0.00007284439,0.000020719666,0.00047500027,6.7347884e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038789297,0.0010195941,0.6722797,0.000069020425,0.00019072657,0.0000029954604,0.00057696796,0.0000053120525,0.3232282,0.00004538154,0.0001094671,0.0020847213],"study_design_scores_gemma":[0.010366893,0.0013348169,0.78485614,0.00015727246,0.0018355756,0.000036446992,0.00034762305,0.00013368839,0.19901139,0.00014983375,0.0015412574,0.0002290801],"about_ca_topic_score_codex":0.000037289214,"about_ca_topic_score_gemma":0.000008963995,"teacher_disagreement_score":0.12421683,"about_ca_system_score_codex":0.000031242347,"about_ca_system_score_gemma":0.0000711507,"threshold_uncertainty_score":0.6651819},"labels":[],"label_agreement":null},{"id":"W1975412693","doi":"10.1016/s0009-9236(03)90518-2","title":"Effect of St. John's Wort on The Pharmacokinetics and Pharmacodynamics of Quazepam","year":2003,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Natural Compound Pharmacology Studies","field":"Agricultural and Biological Sciences","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pharmacodynamics; Pharmacokinetics; Clinical pharmacology; Pharmacology; Medicine","score_opus":0.05637052923680435,"score_gpt":0.3832040229372828,"score_spread":0.32683349370047843,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1975412693","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98979133,0.001876607,0.0000017965838,0.005251456,0.0016168149,0.0006943381,0.0000686128,0.000041196243,0.00065787154],"genre_scores_gemma":[0.9819657,0.0042416584,0.000035495224,0.013372755,0.00026462626,0.000030518062,0.000007648954,0.000004747185,0.00007685206],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9958032,0.0023187695,0.0008035909,0.000414224,0.0002564877,0.00040376702],"domain_scores_gemma":[0.98784596,0.011317771,0.00044583247,0.00010279224,0.00016442961,0.00012319295],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022231645,0.00033590614,0.0006912806,0.00002648959,0.00021697363,0.000009637479,0.0004944377,0.00022246243,0.00052122585],"category_scores_gemma":[0.00008834771,0.00012129339,0.0002762675,0.00039973875,0.001255394,0.000044359713,0.00013791458,0.00082290283,0.000008624537],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027538498,0.0012823105,0.055500984,0.00009043115,0.0025186045,0.000018527839,0.000117197334,0.0000541414,0.86287796,0.0005918726,0.018145923,0.056048192],"study_design_scores_gemma":[0.0073476345,0.013391873,0.037393592,0.00005939924,0.0049257656,0.000034153858,0.00018323875,0.0018346563,0.58603436,0.00092182186,0.3468538,0.0010197315],"about_ca_topic_score_codex":0.000004348438,"about_ca_topic_score_gemma":0.0000046102336,"teacher_disagreement_score":0.32870787,"about_ca_system_score_codex":0.00002001238,"about_ca_system_score_gemma":0.000019850288,"threshold_uncertainty_score":0.5707058},"labels":[],"label_agreement":null},{"id":"W1976694517","doi":"10.1038/clpt.2011.174","title":"Plasma Letrozole Concentrations in Postmenopausal Women With Breast Cancer Are Associated With CYP2A6 Genetic Variants, Body Mass Index, and Age","year":2011,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":108,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Center for Research Resources; National Institute of General Medical Sciences; Canadian Institutes of Health Research; Novartis Pharma; Pfizer; Johns Hopkins University; National Institute on Drug Abuse; AstraZeneca; National Institutes of Health","keywords":"Letrozole; CYP2A6; Medicine; Breast cancer; Exemestane; Pharmacogenomics; Pharmacogenetics; Internal medicine; Body mass index; Pharmacology; Oncology; Aromatase inhibitor; Endocrinology; Aromatase; Genotype; Cancer; Biology; Genetics; Metabolism","score_opus":0.02334594151501695,"score_gpt":0.3057416044835733,"score_spread":0.28239566296855634,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1976694517","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980911,0.0006360872,0.000065063345,0.00041270928,0.00020939187,0.0003665039,0.000057989862,0.000021423808,0.00013971601],"genre_scores_gemma":[0.99363995,0.0014747966,0.00013814097,0.0043529007,0.00013413228,0.00008296234,0.00002796241,0.000039658567,0.00010950957],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983761,0.0003115341,0.00032467247,0.00042864657,0.000097859775,0.00046124007],"domain_scores_gemma":[0.9993063,0.00007038916,0.0001933213,0.00016212021,0.00008240438,0.00018542164],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019145098,0.00023741164,0.0003191971,0.000039371087,0.000086903754,0.000014510156,0.0001648995,0.00040791198,0.00005864455],"category_scores_gemma":[0.0000052181613,0.0001803773,0.000029309433,0.00013853644,0.0005056675,0.00000780068,0.000050881743,0.00046510916,0.0000034142993],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004255695,0.0010139672,0.7844974,0.000011343558,0.0022747794,0.00034674848,0.00022249688,0.000103665,0.20606188,0.0000056810923,0.0003367686,0.00086959015],"study_design_scores_gemma":[0.007497755,0.0029899592,0.9799886,0.000032901513,0.0004712172,0.00007244788,0.00012662366,0.00048661444,0.0073509966,0.000025207262,0.0005870634,0.00037064072],"about_ca_topic_score_codex":0.000015259968,"about_ca_topic_score_gemma":0.00005214702,"teacher_disagreement_score":0.19871089,"about_ca_system_score_codex":0.000045881647,"about_ca_system_score_gemma":0.0001877744,"threshold_uncertainty_score":0.73555726},"labels":[],"label_agreement":null},{"id":"W1976804024","doi":"10.1038/clpt.2011.47","title":"Effects of Valproic Acid on Organic Acid Metabolism in Children: A Metabolic Profiling Study","year":2011,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacological Effects and Toxicity Studies","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Eunice Kennedy Shriver National Institute of Child Health and Human Development","keywords":"Valproic Acid; Carbamazepine; Metabolomics; Metabolism; Pharmacology; Organic acid; Medicine; Physiology; Internal medicine; Chemistry; Bioinformatics; Biology; Biochemistry; Epilepsy; Psychiatry","score_opus":0.08653330729861784,"score_gpt":0.4028912042756027,"score_spread":0.31635789697698485,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1976804024","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.989071,0.0055303853,0.000027775919,0.0004937561,0.0010033475,0.0035349324,0.000005460645,0.00011385274,0.00021947453],"genre_scores_gemma":[0.97318643,0.0019472815,0.00033150497,0.023775626,0.0004774106,0.00019727774,0.000002995212,0.000052139985,0.00002935191],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99611384,0.0011635598,0.0011097892,0.00069138425,0.00031539862,0.0006060315],"domain_scores_gemma":[0.9981493,0.00082438596,0.00033498937,0.00030880983,0.00014078815,0.00024176596],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0012133116,0.00043866844,0.0016470067,0.00023287802,0.000091527174,0.0000051968877,0.00036124367,0.00030734795,0.00022869515],"category_scores_gemma":[0.00016365871,0.0003157175,0.0003101721,0.00057868194,0.0004814588,0.000062322295,0.00021584674,0.0013565295,0.00006699371],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004502177,0.02905137,0.3535547,0.00012658878,0.007240161,0.00024274923,0.001182067,0.0000018703809,0.59625643,0.000060993174,0.00020466621,0.007576258],"study_design_scores_gemma":[0.011300555,0.004481461,0.57321656,0.00002172466,0.004212763,0.0000100249645,0.000054805718,0.000044476245,0.40617985,0.000096723474,0.00016924714,0.0002118419],"about_ca_topic_score_codex":0.0000069787707,"about_ca_topic_score_gemma":0.0000017573714,"teacher_disagreement_score":0.21966185,"about_ca_system_score_codex":0.000036012687,"about_ca_system_score_gemma":0.0001173674,"threshold_uncertainty_score":0.9999295},"labels":[],"label_agreement":null},{"id":"W1977589606","doi":"10.1002/cpt.10","title":"Soluble Guanylate Cyclase: A New Therapeutic Target for Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension","year":2014,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Pulmonary Hypertension Research and Treatments","field":"Medicine","cited_by":81,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"National Heart, Lung, and Blood Institute; Canadian Institutes of Health Research","keywords":"Riociguat; Nitric oxide; Cyclic guanosine monophosphate; Pulmonary hypertension; Medicine; Heme; Pharmacology; Soluble guanylyl cyclase; Vasodilation; cGMP-dependent protein kinase; Internal medicine; Cardiology; Chronic thromboembolic pulmonary hypertension; Chemistry; Guanylate cyclase; Biochemistry; Enzyme","score_opus":0.17882094088378364,"score_gpt":0.44878583287023316,"score_spread":0.2699648919864495,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1977589606","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0014683343,0.98467094,0.00010970636,0.0034065165,0.004405908,0.005464956,0.00010403424,0.00025613062,0.00011348562],"genre_scores_gemma":[0.00072347204,0.971563,0.00082433695,0.018203683,0.0052227536,0.00042240028,0.0009896108,0.0003805455,0.0016702116],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99226713,0.0011563596,0.002260714,0.0020518617,0.0005953997,0.0016685053],"domain_scores_gemma":[0.99372923,0.002606081,0.00077768357,0.0011215722,0.00037821216,0.0013871981],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0010029944,0.0014800011,0.006257491,0.00042775375,0.0005034263,0.000065851375,0.0005874873,0.0019990378,0.00036367518],"category_scores_gemma":[0.00007033226,0.0010691006,0.0018845809,0.00042188488,0.0009058487,0.00015762237,0.00044023414,0.0020295389,0.00033504967],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018252345,0.0038738055,0.000056696255,0.005424576,0.005929364,0.0030053176,0.0000045921083,9.333453e-7,0.0023109464,0.0000066586394,0.015364647,0.96219724],"study_design_scores_gemma":[0.0064448053,0.003515862,0.00028437804,0.0024747006,0.018192433,0.0048497175,0.000004991373,0.0037170541,0.000035037196,0.0004383982,0.95914614,0.00089649204],"about_ca_topic_score_codex":0.000013680872,"about_ca_topic_score_gemma":0.0000014173523,"teacher_disagreement_score":0.96130073,"about_ca_system_score_codex":0.00028407827,"about_ca_system_score_gemma":0.0022465086,"threshold_uncertainty_score":0.9997949},"labels":[],"label_agreement":null},{"id":"W1977830912","doi":"10.1067/mcp.2001.116977","title":"Simple approach to predict the maximal effect elicited by a drug when plasma concentrations are not available or are dissociated from the effect, as illustrated with chondroitin sulfate data","year":2001,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Analytical Methods in Pharmaceuticals","field":"Chemistry","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Chondroitin sulfate; Simple (philosophy); Drug; Plasma concentration; Pharmacology; Chemistry; Medicine; Biochemistry; Glycosaminoglycan; Philosophy","score_opus":0.2298775033815515,"score_gpt":0.47333417534679884,"score_spread":0.24345667196524734,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1977830912","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.009896345,0.93365574,0.001207097,0.008029287,0.0019300669,0.012917038,0.027280008,0.0012962694,0.0037881597],"genre_scores_gemma":[0.0010605394,0.95252305,0.00062166585,0.026634164,0.002735967,0.0015301757,0.00795946,0.00053754513,0.006397408],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9843654,0.007974816,0.0026455447,0.0024617286,0.00093029457,0.0016222068],"domain_scores_gemma":[0.9482941,0.04616164,0.0018692804,0.002633669,0.00025928352,0.0007820386],"candidate_categories":["metaepi_narrow","open_science","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","research_integrity"],"category_scores_codex":[0.0041077673,0.0016599918,0.0043824078,0.00006118942,0.00077002344,0.00029888435,0.0054162233,0.001579546,0.005393849],"category_scores_gemma":[0.0017788397,0.00083068735,0.00076428446,0.001183144,0.001757291,0.000157628,0.0011962514,0.0059983926,0.0006939212],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008691093,0.0028712116,0.004709438,0.0041330066,0.0316406,0.00040268427,0.00017366702,0.000043276497,0.00036599764,0.000009166747,0.7994684,0.14749146],"study_design_scores_gemma":[0.004403731,0.0004070083,0.000028718156,0.0012374101,0.029915698,0.000047153986,0.000076523196,0.006137646,0.000503778,0.000020385953,0.9562176,0.0010043619],"about_ca_topic_score_codex":0.00006152311,"about_ca_topic_score_gemma":0.000021717336,"teacher_disagreement_score":0.15674917,"about_ca_system_score_codex":0.00034112853,"about_ca_system_score_gemma":0.00063322234,"threshold_uncertainty_score":0.99996495},"labels":[],"label_agreement":null},{"id":"W1978174606","doi":"10.1016/s0009-9236(03)90387-0","title":"Pregnancy outcome in women receiving atypical antipsychotic drugs: A prospective, multicentre, controlled study","year":2003,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pregnancy and Medication Impact","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"","keywords":"Clinical pharmacology; Medicine; Antipsychotic; Pregnancy; Prospective cohort study; Atypical antipsychotic; Outcome (game theory); Pharmacology; Internal medicine; Psychiatry; Schizophrenia (object-oriented programming)","score_opus":0.09371956116930731,"score_gpt":0.46689346688756395,"score_spread":0.37317390571825665,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1978174606","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9869166,0.0027372537,0.000090055975,0.0022537934,0.0021243715,0.0045980285,0.0000027973547,0.0001263528,0.0011507253],"genre_scores_gemma":[0.9731451,0.0016187725,0.00025231636,0.023290332,0.00018745301,0.00049660326,0.0000016568883,0.000042627,0.0009651247],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9953571,0.0013565135,0.0015676385,0.00064551155,0.00031398653,0.00075923715],"domain_scores_gemma":[0.99702775,0.001606332,0.00032963578,0.00044725774,0.00014158152,0.00044742244],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0018312222,0.00031767378,0.0012927018,0.00016404121,0.0000933429,0.000013904019,0.000223042,0.0002998936,0.00062107353],"category_scores_gemma":[0.0006613996,0.00025187052,0.00020608467,0.0003955985,0.0003088534,0.00009223255,0.000038242077,0.0012327167,0.000108509834],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012026435,0.012561914,0.96348965,0.00005517201,0.001301775,0.00014296097,0.0034417966,0.0000043738796,0.00054787967,0.000026037169,0.00027280158,0.0061292257],"study_design_scores_gemma":[0.13728109,0.00254678,0.8525256,0.00030363715,0.0012841491,0.000019593022,0.0015349367,0.00038732684,0.00012893125,0.0002477693,0.0034141834,0.00032597862],"about_ca_topic_score_codex":0.0000010260471,"about_ca_topic_score_gemma":0.0000019420659,"teacher_disagreement_score":0.12525466,"about_ca_system_score_codex":0.00024216781,"about_ca_system_score_gemma":0.00031151873,"threshold_uncertainty_score":0.9999933},"labels":[],"label_agreement":null},{"id":"W1978813423","doi":"10.1016/j.clpt.2003.11.146","title":"Pharmacokinetics and tissue distribution of a new mesalamine rectal gel in ulcerative colitis patients","year":2004,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Pharmacokinetics; Cmin; Cmax; Suppository; Ulcerative colitis; Medicine; Urine; Rectal administration; Pharmacology; Volume of distribution; Adverse effect; Enema; Gastroenterology; Internal medicine","score_opus":0.04348085409112832,"score_gpt":0.3898331272675848,"score_spread":0.34635227317645645,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1978813423","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99307734,0.00033623102,0.0010554142,0.0038481662,0.0008155916,0.0006676822,0.00006150863,0.00003009398,0.00010800353],"genre_scores_gemma":[0.99104977,0.0023699205,0.00066235627,0.005230989,0.00025117304,0.000011478095,0.00013927823,0.000022554263,0.0002625111],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998445,0.0001014633,0.0007016176,0.00029960443,0.00017287226,0.0002794629],"domain_scores_gemma":[0.999257,0.00013110496,0.00015857525,0.00010966117,0.00014173765,0.0002018946],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027002694,0.00018295011,0.00052412285,0.00005524151,0.000034890614,0.000003939146,0.00008531806,0.0002180011,0.00007810536],"category_scores_gemma":[0.000013754957,0.00016047356,0.00008560085,0.00020492912,0.0003287293,0.00004387918,0.000026939164,0.0004272105,0.000005802635],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03580929,0.021021912,0.54751474,0.0008660452,0.0037335914,0.0008797675,0.0057816408,0.00023583522,0.1717838,0.0014128688,0.009135323,0.2018252],"study_design_scores_gemma":[0.03326577,0.0026938186,0.8579189,0.00013158805,0.0013910659,0.000014707857,0.00008335173,0.00013098415,0.07897314,0.0011127646,0.023995101,0.00028881239],"about_ca_topic_score_codex":0.000016330192,"about_ca_topic_score_gemma":0.000036668946,"teacher_disagreement_score":0.31040418,"about_ca_system_score_codex":0.00007758518,"about_ca_system_score_gemma":0.00020334161,"threshold_uncertainty_score":0.6543922},"labels":[],"label_agreement":null},{"id":"W1979098773","doi":"10.1016/j.clpt.2004.11.010","title":"Effect of NONMEM minimization status and number of replicates on bootstrap parameter distributions for population pharmacokinetic models: A case study","year":2005,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Statistical Methods in Clinical Trials","field":"Mathematics","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Purdue Pharma (Canada)","funders":"","keywords":"NONMEM; Covariate; Statistics; Nonparametric statistics; Population; Mathematics; Confidence interval; Pharmacokinetics; Coverage probability; Medicine; Econometrics; Pharmacology","score_opus":0.5229012801892853,"score_gpt":0.6348841190895517,"score_spread":0.11198283890026639,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1979098773","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9506858,0.000054260323,0.045440875,0.00036397917,0.00042728384,0.002647111,0.00030356503,0.000050370207,0.000026739739],"genre_scores_gemma":[0.9043907,0.0001575781,0.0941783,0.0007202853,0.0002664288,0.0002150039,0.00001271013,0.000043485536,0.000015493522],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9942473,0.0025370086,0.0021086012,0.0005426081,0.00022047588,0.00034397087],"domain_scores_gemma":[0.9031148,0.09540986,0.00076075626,0.00035607573,0.00020162633,0.00015687884],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0035635147,0.00028605157,0.0011237689,0.00006212259,0.000088804765,0.000010432015,0.0001664667,0.00028172962,0.00009993253],"category_scores_gemma":[0.004021107,0.00023418556,0.00023380981,0.00017931666,0.00043094248,0.00006782721,0.000074177515,0.00038356893,0.0000024486726],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.030498413,0.035146512,0.1506844,0.0021754673,0.009656432,0.00013549917,0.0015796617,0.0036173896,0.0039128065,0.009806339,0.004335595,0.7484515],"study_design_scores_gemma":[0.06969138,0.037955817,0.0076030255,0.00023451661,0.034568105,0.00022775264,0.00034597723,0.36080566,0.037626367,0.44750127,0.0016388707,0.0018012476],"about_ca_topic_score_codex":0.000009112122,"about_ca_topic_score_gemma":0.0000024441076,"teacher_disagreement_score":0.7466502,"about_ca_system_score_codex":0.00004019822,"about_ca_system_score_gemma":0.000032029453,"threshold_uncertainty_score":0.95498097},"labels":[],"label_agreement":null},{"id":"W1979383226","doi":"10.1038/clpt.2008.229","title":"The Critical Role of Clinical Pharmacology in Geriatric Psychopharmacology","year":2008,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Baycrest Hospital; University of Toronto; Centre for Addiction and Mental Health","funders":"","keywords":"Psychopharmacology; Clinical pharmacology; Pharmacology; Medicine","score_opus":0.2131802617487013,"score_gpt":0.5840275869813631,"score_spread":0.37084732523266184,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1979383226","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0024744214,0.97725725,0.0000036224305,0.005558469,0.010964422,0.003210075,0.0000644542,0.00008490578,0.00038238292],"genre_scores_gemma":[0.00045625455,0.98271734,0.00045856478,0.00961277,0.005639518,0.000675587,0.000051494397,0.00015673199,0.00023173417],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9841784,0.0064869956,0.005808208,0.0014002866,0.0006001082,0.0015259752],"domain_scores_gemma":[0.97067267,0.025977936,0.0011810194,0.00081508677,0.00043596185,0.0009173124],"candidate_categories":["metaepi_narrow","sts","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0029562812,0.0009526865,0.006163945,0.0005061613,0.00027114424,0.00001731337,0.0012237183,0.0021407995,0.00080206105],"category_scores_gemma":[0.00040212885,0.0006186992,0.0030006238,0.0010714709,0.00421506,0.0000605026,0.00043281092,0.0059645497,0.00047045766],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013259339,0.006261283,0.0013805247,0.0012499595,0.0068091676,0.0011717,0.000024161454,4.825078e-7,0.000014995375,0.000057058776,0.038723327,0.931048],"study_design_scores_gemma":[0.014014194,0.0026288556,0.0017118737,0.00037904736,0.010391519,0.000531199,0.000014920603,0.00010681945,0.000012685538,0.0002284349,0.96956164,0.0004188089],"about_ca_topic_score_codex":0.00000933824,"about_ca_topic_score_gemma":0.000011229474,"teacher_disagreement_score":0.9308383,"about_ca_system_score_codex":0.00024411769,"about_ca_system_score_gemma":0.004611227,"threshold_uncertainty_score":0.99962646},"labels":[],"label_agreement":null},{"id":"W1979585641","doi":"10.1038/clpt.2013.122","title":"Profiling Serum Bile Acid Glucuronides in Humans: Gender Divergences, Genetic Determinants, and Response to Fenofibrate","year":2013,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"National Heart, Lung, and Blood Institute; Canadian Liver Foundation; Canadian Institutes of Health Research; Health Canada; Institut Universitaire de France; National Institutes of Health","keywords":"UGT2B7; Glucuronidation; Fenofibrate; Chenodeoxycholic acid; Glucuronosyltransferase; Chemistry; Internal medicine; Bile acid; Endocrinology; Pharmacology; Biochemistry; Enzyme; Biology; Microsome; Medicine","score_opus":0.07475749646715302,"score_gpt":0.3924157924352398,"score_spread":0.31765829596808676,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1979585641","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9927725,0.0018137348,0.00017154332,0.0029941169,0.0010110706,0.001116162,0.000009367726,0.00006096987,0.000050509472],"genre_scores_gemma":[0.96942943,0.0016154819,0.004135669,0.02401141,0.00025787333,0.00010462373,0.0000033103809,0.0000396656,0.0004025239],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977111,0.00035143647,0.0007332502,0.000524057,0.00016829385,0.00051185786],"domain_scores_gemma":[0.998996,0.0002726759,0.00010284367,0.00023529484,0.00009165734,0.0003014924],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007484918,0.00024036744,0.0005083831,0.00013432358,0.00010711445,0.00001946996,0.00018733079,0.00027324475,0.00046613754],"category_scores_gemma":[0.00001693188,0.000191615,0.000107237785,0.00021395288,0.00027077523,0.00007606077,0.0000724852,0.00044642828,0.00012909232],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025570265,0.00049700326,0.64556515,0.000106023326,0.0002228229,0.00025816663,0.00058050785,0.000015305306,0.33234182,0.000005962813,0.00035360522,0.01749663],"study_design_scores_gemma":[0.0033501966,0.0010885912,0.9381708,0.000059450238,0.00046850057,0.000016839042,0.00034905062,0.0006119883,0.049426053,0.0003523849,0.0057787546,0.0003273792],"about_ca_topic_score_codex":0.000006869837,"about_ca_topic_score_gemma":0.000020256079,"teacher_disagreement_score":0.2926057,"about_ca_system_score_codex":0.000042751628,"about_ca_system_score_gemma":0.0001621943,"threshold_uncertainty_score":0.78138334},"labels":[],"label_agreement":null},{"id":"W1982471127","doi":"10.1016/s0009-9236(03)90668-0","title":"Population Pharmacokinetics of Meropenem in Febrile Neutropenics Using NPEM and Optimal Sampling Design","year":2003,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Antibiotics Pharmacokinetics and Efficacy","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Meropenem; Pharmacokinetics; Medicine; Population pharmacokinetics; Clinical pharmacology; Pharmacology; Sampling (signal processing); Population; Intensive care medicine; Antibiotics; Biology; Computer science; Microbiology; Environmental health; Antibiotic resistance","score_opus":0.23623169247991838,"score_gpt":0.4720359587662643,"score_spread":0.23580426628634593,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1982471127","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98549956,0.0014570054,0.01074053,0.0005533749,0.0008644042,0.0007433511,0.0000060210878,0.000030327425,0.00010540229],"genre_scores_gemma":[0.9534078,0.0037267513,0.036094096,0.006454838,0.00021166468,0.0000027923043,0.000009813924,0.000059184,0.000033052504],"study_design_codex":"bench_or_experimental","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9972649,0.0005290307,0.0011158924,0.0004481085,0.00020310859,0.0004389135],"domain_scores_gemma":[0.99844813,0.0006429041,0.00031257432,0.00020971433,0.00016257883,0.00022408302],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011659078,0.0002745009,0.00075731607,0.00016395224,0.00007809897,0.000015170982,0.00014358253,0.0002533013,0.00014664019],"category_scores_gemma":[0.000047415357,0.00026277328,0.00014172932,0.00032809278,0.00032348424,0.000065213855,0.00008208736,0.0006598775,0.000005464985],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037850437,0.0037220358,0.29901758,0.00029443167,0.001557636,0.00014444256,0.00040914476,0.05211671,0.6226279,0.00031635744,0.000839939,0.015168758],"study_design_scores_gemma":[0.039981898,0.0033756145,0.26322326,0.00031044148,0.009141205,0.00034945627,0.00024789324,0.49312395,0.16347642,0.0003936085,0.024848046,0.0015281884],"about_ca_topic_score_codex":0.000010881629,"about_ca_topic_score_gemma":6.7561695e-7,"teacher_disagreement_score":0.45915148,"about_ca_system_score_codex":0.00005563072,"about_ca_system_score_gemma":0.00014541684,"threshold_uncertainty_score":0.9999825},"labels":[],"label_agreement":null},{"id":"W1982900038","doi":"10.1016/s0009-9236(03)90392-4","title":"Artificial intelligence (AI) in prediction of beta‐lactam antibiotic toxicity","year":2003,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Analytical Methods in Pharmaceuticals","field":"Chemistry","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Beta-lactam; Antibiotics; Lactam; Medicine; Chemistry; Microbiology; Biology; Stereochemistry","score_opus":0.24756681448672718,"score_gpt":0.5019714092959835,"score_spread":0.2544045948092563,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1982900038","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9621075,0.0007034989,0.022463292,0.00357717,0.0027441431,0.00038636566,0.00005569647,0.00016404373,0.0077983155],"genre_scores_gemma":[0.98496497,0.0007791895,0.004142335,0.009614219,0.00035919962,0.000007854775,0.0000046201503,0.00003869407,0.00008892819],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9958307,0.00087978225,0.0018516514,0.0005901659,0.00028226877,0.00056544255],"domain_scores_gemma":[0.99583083,0.0030914359,0.00030840715,0.0003817334,0.00015396923,0.00023360732],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0022557506,0.00028628253,0.0007329083,0.0001050655,0.00006291802,0.000012490615,0.0004541727,0.0006030505,0.0021455886],"category_scores_gemma":[0.0003722658,0.00027923074,0.00028584152,0.00042315357,0.0011897443,0.00008922228,0.00009326513,0.0015277405,0.00006984864],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00093403755,0.006115504,0.09664072,0.00026654938,0.0011849579,0.000065748056,0.00017344362,0.00033646633,0.774831,0.0057520317,0.0006797358,0.113019824],"study_design_scores_gemma":[0.00058280036,0.0002091435,0.002142515,0.000042238113,0.00087250955,0.00000938682,0.00008869162,0.013674656,0.9622387,0.0124907745,0.0073586875,0.00028988262],"about_ca_topic_score_codex":0.0000017653723,"about_ca_topic_score_gemma":0.000001470355,"teacher_disagreement_score":0.18740775,"about_ca_system_score_codex":0.0000984872,"about_ca_system_score_gemma":0.00016023825,"threshold_uncertainty_score":0.99996597},"labels":[],"label_agreement":null},{"id":"W1984346203","doi":"10.1038/clpt.2011.95","title":"Mycophenolate Mofetil Monitoring: Is There Evidence That It Can Improve Outcomes?","year":2011,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Renal Transplantation Outcomes and Treatments","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Pharmacy; Library science; Family medicine; Internal medicine; Medical education; Computer science","score_opus":0.3805374254270274,"score_gpt":0.48477275951386484,"score_spread":0.10423533408683744,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1984346203","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97682196,0.0015742665,0.00013533246,0.014577359,0.004299076,0.0008145188,0.000041424817,0.00013971126,0.0015963519],"genre_scores_gemma":[0.9257537,0.008846451,0.0009406471,0.060528778,0.00029675924,0.000044297238,0.000005083206,0.000048783586,0.0035354854],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979228,0.00018759494,0.00067606964,0.00049375655,0.0002723854,0.0004474069],"domain_scores_gemma":[0.9981371,0.00070367724,0.00031020876,0.0003945382,0.00013491324,0.0003195363],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003191218,0.0003266601,0.00064238947,0.00006067439,0.00011259213,0.000013803164,0.00027089255,0.00025162514,0.0013659594],"category_scores_gemma":[0.0000141268965,0.00023282922,0.00040547142,0.000114544775,0.00024607257,0.00009681075,0.00004869437,0.00063661503,0.00028212124],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001142892,0.0008066924,0.98659724,0.000081083665,0.002578824,0.00030230268,0.000973451,3.698714e-7,0.0022701982,0.000006663915,0.0003585219,0.0048817606],"study_design_scores_gemma":[0.008426695,0.0015599611,0.9398763,0.00023706983,0.004597276,0.00004499343,0.0001931723,0.00005887424,0.038939487,0.00023128104,0.0054834923,0.0003513782],"about_ca_topic_score_codex":0.000047049227,"about_ca_topic_score_gemma":0.0000026446278,"teacher_disagreement_score":0.051068243,"about_ca_system_score_codex":0.000069141766,"about_ca_system_score_gemma":0.00014283118,"threshold_uncertainty_score":0.99954695},"labels":[],"label_agreement":null},{"id":"W1984939312","doi":"10.1038/clpt.2011.42","title":"Environmental and Genetic Factors Affecting Transport of Imatinib by OATP1A2","year":2011,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":60,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"National Cancer Institute; American Lebanese Syrian Associated Charities","keywords":"Imatinib; Pharmacology; Bioavailability; Rosuvastatin; Organic anion-transporting polypeptide; Transporter; Drug; Chemistry; Medicine; Internal medicine; Biochemistry; Gene","score_opus":0.08487687495840779,"score_gpt":0.3675479273089365,"score_spread":0.2826710523505287,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1984939312","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974951,0.001206776,0.00004744065,0.00013189725,0.000362567,0.00045644867,0.00003336142,0.0000385407,0.00022786665],"genre_scores_gemma":[0.9940376,0.0016892464,0.0009385421,0.0030972753,0.00008502484,0.0000075119005,0.000022320226,0.000035867983,0.00008660558],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985516,0.00012801915,0.00059969194,0.0003230631,0.00013048528,0.00026716216],"domain_scores_gemma":[0.9990739,0.00035147453,0.0001962085,0.00018330339,0.000012382885,0.00018269315],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015561124,0.00020548848,0.00049527775,0.00003527608,0.000046450867,0.0000011798553,0.00009653021,0.00021568169,0.00083678716],"category_scores_gemma":[0.000004440343,0.00017069123,0.00015380766,0.00004194227,0.00055342563,0.000029794444,0.000033025834,0.00035633225,0.000018375707],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039551253,0.0012699335,0.8913983,0.000045209523,0.0010912678,0.00005127503,0.0011319875,2.795747e-7,0.09697889,4.031812e-7,0.00033416992,0.0073027737],"study_design_scores_gemma":[0.0066499426,0.0014604738,0.91921955,0.000016003525,0.0023398048,0.00004598652,0.00020226401,0.00007617699,0.06840345,0.0000147995515,0.0014115395,0.00016001318],"about_ca_topic_score_codex":0.000012457023,"about_ca_topic_score_gemma":8.733072e-7,"teacher_disagreement_score":0.028575432,"about_ca_system_score_codex":0.00008784921,"about_ca_system_score_gemma":0.00007915699,"threshold_uncertainty_score":0.9162233},"labels":[],"label_agreement":null},{"id":"W1985860900","doi":"10.1016/s0009-9236(03)90451-6","title":"Understanding Why Physicians Modify or Ignore Prescribing Guidelines","year":2003,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Clinical practice guidelines implementation","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; St. Joseph’s Healthcare Hamilton","funders":"","keywords":"Clinical pharmacology; Medicine; Pharmacology; Intensive care medicine; Family medicine","score_opus":0.8390255197767043,"score_gpt":0.6068816241768574,"score_spread":0.23214389559984683,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1985860900","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.42237878,0.0017596581,0.24355361,0.3016885,0.017907932,0.0050021084,0.00007712408,0.0010748683,0.006557447],"genre_scores_gemma":[0.44527632,0.002219782,0.012973844,0.53654885,0.0020591542,0.00004342046,0.00004290544,0.00010586922,0.0007298268],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9950285,0.0008563012,0.0024495304,0.0006580087,0.00040344585,0.00060419866],"domain_scores_gemma":[0.9936331,0.0045208298,0.0006044095,0.0004476667,0.0005265037,0.0002674718],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.002569974,0.00033805246,0.00075761444,0.00010547087,0.00022851564,0.000035595494,0.00022500996,0.0003669705,0.0012393506],"category_scores_gemma":[0.0017307517,0.0002756011,0.0003690499,0.0003890915,0.00043207535,0.00021455775,0.000079485595,0.0010660032,0.00010796825],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005923327,0.0038736234,0.054425035,0.00016001058,0.0043165735,0.0003763615,0.00043432688,0.00052372384,0.023002435,0.001162985,0.8766787,0.02912292],"study_design_scores_gemma":[0.020790007,0.0030321814,0.0024046714,0.00017011407,0.008184455,0.00020749988,0.003034262,0.015313867,0.0035158372,0.0048059286,0.9376633,0.00087783125],"about_ca_topic_score_codex":0.000011812421,"about_ca_topic_score_gemma":0.00002801941,"teacher_disagreement_score":0.23486039,"about_ca_system_score_codex":0.00023092229,"about_ca_system_score_gemma":0.0005011214,"threshold_uncertainty_score":0.9999696},"labels":[],"label_agreement":null},{"id":"W1986311009","doi":"10.1016/j.clpt.2004.12.026","title":"Effect of St. John's Wort administration on CYP2C8 mediated rosiglitazone metabolism","year":2005,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Rosiglitazone; Pharmacokinetics; CYP2C8; Pharmacology; Medicine; Internal medicine; Metabolism; Receptor; CYP3A4; Cytochrome P450","score_opus":0.13527301971220893,"score_gpt":0.516411642202892,"score_spread":0.3811386224906831,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1986311009","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9714834,0.00514075,0.000097838136,0.009106953,0.00887088,0.0014199052,0.00037821665,0.00025306345,0.0032489628],"genre_scores_gemma":[0.9238235,0.006908279,0.00027297033,0.0646083,0.0034920021,0.00015475757,0.00013116507,0.000107172265,0.00050186005],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99083394,0.004596909,0.0020389052,0.0009375609,0.00052780705,0.0010648998],"domain_scores_gemma":[0.99178326,0.005761305,0.0008413214,0.0005405472,0.00031717285,0.0007563717],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0050783455,0.0007718794,0.0014750926,0.00030250897,0.00030099886,0.000024638097,0.00096654834,0.0012059312,0.0031657966],"category_scores_gemma":[0.00015750667,0.0006678371,0.00068566017,0.00056190597,0.0011378217,0.00017150806,0.0001904437,0.0026487703,0.0006851286],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.026014488,0.009425512,0.010483329,0.00021528613,0.007381479,0.00017386534,0.00066874025,0.0023163569,0.435251,0.00065203465,0.06698462,0.4404333],"study_design_scores_gemma":[0.009221068,0.0018909888,0.0022331749,0.000011201185,0.0031704106,0.000015082525,0.000011555138,0.003991573,0.36799136,0.0000678247,0.61091304,0.00048270856],"about_ca_topic_score_codex":0.000002578538,"about_ca_topic_score_gemma":0.0000046023024,"teacher_disagreement_score":0.54392844,"about_ca_system_score_codex":0.00008608516,"about_ca_system_score_gemma":0.00030971842,"threshold_uncertainty_score":0.99965215},"labels":[],"label_agreement":null},{"id":"W1987001131","doi":"10.1038/sj.clpt.6100432","title":"Looking at Research Through a Different Lens: The Canadian Institute of Gender and Health","year":2007,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Sex and Gender in Healthcare","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Institute of Gender and Health; Dalhousie University","funders":"Canadian Institutes of Health Research; National Institutes of Health","keywords":"Sociocultural evolution; Psychological intervention; Psychology; Gender disparity; Gerontology; Gender studies; Medicine; Sociology; Psychiatry","score_opus":0.6929637212245021,"score_gpt":0.6100638401577978,"score_spread":0.08289988106670432,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1987001131","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8750381,0.013935546,0.00007185812,0.10502768,0.0023663584,0.0011684691,0.000010201629,0.000028842987,0.0023529644],"genre_scores_gemma":[0.827376,0.0054424386,0.00018603064,0.16624229,0.0005925978,0.000008725121,0.000007838583,0.000018124898,0.00012594575],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.997423,0.00046036864,0.000715033,0.00036113887,0.00031984216,0.00072059635],"domain_scores_gemma":[0.9980371,0.00095866184,0.00011826307,0.000329403,0.00024167978,0.0003148778],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004328984,0.0001404198,0.0004145235,0.000098747565,0.0005577399,0.0000067113538,0.00017320797,0.00026544623,0.00007177019],"category_scores_gemma":[0.000030125555,0.00009238443,0.000093444265,0.00020737719,0.0012763384,0.00003342777,0.00010847648,0.0012010757,0.000010758855],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017819735,0.0009730651,0.844176,0.000874488,0.00220037,0.0002285912,0.014512087,0.000004306522,0.0012764508,0.0024621107,0.041054755,0.090455785],"study_design_scores_gemma":[0.0023540142,0.00092962256,0.42595348,0.000036379348,0.00020647074,0.000076913726,0.0008083763,0.00008831381,0.0009062928,0.00081237697,0.5677153,0.00011248469],"about_ca_topic_score_codex":0.0054990305,"about_ca_topic_score_gemma":0.049147125,"teacher_disagreement_score":0.5266605,"about_ca_system_score_codex":0.00037189893,"about_ca_system_score_gemma":0.00095876056,"threshold_uncertainty_score":0.9682035},"labels":[],"label_agreement":null},{"id":"W1987328209","doi":"10.1016/s0009-9236(03)90557-1","title":"Repeated exposure to amethocaine: reports of adverse local skin reactions","year":2003,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Drug-Induced Adverse Reactions","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Clinical pharmacology; Tetracaine; Pharmacology; Medicine; Adverse effect; Dermatology; Anesthesia; Lidocaine","score_opus":0.08029169533552635,"score_gpt":0.437798565426057,"score_spread":0.3575068700905306,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1987328209","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96483475,0.00017108208,0.004367506,0.0067088013,0.005748906,0.0013901398,0.000013266086,0.00027020788,0.01649535],"genre_scores_gemma":[0.9713279,0.0002639924,0.0043804385,0.02166013,0.00032122247,0.00004491849,0.000014897318,0.000057745263,0.0019287776],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99660987,0.0005955046,0.0015171067,0.00058352033,0.00027296197,0.00042103484],"domain_scores_gemma":[0.9969349,0.0009864161,0.00046500558,0.00069967087,0.0004415766,0.00047243835],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013822522,0.000258135,0.00072767626,0.00020642954,0.00009825706,0.0000025308866,0.000110616864,0.0004200028,0.00021173601],"category_scores_gemma":[0.000389158,0.00024015472,0.00041768656,0.00065076497,0.00046474955,0.000070545386,0.000046523957,0.0009915518,0.000115143564],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016087509,0.017134743,0.06477242,0.00030123882,0.010293315,0.0041405684,0.0014604374,0.0035900988,0.73875666,0.0005550173,0.020135624,0.13725111],"study_design_scores_gemma":[0.004258692,0.0009405886,0.056900546,0.00007426262,0.0032915138,0.0011915736,0.0008010859,0.0001465419,0.056751467,0.00020320014,0.87504256,0.00039796095],"about_ca_topic_score_codex":0.000014279957,"about_ca_topic_score_gemma":0.0000050773147,"teacher_disagreement_score":0.8549069,"about_ca_system_score_codex":0.00017449111,"about_ca_system_score_gemma":0.00048574357,"threshold_uncertainty_score":0.97932255},"labels":[],"label_agreement":null},{"id":"W1987702273","doi":"10.1016/s0009-9236(03)90459-0","title":"Suboptimal Pharmacotherapy for Depression in Pregnancy","year":2003,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Maternal Mental Health During Pregnancy and Postpartum","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Pharmacotherapy; Depression (economics); Pregnancy; Medicine; MEDLINE; Psychiatry; Obstetrics; Biology","score_opus":0.13134345792429117,"score_gpt":0.48406170355967454,"score_spread":0.35271824563538334,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1987702273","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9740395,0.014875964,0.00039932548,0.0031161897,0.003968079,0.0023079475,0.000015102477,0.00010032736,0.0011775607],"genre_scores_gemma":[0.9152898,0.012236983,0.0034554163,0.06694511,0.0004069769,0.00037817968,0.000012680912,0.00006518946,0.0012096154],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99789935,0.0003255859,0.0007374142,0.0003999257,0.00012462799,0.00051309547],"domain_scores_gemma":[0.99881667,0.00055951375,0.00014993995,0.00018755294,0.00006252743,0.00022379952],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005514013,0.00020704763,0.0004586922,0.00007911917,0.000084741776,0.000006547275,0.00012675776,0.00024459563,0.00043090107],"category_scores_gemma":[0.000015180732,0.00017734904,0.00018610895,0.00011484877,0.00013936234,0.000057861776,0.00001844525,0.0005135629,0.000037990227],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014861011,0.0066795256,0.91039264,0.0025586083,0.0007770115,0.00027472037,0.00047322724,0.00003544099,0.027479623,0.00022296642,0.003346897,0.03289834],"study_design_scores_gemma":[0.074137375,0.005405956,0.16531226,0.004421192,0.001654129,0.00026249,0.00006443803,0.0022752124,0.33224595,0.0014656608,0.41166428,0.0010910654],"about_ca_topic_score_codex":0.0000015763272,"about_ca_topic_score_gemma":9.516293e-7,"teacher_disagreement_score":0.74508035,"about_ca_system_score_codex":0.00005663316,"about_ca_system_score_gemma":0.0001382734,"threshold_uncertainty_score":0.72320837},"labels":[],"label_agreement":null},{"id":"W1987867942","doi":"10.1067/mcp.2000.107651","title":"Inhibition of cytochrome P450 2A6 increases nicotine's oral bioavailability and decreases smoking","year":2000,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Smoking Behavior and Cessation","field":"Medicine","cited_by":180,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Addiction and Mental Health; Coalition for Research in Women's Health","funders":"National Institute on Drug Abuse","keywords":"Nicotine; CYP2A6; Pharmacology; Placebo; Bioavailability; Crossover study; Methoxsalen; Nicotine patch; Cmax; Oral administration; Medicine; Chemistry; Internal medicine; Metabolism; Cytochrome P450; CYP1A2; Psoriasis; Dermatology","score_opus":0.09260801774726429,"score_gpt":0.42110883067766636,"score_spread":0.32850081293040206,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1987867942","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99775213,0.0003342495,0.000018564317,0.0010676195,0.0001625001,0.00035850058,0.000016130447,0.00008491811,0.00020535862],"genre_scores_gemma":[0.98811257,0.0010383915,0.0001285969,0.010300602,0.00025938204,0.000016273973,0.000049321847,0.000022144684,0.000072706534],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981947,0.0003299903,0.0006964743,0.0003503293,0.00019780197,0.0002306923],"domain_scores_gemma":[0.99871224,0.00059398334,0.00016261739,0.00021514947,0.00014181063,0.00017420092],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006744538,0.0001761746,0.00048587724,0.000069798385,0.00008050855,0.000009382204,0.000068441936,0.00027786326,0.0023130362],"category_scores_gemma":[0.00004394144,0.00015477251,0.00014937202,0.0001795444,0.0007610316,0.000080765065,0.000035179466,0.0003816394,0.000007606999],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014406382,0.0023026308,0.86271787,0.00006482388,0.00033917231,0.000020945676,0.0000907389,0.0000026243904,0.085232705,0.00000645165,0.00082480797,0.046956617],"study_design_scores_gemma":[0.0044531333,0.0010040806,0.9435131,0.000059801565,0.002326509,0.00005146702,0.000046393874,0.00010069666,0.045171667,0.00013394588,0.002978035,0.00016116883],"about_ca_topic_score_codex":0.00004815482,"about_ca_topic_score_gemma":0.0000026619582,"teacher_disagreement_score":0.08079525,"about_ca_system_score_codex":0.00004502691,"about_ca_system_score_gemma":0.000113476475,"threshold_uncertainty_score":0.998599},"labels":[],"label_agreement":null},{"id":"W1988452792","doi":"10.1038/sj.clpt.6100100","title":"Prenatal Multivitamin Supplementation and Rates of Pediatric Cancers: A Meta-Analysis","year":2007,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Folate and B Vitamins Research","field":"Medicine","cited_by":127,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Western University; SickKids Foundation; Hospital for Sick Children","funders":"","keywords":"Multivitamin; Medicine; Odds ratio; Meta-analysis; Pregnancy; Pediatrics; MEDLINE; Confidence interval; Internal medicine; Obstetrics; Vitamin","score_opus":0.5383269603492036,"score_gpt":0.6126765721517698,"score_spread":0.07434961180256627,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1988452792","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0011287065,0.996614,0.000051674768,0.0002613633,0.0002521919,0.001352165,0.00027322347,0.000019201028,0.00004746614],"genre_scores_gemma":[0.00048725482,0.9952449,0.00044199786,0.0021415914,0.00058133155,0.00010619432,0.00036868494,0.00004627244,0.0005817336],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99610627,0.0007963069,0.0016954853,0.0006152162,0.0003613843,0.00042535304],"domain_scores_gemma":[0.9953136,0.0032293755,0.000664261,0.00032128664,0.00024552344,0.00022598622],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0017652981,0.00041079195,0.0044614845,0.0007372131,0.000052257008,0.000012002115,0.00021902933,0.00060029863,0.0011792729],"category_scores_gemma":[0.00003448825,0.0002802158,0.0025942368,0.0011907076,0.000408301,0.000051967443,0.00013443227,0.001048261,0.00002271516],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000256343,0.000838118,0.0017147007,0.009335129,0.5993151,0.00009352942,0.00006665842,0.0000011655553,0.0000066922544,0.0000015152422,0.0026724457,0.3856986],"study_design_scores_gemma":[0.0011219336,0.00051982055,0.00020421954,0.000036131405,0.6745899,0.000009061605,0.000013097134,0.00007138678,0.00003736679,0.0000016556423,0.32322964,0.0001658346],"about_ca_topic_score_codex":0.000036243877,"about_ca_topic_score_gemma":0.000023421575,"teacher_disagreement_score":0.38553274,"about_ca_system_score_codex":0.0000988392,"about_ca_system_score_gemma":0.0006086328,"threshold_uncertainty_score":0.999965},"labels":[],"label_agreement":null},{"id":"W1988649996","doi":"10.1038/clpt.2010.90","title":"Refilling and Switching of Antiepileptic Drugs and Seizure-Related Events","year":2010,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":75,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Heart, Lung, and Blood Institute; National Institute on Aging","keywords":"Medicine; Medical prescription; Odds ratio; Confidence interval; Epilepsy; Antiepileptic drug; Odds; Pediatrics; Emergency medicine; Anesthesia; Internal medicine; Psychiatry; Pharmacology","score_opus":0.07577093616275075,"score_gpt":0.3784942365549937,"score_spread":0.30272330039224293,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1988649996","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98833776,0.0011317371,0.00006316818,0.0057944236,0.0019631055,0.00018941752,0.000033412045,0.00002798326,0.002459016],"genre_scores_gemma":[0.97581834,0.005051712,0.0005077236,0.018271131,0.00023883677,0.0000056964554,0.0000034398574,0.00003081366,0.00007233133],"study_design_codex":"observational","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9979702,0.000058056226,0.0011930079,0.0004293907,0.000023192602,0.0003261279],"domain_scores_gemma":[0.99853367,0.000547271,0.00048128763,0.00019511148,0.000029700568,0.00021296732],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012925257,0.00018510946,0.00061463617,0.00012438964,0.00010374756,0.000018903836,0.00020836247,0.00031917763,0.00030409553],"category_scores_gemma":[0.00003541031,0.00020181444,0.00012298106,0.000107792664,0.0002819238,0.00011304445,0.00017157347,0.000906406,0.0000623691],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047093577,0.0013883878,0.80336934,0.00021928934,0.003124987,0.000013974516,0.0025306381,0.00004381395,0.03900278,0.09083413,0.0018015092,0.057200216],"study_design_scores_gemma":[0.014846987,0.00085668324,0.2503883,0.000043534084,0.0008647283,0.00007036176,0.00012964208,0.09615108,0.0037840437,0.319761,0.31136936,0.0017343006],"about_ca_topic_score_codex":0.000015332656,"about_ca_topic_score_gemma":0.0000025442805,"teacher_disagreement_score":0.5529811,"about_ca_system_score_codex":0.000012595742,"about_ca_system_score_gemma":0.00002729627,"threshold_uncertainty_score":0.8229754},"labels":[],"label_agreement":null},{"id":"W1989066750","doi":"10.1016/j.clpt.2004.11.109","title":"Child neurodevelopment following treatment for nausea and vomiting of pregnancy with diclectin: A prospective controlled study","year":2005,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pregnancy and Medication Impact","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Vomiting; Nausea; Medicine; Hyperemesis gravidarum; Pregnancy; Prospective cohort study; Pediatrics; Adverse effect; In utero; Percentile; Antiemetic; Obstetrics; Fetus; Anesthesia; Internal medicine","score_opus":0.08374206248901647,"score_gpt":0.4421941945630332,"score_spread":0.3584521320740167,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1989066750","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98637396,0.0021200292,0.00034524078,0.005261961,0.0002783242,0.005243594,0.000004908503,0.000056721703,0.00031528552],"genre_scores_gemma":[0.9912006,0.00065636495,0.0010975928,0.0059456453,0.00024793777,0.0005901724,0.0000031821496,0.000027507009,0.00023095423],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99838513,0.00016003242,0.0006624842,0.0003665281,0.0001521352,0.000273707],"domain_scores_gemma":[0.9984486,0.00083904556,0.00027408847,0.00016062017,0.000109732,0.00016789063],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000412431,0.00020044742,0.00078219495,0.00005952272,0.00013243122,0.000005789109,0.00006894063,0.00009112875,0.000015975185],"category_scores_gemma":[0.00007062379,0.00013255219,0.00014985981,0.00010168254,0.00015473085,0.000052186937,0.000023041319,0.00022416886,0.0000013682537],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.025891019,0.016439008,0.8227486,0.00011189283,0.014427487,0.00006730863,0.005888735,0.000024011128,0.0038034825,0.000019090769,0.00016116921,0.11041822],"study_design_scores_gemma":[0.3316761,0.03759818,0.5960514,0.0008953795,0.013772625,0.00006957703,0.00066943903,0.0019522809,0.011812017,0.000042327225,0.0049977275,0.00046299005],"about_ca_topic_score_codex":0.0000010416613,"about_ca_topic_score_gemma":0.0000048649786,"teacher_disagreement_score":0.30578506,"about_ca_system_score_codex":0.00007606588,"about_ca_system_score_gemma":0.00023825155,"threshold_uncertainty_score":0.5405321},"labels":[],"label_agreement":null},{"id":"W1989512634","doi":"10.1038/sj.clpt.6100033","title":"Cytochrome P4502D6 (CYP2D6) Gene Locus Heterogeneity: Characterization of Gene Duplication Events","year":2007,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":149,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Center for Research Resources; National Heart, Lung, and Blood Institute","keywords":"Gene duplication; Gene; Locus (genetics); Genetics; Biology; CYP2D6; Allele; Polymerase chain reaction; Copy-number variation; Genotype; Genome","score_opus":0.20364432140957647,"score_gpt":0.5107263157474201,"score_spread":0.30708199433784367,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1989512634","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97982544,0.001622519,0.007991991,0.0017525089,0.006736845,0.0012509979,0.00027046815,0.00017245574,0.0003767873],"genre_scores_gemma":[0.94841635,0.0066902456,0.00088075397,0.0409203,0.0023332601,0.00007732267,0.00028495395,0.00011300799,0.00028381354],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9939475,0.0012952329,0.0022877692,0.0009243737,0.00043197465,0.0011131648],"domain_scores_gemma":[0.9960444,0.0009766412,0.0011440943,0.0005746651,0.000570129,0.00069007033],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.003972315,0.0005988547,0.0010110918,0.0003216594,0.0003174034,0.000015018882,0.00094854576,0.0011333455,0.00079580856],"category_scores_gemma":[0.000037146016,0.00060904084,0.00051073346,0.0006419306,0.00077192974,0.00017202494,0.00023723242,0.0014963874,0.0002752748],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014172572,0.00194122,0.015733173,0.0000434092,0.0014913367,0.000039443647,0.00023491212,0.00010229878,0.93820107,0.000039809212,0.00028229685,0.040473767],"study_design_scores_gemma":[0.0049788523,0.00034435547,0.0684465,0.000008049766,0.0017305971,0.000043346765,0.000012476851,0.0013406313,0.8395912,0.00028526777,0.08268771,0.0005310117],"about_ca_topic_score_codex":0.0000039631727,"about_ca_topic_score_gemma":0.0000035327548,"teacher_disagreement_score":0.09860988,"about_ca_system_score_codex":0.00011146778,"about_ca_system_score_gemma":0.00020636956,"threshold_uncertainty_score":0.9996361},"labels":[],"label_agreement":null},{"id":"W1989597392","doi":"10.1038/clpt.2011.112","title":"Chemotherapy and Cognitive Impairment: Treatment Options","year":2011,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Cancer-related cognitive impairment studies","field":"Medicine","cited_by":98,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Baycrest Hospital","funders":"","keywords":"Etiology; Chemotherapy; Cognition; Medicine; Intensive care medicine; Psychological intervention; Cognitive impairment; MEDLINE; Psychiatry; Surgery","score_opus":0.23600879077622297,"score_gpt":0.510962765064955,"score_spread":0.27495397428873203,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1989597392","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0003090562,0.9905339,0.000017751268,0.0015183095,0.001989312,0.0045104427,0.00020029921,0.00016950381,0.00075141486],"genre_scores_gemma":[0.000037362362,0.9770015,0.00009765416,0.018615259,0.0013669045,0.0007027841,0.00014596019,0.00014629934,0.0018862778],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99646544,0.00060192303,0.0012773111,0.00091034855,0.00014521745,0.0005997519],"domain_scores_gemma":[0.9972038,0.0013509415,0.00057651097,0.00027586962,0.00022685663,0.00036600797],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00036689214,0.0008593225,0.00316058,0.00022474678,0.00022177592,0.00001571466,0.00014060496,0.0008448203,0.0008811206],"category_scores_gemma":[0.00001562928,0.0006320745,0.0011211596,0.00028251993,0.0012832683,0.000045891225,0.00012070536,0.0011063612,0.0002977274],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007236059,0.0025583252,0.00021925344,0.0011891501,0.019963684,0.00005217832,0.00029189466,7.1606294e-9,6.921591e-7,0.00000458817,0.0046070763,0.97038954],"study_design_scores_gemma":[0.008133637,0.0051317224,0.0005077244,0.0027415669,0.054040022,0.00019789957,0.00004834259,0.0000053306567,0.000004468772,0.000025934252,0.9286968,0.00046653202],"about_ca_topic_score_codex":0.000004694291,"about_ca_topic_score_gemma":0.000001950245,"teacher_disagreement_score":0.969923,"about_ca_system_score_codex":0.00031115793,"about_ca_system_score_gemma":0.00061724865,"threshold_uncertainty_score":0.99961305},"labels":[],"label_agreement":null},{"id":"W1989806059","doi":"10.1016/s0009-9236(03)90448-6","title":"The effect of Hemodialysis on the Export of Homocysteine by Erythrocytes","year":2003,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Erythrocyte Function and Pathophysiology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Pharmacology; Hemodialysis; Homocysteine; Medicine; Chemistry; Internal medicine","score_opus":0.04634742188722327,"score_gpt":0.3779020907042069,"score_spread":0.3315546688169836,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1989806059","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9877982,0.0019337005,0.000058726877,0.006590042,0.00157547,0.0005769679,0.000009980117,0.000027305017,0.0014295799],"genre_scores_gemma":[0.97621447,0.0026694362,0.000032479446,0.020080622,0.00022644826,0.00004123036,0.0000087306635,0.00002323366,0.0007033499],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9970383,0.001452834,0.0008015234,0.00025506783,0.00019612159,0.00025617224],"domain_scores_gemma":[0.991145,0.0077988524,0.00038276106,0.0004509318,0.00013687162,0.00008554867],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016519575,0.00019709484,0.00071536005,0.000036890968,0.00014131669,0.0000029377088,0.00020085172,0.00022894409,0.00037556046],"category_scores_gemma":[0.00021350234,0.00009513501,0.00042622685,0.00022722015,0.001156998,0.000013725497,0.000030859075,0.0005548169,0.0000385934],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015209515,0.0023328275,0.06013679,0.00020054095,0.0071825185,0.000029164074,0.00024839156,0.000038332455,0.6898164,0.00072531117,0.20444444,0.019635726],"study_design_scores_gemma":[0.008109194,0.013537523,0.004549331,0.00003354512,0.003156226,0.000030205569,0.00011313728,0.00020052517,0.69306976,0.00017875187,0.27683163,0.00019019506],"about_ca_topic_score_codex":0.000001325853,"about_ca_topic_score_gemma":5.0786593e-7,"teacher_disagreement_score":0.07238718,"about_ca_system_score_codex":0.000020336214,"about_ca_system_score_gemma":0.00008681157,"threshold_uncertainty_score":0.42630073},"labels":[],"label_agreement":null},{"id":"W1990359955","doi":"10.1038/clpt.2013.45","title":"ITC Recommendations for Transporter Kinetic Parameter Estimation and Translational Modeling of Transport-Mediated PK and DDIs in Humans","year":2013,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":194,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Institute of General Medical Sciences","keywords":"Transporter; Pharmacology; Computational biology; Pharmacokinetics; Clinical pharmacology; In vivo; Drug; Computer science; Chemistry; Medicine; Biology; Biochemistry","score_opus":0.23383863383423395,"score_gpt":0.4729230737368746,"score_spread":0.23908443990264064,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1990359955","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.007771313,0.9554494,0.028243007,0.0031871654,0.0006574416,0.004189931,0.00042871627,0.000048452453,0.000024584711],"genre_scores_gemma":[0.0070753563,0.97913796,0.01027263,0.0015997146,0.000118584554,0.0003203945,0.0013485162,0.000068698755,0.000058118854],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99706966,0.00013656591,0.0018659328,0.0005045899,0.00013618346,0.0002870955],"domain_scores_gemma":[0.9983031,0.0009732361,0.0003172179,0.00015476138,0.000103644335,0.00014802869],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005225646,0.00037727485,0.0018553874,0.0002273412,0.000053792683,0.0000057103666,0.00010344518,0.0006604992,0.00015524194],"category_scores_gemma":[0.0000064593355,0.00030429283,0.00042899078,0.0001612435,0.00027877744,0.000067753885,0.000004276349,0.0006439373,0.0000020380953],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00078276236,0.0017630286,0.0014456228,0.022906229,0.0027251688,0.000024286868,0.0009691528,0.00016369492,0.00012352428,0.0001342444,0.00025879138,0.9687035],"study_design_scores_gemma":[0.017802376,0.0014640052,0.0018310628,0.009534524,0.045571867,0.000033529395,0.000097368466,0.12695093,0.000021897176,0.0025589895,0.7926863,0.0014471501],"about_ca_topic_score_codex":0.0000043054897,"about_ca_topic_score_gemma":0.000016532142,"teacher_disagreement_score":0.96725637,"about_ca_system_score_codex":0.000016878093,"about_ca_system_score_gemma":0.00018119023,"threshold_uncertainty_score":0.99994093},"labels":[],"label_agreement":null},{"id":"W1990473701","doi":"10.1038/sj.clpt.6100345","title":"Pharmacokinetics, Pharmacodynamics, and Safety of a Prostaglandin D2 Receptor Antagonist","year":2007,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Merck Canada Inc. (Canada)","funders":"","keywords":"Pharmacokinetics; Pharmacology; Pharmacodynamics; Antagonist; Tolerability; Medicine; Crossover study; Clinical pharmacology; Receptor antagonist; Chemistry; Placebo; Receptor; Adverse effect; Internal medicine","score_opus":0.039673737585190556,"score_gpt":0.3898679952633786,"score_spread":0.35019425767818807,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1990473701","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98331344,0.008444453,0.0019718718,0.0026680394,0.0017812042,0.0010122344,0.000091562586,0.00011458136,0.00060259027],"genre_scores_gemma":[0.93769574,0.03494314,0.0009379631,0.024874961,0.0010847575,0.000010026225,0.00007571682,0.000062717016,0.00031499352],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9974221,0.00026063458,0.0010600768,0.00047714188,0.00028995032,0.00049012515],"domain_scores_gemma":[0.9983289,0.0005175944,0.00026800676,0.00026847835,0.00021872867,0.0003982779],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0016894306,0.0002983937,0.00083610276,0.00011455462,0.00012273609,0.000009587405,0.00017178062,0.00027487485,0.0004530783],"category_scores_gemma":[0.000018350758,0.00026061802,0.00048638333,0.0002285903,0.0011392582,0.000058276502,0.00008778219,0.00063106796,0.000023810957],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04800016,0.0045924075,0.30063224,0.0005682348,0.015334414,0.00047713186,0.0005620522,0.000015843723,0.37426078,0.00013308357,0.011825387,0.24359827],"study_design_scores_gemma":[0.042094577,0.002257276,0.09498211,0.000121988814,0.009440554,0.00028773077,0.00033851183,0.0011883484,0.11672976,0.000094441944,0.7316693,0.00079538126],"about_ca_topic_score_codex":0.0000032292176,"about_ca_topic_score_gemma":0.0000010477421,"teacher_disagreement_score":0.7198439,"about_ca_system_score_codex":0.00004660246,"about_ca_system_score_gemma":0.00014653405,"threshold_uncertainty_score":0.9999846},"labels":[],"label_agreement":null},{"id":"W1990927912","doi":"10.1038/clpt.2008.11","title":"Drug Addiction: A Critical Problem Calling for Novel Solutions","year":2008,"lang":"en","type":"editorial","venue":"Clinical Pharmacology & Therapeutics","topic":"Neurotransmitter Receptor Influence on Behavior","field":"Neuroscience","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"University of Toronto","keywords":"Citation; Clinical pharmacology; Addiction; Computer science; Library science; Medicine; World Wide Web; Pharmacology; Psychiatry","score_opus":0.19523616979030597,"score_gpt":0.4622269179221973,"score_spread":0.2669907481318913,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1990927912","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0009749165,0.0004754459,0.004230551,0.008369721,0.9808602,0.0023799902,0.0019974199,0.0005859817,0.00012578958],"genre_scores_gemma":[0.0009949154,0.0066029294,0.0042781443,0.050549097,0.9338191,0.0018471581,0.00012905216,0.0004006128,0.0013789689],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9928461,0.0008283075,0.001956233,0.001974627,0.0009390535,0.0014556817],"domain_scores_gemma":[0.9780252,0.019762179,0.0005057403,0.0006079015,0.0006192485,0.00047975522],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0009295324,0.0007994123,0.0011733136,0.00019893523,0.0009885932,0.00009983598,0.001535235,0.0018729774,0.00032476246],"category_scores_gemma":[0.00085611956,0.0008133097,0.000964368,0.0003688845,0.0026958191,0.0002492631,0.000224655,0.004684775,0.00028171172],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042478097,0.0017332782,0.00001256974,0.00007406113,0.00012369535,0.000051411906,0.00009071019,0.000023195693,0.057411708,0.000033851717,0.9386811,0.0013396088],"study_design_scores_gemma":[0.0032545656,0.0005650041,0.000010252046,0.00007164468,0.0017838064,0.000032549757,0.000003870502,0.00045086976,0.008731726,0.00012559378,0.984225,0.00074511964],"about_ca_topic_score_codex":0.000006305296,"about_ca_topic_score_gemma":0.0000038483026,"teacher_disagreement_score":0.04867998,"about_ca_system_score_codex":0.00020436262,"about_ca_system_score_gemma":0.0011656221,"threshold_uncertainty_score":0.9994318},"labels":[],"label_agreement":null},{"id":"W1992259971","doi":"10.1038/sj.clpt.6100434","title":"Combination of Phenotype Assessments and CYP2C9-VKORC1 Polymorphisms in the Determination of Warfarin Dose Requirements in Heavily Medicated Patients","year":2007,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":53,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cégep Saint-Jean-sur-Richelieu; Institut universitaire de cardiologie et de pneumologie de Québec; Montreal Heart Institute; Bausch Health (Canada); Centre Integre de Sante et de Services Sociaux de Laval; Université de Montréal","funders":"Canadian Institutes of Health Research","keywords":"VKORC1; Warfarin; Vitamin K epoxide reductase; CYP2C9; Medicine; Internal medicine; Pharmacology; Genotype; Losartan; Biology; Genetics; Gene; Atrial fibrillation; Cytochrome P450; Renin–angiotensin system","score_opus":0.24618215903103102,"score_gpt":0.5471762856085234,"score_spread":0.30099412657749236,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1992259971","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9938775,0.00095262897,0.00020029364,0.0011379155,0.002129898,0.0009595372,0.000030925825,0.00001574852,0.00069556554],"genre_scores_gemma":[0.9841516,0.002035253,0.00028986819,0.013287379,0.000116435695,0.000029804733,0.00004190001,0.000025335998,0.00002244312],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99515206,0.0017466078,0.001780871,0.000403944,0.00039280587,0.0005236889],"domain_scores_gemma":[0.99674463,0.0019117284,0.0007331959,0.00021849464,0.00023787918,0.0001540589],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0059119253,0.00027646005,0.00059676816,0.0003498511,0.00008333494,0.0000065749427,0.0005628023,0.0005120131,0.00014723028],"category_scores_gemma":[0.000068727386,0.00023483689,0.00010777975,0.0005993094,0.0007751295,0.00012079285,0.00015261678,0.0010880262,0.0000059503855],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026462341,0.008395287,0.69863564,0.00007278642,0.00032324466,0.000038181093,0.0018319496,0.000027579703,0.09506414,0.00023472717,0.00032843137,0.1924018],"study_design_scores_gemma":[0.017990762,0.0008849435,0.93327534,0.000029211993,0.00072935526,0.0000034209008,0.00014774439,0.004679838,0.03370674,0.0014273783,0.006821848,0.00030338793],"about_ca_topic_score_codex":0.000029400058,"about_ca_topic_score_gemma":0.000027314405,"teacher_disagreement_score":0.23463973,"about_ca_system_score_codex":0.000066168715,"about_ca_system_score_gemma":0.00011907978,"threshold_uncertainty_score":0.957637},"labels":[],"label_agreement":null},{"id":"W1992499756","doi":"10.1016/s0009-9236(03)90365-1","title":"Amiodarone for in‐hospital cardiac resuscitation: A cohort study with long‐term follow up and neurological outcomes","year":2003,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Cardiac Arrest and Resuscitation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lawson Health Research Institute; Dalhousie University; Western University","funders":"","keywords":"Medicine; Amiodarone; Resuscitation; Cohort; Cohort study; Term (time); Emergency medicine; Internal medicine; Intensive care medicine; Cardiology; Pediatrics; Atrial fibrillation","score_opus":0.052545102555996585,"score_gpt":0.4073779371636639,"score_spread":0.3548328346076673,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1992499756","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.985604,0.00029068557,0.00013791067,0.0047977422,0.0058292216,0.0031726866,0.000008027756,0.000052048705,0.00010768492],"genre_scores_gemma":[0.9913239,0.00028773033,0.00036516713,0.007229239,0.00033000697,0.00028209,0.00001869417,0.000031490516,0.0001317177],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978011,0.00052155275,0.000577507,0.0005379769,0.00022106178,0.0003408057],"domain_scores_gemma":[0.9979108,0.0014000525,0.00013836942,0.00021411873,0.000164407,0.00017227797],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010975414,0.00023092302,0.000796059,0.00008058212,0.00010516696,0.000018102131,0.00007497951,0.0002149753,0.000016121756],"category_scores_gemma":[0.00010219905,0.00016289692,0.00022028494,0.00017943628,0.00039890388,0.00006057534,0.000029077,0.00046485028,0.0000057146403],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023255222,0.0014159046,0.99263895,0.000022196684,0.0013074268,0.00008057345,0.00032790762,0.0000038956023,0.00009048435,0.000017658827,0.00067809585,0.0010913991],"study_design_scores_gemma":[0.0128834015,0.0044180495,0.97760963,0.000008282362,0.0021771365,0.0000030319836,0.00016739087,0.00003893251,0.000020530892,0.000066313914,0.0024234385,0.00018385283],"about_ca_topic_score_codex":0.0000016064372,"about_ca_topic_score_gemma":0.0000108932945,"teacher_disagreement_score":0.015029296,"about_ca_system_score_codex":0.000031123207,"about_ca_system_score_gemma":0.00011448664,"threshold_uncertainty_score":0.6642744},"labels":[],"label_agreement":null},{"id":"W1992517458","doi":"10.1038/clpt.2010.175","title":"Breaking Barriers in the Genomics and Pharmacogenetics of Drug Addiction","year":2010,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Neurotransmitter Receptor Influence on Behavior","field":"Neuroscience","cited_by":91,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"National Institute on Drug Abuse; National Center for Research Resources; National Institute of Mental Health; National Institute on Alcohol Abuse and Alcoholism; Economic and Social Research Council; Canadian Institutes of Health Research; National Institutes of Health","keywords":"Addiction; Pharmacogenetics; Missing heritability problem; Genetic architecture; Precision medicine; Pharmacogenomics; Personalized medicine; Genomics; Clinical pharmacology; Genome-wide association study; Biobank; Medicine; Computational biology; Biology; Bioinformatics; Psychiatry; Pharmacology; Genome; Genetics; Genetic variants; Gene; Single-nucleotide polymorphism; Phenotype","score_opus":0.1614504724314493,"score_gpt":0.4681222746317638,"score_spread":0.30667180220031454,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1992517458","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.060087427,0.93227714,0.0000083537725,0.0005835861,0.0045124935,0.0022447393,0.00016123358,0.00005823077,0.000066789195],"genre_scores_gemma":[0.0014966858,0.97815526,0.00007411487,0.019609759,0.0004114667,0.0001390957,0.000004849645,0.00008966767,0.000019128582],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99401474,0.0026438355,0.001716533,0.0008348132,0.00030171144,0.00048835785],"domain_scores_gemma":[0.9951158,0.0033500078,0.00084354274,0.00046712317,0.000044318298,0.00017916772],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0012975552,0.00052229635,0.0014017991,0.0002118433,0.00014166192,0.00004128132,0.001367207,0.0006017617,0.00016675859],"category_scores_gemma":[0.000058323585,0.0003864374,0.0004883604,0.00047380358,0.0015547826,0.00008275833,0.00015818169,0.003253597,0.00003069878],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000047377787,0.00027291238,0.00028146355,0.0005950389,0.000078963676,0.000055144046,0.0003667138,0.00000180903,0.011424957,0.0000076172746,0.0004276376,0.98644036],"study_design_scores_gemma":[0.000788006,0.00010174665,0.000077898716,0.00026065196,0.0030903763,0.000112315814,0.000012772078,0.000032847078,0.002774648,0.00001956435,0.99239814,0.00033103797],"about_ca_topic_score_codex":0.0000028963912,"about_ca_topic_score_gemma":0.0000025671716,"teacher_disagreement_score":0.9919705,"about_ca_system_score_codex":0.000046476678,"about_ca_system_score_gemma":0.00035883192,"threshold_uncertainty_score":0.99985874},"labels":[],"label_agreement":null},{"id":"W1993226580","doi":"10.1038/sj.clpt.6100274","title":"Professional Students' Perceptions of the Value, Role, and Impact of Science in Clinical Education","year":2007,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Innovations in Medical Education","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Clinical pharmacology; Perception; Value (mathematics); Medical education; Medicine; Psychology; Pharmacology; Mathematics education; Mathematics; Neuroscience","score_opus":0.05687965832188259,"score_gpt":0.5829835005610173,"score_spread":0.5261038422391348,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1993226580","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99232405,0.000114118906,0.000053361004,0.003284759,0.0034641474,0.0005448112,0.0000018423684,0.0000074485015,0.0002054484],"genre_scores_gemma":[0.98561114,0.00019639182,0.0010736431,0.012585304,0.00037180528,0.000009892991,0.0000034905286,0.0000089445175,0.0001394081],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99755484,0.00026076788,0.0012968668,0.00024279699,0.00042886994,0.00021583748],"domain_scores_gemma":[0.998084,0.0006347803,0.00037924375,0.00027025782,0.0005352827,0.00009643292],"candidate_categories":["sts"],"consensus_categories":[],"category_scores_codex":[0.0060894336,0.00009636745,0.0003183013,0.00020891312,0.00009504051,0.0000032738942,0.00033610335,0.00021010348,0.000120713055],"category_scores_gemma":[0.00051530264,0.00006291957,0.00014216268,0.0009667778,0.0038096749,0.000060752773,0.00013676805,0.00083092024,0.000002923685],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022670405,0.0038731582,0.9407747,0.000016922806,0.00007523919,2.7364183e-7,0.0004168618,0.0000023891523,0.0090881735,0.00008338072,0.0010486483,0.044393558],"study_design_scores_gemma":[0.0013847953,0.00041219912,0.99570346,0.000063191874,0.0002316223,0.000007923676,0.00079203723,0.00027750927,0.00035623205,0.00028563183,0.0004344846,0.000050930998],"about_ca_topic_score_codex":0.000010850534,"about_ca_topic_score_gemma":0.0000018857764,"teacher_disagreement_score":0.054928754,"about_ca_system_score_codex":0.00012469954,"about_ca_system_score_gemma":0.0021467805,"threshold_uncertainty_score":0.99890137},"labels":[],"label_agreement":null},{"id":"W1994118391","doi":"10.1016/s0009-9236(03)90699-0","title":"Effects of amitriptyline, gabapentin, and carbamazepine on morphine‐induced respiratory depression in rabbits","year":2003,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Neuropeptides and Animal Physiology","field":"Neuroscience","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Amitriptyline; Gabapentin; Carbamazepine; Morphine; Depression (economics); Medicine; Pharmacology; Anesthesia; Respiratory system; Clinical pharmacology; Anticonvulsant; Drug; Epilepsy; Internal medicine; Psychiatry","score_opus":0.10543303560678406,"score_gpt":0.3957801989706196,"score_spread":0.29034716336383554,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1994118391","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99765575,0.0003456051,0.0000031215845,0.00017628324,0.00096288166,0.00041957857,0.000002624486,0.000032190375,0.00040196365],"genre_scores_gemma":[0.9509008,0.0007999428,0.000020600599,0.04803404,0.00015496039,0.00001651367,3.3063952e-7,0.000030107203,0.000042683645],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9969582,0.0013049835,0.0006460799,0.00060735404,0.00013533347,0.0003480746],"domain_scores_gemma":[0.99678785,0.0026196563,0.0002447155,0.0001908161,0.00003788563,0.0001190885],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035428043,0.00021999668,0.00048457997,0.00010744607,0.00006358166,0.0000068712534,0.00023306346,0.00019074137,0.00003239285],"category_scores_gemma":[0.0003183306,0.00018316665,0.00010726956,0.00024923886,0.00034422596,0.000055542252,0.00009445612,0.0006821086,0.000021048525],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044961166,0.0007027989,0.005183845,0.000033905635,0.0000183723,0.000085476284,0.000018087141,0.0000209005,0.9912623,0.0001225482,0.00033048837,0.0017716653],"study_design_scores_gemma":[0.0036676223,0.0013068988,0.034117524,0.00003074311,0.00007952981,0.0000050464414,0.0000043090154,0.0001483512,0.9537425,0.00023047865,0.0064948793,0.00017212948],"about_ca_topic_score_codex":0.0000015817247,"about_ca_topic_score_gemma":7.7271585e-7,"teacher_disagreement_score":0.047857758,"about_ca_system_score_codex":0.000012769522,"about_ca_system_score_gemma":0.000046543544,"threshold_uncertainty_score":0.7469319},"labels":[],"label_agreement":null},{"id":"W1996874607","doi":"10.1016/s0009-9236(03)90534-0","title":"Duration of Grapefruit Juice Effect on Fexofenadine Interaction","year":2003,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Grapefruit juice; Fexofenadine; Terfenadine; Duration (music); Pharmacology; Food science; Medicine; Chemistry; Pharmacokinetics; Physics","score_opus":0.18959654549128294,"score_gpt":0.522796970606952,"score_spread":0.33320042511566905,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1996874607","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9733791,0.00084994803,0.00011032789,0.011476059,0.0033628761,0.0006727876,0.0000046657246,0.00006230983,0.010081953],"genre_scores_gemma":[0.9467576,0.0021643233,0.00014206127,0.050257795,0.00038683254,0.000023078725,0.0000069057833,0.000022088325,0.00023931482],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9976794,0.0008276626,0.00071465253,0.00030702905,0.00019869872,0.00027255496],"domain_scores_gemma":[0.9958864,0.0033081595,0.00031824925,0.00018044125,0.00013817317,0.00016861343],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011833436,0.00019733944,0.0005295066,0.00006706996,0.00010321665,0.000007295142,0.00009049094,0.00019457388,0.0006484378],"category_scores_gemma":[0.00021912418,0.00014892487,0.0002364965,0.0002135104,0.0002565796,0.00008288774,0.000025172847,0.0008091238,0.00013780055],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.044053134,0.009765515,0.18567756,0.0007717534,0.013649672,0.00027198106,0.000650386,0.00006624575,0.48458016,0.0014824829,0.04816869,0.21086243],"study_design_scores_gemma":[0.007728591,0.008203863,0.0136424275,0.00004940421,0.003604841,0.000058945614,0.0000506475,0.00048890326,0.1560409,0.00015824992,0.80974436,0.0002288895],"about_ca_topic_score_codex":0.0000027923306,"about_ca_topic_score_gemma":0.0000015014591,"teacher_disagreement_score":0.76157564,"about_ca_system_score_codex":0.000051447456,"about_ca_system_score_gemma":0.00004717373,"threshold_uncertainty_score":0.7099939},"labels":[],"label_agreement":null},{"id":"W1997060267","doi":"10.1016/s0009-9236(03)90578-9","title":"Interleukin (IL)‐6 downregulates expression of the pregnane X receptor (PXR) in mice","year":2003,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Hormonal Regulation and Hypertension","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Pregnane X receptor; Pregnane; Receptor; Pharmacology; Chemistry; Internal medicine; Endocrinology; Biology; Medicine; Nuclear receptor; Stereochemistry; Biochemistry; Gene; Transcription factor","score_opus":0.08460571790958556,"score_gpt":0.4001334436873575,"score_spread":0.31552772577777194,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1997060267","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98973334,0.0011048662,0.00001969634,0.007086653,0.0010055074,0.00044449384,0.0000032758958,0.000023180228,0.00057899376],"genre_scores_gemma":[0.9816906,0.0008132876,0.00053686625,0.015998004,0.00011646815,0.000010411103,0.0000038575486,0.000020037229,0.0008104757],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980729,0.000525477,0.0007561768,0.00025027563,0.0001835379,0.00021161824],"domain_scores_gemma":[0.9988206,0.0005134393,0.00020748208,0.00022810491,0.00013253413,0.00009780749],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006195275,0.00014257646,0.00042013216,0.00006192856,0.000044199343,0.000003370191,0.0001579242,0.00025869356,0.00048603548],"category_scores_gemma":[0.00009048028,0.00008878627,0.00019588017,0.00021347312,0.00037090114,0.000034724682,0.00005437172,0.0004857835,0.00003100611],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007477412,0.00088840484,0.029402094,0.000024447138,0.00010869823,0.000009006046,0.0001873361,0.000015655487,0.95857996,0.00006724909,0.0044065313,0.0055628875],"study_design_scores_gemma":[0.00667757,0.00062543293,0.1260992,0.0002833892,0.00047643358,0.000055060686,0.00013888461,0.00048169433,0.6161011,0.00030429687,0.24856597,0.00019096232],"about_ca_topic_score_codex":0.000001794896,"about_ca_topic_score_gemma":0.0000027625756,"teacher_disagreement_score":0.34247884,"about_ca_system_score_codex":0.00004528728,"about_ca_system_score_gemma":0.00013768733,"threshold_uncertainty_score":0.53217477},"labels":[],"label_agreement":null},{"id":"W1997519635","doi":"10.1038/sj.clpt.6100096","title":"Molecular Imaging as a Tool for Personalized and Targeted Anticancer Therapy","year":2007,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto","funders":"","keywords":"Library science; Citation; Psychology; Sociology; Computer science","score_opus":0.32858627950061575,"score_gpt":0.6135134024562962,"score_spread":0.2849271229556804,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1997519635","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00044709994,0.98830146,0.0004695393,0.0039666547,0.0015308482,0.00488975,0.00006972408,0.000115036324,0.00020989995],"genre_scores_gemma":[0.000029467485,0.91737396,0.001040402,0.078649156,0.0014951167,0.0005525332,0.00008292021,0.00022842549,0.000547998],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9950816,0.0008058282,0.0015206812,0.0010935792,0.00049316284,0.0010051407],"domain_scores_gemma":[0.99503505,0.00320054,0.00041433232,0.00051313406,0.00040420046,0.00043271208],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0025347394,0.0006842519,0.003014565,0.00026624056,0.00014040933,0.0000429246,0.0004318215,0.0008432132,0.00077604846],"category_scores_gemma":[0.00012968743,0.00054016593,0.0012202159,0.0004015225,0.0014335418,0.00004036486,0.00014056482,0.0020455208,0.00007264081],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011376232,0.00042836272,0.00020319363,0.0039572082,0.003330116,0.00028583256,0.00004975732,6.94434e-8,0.00022707769,0.000047355643,0.007950394,0.982383],"study_design_scores_gemma":[0.006152824,0.00086506864,0.000022411861,0.0013061312,0.00530887,0.00016301457,0.000011842701,0.00009929731,0.00010257207,0.00009128029,0.9853918,0.00048489106],"about_ca_topic_score_codex":0.000004406111,"about_ca_topic_score_gemma":2.794585e-7,"teacher_disagreement_score":0.9818981,"about_ca_system_score_codex":0.00025183437,"about_ca_system_score_gemma":0.0019805888,"threshold_uncertainty_score":0.999705},"labels":[],"label_agreement":null},{"id":"W1997897011","doi":"10.1038/clpt.2014.89","title":"Inflammation-Related Genetic Variations and Survival in Patients With Advanced Non–Small Cell Lung Cancer Receiving First-Line Chemotherapy","year":2014,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"vaccines and immunoinformatics approaches","field":"Biochemistry, Genetics and Molecular Biology","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"National Cancer Institute; University of Texas MD Anderson Cancer Center; National Institutes of Health; Harvard University","keywords":"Internal medicine; Oncology; Single-nucleotide polymorphism; Medicine; Hazard ratio; Lung cancer; Confidence interval; SNP; Gene; Biology; Genotype; Genetics","score_opus":0.015025441563181145,"score_gpt":0.3016473445819246,"score_spread":0.28662190301874346,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1997897011","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944691,0.00042363934,0.0031982046,0.0008227229,0.0003992461,0.0005231449,0.0000067380556,0.000012862888,0.00014435132],"genre_scores_gemma":[0.9925154,0.0026693656,0.0017920732,0.0025807186,0.00018928615,0.00005792436,0.000064791086,0.0000366928,0.000093735085],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986507,0.00012316933,0.00059009244,0.0002942977,0.00007770724,0.00026400777],"domain_scores_gemma":[0.9992203,0.00011642288,0.00025233073,0.0002160832,0.0001226108,0.00007221243],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031929908,0.00020441774,0.00027560644,0.00004412838,0.00009809938,0.000018978131,0.00017959003,0.00023818976,0.00003895196],"category_scores_gemma":[0.000013594889,0.00017505337,0.000054977663,0.00011895947,0.00008194055,0.000010478574,0.00007452875,0.0002485349,0.0000021755807],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006874231,0.0005261713,0.94418347,0.00009150832,0.0005510163,4.2923733e-7,0.00040737152,0.0059114117,0.010373125,0.0000059642775,0.00023601708,0.037026092],"study_design_scores_gemma":[0.012667612,0.0009619651,0.9150989,0.000029299554,0.00028838293,7.0137e-7,0.000024370871,0.060750492,0.0033793084,0.000031001848,0.006374704,0.00039325966],"about_ca_topic_score_codex":0.000006142147,"about_ca_topic_score_gemma":0.000041068448,"teacher_disagreement_score":0.05483908,"about_ca_system_score_codex":0.000018117755,"about_ca_system_score_gemma":0.00006809758,"threshold_uncertainty_score":0.7138469},"labels":[],"label_agreement":null},{"id":"W1998309751","doi":"10.1038/clpt.2008.58","title":"Optical Molecular Imaging: From Single Cell to Patient","year":2008,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Spectroscopy Techniques in Biomedical and Chemical Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Ontario Institute for Cancer Research","funders":"National Cancer Institute","keywords":"Molecular imaging; Drug discovery; Nanotechnology; Clinical pharmacology; Optical imaging; Computer science; Computational biology; Drug delivery; Drug development; Medical physics; Drug; Data science; Medicine; Bioinformatics; Pharmacology; Biology; Biotechnology; Materials science; Physics; In vivo","score_opus":0.048950665375147556,"score_gpt":0.4047380817440643,"score_spread":0.35578741636891675,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1998309751","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9792054,0.0010396331,0.009164523,0.0063114725,0.0006314876,0.00030837834,0.000023731598,0.0000663328,0.0032490182],"genre_scores_gemma":[0.8787478,0.0007603733,0.010933428,0.10848078,0.0006695204,0.00005231435,0.00007135252,0.000045446126,0.0002389709],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.997857,0.00016401587,0.0004975374,0.00065007963,0.0002950404,0.0005363592],"domain_scores_gemma":[0.9987607,0.00015691917,0.00006791901,0.00039961716,0.00012935218,0.00048552174],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017396238,0.00022446694,0.0002738122,0.000038614602,0.00008827699,0.000011203442,0.0005333997,0.00032621968,0.00025837938],"category_scores_gemma":[0.000056598175,0.00020155164,0.00020918674,0.00014250088,0.000762064,0.0000027604926,0.00045360386,0.00048145803,0.00011469879],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031651277,0.000925654,0.0017006228,0.000002499138,0.000094236755,0.00008488424,0.000018107308,0.0000016122043,0.91170204,0.0000028202342,0.081378035,0.0037729882],"study_design_scores_gemma":[0.0005133869,0.0008202051,0.00022397804,0.000002742265,0.00004839129,0.0000084818785,0.000007209807,0.000044615375,0.6836875,0.00012249056,0.31434828,0.00017272412],"about_ca_topic_score_codex":0.0000037932205,"about_ca_topic_score_gemma":3.2404594e-7,"teacher_disagreement_score":0.23297024,"about_ca_system_score_codex":0.000037373946,"about_ca_system_score_gemma":0.00011120456,"threshold_uncertainty_score":0.82190377},"labels":[],"label_agreement":null},{"id":"W1999064448","doi":"10.1016/s0009-9236(03)00200-5","title":"Folic acid food fortification is associated with a decline in neuroblastoma","year":2003,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":155,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hospital for Sick Children; Health Sciences Centre; Pediatric Oncology Group; SickKids Foundation; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Hepatoblastoma; Neuroblastoma; Confidence interval; Incidence (geometry); Rate ratio; Pediatrics; Gastroenterology; Internal medicine; Biology","score_opus":0.10127665997931388,"score_gpt":0.4183061422281397,"score_spread":0.3170294822488258,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1999064448","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9821178,0.00024465032,0.0007585634,0.015003309,0.0003887102,0.00084835687,0.000012394351,0.000098032426,0.00052823726],"genre_scores_gemma":[0.8903885,0.00031381383,0.00047424782,0.10821509,0.00014290148,0.00007328094,0.000018763007,0.00005987043,0.00031355038],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969464,0.00062160153,0.00085714745,0.0005506393,0.00039433633,0.00062988454],"domain_scores_gemma":[0.9975254,0.0013136315,0.00023795562,0.00036677608,0.00027536767,0.00028088325],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010664372,0.0002523165,0.0006042327,0.00016846858,0.00007455209,0.000014753398,0.0002357198,0.00040061492,0.00030707],"category_scores_gemma":[0.0002914175,0.00020322157,0.00014971448,0.0006878521,0.00047111482,0.00006550685,0.00006688036,0.0009788238,0.00009828182],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.022377793,0.026180942,0.65233094,0.0002537761,0.012510619,0.0021669678,0.002214515,0.00015037759,0.17397477,0.0005198556,0.07445878,0.032860678],"study_design_scores_gemma":[0.13559717,0.03192015,0.43866932,0.00031789832,0.0062893457,0.00082352996,0.00031744182,0.030945307,0.15584967,0.0023738868,0.19513237,0.0017639219],"about_ca_topic_score_codex":0.0000027266221,"about_ca_topic_score_gemma":0.00003108562,"teacher_disagreement_score":0.21366163,"about_ca_system_score_codex":0.0003600706,"about_ca_system_score_gemma":0.0009320014,"threshold_uncertainty_score":0.82871354},"labels":[],"label_agreement":null},{"id":"W1999481780","doi":"10.1038/clpt.2013.57","title":"Biomarkers for Smoking Cessation","year":2013,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Adipose Tissue and Metabolism","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Institutes of Health; National Cancer Institute; National Institute on Drug Abuse; National Institute of Environmental Health Sciences; Canadian Institutes of Health Research; Pfizer","keywords":"Drug development; Biomarker; Biomarker discovery; Identification (biology); Medicine; Disease; Drug discovery; Regulatory science; Pharmacodynamics; Smoking cessation; Computational biology; Personalized medicine; Bioinformatics; Drug; Pharmacology; Biology; Pathology; Pharmacokinetics; Proteomics","score_opus":0.3310320414159591,"score_gpt":0.541898029911326,"score_spread":0.21086598849536686,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1999481780","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000038149203,0.9890093,0.00032460698,0.0012229056,0.005654567,0.0032982524,0.000035791967,0.000109317254,0.00030707257],"genre_scores_gemma":[0.0000051740217,0.9718376,0.0011352085,0.02061864,0.0038090667,0.00050671486,0.00025759928,0.0001256784,0.0017043559],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.996979,0.000410484,0.0014008664,0.00058223057,0.00015872759,0.00046870325],"domain_scores_gemma":[0.9967927,0.001713543,0.000674127,0.00036181853,0.00020085998,0.0002570048],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00084390584,0.00045868556,0.0025167079,0.00016589348,0.00010136767,0.000016697695,0.0002741056,0.001170808,0.00054574205],"category_scores_gemma":[0.000045455647,0.0003437051,0.0012047543,0.0002100771,0.00031725946,0.000052951957,0.00006875953,0.00091125345,0.00022443302],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000059897273,0.00024497876,0.000019978483,0.0032827156,0.0056770365,0.000010073024,0.000016042235,3.1889726e-8,0.000011804163,0.000015680554,0.041128296,0.94953346],"study_design_scores_gemma":[0.0020799718,0.0003043022,0.000023724551,0.0008865317,0.042347286,0.000037215326,0.0000055336686,0.000024918685,0.000011009469,0.00006724282,0.95392424,0.00028803738],"about_ca_topic_score_codex":0.0000016270618,"about_ca_topic_score_gemma":1.8100786e-7,"teacher_disagreement_score":0.94924545,"about_ca_system_score_codex":0.00007524064,"about_ca_system_score_gemma":0.0005029253,"threshold_uncertainty_score":0.9999015},"labels":[],"label_agreement":null},{"id":"W1999615559","doi":"10.1016/s0009-9236(03)90391-2","title":"Health‐related quality of life among children with adverse drug reactions","year":2003,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Drug; Medicine; Drug reaction; Adverse effect; Quality (philosophy); Intensive care medicine; Environmental health; Pharmacology; Emergency medicine","score_opus":0.17470963778169132,"score_gpt":0.4918954244785921,"score_spread":0.3171857866969008,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1999615559","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9667915,0.0027395948,0.00004423602,0.026257006,0.0007292396,0.0007653819,0.000014545504,0.00008393314,0.0025745765],"genre_scores_gemma":[0.94676834,0.004847594,0.0004146863,0.04735281,0.00015206244,0.000018221666,0.000011437901,0.000028033459,0.00040680054],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9961781,0.0014046679,0.0013915449,0.00037129116,0.00024697467,0.00040745747],"domain_scores_gemma":[0.99654925,0.0017404672,0.00078695244,0.00026268864,0.00017851421,0.00048213036],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021319056,0.00021395423,0.0009060928,0.000048661117,0.00019402776,0.0000038376147,0.00012426285,0.00017326136,0.0006941599],"category_scores_gemma":[0.0001945938,0.00015951936,0.00023430937,0.0003095753,0.0009299288,0.00009297893,0.000040531366,0.001134264,0.000043240707],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002196924,0.0025756126,0.9787342,0.00008477163,0.005605939,0.000009186561,0.00024020873,0.00003189483,0.00047228136,0.00019059352,0.0074565783,0.0024018087],"study_design_scores_gemma":[0.009441681,0.00089892093,0.8974102,0.000031360356,0.0017908626,0.00003102333,0.00022326254,0.000082321596,0.0004888233,0.000103911574,0.08926692,0.00023069633],"about_ca_topic_score_codex":0.000120301316,"about_ca_topic_score_gemma":0.000025743513,"teacher_disagreement_score":0.08181034,"about_ca_system_score_codex":0.00005097921,"about_ca_system_score_gemma":0.00034912763,"threshold_uncertainty_score":0.7600564},"labels":[],"label_agreement":null},{"id":"W1999813571","doi":"10.1016/s0009-9236(03)90626-6","title":"Pain control in children with otitis media","year":2003,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pediatric Pain Management Techniques","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's Health Research Institute","funders":"","keywords":"Otitis; Medicine; Clinical pharmacology; Pain control; Intensive care medicine; Audiology; Pharmacology; Anesthesia; Surgery","score_opus":0.0415964455890094,"score_gpt":0.3801473200717874,"score_spread":0.33855087448277804,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1999813571","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.970773,0.0013499341,0.013352377,0.009239624,0.0005137628,0.0020780528,0.000009659467,0.00042122533,0.0022623872],"genre_scores_gemma":[0.8385035,0.0014953896,0.0023060474,0.15715225,0.00035154715,0.00006954599,0.000010527575,0.000033718294,0.00007751637],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99711025,0.0013118242,0.00057492877,0.00038427082,0.00020026334,0.00041844236],"domain_scores_gemma":[0.99798644,0.0013726881,0.00014034753,0.00026639164,0.00006706768,0.00016704494],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029653753,0.00020378987,0.0005236562,0.00015412238,0.00003582261,0.0000071883624,0.00017786528,0.00024138605,0.00028194522],"category_scores_gemma":[0.00014144088,0.00016841828,0.00011064091,0.00031529716,0.00034372573,0.000043730804,0.000022223934,0.0007229911,0.00003888683],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000251674,0.00069092214,0.9796231,0.000008031291,0.0006101221,0.00007587023,0.00002349618,0.0000031522773,0.0002175811,0.00003316765,0.014397304,0.0040655797],"study_design_scores_gemma":[0.013571517,0.0012474374,0.9432018,0.000020900778,0.0017476396,0.000040180388,0.000021692056,0.00048599573,0.00016255933,0.00048666482,0.03872284,0.0002908219],"about_ca_topic_score_codex":0.0000047024896,"about_ca_topic_score_gemma":0.0000065323306,"teacher_disagreement_score":0.14791264,"about_ca_system_score_codex":0.00006564859,"about_ca_system_score_gemma":0.00013805144,"threshold_uncertainty_score":0.6867898},"labels":[],"label_agreement":null},{"id":"W2001716038","doi":"10.1016/s0009-9236(03)90533-9","title":"Population Pharmacokinetics of Omeprazole in Healthy Adults and in Children With Gastroesophageal Reflux Disease","year":2003,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Gastroesophageal reflux and treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Omeprazole; Pharmacokinetics; Reflux; Medicine; Disease; Pharmacology; Population; Gastroenterology; GERD; Internal medicine; Environmental health","score_opus":0.033022999228771395,"score_gpt":0.39068193855790295,"score_spread":0.35765893932913156,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2001716038","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99760437,0.0007822824,0.000011848823,0.0005245873,0.00015241501,0.00084992306,0.000017630076,0.000020399037,0.000036544097],"genre_scores_gemma":[0.99175185,0.00084978295,0.00078016036,0.00641238,0.0000757049,0.00003108394,0.00004957901,0.000030317755,0.000019156338],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979663,0.0003268739,0.00071989093,0.0004140885,0.00018420225,0.000388648],"domain_scores_gemma":[0.99909395,0.00015330374,0.0001894257,0.00018173618,0.000059724225,0.00032187233],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034546087,0.00022203768,0.00054793834,0.00016933013,0.000029870322,0.0000039563533,0.00007211558,0.00012024277,0.000056088717],"category_scores_gemma":[0.000021175238,0.00017968057,0.00006929045,0.00026056645,0.00022415086,0.00005833783,0.000025362044,0.0004851883,0.0000046816954],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00691561,0.0019480173,0.9881259,0.000043827364,0.00023095464,0.00019282219,0.00004283553,0.000052514275,0.00007738404,0.0000070260594,0.000017910625,0.002345193],"study_design_scores_gemma":[0.021606386,0.002255848,0.9749025,0.00003759171,0.00052388967,0.000032867112,0.000008146524,0.00025627896,0.00022457053,0.00004646193,0.000036253325,0.00006922462],"about_ca_topic_score_codex":0.000009791748,"about_ca_topic_score_gemma":0.000006988069,"teacher_disagreement_score":0.014690775,"about_ca_system_score_codex":0.00006513241,"about_ca_system_score_gemma":0.00012560391,"threshold_uncertainty_score":0.7327161},"labels":[],"label_agreement":null},{"id":"W2002894959","doi":"10.1016/s0009-9236(03)00238-8","title":"Multiple transport mechanisms involved in the intestinal absorption and first-pass extraction of fexofenadine,","year":2003,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":89,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Hospital","funders":"","keywords":"Fexofenadine; Verapamil; Terfenadine; Bioavailability; Chemistry; Pharmacology; Jejunum; Pharmacokinetics; Intestinal permeability; Absorption (acoustics); Perfusion; First pass effect; Chromatography; Internal medicine; Medicine; Biochemistry; Calcium; Materials science","score_opus":0.07520230082439355,"score_gpt":0.3770851599621532,"score_spread":0.30188285913775964,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2002894959","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98588574,0.0003894829,0.008303134,0.003624255,0.00083288236,0.00066829886,0.0000053545714,0.000033468386,0.00025737082],"genre_scores_gemma":[0.9881105,0.0011198187,0.0026504167,0.007873245,0.00009033229,0.0000327364,0.000015960008,0.00002066557,0.00008633808],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983806,0.00020808981,0.00069190015,0.0002838686,0.00018612153,0.00024939174],"domain_scores_gemma":[0.9988686,0.0006118171,0.00017029527,0.00017017336,0.00008746359,0.00009164986],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001211408,0.00017276636,0.0004076184,0.0000831644,0.000069261005,0.0000035614246,0.00009614436,0.00023488411,0.00010341497],"category_scores_gemma":[0.00002303544,0.00012150542,0.00014165787,0.00020403744,0.00027179526,0.00005327268,0.000004662525,0.0005937987,0.0000045491506],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0053159883,0.006172664,0.5119058,0.00051954814,0.00083501195,0.00057003985,0.0020472254,0.00009471176,0.46460235,0.0037288954,0.0005971504,0.0036106221],"study_design_scores_gemma":[0.020509012,0.0027705636,0.853817,0.00023990178,0.0032777207,0.00026705864,0.001968119,0.002968534,0.07137171,0.0074360953,0.034799322,0.0005749884],"about_ca_topic_score_codex":0.000010857777,"about_ca_topic_score_gemma":0.0001866282,"teacher_disagreement_score":0.39323065,"about_ca_system_score_codex":0.000026281115,"about_ca_system_score_gemma":0.000086329965,"threshold_uncertainty_score":0.4954847},"labels":[],"label_agreement":null},{"id":"W2003017820","doi":"10.1067/mcp.2000.106464","title":"Significant interaction between the nonprescription antihistamine diphenhydramine and the CYP2D6 substrate metoprolol in healthy men with high or low CYP2D6 activity","year":2000,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":143,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Metoprolol; Pharmacology; Diphenhydramine; Antihistamine; CYP2D6; Drug interaction; Debrisoquine; Medicine; Pharmacokinetics; Chemistry; In vivo; Histamine; Endocrinology; Internal medicine; Cytochrome P450; Biology; Metabolism","score_opus":0.15374140742723044,"score_gpt":0.46811064952311976,"score_spread":0.31436924209588935,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2003017820","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96921396,0.0011824861,0.00008968982,0.024788607,0.0014874196,0.002130651,0.00009901811,0.000091666916,0.00091647625],"genre_scores_gemma":[0.9449418,0.015190858,0.0000670089,0.037455842,0.0013463815,0.00026249728,0.000030875795,0.00006590517,0.0006387938],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9918072,0.004814406,0.0012480165,0.00086250145,0.00032216494,0.0009457089],"domain_scores_gemma":[0.99380636,0.0047001042,0.00052644627,0.00044946076,0.00015117598,0.00036644642],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.003987715,0.00059582444,0.0010601392,0.0001281499,0.00059247407,0.0000694412,0.0007334815,0.0005849196,0.0013119741],"category_scores_gemma":[0.000032224187,0.00032516097,0.00019494662,0.0005539975,0.0025490164,0.00022863233,0.00014071557,0.0032708058,0.00007999193],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.2642797,0.007439859,0.07638313,0.00025263676,0.0085934065,0.00038939368,0.0048592933,0.0051975213,0.07010399,0.00036255355,0.007569688,0.5545688],"study_design_scores_gemma":[0.10003263,0.005000893,0.34003496,0.00007523522,0.011169413,0.0001669272,0.00063305453,0.072368056,0.059871815,0.0012803962,0.40719527,0.0021713644],"about_ca_topic_score_codex":0.00013927402,"about_ca_topic_score_gemma":0.000080039834,"teacher_disagreement_score":0.5523975,"about_ca_system_score_codex":0.000100295125,"about_ca_system_score_gemma":0.00023333891,"threshold_uncertainty_score":0.99992007},"labels":[],"label_agreement":null},{"id":"W2003043566","doi":"10.1016/j.clpt.2004.08.025","title":"Population pharmacokinetics of CCI-779: Correlations to safety and pharmacogenomic responses in patients with advanced renal cancer","year":2005,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Cancer therapeutics and mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":87,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's Health Research Institute","funders":"","keywords":"Sirolimus; Medicine; Pharmacokinetics; Population; Pharmacology; Adverse effect; Pharmacogenomics; Peripheral blood mononuclear cell; Internal medicine; Area under the curve; Hematocrit; Oncology; Biology; In vitro","score_opus":0.02514505152344249,"score_gpt":0.37672007863888796,"score_spread":0.35157502711544547,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2003043566","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99541324,0.0008258085,0.0009493532,0.0015400845,0.0005052059,0.0006205939,0.00010225201,0.000011653909,0.00003179818],"genre_scores_gemma":[0.98149735,0.0030515196,0.0011921917,0.013626982,0.00032394892,0.000039063667,0.0000831384,0.00003951192,0.00014628796],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9983598,0.00019596622,0.000612596,0.00041486486,0.0001305182,0.0002862726],"domain_scores_gemma":[0.9992224,0.0000943147,0.00021330045,0.00018186998,0.00014593346,0.00014220478],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030126644,0.00020844697,0.00031789445,0.000095213734,0.00006594993,0.0000067717046,0.00016833033,0.00015776881,0.00007858635],"category_scores_gemma":[0.000007743682,0.00019558579,0.0000674301,0.00015879572,0.00012581829,0.000009692184,0.00009028659,0.00023018497,0.0000034644115],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.023004672,0.0010742757,0.21020052,0.000021036965,0.0007473519,0.0000017514112,0.00018866168,0.012926225,0.55859244,0.000026195425,0.00046366078,0.19275324],"study_design_scores_gemma":[0.023956193,0.0034452393,0.5543077,0.00005383548,0.0010067963,0.000003459706,0.000029938563,0.0023751033,0.13822046,0.00004111355,0.27577832,0.00078186666],"about_ca_topic_score_codex":0.000009267547,"about_ca_topic_score_gemma":0.00005436927,"teacher_disagreement_score":0.42037195,"about_ca_system_score_codex":0.000053299435,"about_ca_system_score_gemma":0.00010289031,"threshold_uncertainty_score":0.79757565},"labels":[],"label_agreement":null},{"id":"W2003795943","doi":"10.1016/s0009-9236(03)90535-2","title":"Volume of Grapefruit Juice and Bioavailability of Fexofenadine","year":2003,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacology and Obesity Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Grapefruit juice; Fexofenadine; Bioavailability; Terfenadine; Volume (thermodynamics); Pharmacology; Chemistry; Medicine; Pharmacokinetics","score_opus":0.09259043979338591,"score_gpt":0.43360508676102094,"score_spread":0.34101464696763506,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2003795943","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9922734,0.0023832114,0.000048772108,0.0031568918,0.0008484345,0.0004669963,0.000014231657,0.00002842731,0.00077963865],"genre_scores_gemma":[0.9825438,0.00232252,0.0009571382,0.0134608215,0.00007557521,0.0000111932595,0.000005231624,0.000015598685,0.0006080761],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99803483,0.0004831646,0.0007771633,0.00032494887,0.000120397635,0.00025949],"domain_scores_gemma":[0.9984039,0.0007106188,0.00025534822,0.00023649019,0.00019491442,0.0001987243],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00087826396,0.00017964291,0.00072657235,0.000074695265,0.00005101682,0.0000013427325,0.00010299872,0.00028288757,0.00074403075],"category_scores_gemma":[0.00005166331,0.00015049752,0.0001939274,0.00018147843,0.001400441,0.000033854845,0.000043445838,0.00040337918,0.000023181254],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016691153,0.0051962337,0.9036782,0.00020148502,0.0024643503,0.000041943742,0.00018918353,0.0000022687925,0.077226624,0.0001346793,0.005266863,0.0039290637],"study_design_scores_gemma":[0.018446714,0.0053478675,0.63953733,0.00004090001,0.009054437,0.000116227704,0.00009252413,0.00028816028,0.18850008,0.001101021,0.13713147,0.00034326187],"about_ca_topic_score_codex":0.0000051302513,"about_ca_topic_score_gemma":0.0000019869995,"teacher_disagreement_score":0.26414084,"about_ca_system_score_codex":0.0000289732,"about_ca_system_score_gemma":0.00015850672,"threshold_uncertainty_score":0.8146615},"labels":[],"label_agreement":null},{"id":"W2003955744","doi":"10.1038/clpt.2013.80","title":"Replication of TPMT and ABCC3 Genetic Variants Highly Associated With Cisplatin-Induced Hearing Loss in Children","year":2013,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Cancer therapeutics and mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":129,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Heart Institute; BC Children's Hospital; Université de Montréal; Child and Family Research Institute; University of British Columbia","funders":"Canadian Institutes of Health Research","keywords":"Columbia university; Library science; Medicine; Family medicine; Media studies; Sociology","score_opus":0.04276627127521036,"score_gpt":0.3529355795704113,"score_spread":0.3101693082952009,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2003955744","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977815,0.00041465848,0.0003437125,0.0006661265,0.00018462093,0.0005465983,0.000010057151,0.000012411183,0.00004027294],"genre_scores_gemma":[0.99242043,0.0010368087,0.00039709074,0.005825921,0.00014631779,0.00005204627,0.00003497136,0.000032985863,0.000053420976],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9984178,0.00018736857,0.0004997489,0.00051974604,0.00009910883,0.00027625437],"domain_scores_gemma":[0.999073,0.00007879259,0.00024714056,0.0003837452,0.00012495348,0.00009233323],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003902159,0.00017496989,0.0002970617,0.000047074987,0.00004636744,0.000012236337,0.0001978201,0.0002982519,0.0000278041],"category_scores_gemma":[0.000016447266,0.00015766782,0.000060199327,0.00012185503,0.0001738588,0.0000061258297,0.00009190802,0.00023846401,0.0000034968316],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019780338,0.00034963153,0.1686971,0.0000062419317,0.0006204946,0.0000018554949,0.000043782627,0.00002863394,0.8149047,0.00001738487,0.00010383473,0.015028542],"study_design_scores_gemma":[0.0037161997,0.0011915127,0.8728717,0.000020088746,0.0002657943,0.00001860562,0.0000121207095,0.00079287624,0.12015154,0.00030479179,0.00039741915,0.00025734978],"about_ca_topic_score_codex":0.00004093914,"about_ca_topic_score_gemma":0.000019602869,"teacher_disagreement_score":0.7041746,"about_ca_system_score_codex":0.000019108746,"about_ca_system_score_gemma":0.000089881345,"threshold_uncertainty_score":0.64295065},"labels":[],"label_agreement":null},{"id":"W2004772633","doi":"10.1038/clpt.2009.201","title":"Sustained Neurobehavioral Effects of Exposure to SSRI Antidepressants During Development: Molecular to Clinical Evidence","year":2009,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Maternal Mental Health During Pregnancy and Postpartum","field":"Medicine","cited_by":238,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Child and Family Research Institute; University of British Columbia","funders":"National Institute of Mental Health","keywords":"Serotonergic; Clinical pharmacology; Serotonin reuptake inhibitor; Serotonin; Mood; Fluoxetine; Medicine; Serotonin Uptake Inhibitors; Psychiatry; Sertraline; Psychology; Prenatal exposure; Antidepressant; Pharmacology; Pregnancy; Internal medicine; Anxiety; Biology; Gestation","score_opus":0.09180549067901014,"score_gpt":0.4731599964903224,"score_spread":0.38135450581131225,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2004772633","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98966247,0.0011937079,0.00013650798,0.00515928,0.0021427465,0.0015847133,0.000002372937,0.0000876572,0.0000305502],"genre_scores_gemma":[0.9257705,0.00058795174,0.0014921813,0.07156754,0.00031518482,0.00003564501,0.0000022627496,0.000029775247,0.00019893175],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99642545,0.00055499194,0.001503023,0.0005840945,0.00031368388,0.0006187551],"domain_scores_gemma":[0.997769,0.000692446,0.00023761111,0.00039570723,0.0001834009,0.0007218593],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000787452,0.00028024553,0.000819927,0.00012476328,0.000097676915,0.0000096667745,0.00034223776,0.00026983698,0.000044132663],"category_scores_gemma":[0.00014795928,0.00025536862,0.00021357687,0.00024484776,0.00012144029,0.00006577273,0.00020451866,0.00068257016,0.00007281455],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016682515,0.0048160376,0.779598,0.0031625384,0.0004449923,0.002623665,0.00086768414,0.000061643324,0.15439877,0.000013070454,0.0005174638,0.036813635],"study_design_scores_gemma":[0.0033270477,0.005118426,0.80888146,0.001844189,0.0004588454,0.00003401209,0.000009745105,0.0000071555137,0.17936227,0.000016842096,0.0007250754,0.00021492156],"about_ca_topic_score_codex":0.0000018429818,"about_ca_topic_score_gemma":5.240098e-7,"teacher_disagreement_score":0.06640827,"about_ca_system_score_codex":0.000055470733,"about_ca_system_score_gemma":0.00021694781,"threshold_uncertainty_score":0.99998987},"labels":[],"label_agreement":null},{"id":"W2005533850","doi":"10.1038/sj.clpt.6100506","title":"Novel Methods for the Detection of Drug and Alcohol Exposure During Pregnancy:Implications for Maternal and Child Health","year":2008,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Prenatal Substance Exposure Effects","field":"Medicine","cited_by":59,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children","funders":"","keywords":"Pregnancy; Drug; Alcohol; Obstetrics; Medicine; Environmental health; Maternal health; Psychiatry; Health services; Chemistry; Biology","score_opus":0.1822372335718684,"score_gpt":0.521680560583615,"score_spread":0.3394433270117466,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2005533850","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0002157313,0.96303564,0.027316464,0.0021669595,0.00091577496,0.0061468016,0.00015699498,0.00004244247,0.00000317088],"genre_scores_gemma":[0.0007487937,0.98501706,0.010460285,0.0017952218,0.0005820227,0.0012567266,0.000024884888,0.00007637648,0.000038652117],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9974799,0.000439387,0.0011586582,0.0005124429,0.00007293475,0.0003366653],"domain_scores_gemma":[0.9932858,0.0052391347,0.0008592455,0.00033122805,0.00012464,0.00016000356],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007841688,0.0003434683,0.0016837167,0.00008192992,0.00030552017,0.000008536829,0.00020489415,0.00037367892,0.0000018830945],"category_scores_gemma":[0.00007229931,0.00023211476,0.0004651841,0.00013312743,0.0004579404,0.000037990238,0.00008479784,0.00068743416,3.7508198e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024811775,0.00017151679,0.00015763566,0.011996653,0.0016420422,6.5277374e-7,0.00007421047,2.0597699e-7,0.0005654365,0.000008733468,0.00006187353,0.9850729],"study_design_scores_gemma":[0.008970901,0.001456385,0.00867059,0.0068976916,0.009457326,0.0011706245,0.000008533173,0.00019554792,0.0013486402,0.0000748805,0.9613442,0.0004046775],"about_ca_topic_score_codex":0.0000018802272,"about_ca_topic_score_gemma":0.0000030591912,"teacher_disagreement_score":0.98466825,"about_ca_system_score_codex":0.00006654788,"about_ca_system_score_gemma":0.0001922308,"threshold_uncertainty_score":0.94653654},"labels":[],"label_agreement":null},{"id":"W2005818996","doi":"10.1038/clpt.2008.50","title":"Mice as Clinically Relevant Models for the Study of Cytochrome P450-dependent Metabolism","year":2008,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":72,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"Canadian Institutes of Health Research; Research Nova Scotia","keywords":"Drug metabolism; Cytochrome P450; Biology; Computational biology; Drug; Xenobiotic; Drug discovery; Function (biology); Gene; Metabolism; Drug development; Pharmacology; Bioinformatics; Genetics; Biochemistry; Enzyme","score_opus":0.46419484390673466,"score_gpt":0.5847167342678442,"score_spread":0.12052189036110955,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2005818996","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0020066514,0.96916634,0.00034503697,0.00085357315,0.0141565725,0.011869054,0.0009639662,0.00017975067,0.00045905457],"genre_scores_gemma":[0.0013990655,0.9642879,0.0002991181,0.025397193,0.0047493894,0.002343028,0.000110077344,0.00038921527,0.0010250328],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9801907,0.007867345,0.0072288327,0.0021159328,0.00085447426,0.001742739],"domain_scores_gemma":[0.9685193,0.024291206,0.0039170627,0.0014817652,0.00093772606,0.00085299823],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["metaepi_narrow","research_integrity"],"category_scores_codex":[0.006252494,0.0018642854,0.006844502,0.00042573496,0.0009747518,0.00004744412,0.0043002726,0.0030673202,0.000787337],"category_scores_gemma":[0.00023689077,0.0013165058,0.003552846,0.00080577104,0.0020654383,0.0001578369,0.0010829523,0.0068189655,0.00031853328],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029541368,0.014346153,0.000020961174,0.0018698716,0.031853545,0.00019770906,0.0013532605,0.0012683506,0.00036044253,0.00016191941,0.02152896,0.92408466],"study_design_scores_gemma":[0.010022847,0.0016385621,0.000021342657,0.00017136893,0.053318072,0.00016550161,0.00017655983,0.0024785039,0.00008589188,0.0005595074,0.9301996,0.0011621965],"about_ca_topic_score_codex":0.000022958446,"about_ca_topic_score_gemma":0.000007710907,"teacher_disagreement_score":0.9229225,"about_ca_system_score_codex":0.0001342508,"about_ca_system_score_gemma":0.0019533,"threshold_uncertainty_score":0.99941015},"labels":[],"label_agreement":null},{"id":"W2006541492","doi":"10.1016/s0009-9236(03)90685-0","title":"Folic Acid Fortification and Rates of Neuroblastoma in Ontario","year":2003,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Folic acid; Neuroblastoma; Fortification; Medicine; Environmental health; Internal medicine; Chemistry; Food science; Biology; Genetics","score_opus":0.16696521616172066,"score_gpt":0.463072148956833,"score_spread":0.29610693279511235,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2006541492","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973004,0.00021924044,0.000015675105,0.0013876267,0.00021728763,0.00041587508,0.0000015341708,0.0000139652175,0.00042841904],"genre_scores_gemma":[0.9930104,0.00044262392,0.00024652938,0.00592442,0.00002304515,0.00002239292,0.0000036348915,0.000015084779,0.00031186707],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986844,0.00025719946,0.00045331632,0.00025473797,0.00010909073,0.00024126239],"domain_scores_gemma":[0.99919564,0.00034098126,0.000098926415,0.0001517024,0.0000669663,0.00014579372],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027979424,0.00011460106,0.00031904795,0.00009254707,0.00002831437,0.000004188708,0.00005916499,0.000106120555,0.00015116141],"category_scores_gemma":[0.000033871544,0.000096547294,0.000074143216,0.00012965706,0.000278496,0.000038540056,0.00002388523,0.00043171676,0.000017964867],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016748878,0.0023637468,0.83811224,0.00003593266,0.00044354584,0.00014007282,0.00016318384,0.0000022414488,0.15071161,0.00006985465,0.00046597375,0.0058167214],"study_design_scores_gemma":[0.006719976,0.0022453708,0.85261816,0.000016040236,0.00032254762,0.00005464872,0.000017100458,0.00010718635,0.12780592,0.0003319785,0.009672615,0.00008846198],"about_ca_topic_score_codex":0.000096175856,"about_ca_topic_score_gemma":0.0010261787,"teacher_disagreement_score":0.022905696,"about_ca_system_score_codex":0.000045738794,"about_ca_system_score_gemma":0.00024152572,"threshold_uncertainty_score":0.39370844},"labels":[],"label_agreement":null},{"id":"W2006793732","doi":"10.1067/mcp.2002.126409","title":"Evaluation of peppermint oil and ascorbyl palmitate as inhibitors of cytochrome P4503A4 activity in vitro and in vivo","year":2002,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":87,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"","keywords":"Felodipine; Ascorbyl palmitate; Chemistry; Bioavailability; Grapefruit juice; Pharmacokinetics; Pharmacology; Nifedipine; Food science; Chromatography; Ascorbic acid; Calcium; Endocrinology; Medicine","score_opus":0.2868937453360573,"score_gpt":0.5101501110644951,"score_spread":0.22325636572843782,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2006793732","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9858888,0.0089052385,0.0000021845824,0.0020914497,0.0011930602,0.00042439223,0.00006895597,0.000019538717,0.0014064292],"genre_scores_gemma":[0.97062016,0.024090962,0.00007943715,0.004774859,0.0002102454,0.00007217026,0.0000029649216,0.000034133667,0.00011508856],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99397504,0.0032054028,0.0012821608,0.0005877617,0.00041415356,0.0005355023],"domain_scores_gemma":[0.99708724,0.0016338348,0.00051575014,0.00021052832,0.00028800775,0.00026462457],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0054856776,0.00035369568,0.0009288999,0.0003434458,0.000071485025,0.000007756342,0.00026664557,0.0006056038,0.00084112317],"category_scores_gemma":[0.00013041255,0.00035509732,0.00014841389,0.00040983016,0.0011866271,0.00012561207,0.0002054738,0.001277949,0.000010926254],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012416772,0.001784702,0.01147588,0.00007658332,0.000398547,0.000024943996,0.0009386088,0.00026578506,0.7717671,0.000008198006,0.0002488246,0.21176918],"study_design_scores_gemma":[0.021387404,0.00055539707,0.044633586,0.000042517942,0.0030106655,0.000036828766,0.00015936107,0.09038463,0.81894124,0.00092044525,0.019313361,0.000614563],"about_ca_topic_score_codex":0.000023960198,"about_ca_topic_score_gemma":0.00002170205,"teacher_disagreement_score":0.21115462,"about_ca_system_score_codex":0.000072800525,"about_ca_system_score_gemma":0.00015516918,"threshold_uncertainty_score":0.9998901},"labels":[],"label_agreement":null},{"id":"W2007200590","doi":"10.1038/clpt.2012.55","title":"Translational Bioinformatics: Data-driven Drug Discovery and Development","year":2012,"lang":"en","type":"editorial","venue":"Clinical Pharmacology & Therapeutics","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"U.S. National Library of Medicine; National Cancer Institute; David and Lucile Packard Foundation","keywords":"Translational bioinformatics; Clinical pharmacology; Data sharing; Translational research; Data science; Drug reaction; Drug discovery; Drug development; Computer science; The Internet; Clinical trial; Medicine; Bioinformatics; Computational biology; Drug; Genomics; Pharmacology; World Wide Web; Genome; Biology; Alternative medicine; Pathology","score_opus":0.12859080116938446,"score_gpt":0.43442698686586195,"score_spread":0.3058361856964775,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2007200590","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0004791277,0.01614832,0.0017374333,0.0032320216,0.9758764,0.00055213674,0.0016265578,0.0001063761,0.00024161856],"genre_scores_gemma":[0.0008882053,0.023226785,0.039047092,0.035644453,0.8781104,0.00007800139,0.013106744,0.00022083521,0.009677478],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9959722,0.0009358656,0.0015141417,0.000720813,0.00015352166,0.0007034274],"domain_scores_gemma":[0.9929945,0.0056585367,0.000498036,0.00057573937,0.00015666163,0.00011651808],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.002174485,0.00053788244,0.0010800259,0.00010661008,0.00026401549,0.00005241125,0.00108429,0.0024621782,0.00076280546],"category_scores_gemma":[0.00008602785,0.00041836806,0.00017269877,0.00009164284,0.0014480684,0.00029458862,0.0006746437,0.0027700597,0.0002873301],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031386563,0.00043413747,0.00037856746,0.000088516485,0.0031427296,0.0000028963539,0.00016540373,4.2618709e-7,0.00024834185,0.0000066430853,0.9675978,0.02762072],"study_design_scores_gemma":[0.0021945508,0.000102033926,0.0003501749,0.000034188466,0.002159098,0.00000561715,0.000031847525,0.00008840298,0.000350571,0.00003307488,0.99414563,0.0005048016],"about_ca_topic_score_codex":0.0000027121062,"about_ca_topic_score_gemma":0.000008509917,"teacher_disagreement_score":0.097766005,"about_ca_system_score_codex":0.000040585994,"about_ca_system_score_gemma":0.00072188076,"threshold_uncertainty_score":0.9998268},"labels":[],"label_agreement":null},{"id":"W2007339547","doi":"10.1038/clpt.2013.195","title":"Network Medicine: Finding the Links to Personalized Therapy","year":2013,"lang":"en","type":"editorial","venue":"Clinical Pharmacology & Therapeutics","topic":"Computational Drug Discovery Methods","field":"Computer Science","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Clinical pharmacology; Systems pharmacology; Personalized medicine; Systems biology; Pharmacology; Medicine; Molecular Pharmacology; Computational biology; Bioinformatics; Biology; Internal medicine; Drug","score_opus":0.14999039163701658,"score_gpt":0.4836010300640656,"score_spread":0.33361063842704897,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2007339547","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0003206458,0.003935205,0.08540492,0.07598405,0.83263195,0.0011810075,0.0000137849,0.00023021252,0.00029822893],"genre_scores_gemma":[0.000047706082,0.004612245,0.014427562,0.2065879,0.7728486,0.00021869199,0.000042057905,0.00008550771,0.001129763],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99071074,0.00412359,0.0015187731,0.0013580552,0.0012718878,0.0010169568],"domain_scores_gemma":[0.9562943,0.040755954,0.00074111833,0.001108138,0.0007356151,0.0003648711],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.006197897,0.0007139805,0.0012391845,0.00014875569,0.00056221697,0.00022425392,0.005320919,0.0019469504,0.00038467077],"category_scores_gemma":[0.00044172668,0.00047179227,0.00047485658,0.000900952,0.000953014,0.000202658,0.0010955558,0.0053867325,0.00046236342],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013625734,0.00012249162,0.000017761815,0.000008109313,0.00075383566,0.00001259468,0.0005318047,0.0018191735,0.00003433038,0.00043380892,0.9619916,0.03413822],"study_design_scores_gemma":[0.0018904973,0.0006060772,0.00015015525,0.000052690248,0.00022201148,0.0000030677184,0.00001352943,0.014518655,0.000009386241,0.007494442,0.9745418,0.0004976994],"about_ca_topic_score_codex":0.000014646256,"about_ca_topic_score_gemma":0.0000015923619,"teacher_disagreement_score":0.13060383,"about_ca_system_score_codex":0.00016519862,"about_ca_system_score_gemma":0.0010821444,"threshold_uncertainty_score":0.9997734},"labels":[],"label_agreement":null},{"id":"W2007855317","doi":"10.1016/s0009-9236(03)90662-x","title":"Pharmacokinetics of Trastuzumab in Combination With Paclitaxel Given Every 3 Weeks in Women With HER2 Positive Metastatic Breast Cancer","year":2003,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; BC Cancer Agency","funders":"","keywords":"Trastuzumab; Paclitaxel; Medicine; Metastatic breast cancer; Pharmacokinetics; Oncology; Breast cancer; Internal medicine; Cancer","score_opus":0.07312905217516238,"score_gpt":0.44980259319497,"score_spread":0.37667354101980766,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2007855317","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9886063,0.0007389501,0.0001366171,0.0083536375,0.0002594615,0.0013991203,0.00008177604,0.000024376222,0.00039979094],"genre_scores_gemma":[0.98533446,0.002061727,0.00056544563,0.011475883,0.000075695025,0.0002784469,0.000008635251,0.0000657557,0.00013395639],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99623793,0.0011642099,0.0008997045,0.00050288637,0.00049938477,0.00069587864],"domain_scores_gemma":[0.9978549,0.0010078244,0.00026209897,0.00023959563,0.00038213228,0.00025345804],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014591853,0.00029514442,0.0008973419,0.00027716803,0.000036875652,0.000009032274,0.00020632081,0.00016910111,0.00065550854],"category_scores_gemma":[0.000024511677,0.00022989992,0.000069246125,0.00086043886,0.00082526397,0.00009242154,0.00003549054,0.0012462023,0.000008379075],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.052828286,0.023355825,0.8239048,0.0009074769,0.005611564,0.0014410623,0.0064195585,0.0013367047,0.025007904,0.00008507616,0.0026188325,0.056482926],"study_design_scores_gemma":[0.06571095,0.0149338385,0.8920719,0.00078355003,0.001802181,0.00025839044,0.0020665561,0.0019482023,0.0128370635,0.0003767826,0.0064697843,0.00074078713],"about_ca_topic_score_codex":0.00009308847,"about_ca_topic_score_gemma":0.00008471256,"teacher_disagreement_score":0.068167135,"about_ca_system_score_codex":0.0007369183,"about_ca_system_score_gemma":0.0012029995,"threshold_uncertainty_score":0.93750465},"labels":[],"label_agreement":null},{"id":"W2008077991","doi":"10.1038/sj.clpt.6100191","title":"Induction of Intestinal P-glycoprotein by St John's Wort Reduces the Oral Bioavailability of Talinolol","year":2007,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":129,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"National Institute of General Medical Sciences; U.S. Public Health Service; Australian Geographic Society","keywords":"Bioavailability; Pharmacokinetics; Cmax; Pharmacology; P-glycoprotein; CYP3A4; Oral administration; Ex vivo; Chemistry; Medicine; Internal medicine; Cytochrome P450; Metabolism; In vitro; Biochemistry; Antibiotics","score_opus":0.08313587851896263,"score_gpt":0.41642578633400573,"score_spread":0.3332899078150431,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2008077991","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9913826,0.0008124264,0.0009377956,0.0045881886,0.0013188444,0.0006526499,0.000021236967,0.000042466258,0.00024382143],"genre_scores_gemma":[0.99441,0.00041402265,0.0010971781,0.0034234985,0.00029700925,0.000010369593,0.000020543604,0.000020940864,0.00030647125],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9978304,0.00018505433,0.001125086,0.00030304163,0.00025756593,0.0002988581],"domain_scores_gemma":[0.9984813,0.00042797896,0.00041942886,0.00027952934,0.00027871638,0.00011304933],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022576225,0.00017615789,0.0005486466,0.000060307717,0.000063500025,0.000002561646,0.00024090068,0.00029286332,0.00029879872],"category_scores_gemma":[0.000035969337,0.00011374676,0.00023623151,0.00030013133,0.0016510338,0.00003632572,0.000031884338,0.0007152105,0.0000060842503],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0049610087,0.0026754702,0.03402252,0.000115281815,0.00081497204,0.000026107124,0.00022456248,0.00000202195,0.89962196,0.000049427585,0.004090957,0.053395703],"study_design_scores_gemma":[0.0031879176,0.0017125596,0.038635433,0.00006926686,0.0014467473,0.000022031007,0.00042980336,0.000052354524,0.92388797,0.0003178928,0.03006763,0.00017040446],"about_ca_topic_score_codex":0.000013627041,"about_ca_topic_score_gemma":0.000008719014,"teacher_disagreement_score":0.0532253,"about_ca_system_score_codex":0.00003340289,"about_ca_system_score_gemma":0.00016473854,"threshold_uncertainty_score":0.60833025},"labels":[],"label_agreement":null},{"id":"W2008228624","doi":"10.1038/clpt.2008.29","title":"Integrating Family Medicine and Pharmacy to Advance Primary Care Therapeutics","year":2008,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmaceutical Practices and Patient Outcomes","field":"Medicine","cited_by":195,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Joseph’s Healthcare Hamilton; University of British Columbia; University of Ottawa; McMaster University; Child and Family Research Institute","funders":"","keywords":"Medicine; Multidisciplinary approach; Pharmacist; Pharmacy; Medical home; Clinical pharmacy; Family medicine; Health care; MEDLINE; Primary care; Nursing","score_opus":0.5029480220296687,"score_gpt":0.5943371294147648,"score_spread":0.09138910738509609,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2008228624","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00036773374,0.9833978,0.00012881398,0.0052759787,0.004303915,0.0034469715,0.00006892383,0.00021439172,0.0027954972],"genre_scores_gemma":[0.000038767208,0.77915734,0.001519249,0.21638925,0.002107182,0.00013581016,0.0001800802,0.00017742394,0.00029491604],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9931888,0.001289852,0.0026472334,0.0013342467,0.00060659443,0.0009332836],"domain_scores_gemma":[0.9912071,0.0057870806,0.00096376654,0.00066719466,0.00039502428,0.0009798205],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.000655518,0.00120584,0.0046541924,0.0003535491,0.0003072832,0.000027058028,0.00062256464,0.00074102404,0.00016004892],"category_scores_gemma":[0.00010035977,0.0008507381,0.00093176885,0.00068609737,0.0011666015,0.0001619017,0.00041684616,0.0040165386,0.00019244781],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006550823,0.00046368592,0.0008444326,0.0073887696,0.00279078,0.00023212573,0.0005700653,4.5285026e-7,0.00006757563,0.000008981222,0.0057960767,0.981182],"study_design_scores_gemma":[0.004405715,0.0014228324,0.00010377603,0.0040787673,0.016759712,0.00033902796,0.00015391005,0.000066251785,0.000005910493,0.000010873536,0.9719198,0.0007334383],"about_ca_topic_score_codex":0.0000069031257,"about_ca_topic_score_gemma":0.0000011882069,"teacher_disagreement_score":0.98044854,"about_ca_system_score_codex":0.00033950768,"about_ca_system_score_gemma":0.00093614426,"threshold_uncertainty_score":0.99939436},"labels":[],"label_agreement":null},{"id":"W2008500593","doi":"10.1016/s0009-9236(03)90532-7","title":"Brain and Spinal Cord Distribution of Reference Compounds With Varying Degrees of CNS Penetration in A Rat Model of Cerebral Inflammation","year":2003,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Neuroinflammation and Neurodegeneration Mechanisms","field":"Neuroscience","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; AstraZeneca (Canada)","funders":"","keywords":"Spinal cord; Inflammation; Pharmacology; Medicine; Central nervous system; Penetration (warfare); Neuroscience; Anesthesia; Immunology; Biology; Internal medicine","score_opus":0.18920054382515236,"score_gpt":0.39963630055949023,"score_spread":0.21043575673433787,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2008500593","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9904191,0.0000147371275,0.008442587,0.00055689143,0.00015088537,0.00029918976,0.000016141332,0.000015116692,0.00008533841],"genre_scores_gemma":[0.99793136,0.00015131777,0.0008411361,0.0010163535,0.000016908132,0.000008415643,0.000009360881,0.000009796261,0.00001537901],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979638,0.00063403044,0.00080366834,0.00027076967,0.00019031682,0.00013741366],"domain_scores_gemma":[0.9987075,0.0004884528,0.0005077278,0.00013028798,0.000118775395,0.00004725991],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047034933,0.00012441863,0.00028735446,0.0000827725,0.000049387378,0.00000780214,0.0001193472,0.0001028656,0.000013384992],"category_scores_gemma":[0.000103202525,0.00011310851,0.000038131067,0.00023001761,0.00032623025,0.00015796648,0.000024345492,0.00023251158,7.087272e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010158748,0.00015595407,0.0015966779,0.000035722074,0.0000075329735,0.0000013795963,0.000053037907,0.005233238,0.9822553,0.008970324,0.00001668412,0.0006582839],"study_design_scores_gemma":[0.0018199293,0.0012140569,0.0019937456,0.000018651668,0.000050347877,0.0000074805084,0.000010089828,0.07763108,0.9165588,0.000531615,0.00007254638,0.00009164733],"about_ca_topic_score_codex":0.0000015365121,"about_ca_topic_score_gemma":0.000007885141,"teacher_disagreement_score":0.07239784,"about_ca_system_score_codex":0.000017907876,"about_ca_system_score_gemma":0.00011827872,"threshold_uncertainty_score":0.46124312},"labels":[],"label_agreement":null},{"id":"W2009420048","doi":"10.1038/clpt.2011.22","title":"iPSC Technology: Platform for Drug Discovery","year":2011,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pluripotent Stem Cells Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Occupational Cancer Research Centre; SickKids Foundation; McMaster University; University of Toronto","funders":"","keywords":"Induced pluripotent stem cell; Drug discovery; Embryonic stem cell; Somatic cell; Drug; Stem cell; Biology; Computational biology; Pharmacology; Medicine; Bioinformatics; Cell biology; Genetics; Gene","score_opus":0.11986403750533448,"score_gpt":0.4105239276252117,"score_spread":0.29065989011987725,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2009420048","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98877394,0.0014696755,0.0028720344,0.0027678323,0.0017462263,0.00089558394,0.000054185773,0.00006948014,0.0013510449],"genre_scores_gemma":[0.970764,0.00263251,0.0024912874,0.017904477,0.0009440774,0.00020865127,0.0000811551,0.00007743238,0.004896414],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980916,0.00010829127,0.00051820744,0.0005874943,0.000118358155,0.0005760455],"domain_scores_gemma":[0.9989895,0.00014029258,0.00014667689,0.0004341807,0.00015635518,0.00013298218],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00067604834,0.00022601517,0.00030216426,0.00009133016,0.00013838494,0.0000148083445,0.0007026071,0.00049182726,0.000070679445],"category_scores_gemma":[0.000032549742,0.0002013486,0.0002659504,0.00014194049,0.00069430046,0.000010767088,0.00032303995,0.00041164286,0.00006670179],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038203641,0.0021215572,0.028435314,0.00007642664,0.0024303792,0.00003408505,0.00013308953,0.000009676517,0.85010844,0.00030086286,0.09464212,0.017887652],"study_design_scores_gemma":[0.0038035142,0.0014751707,0.0019192607,0.00000854948,0.0003769958,0.000018254046,0.00011591905,0.00025681456,0.5570557,0.0015780183,0.43294197,0.0004498139],"about_ca_topic_score_codex":0.000001783128,"about_ca_topic_score_gemma":0.0000056972444,"teacher_disagreement_score":0.33829987,"about_ca_system_score_codex":0.000019511013,"about_ca_system_score_gemma":0.00016352582,"threshold_uncertainty_score":0.82107574},"labels":[],"label_agreement":null},{"id":"W2010038158","doi":"10.1038/clpt.2012.233","title":"Gender Differences in Drug Bioequivalence: Time to Rethink Practices","year":2012,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Hospital for Sick Children; University of Toronto; SickKids Foundation","funders":"","keywords":"Bioequivalence; Drug; Medicine; Pharmacology; Pharmacokinetics","score_opus":0.8652221277144911,"score_gpt":0.6338304453666238,"score_spread":0.23139168234786733,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2010038158","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00045303258,0.96487254,0.00004702519,0.025621831,0.0045321183,0.002316172,0.0003030865,0.00008789136,0.0017662756],"genre_scores_gemma":[0.00007020878,0.88184255,0.0008074834,0.11192065,0.0024901498,0.00035825497,0.00005213574,0.00010333596,0.0023552214],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.98242134,0.0047155186,0.010325136,0.0013576089,0.00015192978,0.0010284592],"domain_scores_gemma":[0.9750179,0.013517906,0.010028811,0.00081077043,0.000083436695,0.00054114236],"candidate_categories":["metaresearch","metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.03691672,0.00067796867,0.0057056206,0.00066046446,0.00016635198,0.00008689949,0.0013739546,0.001188572,0.0050472477],"category_scores_gemma":[0.0014083461,0.00070935173,0.0006996421,0.00053123466,0.0003506683,0.00040495823,0.00030721913,0.001946014,0.039286304],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023491973,0.005671575,0.0274184,0.040908843,0.009643248,0.000046162848,0.007635879,0.000008926807,0.0000012669185,0.0037088555,0.6070211,0.29770082],"study_design_scores_gemma":[0.0005001794,0.00009545648,0.0006531022,0.0005590918,0.00080764655,0.000007529323,0.00005674397,0.00009428889,7.681304e-8,0.0006994733,0.9958303,0.00069610745],"about_ca_topic_score_codex":0.000067009576,"about_ca_topic_score_gemma":0.0000140574075,"teacher_disagreement_score":0.3888092,"about_ca_system_score_codex":0.00064371736,"about_ca_system_score_gemma":0.0007507152,"threshold_uncertainty_score":0.99953574},"labels":[],"label_agreement":null},{"id":"W2010683229","doi":"10.1067/mcp.2000.105152","title":"Growth in use of statins after trials is not targeted to most appropriate patients","year":2000,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Trinity College","funders":"","keywords":"Medicine; Simvastatin; Population; Statin; Clinical trial; Coronary heart disease; Ezetimibe; Defined daily dose; Internal medicine; Medical prescription; Environmental health; Pharmacology","score_opus":0.13488067877343987,"score_gpt":0.42747636411346634,"score_spread":0.29259568534002645,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2010683229","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99151367,0.00018228454,0.00006424291,0.0056481706,0.00058128283,0.001806243,0.00012722786,0.00002883944,0.000048037367],"genre_scores_gemma":[0.8209698,0.001750368,0.0013366381,0.17520152,0.0003722795,0.00010185704,0.000025265377,0.000038210095,0.00020403141],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9960235,0.0011673251,0.0016068817,0.00042821997,0.00037039173,0.00040370264],"domain_scores_gemma":[0.9982728,0.0006125681,0.00020274955,0.00035324797,0.00027146688,0.0002872055],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0021371145,0.00021269302,0.0012695113,0.00011362072,0.00003052466,0.000008270467,0.00013109476,0.00028681563,0.0014329801],"category_scores_gemma":[0.00016577322,0.00016705816,0.00043662888,0.00036605206,0.0001530403,0.00006408198,0.00004506294,0.0005150193,0.00009620192],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.037912972,0.008145217,0.4041103,0.00033712634,0.004702343,0.00014260365,0.0020798342,0.000057886402,0.005063631,0.0000067614556,0.013035621,0.5244057],"study_design_scores_gemma":[0.024035208,0.0032655916,0.81660587,0.00009095312,0.0022453892,0.000003994761,0.000025588717,0.00033981906,0.015905397,0.00008422538,0.13699771,0.00040025567],"about_ca_topic_score_codex":0.000088375375,"about_ca_topic_score_gemma":0.000005873012,"teacher_disagreement_score":0.5240054,"about_ca_system_score_codex":0.000058954527,"about_ca_system_score_gemma":0.00021410141,"threshold_uncertainty_score":0.99947983},"labels":[],"label_agreement":null},{"id":"W2010759425","doi":"10.1038/sj.clpt.6100502","title":"Public Alcohol Policy: Current Directions and New Opportunities","year":2008,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Substance Abuse Treatment and Outcomes","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"National Institute on Alcohol Abuse and Alcoholism","keywords":"Addiction; Alcohol; Public policy; Alcohol addiction; Term (time); Control (management); Psychiatry; Psychology; Public economics; Medicine; Political science; Computer science; Economics; Law; Artificial intelligence","score_opus":0.7415395235250991,"score_gpt":0.560675869909654,"score_spread":0.1808636536154451,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2010759425","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0001030055,0.98708516,0.000005429448,0.007954176,0.002957101,0.0010004577,0.000013984538,0.00020925554,0.00067143736],"genre_scores_gemma":[0.000011926098,0.9763493,0.0000872511,0.015645197,0.003704849,0.00009497283,0.00013173885,0.000093988965,0.003880796],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99715227,0.00042185953,0.0011394566,0.0005621222,0.0001991815,0.00052511104],"domain_scores_gemma":[0.99702966,0.0014103594,0.0004119465,0.00037762616,0.00011068314,0.00065970834],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00019322122,0.00059075886,0.0025091574,0.00039578206,0.00018860842,0.000023023687,0.000210145,0.0005850179,0.00026888298],"category_scores_gemma":[0.00004225683,0.00043098,0.00095706875,0.00037330503,0.00070933346,0.00007890687,0.000097783035,0.0012203942,0.00012482856],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000034223325,0.00047257153,0.00086542947,0.0003841128,0.0030361512,0.00009535654,0.00007390838,5.2999054e-9,1.176144e-7,0.000044757602,0.044173237,0.95082015],"study_design_scores_gemma":[0.0025556379,0.00022918958,0.00015310914,0.0006950087,0.009875348,0.00034010666,0.000017322009,0.0000018654675,5.139642e-7,0.0000491598,0.98576903,0.0003137286],"about_ca_topic_score_codex":0.0000033209428,"about_ca_topic_score_gemma":0.0000043201007,"teacher_disagreement_score":0.9505064,"about_ca_system_score_codex":0.00018667168,"about_ca_system_score_gemma":0.0028173462,"threshold_uncertainty_score":0.9998142},"labels":[],"label_agreement":null},{"id":"W2011586410","doi":"10.1067/mcp.2002.126174","title":"Effect of sex and menstrual cycle phase on cytochrome P450 2C19 activity with omeprazole used as a biomarker","year":2002,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; University of Toronto","funders":"","keywords":"CYP2C19; Omeprazole; Menstrual cycle; Medicine; Internal medicine; Endocrinology; Cytochrome P450; Physiology; Hormone; Metabolism","score_opus":0.18530976811129077,"score_gpt":0.5257971988813166,"score_spread":0.34048743077002586,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2011586410","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9905106,0.0014822196,0.000037632788,0.002321997,0.0014760677,0.0012575277,0.00015536397,0.00014201255,0.0026165864],"genre_scores_gemma":[0.9787159,0.0033491016,0.00006663458,0.016735619,0.0005244116,0.000115026705,0.000011327346,0.000093957664,0.00038800677],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9926437,0.0041403654,0.0009356019,0.000943923,0.00040578272,0.00093063834],"domain_scores_gemma":[0.992801,0.005380222,0.0005416466,0.0004455727,0.00013145896,0.00070006814],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0028571002,0.0007065596,0.0012930204,0.000234713,0.0003814338,0.000025981415,0.00053369236,0.0007944289,0.0030765727],"category_scores_gemma":[0.00005361006,0.0005646751,0.000311055,0.0004243952,0.0018042497,0.00013607228,0.00020535418,0.002192624,0.00023257555],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0110880295,0.005445416,0.0032746329,0.00011858022,0.0035162978,0.00021632451,0.00078010064,0.00013347522,0.7214809,0.000025349453,0.0038197732,0.25010112],"study_design_scores_gemma":[0.05729628,0.013713719,0.0033845962,0.000031610052,0.005494733,0.00015688606,0.00005615481,0.043304995,0.7198809,0.00011534025,0.15547688,0.0010879363],"about_ca_topic_score_codex":0.0000059597487,"about_ca_topic_score_gemma":0.000001473241,"teacher_disagreement_score":0.24901319,"about_ca_system_score_codex":0.0000520295,"about_ca_system_score_gemma":0.00008693167,"threshold_uncertainty_score":0.99968046},"labels":[],"label_agreement":null},{"id":"W2011711268","doi":"10.1038/clpt.2008.57","title":"Toward Personalized Therapy for Smoking Cessation: A Randomized Placebo-controlled Trial of Bupropion","year":2008,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Smoking Behavior and Cessation","field":"Medicine","cited_by":182,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"National Cancer Institute; National Institute on Drug Abuse","keywords":"Bupropion; Placebo; Smoking cessation; Medicine; Quartile; Cotinine; Randomized controlled trial; Internal medicine; Clinical trial; Pharmacology; Nicotine; Anesthesia; Alternative medicine; Confidence interval","score_opus":0.19584756825107305,"score_gpt":0.45079495218444576,"score_spread":0.2549473839333727,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2011711268","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9811721,0.00052041624,0.0024104351,0.0050764848,0.0031547444,0.007377422,0.00000610714,0.00008810421,0.0001941828],"genre_scores_gemma":[0.9804503,0.0046253284,0.0003358773,0.011669304,0.0013310554,0.001145924,0.000040243438,0.000038717335,0.00036326965],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9969205,0.00080926943,0.00129871,0.0003493078,0.000354935,0.0002672481],"domain_scores_gemma":[0.99550986,0.0031771995,0.00061110326,0.00019836049,0.00039884652,0.00010463815],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022988247,0.00023118757,0.0016674837,0.00011182874,0.00013957768,0.0000066489683,0.00014574305,0.00039507227,0.00036304173],"category_scores_gemma":[0.00015765561,0.00016895824,0.0010532292,0.00014213969,0.00078850554,0.000054735854,0.000017191933,0.0004012321,0.000001587228],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9861062,0.0015820445,0.0033101859,0.000022532648,0.0018091283,0.000008775147,0.00073823147,0.0000035261153,0.002135512,0.000040998875,0.000903423,0.0033394014],"study_design_scores_gemma":[0.98485446,0.0021426545,0.00155677,0.000019004516,0.002828443,0.00001923823,0.0000574231,0.00069607294,0.0028709508,0.00017523846,0.004623244,0.00015649956],"about_ca_topic_score_codex":0.0000033698734,"about_ca_topic_score_gemma":1.00512864e-7,"teacher_disagreement_score":0.00659282,"about_ca_system_score_codex":0.000053569063,"about_ca_system_score_gemma":0.00033171228,"threshold_uncertainty_score":0.6889917},"labels":[],"label_agreement":null},{"id":"W2012457277","doi":"10.1016/s0009-9236(03)90450-4","title":"Development of A Concurrent Disorders Training Program for Health Care Professionals","year":2003,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacy and Medical Practices","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Addiction and Mental Health","funders":"","keywords":"Health professionals; Training (meteorology); Medical education; Health care; Medicine; Nursing; Psychology; Political science","score_opus":0.4656224147486013,"score_gpt":0.6518131913536417,"score_spread":0.1861907766050404,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2012457277","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.817678,0.03433348,0.0084817,0.06409511,0.050360166,0.016963743,0.0003834613,0.00097044697,0.0067339083],"genre_scores_gemma":[0.8432128,0.0018849006,0.017216174,0.13549116,0.0005842236,0.0012151783,0.000102534235,0.00007396375,0.00021905925],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99398863,0.0022865715,0.001830262,0.0006165767,0.00028044527,0.0009975049],"domain_scores_gemma":[0.9943969,0.0035827106,0.0009358321,0.00018541001,0.00024966884,0.0006494763],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0038675286,0.00039868997,0.00088522094,0.000107914384,0.000585551,0.000009839523,0.00047978634,0.0005424032,0.000808686],"category_scores_gemma":[0.00021343112,0.00035307603,0.0003582597,0.00024753154,0.0008644435,0.00012385673,0.000081728715,0.0016970783,0.00003154742],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001127203,0.006380196,0.0011926035,0.00053654885,0.0022439158,0.000004405663,0.014889523,0.000020593077,0.0026148516,0.0006512599,0.030249644,0.9400892],"study_design_scores_gemma":[0.0075238757,0.0008825993,0.0002568016,0.000036036028,0.0006794755,0.000005236359,0.002724417,0.00039107402,0.0094735045,0.00013221684,0.9775426,0.00035215984],"about_ca_topic_score_codex":6.5714255e-7,"about_ca_topic_score_gemma":0.000011300136,"teacher_disagreement_score":0.947293,"about_ca_system_score_codex":0.000114657516,"about_ca_system_score_gemma":0.0022706275,"threshold_uncertainty_score":0.9998921},"labels":[],"label_agreement":null},{"id":"W2013161419","doi":"10.1002/cpt.119","title":"Cannabinoids: Friend or foe?","year":2015,"lang":"en","type":"editorial","venue":"Clinical Pharmacology & Therapeutics","topic":"Cannabis and Cannabinoid Research","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"National Institute on Drug Abuse; National Institute of Mental Health; Canadian Institutes of Health Research; Department of Psychiatry, University of Toronto; Centre for Addiction and Mental Health; National Institutes of Health; University of Toronto; Campbell Family Mental Health Research Institute; GW Pharmaceuticals","keywords":"Cannabis; Clinical pharmacology; Cannabinoid; Pharmacology; Synthetic cannabinoids; Dronabinol; Harm; Addiction; Medicine; Psychology; Psychiatry","score_opus":0.12837458483446987,"score_gpt":0.504768150150853,"score_spread":0.3763935653163831,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2013161419","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0012303805,0.0048455894,0.000013190585,0.05489893,0.933982,0.0015505676,0.0004235276,0.00024107033,0.0028147472],"genre_scores_gemma":[0.00005585204,0.007704252,0.00009795663,0.025807908,0.7895702,0.00023317206,0.0005005919,0.00023683665,0.17579322],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9929196,0.0008288433,0.001715554,0.0013449207,0.0018586731,0.0013323685],"domain_scores_gemma":[0.99376243,0.0007967933,0.00051589217,0.0010278212,0.0024930232,0.0014040372],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0027447536,0.0008054834,0.0021348952,0.00028843782,0.00018870455,0.0000735768,0.00091061747,0.003824221,0.003665551],"category_scores_gemma":[0.00081258605,0.00059328886,0.00081803446,0.0005196895,0.0015362691,0.00007613012,0.00046511443,0.0068217884,0.00061213627],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006245488,0.0013168692,0.00009509734,0.00026093132,0.0020208133,0.00080250873,0.00011920785,0.0000010631704,0.00019683313,0.0000017719361,0.9789699,0.009969536],"study_design_scores_gemma":[0.008826884,0.004255649,0.000088646586,0.00007955777,0.003800838,0.00004076176,0.00008534388,0.0000780565,0.00014740384,0.00008086303,0.981906,0.0006100073],"about_ca_topic_score_codex":0.000051776973,"about_ca_topic_score_gemma":0.000043602184,"teacher_disagreement_score":0.17297846,"about_ca_system_score_codex":0.0006235421,"about_ca_system_score_gemma":0.011622234,"threshold_uncertainty_score":0.99965185},"labels":[],"label_agreement":null},{"id":"W2014144507","doi":"10.1038/clpt.2011.18","title":"Pharmacogenetic Testing: Time for Clinical Practice Guidelines","year":2011,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":61,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Child and Family Research Institute; BC Children's Hospital","funders":"","keywords":"Pharmacogenetics; Clinical pharmacology; Clinical Practice; Drug; Medicine; Genetic testing; Drug reaction; Pharmacology; Drug response; Adverse effect; Intensive care medicine; Medical physics; Internal medicine; Family medicine; Biology; Gene; Genetics; Genotype","score_opus":0.806811082690761,"score_gpt":0.6867118532933741,"score_spread":0.12009922939738682,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2014144507","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000035179226,0.9502405,0.00027768832,0.0028462776,0.03469459,0.00639405,0.0011245146,0.0006228617,0.0037643223],"genre_scores_gemma":[7.0685e-7,0.7963672,0.016151866,0.16613255,0.01605206,0.0012162046,0.00030715295,0.000574212,0.0031980416],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.97381413,0.010285639,0.009687733,0.0030791613,0.00054323016,0.002590083],"domain_scores_gemma":[0.95823264,0.029840203,0.004672022,0.001327096,0.0039701564,0.0019578582],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"category_scores_codex":[0.015881486,0.0025332845,0.007242541,0.0005369956,0.0008115683,0.000099572804,0.003709307,0.005306634,0.0031125606],"category_scores_gemma":[0.0030584875,0.0022525932,0.0044369893,0.001164474,0.0022068536,0.00026047998,0.0010517518,0.007522948,0.004515315],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000664176,0.0024545297,0.000021077092,0.0013500976,0.007917409,0.00009748219,0.00003801364,0.00000704255,0.00006755299,0.000018667786,0.32812098,0.659243],"study_design_scores_gemma":[0.00617771,0.0010007395,0.0000047484323,0.0005333445,0.078379236,0.00026822838,0.000011730312,0.0013203012,0.00007812856,0.0002001856,0.909969,0.0020566897],"about_ca_topic_score_codex":0.0000027053459,"about_ca_topic_score_gemma":4.3006068e-7,"teacher_disagreement_score":0.65718627,"about_ca_system_score_codex":0.0001732188,"about_ca_system_score_gemma":0.0028306926,"threshold_uncertainty_score":0.9987403},"labels":[],"label_agreement":null},{"id":"W2014151394","doi":"10.1038/sj.clpt.6100261","title":"Why Can’t a Woman Be More Like a Man?","year":2007,"lang":"en","type":"letter","venue":"Clinical Pharmacology & Therapeutics","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Clinical pharmacology; Pharmacodynamics; Pharmacokinetics; Drug; Pharmacology; Medicine; Population; Gerontology; Physiology; Environmental health","score_opus":0.6000677385811612,"score_gpt":0.5543107777363848,"score_spread":0.04575696084477643,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2014151394","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0033215862,0.0042649726,0.00063846144,0.97958004,0.008657821,0.0015327276,0.0009984808,0.0002114531,0.0007944772],"genre_scores_gemma":[0.000040310697,0.0017673696,0.0009909553,0.979085,0.012602195,0.00021275588,0.00047613346,0.00024175525,0.0045835054],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9862391,0.0015558182,0.008698712,0.0017509527,0.0002418292,0.0015136313],"domain_scores_gemma":[0.98782945,0.0056275236,0.0047298614,0.0012159398,0.00018558065,0.0004116427],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity","insufficient_payload"],"category_scores_codex":[0.013474056,0.0008117809,0.0031759834,0.00066135795,0.0003215486,0.00009989247,0.0013992252,0.0031959168,0.0026737915],"category_scores_gemma":[0.00032570522,0.0010182996,0.0008578877,0.00032294475,0.00092921284,0.00018326596,0.00024113669,0.0049101776,0.0025277103],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005223809,0.00024948106,0.0027650206,0.0003008032,0.0014350007,0.00011323817,0.0005301637,0.000008083625,0.0000010612237,0.00001767595,0.9944952,0.00003199947],"study_design_scores_gemma":[0.0019552356,0.00026500665,0.0010426728,0.000047764624,0.00034510516,0.000022885039,0.00011413018,0.00058852596,0.0000020903535,0.00038558783,0.9943091,0.00092184386],"about_ca_topic_score_codex":0.00030265062,"about_ca_topic_score_gemma":0.000090462345,"teacher_disagreement_score":0.013148351,"about_ca_system_score_codex":0.00094750524,"about_ca_system_score_gemma":0.00051864353,"threshold_uncertainty_score":0.99922675},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"not_applicable","genre":"commentary","about_ca_system":false,"about_ca_topic":false,"confidence":"medium"},{"model":"gpt","categories":[],"domain":null,"study_design":"not_applicable","genre":"commentary","about_ca_system":false,"about_ca_topic":false,"confidence":"low"}],"label_agreement":"agree"},{"id":"W2015234747","doi":"10.1016/j.clpt.2006.02.006","title":"Nicotine metabolite ratio predicts efficacy of transdermal nicotine for smoking cessation","year":2006,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Smoking Behavior and Cessation","field":"Medicine","cited_by":276,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"National Cancer Institute; National Center for Research Resources; National Institute on Drug Abuse; U.S. Public Health Service","keywords":"Cotinine; Nicotine; CYP2A6; Odds ratio; Smoking cessation; Medicine; Metabolite; Confidence interval; Abstinence; Pharmacology; Internal medicine; Nicotine withdrawal; Physiology; Metabolism; Cytochrome P450; Psychiatry; CYP1A2","score_opus":0.08963809978074626,"score_gpt":0.42237025566640995,"score_spread":0.3327321558856637,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2015234747","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98633766,0.0004588301,0.0067757554,0.0033248689,0.0017795918,0.000992157,0.000045078676,0.00011482354,0.00017120467],"genre_scores_gemma":[0.990945,0.00019988349,0.00044614825,0.006199194,0.0015681034,0.000057122943,0.00032722094,0.000044953395,0.00021241452],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976549,0.00020123283,0.0011579049,0.00037181732,0.00028257677,0.00033157688],"domain_scores_gemma":[0.9980743,0.0008695344,0.00039464928,0.00023184846,0.00033378595,0.00009588882],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008531205,0.00021592522,0.0006051867,0.00011284751,0.00009750418,0.000010754967,0.00014714545,0.00034468612,0.00014959357],"category_scores_gemma":[0.00003219521,0.00019435267,0.00035608784,0.00022463639,0.00028565145,0.00008855783,0.000019340385,0.00041403572,0.0000017314059],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036971774,0.005004377,0.67152315,0.0002190058,0.0013232316,0.0000045393526,0.00029852978,0.0005056505,0.28985253,0.00037072477,0.004396915,0.02280418],"study_design_scores_gemma":[0.020186324,0.0009282941,0.7033731,0.000037253227,0.007221463,0.000011144727,0.00002503639,0.0022981719,0.24809873,0.00016899,0.017428733,0.0002228117],"about_ca_topic_score_codex":0.000008550174,"about_ca_topic_score_gemma":0.0000016013222,"teacher_disagreement_score":0.04175379,"about_ca_system_score_codex":0.00004174281,"about_ca_system_score_gemma":0.00014871199,"threshold_uncertainty_score":0.79254717},"labels":[],"label_agreement":null},{"id":"W2016093188","doi":"10.1038/clpt.2009.212","title":"Neonatal Pharmacology: Rational Therapeutics for the Most Vulnerable","year":2009,"lang":"en","type":"editorial","venue":"Clinical Pharmacology & Therapeutics","topic":"Pregnancy and Medication Impact","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Institute of Diabetes and Digestive and Kidney Diseases; Canadian Institutes of Health Research","keywords":"Clinical pharmacology; Medicine; Citation; Associate editor; Library science; Family medicine; Pharmacology; Computer science","score_opus":0.09024227698780275,"score_gpt":0.4754122976086613,"score_spread":0.3851700206208586,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2016093188","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00016650955,0.020791905,0.0037722883,0.068183415,0.9023698,0.0034226722,0.00068598887,0.00024847922,0.00035892657],"genre_scores_gemma":[0.0006846192,0.034045275,0.0006163484,0.21572171,0.7395703,0.00054739503,0.0013011384,0.00014153951,0.007371641],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9946123,0.0008318714,0.001672129,0.000981045,0.0009053274,0.0009973781],"domain_scores_gemma":[0.9780843,0.01882532,0.0008640403,0.0007094759,0.0010736864,0.0004431638],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0028934518,0.0007503276,0.00136481,0.00014924866,0.0007390807,0.000051890234,0.0010055229,0.002540516,0.000848834],"category_scores_gemma":[0.00040369888,0.00052779715,0.0008131641,0.0003184517,0.001250566,0.00011607834,0.00011624872,0.005562827,0.00012311849],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028356756,0.0009235212,0.000030831892,0.00010128406,0.004711338,0.000036669175,0.00014470663,0.000020205265,0.0011190377,0.000012654644,0.94430035,0.045763697],"study_design_scores_gemma":[0.011901647,0.001733815,0.00011447234,0.000098569595,0.013464743,0.000026464579,0.000040965344,0.0020278988,0.0013967503,0.00025222433,0.96846336,0.0004790691],"about_ca_topic_score_codex":0.000003093923,"about_ca_topic_score_gemma":0.0000026123719,"teacher_disagreement_score":0.16279948,"about_ca_system_score_codex":0.000241491,"about_ca_system_score_gemma":0.0038981417,"threshold_uncertainty_score":0.99971735},"labels":[],"label_agreement":null},{"id":"W2016523223","doi":"10.1067/mcp.2000.112363","title":"Effect of ketoconazole on ritonavir and saquinavir concentrations in plasma and cerebrospinal fluid from patients infected with human immunodeficiency virus","year":2000,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":84,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Saquinavir; Ketoconazole; Ritonavir; Pharmacokinetics; Medicine; Confidence interval; Pharmacology; Cerebrospinal fluid; Internal medicine; Human immunodeficiency virus (HIV); Immunology; Viral load; Antiretroviral therapy","score_opus":0.021377398073675405,"score_gpt":0.3672882227734733,"score_spread":0.3459108246997979,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2016523223","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978607,0.00026032593,0.0000010065432,0.0004658746,0.00009205596,0.0009226594,0.000031673924,0.000025614796,0.00034007893],"genre_scores_gemma":[0.99757075,0.0006084452,0.000068110916,0.0014045684,0.000039133025,0.000051998715,0.00008697599,0.000017192173,0.00015282903],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99852955,0.00028160767,0.0004998368,0.00032256093,0.00014188033,0.000224546],"domain_scores_gemma":[0.99897194,0.0006580549,0.0000978489,0.00012721053,0.000044316206,0.000100648576],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019481879,0.00021190876,0.0005104795,0.00005824841,0.0000948972,0.000007987789,0.000060544542,0.00014891279,0.0002541291],"category_scores_gemma":[0.000006740499,0.0001537803,0.000048394628,0.00012231304,0.00046893663,0.000045393543,0.000022850789,0.00032538004,0.00001752655],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0045107384,0.00207834,0.9510956,0.000025061074,0.0004526806,0.000026577243,0.00033266994,0.0000050480357,0.015553478,0.0000073266715,0.0000994699,0.025813058],"study_design_scores_gemma":[0.030651147,0.009442145,0.9267877,0.00012599441,0.0010268854,0.0000063204366,0.000013850321,0.00036112862,0.028669847,0.000020530053,0.0026839408,0.00021052972],"about_ca_topic_score_codex":0.000019742703,"about_ca_topic_score_gemma":0.000011681549,"teacher_disagreement_score":0.026140409,"about_ca_system_score_codex":0.0000449783,"about_ca_system_score_gemma":0.000061530234,"threshold_uncertainty_score":0.62709785},"labels":[],"label_agreement":null},{"id":"W2016646371","doi":"10.1038/clpt.2011.23","title":"Prediction of Infant Drug Exposure Through Breastfeeding: Population PK Modeling and Simulation of Fluoxetine Exposure","year":2011,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Breastfeeding Practices and Influences","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"Canadian Institutes of Health Research","keywords":"Breastfeeding; Medicine; Breast milk; Pharmacokinetics; Population; Metabolite; Drug; Fluoxetine; Breast feeding; Infant formula; Plasma concentration; Physiology; Pediatrics; Pharmacology; Internal medicine; Environmental health; Chemistry","score_opus":0.17691039059307476,"score_gpt":0.4081107410624852,"score_spread":0.23120035046941043,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2016646371","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945449,0.0009565116,0.0010090644,0.0021052917,0.00074194634,0.00033551178,0.000012203236,0.00004851574,0.000246034],"genre_scores_gemma":[0.9949079,0.000977092,0.0018064987,0.0018659701,0.00037682394,0.000006610358,0.000018030143,0.000021212454,0.000019818874],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99807006,0.00016514373,0.0010818752,0.00028870668,0.00021264587,0.00018155853],"domain_scores_gemma":[0.9984764,0.00035890983,0.0005595041,0.00016746136,0.00034757762,0.000090154324],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007721195,0.00016501559,0.00049653597,0.000072881325,0.000062584884,0.0000046249966,0.000091488735,0.00025195352,0.0001128277],"category_scores_gemma":[0.000052643652,0.0001389631,0.00012603604,0.00015279044,0.00024589233,0.00031067012,0.000051855186,0.00038929572,0.0000014532346],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004224451,0.0012964583,0.93170613,0.00028333516,0.0010417784,0.0000049109744,0.003739254,0.008964045,0.016842,0.000063095635,0.000121687146,0.031712834],"study_design_scores_gemma":[0.0044301646,0.0016962144,0.71938914,0.00014055143,0.0024098328,0.000034073608,0.00026002727,0.26795858,0.0025720666,0.0005294379,0.00041987028,0.00016006352],"about_ca_topic_score_codex":0.00010135384,"about_ca_topic_score_gemma":0.0000017566975,"teacher_disagreement_score":0.25899452,"about_ca_system_score_codex":0.000014972296,"about_ca_system_score_gemma":0.00004822333,"threshold_uncertainty_score":0.5666751},"labels":[],"label_agreement":null},{"id":"W2019126421","doi":"10.1038/clpt.2010.125","title":"Communicating Pharmacogenetic Research Results to Breastfeeding Mothers Taking Codeine: A Pilot Study of Perceptions and Benefits","year":2010,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Child and Family Research Institute; Children's & Women's Health Centre of British Columbia; McGill University; Mount Sinai Hospital; SickKids Foundation; University of British Columbia; Hospital for Sick Children","funders":"Canadian Institutes of Health Research","keywords":"Breastfeeding; Codeine; Pharmacogenetics; Medicine; Perception; Psychology; Family medicine; Environmental health; Anesthesia; Pediatrics; Genotype","score_opus":0.4810274459873395,"score_gpt":0.576050962485156,"score_spread":0.09502351649781648,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2019126421","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95946985,0.000740778,0.000008983169,0.03648128,0.00065770786,0.0012931332,0.000022829547,0.000056585406,0.0012688343],"genre_scores_gemma":[0.9795106,0.0027300138,0.001138261,0.0158514,0.00059978286,0.00007018836,0.000003273127,0.00004400043,0.0000524595],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99647075,0.0009475416,0.001042909,0.00054207654,0.00042738416,0.00056932],"domain_scores_gemma":[0.9932177,0.0049972055,0.0003248207,0.0004505865,0.00052974635,0.00047994108],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.004306978,0.00023231724,0.000602451,0.00017013775,0.00053636625,0.000029023364,0.0004261222,0.00012702392,0.0002383036],"category_scores_gemma":[0.0004229321,0.00020064022,0.00007811326,0.0005260173,0.00078318914,0.00007219051,0.0005956266,0.0024801497,0.000028220435],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012950969,0.013519796,0.13766007,0.000105838786,0.002682269,0.000036603735,0.0068818205,0.000092792,0.64883745,0.000024192794,0.0036315515,0.17357667],"study_design_scores_gemma":[0.034956258,0.034176398,0.82518417,0.00018691776,0.005686237,0.00016834725,0.0073894537,0.006247354,0.0060676318,0.000073039206,0.07906261,0.0008015837],"about_ca_topic_score_codex":0.00008095986,"about_ca_topic_score_gemma":0.00009593911,"teacher_disagreement_score":0.6875241,"about_ca_system_score_codex":0.00003170116,"about_ca_system_score_gemma":0.00008480714,"threshold_uncertainty_score":0.9998212},"labels":[],"label_agreement":null},{"id":"W2019193819","doi":"10.1038/sj.clpt.6100124","title":"Decreased Skeletal Muscle Mitochondrial DNA in Patients Treated with High-Dose Simvastatin","year":2007,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Mitochondrial Function and Pathology","field":"Biochemistry, Genetics and Molecular Biology","cited_by":102,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"University of British Columbia; Michael Smith Health Research BC","keywords":"Simvastatin; Atorvastatin; Mitochondrial DNA; Skeletal muscle; Muscle biopsy; Medicine; Pharmacology; Placebo; Mitochondrial myopathy; Clinical pharmacology; Internal medicine; Endocrinology; Biology; Biopsy; Pathology; Genetics; Gene","score_opus":0.02796687818406735,"score_gpt":0.3389910367451989,"score_spread":0.3110241585611316,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2019193819","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99527365,0.00006752949,0.0010015239,0.00030194034,0.0024889195,0.00055734836,0.000025867137,0.000033815784,0.00024940688],"genre_scores_gemma":[0.9778354,0.00010876369,0.001563596,0.018273385,0.001403811,0.000028426093,0.00036912455,0.000054457672,0.00036303594],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9975353,0.00045803725,0.0007005119,0.000625169,0.00015293747,0.0005280468],"domain_scores_gemma":[0.9988671,0.00023511446,0.00020302275,0.0003047179,0.00016075619,0.00022928447],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042117236,0.0002835755,0.00036970648,0.000094028444,0.000079149075,0.000011268036,0.00024134856,0.0004976417,0.00022040393],"category_scores_gemma":[0.000048008922,0.00024250762,0.0001443911,0.00020474022,0.000361502,0.000006283357,0.000071244125,0.00041214353,0.0000541899],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013771262,0.003503942,0.18730073,0.000013302097,0.0005672485,0.000119296616,0.00007106059,0.000053986383,0.76909786,0.000017629543,0.010531743,0.014951942],"study_design_scores_gemma":[0.04143315,0.009102293,0.6614145,0.000015450552,0.00056167913,0.000014524456,0.000058903035,0.00006161082,0.081734255,0.00004794793,0.20464924,0.0009064592],"about_ca_topic_score_codex":0.000014867527,"about_ca_topic_score_gemma":0.00010390295,"teacher_disagreement_score":0.6873636,"about_ca_system_score_codex":0.000028332282,"about_ca_system_score_gemma":0.000116998955,"threshold_uncertainty_score":0.98891735},"labels":[],"label_agreement":null},{"id":"W2019915557","doi":"10.1002/cpt.103","title":"Medical education on cannabis and cannabinoids: Perspectives, challenges, and opportunities","year":2015,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Cannabis and Cannabinoid Research","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Journal of Administrative Sciences; McGill University Health Centre","funders":"","keywords":"Cannabis; Medical cannabis; Curriculum; Subject (documents); Health care; Health professionals; Medicine; Effects of cannabis; Medical education; Psychiatry; Psychology; Political science; Library science; Cannabidiol; Pedagogy","score_opus":0.21885480446735284,"score_gpt":0.46494520257343275,"score_spread":0.2460903981060799,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2019915557","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.3256855,0.0575366,0.0000025053614,0.610479,0.00088336825,0.00045618918,0.000006386446,0.000060480652,0.0048899753],"genre_scores_gemma":[0.42175737,0.24261941,0.00010334014,0.28936735,0.0034304857,0.0002733161,0.00003069069,0.0001087958,0.042309236],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9977322,0.00041822332,0.00043600786,0.00051742094,0.00050773035,0.0003884009],"domain_scores_gemma":[0.99778265,0.000057511334,0.00008942236,0.000242739,0.00047635517,0.001351346],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001367447,0.00022800785,0.00047352345,0.0001499644,0.00009166693,0.000020200174,0.00013790416,0.00037778745,0.00026596372],"category_scores_gemma":[0.00018890352,0.00018784565,0.00008374844,0.00007399735,0.0012729001,0.000060805978,0.00012657576,0.00091077853,0.0000125166725],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010824761,0.0016662743,0.0010056014,0.00008179504,0.0003848189,0.0001156586,0.002361732,1.9624402e-7,0.00007053748,0.002093,0.63826454,0.35287338],"study_design_scores_gemma":[0.003611421,0.0025173812,0.018234948,0.000047562622,0.00036556146,0.0002364861,0.0057451613,0.00021740215,0.00005977369,0.00044329092,0.9683034,0.00021760067],"about_ca_topic_score_codex":0.00004388383,"about_ca_topic_score_gemma":0.000024563675,"teacher_disagreement_score":0.3526558,"about_ca_system_score_codex":0.00013927172,"about_ca_system_score_gemma":0.0032447702,"threshold_uncertainty_score":0.7660124},"labels":[],"label_agreement":null},{"id":"W2020026521","doi":"10.1038/clpt.2009.243","title":"The (Possible) Impact of Comparative Effectiveness Research on Pharmaceutical Industry Decision Making","year":2010,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Nickel Institute","funders":"National Institutes of Health","keywords":"Pharmaceutical industry; Comparative effectiveness research; Management science; Business; Medicine; Pharmacology; Economics; Alternative medicine","score_opus":0.637574940144511,"score_gpt":0.6468215544832479,"score_spread":0.009246614338736858,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2020026521","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.009270178,0.9779322,0.000047717585,0.00041959647,0.004866098,0.0019588459,0.0006797468,0.00003981188,0.004785761],"genre_scores_gemma":[0.014838242,0.9807009,0.0000632973,0.0024861402,0.0015037908,0.00019910352,0.000019100054,0.00011939106,0.00007005093],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9919478,0.0020853004,0.003373339,0.0011880189,0.00015732321,0.0012481773],"domain_scores_gemma":[0.96397007,0.03291662,0.0015245078,0.0009333583,0.00021929019,0.00043613356],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.011044039,0.00076014065,0.0039521237,0.00058751745,0.00056655175,0.00014896462,0.0020537283,0.0026581052,0.00064889924],"category_scores_gemma":[0.00020506335,0.00055316015,0.0021076084,0.0009213202,0.002377206,0.00010305505,0.0005607996,0.012189281,0.0012915763],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012761515,0.0016355854,0.0010336216,0.0010653031,0.00506369,0.000020041052,0.00007631191,0.00007268078,0.0000041268618,0.013870401,0.009572573,0.9663095],"study_design_scores_gemma":[0.0013326199,0.00070844614,0.0006033635,0.0009572714,0.00055844075,0.000012999972,0.0000058366045,0.0009778799,0.000010939334,0.011130478,0.9831852,0.000516538],"about_ca_topic_score_codex":0.000006597323,"about_ca_topic_score_gemma":0.0000025301536,"teacher_disagreement_score":0.9736126,"about_ca_system_score_codex":0.0005587625,"about_ca_system_score_gemma":0.00076458964,"threshold_uncertainty_score":0.99969196},"labels":[],"label_agreement":null},{"id":"W2021250625","doi":"10.1038/sj.clpt.6100240","title":"Current Assessment of Risk–Benefit by Regulators: Is It Time to Introduce Decision Analyses?","year":2007,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; University of Toronto","funders":"","keywords":"Clinical pharmacology; Risk assessment; Terfenadine; Risk analysis (engineering); Actuarial science; Quality (philosophy); Medicine; Management science; Psychology; Computer science; Business; Pharmacology; Economics","score_opus":0.5122946078377717,"score_gpt":0.6222662990845224,"score_spread":0.10997169124675066,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2021250625","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8728656,0.0044425675,0.056747325,0.05973019,0.0038173657,0.0010421552,0.00066009344,0.000055713263,0.00063899707],"genre_scores_gemma":[0.48223242,0.005372609,0.030364096,0.47685978,0.0037409787,0.000081261285,0.00011306499,0.00015189621,0.0010838837],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.990826,0.0005206094,0.0070307683,0.0008818079,0.00017496957,0.0005658267],"domain_scores_gemma":[0.9895787,0.005872915,0.0032159449,0.000696645,0.00021379636,0.00042194728],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.028468778,0.0002783212,0.0015205044,0.00036045758,0.0001522546,0.000027978263,0.00060203904,0.00031846212,0.0038075321],"category_scores_gemma":[0.00073236413,0.00032270173,0.00035197605,0.0004272226,0.00019959344,0.00015898184,0.00014474518,0.00060428254,0.0031756351],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023433594,0.0014110433,0.09517941,0.00006488195,0.0009705829,9.129078e-7,0.0006653295,0.0005087901,0.00029440236,0.0006523343,0.88884133,0.01117667],"study_design_scores_gemma":[0.002619358,0.00050315395,0.12222261,0.00005657234,0.0002891544,0.0000014978756,0.00013605718,0.014746804,0.00036312354,0.004694959,0.8538103,0.0005563902],"about_ca_topic_score_codex":0.00003753623,"about_ca_topic_score_gemma":0.000009447385,"teacher_disagreement_score":0.41712958,"about_ca_system_score_codex":0.00043036838,"about_ca_system_score_gemma":0.00015550951,"threshold_uncertainty_score":0.9999225},"labels":[],"label_agreement":null},{"id":"W2021635654","doi":"10.1038/clpt.2013.2","title":"Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Tricyclic Antidepressants","year":2013,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":453,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"National Institute on Drug Abuse; National Institute of General Medical Sciences; National Institute of Mental Health; National Heart, Lung, and Blood Institute; American Lebanese Syrian Associated Charities; Canadian Institutes of Health Research; Agency for Healthcare Research and Quality; National Institutes of Health","keywords":"Doxepin; Nortriptyline; Desipramine; Tricyclic; CYP2D6; Pharmacology; Pharmacogenetics; Clomipramine; CYP2C19; Dosing; Active metabolite; Medicine; Imipramine; Pharmacokinetics; Amitriptyline; Genotype; Chemistry; Internal medicine; Antidepressant; Cytochrome P450; Metabolism; Biochemistry","score_opus":0.2465648872691833,"score_gpt":0.5759832517471809,"score_spread":0.3294183644779976,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2021635654","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9727828,0.013036054,0.0014691887,0.0048297043,0.004752525,0.0025581217,0.0003004723,0.00008973664,0.00018139747],"genre_scores_gemma":[0.8877426,0.044327933,0.006489545,0.059278946,0.0016718467,0.00020791867,0.00007479814,0.00009792797,0.00010851747],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9930208,0.0016952534,0.0032006472,0.00094798254,0.00023672952,0.0008985967],"domain_scores_gemma":[0.9935886,0.0036449288,0.0011034756,0.0003013644,0.0006652998,0.00069628964],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.003530958,0.00055346015,0.001226909,0.00020800634,0.00035061678,0.0000450257,0.0004719698,0.0007523093,0.001023508],"category_scores_gemma":[0.00009382887,0.0005246054,0.0003515073,0.00025169924,0.0016523439,0.00018352526,0.0003439417,0.0011076833,0.00003100665],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012414071,0.0012870257,0.21787672,0.00015014163,0.0030170907,0.000010881828,0.0003529487,0.00007852372,0.27029055,0.000095135336,0.03935469,0.46624488],"study_design_scores_gemma":[0.03031716,0.0013277971,0.1023674,0.000020748636,0.008698308,0.000051539762,0.00036238483,0.028985048,0.13288769,0.0022365118,0.6915322,0.0012132324],"about_ca_topic_score_codex":0.00002350261,"about_ca_topic_score_gemma":0.0000045115557,"teacher_disagreement_score":0.6521775,"about_ca_system_score_codex":0.000023874605,"about_ca_system_score_gemma":0.000207218,"threshold_uncertainty_score":0.9998897},"labels":[],"label_agreement":null},{"id":"W2021997289","doi":"10.1038/clpt.2011.245","title":"Pathways to Drug Development for Autism Spectrum Disorders","year":2011,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Genetics and Neurodevelopmental Disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":57,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Canadian Institutes of Health Research","keywords":"Rett syndrome; Autism; Psychiatry; Medicine; Clinical trial; Neuropathology; Fragile X syndrome; Pharmacotherapy; Autism spectrum disorder; Drug development; Neurochemical; Psychology; Drug; Neuroscience; Disease; Pathology; Biology","score_opus":0.12347155197608628,"score_gpt":0.408684906927953,"score_spread":0.2852133549518667,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2021997289","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0008705414,0.9902778,0.0009150649,0.0009171321,0.003902993,0.0027068108,0.00009895213,0.000044996264,0.0002656899],"genre_scores_gemma":[0.00019395111,0.9816349,0.0025881617,0.013153955,0.0002439261,0.0006781195,0.00039537478,0.00018404811,0.0009275424],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9963588,0.00030582113,0.0012773124,0.0011807284,0.00012008292,0.0007572536],"domain_scores_gemma":[0.9986521,0.00014589411,0.00037240112,0.00046921484,0.000029975854,0.00033038552],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00051339634,0.0007159706,0.001224825,0.00012115214,0.00019889463,0.000022119435,0.000915117,0.0006870423,0.00007426857],"category_scores_gemma":[0.0000125394545,0.0006571185,0.00078468147,0.00016093568,0.00020794554,0.000002220336,0.00048962596,0.00046348237,0.00018095851],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015607623,0.0007711444,0.000026827403,0.0011670423,0.0020286362,0.0000029857506,0.00013747114,0.0000023623677,0.00026161072,0.000060253376,0.028431335,0.96695423],"study_design_scores_gemma":[0.00078494113,0.0005047433,0.0001304572,0.0001580459,0.0010341817,0.0000047800227,0.000007700109,0.0000018655875,0.00031275692,0.00019962326,0.99608374,0.0007771757],"about_ca_topic_score_codex":0.0000010116079,"about_ca_topic_score_gemma":0.000026204258,"teacher_disagreement_score":0.9676524,"about_ca_system_score_codex":0.000043542208,"about_ca_system_score_gemma":0.0008541097,"threshold_uncertainty_score":0.999588},"labels":[],"label_agreement":null},{"id":"W2022028441","doi":"10.1067/mcp.2001.112513","title":"Pharmacokinetic interaction between single oral doses of ditiazem and sirolimus in healthy volunteers*1","year":2001,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Renal Transplantation Outcomes and Treatments","field":"Medicine","cited_by":76,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's Health Research Institute","funders":"","keywords":"Diltiazem; Sirolimus; Pharmacokinetics; Crossover study; Pharmacology; Half-life; Medicine; Drug interaction; Volume of distribution; Chemistry; Internal medicine; Calcium","score_opus":0.18554419111631165,"score_gpt":0.48513317753946295,"score_spread":0.2995889864231513,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2022028441","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939505,0.0005272015,0.00010444604,0.0041675805,0.0005945837,0.0003396859,0.000014344312,0.00002671502,0.00027495663],"genre_scores_gemma":[0.98118734,0.004779025,0.0002588326,0.013425467,0.00022470739,0.000009287398,0.000031000916,0.000017729717,0.00006661342],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985707,0.00019262235,0.000659266,0.00023748678,0.0001142811,0.00022563581],"domain_scores_gemma":[0.99893713,0.00064150646,0.00013249888,0.00008801674,0.00005722571,0.00014364999],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001996939,0.0001477448,0.00048753625,0.00011468444,0.000030099549,0.0000047281665,0.000059313563,0.00012689231,0.00020977622],"category_scores_gemma":[0.0000062697227,0.00012218443,0.00010588773,0.00016094308,0.00019681426,0.0000618027,0.000017238805,0.00034144716,0.000013396196],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004142391,0.0014149668,0.95360404,0.00011777094,0.0006840855,0.000115261675,0.00016309561,0.00001410987,0.00727789,0.000003042156,0.000074965865,0.03238839],"study_design_scores_gemma":[0.020487195,0.0043502455,0.95765144,0.00012433164,0.0022038538,0.000105915344,0.00007618055,0.00096393924,0.0036923874,0.00008726331,0.010080201,0.00017702427],"about_ca_topic_score_codex":0.0000236543,"about_ca_topic_score_gemma":0.000008489795,"teacher_disagreement_score":0.032211363,"about_ca_system_score_codex":0.00004369898,"about_ca_system_score_gemma":0.00003973995,"threshold_uncertainty_score":0.49825367},"labels":[],"label_agreement":null},{"id":"W2023176983","doi":"10.1016/s0009-9236(03)90388-2","title":"Monitoring lithium in breast milk: An individualized approach for breastfeeding mothers","year":2003,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Breastfeeding Practices and Influences","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Breastfeeding; Breast milk; Lithium (medication); Clinical pharmacology; Medicine; Breast feeding; Pharmacology; Lactation; Internal medicine; Obstetrics; Pediatrics; Chemistry; Pregnancy; Biology; Biochemistry; Genetics","score_opus":0.14616759093040865,"score_gpt":0.45379399226021105,"score_spread":0.3076264013298024,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2023176983","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96186894,0.0014605352,0.0017098761,0.02445084,0.003937849,0.001762462,0.000034078177,0.00022852918,0.004546881],"genre_scores_gemma":[0.9572454,0.0007305601,0.022356661,0.017876802,0.0013868391,0.00012795227,0.000013218421,0.000072754796,0.00018982386],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99726224,0.00045650057,0.00084569445,0.00059391017,0.00022994925,0.0006117356],"domain_scores_gemma":[0.99820435,0.00076984207,0.00028569033,0.00024695104,0.00017566043,0.00031751025],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0023847905,0.0002854881,0.00064266915,0.00015103318,0.00013768843,0.00004284747,0.00025833127,0.00042711914,0.00011102514],"category_scores_gemma":[0.00005637685,0.00024982824,0.00022238531,0.00030647995,0.00033684616,0.00030794824,0.00003452048,0.00086773525,0.000008688281],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0039651557,0.00444772,0.8548057,0.00015128302,0.0014174642,0.000024691686,0.0014064199,0.00010759296,0.02045259,0.00014421449,0.001209637,0.1118675],"study_design_scores_gemma":[0.04215955,0.0032824986,0.8338751,0.00024286,0.004759868,0.0012320854,0.0029058517,0.009831437,0.010951021,0.0006136853,0.08876121,0.0013848402],"about_ca_topic_score_codex":0.000015251857,"about_ca_topic_score_gemma":5.293176e-7,"teacher_disagreement_score":0.11048266,"about_ca_system_score_codex":0.00007472633,"about_ca_system_score_gemma":0.00020374813,"threshold_uncertainty_score":0.9999954},"labels":[],"label_agreement":null},{"id":"W2023380505","doi":"10.1016/j.clpt.2004.12.157","title":"Oxidative activation of linezolid to a reactive species: Implications for linezolid adverse drug reactions","year":2005,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Antimicrobial Resistance in Staphylococcus","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Linezolid; Viability assay; Pharmacology; Chemistry; Metabolite; Toxicity; Incubation; Biochemistry; Biology; Bacteria; Cell; Staphylococcus aureus","score_opus":0.11335789911548225,"score_gpt":0.4595326298042175,"score_spread":0.3461747306887353,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2023380505","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8742103,0.00006708,0.017898591,0.10191082,0.00070619414,0.0031321135,0.0002740226,0.000110092406,0.0016907735],"genre_scores_gemma":[0.92705154,0.00050452055,0.01804368,0.04907323,0.0018458256,0.00026354607,0.00006754001,0.00006112748,0.003089007],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9978258,0.0001338401,0.0010681459,0.00047649868,0.00013155126,0.0003641714],"domain_scores_gemma":[0.9957729,0.002188911,0.0004977157,0.00040336684,0.0008980088,0.00023907416],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047514963,0.00023561524,0.00060835975,0.0001775452,0.00013785859,0.000005409271,0.00022156382,0.00023331979,0.00017971171],"category_scores_gemma":[0.00027110145,0.00022421757,0.0003626492,0.0004261,0.0004140232,0.0000982813,0.000060471037,0.00051746354,0.00005622029],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034273884,0.0018518426,0.0025187111,0.0000470353,0.00088520156,9.463594e-7,0.0005827985,0.00017342145,0.94618964,0.00024894273,0.03757984,0.0064942604],"study_design_scores_gemma":[0.003773938,0.00070650864,0.039518006,0.00007870344,0.0012048973,0.000005023397,0.00036427265,0.00032290322,0.2960002,0.00021328109,0.65755635,0.00025591283],"about_ca_topic_score_codex":0.000005441391,"about_ca_topic_score_gemma":0.000010623032,"teacher_disagreement_score":0.6501894,"about_ca_system_score_codex":0.00023855887,"about_ca_system_score_gemma":0.00035320286,"threshold_uncertainty_score":0.91433275},"labels":[],"label_agreement":null},{"id":"W2023946039","doi":"10.1016/s0009-9236(03)90454-1","title":"Response Surface Analysis of Acetaminophen (APAP) Overdose Hepatotoxicity — Unmasking the Data","year":2003,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Drug-Induced Hepatotoxicity and Protection","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Purdue Pharma (Canada)","funders":"","keywords":"Acetaminophen; acetaminophen overdose; Drug overdose; Pharmacology; Medicine; Clinical pharmacology; Chemistry; Emergency medicine; Poison control; Acetylcysteine; Biochemistry","score_opus":0.46546555481481916,"score_gpt":0.55060402799214,"score_spread":0.08513847317732087,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2023946039","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98601043,0.00093580235,0.0007495385,0.0049355105,0.004744923,0.0011279032,0.00036223355,0.00015179848,0.0009818497],"genre_scores_gemma":[0.9541241,0.0015675804,0.00040473085,0.043019075,0.00027225682,0.000034693774,0.00006848344,0.000056109595,0.0004529884],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9821878,0.013772359,0.0016940073,0.0010401867,0.00041363412,0.00089197606],"domain_scores_gemma":[0.98687935,0.009751815,0.0011904313,0.001527943,0.000299674,0.00035076155],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.01476198,0.00052384875,0.0011935986,0.00026049948,0.0007308044,0.0000345027,0.0019255138,0.0011936914,0.0017647869],"category_scores_gemma":[0.00062156067,0.0004263392,0.0006068105,0.0020429941,0.0015764944,0.0002649691,0.0005007203,0.0030662657,0.00012181432],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015336339,0.0068246294,0.33262512,0.000110236455,0.048472777,0.0001436593,0.003205335,0.01727669,0.5401501,0.001061863,0.016753422,0.018039806],"study_design_scores_gemma":[0.006004256,0.0006924945,0.048715103,0.000016883863,0.02466598,0.000031592706,0.00041711834,0.06862703,0.16421041,0.0006024428,0.68502176,0.0009949252],"about_ca_topic_score_codex":0.000032526434,"about_ca_topic_score_gemma":0.00004339261,"teacher_disagreement_score":0.6682683,"about_ca_system_score_codex":0.00014620827,"about_ca_system_score_gemma":0.00045590408,"threshold_uncertainty_score":0.99981886},"labels":[],"label_agreement":null},{"id":"W2025753477","doi":"10.1038/clpt.2011.311","title":"Uncoupling the Dopamine D1–D2 Receptor Complex: A Novel Target for Antidepressant Treatment","year":2011,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Treatment of Major Depression","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"","keywords":"Antidepressant; Dopamine; Neurotransmitter; Dopamine receptor D2; Major depressive disorder; Norepinephrine; Depression (economics); Neurotransmitter receptor; Mood; Pharmacology; Dopamine receptor D3; Psychiatry; Medicine; Serotonin; Neurotransmitter systems; Psychology; Clinical pharmacology; Neuroscience; Internal medicine; Receptor","score_opus":0.34029955712793747,"score_gpt":0.45619462185437587,"score_spread":0.1158950647264384,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2025753477","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96070683,0.0024185868,0.0061528473,0.01950659,0.0047431015,0.0046856534,0.00019932601,0.00039208686,0.0011949717],"genre_scores_gemma":[0.93101007,0.002178038,0.033415776,0.029099226,0.0019997412,0.0004995383,0.00017257343,0.00013435545,0.0014906945],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9976665,0.00015799436,0.0008326363,0.00059680984,0.00020568963,0.00054038304],"domain_scores_gemma":[0.99732333,0.0014118963,0.00030740778,0.0005365279,0.00018324623,0.00023757643],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005695276,0.00038027158,0.00074405276,0.000062617124,0.00025394236,0.000012343166,0.00030812772,0.000276014,0.0008194043],"category_scores_gemma":[0.00003487761,0.00022200942,0.0004666209,0.00012777837,0.0005276513,0.000053314136,0.00009753275,0.00037779319,0.00009158916],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02923659,0.044036716,0.2666887,0.00020005614,0.017548392,0.00018071491,0.0017628602,0.00009040832,0.48672667,0.00023934545,0.06665641,0.08663311],"study_design_scores_gemma":[0.04447755,0.014068466,0.09396527,0.00008708572,0.00884128,0.00009211902,0.00020823553,0.008121822,0.07943989,0.0003193482,0.7497226,0.0006563345],"about_ca_topic_score_codex":0.000015287216,"about_ca_topic_score_gemma":0.000003542847,"teacher_disagreement_score":0.6830662,"about_ca_system_score_codex":0.00012208076,"about_ca_system_score_gemma":0.00015331096,"threshold_uncertainty_score":0.90532815},"labels":[],"label_agreement":null},{"id":"W2027045087","doi":"10.1038/sj.clpt.6100157","title":"The Effect of ABCB1 Polymorphism on the Pharmacokinetics of Saquinavir Alone and in Combination with Ritonavir","year":2007,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Canada; University of Ottawa; Ottawa Hospital","funders":"Ontario HIV Treatment Network","keywords":"Saquinavir; Pharmacokinetics; Ritonavir; Pharmacology; P-glycoprotein; Medicine; Genotype; Peripheral blood mononuclear cell; Internal medicine; Immunology; Biology; Genetics; Gene; Viral load","score_opus":0.030320072385052604,"score_gpt":0.37548348537386395,"score_spread":0.34516341298881137,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2027045087","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9896,0.0011564448,0.00012764799,0.0075284583,0.00049705215,0.0008064291,0.000004086768,0.000014017034,0.00026587697],"genre_scores_gemma":[0.9937095,0.0015947581,0.00006756175,0.004371373,0.00010395553,0.000013370057,0.000004046582,0.000021109508,0.00011433299],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99841064,0.00026540333,0.0006304437,0.00019374194,0.00024697403,0.00025276645],"domain_scores_gemma":[0.9963115,0.003102763,0.00023734245,0.00019788391,0.00007768554,0.00007280998],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022564686,0.00016606158,0.00044919754,0.000061978404,0.00007526682,0.0000029844614,0.00016276438,0.00014629122,0.000018920256],"category_scores_gemma":[0.000013742544,0.00007981465,0.00009684417,0.00022062339,0.0009955127,0.000016926482,0.00001972993,0.0005733681,0.00000172215],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06773744,0.0032535328,0.3904327,0.00035465293,0.0021448832,0.0002494964,0.00064543844,0.000033121254,0.45775828,0.00088752876,0.0006608779,0.07584209],"study_design_scores_gemma":[0.021098027,0.009449694,0.35925382,0.0001886441,0.001959105,0.000021697077,0.000120725876,0.00037719237,0.5987255,0.00027663363,0.008332283,0.0001966842],"about_ca_topic_score_codex":0.0000036770496,"about_ca_topic_score_gemma":0.0000118194,"teacher_disagreement_score":0.14096723,"about_ca_system_score_codex":0.000019740912,"about_ca_system_score_gemma":0.000041397867,"threshold_uncertainty_score":0.3668008},"labels":[],"label_agreement":null},{"id":"W2027255015","doi":"10.1038/clpt.2013.74","title":"Emerging Transporters of Clinical Importance: An Update From the International Transporter Consortium","year":2013,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":345,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"National Institute of General Medical Sciences","keywords":"Multidrug resistance-associated protein 2; Transporter; Bile Salt Export Pump; Abcg2; Pharmacology; Efflux; Drug; ATP-binding cassette transporter; Cholestasis; Pharmacokinetics; Chemistry; Medicine; Biochemistry; Internal medicine; Gene","score_opus":0.2187098658280976,"score_gpt":0.5060868766921303,"score_spread":0.28737701086403267,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2027255015","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.010229066,0.96819663,0.00033380787,0.0047208853,0.013304677,0.0022378836,0.0006096607,0.00013117824,0.000236217],"genre_scores_gemma":[0.00085312413,0.96350753,0.0008872534,0.029462116,0.0030622378,0.00011278863,0.0016795718,0.00014790938,0.0002874522],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9916028,0.0006315047,0.0055201035,0.0011032195,0.00058295694,0.00055943243],"domain_scores_gemma":[0.99515814,0.0013025549,0.0018775221,0.0009414276,0.00027999407,0.0004403553],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0021006237,0.00074774836,0.004351147,0.00010522092,0.00009826715,0.000019546578,0.0013306753,0.0013335781,0.004194701],"category_scores_gemma":[0.000013540218,0.0004580714,0.0028420966,0.00023286157,0.0012557242,0.00012241089,0.000034129574,0.0026867855,0.00009773424],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011025958,0.0021742631,0.013780811,0.0013890126,0.012868213,0.00033449594,0.00019716096,8.095108e-7,0.000049323,0.000038750593,0.008516603,0.95954794],"study_design_scores_gemma":[0.0031214638,0.00038113465,0.0025416852,0.0012580224,0.023897529,0.000016544693,0.00008013758,0.00004519392,0.000018236859,0.000084009036,0.96812564,0.00043038462],"about_ca_topic_score_codex":0.000010122649,"about_ca_topic_score_gemma":0.000030316916,"teacher_disagreement_score":0.95960903,"about_ca_system_score_codex":0.000044552435,"about_ca_system_score_gemma":0.0009349567,"threshold_uncertainty_score":0.9999629},"labels":[],"label_agreement":null},{"id":"W2027744617","doi":"10.1038/clpt.2010.184","title":"Dipeptidyl Peptidase-4 Inhibitors Administered in Combination With Metformin Result in an Additive Increase in the Plasma Concentration of Active GLP-1","year":2010,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":177,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Metformin; Incretin; Glucagon-like peptide-1; In vivo; Dipeptidyl peptidase; Endocrinology; Internal medicine; Chemistry; Glucagon; Pharmacology; Dipeptidyl peptidase-4; Pharmacokinetics; Small intestine; Type 2 diabetes; Diabetes mellitus; Hormone; Medicine; Biology; Biochemistry; Enzyme","score_opus":0.05141449335925543,"score_gpt":0.39199612142172,"score_spread":0.3405816280624646,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2027744617","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953278,0.000018251505,0.0000022173185,0.0020844333,0.00026517524,0.0014294175,0.000022593349,0.000014586072,0.00083557796],"genre_scores_gemma":[0.99482995,0.000109603105,0.00020042597,0.004389615,0.000104402694,0.00014359993,0.00016911745,0.000015370195,0.00003794019],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99809486,0.0004931544,0.0006585059,0.00029634152,0.00020006437,0.00025706715],"domain_scores_gemma":[0.9984033,0.0009574752,0.0002553667,0.00020300191,0.000099383105,0.000081446786],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00092972734,0.00017465885,0.00040641875,0.00015620442,0.000026066571,0.000009467488,0.00015181513,0.000187276,0.00005904083],"category_scores_gemma":[0.000049998587,0.000120762474,0.00005955192,0.00035338377,0.00038625265,0.00017840196,0.000031157164,0.0006861844,0.0000049016708],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03152618,0.03347486,0.66699594,0.00011160778,0.0010695013,0.0006790124,0.014366735,0.000029678631,0.045400023,0.0007705381,0.0014103986,0.20416553],"study_design_scores_gemma":[0.052457437,0.010519946,0.8837592,0.00016420743,0.0011393268,0.000008980938,0.0039424086,0.003322537,0.03786656,0.00029302647,0.006180514,0.00034587947],"about_ca_topic_score_codex":0.000034763147,"about_ca_topic_score_gemma":0.0009543792,"teacher_disagreement_score":0.21676324,"about_ca_system_score_codex":0.00007537122,"about_ca_system_score_gemma":0.00013959258,"threshold_uncertainty_score":0.49245507},"labels":[],"label_agreement":null},{"id":"W2027851095","doi":"10.1038/clpt.2011.280","title":"Prediction of Codeine Toxicity in Infants and Their Mothers Using a Novel Combination of Maternal Genetic Markers","year":2012,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":80,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital; Hospital for Sick Children; University of British Columbia; Child and Family Research Institute","funders":"Canadian Institutes of Health Research","keywords":"Codeine; Medicine; CYP2D6; Odds ratio; Pharmacogenetics; Catechol-O-methyl transferase; Depression (economics); Opioid; Genotype; Clinical pharmacology; Pharmacology; Breastfeeding; Internal medicine; Bioinformatics; Pediatrics; Biology; Genetics; Receptor; Morphine; Gene; Cytochrome P450","score_opus":0.25220514093363794,"score_gpt":0.47173391498590633,"score_spread":0.2195287740522684,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2027851095","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99117255,0.003327422,0.00092357944,0.0002760941,0.0033145808,0.00056969747,0.00023104154,0.000025586784,0.00015947061],"genre_scores_gemma":[0.9901591,0.0037088364,0.0010029502,0.004684424,0.00036270067,0.000017288152,0.000008364015,0.000037746937,0.000018595281],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.996775,0.00094408967,0.0012753052,0.00030796012,0.00015559379,0.00054208946],"domain_scores_gemma":[0.99799985,0.0008233392,0.00058838964,0.00017112211,0.00015137525,0.00026593334],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.002004828,0.0002973911,0.0006677041,0.00022624298,0.000077053905,0.000004946401,0.00028192173,0.0005082643,0.00031611396],"category_scores_gemma":[0.000027811102,0.00027384685,0.00014997447,0.00028489355,0.0008372651,0.00013038467,0.00014823514,0.0007678252,0.0000029438936],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010960511,0.0017198799,0.42996424,0.000057157213,0.00050214195,0.0000013158818,0.0006202781,0.00061362406,0.5537344,0.000030885683,0.0000790614,0.011580937],"study_design_scores_gemma":[0.010506165,0.000391465,0.63784677,0.000032254266,0.0010931018,0.000033592278,0.00014446148,0.08115508,0.26023585,0.00025258044,0.008006582,0.000302106],"about_ca_topic_score_codex":0.000017560014,"about_ca_topic_score_gemma":0.0000024555068,"teacher_disagreement_score":0.29349858,"about_ca_system_score_codex":0.00004776359,"about_ca_system_score_gemma":0.0000970241,"threshold_uncertainty_score":0.9999714},"labels":[],"label_agreement":null},{"id":"W2028492424","doi":"10.1016/j.clpt.2005.02.002","title":"The use of tegaserod in critically ill patients with impaired gastric motility","year":2005,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Gastrointestinal motility and disorders","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; Dalhousie University","funders":"","keywords":"Tegaserod; Cisapride; Gastroparesis; Medicine; Domperidone; Gastric emptying; Metoclopramide; Partial agonist; Intensive care unit; Irritable bowel syndrome; Intensive care medicine; Internal medicine; Adverse effect; Parenteral nutrition; Gastroenterology; Agonist; Stomach; Vomiting","score_opus":0.1052418375876186,"score_gpt":0.3869726681467358,"score_spread":0.2817308305591172,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2028492424","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9786292,0.00009808073,0.00022627435,0.020215457,0.0001620289,0.00057721336,0.000012221758,0.000032289765,0.0000472691],"genre_scores_gemma":[0.9376994,0.00010611249,0.0031167078,0.05891221,0.000082560124,0.000011793007,0.0000088197585,0.000017190803,0.000045234203],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978985,0.0003836782,0.00079920655,0.00029676143,0.00021828097,0.00040354615],"domain_scores_gemma":[0.9963705,0.0020363291,0.00013719483,0.00030816038,0.0009649857,0.00018283022],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00053222047,0.00017216393,0.0004022711,0.00005399419,0.000059536593,0.000009580344,0.00016851585,0.00012258832,0.00007282428],"category_scores_gemma":[0.00069785025,0.00010999087,0.00013809727,0.00023887905,0.0010034057,0.00008738798,0.00005297905,0.0006379754,0.000013200762],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004278119,0.003754781,0.97445333,0.00002180213,0.00014747343,0.000008309703,0.00004370743,0.0000825172,0.00015088143,0.000005397843,0.0010290605,0.01602464],"study_design_scores_gemma":[0.006435398,0.0025229566,0.9779649,0.000027372651,0.0003985417,0.000007605044,0.000040619558,0.0018319841,0.00006868678,0.00003785498,0.0105916215,0.00007246517],"about_ca_topic_score_codex":0.00000883968,"about_ca_topic_score_gemma":0.000045701494,"teacher_disagreement_score":0.040929794,"about_ca_system_score_codex":0.00005014986,"about_ca_system_score_gemma":0.00015885159,"threshold_uncertainty_score":0.44852975},"labels":[],"label_agreement":null},{"id":"W2028657603","doi":"10.1016/j.clpt.2005.11.010","title":"Pomelo juice, but not cranberry juice, affects the pharmacokinetics of cyclosporine in humans","year":2006,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pineapple and bromelain studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":97,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"CRANBERRY JUICE; Grapefruit juice; Bioavailability; Pharmacokinetics; Crossover study; Cmax; Pharmacology; Chemistry; Oral administration; CYP3A4; Ciclosporin; Medicine; Food science; Placebo; Internal medicine; Cytochrome P450; Chemotherapy; Biochemistry; Metabolism","score_opus":0.03788078406829018,"score_gpt":0.3734771202042271,"score_spread":0.33559633613593687,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2028657603","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9898729,0.003745794,0.00009839609,0.0030298373,0.0012017814,0.0004590717,0.00005762049,0.000022765476,0.0015118404],"genre_scores_gemma":[0.97441214,0.0073138676,0.00014625181,0.015487362,0.0015513477,0.000049657276,0.000064936045,0.00004079782,0.000933614],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9977311,0.00034378414,0.00077868253,0.0004800712,0.00018879495,0.00047758973],"domain_scores_gemma":[0.9987547,0.0003959268,0.00028675536,0.00037163222,0.00012588753,0.000065101485],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006793203,0.00030085567,0.00049996417,0.000067191846,0.00011107201,0.000009203638,0.0005310939,0.0003032823,0.00006933979],"category_scores_gemma":[0.00001920011,0.00022989884,0.00026178954,0.0002400791,0.0006556398,0.000005178637,0.0002640347,0.00048259096,0.000022403607],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00081934384,0.0012511108,0.058273524,0.00004862118,0.0006795643,0.000030628413,0.00005070057,0.00021865904,0.8945893,0.00006027539,0.04210026,0.0018779889],"study_design_scores_gemma":[0.005862626,0.000970508,0.16026475,0.000019652965,0.00079403806,0.00001151377,0.00009047252,0.00019560092,0.37409392,0.00023420237,0.45691752,0.0005452202],"about_ca_topic_score_codex":0.000029386172,"about_ca_topic_score_gemma":0.00005740771,"teacher_disagreement_score":0.5204954,"about_ca_system_score_codex":0.000015802661,"about_ca_system_score_gemma":0.000078456455,"threshold_uncertainty_score":0.93750024},"labels":[],"label_agreement":null},{"id":"W2028783301","doi":"10.1016/s0009-9236(03)90600-x","title":"Long‐term pharmacotherapy for weight loss in patients with obesity","year":2003,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacology and Obesity Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; University of Toronto; University of Calgary; Sunnybrook Health Science Centre","funders":"","keywords":"Pharmacotherapy; Medicine; Clinical pharmacology; Obesity; Weight loss; Term (time); Intensive care medicine; Pharmacology; Internal medicine","score_opus":0.05414500022239279,"score_gpt":0.4144085399750633,"score_spread":0.3602635397526705,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2028783301","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9923871,0.00084209716,0.00046373295,0.0022589213,0.0015585498,0.0021760836,0.000023547274,0.00008379539,0.00020614364],"genre_scores_gemma":[0.92576766,0.001976888,0.0008270976,0.070470504,0.0003119676,0.0001693336,0.000051559735,0.00005996815,0.00036503078],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99737656,0.00047145595,0.0006818372,0.0006051019,0.0001999889,0.0006650541],"domain_scores_gemma":[0.9983489,0.00066578074,0.00019774974,0.00025996802,0.00021618753,0.00031140647],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00062378636,0.00037131127,0.000763173,0.00012841541,0.00014249519,0.000007215445,0.00019404951,0.0003608187,0.00072678406],"category_scores_gemma":[0.000011392347,0.0002865993,0.00024752202,0.00022883422,0.0004986643,0.000092190836,0.000025038942,0.0007129233,0.000061667924],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007902593,0.010815491,0.9731196,0.000048487498,0.0016952527,0.000116490635,0.00007781762,0.0000065985037,0.0006026253,0.000022936001,0.0030119834,0.0025800988],"study_design_scores_gemma":[0.056231514,0.002724193,0.8977775,0.000025178017,0.0021343494,0.000014361157,0.000002890502,0.000043632706,0.01049812,0.00009612732,0.030139554,0.00031260462],"about_ca_topic_score_codex":7.6615504e-7,"about_ca_topic_score_gemma":0.0000035552507,"teacher_disagreement_score":0.075342156,"about_ca_system_score_codex":0.00017203721,"about_ca_system_score_gemma":0.0002661674,"threshold_uncertainty_score":0.99995863},"labels":[],"label_agreement":null},{"id":"W2028870144","doi":"10.1016/s0009-9236(03)90393-6","title":"Identification of cellular proteins targeted by reactive sulphonamide metabolites and their relation to adverse drug reactions","year":2003,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Analytical Methods in Pharmaceuticals","field":"Chemistry","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Drug; Identification (biology); Pharmacology; Drug reaction; Clinical pharmacology; Chemistry; Drug metabolism; Medicine; Computational biology; Biology","score_opus":0.060915774302148944,"score_gpt":0.4112708383764259,"score_spread":0.35035506407427697,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2028870144","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9704162,0.0017922672,0.022356344,0.0025263503,0.0007668589,0.0006967678,0.00014664276,0.00013153009,0.0011670758],"genre_scores_gemma":[0.9891458,0.0007702262,0.0046260087,0.003773894,0.00015870648,0.000094682444,0.000027383414,0.000053991924,0.0013493077],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99654335,0.0009194244,0.0013688784,0.00060268404,0.00019867352,0.00036700704],"domain_scores_gemma":[0.99547946,0.0030047265,0.0005287297,0.00039957193,0.00028227287,0.00030524874],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.002005247,0.0002873684,0.0005615156,0.00009020491,0.00014000101,0.000012322653,0.00025570288,0.00033073005,0.00060171826],"category_scores_gemma":[0.000704509,0.0002598205,0.00021016199,0.00033445528,0.00060985354,0.0001400761,0.00007242331,0.00083998666,0.0000380476],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019551403,0.0005837799,0.001620294,0.000037366313,0.00064452627,0.0000017038029,0.00025658292,0.000022428294,0.9936083,0.00049785466,0.00076779345,0.0017638541],"study_design_scores_gemma":[0.0009526289,0.000041216237,0.00054552476,0.000013738822,0.0007915612,0.0000026099492,0.0002933364,0.0013759948,0.93073225,0.0028988072,0.06211228,0.00024006072],"about_ca_topic_score_codex":0.0000045041725,"about_ca_topic_score_gemma":4.027479e-7,"teacher_disagreement_score":0.06287606,"about_ca_system_score_codex":0.00007869271,"about_ca_system_score_gemma":0.00008706475,"threshold_uncertainty_score":0.9999854},"labels":[],"label_agreement":null},{"id":"W2030370251","doi":"10.1016/s0009-9236(03)90529-7","title":"The Single‐Dose Pharmacokinetics of Clopidogrel in Healthy Adult Volunteers","year":2003,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pharmaxis (Canada)","funders":"","keywords":"Pharmacokinetics; Clopidogrel; Medicine; Pharmacology; Internal medicine; Aspirin","score_opus":0.06607649872153568,"score_gpt":0.4036290090279938,"score_spread":0.33755251030645816,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2030370251","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9737951,0.015907144,0.00016487647,0.006267894,0.0021584397,0.0007434566,0.000008118863,0.000051961695,0.0009029788],"genre_scores_gemma":[0.915179,0.030927291,0.000224825,0.053130396,0.00032565414,0.000026580841,0.0000059270947,0.000041476167,0.00013883442],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9969099,0.00092117605,0.0010235278,0.0003534174,0.00029436706,0.0004976249],"domain_scores_gemma":[0.9980228,0.00091725856,0.00019871217,0.00038078972,0.00025810814,0.00022233256],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001139839,0.00023393637,0.00064922177,0.00007410811,0.00011105277,0.000008420243,0.00023200597,0.00024336786,0.00012482898],"category_scores_gemma":[0.000089764915,0.0001707638,0.00057966803,0.00034227557,0.0008849566,0.000035625297,0.0000329092,0.0007120413,0.000029570592],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.057949696,0.021656686,0.42088985,0.0006323298,0.020172672,0.0007931578,0.0012218056,0.00052092934,0.05675936,0.0019706634,0.031661835,0.385771],"study_design_scores_gemma":[0.04610802,0.0057765194,0.058068205,0.00011389419,0.0048656105,0.00016905628,0.0006822059,0.0013309671,0.018188586,0.0005478226,0.8634852,0.00066392496],"about_ca_topic_score_codex":0.0000032302848,"about_ca_topic_score_gemma":0.0000048536563,"teacher_disagreement_score":0.83182335,"about_ca_system_score_codex":0.00005889141,"about_ca_system_score_gemma":0.00028474524,"threshold_uncertainty_score":0.69635457},"labels":[],"label_agreement":null},{"id":"W2030471578","doi":"10.1016/j.clpt.2004.02.011","title":"Nicotine metabolite ratio as an index of cytochrome P450 2A6 metabolic activity*1","year":2004,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Nicotinic Acetylcholine Receptors Study","field":"Biochemistry, Genetics and Molecular Biology","cited_by":434,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Addiction and Mental Health","funders":"National Center for Research Resources; National Institute on Drug Abuse","keywords":"CYP2A6; Cotinine; Nicotine; Metabolite; Chemistry; Saliva; Pharmacology; Oral administration; Metabolism; Internal medicine; Cytochrome P450; Medicine; Biochemistry; CYP1A2","score_opus":0.04141083576189477,"score_gpt":0.41391024601281284,"score_spread":0.3724994102509181,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2030471578","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9919684,0.0021782855,0.002241384,0.001627477,0.0010117627,0.00062619784,0.000036298883,0.000050755745,0.00025941714],"genre_scores_gemma":[0.9799882,0.0035485541,0.0007591904,0.0136810625,0.0015478313,0.000047328922,0.00006494485,0.00007832233,0.0002845516],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9967316,0.000683078,0.0009570384,0.0008036495,0.00026948992,0.00055516156],"domain_scores_gemma":[0.998075,0.00012509554,0.00050366967,0.0007204028,0.00028862138,0.0002871774],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009214993,0.00040671593,0.0008352208,0.00008825263,0.00011388013,0.000016512007,0.00070445094,0.000572411,0.00015001663],"category_scores_gemma":[0.00006875292,0.00037899852,0.00041253434,0.00027382356,0.0006864824,0.000020784462,0.00031546224,0.0006519274,0.000063251355],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008369136,0.0024362705,0.0039472184,0.00001141248,0.0015113753,0.0000012158733,0.00008654751,0.00027531924,0.98569816,0.00013856422,0.00031639115,0.0047406075],"study_design_scores_gemma":[0.0069054617,0.0018249757,0.014858173,0.000005355595,0.0009974688,0.000023392235,0.000046922225,0.00010679996,0.8971341,0.00026352552,0.077396594,0.00043723092],"about_ca_topic_score_codex":0.000023937107,"about_ca_topic_score_gemma":0.000016058295,"teacher_disagreement_score":0.08856407,"about_ca_system_score_codex":0.000023637383,"about_ca_system_score_gemma":0.0005168783,"threshold_uncertainty_score":0.9998662},"labels":[],"label_agreement":null},{"id":"W2031083224","doi":"10.1038/clpt.2013.12","title":"International Transporter Consortium Commentary on Clinically Important Transporter Polymorphisms","year":2013,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":163,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Innovation Cluster (Canada)","funders":"National Institute of General Medical Sciences","keywords":"Clinical pharmacology; Transporter; Pharmacodynamics; Pharmacology; Pharmacogenetics; Pharmacokinetics; Allele; Medicine; Biology; Genetics; Computational biology; Gene; Genotype","score_opus":0.04790878477863259,"score_gpt":0.37891199581743323,"score_spread":0.33100321103880065,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2031083224","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.78434604,0.00023199877,0.00094670564,0.20143974,0.007984171,0.0014864623,0.00009147201,0.00025826838,0.003215172],"genre_scores_gemma":[0.60926,0.0016519957,0.00095717376,0.38558802,0.0013124716,0.000075181844,0.00018884131,0.00006096376,0.0009053032],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99565065,0.00014163082,0.0024299445,0.0007140678,0.00045641258,0.00060730975],"domain_scores_gemma":[0.99810207,0.00036307654,0.00039440053,0.00044149384,0.0001949828,0.0005039694],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007426069,0.00042530516,0.000878093,0.0001245822,0.00010789818,0.000020185427,0.0004287242,0.00049400475,0.009572286],"category_scores_gemma":[0.000004382829,0.00033124018,0.0007427586,0.0001311155,0.00068078516,0.000111833266,0.000017051945,0.0012271332,0.0003573334],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010572283,0.011830002,0.68253887,0.00008750612,0.0074894913,0.0016289534,0.0006221878,0.000010411932,0.0657979,0.000118816955,0.18976793,0.029535647],"study_design_scores_gemma":[0.019429721,0.003710736,0.34844047,0.0001308577,0.0041468358,0.00006698373,0.00017095977,0.00069265655,0.007829131,0.00061285205,0.61385244,0.000916375],"about_ca_topic_score_codex":0.000010511486,"about_ca_topic_score_gemma":0.000004352644,"teacher_disagreement_score":0.4240845,"about_ca_system_score_codex":0.000058281134,"about_ca_system_score_gemma":0.00012701395,"threshold_uncertainty_score":0.999914},"labels":[],"label_agreement":null},{"id":"W2031189352","doi":"10.1038/clpt.2012.141","title":"Prenatal and Perinatal Environmental Influences on the Human Fetal and Placental Epigenome","year":2012,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Birth, Development, and Health","field":"Medicine","cited_by":91,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Child and Family Research Institute; University of British Columbia","funders":"","keywords":"Epigenome; Epigenetics; Placenta; In utero; Fetus; Physiology; Pregnancy; Fetal programming; Endocrine system; Epigenesis; Bioinformatics; Medicine; Biology; Hormone; Endocrinology; DNA methylation; Genetics","score_opus":0.18853038322307775,"score_gpt":0.4657378177008968,"score_spread":0.27720743447781904,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2031189352","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.10938237,0.8870435,4.5802304e-7,0.00094773434,0.0008911254,0.001305487,0.00009464871,0.000036155183,0.00029853804],"genre_scores_gemma":[0.016289525,0.964923,0.00004489152,0.017396323,0.0010421391,0.00007557778,0.00007858118,0.00006116426,0.000088794535],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9971417,0.00053807686,0.0009422611,0.00058104075,0.00023452521,0.00056237425],"domain_scores_gemma":[0.99803305,0.00092124566,0.0003807438,0.00024681955,0.000011520858,0.00040664102],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00086702727,0.0005133337,0.001426372,0.00008358599,0.00039063886,0.000023327664,0.0002305303,0.0006286044,0.00044799838],"category_scores_gemma":[0.0000069574517,0.0003179981,0.00026528467,0.00006401592,0.0015117273,0.000056153913,0.00025575949,0.0018609219,0.00010897838],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035181412,0.0014655234,0.029904477,0.008937377,0.0043712435,0.00014413097,0.00068516785,2.5591744e-8,0.00005512431,0.001023858,0.0007074066,0.95235384],"study_design_scores_gemma":[0.0017745456,0.00091159606,0.022503579,0.0008589688,0.0046261516,0.0003231249,0.00006806012,0.0000030692597,0.000009798768,0.00010685255,0.9683887,0.00042560443],"about_ca_topic_score_codex":0.0000018816654,"about_ca_topic_score_gemma":0.0000011501257,"teacher_disagreement_score":0.9676812,"about_ca_system_score_codex":0.00012643135,"about_ca_system_score_gemma":0.0002267705,"threshold_uncertainty_score":0.9999272},"labels":[],"label_agreement":null},{"id":"W2031270991","doi":"10.1038/clpt.2011.2","title":"Use of Transgenic and Knockout Mouse Models to Assess Solute Carrier Transporter Function","year":2011,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lawson Health Research Institute; Western University","funders":"Canadian Institutes of Health Research","keywords":"Transporter; Solute carrier family; Function (biology); In vivo; Pharmacology; Drug; Endogeny; Knockout mouse; Xenobiotic; Genetically modified mouse; Transgene; Computational biology; Biology; Chemistry; Cell biology; Biochemistry; Genetics; Gene; Enzyme","score_opus":0.4428199905092029,"score_gpt":0.4043460352897484,"score_spread":0.038473955219454514,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2031270991","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96986645,0.00023088677,0.02716105,0.0008141823,0.0009914795,0.00063037727,0.000051611234,0.00007293991,0.0001810242],"genre_scores_gemma":[0.9757059,0.0010896921,0.002464396,0.019517545,0.0001508599,0.000026420026,0.000015046122,0.00004902893,0.0009811042],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982331,0.00010755086,0.0007517172,0.00040052077,0.00017579469,0.00033131088],"domain_scores_gemma":[0.9990435,0.000115717536,0.000110865105,0.0002499454,0.00015407334,0.00032589654],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036284927,0.00022240203,0.0006140627,0.00009297013,0.000055724082,0.0000046210603,0.000111277106,0.00032058032,0.00032240842],"category_scores_gemma":[0.0000014448844,0.00018263175,0.0002584643,0.00013182164,0.00028122697,0.00013660087,0.000011209384,0.00041945698,0.000006459141],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03334396,0.005338406,0.046728633,0.000534832,0.0076679606,0.00018868262,0.008432329,0.00020640435,0.8522391,0.00070573343,0.002434225,0.04217977],"study_design_scores_gemma":[0.02953191,0.012541623,0.32427877,0.00027290816,0.037320893,0.000058587197,0.0010089114,0.0058438815,0.4980043,0.0027680935,0.08621102,0.0021591273],"about_ca_topic_score_codex":0.000011192823,"about_ca_topic_score_gemma":0.000023944525,"teacher_disagreement_score":0.35423478,"about_ca_system_score_codex":0.00001528684,"about_ca_system_score_gemma":0.00010204238,"threshold_uncertainty_score":0.7447506},"labels":[],"label_agreement":null},{"id":"W2032376737","doi":"10.1038/clpt.2008.18","title":"Mass Spectrometry–Based Proteomics: A Useful Tool for Biomarker Discovery?","year":2008,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Advanced Proteomics Techniques and Applications","field":"Chemistry","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; University of Toronto","funders":"Canadian Institutes of Health Research","keywords":"Biomarker discovery; False positive paradox; Biomarker; Proteomics; Computational biology; Mass spectrometry; False positives and false negatives; Drug discovery; Computer science; Bioinformatics; Chemistry; Biology; Chromatography; Artificial intelligence","score_opus":0.10526921454691712,"score_gpt":0.41547543097784956,"score_spread":0.31020621643093244,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2032376737","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.40500447,0.00012825207,0.5889933,0.0037036142,0.00023864668,0.0010120304,0.00017641875,0.00029985528,0.0004433904],"genre_scores_gemma":[0.43239212,0.0008956997,0.53797305,0.023944093,0.00094393664,0.0019047742,0.00009755404,0.00012806396,0.0017207221],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99798054,0.000054036424,0.0007519872,0.000598354,0.00012859976,0.00048647754],"domain_scores_gemma":[0.99814427,0.0008223723,0.00030692483,0.0004919871,0.000120813005,0.000113647155],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00030141565,0.00028522284,0.00042900466,0.00005897173,0.00027219264,0.000023506658,0.00050688675,0.00038074373,0.0003554423],"category_scores_gemma":[0.000028526429,0.00027066786,0.00038814166,0.00018320112,0.00053978694,0.000115733375,0.000067627276,0.0005451076,0.000029617375],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00074715336,0.0006891193,0.009420817,0.000045520956,0.00034083522,0.000010481403,0.000013661364,0.00002867599,0.9831325,0.00018854189,0.004775673,0.000607057],"study_design_scores_gemma":[0.0045368588,0.0002406611,0.0006643988,0.000017323171,0.00047346792,0.000018971998,0.000010626255,0.0065863915,0.87371236,0.006873494,0.106213704,0.0006517624],"about_ca_topic_score_codex":9.570358e-7,"about_ca_topic_score_gemma":2.3540356e-7,"teacher_disagreement_score":0.10942012,"about_ca_system_score_codex":0.00010443407,"about_ca_system_score_gemma":0.00018356644,"threshold_uncertainty_score":0.99997455},"labels":[],"label_agreement":null},{"id":"W2033129224","doi":"10.1016/s0009-9236(03)90528-5","title":"Bazedoxifene Acetate Metabolic Disposition in Healthy, Postmenopausal Women","year":2003,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's Health Research Institute","funders":"","keywords":"Disposition; Clinical pharmacology; Pharmacology; Medicine; Postmenopausal women; Metabolic clearance rate; Pharmacokinetics; Internal medicine; Physiology; Endocrinology; Psychology","score_opus":0.026213184115484907,"score_gpt":0.37533872057791173,"score_spread":0.34912553646242683,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2033129224","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9895583,0.0069475784,0.00007463553,0.0012233222,0.0012971987,0.00037202088,0.0000072518787,0.00002404996,0.00049568916],"genre_scores_gemma":[0.95883805,0.008860127,0.00024410074,0.031430762,0.0003071822,0.00006767967,0.00004067796,0.000038934206,0.00017246674],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9973857,0.000950313,0.0005305093,0.00046102528,0.000097017575,0.0005754294],"domain_scores_gemma":[0.999264,0.00009670828,0.00013261393,0.00023585999,0.000051260187,0.00021954114],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00085314777,0.00022722779,0.0003567172,0.00006038917,0.00008239836,0.000010861383,0.00019185581,0.00045356047,0.00006576468],"category_scores_gemma":[0.00002000304,0.00020454409,0.00011508668,0.0001704513,0.00023117755,0.000005667435,0.000057101566,0.0005153128,0.00006114582],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032241119,0.0018621162,0.011269769,0.000019569447,0.0011033951,0.00005886595,0.00016002356,0.00013758983,0.97423494,0.00020831074,0.0019177039,0.0058036316],"study_design_scores_gemma":[0.023985712,0.013560319,0.03601393,0.000020543892,0.0009310293,0.00017223263,0.00017955141,0.00039109212,0.41718122,0.00090825063,0.50528705,0.0013690623],"about_ca_topic_score_codex":0.0000017674171,"about_ca_topic_score_gemma":0.000002012476,"teacher_disagreement_score":0.5570537,"about_ca_system_score_codex":0.000032946402,"about_ca_system_score_gemma":0.00016637566,"threshold_uncertainty_score":0.8341066},"labels":[],"label_agreement":null},{"id":"W2035076759","doi":"10.1038/clpt.2013.55","title":"HLA-A*31:01 and HLA-B*15:02 as Genetic Markers for Carbamazepine Hypersensitivity in Children","year":2013,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Drug-Induced Adverse Reactions","field":"Medicine","cited_by":128,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; Western University; Child and Family Research Institute; University of British Columbia; University of Toronto; BC Children's Hospital","funders":"Canadian Institutes of Health Research","keywords":"Carbamazepine; Human leukocyte antigen; Odds ratio; Medicine; HLA-B; Immunology; Toxic epidermal necrolysis; Anticonvulsant; Antigen; Internal medicine; Epilepsy; Dermatology; Psychiatry","score_opus":0.05152755621598248,"score_gpt":0.4003833235151647,"score_spread":0.3488557672991822,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2035076759","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9824325,0.00040702647,0.000042079588,0.011863999,0.0009716908,0.0022021614,0.000020019048,0.00008834085,0.0019722204],"genre_scores_gemma":[0.9565684,0.0013321419,0.0011377212,0.03937801,0.0007297418,0.00014536794,0.000028112698,0.000061009032,0.0006194771],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99776286,0.0002658189,0.000682377,0.00058564724,0.00015098594,0.0005523263],"domain_scores_gemma":[0.99784887,0.0011717245,0.00016784598,0.0003104867,0.00014443872,0.00035661695],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004918104,0.00029077975,0.0006766679,0.00014795059,0.00009716004,0.000016566752,0.00012119264,0.00040427953,0.0000898545],"category_scores_gemma":[0.00009585186,0.00026992976,0.00022760409,0.00020196453,0.0005195178,0.00009182474,0.00008622359,0.00081722904,0.00018146714],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00081849296,0.0036135428,0.33944452,0.00010738305,0.0037180488,0.00013289515,0.00029186206,0.000059925453,0.10382664,0.000025745869,0.0091724405,0.5387885],"study_design_scores_gemma":[0.008327956,0.00038086306,0.9578545,0.000028081902,0.0016130416,0.00026518296,0.00012709139,0.0033658107,0.00100367,0.0001918446,0.026533395,0.00030858107],"about_ca_topic_score_codex":0.000095342766,"about_ca_topic_score_gemma":0.000013987619,"teacher_disagreement_score":0.61840993,"about_ca_system_score_codex":0.00011756542,"about_ca_system_score_gemma":0.00023541684,"threshold_uncertainty_score":0.99997526},"labels":[],"label_agreement":null},{"id":"W2035965846","doi":"10.1016/j.clpt.2003.10.007","title":"Systemic Exposure to Morphine and the Risk of Acute Chest Syndrome in Sickle Cell Disease","year":2004,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":97,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medicine; Morphine; Acute chest syndrome; Anesthesia; Placebo; Pharmacokinetics; Vaso-occlusive crisis; Area under the curve; Internal medicine; Gastroenterology; Disease; Sickle cell anemia; Pathology","score_opus":0.021496873292248263,"score_gpt":0.3346842541764396,"score_spread":0.31318738088419135,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2035965846","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9706788,0.0050962656,0.00006771603,0.022609118,0.0004866487,0.0009391548,0.000024953359,0.000027658158,0.000069692156],"genre_scores_gemma":[0.9679643,0.012026912,0.000108224915,0.019653887,0.00007360445,0.000030310372,0.000005094664,0.00002309376,0.00011459912],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99837804,0.00027172326,0.00067999057,0.00027723835,0.00013307313,0.00025993778],"domain_scores_gemma":[0.99884856,0.00040281177,0.00017023717,0.0002566878,0.00006056917,0.00026112457],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00070922775,0.00017033708,0.0005932008,0.00006557273,0.000056145953,0.000004582359,0.00015358737,0.00020805304,0.000031363485],"category_scores_gemma":[0.00002690433,0.00010446751,0.00017499391,0.00023206805,0.0006093795,0.000022949744,0.00007821111,0.00068938796,0.000029576457],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.045241024,0.012268783,0.85473794,0.0016172479,0.011755473,0.004436835,0.007311323,0.009913802,0.03891297,0.0003888511,0.0031028548,0.010312896],"study_design_scores_gemma":[0.14607538,0.006889339,0.80200887,0.00068662805,0.028883709,0.0006920505,0.0011621562,0.0020658649,0.002184041,0.0024729823,0.0059843864,0.000894571],"about_ca_topic_score_codex":0.000019974063,"about_ca_topic_score_gemma":0.0000020925445,"teacher_disagreement_score":0.100834355,"about_ca_system_score_codex":0.00003483357,"about_ca_system_score_gemma":0.0001541488,"threshold_uncertainty_score":0.42600614},"labels":[],"label_agreement":null},{"id":"W2036035346","doi":"10.1038/sj.clpt.6100420","title":"Heterologous Prime–Boost Strategy to Immunize Very Young Infants against Measles: Pre-clinical Studies in Rhesus Macaques","year":2007,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Virology and Viral Diseases","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"GlaxoSmithKline (Canada); McGill University","funders":"Centers for Disease Control and Prevention; Johns Hopkins University; Bill and Melinda Gates Foundation","keywords":"Measles; Medicine; Virology; Viremia; Immunology; Vaccination; Rubella; Measles vaccine; DNA vaccination; Immunization; Measles virus; Virus; Antibody","score_opus":0.24621565727239472,"score_gpt":0.5503746806888755,"score_spread":0.3041590234164808,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2036035346","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98523206,0.0070570847,0.000058700556,0.002364604,0.0033888672,0.0011414832,0.000022431963,0.00018137335,0.00055341073],"genre_scores_gemma":[0.878224,0.009082417,0.00024432884,0.111059435,0.0010240596,0.000043272503,0.000031663534,0.00005284152,0.0002379633],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99457586,0.001156429,0.0021879072,0.00082755083,0.00027286794,0.0009793725],"domain_scores_gemma":[0.99562216,0.0027088956,0.0003279756,0.0005439623,0.00025474298,0.0005422737],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0030838205,0.00046717352,0.0014165667,0.00023661977,0.00015292504,0.000013225977,0.00045909235,0.0008790705,0.00010537723],"category_scores_gemma":[0.00042107486,0.0003990699,0.00043803052,0.00033401302,0.0017258107,0.00011372309,0.0002995895,0.0018548996,0.0002100116],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.026309978,0.004713465,0.8953231,0.000094967916,0.0042565553,0.0015839698,0.0008602849,0.000048160462,0.010102511,0.000012051799,0.006971452,0.04972349],"study_design_scores_gemma":[0.00965655,0.006576253,0.9727004,0.00012100228,0.0016250905,0.00006284785,0.00043108643,0.00019339734,0.001870968,0.0002052528,0.0060895947,0.0004675545],"about_ca_topic_score_codex":0.000009784597,"about_ca_topic_score_gemma":0.00007653025,"teacher_disagreement_score":0.10869484,"about_ca_system_score_codex":0.00012633952,"about_ca_system_score_gemma":0.00028461672,"threshold_uncertainty_score":0.9998461},"labels":[],"label_agreement":null},{"id":"W2036297146","doi":"10.1038/sj.clpt.6100064","title":"Safety and Pharmacokinetics of Paracetamol Following Intravenous Administration of 5 g During the First 24 h with a 2-g Starting Dose","year":2007,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Drug-Induced Hepatotoxicity and Protection","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":62,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"ASTER","funders":"","keywords":"Pharmacokinetics; Cmin; Cmax; Medicine; Pharmacology; Analgesic; Anesthesia; Intravenous Infusions; Adverse effect","score_opus":0.12490080159705448,"score_gpt":0.45394046447457537,"score_spread":0.3290396628775209,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2036297146","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9917803,0.000744806,0.000836091,0.00285797,0.0020751595,0.0011182259,0.000030598872,0.0000663438,0.0004905137],"genre_scores_gemma":[0.99039215,0.0012875478,0.0003366832,0.0073617236,0.00046396366,0.000024568004,0.000006398705,0.000040424668,0.00008652867],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.996479,0.00074228394,0.0015027479,0.00042482454,0.0002604572,0.0005907343],"domain_scores_gemma":[0.9961542,0.0023539893,0.00085491355,0.00024346364,0.00018368031,0.00020976897],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0037710234,0.00033368682,0.00064182334,0.0001180184,0.0005214467,0.000012890299,0.0003458169,0.00054061995,0.000097470045],"category_scores_gemma":[0.00004821231,0.00025862938,0.00021439625,0.0003938064,0.0010251519,0.00012224469,0.00010890912,0.0017398172,0.0000061407445],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.05712366,0.005376153,0.2346969,0.0010325039,0.0082108155,0.00045461406,0.0073827947,0.0023606233,0.5872905,0.0005526977,0.00035936202,0.095159374],"study_design_scores_gemma":[0.015914548,0.002970349,0.114248626,0.000104150015,0.004083892,0.00015420651,0.0007145,0.0042719687,0.7857227,0.00027034243,0.07079321,0.0007515161],"about_ca_topic_score_codex":0.00001112339,"about_ca_topic_score_gemma":0.00006889171,"teacher_disagreement_score":0.19843218,"about_ca_system_score_codex":0.00006459213,"about_ca_system_score_gemma":0.00015749219,"threshold_uncertainty_score":0.9999866},"labels":[],"label_agreement":null},{"id":"W2036706177","doi":"10.1038/sj.clpt.6100180","title":"Suppression of Niacin-induced Vasodilation with an Antagonist to Prostaglandin D2 Receptor Subtype 1","year":2007,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":151,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Merck Canada Inc. (Canada)","funders":"","keywords":"Niacin; Medicine; Vasodilation; Antagonist; Pharmacology; Prostaglandin D2; Dyslipidemia; Receptor antagonist; B vitamins; Internal medicine; Endocrinology; Prostaglandin; Receptor","score_opus":0.08715680268425512,"score_gpt":0.43417695683385404,"score_spread":0.3470201541495989,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2036706177","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99142045,0.00005478327,0.00055119785,0.0049233926,0.0012213751,0.0012107621,0.000008995721,0.000069224356,0.00053983956],"genre_scores_gemma":[0.9727867,0.00023876214,0.0021492706,0.023976872,0.00059980294,0.000021064361,0.000051998264,0.000038442802,0.00013708936],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9981957,0.0001420336,0.0006608217,0.00038834917,0.0002503753,0.00036268734],"domain_scores_gemma":[0.99868137,0.00026446625,0.00022998254,0.00031017972,0.00021085916,0.00030314535],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010730171,0.00018854404,0.0005875472,0.00011513085,0.000091752496,0.000009492945,0.0001481745,0.0002054084,0.00032851155],"category_scores_gemma":[0.00001576905,0.00014066778,0.000091373775,0.00024383808,0.00015322132,0.00006576152,0.00005989741,0.0003315499,0.000050094754],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014702073,0.009031468,0.24464601,0.0001711213,0.001507917,0.000077424076,0.0014275201,0.000025368252,0.66845894,0.00014377078,0.02031897,0.03948943],"study_design_scores_gemma":[0.008139913,0.016107209,0.59469086,0.00012243065,0.002207086,0.000011685496,0.00037159902,0.00016720213,0.2688179,0.00004155318,0.10893455,0.00038804655],"about_ca_topic_score_codex":0.000017544242,"about_ca_topic_score_gemma":0.000024707582,"teacher_disagreement_score":0.39964104,"about_ca_system_score_codex":0.000057020967,"about_ca_system_score_gemma":0.000114782924,"threshold_uncertainty_score":0.5736265},"labels":[],"label_agreement":null},{"id":"W2036939467","doi":"10.1002/cpt.8","title":"Advances, Nuances, and Potential Pitfalls When Exploiting the Therapeutic Potential of RNA Interference","year":2015,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"RNA Interference and Gene Delivery","field":"Biochemistry, Genetics and Molecular Biology","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; University of Toronto; University Health Network","funders":"Canadian Institutes of Health Research","keywords":"RNA interference; Biology; Computational biology; Gene; Function (biology); Bioinformatics; Genetics; RNA","score_opus":0.11238987638161706,"score_gpt":0.4289310045970634,"score_spread":0.31654112821544633,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2036939467","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0018390252,0.9929218,0.0014372753,0.00025840942,0.0026169429,0.00067829207,0.000071577524,0.000019168388,0.00015750962],"genre_scores_gemma":[0.008099991,0.9855063,0.00015882724,0.0040903795,0.0016670994,0.00007461998,0.00010947206,0.00007363336,0.00021968564],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99596906,0.0010888046,0.0014077546,0.0008179239,0.00022918961,0.00048724774],"domain_scores_gemma":[0.9977711,0.00019890242,0.0009628076,0.0005874404,0.000316768,0.00016297914],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009991694,0.00058620586,0.0014699403,0.00007266648,0.00012365701,0.000041034626,0.0011510807,0.00079241843,0.000060024242],"category_scores_gemma":[0.000022301014,0.00040073236,0.0006614043,0.000109090404,0.0010976656,0.000015408523,0.0005672888,0.000925049,0.000024594725],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023020116,0.0002042159,0.000016612474,0.0007020089,0.0015176251,0.000012929068,0.000049773545,0.000008480041,0.0025603955,0.0000066650546,0.0035083874,0.9911827],"study_design_scores_gemma":[0.0008216044,0.001101793,0.000007254499,0.0005335596,0.0036026202,0.000081289356,0.00009544448,0.00006555648,0.0004694693,0.00027611878,0.9924619,0.00048339157],"about_ca_topic_score_codex":0.0000038269472,"about_ca_topic_score_gemma":0.000003428403,"teacher_disagreement_score":0.9906993,"about_ca_system_score_codex":0.000024640123,"about_ca_system_score_gemma":0.00047700127,"threshold_uncertainty_score":0.99984443},"labels":[],"label_agreement":null},{"id":"W2039185379","doi":"10.1038/clpt.2014.126","title":"Pharmacogenomics of Human Uridine Diphospho-Glucuronosyltransferases and Clinical Implications","year":2014,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":165,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier universitaire de Québec; Université Laval","funders":"Canadian Institutes of Health Research","keywords":"Glucuronidation; Glucuronosyltransferase; Uridine; Pharmacogenomics; Clinical pharmacology; Uridine diphosphate; Pharmacology; Drug metabolism; Xenobiotic; Pharmacogenetics; Drug; Chemistry; Computational biology; Enzyme; Biochemistry; Biology; RNA; Gene; Microsome","score_opus":0.2620271041099431,"score_gpt":0.5475852774856149,"score_spread":0.2855581733756718,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2039185379","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9780274,0.0040029795,0.00085360784,0.008466263,0.0054590576,0.0009280212,0.00023372323,0.0001818151,0.0018471527],"genre_scores_gemma":[0.9189858,0.022228539,0.00054978527,0.055677127,0.002129759,0.00006595726,0.000059594793,0.00010266239,0.00020081672],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9924076,0.002798474,0.002615548,0.0010417032,0.00022205408,0.00091461936],"domain_scores_gemma":[0.99362767,0.003787432,0.0007219385,0.0005569837,0.00037374534,0.00093223253],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.004062519,0.0006198411,0.0013532228,0.00019065898,0.00051352655,0.000026676576,0.00097088347,0.00088683644,0.00093492045],"category_scores_gemma":[0.000081031285,0.0006082275,0.00061501795,0.00035949305,0.0025221012,0.0001258622,0.00032787138,0.0021624945,0.00009368435],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014072051,0.0055229967,0.25384182,0.00013624299,0.0037313702,0.000015978292,0.00030668094,0.00016063474,0.52924395,0.0035290061,0.016471624,0.1856325],"study_design_scores_gemma":[0.01583516,0.001683239,0.07815997,0.00001771047,0.008449194,0.00004160945,0.000041990937,0.0045086876,0.13860576,0.0038121466,0.7476942,0.001150331],"about_ca_topic_score_codex":0.0000098318515,"about_ca_topic_score_gemma":0.000005899565,"teacher_disagreement_score":0.73122257,"about_ca_system_score_codex":0.00003747086,"about_ca_system_score_gemma":0.00019336402,"threshold_uncertainty_score":0.99997836},"labels":[],"label_agreement":null},{"id":"W2040550914","doi":"10.1038/sj.clpt.6100087","title":"The Pharmacogenetics Research Network: From SNP Discovery to Clinical Drug Response","year":2007,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":243,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Heart, Lung, and Blood Institute; National Institute of General Medical Sciences; National Institute on Drug Abuse; Wellcome Trust","keywords":"Pharmacogenomics; Pharmacogenetics; Drug response; Addiction; Clinical pharmacology; Pharmacology; Medicine; Drug; Disease; Informatics; Bioinformatics; Computational biology; Biology; Psychiatry; Genetics; Genotype; Internal medicine; Gene","score_opus":0.7589401969495758,"score_gpt":0.7016421437167268,"score_spread":0.05729805323284898,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2040550914","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004151307,0.91502744,0.00018982314,0.0057819695,0.067111485,0.005624852,0.0010732271,0.0003163076,0.0007235679],"genre_scores_gemma":[0.0001538513,0.88280344,0.000542137,0.07687185,0.031945296,0.0007421684,0.00020681844,0.00056322874,0.0061711967],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.925787,0.05543238,0.008170812,0.0033917269,0.0016279838,0.0055901],"domain_scores_gemma":[0.89047843,0.101269916,0.0019543606,0.0022303439,0.0011482293,0.0029187268],"candidate_categories":["metaresearch","metaepi_narrow","sts","open_science","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","sts","research_integrity","insufficient_payload"],"category_scores_codex":[0.07682076,0.002365253,0.005889229,0.00071253226,0.0033891345,0.0004635007,0.0071699116,0.0045809634,0.0011555052],"category_scores_gemma":[0.000915401,0.0017750153,0.0038031673,0.0029250912,0.0054785996,0.00021237455,0.003940679,0.021317743,0.004808514],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0060608643,0.0014226404,0.00029783536,0.00025509027,0.007021886,0.00034328792,0.0001496401,0.00008190406,0.00007137591,0.000041974672,0.30087572,0.6833778],"study_design_scores_gemma":[0.004070446,0.0005690082,0.00018919354,0.0005024668,0.014907149,0.0000368388,0.00006979454,0.0002442358,0.00016185467,0.0004833578,0.9769725,0.0017931369],"about_ca_topic_score_codex":0.000021361975,"about_ca_topic_score_gemma":0.00003595947,"teacher_disagreement_score":0.68158466,"about_ca_system_score_codex":0.0005300657,"about_ca_system_score_gemma":0.0036539203,"threshold_uncertainty_score":0.9997576},"labels":[],"label_agreement":null},{"id":"W2040739081","doi":"10.1038/clpt.2009.133","title":"Predicting Age-Specific Dosing of Antipsychotics","year":2009,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Baycrest Hospital; Centre for Addiction and Mental Health","funders":"","keywords":"Dosing; Tolerability; Medicine; Antipsychotic; Schizophrenia (object-oriented programming); Intensive care medicine; Psychiatry; Pharmacology; Adverse effect","score_opus":0.16210272986398147,"score_gpt":0.472307894345333,"score_spread":0.3102051644813515,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2040739081","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9861746,0.0019855935,0.00018205128,0.00977107,0.00085549726,0.00043534528,0.000005396916,0.000080087564,0.0005104001],"genre_scores_gemma":[0.9762157,0.004091115,0.0047553717,0.014062572,0.0007489067,0.0000039997462,0.000010842494,0.000018801713,0.00009266893],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99821466,0.00018951156,0.000663119,0.00030711267,0.00025137071,0.00037420905],"domain_scores_gemma":[0.99863887,0.00053585035,0.00015441817,0.000280306,0.00014103213,0.00024951808],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046681237,0.00016362198,0.0004896824,0.00009163668,0.00007444099,0.000009399882,0.00015256324,0.00018863395,0.00013986752],"category_scores_gemma":[0.0000189334,0.0001314328,0.00024372639,0.00021960751,0.00035346684,0.000034859262,0.000027109405,0.00060964277,0.000037498077],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.070168585,0.012128458,0.36884683,0.00008946904,0.0039248583,0.00159264,0.0004502341,0.000029746967,0.16176522,0.0005088036,0.016122676,0.36437246],"study_design_scores_gemma":[0.022414394,0.00673318,0.91941434,0.0001040234,0.0016405163,0.00010297848,0.00006631276,0.0013194787,0.026328547,0.0019784602,0.019636603,0.0002611494],"about_ca_topic_score_codex":7.353161e-7,"about_ca_topic_score_gemma":8.028849e-7,"teacher_disagreement_score":0.5505675,"about_ca_system_score_codex":0.000042297626,"about_ca_system_score_gemma":0.00013740097,"threshold_uncertainty_score":0.5359674},"labels":[],"label_agreement":null},{"id":"W2043372450","doi":"10.1038/clpt.2013.99","title":"Bleeding Risk in Atrial Fibrillation Patients Taking Vitamin K Antagonists: Systematic Review and Meta-Analysis","year":2013,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Atrial fibrillation; Meta-analysis; Vitamin k; Confidence interval; Major bleeding; Stroke (engine); Internal medicine; Cardiology","score_opus":0.3448723857089284,"score_gpt":0.5164024024212439,"score_spread":0.1715300167123155,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2043372450","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00005777763,0.99040407,0.00003062185,0.0011434837,0.00060943846,0.0076107993,0.000045321438,0.000055218745,0.000043261927],"genre_scores_gemma":[0.000076521224,0.99378043,0.00024009401,0.0041901604,0.0009780049,0.000044531513,0.00020255237,0.00006233823,0.00042538432],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99234325,0.0023960297,0.003790909,0.00074919814,0.00034970988,0.000370924],"domain_scores_gemma":[0.9921669,0.0034684322,0.0035603715,0.00045237085,0.00018766553,0.0001643024],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0026029986,0.0006332326,0.011855139,0.00053346314,0.00010942685,0.000051049698,0.00021661684,0.0005892095,0.00061538094],"category_scores_gemma":[0.00038271927,0.00041951457,0.0055316496,0.0010749482,0.00015603825,0.00011642451,0.00017974534,0.0007989472,0.00010283651],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004651438,0.000029646084,0.008005514,0.4624099,0.5062489,0.000009123764,0.000025746822,0.000007387878,8.040437e-8,0.000007783702,0.0005258047,0.022683607],"study_design_scores_gemma":[0.0010201674,0.000117953176,0.00021235674,0.0040178765,0.84050035,0.000002332272,0.000004388692,0.00011438593,4.3815813e-8,0.0000060226007,0.1537133,0.00029080544],"about_ca_topic_score_codex":0.000007543177,"about_ca_topic_score_gemma":0.0000020321322,"teacher_disagreement_score":0.45839202,"about_ca_system_score_codex":0.00014354751,"about_ca_system_score_gemma":0.000092930706,"threshold_uncertainty_score":0.99982566},"labels":[],"label_agreement":null},{"id":"W2045148891","doi":"10.1038/clpt.2011.10","title":"The Value and Benefits of the International Conference on Harmonisation to Drug Regulatory Authorities: Advancing Harmonization for Better Public Health","year":2011,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":55,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Canada","funders":"","keywords":"Harmonization; Public health; Drug approval; Drug; Value (mathematics); Business; Pharmacology; Medicine; Environmental health; Public administration; Political science; Computer science","score_opus":0.35828282244946014,"score_gpt":0.40471093666152846,"score_spread":0.04642811421206833,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2045148891","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6047359,0.0013415398,0.0028325168,0.3808842,0.0061427513,0.0012063982,0.0003160603,0.00003430765,0.0025063024],"genre_scores_gemma":[0.8491364,0.0027541579,0.0009570142,0.14650528,0.0003827744,0.000060450413,0.000006225445,0.000023973285,0.00017370879],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.99839026,0.000097116856,0.0008615751,0.00030633292,0.00003942914,0.00030529217],"domain_scores_gemma":[0.99857765,0.00047644918,0.00049408467,0.00021563924,0.00008961321,0.00014656645],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019102311,0.00012705434,0.0002702764,0.0000685716,0.00026876328,0.000043671993,0.0004667518,0.000087856075,0.00006867489],"category_scores_gemma":[0.00007208916,0.00010311548,0.000112748756,0.00008325039,0.00025775976,0.00009770159,0.00012295923,0.00024195372,0.000017091206],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037249658,0.00050505647,0.038204495,0.000053711075,0.0007013452,1.5731176e-7,0.003944124,0.00014615398,0.00018289882,0.8872354,0.023454117,0.04520005],"study_design_scores_gemma":[0.0031700165,0.0005543884,0.10495766,0.000033373537,0.00008374166,0.0000020769708,0.00029219716,0.047595054,0.002722764,0.11831528,0.721806,0.0004674709],"about_ca_topic_score_codex":0.000011097819,"about_ca_topic_score_gemma":0.000010024324,"teacher_disagreement_score":0.7689201,"about_ca_system_score_codex":0.00010047323,"about_ca_system_score_gemma":0.00009967994,"threshold_uncertainty_score":0.42049274},"labels":[],"label_agreement":null},{"id":"W2045567622","doi":"10.1067/mcp.2002.121152","title":"Fruit juices inhibit organic anion transporting polypeptide–mediated drug uptake to decrease the oral availability of fexofenadine","year":2002,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":606,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"National Institute of General Medical Sciences","keywords":"Grapefruit juice; Fexofenadine; Chemistry; Pharmacokinetics; Organic anion-transporting polypeptide; Pharmacology; Organic anion transporter 1; Aspartame; Food science; Crossover study; Terfenadine; Oral administration; Biochemistry; Transporter; Medicine","score_opus":0.08481314750014701,"score_gpt":0.3684336159384128,"score_spread":0.28362046843826577,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2045567622","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.969877,0.0010982796,0.00015291406,0.026351023,0.001088783,0.0009900569,0.00003766307,0.0001322175,0.0002720806],"genre_scores_gemma":[0.94396454,0.00091715547,0.0005818845,0.053028528,0.00040185207,0.000023361661,0.000032222746,0.000056056328,0.0009944034],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9966648,0.0002813017,0.0015771309,0.00054696697,0.0003681293,0.00056164165],"domain_scores_gemma":[0.99758214,0.00065927824,0.00036913552,0.00046828832,0.0002517319,0.00066940143],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0015724273,0.00032531668,0.00084405305,0.00009111094,0.00016481623,0.00000965565,0.00037286276,0.00027855852,0.005788528],"category_scores_gemma":[0.00011085755,0.00021984329,0.00037699373,0.00057453214,0.0005426274,0.00006584452,0.000034939625,0.0008335266,0.00017177634],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005488183,0.0075707952,0.16564852,0.00042075475,0.002397064,0.0003425025,0.004442051,0.000023371702,0.76619697,0.00006139119,0.019277278,0.028131157],"study_design_scores_gemma":[0.02711539,0.00429735,0.35483578,0.0004540647,0.012897488,0.0000872562,0.0017733079,0.0030300282,0.24164902,0.00046842924,0.35167098,0.0017208899],"about_ca_topic_score_codex":0.000019157304,"about_ca_topic_score_gemma":0.00017374558,"teacher_disagreement_score":0.52454793,"about_ca_system_score_codex":0.00005607053,"about_ca_system_score_gemma":0.00018405005,"threshold_uncertainty_score":0.9951203},"labels":[],"label_agreement":null},{"id":"W2046426458","doi":"10.1038/clpt.2011.345","title":"Adaptive Licensing: Taking the Next Step in the Evolution of Drug Approval","year":2012,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":270,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Agency for Drugs and Technologies in Health; Health Canada","funders":"","keywords":"Transformative learning; Legislature; Clinical pharmacology; Engineering ethics; Action (physics); Drug approval; Management science; Computer science; Risk analysis (engineering); Medicine; Psychology; Political science; Drug; Pharmacology; Law; Engineering","score_opus":0.7984869042927707,"score_gpt":0.5808708196287621,"score_spread":0.2176160846640086,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2046426458","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00026004252,0.9783719,0.00062352733,0.01334321,0.003744147,0.002485597,0.00010616365,0.000025049554,0.0010403267],"genre_scores_gemma":[0.0036316393,0.9424747,0.00045028146,0.05052784,0.0024658302,0.00023860412,0.000023643432,0.000074107724,0.00011332536],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9836757,0.0064671785,0.008383934,0.0006788873,0.00013872674,0.00065554207],"domain_scores_gemma":[0.9747201,0.015051868,0.009207051,0.0008174928,0.00009219015,0.00011128127],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.044322953,0.000450764,0.0033914817,0.00028479815,0.00022247504,0.00004462305,0.0013330146,0.0006778114,0.00023098594],"category_scores_gemma":[0.00049391494,0.0003367194,0.00084104727,0.0005107607,0.0006803138,0.00022904573,0.00016316814,0.0018449018,0.0007625154],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026729828,0.0043491637,0.006364602,0.01728936,0.00784076,0.000011234606,0.016275458,0.00011293054,5.582158e-7,0.05646063,0.10390178,0.78712624],"study_design_scores_gemma":[0.0005976205,0.000087332555,0.00066290365,0.00050958263,0.00094103464,0.000011196943,0.0013224115,0.0013015541,3.928845e-8,0.00072688615,0.9935131,0.00032630665],"about_ca_topic_score_codex":0.00019759376,"about_ca_topic_score_gemma":0.00006244235,"teacher_disagreement_score":0.88961136,"about_ca_system_score_codex":0.00083523797,"about_ca_system_score_gemma":0.0006609656,"threshold_uncertainty_score":0.9999085},"labels":[],"label_agreement":null},{"id":"W2047284784","doi":"10.1038/clpt.2012.112","title":"Ammonia-Lowering Strategies for the Treatment of Hepatic Encephalopathy","year":2012,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Liver Disease and Transplantation","field":"Medicine","cited_by":112,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôpital Saint-Luc","funders":"","keywords":"Hyperammonemia; Ammonia; Hepatic encephalopathy; Glutamine; Context (archaeology); Glutaminase; Chemistry; Biochemistry; Glutamine synthetase; Pharmacology; Medicine; Internal medicine; Biology; Amino acid","score_opus":0.29207939716270587,"score_gpt":0.5116914126780111,"score_spread":0.21961201551530524,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2047284784","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0013350646,0.99389744,0.000344281,0.00015885226,0.0018099324,0.002280764,0.00010215153,0.0000331305,0.000038386028],"genre_scores_gemma":[0.0024932835,0.99429595,0.0001049823,0.0012278907,0.0012488809,0.0004084743,0.000113853384,0.000046115,0.000060593215],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99823624,0.00020066656,0.00089455256,0.00026189847,0.00011855345,0.00028806794],"domain_scores_gemma":[0.9963541,0.002799813,0.0003751031,0.00026371315,0.00008525063,0.00012199024],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002759825,0.0003187069,0.0014366659,0.000054277072,0.00007668646,0.000008828041,0.00016608476,0.0003089426,0.000070905284],"category_scores_gemma":[9.3258836e-7,0.00017720168,0.0010294706,0.00009989446,0.0003095802,0.00004478507,0.000010036855,0.00023726972,0.000026083382],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046313286,0.0019299934,0.00040680985,0.008436112,0.014669766,0.000019075795,0.0004917086,0.0000010537618,0.0000117376385,0.00001895618,0.000040667343,0.973511],"study_design_scores_gemma":[0.002083297,0.0015733754,0.00024264467,0.0006661645,0.1753935,0.000015639163,0.00005511011,0.00003314977,0.00003169255,0.000036321897,0.8197091,0.00015995432],"about_ca_topic_score_codex":0.0000043611253,"about_ca_topic_score_gemma":0.0000022027896,"teacher_disagreement_score":0.97335106,"about_ca_system_score_codex":0.000063762905,"about_ca_system_score_gemma":0.0005396508,"threshold_uncertainty_score":0.7226075},"labels":[],"label_agreement":null},{"id":"W2047398257","doi":"10.1016/j.clpt.2005.06.005","title":"Cytochrome P450 2C9 genotype: Impact on celecoxib safety and pharmacokinetics in a pediatric patient","year":2005,"lang":"en","type":"letter","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Clinical pharmacology; Associate editor; Internal medicine; Family medicine; Oncology; Pharmacology; Library science","score_opus":0.13295563203773855,"score_gpt":0.48423952665964093,"score_spread":0.35128389462190235,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2047398257","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.43269378,0.03408995,0.00003861972,0.5042167,0.016873462,0.00524703,0.0017930539,0.00049982424,0.004547636],"genre_scores_gemma":[0.05198761,0.12665136,0.00017218075,0.7984936,0.02092735,0.00019799244,0.00034984018,0.0003543578,0.00086569815],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9857636,0.004865771,0.0034995454,0.0023040473,0.0008088513,0.0027581593],"domain_scores_gemma":[0.991642,0.0047446666,0.0014175449,0.0008349381,0.00035893655,0.0010019313],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","research_integrity"],"category_scores_codex":[0.0024315952,0.002070368,0.0027538752,0.0010309519,0.00043861906,0.00008670983,0.0015416822,0.005308592,0.0045651533],"category_scores_gemma":[0.000058786274,0.001882333,0.0010451475,0.0009156079,0.001176845,0.00015069146,0.00066342094,0.018390844,0.0007214088],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005064522,0.0030411114,0.0038403664,0.0002628229,0.0031463404,0.002254491,0.00054268393,0.0026915884,0.0060506267,0.000007805453,0.8746192,0.09847846],"study_design_scores_gemma":[0.011110116,0.0014034102,0.011224915,0.000027480193,0.005470277,0.00010837513,0.00001004223,0.004585078,0.0012490073,0.00013679756,0.9628702,0.0018043072],"about_ca_topic_score_codex":0.000010141308,"about_ca_topic_score_gemma":0.0000050888516,"teacher_disagreement_score":0.38070616,"about_ca_system_score_codex":0.00053412747,"about_ca_system_score_gemma":0.000831676,"threshold_uncertainty_score":0.9992038},"labels":[],"label_agreement":null},{"id":"W2047641559","doi":"10.1002/cpt.111","title":"Young brains on cannabis: It's time to clear the smoke","year":2015,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Cannabis and Cannabinoid Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph; Canadian Centre on Substance Use and Addiction","funders":"","keywords":"Cannabis; Smoke; Illicit drug; Substance use; Psychology; Psychiatry; Medicine; Criminology; Drug; Geography","score_opus":0.16843819352847555,"score_gpt":0.47534360627246,"score_spread":0.3069054127439844,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2047641559","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.3161787,0.0002775575,0.000011378078,0.6696592,0.0014815389,0.0009866138,0.000016063106,0.00009452092,0.011294392],"genre_scores_gemma":[0.15357208,0.00019462981,0.00004996885,0.6838954,0.0028123714,0.00014256657,0.000014163842,0.00009053624,0.15922827],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.997082,0.0005645123,0.00061060616,0.00050063577,0.00056982244,0.00067240256],"domain_scores_gemma":[0.99790287,0.000132568,0.00009679739,0.0005749178,0.00043164805,0.00086121267],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0020315205,0.00025217704,0.00049650244,0.0001062713,0.00016644376,0.000038433114,0.00048304908,0.0002837312,0.0019167647],"category_scores_gemma":[0.00018058384,0.00016480338,0.00028199796,0.0003836252,0.0005968671,0.00003697224,0.00019726105,0.0012631693,0.0030867653],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024757134,0.00067910657,0.001166427,0.000008320665,0.00039943165,0.000079672594,0.00043451687,0.000029313745,0.0014190915,0.000026922662,0.98376197,0.0095195435],"study_design_scores_gemma":[0.003068113,0.0038665547,0.012894534,0.000015644755,0.00041433726,0.000047613677,0.00021825575,0.00063090055,0.0006877287,0.00004951324,0.9779193,0.0001875204],"about_ca_topic_score_codex":0.000035216344,"about_ca_topic_score_gemma":0.000012508474,"teacher_disagreement_score":0.16260663,"about_ca_system_score_codex":0.00018980772,"about_ca_system_score_gemma":0.00075709197,"threshold_uncertainty_score":0.9989956},"labels":[],"label_agreement":null},{"id":"W2047667596","doi":"10.1016/j.clpt.2003.11.301","title":"Evaluation of herbal products as potential inhibitors of MDR1","year":2004,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lawson Health Research Institute","funders":"","keywords":"Pharmacology; Black cohosh; Verapamil; Traditional medicine; Digoxin; Valerian; Phytochemical; Chemistry; Kava; Phytotherapy; Ginseng; Medicine","score_opus":0.2840747636108134,"score_gpt":0.5431562213857632,"score_spread":0.25908145777494984,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2047667596","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97178483,0.0081830695,0.00009324184,0.00512282,0.011547176,0.001245055,0.00007279103,0.00007057382,0.0018804249],"genre_scores_gemma":[0.98023534,0.003645426,0.00047922978,0.013656485,0.0017457223,0.0000619263,0.000024266305,0.000059391437,0.00009223084],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9931007,0.0027082309,0.001918862,0.0006708541,0.0009453297,0.0006560031],"domain_scores_gemma":[0.9958914,0.00047573046,0.0009850673,0.00040199037,0.001899616,0.00034619434],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.007692278,0.00042221654,0.0008820073,0.0002121755,0.00016222724,0.000008218739,0.00068758713,0.00077639055,0.0013407455],"category_scores_gemma":[0.00018885764,0.00040740066,0.00042747182,0.0005640198,0.0014428931,0.0001229944,0.0002157277,0.0013454586,0.00013767353],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016999445,0.0052659386,0.0023364094,0.00010355509,0.0034648885,0.000031234777,0.0007724117,0.01733191,0.8758618,0.00035017033,0.0036467223,0.08913502],"study_design_scores_gemma":[0.017314058,0.00086682267,0.0033375495,0.000022950037,0.010968439,0.000036493733,0.0001232388,0.0030624447,0.8857724,0.0061808066,0.07182046,0.0004943164],"about_ca_topic_score_codex":0.000017226057,"about_ca_topic_score_gemma":0.000002408875,"teacher_disagreement_score":0.088640705,"about_ca_system_score_codex":0.00011140701,"about_ca_system_score_gemma":0.0014739453,"threshold_uncertainty_score":0.99983776},"labels":[],"label_agreement":null},{"id":"W2048099302","doi":"10.1016/j.clpt.2006.08.011","title":"CYP2A6 genotype and the metabolism and disposition kinetics of nicotine","year":2006,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Nicotinic Acetylcholine Receptors Study","field":"Biochemistry, Genetics and Molecular Biology","cited_by":219,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Addiction and Mental Health; University of Toronto","funders":"National Center for Research Resources; National Institute on Drug Abuse","keywords":"CYP2A6; Cotinine; Nicotine; Metabolism; Pharmacology; Endocrinology; Internal medicine; Chemistry; Medicine; Cytochrome P450; CYP1A2","score_opus":0.016639488836465984,"score_gpt":0.33754144905568967,"score_spread":0.3209019602192237,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2048099302","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98496056,0.009825834,0.00064536126,0.0034009158,0.0005627551,0.00035135742,0.000014679296,0.000011015058,0.00022752385],"genre_scores_gemma":[0.98706853,0.0045742537,0.0005851739,0.0065689036,0.00091722,0.000013338299,0.00002794034,0.000023921813,0.00022069618],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984823,0.0003895682,0.0005319652,0.0003052584,0.00009031571,0.00020062282],"domain_scores_gemma":[0.9991746,0.00023838184,0.00021770131,0.00021204597,0.00010401601,0.000053274503],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00050277764,0.00016625662,0.00033663333,0.000020172747,0.00006224583,0.000009064716,0.00017101923,0.00020954237,0.000016862297],"category_scores_gemma":[0.000021916701,0.00011654731,0.00010539812,0.00006887681,0.001163106,0.0000028376296,0.00020614432,0.00022496669,0.0000023698308],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001445606,0.0006741932,0.0115978755,0.000019842097,0.0006738534,3.5810737e-7,0.000056631234,0.000023864946,0.9743708,0.00039339752,0.005620012,0.005123594],"study_design_scores_gemma":[0.020147447,0.0012566225,0.061531916,0.000010555502,0.0028798257,0.00004105107,0.00006669163,0.0006547491,0.66891646,0.0009719214,0.24300009,0.00052268954],"about_ca_topic_score_codex":0.00001019052,"about_ca_topic_score_gemma":0.000008724882,"teacher_disagreement_score":0.3054543,"about_ca_system_score_codex":0.0000037422224,"about_ca_system_score_gemma":0.00002285578,"threshold_uncertainty_score":0.47526613},"labels":[],"label_agreement":null},{"id":"W2049901733","doi":"10.1038/clpt.2013.159","title":"Genetic and Pharmacokinetic Determinants of Response to Transdermal Nicotine in White, Black, and Asian Nonsmokers","year":2013,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Nicotinic Acetylcholine Receptors Study","field":"Biochemistry, Genetics and Molecular Biology","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Addiction and Mental Health; University of Toronto","funders":"National Center for Research Resources; NIH Clinical Center; National Institutes of Health; National Cancer Institute; National Institute on Drug Abuse; Canadian Institutes of Health Research; University of California, San Francisco","keywords":"Nicotine; CYP2A6; Pharmacokinetics; Pharmacology; Cotinine; Medicine; Toxicity; Clinical pharmacology; Physiology; Internal medicine; Metabolism","score_opus":0.024496806444383897,"score_gpt":0.3651095928134981,"score_spread":0.3406127863691142,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2049901733","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949269,0.0005336645,0.000080759484,0.003172495,0.00032250286,0.00087083515,0.000012709778,0.000011155419,0.00006893664],"genre_scores_gemma":[0.98773044,0.0014650974,0.0011972244,0.009163062,0.00019315038,0.00005300025,0.0000031709837,0.000042300642,0.00015256085],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99737155,0.0006704522,0.00084036577,0.0005760781,0.00011292958,0.00042863522],"domain_scores_gemma":[0.99902195,0.00020938733,0.0001581037,0.00025066824,0.000098463264,0.00026144178],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006154113,0.00027057427,0.00047573875,0.00010404509,0.00004055996,0.000011548703,0.00026654516,0.00028472857,0.00011137857],"category_scores_gemma":[0.000047257716,0.0002590336,0.00009147299,0.0001631932,0.0006178969,0.000007268577,0.00021437598,0.00031730745,0.000016122098],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013685254,0.00040957727,0.4583789,0.000027066277,0.00016185812,0.000002344284,0.00029667973,0.000031598403,0.52105737,1.3328825e-7,0.0012747092,0.016991226],"study_design_scores_gemma":[0.0074733887,0.0023615907,0.8748512,0.000025149171,0.00033902682,0.00003430504,0.00023504838,0.0010364117,0.10378129,0.000011435363,0.0093912985,0.00045982693],"about_ca_topic_score_codex":0.000008274692,"about_ca_topic_score_gemma":0.000020320793,"teacher_disagreement_score":0.41727608,"about_ca_system_score_codex":0.000011090852,"about_ca_system_score_gemma":0.00008668805,"threshold_uncertainty_score":0.9999862},"labels":[],"label_agreement":null},{"id":"W2050094658","doi":"10.1038/clpt.2008.59","title":"Emerging Evidence of the Impact of Kidney Disease on Drug Metabolism and Transport","year":2008,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":270,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont; Université de Montréal","funders":"","keywords":"Drug metabolism; Kidney disease; Transporter; Medicine; Drug; Kidney; Disease; Metabolism; Pharmacology; Renal function; Gastrointestinal tract; Efflux; Liver disease; Internal medicine; Biology; Biochemistry","score_opus":0.1333107435689933,"score_gpt":0.48076003684806873,"score_spread":0.3474492932790754,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2050094658","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.006885656,0.9890947,0.0000104464,0.0012194455,0.0013239718,0.0012557508,0.0001366629,0.000023860808,0.00004951628],"genre_scores_gemma":[0.006018598,0.9890145,0.000046197743,0.004123045,0.00036068071,0.000029239523,0.000023169352,0.000065262684,0.00031932097],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99682164,0.00044975014,0.0015782389,0.00048521024,0.00034447885,0.0003206543],"domain_scores_gemma":[0.99717784,0.00074695225,0.0008191674,0.0005489292,0.00013423529,0.00057287194],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00052998675,0.0004824401,0.0028204443,0.000120468896,0.00007696429,0.0000017162237,0.00041307992,0.00029121156,0.00013677003],"category_scores_gemma":[0.000047915848,0.0002567977,0.0024734188,0.000328154,0.0009613689,0.00003486144,0.000034694887,0.0011115706,0.0000037554776],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009881006,0.008131938,0.013550022,0.066298835,0.029118475,0.00082083355,0.0010683064,0.000031443495,0.0006429024,0.00013260334,0.018672667,0.85165095],"study_design_scores_gemma":[0.0024890753,0.00044203637,0.008308019,0.018521909,0.035401646,0.000037547776,0.000009506429,0.00002250621,0.00011152935,0.000062237865,0.9341766,0.00041736048],"about_ca_topic_score_codex":0.000005515916,"about_ca_topic_score_gemma":4.954965e-7,"teacher_disagreement_score":0.915504,"about_ca_system_score_codex":0.000039974184,"about_ca_system_score_gemma":0.0020717718,"threshold_uncertainty_score":0.99998844},"labels":[],"label_agreement":null},{"id":"W2050701148","doi":"10.1038/clpt.2011.334","title":"PhRMA Survey of Pharmacogenomic and Pharmacodynamic Evaluations: What Next?","year":2012,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Genome Canada","funders":"","keywords":"Pharmacogenomics; Pharmacodynamics; Clinical pharmacology; Pharmaceutical industry; Drug development; Pharmacology; Drug; Medicine; Pharmacokinetics","score_opus":0.47578842760430606,"score_gpt":0.5873528190965384,"score_spread":0.1115643914922323,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2050701148","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8948001,0.08433366,0.0001770577,0.0018126576,0.017004875,0.0011832569,0.00019674511,0.00013745388,0.00035419397],"genre_scores_gemma":[0.8241326,0.12559424,0.0003514497,0.04777981,0.0016463517,0.00010807354,0.00010678196,0.000110330824,0.00017032992],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.98941916,0.0056712297,0.0021388873,0.00081233046,0.00044604338,0.001512374],"domain_scores_gemma":[0.9924601,0.004367972,0.0009184491,0.00045377217,0.00060986745,0.0011898449],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.008883355,0.0007506047,0.0012631966,0.00033346188,0.0004167031,0.000087247536,0.00089827017,0.0008201819,0.002901899],"category_scores_gemma":[0.000108219734,0.0007412103,0.0003820067,0.00068910467,0.0017192351,0.0014453523,0.00047400978,0.0020300222,0.0003104248],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021646116,0.0038497073,0.13045277,0.000119961,0.004141862,0.000014126908,0.0015623238,0.00022736308,0.45269823,0.000073741154,0.007933545,0.39676178],"study_design_scores_gemma":[0.020955564,0.00058942015,0.28449932,0.000048329242,0.0112848915,0.00012858317,0.0006033807,0.026814595,0.15912396,0.00031811956,0.49363077,0.0020030525],"about_ca_topic_score_codex":0.00003522362,"about_ca_topic_score_gemma":0.0000064931664,"teacher_disagreement_score":0.48569724,"about_ca_system_score_codex":0.00009233178,"about_ca_system_score_gemma":0.00034310683,"threshold_uncertainty_score":0.9995039},"labels":[],"label_agreement":null},{"id":"W2051146972","doi":"10.1038/clpt.2014.90","title":"Response to “Evaluation of Pharmacogenetic Markers to Predict the Risk of Cisplatin-Induced Ototoxicity”","year":2014,"lang":"en","type":"letter","venue":"Clinical Pharmacology & Therapeutics","topic":"Cancer therapeutics and mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital; University of British Columbia; Child and Family Research Institute","funders":"Canadian Institutes of Health Research","keywords":"Columbia university; Medicine; Family medicine; Library science; Media studies; Sociology","score_opus":0.10528048524803607,"score_gpt":0.4159134253206307,"score_spread":0.3106329400725946,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2051146972","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8011014,0.00060404756,0.0015397827,0.18990114,0.0034406448,0.0029598058,0.00031596355,0.000018093258,0.000119153476],"genre_scores_gemma":[0.31278706,0.0006674125,0.00029798388,0.6831496,0.0024926784,0.00024361051,0.00007405469,0.00010131104,0.00018631472],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9917409,0.004742301,0.0013527038,0.0008514844,0.00076409406,0.0005485299],"domain_scores_gemma":[0.99600595,0.0009989393,0.00095054106,0.001032052,0.0008265783,0.00018594094],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00700509,0.00050094345,0.0008105424,0.00016441949,0.000109133754,0.00001384583,0.0011254827,0.0012031021,0.00017404265],"category_scores_gemma":[0.00019473965,0.00040692746,0.0005868328,0.00027186555,0.00029734173,0.0000023955897,0.00032221718,0.0012590268,0.000023484918],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0044559753,0.00013738169,0.00017091121,0.000032790827,0.0021611387,0.0000027956123,0.000072475006,0.00043398226,0.6992611,3.638823e-7,0.28540063,0.007870441],"study_design_scores_gemma":[0.0023795336,0.0032638102,0.00069391687,0.000033057077,0.0040626875,0.0000058646306,0.000014449288,0.00074189156,0.33539513,0.000059922964,0.6529959,0.00035383526],"about_ca_topic_score_codex":0.000009667873,"about_ca_topic_score_gemma":0.00000654779,"teacher_disagreement_score":0.49324843,"about_ca_system_score_codex":0.000065666056,"about_ca_system_score_gemma":0.00068713067,"threshold_uncertainty_score":0.99983823},"labels":[],"label_agreement":null},{"id":"W2051592959","doi":"10.1038/clpt.2014.124","title":"Retreatment With Varenicline for Smoking Cessation in Smokers Who Have Previously Taken Varenicline: A Randomized, Placebo-Controlled Trial","year":2014,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Smoking Behavior and Cessation","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto","funders":"Economic and Social Research Council; Medical Research Council","keywords":"Varenicline; Medicine; Smoking cessation; Placebo; Randomized controlled trial; Pharmacology; Anesthesia; Internal medicine; Alternative medicine","score_opus":0.06995092750868709,"score_gpt":0.4159428427791987,"score_spread":0.3459919152705116,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2051592959","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97707003,0.00018431302,0.004721691,0.0051612915,0.0015645113,0.010823531,0.000007404775,0.000112291185,0.0003549134],"genre_scores_gemma":[0.98278904,0.0004897208,0.00051395985,0.011572895,0.0013570075,0.0024516338,0.00012805033,0.00007158634,0.0006261219],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99534917,0.0013450208,0.0017345034,0.0006644997,0.00038234016,0.00052448723],"domain_scores_gemma":[0.99310225,0.0052990965,0.000736783,0.0003685586,0.00030145445,0.00019182678],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.005210421,0.00039461875,0.0020588832,0.00019303877,0.00012485373,0.000031768137,0.0001874271,0.0005201862,0.00015607834],"category_scores_gemma":[0.0003779822,0.00027950222,0.0006083514,0.00019366488,0.0003748823,0.00009079564,0.000031684274,0.00071302813,0.0000027590236],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9348304,0.0015591327,0.05436901,0.00003723626,0.0016056519,0.0000115156445,0.00032146662,0.00011369325,0.000062158695,0.000025722242,0.00067111995,0.0063928636],"study_design_scores_gemma":[0.963884,0.004104894,0.005929648,0.00010421762,0.009815315,0.000009237549,0.00006165552,0.0128462715,0.00032936467,0.00019093088,0.002442464,0.0002819844],"about_ca_topic_score_codex":0.000018704452,"about_ca_topic_score_gemma":0.000022111442,"teacher_disagreement_score":0.04843936,"about_ca_system_score_codex":0.0002218832,"about_ca_system_score_gemma":0.00027437985,"threshold_uncertainty_score":0.9999657},"labels":[],"label_agreement":null},{"id":"W2051643304","doi":"10.1038/clpt.2013.178","title":"Challenges in Interpreting the Evidence for Genetic Predictors of Ototoxicity","year":2013,"lang":"en","type":"letter","venue":"Clinical Pharmacology & Therapeutics","topic":"Hearing, Cochlea, Tinnitus, Genetics","field":"Neuroscience","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institutes of Health; National Institute of General Medical Sciences; University of British Columbia; Genome Canada","keywords":"Ototoxicity; Clinical pharmacology; Psychology; Medicine; Pharmacology; Internal medicine; Cisplatin","score_opus":0.4914424834688712,"score_gpt":0.48816098741478975,"score_spread":0.0032814960540814564,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2051643304","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.31723526,0.0052730055,0.00027604974,0.6649629,0.007602415,0.0042316443,0.000048559876,0.00012342387,0.00024674804],"genre_scores_gemma":[0.10700999,0.023446115,0.0005760716,0.8635667,0.004573431,0.0004431198,0.0000030209203,0.00014381601,0.00023774932],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9923658,0.0028719066,0.002000982,0.0012985584,0.00048327175,0.0009795034],"domain_scores_gemma":[0.9734951,0.024211083,0.001022189,0.0009528263,0.00020866633,0.00011008944],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.001949434,0.00054825976,0.0010215815,0.00018016872,0.00012803458,0.000040057796,0.0022919704,0.0015514969,0.00011643818],"category_scores_gemma":[0.0017288441,0.0004298427,0.00045734263,0.00025450825,0.0017082837,0.00007995978,0.00055715453,0.004235466,0.00006220683],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007339255,0.0009436852,0.018074693,0.0014224537,0.0007093352,0.00017148757,0.0024277035,0.00030266566,0.10896549,0.000014558637,0.8298542,0.036379825],"study_design_scores_gemma":[0.0020958765,0.0019706867,0.016385796,0.0007132133,0.0011696486,0.000038894854,0.00006200615,0.008492604,0.043127324,0.00080911047,0.9241201,0.001014708],"about_ca_topic_score_codex":0.0000095599635,"about_ca_topic_score_gemma":0.000009359188,"teacher_disagreement_score":0.21022527,"about_ca_system_score_codex":0.00010901946,"about_ca_system_score_gemma":0.00035793346,"threshold_uncertainty_score":0.99981534},"labels":[],"label_agreement":null},{"id":"W2052080148","doi":"10.1038/clpt.2010.67","title":"Subjective and Objective Effects of the Novel Triple Reuptake Inhibitor Tesofensine in Recreational Stimulant Users","year":2010,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacology and Obesity Treatment","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Kensington Health","funders":"","keywords":"Atomoxetine; Bupropion; Stimulant; Amphetamine; Placebo; Pharmacology; Dextroamphetamine; Psychology; Reuptake inhibitor; Medicine; Reboxetine; Antidepressant; Dopamine; Methylphenidate; Psychiatry; Attention deficit hyperactivity disorder; Internal medicine; Anxiety","score_opus":0.03957003734388431,"score_gpt":0.3882556617029775,"score_spread":0.34868562435909317,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2052080148","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99182934,0.0003858307,0.00002064443,0.0037429242,0.0027435247,0.0011261781,0.000016406602,0.00002480733,0.00011037471],"genre_scores_gemma":[0.9829042,0.0004031707,0.00051652396,0.015551601,0.0003344361,0.00003970054,0.000006428035,0.00001856471,0.00022540169],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99847984,0.00028057094,0.00049451477,0.0003451792,0.00014531109,0.00025459292],"domain_scores_gemma":[0.9969923,0.0023402886,0.00019193029,0.0001910473,0.00015816532,0.00012630137],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00050464633,0.00019441625,0.00051033456,0.000087003275,0.00009127466,0.000003151486,0.00012035515,0.00034398024,0.000051922],"category_scores_gemma":[0.00017696558,0.00013285913,0.00014940229,0.00022970006,0.00089745567,0.00004258337,0.00009122054,0.0011543038,0.0000053656104],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002887836,0.003642379,0.45928138,0.000050094994,0.0010798102,0.000049186296,0.00041069364,0.0000060415414,0.5295946,0.000062312436,0.00059287134,0.002342793],"study_design_scores_gemma":[0.013636406,0.0010773017,0.85235786,0.000048469374,0.0013603988,0.00004123185,0.000030493566,0.0004640751,0.12936008,0.00018480018,0.0013254295,0.000113464994],"about_ca_topic_score_codex":0.000013216237,"about_ca_topic_score_gemma":0.00003901458,"teacher_disagreement_score":0.40023452,"about_ca_system_score_codex":0.000062670886,"about_ca_system_score_gemma":0.00028622328,"threshold_uncertainty_score":0.5417838},"labels":[],"label_agreement":null},{"id":"W2052474126","doi":"10.1002/cpt.77","title":"Blood–brain barrier: An impediment to neuropharmaceuticals","year":2015,"lang":"en","type":"editorial","venue":"Clinical Pharmacology & Therapeutics","topic":"Barrier Structure and Function Studies","field":"Neuroscience","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Drug Policy Research Network; University of Toronto","funders":"","keywords":"Blood–brain barrier; Central nervous system; Medicine; Systemic circulation; Drug; Drug delivery; Neuroscience; Site of action; Blood circulation; Intensive care medicine; Pharmacology; Biology; Chemistry; Internal medicine","score_opus":0.16445871331618378,"score_gpt":0.4914402294245855,"score_spread":0.3269815161084017,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2052474126","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0068937656,0.00078138727,0.000065544526,0.01012757,0.97910225,0.0011327917,0.0006542632,0.00044787806,0.0007945294],"genre_scores_gemma":[0.0016447804,0.002219542,0.00012816304,0.24386469,0.74914783,0.00015784561,0.000046798024,0.00019947006,0.0025908896],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9908334,0.0027642557,0.0016771888,0.0021822522,0.0013496962,0.0011932233],"domain_scores_gemma":[0.98804426,0.008243237,0.000514352,0.00094133406,0.0006189507,0.0016378708],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0018808916,0.00095746637,0.0015258472,0.00023012116,0.00044846156,0.00013263825,0.00163932,0.0017364852,0.0006786378],"category_scores_gemma":[0.0017225101,0.00083727966,0.00045086365,0.0005192969,0.0010897487,0.00017690973,0.0008169918,0.0040910277,0.00072433206],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00089652214,0.0004917456,0.000040562427,0.000024284838,0.00046275396,0.00016454264,0.0002421029,0.000011632081,0.035553407,0.000011136223,0.9594661,0.0026352182],"study_design_scores_gemma":[0.0031371939,0.0025291387,0.000015375244,0.000010491137,0.0023521832,0.000009341492,0.000028711951,0.000055691627,0.010274405,0.0002611381,0.98053014,0.0007962071],"about_ca_topic_score_codex":0.0000035366418,"about_ca_topic_score_gemma":0.0000027774574,"teacher_disagreement_score":0.23373711,"about_ca_system_score_codex":0.00010853688,"about_ca_system_score_gemma":0.0009363178,"threshold_uncertainty_score":0.99955946},"labels":[],"label_agreement":null},{"id":"W2054470265","doi":"10.1002/cpt.107","title":"Medical cannabis vs. synthetic cannabinoids: What does the future hold?","year":2015,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Cannabis and Cannabinoid Research","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Synthetic cannabinoids; Cannabis; Cannabinoid; Cannabinoid receptor; Tetrahydrocannabinol; Pharmacology; Dronabinol; Medicine; Chemistry; Receptor; Psychiatry; Internal medicine","score_opus":0.060511334569782506,"score_gpt":0.4244928312992699,"score_spread":0.3639814967294874,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2054470265","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.24544111,0.011533803,0.000022544702,0.7302318,0.011040305,0.0009867649,0.000013926877,0.0001490397,0.0005806603],"genre_scores_gemma":[0.3224288,0.025641738,0.0000632953,0.5962786,0.019674608,0.00044807856,0.0000410213,0.00018892076,0.035234936],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9945785,0.0010871792,0.0010518628,0.00078198005,0.0014588296,0.0010416497],"domain_scores_gemma":[0.9962733,0.00019055071,0.00020772054,0.0008934057,0.000792888,0.0016421746],"candidate_categories":["research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0035515171,0.0004348351,0.0008786004,0.00012681556,0.00027040622,0.0001288384,0.00095517316,0.000833646,0.0023546743],"category_scores_gemma":[0.00021360161,0.00023124053,0.00051976484,0.0005019526,0.0022416585,0.0001930062,0.00036305518,0.0026209631,0.00025042766],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016464291,0.0010189138,0.004747566,0.000054761946,0.0008005899,0.00039642843,0.0008670574,0.000005253818,0.00030297186,0.000059963608,0.9089633,0.08113674],"study_design_scores_gemma":[0.0046187546,0.0012310728,0.0060818424,0.000053074025,0.00096757134,0.00025686919,0.002906197,0.0009886052,0.0007642957,0.00022995041,0.9815869,0.00031488432],"about_ca_topic_score_codex":0.00005527527,"about_ca_topic_score_gemma":0.00010641877,"teacher_disagreement_score":0.13395323,"about_ca_system_score_codex":0.00023784573,"about_ca_system_score_gemma":0.002832788,"threshold_uncertainty_score":0.99968004},"labels":[],"label_agreement":null},{"id":"W2054531404","doi":"10.1016/s0009-9236(03)90395-x","title":"Sulfamethoxazole hydroxylamine (SMX‐HA): Induces increased necrotic versus apoptotic cell death in sensitive lymphocytes","year":2003,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pneumocystis jirovecii pneumonia detection and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Hydroxylamine; Apoptosis; Programmed cell death; Chemistry; Molecular biology; Medicine; Pharmacology; Biology; Biochemistry","score_opus":0.09180987277864083,"score_gpt":0.40075909169272234,"score_spread":0.3089492189140815,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2054531404","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.992327,0.0005062508,0.00006331972,0.0014296698,0.0022767193,0.0008918943,0.0000109156135,0.00013656063,0.0023576843],"genre_scores_gemma":[0.9809058,0.0009375897,0.0009281591,0.016512588,0.00025489766,0.000060838247,0.00001944825,0.00006483665,0.00031587068],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99619746,0.0011875296,0.00095767045,0.00071317353,0.00027126717,0.00067287625],"domain_scores_gemma":[0.99608654,0.002722061,0.00025603158,0.00037866322,0.00014030817,0.0004164086],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008416156,0.00044551326,0.00093821797,0.0002434894,0.00012901037,0.00001981422,0.00014759914,0.00037862704,0.00020438219],"category_scores_gemma":[0.00016444184,0.0003994472,0.00030660012,0.00046625905,0.00035817554,0.000073565105,0.00005642937,0.0008658621,0.0002599201],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.019859504,0.018392622,0.15512101,0.00022586875,0.0047961622,0.005405247,0.00076183124,0.00036835158,0.7832537,0.00015626985,0.0006325813,0.0110268155],"study_design_scores_gemma":[0.08901482,0.007000377,0.21887508,0.00010099459,0.005356108,0.0005884623,0.00042576392,0.0036190348,0.66090024,0.00023166588,0.012795024,0.0010924084],"about_ca_topic_score_codex":0.000037721806,"about_ca_topic_score_gemma":0.000014720756,"teacher_disagreement_score":0.12235348,"about_ca_system_score_codex":0.00046485176,"about_ca_system_score_gemma":0.0004828209,"threshold_uncertainty_score":0.99984574},"labels":[],"label_agreement":null},{"id":"W2055705126","doi":"10.1038/clpt.2012.186","title":"CYP2B6 and Bupropion’s Smoking-Cessation Pharmacology: The Role of Hydroxybupropion","year":2012,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Respiratory and Cough-Related Research","field":"Medicine","cited_by":82,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Addiction and Mental Health; University of Toronto","funders":"National Cancer Institute; National Institute on Minority Health and Health Disparities; Canadian Institutes of Health Research; National Institute on Drug Abuse; U.S. Public Health Service","keywords":"Bupropion; Pharmacology; Active metabolite; Smoking cessation; Medicine; CYP2B6; Internal medicine; Pharmacokinetics; Cytochrome P450; Metabolism","score_opus":0.08222645907467754,"score_gpt":0.4376251572673109,"score_spread":0.35539869819263337,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2055705126","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97883177,0.010038667,0.00003713596,0.0077040466,0.001486138,0.00067065126,0.000004020686,0.00005038266,0.0011771612],"genre_scores_gemma":[0.9729752,0.0036879983,0.00004005206,0.021693375,0.0013139448,0.00004781308,0.000006140632,0.000027203176,0.00020827982],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9975965,0.00076727045,0.00064026826,0.00026391918,0.00028042143,0.00045163138],"domain_scores_gemma":[0.9983014,0.00083135423,0.00022959641,0.00022526705,0.00018232474,0.00023005733],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016594382,0.00018030802,0.00039466599,0.0000818327,0.00018706481,0.000008430683,0.00020340248,0.00038417443,0.00046722556],"category_scores_gemma":[0.00002867756,0.00011556659,0.00014617096,0.0002253724,0.0009276739,0.000116129,0.0001208375,0.0011601947,0.00003691466],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002383566,0.002461909,0.51165223,0.00011380508,0.002701018,0.000017577646,0.0010775966,0.000015276499,0.36046958,0.00030058372,0.0067273094,0.112079576],"study_design_scores_gemma":[0.009076562,0.0022389977,0.20807172,0.000050389408,0.0047681383,0.00009532587,0.00060287735,0.0033750595,0.18704246,0.00083824655,0.5834679,0.00037233386],"about_ca_topic_score_codex":0.000004120922,"about_ca_topic_score_gemma":3.0820226e-7,"teacher_disagreement_score":0.57674056,"about_ca_system_score_codex":0.000040408682,"about_ca_system_score_gemma":0.00014144833,"threshold_uncertainty_score":0.5115792},"labels":[],"label_agreement":null},{"id":"W2056107554","doi":"10.1067/mcp.2000.104737","title":"Assessment and reporting of clinical pharmacology information in drug labeling","year":2000,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Purdue Pharma (Canada)","funders":"","keywords":"Food and drug administration; Medicine; Family medicine; Library science; Environmental health","score_opus":0.2816947961897552,"score_gpt":0.5885005010261709,"score_spread":0.3068057048364157,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2056107554","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9733501,0.0012363238,0.000025968258,0.018560477,0.0017872344,0.0005974223,0.000006253199,0.00004827308,0.0043879454],"genre_scores_gemma":[0.8864848,0.024178218,0.0018087738,0.08659772,0.000751754,0.000025885502,0.000010885538,0.000016340857,0.00012561663],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9935352,0.00080072175,0.004681428,0.00034354205,0.00023054656,0.0004085127],"domain_scores_gemma":[0.9947439,0.0029223757,0.0017345296,0.00016226093,0.00018572998,0.00025123928],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0063008014,0.00021273081,0.0012125042,0.00008437695,0.00009934825,0.000012136959,0.00013636884,0.00027070486,0.0013515028],"category_scores_gemma":[0.00021523466,0.0001773927,0.00021731599,0.0002369146,0.00057757134,0.00026057166,0.00010975543,0.0015274546,0.000033466476],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028812021,0.001988753,0.6231683,0.0001977354,0.0015413928,0.00012697373,0.00036613428,0.00007359155,0.0025467174,0.000021630254,0.008662411,0.35842517],"study_design_scores_gemma":[0.011663027,0.00087453285,0.460135,0.00005889212,0.0021451723,0.000063828316,0.00021864806,0.010824095,0.0008825978,0.00011038416,0.5127614,0.00026236067],"about_ca_topic_score_codex":0.000025423893,"about_ca_topic_score_gemma":0.0000040584355,"teacher_disagreement_score":0.504099,"about_ca_system_score_codex":0.000043854525,"about_ca_system_score_gemma":0.00024869927,"threshold_uncertainty_score":0.99956137},"labels":[],"label_agreement":null},{"id":"W2057311010","doi":"10.1038/sj.clpt.6100474","title":"Monoamine Oxidase Inhibition for Tobacco Pharmacotherapy","year":2007,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Nicotinic Acetylcholine Receptors Study","field":"Biochemistry, Genetics and Molecular Biology","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Institute on Drug Abuse","keywords":"Bupropion; Varenicline; Monoamine oxidase; Medicine; Pharmacology; Nicotine replacement therapy; Addiction; Smoking cessation; Pharmacotherapy; Nicotine; Tobacco harm reduction; Drug; Psychiatry; Tobacco use; Environmental health; Population; Biology","score_opus":0.21264644841810137,"score_gpt":0.5321928604893975,"score_spread":0.31954641207129614,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2057311010","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0011156918,0.98786193,0.0022376599,0.00031380446,0.0046178848,0.0033786925,0.0002524321,0.000085158914,0.00013675692],"genre_scores_gemma":[0.00002983516,0.96672446,0.0012551054,0.020970974,0.007993139,0.00051524624,0.0011381737,0.00027794804,0.0010951178],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9946741,0.0007687437,0.002117066,0.0013315679,0.00021330295,0.0008952485],"domain_scores_gemma":[0.99693763,0.00079461257,0.0010041542,0.0006663009,0.0002840405,0.0003132489],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0017716328,0.00093367783,0.0021194853,0.00016380026,0.00017937503,0.000029804465,0.00070945715,0.0017846306,0.00016038041],"category_scores_gemma":[0.00004943567,0.00082746503,0.0018482296,0.00028204976,0.00046385863,0.000006774781,0.00027231924,0.0011096689,0.000113314156],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041924074,0.0012340456,0.000028085193,0.000838981,0.003245414,0.000003465759,0.000010505081,0.0000012447276,0.0039146645,0.0000036096612,0.06927147,0.92102927],"study_design_scores_gemma":[0.0036464198,0.0011007477,0.0000013649769,0.00025599686,0.0041802353,0.000028420403,0.0000072928624,0.000010397666,0.0047760135,0.0000084079575,0.98519653,0.00078817183],"about_ca_topic_score_codex":0.0000010577863,"about_ca_topic_score_gemma":0.0000028634543,"teacher_disagreement_score":0.9202411,"about_ca_system_score_codex":0.00009240963,"about_ca_system_score_gemma":0.00052371033,"threshold_uncertainty_score":0.99951124},"labels":[],"label_agreement":null},{"id":"W2057926673","doi":"10.1067/mcp.2000.104616","title":"Nonlinear kinetics and pharmacologic response to mibefradil","year":2000,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Potassium and Related Disorders","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Mibefradil; Pharmacokinetics; Heart rate; Internal medicine; Pharmacology; Chemistry; Oral administration; Medicine; Endocrinology; Blood pressure; Antagonist; Receptor","score_opus":0.05877223310805539,"score_gpt":0.42353618010371014,"score_spread":0.36476394699565473,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2057926673","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9321108,0.001728831,0.000027731343,0.062871516,0.0009625708,0.0006183293,0.0000136929675,0.00014810984,0.0015184159],"genre_scores_gemma":[0.5595828,0.009896921,0.002981173,0.42013758,0.0008157362,0.000036423342,0.000013480052,0.00006700296,0.0064688236],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9977148,0.0005027351,0.0006371948,0.00048393154,0.00016946129,0.00049188395],"domain_scores_gemma":[0.99820715,0.0008222727,0.00007246938,0.0002312299,0.00009419795,0.00057266495],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006732651,0.00026040108,0.0005096902,0.00010616759,0.00010706004,0.000014054953,0.00017695191,0.00044590188,0.0026291814],"category_scores_gemma":[0.000038501752,0.00021089203,0.00016460782,0.00028877688,0.0005583914,0.00003543015,0.000058211328,0.0008335039,0.000627062],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.05913101,0.008323045,0.014392299,0.000075057214,0.0030409892,0.00084526924,0.00090073206,0.00015589551,0.53094274,0.0000039828797,0.12369978,0.2584892],"study_design_scores_gemma":[0.009888163,0.0043651764,0.025186896,0.000019277491,0.0021352835,0.0001523979,0.00004041727,0.0016524973,0.0038082572,0.000047539692,0.9523833,0.0003207969],"about_ca_topic_score_codex":0.000001530891,"about_ca_topic_score_gemma":5.1485466e-7,"teacher_disagreement_score":0.8286835,"about_ca_system_score_codex":0.000040601357,"about_ca_system_score_gemma":0.00012852666,"threshold_uncertainty_score":0.99828255},"labels":[],"label_agreement":null},{"id":"W2057948342","doi":"10.1016/j.clpt.2004.11.005","title":"Identification of a dysfunctional missense single nucleotide variant of human adenylyl cyclase VI","year":2005,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Receptor Mechanisms and Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Robarts Clinical Trials","funders":"","keywords":"Adenylyl cyclase; ADCY9; ADCY3; ADCY10; Gs alpha subunit; ADCY6; cAMP-dependent pathway; Missense mutation; Forskolin; Biology; G protein; Molecular biology; Chemistry; Receptor; Internal medicine; Endocrinology; Mutation; Genetics; Gene; Medicine","score_opus":0.0516003922526732,"score_gpt":0.37043372810379693,"score_spread":0.3188333358511237,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2057948342","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99534386,0.00050327316,0.0023105913,0.00067013904,0.00083458703,0.00017171864,0.000022721433,0.000011633243,0.00013147506],"genre_scores_gemma":[0.9945683,0.0002610341,0.00061450794,0.0031441487,0.0009679614,0.000007421987,0.000042369596,0.000024201736,0.0003700905],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99827164,0.00021524858,0.0008888681,0.00031146634,0.00013026812,0.00018249702],"domain_scores_gemma":[0.9989821,0.000085215055,0.0004203743,0.00023099764,0.00020141453,0.000079909805],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005879915,0.00013823331,0.00026521052,0.00004312624,0.00006655494,0.000006375999,0.00020307007,0.00025196638,0.00042705823],"category_scores_gemma":[0.000019670899,0.00013503799,0.00021249408,0.0000710976,0.0002541082,0.0000054039133,0.00006167416,0.00016819178,0.000015367346],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024452512,0.00083231577,0.00021877978,0.000014038899,0.00032765185,0.0000027605238,0.000035104305,0.000112428665,0.99407184,0.00005916844,0.001947075,0.0021343175],"study_design_scores_gemma":[0.0011720886,0.00073751126,0.00035174112,0.0000071031295,0.00026941777,0.00001065158,0.000026548036,0.0006235279,0.9775379,0.00011604509,0.019016864,0.00013060698],"about_ca_topic_score_codex":0.0000017807837,"about_ca_topic_score_gemma":0.0000021881117,"teacher_disagreement_score":0.017069789,"about_ca_system_score_codex":0.000013311795,"about_ca_system_score_gemma":0.00006606248,"threshold_uncertainty_score":0.5506689},"labels":[],"label_agreement":null},{"id":"W2057990093","doi":"10.1067/mcp.2000.108948","title":"A century of discovery: The pharmacologic revolution","year":2000,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Health and Medical Research Impacts","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen Elizabeth II Health Sciences Centre","funders":"","keywords":"Clinical pharmacology; Medicine; Pharmacology","score_opus":0.2759039125807195,"score_gpt":0.5438591686339532,"score_spread":0.2679552560532337,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2057990093","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8438599,0.0038616469,0.000093535455,0.1470389,0.0012097332,0.0011192336,0.000018141898,0.000060760194,0.0027381035],"genre_scores_gemma":[0.63155335,0.04091049,0.00011745889,0.3249226,0.0010109828,0.000029520095,0.000010650362,0.000017670784,0.0014272562],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9969291,0.0008257386,0.00075425487,0.0002710322,0.00041931192,0.0008005294],"domain_scores_gemma":[0.9964555,0.0015883647,0.00013591048,0.00028106762,0.00014020968,0.0013989861],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0026567713,0.0001529221,0.00046922592,0.000047780868,0.000116352894,0.000006662864,0.00026181524,0.00024357173,0.0030979728],"category_scores_gemma":[0.00065115705,0.00008781975,0.00024064032,0.00030539674,0.0011080276,0.00007579959,0.000045635872,0.0011607492,0.00017603708],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00934117,0.0039784843,0.013210179,0.00024962606,0.0012582077,0.00013950143,0.00033200489,0.000011886594,0.02723302,0.000064036016,0.38091525,0.56326663],"study_design_scores_gemma":[0.0050622425,0.0019361343,0.022324007,0.00004041938,0.00085560523,0.00003518681,0.000045751443,0.00057612656,0.0016664012,0.00011332169,0.9672437,0.00010114308],"about_ca_topic_score_codex":0.000008964159,"about_ca_topic_score_gemma":7.199679e-7,"teacher_disagreement_score":0.5863284,"about_ca_system_score_codex":0.000092008755,"about_ca_system_score_gemma":0.0018491431,"threshold_uncertainty_score":0.99781334},"labels":[],"label_agreement":null},{"id":"W2058860931","doi":"10.1016/s0009-9236(01)90121-3","title":"QTc prolongation and drugs","year":2001,"lang":"en","type":"letter","venue":"Clinical Pharmacology & Therapeutics","topic":"Cardiac electrophysiology and arrhythmias","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Hospital and Health Sciences Centre","funders":"","keywords":"Prolongation; Clinical pharmacology; Medicine; QT interval; Pharmacology; Internal medicine","score_opus":0.058218744531903927,"score_gpt":0.4061024109679679,"score_spread":0.34788366643606394,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2058860931","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.11063325,0.0023574312,0.00001806881,0.8823869,0.0027330124,0.0007892711,0.000013892328,0.00013281396,0.0009353221],"genre_scores_gemma":[0.0062153013,0.00811764,0.00011406294,0.9591504,0.022233231,0.00005870019,0.00023939085,0.00007249298,0.003798801],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99741197,0.00057723804,0.0006464734,0.00066277786,0.00017714669,0.0005243788],"domain_scores_gemma":[0.99818134,0.0009757043,0.00026612202,0.00031967126,0.00013941819,0.00011776681],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.00038776346,0.00036905744,0.0010068129,0.000104504106,0.00012100715,0.000010858935,0.00011973185,0.0021535654,0.0002868804],"category_scores_gemma":[0.000016654825,0.00031619394,0.00039457655,0.00013238564,0.0008612862,0.000034459354,0.00007830302,0.0050922083,0.00016016925],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006510227,0.00012663455,0.00079595495,0.00008753871,0.0017703216,0.0017484255,0.000055932538,7.8847154e-7,0.0009257557,0.0000017819002,0.98312587,0.01070995],"study_design_scores_gemma":[0.0026518812,0.0010081199,0.0021730089,0.000030515386,0.003999133,0.0005833748,0.00000529274,0.000082847975,0.00020336454,0.00034078775,0.9886347,0.00028697183],"about_ca_topic_score_codex":0.0000014142306,"about_ca_topic_score_gemma":1.6221836e-7,"teacher_disagreement_score":0.10441794,"about_ca_system_score_codex":0.00005249705,"about_ca_system_score_gemma":0.00021945202,"threshold_uncertainty_score":0.999929},"labels":[],"label_agreement":null},{"id":"W2059515941","doi":"10.1067/mcp.2001.117612","title":"A pharmacokinetic study of intermittent rifabutin dosing with a combination of ritonavir and saquinavir in patients infected with human immunodeficiency virus","year":2001,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Mycobacterium research and diagnosis","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University Health Network; Toronto General Hospital","funders":"","keywords":"Rifabutin; Saquinavir; Ritonavir; Virology; Pharmacokinetics; Medicine; Dosing; Pharmacology; Human immunodeficiency virus (HIV); Clarithromycin; Internal medicine; Viral load; Antiretroviral therapy","score_opus":0.05535563122780661,"score_gpt":0.415445246932836,"score_spread":0.3600896157050294,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2059515941","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99801534,0.00016922795,0.000009123005,0.00023959692,0.000090689704,0.0013719909,0.0000062208605,0.000019782203,0.000078000805],"genre_scores_gemma":[0.998388,0.00044278556,0.00003719012,0.0010080329,0.00002713087,0.00004879822,0.000015852613,0.000022544991,0.000009693293],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978575,0.00044263317,0.00076615537,0.00031703836,0.000314558,0.00030208085],"domain_scores_gemma":[0.9986413,0.00042030364,0.00029922376,0.00019355367,0.00032710467,0.00011849977],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045690843,0.0001888682,0.0005948757,0.00021283662,0.00005230781,0.0000071658105,0.00013235219,0.000097823904,0.00007190879],"category_scores_gemma":[0.000020495152,0.00013784271,0.000048823018,0.00039414375,0.0004704588,0.00006933548,0.00008747554,0.00050801854,0.0000016078728],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0069739707,0.019219935,0.9307999,0.000067270026,0.00037766932,0.00005121084,0.00054333743,0.0000049398186,0.034933403,0.0000012507513,0.000018282633,0.0070088194],"study_design_scores_gemma":[0.031217681,0.024271281,0.9394484,0.00012714045,0.00071120047,0.000009695818,0.00016023374,0.00018846813,0.0036591825,0.0000062058443,0.00007831538,0.00012218853],"about_ca_topic_score_codex":0.00010531125,"about_ca_topic_score_gemma":0.000033542987,"teacher_disagreement_score":0.03127422,"about_ca_system_score_codex":0.000048978698,"about_ca_system_score_gemma":0.000076198216,"threshold_uncertainty_score":0.56210625},"labels":[],"label_agreement":null},{"id":"W2059952793","doi":"10.1002/cpt.93","title":"Cannabis legalization with strict regulation, the overall superior policy option for public health","year":2015,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Cannabis and Cannabinoid Research","field":"Medicine","cited_by":67,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University; University of Toronto; Centre for Addiction and Mental Health","funders":"","keywords":"Legalization; Decriminalization; Cannabis; Harm; Public health; Public economics; Business; Economics; Political science; Medicine; Law; Psychiatry","score_opus":0.23174140033858345,"score_gpt":0.48384529889528494,"score_spread":0.25210389855670146,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2059952793","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.09865037,0.00088086305,0.007318062,0.8900369,0.0006418984,0.0021194553,0.000026781798,0.000087699,0.00023799694],"genre_scores_gemma":[0.6355889,0.0013969203,0.0011786385,0.3252631,0.0054314793,0.0006400579,0.00030025752,0.00013794897,0.030062672],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99754566,0.00057451153,0.0005912372,0.00034975243,0.0003848887,0.00055394013],"domain_scores_gemma":[0.99789405,0.00006912152,0.00020149979,0.0003153445,0.0009984195,0.00052156637],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00235797,0.0001796563,0.00038754466,0.00014232776,0.00024336387,0.000058336216,0.00019975085,0.00017985553,0.000082296814],"category_scores_gemma":[0.0001587808,0.00011306174,0.00014863003,0.00047277106,0.00047160173,0.00012015421,0.00004819623,0.00041831497,0.000010340902],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031385575,0.0009692282,0.0073158527,0.00009932882,0.00065767154,0.000005101172,0.000959035,0.00016856704,0.000578032,0.0022989556,0.95080996,0.032999735],"study_design_scores_gemma":[0.005731369,0.0028325666,0.031413723,0.0000082941715,0.00019413447,0.00003454217,0.00016113359,0.0055490136,0.00013883362,0.00026853662,0.95354134,0.00012653104],"about_ca_topic_score_codex":0.000088183966,"about_ca_topic_score_gemma":0.000035917816,"teacher_disagreement_score":0.56477374,"about_ca_system_score_codex":0.0004039835,"about_ca_system_score_gemma":0.0042226706,"threshold_uncertainty_score":0.74908364},"labels":[],"label_agreement":null},{"id":"W2060479633","doi":"10.1016/s0009-9236(03)90618-7","title":"Treatment for psychiatric disorders is a predictor of problem drinking in pregnant women","year":2003,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Prenatal Substance Exposure Effects","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Psychiatry; Medicine; Clinical pharmacology; Pharmacology","score_opus":0.04924505697009422,"score_gpt":0.3924211302661901,"score_spread":0.34317607329609584,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2060479633","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98999643,0.0031204163,0.0004277266,0.002154431,0.0010972653,0.002771397,0.000015780797,0.000052305695,0.00036425653],"genre_scores_gemma":[0.9882785,0.0029086655,0.0028338942,0.004967056,0.00017089772,0.00059921306,0.0000067580245,0.000042827323,0.00019220177],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99788064,0.00027068946,0.00079850765,0.00040947544,0.0001428422,0.0004978513],"domain_scores_gemma":[0.99844223,0.0008561541,0.00023687149,0.00024397601,0.000061741965,0.00015900233],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00054214266,0.00022536449,0.00065551535,0.00011656304,0.000038446342,0.00000343274,0.0001319555,0.00024085195,0.000075026204],"category_scores_gemma":[0.000030629737,0.00017850964,0.00023494684,0.00028313286,0.0002043121,0.00004188048,0.000019119407,0.00027597306,0.0000061579035],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0053583467,0.010182558,0.9006553,0.0004493327,0.0025639094,0.000024780837,0.003590663,0.000027622662,0.015440581,0.00020063217,0.001609032,0.05989723],"study_design_scores_gemma":[0.19228268,0.06867992,0.26698378,0.0007154283,0.0068166824,0.00006909077,0.0007002858,0.0055407947,0.047858372,0.019014653,0.3895381,0.0018002024],"about_ca_topic_score_codex":0.000002085306,"about_ca_topic_score_gemma":0.00001034962,"teacher_disagreement_score":0.6336715,"about_ca_system_score_codex":0.00021536805,"about_ca_system_score_gemma":0.0002755847,"threshold_uncertainty_score":0.7279412},"labels":[],"label_agreement":null},{"id":"W2060894663","doi":"10.1038/clpt.2014.145","title":"Accelerated Access to Innovative Medicines for Patients in Need","year":2014,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":87,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Canada; Institut National d'Excellence en Santé et en Services Sociaux","funders":"Innovative Medicines Initiative; National Comprehensive Cancer Network; European Federation of Pharmaceutical Industries and Associations; Bill and Melinda Gates Foundation","keywords":"Clinical pharmacology; Variety (cybernetics); Access to medicines; Business; Health care; Medicine; Pharmacology; Economic growth; Computer science; Economics; Nursing; Public health","score_opus":0.27197532223787846,"score_gpt":0.47316314814981514,"score_spread":0.20118782591193668,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2060894663","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9314828,0.00011362818,0.0019921304,0.05626208,0.0040067793,0.0012863263,0.0001678716,0.00005149665,0.0046369187],"genre_scores_gemma":[0.6852491,0.00023407863,0.00024872582,0.3133848,0.00063016044,0.00011988289,0.000029662962,0.000033476637,0.00007012796],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99739456,0.000085540916,0.0014412655,0.00053601543,0.000025983709,0.0005166369],"domain_scores_gemma":[0.9980677,0.0009785938,0.00036191402,0.0002086038,0.00016284936,0.0002203555],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012798416,0.00022051496,0.00073129806,0.0003089916,0.00007252107,0.000051873525,0.00062673516,0.00023442687,0.00028303146],"category_scores_gemma":[0.00022079723,0.00023561655,0.00011473943,0.0006055627,0.00015981705,0.00017481025,0.0001620974,0.00038802298,0.0002781101],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009943907,0.0018376801,0.8510924,0.000046674584,0.00053183973,0.00000124083,0.00038280475,0.0001737468,0.00015627695,0.012872812,0.11588067,0.016029464],"study_design_scores_gemma":[0.0077915164,0.0007416323,0.21174043,0.000009115063,0.00004208693,2.3521297e-7,0.0000088847355,0.013629195,0.00033255323,0.019243348,0.7460267,0.00043428355],"about_ca_topic_score_codex":0.00001728171,"about_ca_topic_score_gemma":0.0000119322185,"teacher_disagreement_score":0.63935196,"about_ca_system_score_codex":0.000089494664,"about_ca_system_score_gemma":0.000043651024,"threshold_uncertainty_score":0.9608164},"labels":[],"label_agreement":null},{"id":"W2060975315","doi":"10.1038/clpt.2012.231","title":"The State of Clinical Pharmacology Today","year":2013,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Clinical pharmacology; Pharmacology; Medicine; Position paper; Engineering ethics; Engineering; Pathology","score_opus":0.22981202993049338,"score_gpt":0.54599887420174,"score_spread":0.3161868442712466,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2060975315","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.825949,0.0067727575,0.00008680768,0.1496205,0.012122248,0.0016336599,0.000014819461,0.000114417504,0.0036857945],"genre_scores_gemma":[0.644466,0.06186234,0.00047849712,0.28727472,0.00330031,0.00013846283,0.000006141316,0.000059594888,0.0024139767],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99440545,0.0016239029,0.0023294406,0.00052951265,0.0003393417,0.00077237433],"domain_scores_gemma":[0.98553896,0.012221398,0.00078119634,0.00038003892,0.0005552489,0.00052314915],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0032447423,0.00031718521,0.001132508,0.000043670498,0.00031535598,0.000024718269,0.00052024866,0.0003023814,0.0020388763],"category_scores_gemma":[0.00022073493,0.00019481675,0.0006062185,0.00026460024,0.002365901,0.00013251351,0.00031586748,0.0019581849,0.00067077024],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0053270175,0.00370308,0.06291718,0.00009053561,0.009105658,0.000077776574,0.00016609987,0.00001369025,0.014230813,0.000046179237,0.42604476,0.4782772],"study_design_scores_gemma":[0.0063084858,0.0016928175,0.07314135,0.000011647952,0.0026134963,0.000023860246,0.00006544274,0.0023609586,0.0036280984,0.000728095,0.90920275,0.00022300598],"about_ca_topic_score_codex":0.000018408075,"about_ca_topic_score_gemma":0.000003433576,"teacher_disagreement_score":0.483158,"about_ca_system_score_codex":0.00003254482,"about_ca_system_score_gemma":0.00026681868,"threshold_uncertainty_score":0.9988734},"labels":[],"label_agreement":null},{"id":"W2061572390","doi":"10.1016/s0009-9236(03)90597-2","title":"Influence of omeprazole (O) on the bioavailability of BI from a single‐triple (ST) capsule of bismuth biskalcitrate (BK) + tetracycline (T) + metronidazole (M) for eradication of helicobacter pylori","year":2003,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Helicobacter pylori-related gastroenterology studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BioPhage Pharma (Canada)","funders":"","keywords":"Omeprazole; Metronidazole; Bioavailability; Tetracycline; Helicobacter pylori; Capsule; Bismuth; Pharmacology; Medicine; Chemistry; Gastroenterology; Antibiotics; Biology; Biochemistry","score_opus":0.08615274834982316,"score_gpt":0.37747404165394927,"score_spread":0.2913212933041261,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2061572390","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9910943,0.0006581676,0.00020775017,0.0058326665,0.0005331035,0.0011873312,0.00041361718,0.000023514878,0.00004956651],"genre_scores_gemma":[0.9910241,0.00070692954,0.0011224772,0.0068812836,0.00010633533,0.000059327765,0.00003371666,0.00003708454,0.00002874817],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.995909,0.0007142036,0.0021763977,0.00049425574,0.0002906611,0.0004154986],"domain_scores_gemma":[0.9941049,0.002649314,0.0014189434,0.00069547683,0.0010076814,0.00012364218],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016772642,0.00031333373,0.0012690941,0.00019399237,0.00006139728,0.0000024972367,0.00035933158,0.0003873394,0.00011892599],"category_scores_gemma":[0.00071572507,0.00022683371,0.0004098427,0.000539782,0.0020482433,0.00006657583,0.000069586094,0.0006360356,0.0000071133],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002673465,0.004389855,0.21119975,0.00014441044,0.0037889655,0.0000015088431,0.00043662824,0.0001238365,0.775403,0.0000531439,0.00071490946,0.001070491],"study_design_scores_gemma":[0.0073611285,0.0046169874,0.19480821,0.00010046422,0.002704105,0.000002618612,0.00016704835,0.00027186627,0.785688,0.0002860506,0.0038364218,0.00015710825],"about_ca_topic_score_codex":0.000029080597,"about_ca_topic_score_gemma":0.000009899525,"teacher_disagreement_score":0.016391527,"about_ca_system_score_codex":0.00007053912,"about_ca_system_score_gemma":0.0002132563,"threshold_uncertainty_score":0.925001},"labels":[],"label_agreement":null},{"id":"W2062113679","doi":"10.1038/clpt.2009.192","title":"Pediatric Drug Development: Concepts and Applications","year":2009,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Child and Family Research Institute; University of British Columbia","funders":"","keywords":"Citation; Library science; Columbia university; Medicine; Computer science; Sociology; Media studies","score_opus":0.13275033498730893,"score_gpt":0.5103151283283531,"score_spread":0.3775647933410442,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2062113679","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8583909,0.03429463,0.00086603337,0.09406231,0.0011654126,0.0017915533,0.000008025486,0.00030428573,0.009116836],"genre_scores_gemma":[0.73224455,0.024934154,0.0014858696,0.23891927,0.0018663697,0.000048244245,0.000008041878,0.000015581116,0.00047792506],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9986332,0.00013794313,0.00048758675,0.00031725178,0.00012784796,0.00029616663],"domain_scores_gemma":[0.9984967,0.0008861893,0.00013119991,0.00011824473,0.00009156477,0.00027608077],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048207058,0.00015708826,0.00034146602,0.00003724058,0.00021724735,0.0000127024705,0.00010854504,0.00012167984,0.00020401698],"category_scores_gemma":[0.000015809395,0.0001285386,0.00007502238,0.00017379332,0.00023924997,0.000058777357,0.00005573916,0.00057339366,0.00011936266],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013549528,0.0035405871,0.15114623,0.00012166048,0.0015253262,0.00007762867,0.0007186199,0.000002310146,0.0024505004,0.00033574514,0.050243527,0.7884829],"study_design_scores_gemma":[0.0023943079,0.00021569178,0.09267824,0.0000031167365,0.0013414382,0.000019579638,0.000037411843,0.00007013582,0.0005071712,0.00022651556,0.90235895,0.00014741975],"about_ca_topic_score_codex":3.5509802e-7,"about_ca_topic_score_gemma":3.3361056e-7,"teacher_disagreement_score":0.85211545,"about_ca_system_score_codex":0.000023360813,"about_ca_system_score_gemma":0.00010490673,"threshold_uncertainty_score":0.52416515},"labels":[],"label_agreement":null},{"id":"W2062587894","doi":"10.1038/sj.clpt.6100060","title":"Biomedical Communications: Collaborative Research in Scientific Visualization, Online Learning, and Knowledge Translation","year":2007,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Biomedical and Engineering Education","field":"Engineering","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; The Wilson Centre","funders":"Health Canada","keywords":"Visualization; Data visualization; Computer science; Visual media; Knowledge translation; Scientific communication; Visual communication; Engineering ethics; Medical education; Data science; Multimedia; Knowledge management; Medicine; Library science; Engineering","score_opus":0.5213258929393779,"score_gpt":0.6131139110420502,"score_spread":0.09178801810267223,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2062587894","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00013354556,0.9951695,0.0005522311,0.00037030975,0.0027577134,0.00067147566,0.000032814638,0.00018304284,0.00012932753],"genre_scores_gemma":[0.00017413078,0.9972927,0.0007412839,0.00012373946,0.0005946619,0.00009181877,0.0007925749,0.00007301443,0.00011605696],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99638736,0.001255646,0.0012297264,0.00043055238,0.00024534905,0.00045134424],"domain_scores_gemma":[0.9954389,0.0036993183,0.00009955864,0.00030133125,0.00023792002,0.00022301811],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0036985872,0.00029690965,0.0008661493,0.00090464484,0.00018744028,0.00005583844,0.0005064652,0.0009883699,0.00003692101],"category_scores_gemma":[0.000056134882,0.00027177512,0.00011001548,0.0028494422,0.0017836628,0.00006709575,0.000118403645,0.0025265377,0.00005992498],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000057811767,0.00058329606,0.00001615749,0.0035764978,0.00021392052,0.0000024893259,0.00048244259,0.000004867426,0.000008425611,0.000024195471,0.0028828676,0.99219906],"study_design_scores_gemma":[0.0004165893,0.000094705676,0.0000167255,0.0012137127,0.0003136145,0.000004279978,0.00010736857,0.012028948,0.0000010195608,0.00004267078,0.9855258,0.00023455458],"about_ca_topic_score_codex":0.000001222709,"about_ca_topic_score_gemma":0.000014204017,"teacher_disagreement_score":0.9919645,"about_ca_system_score_codex":0.00018350856,"about_ca_system_score_gemma":0.00041893858,"threshold_uncertainty_score":0.9999734},"labels":[],"label_agreement":null},{"id":"W2062906696","doi":"10.1038/clpt.2009.127","title":"Macrolide-Induced Digoxin Toxicity: A Population-Based Study","year":2009,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Potassium and Related Disorders","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; St. Michael's Hospital; University of Toronto; Sunnybrook Health Science Centre; Institute for Clinical Evaluative Sciences","funders":"Canadian Institutes of Health Research; Ontario Ministry of Health and Long-Term Care; Institute for Clinical Evaluative Sciences","keywords":"Medicine; Confidence interval; Odds ratio; Azithromycin; Clarithromycin; Digoxin; Cefuroxime; Erythromycin; Toxicity; Clinical pharmacology; Population; Pharmacology; Internal medicine; Antibiotics; Biology; Microbiology; Environmental health","score_opus":0.08299471890286968,"score_gpt":0.4509136339232717,"score_spread":0.367918915020402,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2062906696","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9755595,0.00024994585,0.00007769922,0.02105384,0.0010636974,0.0010031335,0.0000033235922,0.00021290338,0.0007759898],"genre_scores_gemma":[0.84949946,0.0000696854,0.00010726239,0.14969413,0.00037132044,0.000014826669,0.000019324509,0.000025215702,0.00019873862],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976741,0.00039261748,0.0008030496,0.0004496827,0.00024871717,0.00043182305],"domain_scores_gemma":[0.99869245,0.00042492003,0.00017972758,0.0003265863,0.000099745324,0.00027656445],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00051697914,0.00025448215,0.00059474143,0.00011946854,0.00014410536,0.000013910373,0.00018444541,0.0004139252,0.00029195382],"category_scores_gemma":[0.000034163357,0.00020546392,0.0002360213,0.00029414252,0.00008019003,0.000041452167,0.000023152928,0.00092608685,0.000109012035],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004433072,0.026991513,0.8482171,0.000028323973,0.0025681339,0.0005027859,0.0004223939,0.00024025887,0.049671758,0.00002890725,0.0062765097,0.060619194],"study_design_scores_gemma":[0.019772965,0.008260653,0.9546527,0.000024685507,0.0037935306,0.000016240301,0.00014482296,0.0040619154,0.0018656811,0.00040508935,0.0065749455,0.00042676422],"about_ca_topic_score_codex":0.000010155539,"about_ca_topic_score_gemma":0.000005127204,"teacher_disagreement_score":0.1286403,"about_ca_system_score_codex":0.00006853104,"about_ca_system_score_gemma":0.0002017436,"threshold_uncertainty_score":0.83785754},"labels":[],"label_agreement":null},{"id":"W2063194647","doi":"10.1038/clpt.2009.17","title":"Pharmacogenetics of Pharmacoecology: Which Route to Personalized Medicine?","year":2009,"lang":"en","type":"editorial","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Miller; Clinical pharmacology; Pharmacy; Library science; Medicine; Citation; Family medicine; Pharmacology; Computer science; Biology","score_opus":0.20988326001252208,"score_gpt":0.5630251880812913,"score_spread":0.3531419280687692,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2063194647","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.020662162,0.018750058,0.00025019093,0.017104756,0.9318189,0.0035131716,0.00258481,0.00048074604,0.004835222],"genre_scores_gemma":[0.0059889653,0.07951103,0.0013339518,0.15293029,0.752849,0.00040651514,0.0010320103,0.00056322775,0.0053850217],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9797882,0.006571092,0.0056262673,0.0029615527,0.0020020723,0.0030508575],"domain_scores_gemma":[0.97836125,0.011182194,0.0028508785,0.0013328488,0.0036460906,0.0026267401],"candidate_categories":["metaepi_narrow","sts","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"category_scores_codex":[0.008241235,0.002522314,0.0052476376,0.0011637246,0.0006827784,0.00005011123,0.00453139,0.006750743,0.008660635],"category_scores_gemma":[0.0008852796,0.002432105,0.0014433514,0.0020512138,0.002957459,0.00016847775,0.0010106541,0.011119564,0.0009862458],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0044955546,0.0025973178,0.00059324945,0.00026187068,0.006572991,0.000156167,0.0008451157,0.0004605191,0.051990315,0.00003088865,0.89430845,0.037687536],"study_design_scores_gemma":[0.016800068,0.0021362382,0.00031063985,0.0001112186,0.017810458,0.000018698227,0.00007480512,0.0010451747,0.014975609,0.00029665456,0.9444133,0.00200715],"about_ca_topic_score_codex":0.00003176556,"about_ca_topic_score_gemma":0.000023247365,"teacher_disagreement_score":0.17896989,"about_ca_system_score_codex":0.00040255504,"about_ca_system_score_gemma":0.0027250818,"threshold_uncertainty_score":0.9997916},"labels":[],"label_agreement":null},{"id":"W2063970227","doi":"10.1067/mcp.2001.116714","title":"Pharmacogenetics, pharmacogenomics, and pharmacobiology","year":2001,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Pharmacogenomics; Pharmacogenetics; Clinical pharmacology; Medicine; Pharmacology; Biopharmaceutics; Biology; Pharmacognosy; Genotype; Genetics; Gene","score_opus":0.5125665708794018,"score_gpt":0.6075484237968155,"score_spread":0.09498185291741368,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2063970227","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00087411253,0.96135575,0.00008111942,0.0012008897,0.02856256,0.0038980462,0.0011551868,0.00062923145,0.0022430832],"genre_scores_gemma":[0.00006309274,0.9223326,0.00038148815,0.06312959,0.010169994,0.0006512888,0.00045164782,0.0006483006,0.0021720189],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9796223,0.008157512,0.005199517,0.003350391,0.00052906474,0.0031412083],"domain_scores_gemma":[0.9887223,0.004823016,0.0024431264,0.0010553198,0.00045980935,0.0024963813],"candidate_categories":["metaepi_narrow","sts","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"category_scores_codex":[0.0043685567,0.0031303274,0.0071054134,0.0010078762,0.0009646615,0.00014122366,0.0029320288,0.0045013865,0.0061692367],"category_scores_gemma":[0.00006109714,0.0029082897,0.002541366,0.0013576152,0.0035824745,0.00023038029,0.0016973602,0.009455074,0.0022362159],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042658628,0.0015811293,0.00023001737,0.0024487586,0.0108438,0.00054409285,0.00012495057,0.000016313683,0.0005223901,0.000034039964,0.05179771,0.9314302],"study_design_scores_gemma":[0.0064854617,0.00034205292,0.000012332125,0.00034015774,0.04467318,0.0008380075,0.000026140568,0.0006026813,0.0003015138,0.0001331864,0.94364697,0.0025983276],"about_ca_topic_score_codex":0.000009761228,"about_ca_topic_score_gemma":0.0000027322342,"teacher_disagreement_score":0.9288319,"about_ca_system_score_codex":0.0003154007,"about_ca_system_score_gemma":0.0012606508,"threshold_uncertainty_score":0.9991292},"labels":[],"label_agreement":null},{"id":"W2063972278","doi":"10.1016/s0009-9236(03)00051-1","title":"Bergamottin, lime juice, and red wine as inhibitors of cytochrome P450 3a4 activity: comparison with grapefruit juice,","year":2003,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":140,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"","keywords":"Grapefruit juice; Chemistry; Felodipine; Lime; Wine; Citrus paradisi; Food science; Metabolite; Pharmacokinetics; Pharmacology; Biochemistry; Botany; Medicine; Endocrinology","score_opus":0.1754512454019363,"score_gpt":0.5006417785127449,"score_spread":0.32519053311080864,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2063972278","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9815125,0.004604567,0.00009952433,0.004456743,0.0033724648,0.0012710099,0.00006644249,0.00016907293,0.004447676],"genre_scores_gemma":[0.9662181,0.005080685,0.0006863538,0.025945757,0.0009617226,0.00009708426,0.000020568526,0.00013123192,0.0008585088],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99344987,0.002124667,0.0016855674,0.0011088997,0.0004633875,0.0011675835],"domain_scores_gemma":[0.9952524,0.001873669,0.0010353595,0.0005167676,0.00043263,0.000889175],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0023937651,0.00081760937,0.0017253472,0.00031563398,0.0004246217,0.00003489577,0.0006382455,0.0010909406,0.0012567654],"category_scores_gemma":[0.0000636847,0.0007314843,0.00036214676,0.0007724391,0.0021966547,0.00020121438,0.00024265626,0.0027058152,0.000115013136],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008905404,0.009543387,0.09487623,0.00027937058,0.008437385,0.00031986603,0.0013524488,0.0005639619,0.801445,0.00065531465,0.029505339,0.044116255],"study_design_scores_gemma":[0.013899138,0.001997118,0.035468485,0.000031663956,0.005346777,0.00016012958,0.00013620815,0.0012073527,0.24931592,0.00065159757,0.6908015,0.0009841215],"about_ca_topic_score_codex":0.000009871661,"about_ca_topic_score_gemma":0.000008104342,"teacher_disagreement_score":0.6612962,"about_ca_system_score_codex":0.000057481437,"about_ca_system_score_gemma":0.0004283956,"threshold_uncertainty_score":0.9996562},"labels":[],"label_agreement":null},{"id":"W2064179817","doi":"10.1038/clpt.2013.95","title":"Legal Foundations of Adaptive Licensing","year":2013,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"History of Medical Practice","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Canada","funders":"Health Canada; European Commission","keywords":"Statute; Reimbursement; Agency (philosophy); Food and drug administration; Inspector general; Clinical pharmacology; Drug approval; Law; Business; Political science; Public administration; Pharmacology; Medicine; Drug; Health care; Accounting; Sociology","score_opus":0.1709712301570355,"score_gpt":0.47613482848748384,"score_spread":0.30516359833044837,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2064179817","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8750531,0.0008991203,0.0032336444,0.08693832,0.0050636055,0.0013291751,0.000005057574,0.00017550123,0.027302496],"genre_scores_gemma":[0.8768728,0.00026167114,0.0054291585,0.11489372,0.0008691349,0.000018002682,0.0000059070553,0.000029989842,0.0016196496],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99811417,0.00039284033,0.00073030737,0.00026123246,0.00024273057,0.00025870884],"domain_scores_gemma":[0.996788,0.0020271153,0.00028273725,0.00023898587,0.0003867025,0.00027642306],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0006233688,0.00013658522,0.00045569576,0.00006994207,0.00008995696,0.000006133365,0.00014546163,0.00024143927,0.0030714206],"category_scores_gemma":[0.0002023959,0.00012065715,0.00018974266,0.00015371825,0.0011364236,0.00016446167,0.000051460756,0.0009311375,0.00084045203],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033674897,0.009328842,0.016035214,0.00016065074,0.0063556205,0.00022823307,0.0013396498,0.00002392729,0.19367911,0.00093732064,0.57673085,0.19181308],"study_design_scores_gemma":[0.0045875064,0.0017045466,0.026403232,0.000037787107,0.0025675134,0.000077177574,0.00022065137,0.0033293182,0.0016988703,0.00021411994,0.95895594,0.0002033047],"about_ca_topic_score_codex":0.00002937449,"about_ca_topic_score_gemma":0.0000018775944,"teacher_disagreement_score":0.38222513,"about_ca_system_score_codex":0.00007161138,"about_ca_system_score_gemma":0.00035185405,"threshold_uncertainty_score":0.99993753},"labels":[],"label_agreement":null},{"id":"W2064401742","doi":"10.1016/j.clpt.2004.10.005","title":"Effect of Grapefruit Juice Volume on the Reduction of Fexofenadine Bioavailability: Possible Role of Organic Anion Transporting Polypeptides*","year":2005,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":185,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; Lawson Health Research Institute; London Health Sciences Centre","funders":"National Institute of General Medical Sciences","keywords":"Grapefruit juice; Fexofenadine; Chemistry; Bioavailability; Pharmacokinetics; Terfenadine; Crossover study; Pharmacology; Volume (thermodynamics); Volume of distribution; Food science; Chromatography; Medicine","score_opus":0.03041097844041151,"score_gpt":0.35909094045437595,"score_spread":0.32867996201396443,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2064401742","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9930869,0.00083911646,0.000060127968,0.004522521,0.00047111,0.000738886,0.00001530594,0.000039251536,0.0002267883],"genre_scores_gemma":[0.99703544,0.00063533045,0.0002047099,0.0014406843,0.0003248652,0.000010686375,0.000012013317,0.000035397716,0.0003008599],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99746954,0.0003640746,0.0012871065,0.0003189977,0.00028032763,0.00027994762],"domain_scores_gemma":[0.9982139,0.0005767046,0.00059513527,0.0003176834,0.00019440589,0.0001021905],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001967615,0.00021868863,0.00081167894,0.000098633376,0.00006300694,0.0000019008437,0.00022270261,0.00027191505,0.00050777436],"category_scores_gemma":[0.000027402679,0.00014248838,0.00040464467,0.00038730222,0.00067448785,0.000043800323,0.000013603039,0.000529424,0.000013789196],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0039492673,0.0011015098,0.029742833,0.00022399028,0.0005905268,0.000002622516,0.000319726,0.000017526598,0.9473433,0.000037733884,0.000136499,0.016534492],"study_design_scores_gemma":[0.0030333966,0.004462003,0.018477868,0.00012218211,0.0023323172,0.000008844459,0.0001437386,0.00029230845,0.9679196,0.00009067705,0.0029914111,0.00012569272],"about_ca_topic_score_codex":0.000007590663,"about_ca_topic_score_gemma":0.00000999122,"teacher_disagreement_score":0.020576287,"about_ca_system_score_codex":0.000037929036,"about_ca_system_score_gemma":0.00011497801,"threshold_uncertainty_score":0.58105075},"labels":[],"label_agreement":null},{"id":"W2064869484","doi":"10.1038/sj.clpt.6100443","title":"Emergency Contraception Update: A Canadian Perspective","year":2007,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Reproductive Health and Contraception","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia","funders":"Canadian Institutes of Health Research; Health Canada; Ministry of Health, British Columbia","keywords":"Emergency contraception; Levonorgestrel; Medicine; Food and drug administration; Pharmacy; Medical prescription; Family medicine; Family planning; Over-the-counter; Environmental health; Population; Nursing; Research methodology","score_opus":0.09016223894076374,"score_gpt":0.4795986425978645,"score_spread":0.38943640365710075,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2064869484","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8968407,0.0033795557,0.0018777543,0.08563859,0.0058394824,0.0012240305,0.000010192751,0.00012359244,0.0050660954],"genre_scores_gemma":[0.9022651,0.0034909467,0.00030543347,0.089531295,0.0037861888,0.000018016264,0.000017470591,0.000027747727,0.0005578505],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978325,0.00019438029,0.00069942174,0.0004839616,0.00015623186,0.00063355215],"domain_scores_gemma":[0.99818486,0.00013516082,0.00015318352,0.00024720866,0.00058231887,0.00069726363],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0016192906,0.00017311024,0.00035800663,0.00014935725,0.00016996605,0.0000047723115,0.00010057396,0.0003270252,0.0018358651],"category_scores_gemma":[0.000062775754,0.00015847561,0.00018941803,0.00024003009,0.00024035947,0.00006826186,0.00001343288,0.000783185,0.00047127536],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011951189,0.003625584,0.5762458,0.00008852205,0.0029694594,0.00056396844,0.0021299084,0.000008125387,0.058546126,0.0019240361,0.1750683,0.16687897],"study_design_scores_gemma":[0.0036859636,0.0009378649,0.6477198,0.000008291197,0.0009263561,0.00006319186,0.000662978,0.00013911881,0.0008185898,0.0010347804,0.34377423,0.00022881995],"about_ca_topic_score_codex":0.0018259307,"about_ca_topic_score_gemma":0.0053010075,"teacher_disagreement_score":0.16870593,"about_ca_system_score_codex":0.00038697,"about_ca_system_score_gemma":0.0005622189,"threshold_uncertainty_score":0.9990766},"labels":[],"label_agreement":null},{"id":"W2065390851","doi":"10.1038/clpt.2010.355","title":"A Fresh Look at the Mechanism of Isoniazid-Induced Hepatotoxicity","year":2011,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Drug-Induced Hepatotoxicity and Protection","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":191,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Canadian Institutes of Health Research","keywords":"Idiosyncrasy; Isoniazid; Metabolite; Clinical pharmacology; Mechanism (biology); Pharmacology; Medicine; Internal medicine; Tuberculosis; Pathology; Economics; Epistemology","score_opus":0.5197160465884401,"score_gpt":0.5517765724236009,"score_spread":0.032060525835160836,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2065390851","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0064536566,0.96424747,0.00011686476,0.0008202919,0.018488077,0.0057462095,0.0005223229,0.0003414178,0.0032636938],"genre_scores_gemma":[0.0020996665,0.97030216,0.00006842791,0.022783231,0.0020724128,0.0008228054,0.00008254528,0.00024041736,0.0015283222],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.98300576,0.009948041,0.0036642465,0.0015116375,0.00042284888,0.0014474789],"domain_scores_gemma":[0.98929065,0.0055443067,0.0029387206,0.0012522318,0.00036350352,0.0006106078],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"category_scores_codex":[0.005787132,0.0014683286,0.0041923756,0.00034765946,0.0009909209,0.000028597491,0.0024027398,0.0054556318,0.006254684],"category_scores_gemma":[0.00011151771,0.001078041,0.002667365,0.00085182686,0.0018505035,0.00014139118,0.0011102787,0.00863548,0.0018996688],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009693949,0.0032586453,0.0001527194,0.004660973,0.010584101,0.0001083549,0.00066690374,0.0000037033108,0.0023297477,0.0010589211,0.017989548,0.95821697],"study_design_scores_gemma":[0.0019309752,0.0007659889,0.000010367719,0.00049866084,0.013216073,0.00013157517,0.00003177711,0.00015470978,0.007498146,0.00091207435,0.9738602,0.0009894702],"about_ca_topic_score_codex":0.000047115136,"about_ca_topic_score_gemma":0.00008083672,"teacher_disagreement_score":0.9572275,"about_ca_system_score_codex":0.000489539,"about_ca_system_score_gemma":0.001092109,"threshold_uncertainty_score":0.99980664},"labels":[],"label_agreement":null},{"id":"W2065424662","doi":"10.1038/clpt.2011.124","title":"Profile of Serum Bile Acids in Noncholestatic Volunteers: Gender-Related Differences in Response to Fenofibrate","year":2011,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":67,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"National Center for Research Resources; National Heart, Lung, and Blood Institute; Canadian Institutes of Health Research; Centre Hospitalier Universitaire de Québec; University of Minnesota","keywords":"Fenofibrate; Ursodeoxycholic acid; Chenodeoxycholic acid; Deoxycholic acid; Internal medicine; Lithocholic acid; Bile acid; Endocrinology; Medicine; Hepatology; Chemistry","score_opus":0.14608194178824763,"score_gpt":0.38992635435075096,"score_spread":0.24384441256250333,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2065424662","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956909,0.00022451824,0.0001240188,0.001792473,0.0008071988,0.0008582312,0.000024773863,0.0000444026,0.0004335001],"genre_scores_gemma":[0.9910323,0.00022742187,0.0015023929,0.0064270226,0.00004015469,0.00004855844,0.0000057670086,0.00003230276,0.00068409095],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99735844,0.0005106725,0.0011131711,0.0004040148,0.00018226443,0.00043141106],"domain_scores_gemma":[0.99895775,0.00036740117,0.00014574145,0.00024786923,0.000087292414,0.00019394951],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0012890692,0.00021729022,0.00073406094,0.00028516896,0.000025676087,0.0000031406823,0.00024355191,0.00031813694,0.0009465737],"category_scores_gemma":[0.000024218507,0.0001748946,0.00014594676,0.00055085594,0.0003226347,0.0000521303,0.00003934031,0.0005984236,0.00006962747],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01762857,0.0032784618,0.8531346,0.0001662743,0.0004725822,0.00044247368,0.0090747215,0.000009377601,0.11231601,0.000039113133,0.00018207409,0.0032557468],"study_design_scores_gemma":[0.006175611,0.0016696978,0.97294265,0.00012758811,0.00034280622,0.0000058773576,0.0007883535,0.0005461277,0.016373938,0.0003974555,0.00042165627,0.00020825688],"about_ca_topic_score_codex":0.000010499605,"about_ca_topic_score_gemma":0.00003087031,"teacher_disagreement_score":0.11980804,"about_ca_system_score_codex":0.00005178042,"about_ca_system_score_gemma":0.000264062,"threshold_uncertainty_score":0.9999667},"labels":[],"label_agreement":null},{"id":"W2065633317","doi":"10.1016/s0009-9236(03)90368-7","title":"Introduction of intravenous amiodarone has little impact on survival of in‐hospital resuscitation","year":2003,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Cardiac Arrest and Resuscitation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; Western University","funders":"","keywords":"Resuscitation; Medicine; Amiodarone; Anesthesia; Emergency medicine; Intensive care medicine; Internal medicine; Atrial fibrillation","score_opus":0.05522399341226303,"score_gpt":0.4093298903989015,"score_spread":0.35410589698663847,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2065633317","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98711556,0.00019972277,0.00012309224,0.0060031707,0.0057010734,0.0004194465,0.00000960557,0.00001725296,0.00041106506],"genre_scores_gemma":[0.9976239,0.00044805603,0.00021352191,0.0006688912,0.00096085086,0.000007008621,0.000029863679,0.000019090261,0.000028769438],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99806416,0.0004890487,0.00077050313,0.00025546757,0.00021356768,0.00020725603],"domain_scores_gemma":[0.99855405,0.0006527548,0.0002877905,0.00019875252,0.0002243689,0.00008230553],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010457474,0.00014170952,0.00055146636,0.0001495691,0.000031660606,0.0000036958488,0.000062811494,0.00021235636,0.00011153383],"category_scores_gemma":[0.0001559126,0.00011426804,0.00025620876,0.0003098585,0.0004962737,0.000044230837,0.000011513022,0.00041868773,0.00001548932],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.021155674,0.022016441,0.60059726,0.0004995948,0.0049374998,0.00008544559,0.006454366,0.0032428429,0.2748201,0.0014394484,0.030251859,0.034499492],"study_design_scores_gemma":[0.008813544,0.005992806,0.9456644,0.00005248962,0.0010114519,0.000004515035,0.00054942525,0.00028272226,0.02589777,0.00074648915,0.010753651,0.00023070558],"about_ca_topic_score_codex":0.000007824465,"about_ca_topic_score_gemma":0.0000024514177,"teacher_disagreement_score":0.3450672,"about_ca_system_score_codex":0.000084106156,"about_ca_system_score_gemma":0.00022289075,"threshold_uncertainty_score":0.46597156},"labels":[],"label_agreement":null},{"id":"W2065863432","doi":"10.1038/clpt.2010.68","title":"An Individualized Approach to Tracking and Treating Alzheimer’s Disease","year":2010,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Dementia and Cognitive Impairment Research","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"Atlantic Canada Opportunities Agency; Dalhousie Medical Research Foundation","keywords":"Disease; Dementia; Cognition; Alzheimer's disease; Medicine; Psychology; Gerontology; Clinical psychology; Psychiatry; Internal medicine","score_opus":0.15026689970404464,"score_gpt":0.5022433162928386,"score_spread":0.35197641658879397,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2065863432","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9917788,0.00024106281,0.00034895985,0.0043113297,0.00041554437,0.00089026726,0.000011307273,0.00008435345,0.001918355],"genre_scores_gemma":[0.94712824,0.000136203,0.0035147036,0.048314154,0.0006546172,0.00008133841,0.000034961533,0.000031598374,0.00010421552],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981514,0.00032155836,0.0004051313,0.00047357217,0.00024263366,0.00040565408],"domain_scores_gemma":[0.9983216,0.00037146755,0.00006993375,0.00022281552,0.00014922794,0.00086497236],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010076644,0.00017609753,0.00033696822,0.000101330785,0.00015107381,0.00004489646,0.00016333509,0.00014752959,0.00028199365],"category_scores_gemma":[0.000047019545,0.00014539988,0.000105122,0.00015330296,0.00036262235,0.000089574896,0.00008132967,0.0007977663,0.000031766685],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016838857,0.00372146,0.75321084,0.000028147235,0.0009946548,0.00006844569,0.0004192193,0.0000010844467,0.04380248,0.00004795382,0.00089784863,0.195124],"study_design_scores_gemma":[0.0064932383,0.0013401856,0.9614378,0.000012034224,0.0035151315,0.000029115372,0.0001663344,0.0022710175,0.0032041126,0.00013309126,0.021157384,0.00024054368],"about_ca_topic_score_codex":0.0000021360102,"about_ca_topic_score_gemma":0.00000100162,"teacher_disagreement_score":0.208227,"about_ca_system_score_codex":0.000007926637,"about_ca_system_score_gemma":0.0001409819,"threshold_uncertainty_score":0.5929235},"labels":[],"label_agreement":null},{"id":"W2066221966","doi":"10.1038/clpt.2013.133","title":"Do Anticoagulants or Antiplatelet Drugs Have a Role in Treating Heart Failure in the Absence of Atrial Fibrillation?","year":2013,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Atrial fibrillation; Clinical pharmacology; Heart failure; Cardiology; Stroke (engine); Intensive care medicine; Risk stratification; Sinus rhythm; Internal medicine; Pharmacology","score_opus":0.12044952822858218,"score_gpt":0.45067808223645933,"score_spread":0.33022855400787715,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2066221966","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98056406,0.00028681618,0.000011553045,0.017474504,0.00033574586,0.0011176798,0.0000026754838,0.00002170941,0.00018524226],"genre_scores_gemma":[0.9917884,0.00045186744,0.00064609846,0.005705399,0.0012347761,0.0000031186312,0.000008077032,0.000015719723,0.00014656679],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99783623,0.00044915034,0.0009511787,0.00026520967,0.00022186214,0.0002763586],"domain_scores_gemma":[0.9972314,0.0022004473,0.00022994273,0.00021002935,0.00007469063,0.00005346608],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00093764096,0.00015896372,0.0006120568,0.00013947065,0.00004661453,0.000020018118,0.00015369366,0.0001907225,0.0004229236],"category_scores_gemma":[0.0000870484,0.000100633515,0.00023794059,0.00033550322,0.00018852894,0.00010237102,0.000056806424,0.00032638985,0.000052951953],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00086069916,0.000033279874,0.9872613,0.000023620005,0.00017035441,0.000010484329,0.0006898186,0.0002007427,0.001963069,0.000015466647,0.0010740721,0.007697095],"study_design_scores_gemma":[0.011682434,0.00061220775,0.942342,0.000077607474,0.0003873675,0.000015255376,0.001888622,0.008874493,0.00045217836,0.00035827776,0.033096123,0.00021347198],"about_ca_topic_score_codex":0.00004352263,"about_ca_topic_score_gemma":0.00002018688,"teacher_disagreement_score":0.044919338,"about_ca_system_score_codex":0.000023616747,"about_ca_system_score_gemma":0.00007724034,"threshold_uncertainty_score":0.46307167},"labels":[],"label_agreement":null},{"id":"W2066766920","doi":"10.1038/clpt.2009.115","title":"Clozapine, GABAB, and the Treatment of Resistant Schizophrenia","year":2009,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Neuroscience and Neuropharmacology Research","field":"Neuroscience","cited_by":56,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"National Institute on Drug Abuse","keywords":"Clozapine; Schizophrenia (object-oriented programming); GABAergic; Antipsychotic; Long-term potentiation; Neurotransmission; Neuroscience; Pharmacology; Cognition; Clinical pharmacology; Psychology; Medicine; Psychiatry; Internal medicine; Inhibitory postsynaptic potential; Receptor","score_opus":0.3171689902228804,"score_gpt":0.5262549587221403,"score_spread":0.20908596849925992,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2066766920","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0020425904,0.9909403,0.0000015609338,0.0023938569,0.0021422661,0.002236248,0.00006224035,0.00006818241,0.000112781694],"genre_scores_gemma":[0.00015048237,0.9813915,0.000014816518,0.01696217,0.00067900465,0.00015080108,0.0000015767152,0.000061125385,0.0005885445],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9905722,0.005408997,0.0016689983,0.0012351073,0.0003968146,0.0007178647],"domain_scores_gemma":[0.98765314,0.010570555,0.0008208483,0.0006346163,0.00006812757,0.00025272643],"candidate_categories":["metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.0010238634,0.0006484758,0.0027605633,0.000230166,0.00038116978,0.00004673004,0.0012780481,0.00047991754,0.000094601324],"category_scores_gemma":[0.00012448565,0.00035779955,0.0010059719,0.000740054,0.006125216,0.000068873196,0.00019171309,0.0012810606,0.00008164128],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026366678,0.0015934161,0.0000019308782,0.00048409903,0.00026760207,0.00024558167,0.00005300811,3.6467594e-7,0.004555733,0.00017349637,0.0018431843,0.98814493],"study_design_scores_gemma":[0.005758124,0.0025245922,0.0000057379057,0.0001543558,0.0033254898,0.00008985826,0.0000020153964,0.00004820167,0.0021924227,0.00013412688,0.9854864,0.0002786751],"about_ca_topic_score_codex":0.0000013647239,"about_ca_topic_score_gemma":5.747906e-7,"teacher_disagreement_score":0.9878662,"about_ca_system_score_codex":0.0000597135,"about_ca_system_score_gemma":0.0005381271,"threshold_uncertainty_score":0.9998874},"labels":[],"label_agreement":null},{"id":"W2066843681","doi":"10.1067/mcp.2000.104943","title":"Venous responsiveness to norepinephrine in healthy subjects: Effects of single doses of 325 mg aspirin","year":2000,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Diagnosis and Treatment of Venous Diseases","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; London Health Sciences Centre","funders":"","keywords":"Medicine; Norepinephrine; Aspirin; Anesthesia; Placebo; Vasoconstriction; Cold pressor test; Epinephrine; Distension; Hemodynamics; Internal medicine; Catecholamine; Blood pressure; Heart rate","score_opus":0.06563553532904264,"score_gpt":0.4269213811049608,"score_spread":0.36128584577591816,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2066843681","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9905256,0.003657663,0.0000032460212,0.004099837,0.00041772786,0.0009851753,0.000020613135,0.00003343609,0.00025671907],"genre_scores_gemma":[0.9682013,0.0031589747,0.00019813991,0.028089702,0.00016419764,0.00006298776,0.000014468543,0.000030672927,0.000079548874],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99786544,0.00038922176,0.0008631699,0.00034657147,0.00019183129,0.0003437491],"domain_scores_gemma":[0.9969856,0.0021738808,0.00017560787,0.00029315084,0.00013605168,0.0002356707],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031600488,0.00019960485,0.00091801444,0.00016643581,0.00003065013,0.000003069693,0.00015550299,0.00015509737,0.00030472965],"category_scores_gemma":[0.00008186836,0.00017391624,0.0002216312,0.00035849557,0.00026782346,0.000031144707,0.00003872994,0.00020599729,0.000040148516],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.08262187,0.25763583,0.3183503,0.0023070802,0.003074554,0.0013344826,0.0008604863,0.00025549557,0.09554132,0.000030564555,0.0023014518,0.23568657],"study_design_scores_gemma":[0.025285516,0.10542975,0.7288874,0.00085348927,0.0027507402,0.000026279062,0.000052652427,0.00003868365,0.10823935,0.00014160467,0.027935017,0.00035955783],"about_ca_topic_score_codex":0.000032633954,"about_ca_topic_score_gemma":0.000015956275,"teacher_disagreement_score":0.41053706,"about_ca_system_score_codex":0.00007610909,"about_ca_system_score_gemma":0.0002771249,"threshold_uncertainty_score":0.70920986},"labels":[],"label_agreement":null},{"id":"W2067623051","doi":"10.1038/clpt.2008.6","title":"Marijuana as Medicine: Does It Have a Future?","year":2008,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Cannabis and Cannabinoid Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Cannabis; Marijuana smoking; Medical cannabis; Randomized controlled trial; Alternative medicine; Medicine; MEDLINE; Clinical trial; Psychiatry; Psychology; Political science; Law; Substance use; Surgery","score_opus":0.10508287234666604,"score_gpt":0.47224164807318686,"score_spread":0.36715877572652084,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2067623051","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4318818,0.00219664,0.000029436937,0.5504364,0.0041083894,0.00072841544,0.00000785608,0.00012112923,0.010489965],"genre_scores_gemma":[0.30375928,0.023831028,0.0001714415,0.5565383,0.013506969,0.000107916225,0.00003390476,0.00010004613,0.10195114],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9970365,0.00035810546,0.00084606564,0.00057028467,0.0005435512,0.00064549246],"domain_scores_gemma":[0.99819964,0.0002242164,0.0001527811,0.0004567194,0.00037088335,0.00059576187],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00084181986,0.0002901487,0.0007686679,0.00014439112,0.00024913222,0.000007801309,0.0003306488,0.0004388973,0.008223429],"category_scores_gemma":[0.00006553901,0.00018163452,0.00034921215,0.00025951207,0.0019613295,0.000050091217,0.00013082805,0.0014201995,0.00036451776],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001750111,0.0009244642,0.02069364,0.000047240625,0.00090064155,0.00094442186,0.0006916957,7.64338e-7,0.0057912595,0.000049411217,0.9514046,0.01680177],"study_design_scores_gemma":[0.005648747,0.0017626627,0.03697637,0.000019949635,0.00074191403,0.00038100107,0.0005592374,0.00015912716,0.0012975952,0.00020200764,0.9520398,0.0002116006],"about_ca_topic_score_codex":0.00003542204,"about_ca_topic_score_gemma":0.000016579019,"teacher_disagreement_score":0.12812251,"about_ca_system_score_codex":0.00009063584,"about_ca_system_score_gemma":0.0006052879,"threshold_uncertainty_score":0.9926832},"labels":[],"label_agreement":null},{"id":"W2067981076","doi":"10.1016/s0009-9236(03)90530-3","title":"Domperidone As A Substrate Marker Drug for CYP3A4 and CYP3A5","year":2003,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Domperidone; CYP3A4; Drug; Pharmacology; Medicine; Clinical pharmacology; Internal medicine; Cytochrome P450","score_opus":0.21800424138292177,"score_gpt":0.527010602900353,"score_spread":0.3090063615174312,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2067981076","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95954716,0.0133440485,0.00037662985,0.007696841,0.011085503,0.0018517913,0.000117185016,0.00020464351,0.0057761976],"genre_scores_gemma":[0.82964814,0.01855846,0.0014330348,0.14518158,0.0014520911,0.00037414627,0.000032042128,0.00013708843,0.0031834112],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9938797,0.002235521,0.0013360737,0.0010527992,0.00022937891,0.0012665342],"domain_scores_gemma":[0.9948508,0.0031524627,0.00040790587,0.0003725843,0.00031629394,0.000899934],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0036838085,0.0006625687,0.00096993503,0.00016190867,0.00060427224,0.00005474168,0.0005593228,0.00080115104,0.0024212198],"category_scores_gemma":[0.00010868769,0.00062858977,0.0004560632,0.00030146574,0.0013148987,0.00013991291,0.0001429191,0.0017467905,0.00028557985],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014959225,0.00956572,0.076085865,0.0004746726,0.013944902,0.00044746022,0.0029619513,0.00085220876,0.53593534,0.012692133,0.2285682,0.10351231],"study_design_scores_gemma":[0.01189886,0.00033740152,0.0023310282,0.0000071043823,0.0026013812,0.00009091479,0.00011995508,0.0023066534,0.060470134,0.004650727,0.91445076,0.00073507],"about_ca_topic_score_codex":0.000003852262,"about_ca_topic_score_gemma":0.0000044529293,"teacher_disagreement_score":0.68588257,"about_ca_system_score_codex":0.000047512953,"about_ca_system_score_gemma":0.00034979352,"threshold_uncertainty_score":0.99961656},"labels":[],"label_agreement":null},{"id":"W2068075375","doi":"10.1016/j.clpt.2003.10.006","title":"A novel functional polymorphism in the uridine diphosphate–glucuronosyltransferase 2B7 promoter with significant impact on promoter activity","year":2004,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":149,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Single-nucleotide polymorphism; UGT2B7; Morphine; Glucuronosyltransferase; Glucuronide; Chemistry; Uridine; Internal medicine; Glucuronidation; Biology; Pharmacology; Genotype; Biochemistry; Medicine; In vitro; Gene; Metabolism; RNA","score_opus":0.20729445862948895,"score_gpt":0.47151952957898674,"score_spread":0.26422507094949776,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2068075375","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9648707,0.0006338496,0.0014643418,0.027026827,0.0030227324,0.0021532294,0.00022112133,0.0001258036,0.00048139115],"genre_scores_gemma":[0.9117391,0.00090410333,0.00019013247,0.08521204,0.001398832,0.000313329,0.000041354717,0.000097910815,0.000103161474],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99438626,0.001597005,0.001045593,0.0010976833,0.00054246135,0.0013310035],"domain_scores_gemma":[0.99687165,0.0015174925,0.00034403394,0.00054558145,0.00017892948,0.00054232037],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0026462092,0.00086411805,0.0009050973,0.00023752156,0.00042628226,0.00006051456,0.0009559775,0.000732635,0.0012846454],"category_scores_gemma":[0.000021690337,0.00053965196,0.00051242457,0.0006679143,0.0011826577,0.00019497542,0.0001029815,0.0038344038,0.0002285641],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.034377217,0.036951944,0.020643234,0.00008244545,0.0051274276,0.0010624323,0.0027406947,0.023785597,0.8342714,0.00055222085,0.0043679094,0.036037497],"study_design_scores_gemma":[0.082282856,0.010439282,0.30390623,0.000098598844,0.0064942404,0.00056363735,0.00016030323,0.0063396273,0.43472692,0.0018352964,0.15008073,0.0030722944],"about_ca_topic_score_codex":0.000041308776,"about_ca_topic_score_gemma":0.000016269292,"teacher_disagreement_score":0.39954448,"about_ca_system_score_codex":0.0002113576,"about_ca_system_score_gemma":0.0007114146,"threshold_uncertainty_score":0.9997055},"labels":[],"label_agreement":null},{"id":"W2069218640","doi":"10.1038/clpt.2011.66","title":"The Human Placental Perfusion Model: A Systematic Review and Development of a Model to Predict In Vivo Transfer of Therapeutic Drugs","year":2011,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Pregnancy and preeclampsia studies","field":"Medicine","cited_by":192,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"Canadian Institutes of Health Research","keywords":"Perfusion; In vivo; Pharmacokinetics; Placenta; Fetus; Drug; Pharmacology; Medicine; Pregnancy; Internal medicine; Biology; Biotechnology","score_opus":0.21791089192654664,"score_gpt":0.45878184820454326,"score_spread":0.24087095627799662,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2069218640","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0003952527,0.9927565,0.0003105491,0.00022744472,0.00013955652,0.0059231403,0.000036773785,0.000023204513,0.00018759567],"genre_scores_gemma":[0.0014420347,0.9930324,0.00030089772,0.00432331,0.000028827237,0.0006588751,0.000007409149,0.00005792145,0.00014831264],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9949386,0.00087434164,0.0030870277,0.00047769948,0.0002501252,0.00037222242],"domain_scores_gemma":[0.99775785,0.0010177705,0.00049191754,0.0004673839,0.00012152515,0.0001435592],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.002150175,0.0005111143,0.004548568,0.00012605522,0.00013640478,0.0000036765584,0.0004592944,0.0004306813,0.000022997703],"category_scores_gemma":[0.000022173966,0.0002992367,0.0005247696,0.00020475744,0.00049164536,0.000027021362,0.00019542816,0.0008499102,0.0000035405176],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029935475,0.0010306865,0.000055068213,0.9246578,0.004438956,0.000004431783,0.0039592264,0.0000062575505,0.000059148508,0.000081217804,0.00026752774,0.06514033],"study_design_scores_gemma":[0.0047275494,0.0012276114,0.000028882216,0.838373,0.082333066,0.000049118506,0.00019026638,0.0022695393,0.00011485466,0.0001830925,0.06954811,0.0009549225],"about_ca_topic_score_codex":0.0000010227646,"about_ca_topic_score_gemma":0.0000061000064,"teacher_disagreement_score":0.0862848,"about_ca_system_score_codex":0.00007985721,"about_ca_system_score_gemma":0.0006151306,"threshold_uncertainty_score":0.999946},"labels":[],"label_agreement":null},{"id":"W2069667220","doi":"10.1038/sj.clpt.6100135","title":"Using HapMap Tools in Pharmacogenomic Discovery: The Thiopurine Methyltransferase Polymorphism","year":2007,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; National Institute of General Medical Sciences; American Lebanese Syrian Associated Charities; McGill University","keywords":"International HapMap Project; Thiopurine methyltransferase; Pharmacogenomics; Single-nucleotide polymorphism; Haplotype; Pharmacogenetics; Linkage disequilibrium; SNP; Biology; Genetics; 1000 Genomes Project; Candidate gene; Genotyping; SNP genotyping; Imputation (statistics); Computational biology; Gene; Allele; Genotype; Medicine; Internal medicine; Computer science; Azathioprine","score_opus":0.235715593926217,"score_gpt":0.496782670510655,"score_spread":0.261067076584438,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2069667220","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97176176,0.0016499867,0.006702475,0.01611147,0.0018080834,0.0012625108,0.000025111722,0.00007914074,0.0005994867],"genre_scores_gemma":[0.90439993,0.0015583027,0.0010241363,0.09077323,0.0016501683,0.000021750528,0.00001537199,0.000081036706,0.0004760455],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9958846,0.0006391549,0.0013138461,0.0006195748,0.00047472533,0.0010681056],"domain_scores_gemma":[0.9947614,0.0040971255,0.00016390516,0.00048650627,0.00013447202,0.0003565721],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0038026322,0.000369227,0.0007598024,0.00023298855,0.00017749499,0.000045401644,0.0005763703,0.00038408325,0.00039151733],"category_scores_gemma":[0.00008428728,0.00025592887,0.00036451448,0.0006017651,0.0010992134,0.00020910874,0.00018967122,0.0018767648,0.000105557745],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011018928,0.0026115782,0.049838364,0.00008372504,0.0025947331,0.0024499213,0.00063383655,0.00013538745,0.89943445,0.0001541681,0.0037483706,0.027296526],"study_design_scores_gemma":[0.1035662,0.0034473059,0.18192858,0.00024634527,0.011314867,0.0020383087,0.0009296767,0.040538564,0.49851787,0.0009302893,0.15432496,0.00221705],"about_ca_topic_score_codex":0.000057207588,"about_ca_topic_score_gemma":0.000013849304,"teacher_disagreement_score":0.4009166,"about_ca_system_score_codex":0.000695703,"about_ca_system_score_gemma":0.0010046278,"threshold_uncertainty_score":0.9999893},"labels":[],"label_agreement":null},{"id":"W2070911028","doi":"10.1038/sj.clpt.6100509","title":"Reducing the Harm of “Harm Reduction”","year":2008,"lang":"en","type":"letter","venue":"Clinical Pharmacology & Therapeutics","topic":"HIV, Drug Use, Sexual Risk","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Centre on Substance Use and Addiction","funders":"","keywords":"Harm reduction; CLARITY; Harm; Phrase; Reduction (mathematics); Psychological intervention; Political science; Public health; Psychology; Law; Medicine; Computer science; Psychiatry; Nursing; Chemistry; Artificial intelligence","score_opus":0.22450925386584372,"score_gpt":0.4810841791239577,"score_spread":0.256574925258114,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2070911028","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.03879831,0.00268985,0.00002876414,0.94239706,0.011665577,0.0015006945,0.00007855628,0.00020092193,0.0026402962],"genre_scores_gemma":[0.0085607795,0.0130090015,0.00041722113,0.93759155,0.028418075,0.00007973636,0.00018596297,0.00021924266,0.011518407],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9940738,0.0012326104,0.0021520643,0.0009920826,0.0007033578,0.00084609067],"domain_scores_gemma":[0.99454206,0.0023864268,0.0011088948,0.0012155245,0.0005400167,0.00020707106],"candidate_categories":["metaepi_narrow","sts","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0011466588,0.0006553513,0.0017137283,0.00021883138,0.00025607692,0.000013867096,0.0009208692,0.0021771328,0.0009029502],"category_scores_gemma":[0.000108147506,0.0004695696,0.00084246456,0.0004421208,0.0027703445,0.00005913996,0.00022048401,0.009197446,0.00038531385],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045944928,0.00058272417,0.00019072242,0.00016143886,0.0028826427,0.00042556977,0.0018584116,0.0000116650035,0.0042552957,0.0000011457292,0.9809416,0.008229325],"study_design_scores_gemma":[0.0027350306,0.0009013335,0.00036442594,0.00010711162,0.005765299,0.00061055354,0.0005278653,0.00014582806,0.0035070095,0.000055529126,0.98487467,0.00040532177],"about_ca_topic_score_codex":0.000016408181,"about_ca_topic_score_gemma":2.433693e-7,"teacher_disagreement_score":0.030237531,"about_ca_system_score_codex":0.00016430276,"about_ca_system_score_gemma":0.0009088275,"threshold_uncertainty_score":0.99994355},"labels":[],"label_agreement":null},{"id":"W2071573249","doi":"10.1038/clpt.2011.279","title":"The Role and Impact of Research Agendas on the Comparative-Effectiveness Research Among Antihyperlipidemics","year":2012,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmaceutical industry and healthcare","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto; SickKids Foundation","funders":"Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Medical Research Council; U.S. National Library of Medicine; National Institute of Child Health and Human Development; National Health and Medical Research Council; National Institutes of Health","keywords":"Clinical trial; Clinical study design; Clinical research; Research design; Medicine; Alternative medicine; Set (abstract data type); Pharmaceutical industry; Clinical pharmacology; Medical education; Family medicine; Pharmacology; Internal medicine; Computer science; Sociology; Social science; Pathology","score_opus":0.8977318306422296,"score_gpt":0.7546349108145095,"score_spread":0.1430969198277201,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2071573249","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97597164,0.0079237055,0.000004238718,0.008314938,0.0024521055,0.0018177996,0.00006258427,0.000057321446,0.0033956722],"genre_scores_gemma":[0.9842893,0.0067758057,0.000009925453,0.006457047,0.0019569574,0.00021679304,0.000006759849,0.00004504467,0.00024239617],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9632789,0.032388285,0.0010605969,0.0005612693,0.00064629613,0.002064646],"domain_scores_gemma":[0.9242153,0.073132634,0.00027655807,0.00054255215,0.0009110322,0.00092190533],"candidate_categories":["metaresearch","sts","research_integrity"],"consensus_categories":["sts"],"category_scores_codex":[0.04560802,0.00040298078,0.00075840415,0.00019201044,0.0027500214,0.000049613944,0.0011669749,0.0012622178,0.00054656033],"category_scores_gemma":[0.0005723295,0.00022918876,0.00034562792,0.0010087105,0.010539879,0.00018100678,0.00053953513,0.01264284,0.00018980577],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0066672284,0.0029429987,0.90211815,0.000092408205,0.003057649,0.000016311338,0.0024905007,0.00013010274,0.027800357,0.0073598037,0.029818643,0.01750586],"study_design_scores_gemma":[0.003334402,0.002635452,0.5167576,0.00008175266,0.0006613744,0.00002971875,0.0025984696,0.005647896,0.045903187,0.0045437,0.41729498,0.0005114826],"about_ca_topic_score_codex":0.000051522344,"about_ca_topic_score_gemma":0.0000082814195,"teacher_disagreement_score":0.38747633,"about_ca_system_score_codex":0.0002443547,"about_ca_system_score_gemma":0.00044355608,"threshold_uncertainty_score":0.99854827},"labels":[],"label_agreement":null},{"id":"W2072837835","doi":"10.1016/s0009-9236(03)90390-0","title":"The prevalence of prenatal alcohol exposure in neonates suspected of multiple drug exposure","year":2003,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Prenatal Substance Exposure Effects","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; SickKids Foundation; Mount Sinai Hospital","funders":"","keywords":"Prenatal exposure; Medicine; Drug; Prenatal alcohol exposure; Fetal alcohol; Clinical pharmacology; Alcohol; Pharmacology; Physiology; Pregnancy; Gestation; Biology","score_opus":0.04367244063006616,"score_gpt":0.3707738045924394,"score_spread":0.32710136396237327,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2072837835","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98198324,0.01437122,0.000024285473,0.0009635533,0.0012562587,0.0011449772,0.000022568916,0.00004993021,0.00018395294],"genre_scores_gemma":[0.9943287,0.0031243945,0.00037902853,0.0015631429,0.00013115109,0.000057081776,0.0000065083586,0.0000385644,0.0003714762],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99618495,0.0011837006,0.0013486958,0.0004434508,0.00035820514,0.00048098824],"domain_scores_gemma":[0.9934155,0.0050979485,0.00049161917,0.0005505412,0.00029640942,0.00014803525],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001748351,0.00027527328,0.00072428246,0.000089135516,0.00006851228,0.0000054105312,0.0004496183,0.00029672106,0.00013382683],"category_scores_gemma":[0.0005584228,0.00019810752,0.00026904774,0.0004291718,0.001040704,0.00008299767,0.00008281656,0.00092090067,0.000009604092],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029751398,0.0016602674,0.87427014,0.0006276211,0.0008187819,0.000081239705,0.00075523066,0.000053242104,0.10949901,0.00009610126,0.0009699081,0.008193307],"study_design_scores_gemma":[0.014287317,0.0013941133,0.50388473,0.00024262739,0.00087509333,0.0000375697,0.00016722607,0.0005495631,0.47369438,0.0002753878,0.0043112766,0.00028069335],"about_ca_topic_score_codex":0.000005920996,"about_ca_topic_score_gemma":0.000029772526,"teacher_disagreement_score":0.3703854,"about_ca_system_score_codex":0.000055862492,"about_ca_system_score_gemma":0.000257333,"threshold_uncertainty_score":0.807859},"labels":[],"label_agreement":null},{"id":"W2073056252","doi":"10.1067/mcp.2001.116892","title":"Red wine–cisapride interaction: Comparison with grapefruit juice","year":2001,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":51,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre","funders":"","keywords":"Cisapride; Grapefruit juice; Pharmacokinetics; Crossover study; Citrus paradisi; Pharmacology; Area under the curve; Chemistry; Wine; Drug interaction; Oral administration; Medicine; Food science; Placebo; Rutaceae; Botany; Biology","score_opus":0.36433467423857135,"score_gpt":0.5632199207657329,"score_spread":0.19888524652716155,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2073056252","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9358424,0.0032499358,0.0011993514,0.02820753,0.014658841,0.0012369767,0.000052169362,0.00053532264,0.01501749],"genre_scores_gemma":[0.8530948,0.005915531,0.00087850343,0.13356027,0.004420291,0.00014114149,0.000055833323,0.00013228835,0.0018013233],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9933886,0.0020666842,0.0017363825,0.0010912794,0.00042101703,0.0012960556],"domain_scores_gemma":[0.9953461,0.002041481,0.00071843853,0.0005707203,0.00043861548,0.0008846109],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0018191017,0.0007587583,0.0012337533,0.00025341802,0.0005841295,0.000060242783,0.0010822583,0.00089104223,0.0047059613],"category_scores_gemma":[0.00003217694,0.00066188816,0.00043764283,0.0007902883,0.001192715,0.00025254028,0.0002626321,0.003552481,0.0008484696],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.025153419,0.012514984,0.24927062,0.000110414956,0.011846578,0.0018210956,0.0016735763,0.0075209667,0.12400142,0.0002764575,0.3362661,0.22954439],"study_design_scores_gemma":[0.008901616,0.00074932055,0.011868361,0.000014890998,0.0032384968,0.0003003914,0.00017360544,0.008265743,0.01613916,0.00025250023,0.94929576,0.0008001488],"about_ca_topic_score_codex":0.0000081044245,"about_ca_topic_score_gemma":0.000012829649,"teacher_disagreement_score":0.61302966,"about_ca_system_score_codex":0.00010346758,"about_ca_system_score_gemma":0.00025294174,"threshold_uncertainty_score":0.9999295},"labels":[],"label_agreement":null},{"id":"W2073582856","doi":"10.1038/sj.clpt.6100246","title":"Identification of Novel CYP2A6*1B Variants: The CYP2A6*1B Allele is Associated With Faster In Vivo Nicotine Metabolism","year":2007,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":64,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Addiction and Mental Health; University of Toronto","funders":"Canadian Institutes of Health Research; NIH Clinical Center; National Institutes of Health; National Center for Research Resources; National Institute on Drug Abuse; Canada Research Chairs","keywords":"CYP2A6; Nicotine; Cotinine; In vivo; Genotype; Pharmacology; Metabolism; Chemistry; Biology; Medicine; Endocrinology; Internal medicine; Genetics; Cytochrome P450; Biochemistry; CYP1A2; Gene","score_opus":0.17446933955008317,"score_gpt":0.4823130279593351,"score_spread":0.3078436884092519,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2073582856","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97911453,0.002989065,0.0021522162,0.007255483,0.00528568,0.0014737613,0.00036960677,0.00011328868,0.0012463891],"genre_scores_gemma":[0.9155599,0.0028822285,0.00022951969,0.079077214,0.00096630445,0.00007851549,0.000035389803,0.000107549924,0.0010633732],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9926415,0.001705873,0.0028201449,0.0009554085,0.0005615783,0.0013155106],"domain_scores_gemma":[0.99339867,0.0034457713,0.0014556848,0.0006427702,0.00062773784,0.00042935178],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.008779608,0.0006723023,0.001225002,0.0003288573,0.0003444805,0.000036587408,0.0013827268,0.0009455581,0.0014815555],"category_scores_gemma":[0.00013351112,0.0005111289,0.00041477158,0.001130459,0.0015414866,0.00020072065,0.00029272187,0.002674763,0.000073896634],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0044206395,0.014398365,0.023089595,0.000054465658,0.0057974537,0.000082353756,0.0030894254,0.0010731859,0.92389685,0.00048155975,0.01233258,0.011283498],"study_design_scores_gemma":[0.037406825,0.00054415216,0.07168546,0.000038364644,0.0067387875,0.00005356417,0.00050619274,0.020076474,0.48076007,0.00049789745,0.38042563,0.0012665526],"about_ca_topic_score_codex":0.000018026887,"about_ca_topic_score_gemma":0.00006323908,"teacher_disagreement_score":0.4431368,"about_ca_system_score_codex":0.00009890784,"about_ca_system_score_gemma":0.00030399975,"threshold_uncertainty_score":0.99973404},"labels":[],"label_agreement":null},{"id":"W2074061848","doi":"10.1016/s0009-9236(03)90531-5","title":"The single‐Dose Pharmacokinetics of Pergolide in Healthy Adult Volunteers","year":2003,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pituitary Gland Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Paraza Pharma (Canada)","funders":"","keywords":"Pergolide; Pharmacokinetics; Medicine; Pharmacology; Internal medicine; Dopamine agonist; Agonist","score_opus":0.07537746891542815,"score_gpt":0.420606312668151,"score_spread":0.3452288437527229,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2074061848","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98008496,0.0058610984,0.000028761913,0.009723179,0.0015108424,0.00058384426,0.000008669373,0.000028791868,0.0021698521],"genre_scores_gemma":[0.94247824,0.012271297,0.00023421778,0.044603214,0.00012595479,0.000023729097,0.000007534371,0.000025759333,0.000230078],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9978633,0.00040223944,0.00083134446,0.0002857835,0.00017943178,0.00043788494],"domain_scores_gemma":[0.9984316,0.00082116365,0.00015857302,0.0002451464,0.00015854572,0.0001849635],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046924208,0.00019671938,0.0004635808,0.00006341585,0.00009345011,0.0000054081684,0.0001533077,0.00016661349,0.00010521413],"category_scores_gemma":[0.00007116234,0.00013265626,0.00020091052,0.00022642022,0.00047148345,0.000029760842,0.00002762954,0.00048320458,0.000027841701],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.019523103,0.019792067,0.86796623,0.00017194966,0.0037275692,0.0003615449,0.00079745916,0.00011881003,0.011643317,0.00055989757,0.022765582,0.052572455],"study_design_scores_gemma":[0.12121493,0.018080749,0.2747462,0.00013770649,0.0059376685,0.00018452709,0.0012413617,0.003888719,0.012463457,0.0025925974,0.55851465,0.0009974181],"about_ca_topic_score_codex":0.000013350468,"about_ca_topic_score_gemma":0.000030335883,"teacher_disagreement_score":0.59322006,"about_ca_system_score_codex":0.00006153942,"about_ca_system_score_gemma":0.0002191264,"threshold_uncertainty_score":0.54095656},"labels":[],"label_agreement":null},{"id":"W2074179782","doi":"10.1016/j.clpt.2004.11.111","title":"Grapefruit juice ingestion significantly reduces talinolol bioavailability","year":2005,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Alcohol Consumption and Health Effects","field":"Medicine","cited_by":148,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre","funders":"National Institute of General Medical Sciences","keywords":"Grapefruit juice; Ingestion; Cmax; Pharmacokinetics; Bioavailability; Chemistry; Pharmacology; Food science; Medicine; Biochemistry","score_opus":0.31361967455627265,"score_gpt":0.5246484012204284,"score_spread":0.21102872666415579,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2074179782","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9317179,0.001449005,0.00012713582,0.06313507,0.0017301553,0.0009664356,0.000008170289,0.0002961687,0.0005699648],"genre_scores_gemma":[0.8453452,0.0025085853,0.0011139344,0.1489115,0.0015229374,0.000048974594,0.000020852964,0.000030401232,0.0004975847],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99716693,0.0006216955,0.0009383355,0.0005570178,0.00022990858,0.00048610772],"domain_scores_gemma":[0.99768317,0.0010896114,0.00025759728,0.00032261494,0.00024043607,0.00040655155],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0013764694,0.00024338461,0.00055961,0.000110346286,0.0001767611,0.000013445302,0.00018294976,0.0004724548,0.0010498164],"category_scores_gemma":[0.00008487074,0.00021192779,0.00023246168,0.00023146709,0.0007644797,0.00008695444,0.000054921526,0.0010655152,0.0010548949],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009542141,0.00810452,0.16440144,0.00042321454,0.0020862648,0.00010821902,0.00084271474,0.00003196171,0.120390154,0.00015526831,0.090389356,0.60352474],"study_design_scores_gemma":[0.010418491,0.0025699823,0.20431316,0.000078544195,0.0029315937,0.00009402729,0.00009701622,0.0037227566,0.027835492,0.0001448891,0.74720204,0.0005920053],"about_ca_topic_score_codex":0.000003233188,"about_ca_topic_score_gemma":0.000005724701,"teacher_disagreement_score":0.65681267,"about_ca_system_score_codex":0.00012700277,"about_ca_system_score_gemma":0.00032985798,"threshold_uncertainty_score":0.9998634},"labels":[],"label_agreement":null},{"id":"W2074621558","doi":"10.1038/clpt.2008.219","title":"The Increasing Complexity of Mercaptopurine Pharmacogenomics","year":2009,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Renal Transplantation Outcomes and Treatments","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Heart Institute","funders":"","keywords":"Pharmacogenomics; Mercaptopurine; Computational biology; Biopharmaceutics; Pharmacology; Medicine; Biology; Genetics; Pharmacognosy","score_opus":0.3632518415847661,"score_gpt":0.5371047459326055,"score_spread":0.1738529043478394,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2074621558","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00038556388,0.9953969,0.000021833657,0.001095916,0.0012192493,0.001260312,0.0000843514,0.000046440047,0.00048945093],"genre_scores_gemma":[0.00016652908,0.99079573,0.00066625053,0.0073091057,0.0005814959,0.000025863872,0.00015692346,0.000056323363,0.00024178455],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.996112,0.0010048336,0.0018722778,0.000399409,0.00023039914,0.00038107036],"domain_scores_gemma":[0.9957166,0.0026841431,0.00086747686,0.0003777581,0.00014190248,0.00021216278],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00094055594,0.000461698,0.0024726652,0.00008718372,0.00017747638,0.000013659807,0.00038267465,0.00039338385,0.00010703054],"category_scores_gemma":[0.000014313587,0.00026936783,0.0013571042,0.00022434093,0.000978106,0.000024500143,0.000053268443,0.0010263151,0.00006417727],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007075127,0.0009062109,0.0002744704,0.0031689666,0.0075507355,0.00009347647,0.000017311575,4.3288694e-7,0.000019542258,0.00006213725,0.00033183643,0.98686737],"study_design_scores_gemma":[0.0027609773,0.00046575643,0.0004364003,0.0016748523,0.027520165,0.00024024962,0.0000036017786,0.000021018164,0.0000327502,0.00009935103,0.96653914,0.0002057543],"about_ca_topic_score_codex":0.0000049453265,"about_ca_topic_score_gemma":0.0000010147086,"teacher_disagreement_score":0.9866616,"about_ca_system_score_codex":0.000096100426,"about_ca_system_score_gemma":0.00042488417,"threshold_uncertainty_score":0.99997586},"labels":[],"label_agreement":null},{"id":"W2075497716","doi":"10.1038/sj.clpt.6100497","title":"Smoked Marijuana as Medicine: Not Much Future","year":2008,"lang":"en","type":"letter","venue":"Clinical Pharmacology & Therapeutics","topic":"Cannabis and Cannabinoid Research","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Muscular Dystrophy Canada; University of Toronto","funders":"","keywords":"Clinical pharmacology; Citation; Counterpoint; Point (geometry); Library science; Medicine; Psychology; Computer science; Pharmacology; Mathematics","score_opus":0.12816215568624473,"score_gpt":0.46578547536629195,"score_spread":0.3376233196800472,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2075497716","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0067597316,0.004653079,0.000009365367,0.9695235,0.011920341,0.0014102575,0.000060084818,0.0002163764,0.005447296],"genre_scores_gemma":[0.0002902338,0.024094222,0.00006963381,0.80281955,0.0760806,0.00012340021,0.00046704084,0.00020383675,0.09585146],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9930285,0.0010507131,0.0017344092,0.0013757984,0.0014007775,0.0014097557],"domain_scores_gemma":[0.9964087,0.00056845444,0.000509762,0.0011200588,0.0007838972,0.00060914154],"candidate_categories":["metaepi_narrow","sts","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity","insufficient_payload"],"category_scores_codex":[0.0010699147,0.0008809505,0.0022523485,0.000397039,0.00029125696,0.000023329081,0.00092908455,0.0042441953,0.010391528],"category_scores_gemma":[0.000087515495,0.0006733856,0.0010416869,0.00052201917,0.0029391283,0.000048087462,0.00028332343,0.013630043,0.00086142763],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012522826,0.00040193257,0.00040139616,0.00022853671,0.0023478381,0.0062491205,0.0001285126,1.8914533e-7,0.0010328257,0.000004493958,0.97829086,0.009662027],"study_design_scores_gemma":[0.0065075397,0.002497814,0.0026710893,0.00007634503,0.0032817107,0.0007710572,0.000060667502,0.00004271986,0.00033672075,0.00007664123,0.9830916,0.0005860901],"about_ca_topic_score_codex":0.000053896136,"about_ca_topic_score_gemma":0.0000031722907,"teacher_disagreement_score":0.1667039,"about_ca_system_score_codex":0.00027930344,"about_ca_system_score_gemma":0.0017327555,"threshold_uncertainty_score":0.9999165},"labels":[],"label_agreement":null},{"id":"W2075657812","doi":"10.1002/cpt.102","title":"Cannabis and the maturing brain: Role in psychosis development","year":2015,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Cannabis and Cannabinoid Research","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Cannabis; Psychosis; Psychology; Psychiatry; Brain development; Effects of cannabis; Medicine; Neuroscience; Cannabidiol","score_opus":0.09737075642580405,"score_gpt":0.4441014599707155,"score_spread":0.3467307035449114,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2075657812","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6328203,0.0025153833,0.000011424458,0.3623753,0.0005586423,0.0005543733,0.0000011350165,0.00002810221,0.0011353701],"genre_scores_gemma":[0.72364163,0.0012076758,0.0003436306,0.26265153,0.0007600862,0.00027494642,0.0000060001375,0.00004919033,0.011065311],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9981204,0.00037150955,0.0005425476,0.00031438642,0.00025699325,0.00039416307],"domain_scores_gemma":[0.999129,0.00013526535,0.00007525154,0.00020451317,0.00014088646,0.00031510196],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002208867,0.00015287804,0.00040988295,0.00008683986,0.00007896645,0.000021619708,0.00017964406,0.00018077817,0.000101585465],"category_scores_gemma":[0.0000651138,0.00009873752,0.00009162069,0.00021148466,0.00071897375,0.000033212647,0.00013827169,0.0008039581,0.000030823634],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0075481897,0.0010815938,0.08175872,0.00006607304,0.0007925385,0.000096203396,0.0042192857,0.000013033585,0.0012345449,0.00010608567,0.78085566,0.12222807],"study_design_scores_gemma":[0.012614411,0.00024475492,0.0816817,0.00001712405,0.00014398745,0.000039111517,0.00038892642,0.00059880083,0.0008248565,0.00024431242,0.90307474,0.00012726393],"about_ca_topic_score_codex":0.0000376609,"about_ca_topic_score_gemma":0.000043955923,"teacher_disagreement_score":0.12221909,"about_ca_system_score_codex":0.000099926896,"about_ca_system_score_gemma":0.00042407433,"threshold_uncertainty_score":0.4026399},"labels":[],"label_agreement":null},{"id":"W2075872237","doi":"10.1016/s0009-9236(03)90512-1","title":"Transient Downregulation of MDR1A Gene Expression in Brains of Endotoxin‐Treated Rats","year":2003,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Downregulation and upregulation; Pharmacology; Transient (computer programming); Gene; Gene expression; Cell biology; Biology; Medicine; Genetics; Computer science","score_opus":0.033757211325320134,"score_gpt":0.3633216319907018,"score_spread":0.32956442066538166,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2075872237","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967311,0.0019170195,0.00033982238,0.00011247903,0.00026628893,0.00033218865,0.000008877803,0.000007209982,0.00028501748],"genre_scores_gemma":[0.9965514,0.001753384,0.00059322314,0.0009154829,0.00006170732,0.000012299987,0.000037538586,0.000018369343,0.0000565725],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982429,0.000587558,0.0006060943,0.00027223167,0.000088643406,0.00020253025],"domain_scores_gemma":[0.9993393,0.00011615832,0.00020223223,0.00019537893,0.00007819387,0.00006874028],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004353622,0.00014469853,0.00029947495,0.00005625978,0.000024104833,0.0000016147285,0.00012881779,0.0004208678,0.000030754953],"category_scores_gemma":[0.000017846538,0.00012429191,0.00016809173,0.00013172266,0.0002509362,0.0000031651969,0.000024527715,0.00021339169,0.0000023870437],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004991245,0.00064843224,0.008115264,0.000012509411,0.00019238089,0.000004841179,0.000051492025,0.00033180762,0.98903084,0.000007590467,0.00030471964,0.00080097944],"study_design_scores_gemma":[0.002538979,0.00072604016,0.007821828,0.0000131376455,0.00013824276,0.000005070171,0.00001252043,0.00012193023,0.9856947,0.000026788495,0.0027892247,0.00011152601],"about_ca_topic_score_codex":0.0000012417523,"about_ca_topic_score_gemma":0.0000010396311,"teacher_disagreement_score":0.0033361465,"about_ca_system_score_codex":0.0000091719,"about_ca_system_score_gemma":0.000077982906,"threshold_uncertainty_score":0.5068477},"labels":[],"label_agreement":null},{"id":"W2076194172","doi":"10.1038/sj.clpt.6100056","title":"Intestinal Drug Transporter Expression and the Impact of Grapefruit Juice in Humans","year":2007,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":406,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Lawson Health Research Institute; Western University","funders":"National Institute of General Medical Sciences; Canadian Institutes of Health Research; U.S. Public Health Service; Health Canada; Deutsche Forschungsgemeinschaft; Vanderbilt University; GlaxoSmithKline","keywords":"Fexofenadine; Grapefruit juice; Pharmacology; Transporter; CYP3A4; Efflux; Chemistry; Organic anion-transporting polypeptide; Terfenadine; Pharmacokinetics; Biochemistry; Biology; Cytochrome P450; Metabolism; Gene","score_opus":0.05382730719279665,"score_gpt":0.43285645951449836,"score_spread":0.3790291523217017,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2076194172","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949681,0.0011123087,0.00084971794,0.0018362269,0.00036401048,0.0004926399,0.000004003089,0.000026164265,0.0003467904],"genre_scores_gemma":[0.99321425,0.000953129,0.00035887782,0.005066459,0.00018800954,0.000008057846,0.000006786374,0.000020745241,0.00018367448],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99830264,0.00014838886,0.00083097804,0.00025499254,0.00015342036,0.00030956234],"domain_scores_gemma":[0.99865764,0.0007854797,0.00016982708,0.00018037071,0.00007755181,0.00012911671],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018509233,0.0001780715,0.00056367076,0.00008990001,0.00005194877,0.0000031612371,0.00015215017,0.00016013414,0.00014413995],"category_scores_gemma":[0.0000070047126,0.000098763696,0.00030576054,0.0001714565,0.0009387245,0.000034955465,0.000015157536,0.00069464516,0.0000028342645],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.033265363,0.00306357,0.724593,0.0001717949,0.0010082538,0.00041843439,0.00666604,0.0000190823,0.21892515,0.00013658256,0.0010730834,0.010659646],"study_design_scores_gemma":[0.027289253,0.000895947,0.94021696,0.000199782,0.0014621593,0.00003180639,0.0006460249,0.0002342146,0.025665108,0.00095740065,0.0021466322,0.00025473363],"about_ca_topic_score_codex":0.000018996787,"about_ca_topic_score_gemma":0.00003576485,"teacher_disagreement_score":0.21562393,"about_ca_system_score_codex":0.000023257231,"about_ca_system_score_gemma":0.00007440744,"threshold_uncertainty_score":0.40274665},"labels":[],"label_agreement":null},{"id":"W2077136462","doi":"10.1067/mcp.2001.113185","title":"Seville orange juice-felodipine interaction: Comparison with dilute grapefruit juice and involvement of furocoumarins","year":2001,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":208,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"American Association of Pharmaceutical Scientists; U.S. Public Health Service; Medical Research Council Canada; National Center for Research Resources; National Institute of General Medical Sciences; Medical Research Council; University of Washington","keywords":"Grapefruit juice; Chemistry; Felodipine; Orange juice; Furocoumarins; Orange (colour); Food science; Citrus paradisi; Pharmacokinetics; Metabolite; Pharmacology; Chromatography; Biochemistry; Rutaceae; Botany; Medicine; Endocrinology","score_opus":0.3144994907808211,"score_gpt":0.5280572764054656,"score_spread":0.2135577856246445,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2077136462","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97517496,0.0072057415,0.00043465177,0.0073205456,0.0054345494,0.0011247816,0.00005615264,0.00015157551,0.0030970357],"genre_scores_gemma":[0.9294834,0.020059092,0.00076436397,0.047557224,0.001152549,0.00011529152,0.00004345909,0.00008294847,0.00074164337],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9951923,0.0012604059,0.0015643388,0.0008161742,0.0003422033,0.0008246079],"domain_scores_gemma":[0.9965116,0.0013249721,0.000775669,0.00039252767,0.0003977115,0.0005975186],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0014351675,0.0005932592,0.0011600166,0.00022381345,0.00034407462,0.000029635565,0.00060888135,0.0005787189,0.002124742],"category_scores_gemma":[0.00001714054,0.0005113449,0.00025292565,0.0005437453,0.0012801545,0.00018509012,0.00033182857,0.0019394169,0.00010940506],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016873846,0.012191668,0.55759,0.00039963596,0.011740413,0.00030857345,0.0030172223,0.001818555,0.113574296,0.00044225095,0.058053747,0.22398975],"study_design_scores_gemma":[0.010222769,0.0012027643,0.016328383,0.000025962261,0.0036088156,0.00007623861,0.00032047412,0.0052611334,0.019159215,0.00013444175,0.94304407,0.00061575964],"about_ca_topic_score_codex":0.000021646325,"about_ca_topic_score_gemma":0.000050234023,"teacher_disagreement_score":0.8849903,"about_ca_system_score_codex":0.00006132498,"about_ca_system_score_gemma":0.00017573207,"threshold_uncertainty_score":0.9997338},"labels":[],"label_agreement":null},{"id":"W2077489654","doi":"10.1038/clpt.2013.127","title":"Regulatory Review: How Do Agencies Ensure the Quality of Decision Making?","year":2013,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Institutes of Health Research","funders":"","keywords":"Multinational corporation; Quality (philosophy); Business; Clinical pharmacology; Regulatory science; Public relations; Pharmacology; Political science; Medicine; Finance","score_opus":0.5983493181868063,"score_gpt":0.5783310968958172,"score_spread":0.02001822129098907,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2077489654","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6081503,0.09265561,0.0016461652,0.28996918,0.003988227,0.0022539299,0.00012379147,0.00007043324,0.0011423773],"genre_scores_gemma":[0.5590963,0.01893416,0.001741377,0.41896328,0.0006882623,0.000140915,0.000006144948,0.000036132198,0.00039344],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99114066,0.002091598,0.0056585795,0.0005539563,0.0001549794,0.00040024347],"domain_scores_gemma":[0.9839464,0.010473584,0.0042084116,0.00094339706,0.00028529065,0.00014295378],"candidate_categories":["metaresearch","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.03190834,0.00022925419,0.0014999721,0.00009487406,0.00019498172,0.00004184515,0.0007581314,0.00031141267,0.0019078271],"category_scores_gemma":[0.0021607587,0.0001992443,0.00042287746,0.00021196167,0.00063498947,0.0002373993,0.00013843448,0.00053155166,0.0012559642],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000059308128,0.00031175526,0.068027265,0.00083287386,0.0006933464,8.7811685e-7,0.000642788,0.00002544064,0.00007735226,0.005204129,0.91752577,0.006599087],"study_design_scores_gemma":[0.0017904952,0.00026485318,0.36244634,0.00044316726,0.00021111147,0.000006243736,0.00068179803,0.0014060221,0.000029762512,0.03350355,0.598628,0.00058866764],"about_ca_topic_score_codex":0.000024458637,"about_ca_topic_score_gemma":0.000006662989,"teacher_disagreement_score":0.31889778,"about_ca_system_score_codex":0.00017710093,"about_ca_system_score_gemma":0.00017707354,"threshold_uncertainty_score":0.9995217},"labels":[],"label_agreement":null},{"id":"W2079813147","doi":"10.1038/clpt.2008.83","title":"Translational Pharmacology: Harnessing Increased Specialization of Research Within the Basic Biological Sciences","year":2008,"lang":"en","type":"editorial","venue":"Clinical Pharmacology & Therapeutics","topic":"Health and Medical Research Impacts","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Translational research; Clinical pharmacology; Biological sciences; Translational medicine; Computational biology; Medicine; Biology; Pharmacology; Biotechnology; Pathology","score_opus":0.5693454162406317,"score_gpt":0.6218048982235849,"score_spread":0.05245948198295314,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2079813147","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.06938247,0.006069462,0.00018399215,0.08928852,0.82979816,0.003477388,0.0002207307,0.00014266021,0.0014366233],"genre_scores_gemma":[0.02294373,0.030513126,0.00042070364,0.060719214,0.88444453,0.00012341986,0.0003905273,0.00007850677,0.00036621216],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9870745,0.005733912,0.0019041352,0.00087214913,0.0029381083,0.0014771945],"domain_scores_gemma":[0.93985975,0.052428514,0.0010120152,0.0005443858,0.002907116,0.0032482222],"candidate_categories":["metaresearch","sts","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.022153249,0.00039037975,0.0012669978,0.00044152755,0.00087181036,0.00002779408,0.00091533875,0.0021890095,0.0008749346],"category_scores_gemma":[0.015957369,0.00023845423,0.00037353204,0.0013027876,0.012567206,0.000084138796,0.0001714758,0.006890001,0.00006732663],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029449158,0.0011571806,0.0017805086,0.0002186939,0.00052583555,0.00010740218,0.00020303,0.0000060111734,0.0024847505,0.000020673227,0.98791736,0.0026336233],"study_design_scores_gemma":[0.0058282483,0.0030461596,0.0014063066,0.00022377087,0.0006982359,0.000022515613,0.00006735049,0.0009473451,0.0013818981,0.00029096115,0.9858659,0.00022133785],"about_ca_topic_score_codex":0.00004162851,"about_ca_topic_score_gemma":0.000004833875,"teacher_disagreement_score":0.054646395,"about_ca_system_score_codex":0.00022505443,"about_ca_system_score_gemma":0.033164296,"threshold_uncertainty_score":0.99910635},"labels":[],"label_agreement":null},{"id":"W2082018725","doi":"10.1038/clpt.2010.309","title":"Science Spin: iPS Cell Research in the News","year":2011,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pluripotent Stem Cells Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Stem Cell Network","keywords":"Induced pluripotent stem cell; Reprogramming; Embryonic stem cell; Context (archaeology); Stem cell; Cell biology; Phenomenon; Biology; Neuroscience; Cell; Genetics; Epistemology; Gene; Philosophy","score_opus":0.35425265112825316,"score_gpt":0.5173011750355407,"score_spread":0.16304852390728758,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2082018725","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97542965,0.0010452439,0.000049794085,0.003201608,0.0007522346,0.00057731004,0.0000035275866,0.000010610225,0.018930012],"genre_scores_gemma":[0.9776862,0.0023365372,0.00029545816,0.018489104,0.00055437785,0.00004302412,0.0000054103893,0.0000219997,0.00056786946],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9960502,0.0014806419,0.00047080533,0.0006611029,0.00048958516,0.0008476623],"domain_scores_gemma":[0.9985771,0.00028197395,0.00007630282,0.00064942,0.00025451384,0.00016068613],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006563749,0.0001536273,0.00018493942,0.0002060813,0.00025960995,0.000031005253,0.0019217724,0.00026359782,0.000101361395],"category_scores_gemma":[0.00003418587,0.00011126214,0.00011367863,0.00087024417,0.0026704448,0.000008125912,0.0005373537,0.0010637128,0.00021420381],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006452337,0.0018878761,0.026396701,0.00002078616,0.000076706325,0.00008365338,0.0005072607,0.000005261373,0.9436181,0.00007275539,0.020163167,0.0065224757],"study_design_scores_gemma":[0.0036499887,0.003962898,0.045209378,0.0000123088,0.00009932517,0.00003526209,0.0010532503,0.000323735,0.49598542,0.0007963038,0.4483874,0.00048473387],"about_ca_topic_score_codex":0.000017672477,"about_ca_topic_score_gemma":0.000018670944,"teacher_disagreement_score":0.44763273,"about_ca_system_score_codex":0.00003061683,"about_ca_system_score_gemma":0.0006292671,"threshold_uncertainty_score":0.9839365},"labels":[],"label_agreement":null},{"id":"W2085993091","doi":"10.1038/sj.clpt.6100272","title":"Stimulation of Cholecystokinin-A Receptors With GI181771X does not Cause Weight Loss in Overweight or Obese Patients","year":2007,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Neuropeptides and Animal Physiology","field":"Neuroscience","cited_by":118,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; University of Toronto","funders":"","keywords":"Cholecystokinin; Overweight; Weight loss; Stimulation; Receptor; Medicine; Endocrinology; Internal medicine; Obesity; Cholecystokinin receptor","score_opus":0.09015561396236035,"score_gpt":0.4032381747137445,"score_spread":0.3130825607513842,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2085993091","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99716187,0.000012793719,0.000024469284,0.00035564444,0.00172575,0.00043054254,0.000021230579,0.00004750351,0.0002201784],"genre_scores_gemma":[0.97363436,0.00059304805,0.00011687076,0.025089372,0.0003067578,0.000007682971,0.000004447936,0.000044255186,0.00020321543],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99706435,0.0004845911,0.0010067718,0.0006516108,0.0002659665,0.0005267146],"domain_scores_gemma":[0.9967851,0.0022534088,0.0004377877,0.0002536578,0.00011928164,0.0001507465],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004325015,0.0002704842,0.0005091832,0.00013791963,0.000083734536,0.000008912885,0.00040675644,0.00022294515,0.00030507275],"category_scores_gemma":[0.00009202415,0.00016557425,0.000110456225,0.00044112408,0.00084344763,0.00015896808,0.00012576576,0.0006557754,0.00005006454],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014834416,0.0035714698,0.2546477,0.00004171642,0.00010925559,0.00023401211,0.00024704452,0.00014254822,0.7178631,0.00018753544,0.00063848624,0.0074827415],"study_design_scores_gemma":[0.01042586,0.0050238194,0.3583371,0.00005296822,0.00024868155,0.000009480714,0.000016635866,0.0003139333,0.5787081,0.00032076865,0.046031572,0.0005110793],"about_ca_topic_score_codex":0.0000051771053,"about_ca_topic_score_gemma":0.000027140759,"teacher_disagreement_score":0.13915497,"about_ca_system_score_codex":0.000048298083,"about_ca_system_score_gemma":0.00007967608,"threshold_uncertainty_score":0.67519224},"labels":[],"label_agreement":null},{"id":"W2086282994","doi":"10.1038/clpt.2011.37","title":"Human Induced Pluripotent Stem Cells: The Past, Present, and Future","year":2011,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Pluripotent Stem Cells Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital","funders":"","keywords":"Induced pluripotent stem cell; Reprogramming; Regenerative medicine; Stem cell; Drug discovery; Somatic cell; Biology; Neuroscience; Engineering ethics; Embryonic stem cell; Cell biology; Bioinformatics; Cell; Engineering; Genetics","score_opus":0.18575731096352333,"score_gpt":0.4484902227186909,"score_spread":0.26273291175516755,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2086282994","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0014391306,0.99247944,0.000008175789,0.0014159757,0.0024485001,0.0017652027,0.00005527072,0.000032642576,0.0003556557],"genre_scores_gemma":[0.00007547463,0.9815613,0.00002370503,0.004064838,0.011893532,0.00020343543,0.00007178288,0.00013698055,0.0019689514],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9943254,0.002294739,0.0012290877,0.0011482263,0.00024752546,0.00075501116],"domain_scores_gemma":[0.997702,0.0002356169,0.00061004754,0.0009836027,0.0001546057,0.00031409843],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0010635147,0.00071025174,0.0013699512,0.00008970952,0.00032622946,0.000051905543,0.0014572778,0.0015999619,0.00009468505],"category_scores_gemma":[0.0000016013034,0.00046149344,0.0008045289,0.0001776436,0.00078246923,0.000004809288,0.0010889431,0.0018887497,0.00009859062],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000094788964,0.0005693363,0.000033918466,0.001886321,0.003900115,0.000038652724,0.000037344667,3.287481e-7,0.0040337085,0.000009404381,0.06302593,0.92637014],"study_design_scores_gemma":[0.0007475304,0.000657369,0.000020104071,0.00012355551,0.0026027348,0.00004291452,0.0000293086,0.000004007337,0.00049611786,0.000010242864,0.99480134,0.00046480124],"about_ca_topic_score_codex":0.0000039139195,"about_ca_topic_score_gemma":0.0000021097655,"teacher_disagreement_score":0.9317754,"about_ca_system_score_codex":0.00003484107,"about_ca_system_score_gemma":0.0002972308,"threshold_uncertainty_score":0.9997837},"labels":[],"label_agreement":null},{"id":"W2086349371","doi":"10.1038/clpt.2012.171","title":"A Population-Based Assessment of the Drug Interaction Between Levothyroxine and Warfarin","year":2012,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; St. Michael's Hospital; St. Joseph’s Healthcare Hamilton; Institute for Clinical Evaluative Sciences; McMaster University; University of Toronto","funders":"Canadian Institutes of Health Research; Institute for Clinical Evaluative Sciences","keywords":"Levothyroxine; Warfarin; Medicine; Odds ratio; Drug interaction; Confidence interval; Drug; Population; Internal medicine; Pharmacology; Atrial fibrillation; Hormone","score_opus":0.23197241596887405,"score_gpt":0.5234777862234357,"score_spread":0.2915053702545616,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2086349371","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9756083,0.00014111777,0.00034428807,0.02183447,0.0014133236,0.0004136982,0.0000030029282,0.000026701207,0.00021511539],"genre_scores_gemma":[0.98814577,0.00007457552,0.00058464636,0.0095929,0.0012702815,0.0000022163283,0.000014214937,0.000011945288,0.00030347242],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99885213,0.0002597053,0.00048518353,0.00011961555,0.00013707514,0.00014630567],"domain_scores_gemma":[0.99856687,0.00093168777,0.00023651429,0.00014127932,0.000048084516,0.00007558481],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00051307824,0.00009682548,0.0003207395,0.00004671039,0.00006363777,0.000004457628,0.00006498946,0.00008364452,0.00013070506],"category_scores_gemma":[0.000021562528,0.00006405729,0.00015415375,0.00011114627,0.00010896026,0.00006152779,0.000057456906,0.00025009684,0.00000412342],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008410125,0.000050829247,0.99452007,0.000022970296,0.00028423793,1.472216e-7,0.00003104236,0.000019806095,0.0007843389,0.000053156018,0.00051434105,0.0036349422],"study_design_scores_gemma":[0.0018338516,0.00007877666,0.97133315,0.000010752437,0.0012264706,5.583471e-7,0.000022242351,0.001287611,0.0006282099,0.000035160065,0.023484139,0.00005907332],"about_ca_topic_score_codex":0.000008902032,"about_ca_topic_score_gemma":0.0000012563542,"teacher_disagreement_score":0.023186931,"about_ca_system_score_codex":0.00003747056,"about_ca_system_score_gemma":0.000037677466,"threshold_uncertainty_score":0.26121804},"labels":[],"label_agreement":null},{"id":"W2089308487","doi":"10.1038/sj.clpt.6100068","title":"Clinical Pharmacology Education: Looking into the Future","year":2007,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal College of Physicians and Surgeons of Canada; Dalhousie University","funders":"International Union of Basic and Clinical Pharmacology","keywords":"Clinical pharmacology; Accreditation; Pharmacology; Medicine; Clinical Practice; Engineering ethics; Medical education; Drug development; Drug; Family medicine; Engineering","score_opus":0.31771547726393434,"score_gpt":0.6228767785474149,"score_spread":0.3051613012834805,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2089308487","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00007493727,0.9024972,0.000036389618,0.036038857,0.05606413,0.0025580463,0.000012826377,0.00016925711,0.0025483668],"genre_scores_gemma":[0.000008910035,0.7033529,0.0004364632,0.25053492,0.044030167,0.0001922985,0.000058168807,0.00012500794,0.0012611724],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.98909885,0.0038644026,0.003947442,0.0014049708,0.00053573115,0.00114859],"domain_scores_gemma":[0.9826595,0.013348681,0.0017375462,0.00081812445,0.0005896409,0.00084648543],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity","insufficient_payload"],"category_scores_codex":[0.006217313,0.0010810973,0.004364433,0.00019440656,0.0006918368,0.00005644786,0.001296281,0.0022709798,0.002247601],"category_scores_gemma":[0.0001382422,0.0006592882,0.0026444348,0.00086025393,0.0023219304,0.00011685515,0.000677227,0.009076868,0.0010385487],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045642167,0.001943541,0.00030418212,0.0021071369,0.007295143,0.00011691668,0.00007350459,8.5798845e-8,0.0000013257646,0.000022305088,0.18189508,0.80578434],"study_design_scores_gemma":[0.0020897265,0.000721037,0.000109056644,0.00073000044,0.045351442,0.00026111456,0.00012570927,0.000018031746,0.000002550291,0.00006737752,0.94993246,0.0005914778],"about_ca_topic_score_codex":0.000005290088,"about_ca_topic_score_gemma":0.0000055712226,"teacher_disagreement_score":0.8051929,"about_ca_system_score_codex":0.00028252043,"about_ca_system_score_gemma":0.0027537544,"threshold_uncertainty_score":0.9997392},"labels":[],"label_agreement":null},{"id":"W2089354656","doi":"10.1038/clpt.2009.311","title":"Obesity, Inflammation, and Cardiovascular Risk","year":2010,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Adipokines, Inflammation, and Metabolic Diseases","field":"Medicine","cited_by":421,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Adipose tissue; Context (archaeology); Inflammation; Obesity; Disease; Medicine; Bioinformatics; Epidemiology; Metabolic syndrome; Dysfunctional family; Internal medicine; Endocrinology; Biology","score_opus":0.09156070844176087,"score_gpt":0.427290571305833,"score_spread":0.33572986286407214,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2089354656","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.002442951,0.9921655,0.00006811751,0.0002608614,0.0028323291,0.0016680461,0.000061984756,0.0001472897,0.00035289052],"genre_scores_gemma":[0.000025750624,0.9903429,0.0003301074,0.0021359946,0.0063921288,0.00012450185,0.00015413757,0.00009457059,0.00039988192],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99605143,0.0009699251,0.0015590829,0.0007014829,0.00032329443,0.00039476703],"domain_scores_gemma":[0.9968508,0.0009919843,0.00064471323,0.0007499339,0.0002987646,0.0004638435],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0015390079,0.0005619138,0.0031910907,0.00018838282,0.00018527807,0.000029686713,0.00028099003,0.0012043981,0.00027023605],"category_scores_gemma":[0.00016535804,0.00043238924,0.001817312,0.00023713688,0.0007325204,0.00007747505,0.0001463398,0.0019452666,0.00020285715],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000041285693,0.00022261753,0.0014658879,0.00281915,0.00744561,0.000033363474,0.000029842871,5.8411126e-7,0.0000020334626,0.000018374907,0.002002999,0.9859182],"study_design_scores_gemma":[0.0015838395,0.00010652924,0.0016238594,0.0004915522,0.0787534,0.00009772861,0.0000045409665,0.000016982889,0.0000045417264,0.00007959743,0.91689736,0.0003400707],"about_ca_topic_score_codex":0.0000043464843,"about_ca_topic_score_gemma":0.000002102684,"teacher_disagreement_score":0.9855782,"about_ca_system_score_codex":0.000029087985,"about_ca_system_score_gemma":0.0007647518,"threshold_uncertainty_score":0.9998128},"labels":[],"label_agreement":null},{"id":"W2089453005","doi":"10.1038/clpt.2009.179","title":"Expediting Patients’ Access to Medicines by Improving the Predictability of Drug Development and the Regulatory Approval Process","year":2009,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Expediting; Drug development; Clinical pharmacology; Regulatory science; Risk analysis (engineering); Drug approval; Business; Access to medicines; Process (computing); Medicine; Drug; Process management; Pharmacology; Computer science; Engineering","score_opus":0.08671489304942995,"score_gpt":0.38417699705932334,"score_spread":0.29746210400989337,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2089453005","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9563873,0.0013991256,0.00016522764,0.03972129,0.0008507557,0.00078862166,0.000039833234,0.000023223762,0.0006246119],"genre_scores_gemma":[0.8789926,0.00024608482,0.00007146765,0.12021002,0.0003838307,0.000050619703,0.000005321696,0.00001410013,0.000025948375],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976326,0.00013283438,0.0013979479,0.00043346142,0.000059188846,0.00034395163],"domain_scores_gemma":[0.99796224,0.00093846844,0.00059501966,0.00026319147,0.0000806916,0.00016039179],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00276248,0.00019207675,0.000556442,0.00005260948,0.00021040939,0.000043169945,0.00070336444,0.00011413793,0.000051991374],"category_scores_gemma":[0.00013400879,0.00012998898,0.00010581129,0.00015232434,0.00072735065,0.0001354014,0.0001758235,0.00043067397,0.000009914551],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032168853,0.0032463558,0.6921648,0.000333316,0.0017100896,0.0000019140223,0.020322055,0.00019548733,0.00041403936,0.00817947,0.09721923,0.17299636],"study_design_scores_gemma":[0.020913687,0.00066732743,0.62209046,0.000045641107,0.0005327695,0.0000037441857,0.00064087304,0.017559495,0.0083449,0.028811026,0.29916903,0.0012210765],"about_ca_topic_score_codex":0.000008252768,"about_ca_topic_score_gemma":0.0000021562353,"teacher_disagreement_score":0.20194979,"about_ca_system_score_codex":0.0000479653,"about_ca_system_score_gemma":0.0000722611,"threshold_uncertainty_score":0.53007966},"labels":[],"label_agreement":null},{"id":"W2090321716","doi":"10.1038/sj.clpt.6100510","title":"Human Abuse Liability of the Smoking Cessation Drug Varenicline in Smokers and Nonsmokers","year":2008,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Smoking Behavior and Cessation","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Pfizer","keywords":"Varenicline; Placebo; Partial agonist; Drug; Abuse liability; Medicine; Pharmacology; Smoking cessation; Crossover study; Agonist; Nicotinic agonist; Clinical pharmacology; Amphetamine; Anesthesia; Nicotine; Psychiatry; Internal medicine; Receptor; Alternative medicine","score_opus":0.11335708213670695,"score_gpt":0.4271345216535918,"score_spread":0.31377743951688486,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2090321716","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958517,0.000101850965,0.000009018277,0.0027016976,0.00078482507,0.0004034105,0.000004264956,0.00003097701,0.00011223138],"genre_scores_gemma":[0.9917341,0.0004256725,0.000038228278,0.007524897,0.00014531103,0.000014817229,0.000007775379,0.000017069937,0.000092118724],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981772,0.00037826755,0.0007388386,0.00028926856,0.00022019753,0.00019624118],"domain_scores_gemma":[0.99890256,0.00038516984,0.00024716795,0.00027552698,0.000116048715,0.00007355584],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00096503005,0.00013858743,0.00036384896,0.000073129806,0.0001339602,0.0000034385828,0.0001430956,0.00021477079,0.00008524687],"category_scores_gemma":[0.000030588468,0.00010409203,0.00013946815,0.0002568287,0.00088100147,0.00005775245,0.000046712667,0.00068520376,5.359119e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001423614,0.00058528443,0.99332756,0.00002297425,0.00010236717,0.000007412457,0.001069776,0.000019530722,0.0036362866,0.0000071380746,0.0003249989,0.00075429206],"study_design_scores_gemma":[0.0039411136,0.00014892168,0.9899509,0.00003212029,0.0006346904,0.000014052031,0.00011510875,0.00017463799,0.003855043,0.00007950314,0.00095961854,0.00009429134],"about_ca_topic_score_codex":0.000040536626,"about_ca_topic_score_gemma":0.000013610655,"teacher_disagreement_score":0.0048231995,"about_ca_system_score_codex":0.00007323134,"about_ca_system_score_gemma":0.00010158078,"threshold_uncertainty_score":0.42447498},"labels":[],"label_agreement":null},{"id":"W2091899294","doi":"10.1038/clpt.2011.155","title":"In Vitro Testing for Hypersensitivity-Mediated Adverse Drug Reactions: Challenges and Future Directions","year":2011,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Drug-Induced Adverse Reactions","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Drug reaction; Drug; Clinical pharmacology; Medicine; In vitro; Pharmacology; Gold standard (test); Presentation (obstetrics); Adverse effect; Intensive care medicine; Chemistry; Internal medicine; Surgery","score_opus":0.28181353493323713,"score_gpt":0.4664910402929285,"score_spread":0.18467750535969135,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2091899294","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0001060202,0.9844531,0.0000017690525,0.0040205,0.0056319167,0.0025697572,0.000113586386,0.00021448912,0.0028889047],"genre_scores_gemma":[0.000033427194,0.9895924,0.0010208066,0.0042325757,0.003957429,0.00046814908,0.00011131548,0.0001449429,0.00043899167],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9962622,0.0007713801,0.0013698733,0.0009056501,0.00012504106,0.0005658365],"domain_scores_gemma":[0.9909646,0.0073903115,0.00065466523,0.00040298788,0.0002541358,0.00033331924],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0010996283,0.0006019649,0.002430424,0.00047617033,0.00017657614,0.000006614322,0.00013852757,0.0010566334,0.00001189014],"category_scores_gemma":[0.0002653687,0.0005309806,0.00069454673,0.00045027456,0.00042800696,0.00013940422,0.0000858683,0.002460281,0.00008076773],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000076891745,0.001043473,0.000002891058,0.0026031462,0.0014452854,0.000079173464,0.00017330554,4.678647e-8,0.00019473824,0.000014481216,0.00016878216,0.9941978],"study_design_scores_gemma":[0.0021093225,0.00010400881,0.00019422114,0.0010919402,0.0098688435,0.00044812672,0.00029718774,0.000040617288,0.000009208759,0.000035359782,0.9853968,0.00040435683],"about_ca_topic_score_codex":0.000012146662,"about_ca_topic_score_gemma":0.000012781838,"teacher_disagreement_score":0.9937934,"about_ca_system_score_codex":0.00025309838,"about_ca_system_score_gemma":0.0006169111,"threshold_uncertainty_score":0.9998411},"labels":[],"label_agreement":null},{"id":"W2091956683","doi":"10.1038/clpt.2008.143","title":"Thorough QT/QTc Study in Patients With Advanced Parkinson's Disease: Cardiac Safety of Rotigotine","year":2008,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Cardiac electrophysiology and arrhythmias","field":"Medicine","cited_by":79,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Saint Paul University","funders":"","keywords":"QT interval; Rotigotine; Medicine; Moxifloxacin; Placebo; Internal medicine; Anesthesia; Cardiology; Heart rate; Confidence interval; Parkinson's disease; Disease; Antibiotics","score_opus":0.032528974817792364,"score_gpt":0.3625169162245537,"score_spread":0.3299879414067613,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2091956683","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955392,0.0008665417,0.000012822825,0.0010153988,0.0007668837,0.0016120999,0.000027608932,0.000046945028,0.000112480964],"genre_scores_gemma":[0.9914704,0.0016394752,0.00019535719,0.0060963044,0.0003659583,0.000056300014,0.000044023134,0.00003746268,0.00009474789],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997409,0.0006646707,0.0007579922,0.00050557835,0.00025196507,0.00041083034],"domain_scores_gemma":[0.9984402,0.0005343199,0.00023008902,0.0003855181,0.00020371952,0.00020616343],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003509611,0.00026152094,0.0010592651,0.0000797735,0.00009542799,0.0000013098403,0.00013299551,0.00016440147,0.000069092304],"category_scores_gemma":[0.000029559773,0.00020242704,0.000279035,0.00031112868,0.00062475726,0.000057467365,0.00007021189,0.00076049374,0.0000150521],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.023352658,0.004170543,0.966118,0.00002117782,0.0011703722,0.00024476674,0.00016481696,0.0002309461,0.0002861708,0.0000028549712,0.00049107283,0.0037466323],"study_design_scores_gemma":[0.013390907,0.0041919285,0.9733902,0.000023800287,0.0011124678,0.000004783273,0.000030877007,0.000026808211,0.00020066735,0.000011762522,0.007427356,0.00018839826],"about_ca_topic_score_codex":0.0000020846112,"about_ca_topic_score_gemma":0.0000011559464,"teacher_disagreement_score":0.009961752,"about_ca_system_score_codex":0.00005711482,"about_ca_system_score_gemma":0.0002553613,"threshold_uncertainty_score":0.8254735},"labels":[],"label_agreement":null},{"id":"W2092261835","doi":"10.1016/s0009-9236(03)90386-9","title":"Pregnancy outcome and maternal changes in smoking habits with gestational exposure to bupropion","year":2003,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pregnancy and Medication Impact","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"","keywords":"Bupropion; Medicine; Pregnancy; Obstetrics; Gestation; Gestational age; Smoking cessation; Biology","score_opus":0.11165288277075909,"score_gpt":0.43743774961807347,"score_spread":0.3257848668473144,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2092261835","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9817053,0.0013819874,0.00037723006,0.014980139,0.0006551753,0.0005865735,0.0000058627156,0.000039354196,0.00026835105],"genre_scores_gemma":[0.9557341,0.0009304438,0.0011260438,0.041561957,0.00013526114,0.00006922533,0.0000047007966,0.000020020132,0.00041827533],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99867564,0.00019279186,0.00040102587,0.00028437315,0.00017245654,0.00027373084],"domain_scores_gemma":[0.9991748,0.00027788634,0.000107485204,0.00013226067,0.00007324649,0.00023433943],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039091796,0.00014295858,0.0003097385,0.00009697274,0.00004610333,0.0000071861114,0.000069905145,0.00015354206,0.00015991635],"category_scores_gemma":[0.0000580765,0.00010682291,0.000032030905,0.00013696865,0.0001591393,0.000046354042,0.000020032667,0.0004026042,0.000011479384],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034555176,0.00028289776,0.98048073,0.000061841136,0.0001446639,0.00007104245,0.00027501796,0.0000060289226,0.0026335982,0.00006765314,0.00013374072,0.015497224],"study_design_scores_gemma":[0.005888923,0.0015828091,0.9780643,0.00040631316,0.00032845532,0.00008919933,0.000045773715,0.000034364155,0.0029847529,0.00007750457,0.010346946,0.00015064921],"about_ca_topic_score_codex":0.0000015476096,"about_ca_topic_score_gemma":0.0000112910375,"teacher_disagreement_score":0.02658182,"about_ca_system_score_codex":0.00003891139,"about_ca_system_score_gemma":0.00012742884,"threshold_uncertainty_score":0.4356112},"labels":[],"label_agreement":null},{"id":"W2092855364","doi":"10.1016/s0009-9236(03)90700-4","title":"CYP3A and P‐glycoprotein induction with St. John's wort in healthy volunteers of selected ethnic populations","year":2003,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Phytochemistry and biological activity of medicinal plants","field":"Agricultural and Biological Sciences","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"CYP3A; Ethnic group; Traditional medicine; Glycoprotein; Medicine; Pharmacology; Internal medicine; Biology; Anthropology; Genetics; Sociology; Metabolism; Cytochrome P450","score_opus":0.15026811057444686,"score_gpt":0.3859513797236898,"score_spread":0.23568326914924295,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2092855364","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99536705,0.0003471928,0.0000067781734,0.0036908942,0.000172546,0.00028606495,0.000015927535,0.000024939814,0.00008863318],"genre_scores_gemma":[0.995241,0.00051925605,0.00014653103,0.0038918797,0.00013246473,0.000013608192,0.000028238961,0.0000010249347,0.00002601061],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9985607,0.00037984556,0.0003843602,0.00030105913,0.000116169125,0.00025786608],"domain_scores_gemma":[0.9991645,0.0004566615,0.000152202,0.000038048332,0.000073910036,0.00011464319],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005472071,0.00013386097,0.00031689633,0.000013539071,0.000079839374,0.000004268999,0.00011306671,0.00025879734,0.00015930644],"category_scores_gemma":[0.000051706287,0.000054531567,0.00004117494,0.00042960318,0.00034217653,0.000055333363,0.000019835967,0.0005264074,0.0000021469975],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028317529,0.0017341162,0.2698544,0.000029083938,0.00015178308,0.000017595768,0.000064491855,0.00001755525,0.66354936,0.000026887392,0.00049272133,0.061230242],"study_design_scores_gemma":[0.0014502516,0.0033281185,0.9782205,0.000034417866,0.0001082368,0.0000320023,0.0001610597,0.000078055695,0.009504023,0.0005022923,0.006358713,0.0002222808],"about_ca_topic_score_codex":0.000039162802,"about_ca_topic_score_gemma":0.00022472149,"teacher_disagreement_score":0.70836616,"about_ca_system_score_codex":0.000019329253,"about_ca_system_score_gemma":0.00002967756,"threshold_uncertainty_score":0.22870076},"labels":[],"label_agreement":null},{"id":"W2094049166","doi":"10.1067/mcp.2002.129322","title":"Single‐dose and steady‐state pharmacokinetics of celecoxib in children","year":2002,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":89,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children","funders":"","keywords":"Celecoxib; Pharmacokinetics; Volume of distribution; Pharmacology; Clearance; Medicine; Cyclooxygenase; Dosing; Drug; Oral administration; Steady state (chemistry); Bioavailability; Half-life; Distribution (mathematics); Chemistry; Urology; Enzyme; Biochemistry","score_opus":0.06713841475158734,"score_gpt":0.3718759105382496,"score_spread":0.30473749578666226,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2094049166","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943485,0.002402307,0.00001124964,0.0014222874,0.000725462,0.0006744346,0.000008735758,0.000042956548,0.00036406438],"genre_scores_gemma":[0.9782795,0.004834262,0.00016431836,0.016056124,0.0004216892,0.000014423714,0.0000050103504,0.000037972837,0.00018671082],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99799025,0.0003180605,0.00080835976,0.00032876479,0.00017048209,0.00038408773],"domain_scores_gemma":[0.99877256,0.0005244164,0.00020742169,0.00018924719,0.00008176029,0.00022459848],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005578474,0.00021924412,0.00062057417,0.00013609213,0.000033022756,0.000005242297,0.0001246659,0.00021609278,0.0003430384],"category_scores_gemma":[0.000026148507,0.00019459423,0.00012388156,0.00020210574,0.0005028427,0.00004359495,0.000064596585,0.00066305645,0.000036013895],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010198102,0.0034101247,0.7710141,0.00013923614,0.00092925254,0.00014783528,0.0006551755,0.000017768733,0.11819797,0.0000051690718,0.005128248,0.09933529],"study_design_scores_gemma":[0.03750549,0.0040987586,0.84140944,0.00011633635,0.0025186439,0.00019443141,0.000044535554,0.014218627,0.07216689,0.00012554502,0.026910555,0.0006907127],"about_ca_topic_score_codex":0.0000025598665,"about_ca_topic_score_gemma":0.0000013446231,"teacher_disagreement_score":0.09864458,"about_ca_system_score_codex":0.000033318647,"about_ca_system_score_gemma":0.000036060534,"threshold_uncertainty_score":0.79353225},"labels":[],"label_agreement":null},{"id":"W2095075931","doi":"10.1038/clpt.2011.73","title":"Ethical Considerations Regarding Disparities Pertaining to Kidney Transplant Patients","year":2011,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Renal Transplantation Outcomes and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Health equity; Referral; Medicine; Ethnic group; Equity (law); Organ transplantation; Health care; Family medicine; Intensive care medicine; Transplantation; Kidney transplant; Kidney transplantation; Nursing; Public health; Internal medicine; Political science","score_opus":0.1924929813423124,"score_gpt":0.437175941495525,"score_spread":0.24468296015321261,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2095075931","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9548935,0.00009357451,0.0014830838,0.034949496,0.0026452744,0.00110332,0.00012749364,0.00018974206,0.0045144646],"genre_scores_gemma":[0.7543001,0.0003087765,0.0029880814,0.2419911,0.00013364971,0.000033194843,0.000050567643,0.00002234293,0.00017215553],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99828756,0.00024647755,0.0006287294,0.00032853746,0.000187799,0.0003208777],"domain_scores_gemma":[0.9984072,0.000687966,0.00007899791,0.0001582376,0.00016312441,0.0005045061],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002874162,0.000195293,0.00043933373,0.00007835233,0.00017717684,0.000012989335,0.000080262726,0.0003153436,0.00062296726],"category_scores_gemma":[0.000049899114,0.00015325261,0.00021797168,0.00008989835,0.00020157875,0.000045990848,0.000017918828,0.00073142676,0.00011412924],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001970378,0.001523382,0.9847479,0.000087660264,0.0020211635,0.00024724434,0.002545071,0.0000043264668,0.0007462696,0.0007504482,0.0043712417,0.0009849144],"study_design_scores_gemma":[0.021346178,0.0035700018,0.9406782,0.00039864334,0.0065229763,0.000120460674,0.00011895409,0.00030780007,0.0057914667,0.0010634155,0.019472554,0.00060937484],"about_ca_topic_score_codex":0.000011797211,"about_ca_topic_score_gemma":0.0000034523014,"teacher_disagreement_score":0.2070416,"about_ca_system_score_codex":0.000034173016,"about_ca_system_score_gemma":0.00014053029,"threshold_uncertainty_score":0.6821055},"labels":[],"label_agreement":null},{"id":"W2095161324","doi":"10.1038/clpt.2011.328","title":"Anti-TNF Monoclonal Antibodies in Inflammatory Bowel Disease: Pharmacokinetics-Based Dosing Paradigms","year":2012,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":503,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Ulcerative colitis; Monoclonal antibody; Inflammatory bowel disease; Pharmacokinetics; Immunogenicity; Immunology; Crohn's disease; Dosing; Immune system; Disease; Concomitant; Antibody; Inflammation; Tumor necrosis factor alpha; Internal medicine; Pharmacology","score_opus":0.09053051746378393,"score_gpt":0.42431111061237775,"score_spread":0.3337805931485938,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2095161324","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.027634418,0.9663223,0.000049160768,0.00020701891,0.0036758368,0.0016667239,0.00026317572,0.00008482079,0.000096554766],"genre_scores_gemma":[0.0051395893,0.98058,0.00017288724,0.009095104,0.0034991242,0.0002923063,0.00083303615,0.00026374115,0.00012425103],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9928245,0.0020141348,0.0022416275,0.0012976857,0.0003544332,0.001267595],"domain_scores_gemma":[0.9967853,0.00039689688,0.00094920467,0.00093092246,0.000150278,0.0007874047],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0012720989,0.0011779725,0.0017775176,0.00029062422,0.00019535839,0.00006484414,0.0011285173,0.0012823967,0.00020004733],"category_scores_gemma":[0.000041195995,0.0011237768,0.0014467166,0.00020479358,0.0010989371,0.000018234545,0.00041447888,0.0015097131,0.00020046372],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004776445,0.008223989,0.19142021,0.03473423,0.011567353,0.0043510087,0.00009661223,0.0011728122,0.0026199406,0.00007822064,0.022257363,0.71870184],"study_design_scores_gemma":[0.0023384774,0.00009158086,0.013135232,0.00078358006,0.0064196386,0.000012375028,0.0000030601188,0.00031227668,0.00009253455,0.000011984866,0.9756056,0.0011936582],"about_ca_topic_score_codex":8.2554084e-7,"about_ca_topic_score_gemma":0.0000023831988,"teacher_disagreement_score":0.9533482,"about_ca_system_score_codex":0.00012225944,"about_ca_system_score_gemma":0.0016036389,"threshold_uncertainty_score":0.99912125},"labels":[],"label_agreement":null},{"id":"W2095835387","doi":"10.1016/j.clpt.2004.12.165","title":"Impact of formulary policy on thiazolidinedione (TZD) use in the ontario drug benefit (ODB) program","year":2005,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmaceutical Practices and Patient Outcomes","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"St. Joseph’s Healthcare Hamilton; McMaster University; St. Joseph's Hospital","funders":"","keywords":"Formulary; Medicine; Reimbursement; Prior authorization; Pharmacy; Clinical pharmacology; Drug; Intensive care medicine; Pharmacology; Family medicine","score_opus":0.29668922440862244,"score_gpt":0.5518831633697046,"score_spread":0.2551939389610821,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2095835387","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9706007,0.00023548196,0.0000042320116,0.025755405,0.0004096048,0.0015129148,0.000013097928,0.000055174223,0.0014133715],"genre_scores_gemma":[0.89871514,0.0008129177,0.000395452,0.09865549,0.00086970296,0.0000485557,0.000022872813,0.00002921358,0.00045064552],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99730843,0.00038050627,0.0010275157,0.0003553023,0.00037503615,0.00055319327],"domain_scores_gemma":[0.9959679,0.0029283834,0.00032302015,0.00041855947,0.00012126544,0.0002408452],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010662382,0.00029910292,0.0006788248,0.00017479692,0.00007756739,0.000021967307,0.00035485465,0.00024784074,0.0003931487],"category_scores_gemma":[0.00008353095,0.0001803915,0.00057732593,0.00037270182,0.00031261178,0.00022651322,0.00007964081,0.0017112654,0.00006919],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0064711175,0.012172863,0.92439973,0.000035061938,0.0013255132,0.000050815124,0.0015520612,0.00024867026,0.0006202224,0.0001695197,0.0044581788,0.048496265],"study_design_scores_gemma":[0.010397575,0.0051976,0.7376494,0.000047420326,0.0012782154,0.000044861248,0.00005126494,0.0048052724,0.00063888443,0.00021890795,0.23938824,0.00028236967],"about_ca_topic_score_codex":0.0012392814,"about_ca_topic_score_gemma":0.0008968454,"teacher_disagreement_score":0.23493007,"about_ca_system_score_codex":0.00029352595,"about_ca_system_score_gemma":0.00050456135,"threshold_uncertainty_score":0.7434692},"labels":[],"label_agreement":null},{"id":"W2097851755","doi":"10.1038/clpt.2013.114","title":"CYP2A6 Genotype but not Age Determines Cotinine Half-Life in Infants and Children","year":2013,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Synthesis and Biological Evaluation","field":"Chemistry","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"Canadian Institutes of Health Research; National Institute on Drug Abuse; U.S. Public Health Service","keywords":"CYP2A6; Cotinine; Genotype; Medicine; Pediatrics; Biology; Genetics; Nicotine; Internal medicine; Gene; Metabolism","score_opus":0.11882131918336536,"score_gpt":0.4010143497930177,"score_spread":0.28219303060965234,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2097851755","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951091,0.00053379283,0.000005914252,0.003286501,0.00031315262,0.00023623166,0.000011495242,0.000061429135,0.00044242336],"genre_scores_gemma":[0.966805,0.0013373211,0.00020805649,0.030695325,0.00065408106,0.000047500052,0.000024101677,0.000019980374,0.0002086368],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99810046,0.00022206752,0.0007666839,0.00043446533,0.00013079976,0.00034553595],"domain_scores_gemma":[0.9980634,0.0012978964,0.00020463059,0.0001900699,0.00007467894,0.0001693596],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00051752874,0.00021932776,0.00046726246,0.000036845926,0.00006632042,0.000029581544,0.00026434773,0.00044552155,0.0030160716],"category_scores_gemma":[0.0001717223,0.00016494356,0.000097571865,0.00007713278,0.00041252284,0.00006465186,0.00013370316,0.00045809784,0.0001538285],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004088846,0.00062289764,0.49710318,0.000019342138,0.00034248532,0.000014646802,0.00006676363,0.0000065249465,0.396509,0.0000054693182,0.001282341,0.10361846],"study_design_scores_gemma":[0.00348402,0.00020104006,0.9534278,0.000021127156,0.00032710965,0.000011929509,0.00002910141,0.0036405425,0.03403873,0.00028025644,0.004140073,0.00039826502],"about_ca_topic_score_codex":0.00005067993,"about_ca_topic_score_gemma":0.000013786677,"teacher_disagreement_score":0.45632464,"about_ca_system_score_codex":0.000019711646,"about_ca_system_score_gemma":0.000048264676,"threshold_uncertainty_score":0.9978953},"labels":[],"label_agreement":null},{"id":"W2098436801","doi":"10.1016/j.clpt.2004.10.011","title":"Implications of CYP2A6 Genetic Variation for Smoking Behaviors and Nicotine Dependence*","year":2005,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Nicotinic Acetylcholine Receptors Study","field":"Biochemistry, Genetics and Molecular Biology","cited_by":265,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"","keywords":"CYP2A6; Nicotine; Addiction; Context (archaeology); Nicotine dependence; Cotinine; Smoking cessation; Cigarette smoke; Abstinence; Pharmacology; Medicine; Psychology; Psychiatry; Biology; Cytochrome P450; Internal medicine; Environmental health","score_opus":0.11756665421989938,"score_gpt":0.48392796129094773,"score_spread":0.36636130707104836,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2098436801","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0033923567,0.9911195,0.0021215468,0.0002990734,0.0010040809,0.0018272063,0.00018329159,0.000021204452,0.00003175498],"genre_scores_gemma":[0.0012961832,0.99160045,0.0030485846,0.001638018,0.0016205141,0.000330436,0.00024927012,0.000095323194,0.00012123559],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9967927,0.00042305246,0.0015329667,0.000776154,0.0001082288,0.00036692942],"domain_scores_gemma":[0.99766445,0.000506065,0.0010029416,0.00048129368,0.00021514352,0.0001301285],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006850055,0.00042186552,0.0012457944,0.00008095253,0.00010653051,0.000011956161,0.00051873847,0.0009979468,0.000042708525],"category_scores_gemma":[0.000052050407,0.00038940733,0.0005939128,0.00013806079,0.00031818205,0.000003841707,0.0002706073,0.0004879091,0.0000043973655],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004919433,0.00064127584,0.0009308032,0.00064668816,0.0016173846,1.199174e-7,0.000021791957,0.000005292037,0.0020099927,0.00000964235,0.0018406586,0.99222714],"study_design_scores_gemma":[0.0011925636,0.00058718276,0.0004534708,0.00013895973,0.007891927,0.000023836896,0.0000049658465,0.00001813888,0.00032108554,0.000020006188,0.9889771,0.00037077867],"about_ca_topic_score_codex":0.0000017610192,"about_ca_topic_score_gemma":0.000005511169,"teacher_disagreement_score":0.9918564,"about_ca_system_score_codex":0.000037909325,"about_ca_system_score_gemma":0.00038961385,"threshold_uncertainty_score":0.99985576},"labels":[],"label_agreement":null},{"id":"W2099539451","doi":"10.1038/clpt.2012.179","title":"Epigenetics: A New Link Toward Understanding Human Disease and Drug Response","year":2012,"lang":"en","type":"editorial","venue":"Clinical Pharmacology & Therapeutics","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Epigenomics; Epigenetics; Clinical pharmacology; Human disease; Computational biology; Drug response; Human health; Genomics; Phenotype; Biology; Drug; Pharmacology; Genetics; Gene; Medicine; Genome; Gene expression; DNA methylation","score_opus":0.12100400323660812,"score_gpt":0.4349502218091449,"score_spread":0.3139462185725368,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2099539451","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.10803652,0.06290327,0.0038572242,0.006856972,0.8167569,0.0010867212,0.0002761991,0.00008222273,0.00014395035],"genre_scores_gemma":[0.08659987,0.03737654,0.0004795733,0.0041039526,0.86759925,0.000036167225,0.0008509313,0.00020928393,0.0027444388],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9957832,0.0013192318,0.00094496214,0.0009433587,0.0003666687,0.0006425934],"domain_scores_gemma":[0.9967456,0.0012246419,0.00047676687,0.0005657235,0.0001787392,0.00080853136],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0019644324,0.0005546542,0.00062191923,0.00010658486,0.00023976198,0.0000673941,0.0004805748,0.0016066829,0.000084642714],"category_scores_gemma":[0.00025859603,0.0005623352,0.00033576868,0.000090294256,0.0005743261,0.000006175878,0.00041008933,0.0011747428,0.000022420576],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003301756,0.00026221588,0.0019142951,0.0000833389,0.001216202,0.000015466776,0.00016825931,0.000015791726,0.075036585,0.0000084788935,0.9161563,0.0018213289],"study_design_scores_gemma":[0.002317181,0.0006597267,0.00091173063,0.000030614734,0.001870603,4.4434074e-7,0.000035357058,0.000020003285,0.004653283,0.0012150591,0.98764586,0.00064014964],"about_ca_topic_score_codex":0.000008277457,"about_ca_topic_score_gemma":0.000011470327,"teacher_disagreement_score":0.071489565,"about_ca_system_score_codex":0.0000934819,"about_ca_system_score_gemma":0.0008795485,"threshold_uncertainty_score":0.99968946},"labels":[],"label_agreement":null},{"id":"W2100464321","doi":"10.1038/clpt.2011.212","title":"StaR Child Health: Developing Evidence-Based Guidance for the Design, Conduct, and Reporting of Pediatric Trials","year":2011,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's Hospital Research Institute of Manitoba; Health Sciences Centre; Winnipeg Regional Health Authority; University of Alberta","funders":"","keywords":"Pediatric research; Star (game theory); MEDLINE; Medicine; Pediatrics; Political science","score_opus":0.8890412768937818,"score_gpt":0.6229892954052657,"score_spread":0.26605198148851605,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2100464321","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.20838082,0.27736747,0.06361792,0.43526426,0.0056679626,0.009328648,0.00003530016,0.00016733237,0.00017028184],"genre_scores_gemma":[0.5710387,0.11275665,0.046641603,0.26717824,0.0020919908,0.0002105468,0.0000027422802,0.00004670226,0.00003280115],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99456555,0.001372121,0.0031657084,0.00035203758,0.00017019958,0.00037439904],"domain_scores_gemma":[0.96867317,0.026808374,0.0037751049,0.00021764393,0.00034890504,0.00017680581],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.019390345,0.00019622898,0.0012074942,0.00004252833,0.00031713877,0.000008248634,0.00017824229,0.00013774226,0.000091907576],"category_scores_gemma":[0.005354063,0.00011632091,0.00026347017,0.00019214765,0.0004316967,0.000083689265,0.00007364446,0.0005159146,0.0000022948414],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.09205517,0.0052644927,0.34777245,0.005918819,0.022235474,0.00016526194,0.0047209803,0.000064222266,0.013390045,0.0005860222,0.11288474,0.3949423],"study_design_scores_gemma":[0.03253465,0.016448984,0.2151043,0.001031558,0.033922028,0.00013345342,0.00083697424,0.010390624,0.06533295,0.0017914613,0.62115,0.0013229819],"about_ca_topic_score_codex":0.0000133892045,"about_ca_topic_score_gemma":0.0000014226911,"teacher_disagreement_score":0.5082653,"about_ca_system_score_codex":0.00003555753,"about_ca_system_score_gemma":0.0005501165,"threshold_uncertainty_score":0.6720345},"labels":[],"label_agreement":null},{"id":"W2100964614","doi":"10.1067/mcp.2000.107507","title":"Quetiapine fumarate overdose: Clinical and pharmacokinetic lessons from extreme conditions","year":2000,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Poisoning and overdose treatments","field":"Medicine","cited_by":70,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Quetiapine; Drug overdose; Medicine; Pharmacokinetics; Clinical pharmacology; Atypical antipsychotic; Clozapine; Pharmacology; Antipsychotic; Antipsychotic Agent; Anesthesia; Poison control; Emergency medicine; Psychiatry; Schizophrenia (object-oriented programming)","score_opus":0.20610934837080574,"score_gpt":0.5020234828529074,"score_spread":0.2959141344821017,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2100964614","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9639914,0.0032259838,0.000032649248,0.028779203,0.0012939266,0.00052264216,0.0001329472,0.00021319925,0.0018080585],"genre_scores_gemma":[0.8830321,0.01783837,0.00049683853,0.0918702,0.0014930777,0.000037655467,0.00014178327,0.00006276313,0.005027213],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967082,0.0006524587,0.0011344784,0.000768036,0.0002160678,0.00052074745],"domain_scores_gemma":[0.99745995,0.0013078239,0.00018027134,0.0003886191,0.000094618685,0.00056869275],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00048089318,0.00037306384,0.0008979916,0.00006610329,0.00020172706,0.000025345533,0.00018992096,0.00043366873,0.007476842],"category_scores_gemma":[0.000025510757,0.00032059246,0.0003367264,0.00018051213,0.0011899282,0.00008900106,0.00006795474,0.0010442421,0.0007124857],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006470147,0.009113415,0.5459735,0.000049957187,0.009751958,0.0010005975,0.0003159781,0.00003142653,0.0117030535,0.00007819922,0.14445366,0.27105814],"study_design_scores_gemma":[0.02546944,0.0015017235,0.6094256,0.000089004294,0.0070207175,0.00009515374,0.000024363319,0.0033585487,0.0011032877,0.0007549717,0.3506774,0.0004798214],"about_ca_topic_score_codex":0.000028832004,"about_ca_topic_score_gemma":0.0000042621227,"teacher_disagreement_score":0.27057832,"about_ca_system_score_codex":0.000043335767,"about_ca_system_score_gemma":0.00018491772,"threshold_uncertainty_score":0.9999246},"labels":[],"label_agreement":null},{"id":"W2101566038","doi":"10.1038/clpt.2009.19","title":"Association of Nicotine Metabolite Ratio and CYP2A6 Genotype With Smoking Cessation Treatment in African-American Light Smokers","year":2009,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Smoking Behavior and Cessation","field":"Medicine","cited_by":168,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Addiction and Mental Health; University of Toronto","funders":"National Cancer Institute; Canadian Institutes of Health Research; National Institute on Drug Abuse; U.S. Public Health Service","keywords":"CYP2A6; Cotinine; Odds ratio; Nicotine; Confidence interval; Smoking cessation; Genotype; Medicine; Quartile; Internal medicine; Pharmacogenetics; Pharmacology; Physiology; Genetics; Biology; CYP1A2; Cytochrome P450; Pathology; Metabolism","score_opus":0.04995220118061289,"score_gpt":0.3952817783533171,"score_spread":0.34532957717270424,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2101566038","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9874141,0.00023472118,0.00008696654,0.01143183,0.00022196145,0.00038211572,0.000004540792,0.000034181612,0.00018956272],"genre_scores_gemma":[0.9925587,0.0011273549,0.00016669708,0.0057969857,0.00017373373,0.000016392069,0.000026857977,0.000014375465,0.000118861884],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985251,0.00024390998,0.0005351448,0.00026615316,0.00021379182,0.00021592712],"domain_scores_gemma":[0.9989346,0.00028039084,0.00043235187,0.00013255753,0.00014071057,0.00007939229],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005195392,0.00015720759,0.0005018132,0.00012437107,0.000043190073,0.000009009031,0.000051985786,0.00014926812,0.00003531766],"category_scores_gemma":[0.000017462131,0.0001222598,0.00007112879,0.00033598262,0.00011934322,0.00006442344,0.000008223662,0.0002649023,6.159956e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00077040464,0.00083599397,0.9512784,0.0000062489344,0.00044636303,0.0000062551453,0.00080117694,0.000022332639,0.014553953,0.000014043051,0.00007496465,0.031189892],"study_design_scores_gemma":[0.0053615,0.0023310124,0.9697396,0.000014237005,0.0025952652,0.000003978476,0.00019069132,0.00020763761,0.016018039,0.000037351256,0.003381431,0.00011922403],"about_ca_topic_score_codex":0.000033529617,"about_ca_topic_score_gemma":0.000015618323,"teacher_disagreement_score":0.031070668,"about_ca_system_score_codex":0.00022518387,"about_ca_system_score_gemma":0.00011695774,"threshold_uncertainty_score":0.49856097},"labels":[],"label_agreement":null},{"id":"W2101785485","doi":"10.1016/j.clpt.2003.11.313","title":"Drug-disease interaction:effect of rheumatoid arthritis (RA) on the pharmacodynamics (PD) and pharmacokinetics (PK) of AT1 receptor antagonists","year":2004,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Receptor Mechanisms and Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Active metabolite; Rheumatoid arthritis; Pharmacokinetics; Pharmacology; Medicine; Losartan; Downregulation and upregulation; Pharmacodynamics; Valsartan; Angiotensin II receptor type 1; Arthritis; Metabolite; Internal medicine; Receptor; Endocrinology; Angiotensin II; Blood pressure; Chemistry","score_opus":0.02375094706231464,"score_gpt":0.3514826693637446,"score_spread":0.32773172230143,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2101785485","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9910415,0.0030332338,0.00043942826,0.0027656911,0.002026677,0.00053118507,0.00008069175,0.000018548131,0.00006307687],"genre_scores_gemma":[0.95139116,0.04154765,0.00023517675,0.006274896,0.00039048513,0.000034418244,0.00004727923,0.000045516408,0.000033412733],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9976656,0.0005712985,0.000797522,0.00045797485,0.00020290297,0.00030471926],"domain_scores_gemma":[0.99845725,0.00046742638,0.00043325862,0.00029854005,0.00015200232,0.0001915063],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00088213006,0.000308713,0.00047213899,0.00005380479,0.00012588002,0.000014514616,0.00034703797,0.00018837514,0.00020480291],"category_scores_gemma":[0.00004711884,0.00023629343,0.00029490495,0.00011779188,0.00060350803,0.000008307126,0.0001475001,0.00045497948,0.000009801336],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027341046,0.0004857039,0.0009836934,0.000051806997,0.00069865905,0.0000067800433,0.00007744095,0.0007664743,0.98468274,0.000105791834,0.0024677452,0.006939086],"study_design_scores_gemma":[0.0043141167,0.0014511257,0.00013112045,0.00007908629,0.00020900807,0.0000105543595,0.000045960765,0.00059070234,0.9622561,0.0001352018,0.030530207,0.0002468484],"about_ca_topic_score_codex":0.000004415007,"about_ca_topic_score_gemma":0.0000015976265,"teacher_disagreement_score":0.039650302,"about_ca_system_score_codex":0.000021898391,"about_ca_system_score_gemma":0.00012175526,"threshold_uncertainty_score":0.9635766},"labels":[],"label_agreement":null},{"id":"W2103438776","doi":"10.1038/clpt.2010.3","title":"Genetic Variation in Nicotine Metabolism Predicts the Efficacy of Extended-Duration Transdermal Nicotine Therapy","year":2010,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Nicotinic Acetylcholine Receptors Study","field":"Biochemistry, Genetics and Molecular Biology","cited_by":107,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"National Cancer Institute; National Institute on Drug Abuse; Canadian Institutes of Health Research","keywords":"Nicotine; Transdermal; Pharmacology; Medicine; Duration (music); Internal medicine","score_opus":0.029506908108715247,"score_gpt":0.3638098091640545,"score_spread":0.3343029010553392,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2103438776","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99144536,0.00143586,0.00085461047,0.002564335,0.0026548614,0.0009213991,0.000015677962,0.000026028007,0.000081875805],"genre_scores_gemma":[0.98764724,0.003544609,0.00095759163,0.005730522,0.0019092099,0.000056510846,0.00003503356,0.000050010913,0.00006928331],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9968248,0.0007469448,0.0012457755,0.0005535531,0.00022560458,0.00040330374],"domain_scores_gemma":[0.9982813,0.00042461068,0.0004471206,0.0005531512,0.0001933319,0.00010046187],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012662815,0.0002948034,0.0004455915,0.000064060245,0.0000937594,0.000013188173,0.00063443976,0.00049799454,0.00014663809],"category_scores_gemma":[0.00010134283,0.00022122482,0.000268733,0.00024350442,0.0005035145,0.000009537806,0.00010973212,0.0008875674,0.000011193696],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008621068,0.0017070426,0.014118082,0.0000063207985,0.00046569094,3.613554e-7,0.0002344626,0.00013778762,0.9702468,0.000022227792,0.0005945154,0.011604597],"study_design_scores_gemma":[0.012012205,0.0009176061,0.5281513,0.000005988791,0.0004874708,0.00001598435,0.000032915228,0.0014593404,0.40845263,0.00007285024,0.0480335,0.00035822068],"about_ca_topic_score_codex":0.0000110921455,"about_ca_topic_score_gemma":0.000050859457,"teacher_disagreement_score":0.56179416,"about_ca_system_score_codex":0.000009035096,"about_ca_system_score_gemma":0.00021451483,"threshold_uncertainty_score":0.90212864},"labels":[],"label_agreement":null},{"id":"W2103510620","doi":"10.1038/clpt.2008.51","title":"Lazarus's Gate: Challenges and Potential of Epigenetic Reprogramming of Somatic Cells","year":2008,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Pluripotent Stem Cells Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Reprogramming; Somatic cell nuclear transfer; Somatic cell; Epigenetics; Induced pluripotent stem cell; Biology; Cell biology; Biotechnology; Genetics; Cell; Embryonic stem cell; Embryo; Blastocyst; Gene; Embryogenesis","score_opus":0.14188711957956865,"score_gpt":0.4420112161389818,"score_spread":0.3001240965594132,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2103510620","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0038945153,0.9942496,0.000061285304,0.00008125631,0.0006717696,0.0009044822,0.000036365593,0.000011688531,0.00008905179],"genre_scores_gemma":[0.0013577681,0.99713594,0.00050245906,0.00021508033,0.0004288322,0.000049719732,0.000057104895,0.00008333117,0.00016975013],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9956043,0.0012229481,0.0016401757,0.0008013503,0.00026016354,0.00047106383],"domain_scores_gemma":[0.99766845,0.00038807382,0.0009366266,0.0006427864,0.0001856333,0.00017842227],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007191962,0.0004474638,0.0019206482,0.00012602792,0.000055360644,0.0000055145274,0.00063712936,0.0010443577,0.000029915771],"category_scores_gemma":[0.000028893734,0.0003890941,0.00077388773,0.00011547961,0.0012054304,0.000002775683,0.00049307477,0.00059439475,0.000012873009],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010356585,0.00069109316,0.000010485956,0.008369801,0.0025441302,0.000038974118,0.0000317913,0.000006498592,0.017156722,0.0000013739532,0.00044188034,0.9706037],"study_design_scores_gemma":[0.0011249839,0.0013095089,0.000041485087,0.0007780891,0.0026038326,0.0001091551,0.000022671522,0.00003854771,0.009977187,0.000020765596,0.9835376,0.0004361418],"about_ca_topic_score_codex":0.0000013463974,"about_ca_topic_score_gemma":7.56e-7,"teacher_disagreement_score":0.98309577,"about_ca_system_score_codex":0.000013938718,"about_ca_system_score_gemma":0.00037082363,"threshold_uncertainty_score":0.9998561},"labels":[],"label_agreement":null},{"id":"W2104356666","doi":"10.1016/s0009-9236(03)90423-1","title":"Induction of the MRP3 transporter by activators of the pregnane X receptor","year":2003,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Hormonal Regulation and Hypertension","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Pregnane X receptor; Transporter; Pharmacology; Clinical pharmacology; Receptor; Chemistry; Medicine; Nuclear receptor; Internal medicine; Biochemistry; Transcription factor; Gene","score_opus":0.07615868952795583,"score_gpt":0.3804708564681049,"score_spread":0.30431216694014906,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2104356666","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98666376,0.00041831823,0.000026006097,0.010720578,0.0014202722,0.00038210224,0.000006833261,0.000010354198,0.0003517792],"genre_scores_gemma":[0.98577434,0.00042667368,0.00005313473,0.01286662,0.00008886657,0.000004550871,0.0000024326623,0.00001389469,0.00076946866],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987085,0.00032689344,0.0004972817,0.00014671386,0.0001998413,0.00012077168],"domain_scores_gemma":[0.99912196,0.00022161297,0.00023802837,0.0002289508,0.00013268685,0.00005676772],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033335062,0.000096759526,0.00029223965,0.00001824567,0.000054903066,0.0000010276834,0.00012558752,0.00021091425,0.0003628593],"category_scores_gemma":[0.00003495605,0.00004993995,0.00024246548,0.00018359788,0.00050768396,0.000024074541,0.000013514293,0.0003968136,0.0000040284826],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005097441,0.0009784595,0.045100573,0.000023628054,0.00049953733,6.134487e-7,0.00020900331,0.0000049152745,0.92845726,0.00007755349,0.014078631,0.01006011],"study_design_scores_gemma":[0.0029260907,0.0003443315,0.15043376,0.00005205477,0.0010563727,0.00001291998,0.00007900583,0.000047825124,0.5021316,0.00009195331,0.3427411,0.00008296518],"about_ca_topic_score_codex":0.00000149813,"about_ca_topic_score_gemma":4.868024e-7,"teacher_disagreement_score":0.42632562,"about_ca_system_score_codex":0.00002279811,"about_ca_system_score_gemma":0.00014599891,"threshold_uncertainty_score":0.3973055},"labels":[],"label_agreement":null},{"id":"W2104497498","doi":"10.1016/s0009-9236(03)90424-3","title":"Organic cation transport in the human mammary gland","year":2003,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Mammary gland; Chemistry; Pharmacology; Medicine; Internal medicine; Cancer","score_opus":0.035462801144672054,"score_gpt":0.37332007933238254,"score_spread":0.3378572781877105,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2104497498","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944929,0.001712844,0.00028226554,0.001431894,0.00048094508,0.0002732002,0.0000015481255,0.000012359604,0.0013120507],"genre_scores_gemma":[0.9815008,0.0015200174,0.00007201326,0.01641417,0.00020731818,0.000019855195,0.000044465804,0.000017006776,0.00020431963],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9985138,0.0005987935,0.00032813134,0.00026358775,0.00007329597,0.00022238893],"domain_scores_gemma":[0.9995316,0.00007698557,0.00007113971,0.00023857511,0.00003124214,0.00005041954],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00073716586,0.00013088516,0.00014814764,0.000023732824,0.0000878144,0.000006855623,0.0002776279,0.00034216323,0.00003397323],"category_scores_gemma":[0.000008076624,0.00009457816,0.000107944914,0.000116377065,0.00015203202,0.0000031213315,0.000015780353,0.00040842546,0.00001682994],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000121007506,0.0009140806,0.08167725,0.0000116775645,0.000427128,0.000053364118,0.0001994891,0.00001728458,0.90992403,0.00023692603,0.0052332953,0.0011844531],"study_design_scores_gemma":[0.010993553,0.002766175,0.15237994,0.000014963145,0.0011050457,0.00020546657,0.00018163904,0.00009480656,0.31621474,0.0011833342,0.5139783,0.00088205247],"about_ca_topic_score_codex":0.0000013730362,"about_ca_topic_score_gemma":0.0000061282344,"teacher_disagreement_score":0.5937093,"about_ca_system_score_codex":0.0000083910045,"about_ca_system_score_gemma":0.00008397048,"threshold_uncertainty_score":0.38567853},"labels":[],"label_agreement":null},{"id":"W2105940326","doi":"10.1038/clpt.2010.340","title":"Pharmacogenomics at the Tipping Point: Challenges and Opportunities","year":2011,"lang":"en","type":"editorial","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Addiction and Mental Health; University of Toronto","funders":"National Institute of General Medical Sciences; National Institute on Drug Abuse; National Heart, Lung, and Blood Institute; National Institutes of Health; U.S. Department of Health and Human Services","keywords":"Pharmacogenomics; Citation; Clinical pharmacology; Library science; Addiction; Medicine; Psychology; Psychiatry; Pharmacology; Computer science","score_opus":0.46675862260967427,"score_gpt":0.5089552714008087,"score_spread":0.042196648791134383,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2105940326","genre_codex":"editorial","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0066096047,0.23584783,0.000012417838,0.013766654,0.73306763,0.0013456998,0.00090316,0.0002702218,0.008176784],"genre_scores_gemma":[0.00084267615,0.55442804,0.000042798532,0.058282916,0.3803036,0.00021691744,0.00020842814,0.00024975892,0.0054248464],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.98807424,0.0050924337,0.0024075177,0.0018667415,0.0007181223,0.0018409354],"domain_scores_gemma":[0.9852134,0.010525719,0.0015029308,0.00094751414,0.000676507,0.0011339358],"candidate_categories":["metaepi_narrow","sts","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","research_integrity"],"category_scores_codex":[0.0065960684,0.001590457,0.0020597407,0.00029254353,0.0012371062,0.00007431428,0.0022035814,0.0043200683,0.0037375453],"category_scores_gemma":[0.00013961432,0.001283494,0.00083801034,0.00015922857,0.004122387,0.00018567474,0.0020417569,0.008554121,0.0006349535],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015359002,0.0007039622,0.00003147645,0.00019336923,0.00507331,0.00019745804,0.0014979718,0.000013410447,0.002467839,0.000083834966,0.8570408,0.13116066],"study_design_scores_gemma":[0.005363992,0.0003515112,0.000050740244,0.00003537324,0.009734982,0.000054569668,0.0001918087,0.00037641454,0.0028646719,0.00069426507,0.9789563,0.0013253739],"about_ca_topic_score_codex":0.000010370856,"about_ca_topic_score_gemma":0.000023335482,"teacher_disagreement_score":0.35276404,"about_ca_system_score_codex":0.00022883299,"about_ca_system_score_gemma":0.00088337384,"threshold_uncertainty_score":0.99968433},"labels":[],"label_agreement":null},{"id":"W2106499597","doi":"10.1038/clpt.2011.20","title":"Evaluation of the Abuse Potential of Lorcaserin, a Serotonin 2C (5-HT2C) Receptor Agonist, in Recreational Polydrug Users","year":2011,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacology and Obesity Treatment","field":"Medicine","cited_by":63,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Zolpidem; Placebo; Pharmacology; Agonist; Ketamine; Crossover study; Medicine; Psychology; Anesthesia; Internal medicine; Receptor; Insomnia","score_opus":0.19277405444319573,"score_gpt":0.43768074783623734,"score_spread":0.2449066933930416,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2106499597","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943011,0.0008069809,0.000017076502,0.0016416704,0.001405078,0.0012310687,0.000024624802,0.000019111527,0.00055333413],"genre_scores_gemma":[0.99075943,0.0011224854,0.0005364581,0.0071481764,0.0001623984,0.000085041254,0.000017243745,0.000019641562,0.00014913997],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9968179,0.0013266591,0.0008740784,0.00029599335,0.00043586417,0.00024951482],"domain_scores_gemma":[0.99845177,0.0003001719,0.00040428116,0.00027588318,0.00046169144,0.000106199055],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0021885752,0.00018237955,0.00048641275,0.00009675984,0.000063869025,0.0000015986864,0.0002432762,0.00029233363,0.0013359892],"category_scores_gemma":[0.000036964433,0.00013603696,0.00027755584,0.00024394097,0.00075113215,0.000057354868,0.00006132145,0.0005142336,0.000024809557],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018786145,0.023084084,0.6246578,0.00017089555,0.009336551,0.00007324344,0.0062517016,0.0005010421,0.28640828,0.0001262732,0.0054984577,0.025105517],"study_design_scores_gemma":[0.01935364,0.0014084633,0.71935576,0.0001050707,0.010567748,0.00002250823,0.00020981819,0.0034648888,0.24178207,0.00036494053,0.0031473686,0.00021770042],"about_ca_topic_score_codex":0.000029659655,"about_ca_topic_score_gemma":0.000022700713,"teacher_disagreement_score":0.094697975,"about_ca_system_score_codex":0.00014792744,"about_ca_system_score_gemma":0.00062950456,"threshold_uncertainty_score":0.9995769},"labels":[],"label_agreement":null},{"id":"W2107194313","doi":"10.1067/mcp.2000.104610","title":"Venous neuropeptide Y receptor responsiveness in patients with chronic heart failure","year":2000,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Neuropeptides and Animal Physiology","field":"Neuroscience","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"","keywords":"Neuropeptide Y receptor; Internal medicine; Ejection fraction; Medicine; Heart failure; Neuropeptide; Endocrinology; Norepinephrine; Venous blood; Cardiology; Receptor; Dopamine","score_opus":0.044431932608536805,"score_gpt":0.34557983647349294,"score_spread":0.30114790386495616,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2107194313","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959773,0.000040162748,6.878051e-7,0.0025867848,0.0005989776,0.0005178457,0.000018744133,0.0000931218,0.0001663992],"genre_scores_gemma":[0.91943747,0.00030397647,0.00006594783,0.07937857,0.000392494,0.000023210587,0.000004789323,0.00006330144,0.00033027126],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9964539,0.0013268963,0.00058424956,0.0008114912,0.00019094127,0.0006325175],"domain_scores_gemma":[0.9983796,0.0009572861,0.00012434863,0.0003205557,0.000059533082,0.00015866116],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00020056462,0.00028433133,0.0004922986,0.00007373785,0.00015077757,0.000023484889,0.00049506064,0.00015942172,0.0014169265],"category_scores_gemma":[0.00003125526,0.00022948929,0.000121258614,0.00039176331,0.00067821424,0.00013690222,0.000087966924,0.00092038076,0.0010292844],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010877612,0.004213325,0.041071426,0.000025625743,0.00007394515,0.00012907015,0.00007872786,0.0007913539,0.91387624,0.000028759267,0.010845113,0.017988835],"study_design_scores_gemma":[0.0062471195,0.0084585585,0.23297131,0.00003078157,0.00009299045,0.000009923953,0.0000041214103,0.00009423792,0.029513892,0.00005551026,0.7220546,0.00046698068],"about_ca_topic_score_codex":0.0000032594355,"about_ca_topic_score_gemma":0.0000054529414,"teacher_disagreement_score":0.88436234,"about_ca_system_score_codex":0.00005860879,"about_ca_system_score_gemma":0.00014968049,"threshold_uncertainty_score":0.9997485},"labels":[],"label_agreement":null},{"id":"W2109007642","doi":"10.1038/clpt.2009.211","title":"Can We Afford It?: Ethical Consideration of Expensive Drug Treatment for Neonates and Infants","year":2009,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; Hospital for Sick Children; SickKids Foundation","funders":"","keywords":"Charter; Clinical pharmacology; Health care; Drug; Medicine; Law and economics; Intensive care medicine; Psychology; Engineering ethics; Law; Political science; Pharmacology; Economics","score_opus":0.24045810408401275,"score_gpt":0.5321726234636605,"score_spread":0.2917145193796477,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2109007642","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.47682574,0.004507793,0.00005108689,0.5168009,0.0005460115,0.0009180999,0.000025125217,0.00003102753,0.00029426455],"genre_scores_gemma":[0.77119404,0.02601153,0.0007171472,0.20156658,0.00032816036,0.000026507525,0.000009506552,0.000010707626,0.00013581915],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99847686,0.00023820838,0.0005983957,0.00029616125,0.00011766227,0.0002727136],"domain_scores_gemma":[0.9949598,0.0043089464,0.00020709923,0.00011153301,0.0002147831,0.00019789253],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045380433,0.00018815795,0.00060167216,0.00003430052,0.00013415792,0.000009583984,0.000055696753,0.0002747866,0.00009860328],"category_scores_gemma":[0.000118799515,0.00013873453,0.00015493971,0.000062342464,0.0004509351,0.000038233382,0.000027839076,0.00047847265,0.0000039626793],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03523096,0.0059826914,0.017148213,0.00026604882,0.008256368,0.00016563183,0.0076077757,0.000022651799,0.070694625,0.0014119147,0.079738945,0.77347416],"study_design_scores_gemma":[0.02681058,0.012724175,0.008806965,0.00009025905,0.007153636,0.00008071057,0.001156411,0.00371596,0.06580405,0.008181244,0.8649989,0.00047712855],"about_ca_topic_score_codex":0.000007236712,"about_ca_topic_score_gemma":0.000022456572,"teacher_disagreement_score":0.78525996,"about_ca_system_score_codex":0.000037694826,"about_ca_system_score_gemma":0.00012637168,"threshold_uncertainty_score":0.56574297},"labels":[],"label_agreement":null},{"id":"W2111819588","doi":"10.1038/clpt.2011.79","title":"Phenotype Standardization for Immune-Mediated Drug-Induced Skin Injury","year":2011,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Drug-Induced Adverse Reactions","field":"Medicine","cited_by":110,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University of British Columbia","funders":"Wellcome Trust","keywords":"Toxic epidermal necrolysis; Acute generalized exanthematous pustulosis; Pharmacogenomics; Medicine; Drug; Biopharmaceutics; Clinical pharmacology; Dermatology; Intensive care medicine; Immunology; Pharmacology; Bioinformatics; Biology; Genetics","score_opus":0.23693289434562287,"score_gpt":0.5141582324764793,"score_spread":0.2772253381308564,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2111819588","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00008640312,0.977994,0.0005760886,0.0008480458,0.011658989,0.0058431895,0.00046136617,0.00041433636,0.0021175754],"genre_scores_gemma":[0.00014839359,0.98514277,0.0005681201,0.00888185,0.002606505,0.0005035469,0.0009391118,0.0003045676,0.00090513815],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9946389,0.0008292315,0.002489164,0.000988516,0.00027863594,0.0007755046],"domain_scores_gemma":[0.99439913,0.002518363,0.0013169845,0.00080161064,0.000598645,0.00036528753],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0014034216,0.0008356129,0.003644878,0.00038388715,0.00021325434,0.00002145376,0.0004910382,0.0015899657,0.00016439456],"category_scores_gemma":[0.00018436454,0.0007069815,0.0019187601,0.00061997405,0.00037685994,0.000105346146,0.0001513141,0.0023159538,0.00060697517],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019375997,0.0011420813,0.000004181671,0.0025320249,0.004773293,0.00001561053,0.00007220145,1.9484767e-7,0.00019789828,0.000034868524,0.0045194845,0.9865144],"study_design_scores_gemma":[0.0028461788,0.0003226743,0.000041360923,0.0011950823,0.023513127,0.000028161203,0.000021429432,0.00002716738,0.00010551771,0.000044903187,0.9712818,0.0005725796],"about_ca_topic_score_codex":0.000005296448,"about_ca_topic_score_gemma":0.0000021997641,"teacher_disagreement_score":0.9859418,"about_ca_system_score_codex":0.00046106192,"about_ca_system_score_gemma":0.0021979874,"threshold_uncertainty_score":0.99998575},"labels":[],"label_agreement":null},{"id":"W2112547742","doi":"10.1067/mcp.2000.110774","title":"Grapefruit-felodipine interaction: Effect of unprocessed fruit and probable active ingredients","year":2000,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":162,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; London Health Sciences Centre","funders":"","keywords":"Grapefruit juice; Naringin; Felodipine; Naringenin; Chemistry; Pharmacology; Furanocoumarin; Citrus paradisi; CYP3A4; Drug interaction; Pharmacokinetics; Food science; Flavonoid; Rutaceae; Chromatography; Biochemistry; Botany; Cytochrome P450; Medicine; Metabolism; Biology","score_opus":0.15016354409023558,"score_gpt":0.5123970513687449,"score_spread":0.36223350727850934,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2112547742","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9838666,0.0032296134,0.000017248432,0.0020496321,0.0045128292,0.0011077741,0.00008760024,0.00013405886,0.004994695],"genre_scores_gemma":[0.95766526,0.0144748585,0.0001577506,0.025037086,0.0011387349,0.00014199191,0.000035874586,0.000071904855,0.0012765063],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99501675,0.0019031081,0.0012510722,0.00078227604,0.00026539876,0.00078140025],"domain_scores_gemma":[0.9964247,0.0020759485,0.0004650307,0.00029287805,0.00023402944,0.0005074193],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001689468,0.00055376126,0.0010738753,0.00017195077,0.0003124782,0.000022071998,0.0005770852,0.0007239363,0.0064672423],"category_scores_gemma":[0.00004262656,0.00048486792,0.0003094284,0.00047187385,0.0011780971,0.00020913003,0.0001697207,0.0018820813,0.00023905399],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014844782,0.0026810095,0.027450891,0.0003297721,0.004713691,0.000077347104,0.0011870133,0.00049086806,0.1317349,0.000047210397,0.012897177,0.80354536],"study_design_scores_gemma":[0.014038017,0.0018052778,0.006068921,0.000034346263,0.003941765,0.000054955966,0.000052032028,0.0031444295,0.2770573,0.0004003247,0.69276595,0.0006366841],"about_ca_topic_score_codex":0.0000057403763,"about_ca_topic_score_gemma":0.0000027624972,"teacher_disagreement_score":0.80290866,"about_ca_system_score_codex":0.000047413003,"about_ca_system_score_gemma":0.00013293535,"threshold_uncertainty_score":0.99976027},"labels":[],"label_agreement":null},{"id":"W2112841525","doi":"10.1016/s0009-9236(03)90696-5","title":"Digoxin‐carvedilol interactions in children","year":2003,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Digoxin; Carvedilol; Medicine; Pharmacology; Internal medicine; Cardiology; Heart failure","score_opus":0.20920861865490625,"score_gpt":0.527686402183443,"score_spread":0.31847778352853673,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2112841525","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95467263,0.002536285,0.00011823377,0.024894942,0.0026608745,0.0007887965,0.000008432912,0.00009964995,0.014220161],"genre_scores_gemma":[0.884498,0.0049171974,0.00033711767,0.1090976,0.0005444852,0.000037303216,0.0000067886426,0.000026098169,0.00053542457],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99783933,0.0005427442,0.0006645693,0.00037277804,0.00014670855,0.00043384993],"domain_scores_gemma":[0.99807775,0.0012743276,0.0001374223,0.0001911488,0.00007856547,0.00024079537],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00076715584,0.00019869531,0.00047457856,0.0000751993,0.00010990419,0.000013263433,0.00013187845,0.00013220239,0.0015277725],"category_scores_gemma":[0.000112449154,0.00016517205,0.00020837346,0.00027108146,0.00032006606,0.00010913061,0.00005854783,0.001313748,0.00026564495],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00077902235,0.0027936734,0.9620577,0.0000146642005,0.0018004369,0.000059872807,0.00009561465,0.0000069668095,0.0028260187,0.000151157,0.01329791,0.016116953],"study_design_scores_gemma":[0.0055698776,0.00032139473,0.2526189,0.00001513857,0.0013647127,0.00013734002,0.00006396387,0.00028084553,0.0017313457,0.00024980653,0.7374281,0.00021851764],"about_ca_topic_score_codex":0.000008186917,"about_ca_topic_score_gemma":0.000007305814,"teacher_disagreement_score":0.7241303,"about_ca_system_score_codex":0.00006900602,"about_ca_system_score_gemma":0.00010074984,"threshold_uncertainty_score":0.99938494},"labels":[],"label_agreement":null},{"id":"W2115647563","doi":"10.1038/clpt.2014.82","title":"Pharmacogenomics, Lipid Disorders, and Treatment Options","year":2014,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"Canadian Institutes of Health Research","keywords":"Pharmacogenomics; Clinical pharmacology; Pharmacodynamics; Pharmacology; Medicine; Bioinformatics; Pharmacogenetics; Adverse effect; Pharmacokinetics; Intensive care medicine; Biology; Gene; Genetics; Genotype","score_opus":0.15900569609211934,"score_gpt":0.4827303659860899,"score_spread":0.3237246698939706,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2115647563","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00012398743,0.9907002,0.000067277055,0.0026846149,0.0031474256,0.0028760512,0.00006682845,0.00010871379,0.0002249348],"genre_scores_gemma":[0.000011494238,0.9788252,0.0003421013,0.013927066,0.0056960057,0.00028282078,0.000168953,0.00013130104,0.0006150528],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99608815,0.0010988087,0.0012919303,0.0008108456,0.00018729418,0.0005229783],"domain_scores_gemma":[0.99785495,0.0005453529,0.00039152757,0.00062911224,0.000067268,0.00051180355],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010331634,0.00062663056,0.0035584415,0.00013654666,0.00019136607,0.000020006062,0.0001970956,0.0007854294,0.00019184093],"category_scores_gemma":[0.000010359159,0.0004525216,0.0019844233,0.00016343768,0.00048104822,0.000025377576,0.00011021301,0.0010333572,0.00019830378],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006953435,0.0006454059,0.00003330883,0.0021972707,0.006672689,0.0000137253965,0.000022446502,1.9459637e-7,0.0000015327056,0.000009892562,0.0032046519,0.98712933],"study_design_scores_gemma":[0.0033865767,0.0010942691,0.000025905694,0.0005039432,0.029908089,0.00013944489,0.000004066783,0.000044301913,0.0000011978906,0.000012981082,0.96452975,0.0003494535],"about_ca_topic_score_codex":0.000009994358,"about_ca_topic_score_gemma":0.0000046463265,"teacher_disagreement_score":0.98677987,"about_ca_system_score_codex":0.00021857096,"about_ca_system_score_gemma":0.0007272298,"threshold_uncertainty_score":0.99979264},"labels":[],"label_agreement":null},{"id":"W2116823219","doi":"10.1038/sj.clpt.6100073","title":"The Impact of UGT1A8, UGT1A9, and UGT2B7 Genetic Polymorphisms on the Pharmacokinetic Profile of Mycophenolic Acid After a Single Oral Dose in Healthy Volunteers","year":2007,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Renal Transplantation Outcomes and Treatments","field":"Medicine","cited_by":160,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Hôtel-Dieu de Québec; Centre hospitalier de l'Université Laval; Hôpital de l'Enfant-Jésus","funders":"Hydro-Québec; Canada Research Chairs; Canadian Institutes of Health Research; Université Laval","keywords":"UGT2B7; Mycophenolate; Pharmacokinetics; Mycophenolic acid; Pharmacology; Chemistry; Allele; Medicine; Glucuronidation; Internal medicine; Biochemistry; Enzyme; Gene; Microsome; Transplantation","score_opus":0.08041892493863081,"score_gpt":0.44067127996674765,"score_spread":0.3602523550281168,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2116823219","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.993471,0.0024386188,0.00002315682,0.002592979,0.0003458569,0.0009087194,0.000029670395,0.000012889559,0.00017711037],"genre_scores_gemma":[0.9886676,0.0022518039,0.00017909949,0.0086601265,0.000106924716,0.00003423689,0.0000056927383,0.000027329264,0.000067159606],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979026,0.00031016907,0.00091588043,0.00025653932,0.00020975582,0.00040506257],"domain_scores_gemma":[0.99783975,0.0014307867,0.00024653864,0.00023526783,0.00008826438,0.00015937586],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00070151006,0.00022452982,0.0004938351,0.00010176732,0.0000663596,0.000006312419,0.00015796564,0.00013776659,0.0002152376],"category_scores_gemma":[0.00001615763,0.00011655044,0.0002478229,0.00026212801,0.00066768925,0.000023589238,0.000028780458,0.00043306366,0.0000122792],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.051765464,0.0049496014,0.81016135,0.00016597123,0.0031545933,0.00023043955,0.001455082,0.00007318638,0.08898369,0.000024979214,0.0002866702,0.03874899],"study_design_scores_gemma":[0.0102160415,0.006000756,0.9683341,0.00008730528,0.0008464458,0.000043326236,0.000070673785,0.0004655772,0.013484117,0.00008183403,0.00024266301,0.00012717224],"about_ca_topic_score_codex":0.000049613314,"about_ca_topic_score_gemma":0.000016528844,"teacher_disagreement_score":0.15817276,"about_ca_system_score_codex":0.00007196261,"about_ca_system_score_gemma":0.00013209408,"threshold_uncertainty_score":0.4752789},"labels":[],"label_agreement":null},{"id":"W2117518921","doi":"10.1016/s0009-9236(03)90707-7","title":"Teaching pharmacokinetic logic through example: Application of modeling to observations from three perplexing overdoses","year":2003,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Pharmacokinetics; Computer science; Intensive care medicine; Medicine; Pharmacology","score_opus":0.47775503349477993,"score_gpt":0.5345246530623515,"score_spread":0.056769619567571594,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2117518921","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8607071,0.0036979306,0.1212186,0.004313804,0.005985974,0.0015358061,0.0002071618,0.00023223544,0.0021013853],"genre_scores_gemma":[0.8794701,0.0018210853,0.015825283,0.10099203,0.0013447405,0.0002310935,0.00007246006,0.000113841044,0.00012933182],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9932324,0.0022728452,0.0019658639,0.0011265083,0.00040032223,0.0010020057],"domain_scores_gemma":[0.9953736,0.0024740458,0.0005890018,0.000609913,0.0004023109,0.000551141],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0023740677,0.0006467927,0.0010441879,0.00017988902,0.0005766518,0.000029860123,0.0010432326,0.00070956233,0.0012087005],"category_scores_gemma":[0.00013269039,0.0006512426,0.0004426619,0.0005674437,0.0004653405,0.00022722692,0.00027320627,0.0022741314,0.00019685211],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010855625,0.0034371526,0.04612599,0.00008412709,0.0029643083,0.000024604611,0.0024164543,0.07777453,0.8094714,0.009307099,0.0043985955,0.04291012],"study_design_scores_gemma":[0.0069655706,0.00035112203,0.0037159857,0.000024078909,0.004061276,0.000012343041,0.0002193487,0.24019164,0.051109172,0.024330646,0.6678982,0.0011206268],"about_ca_topic_score_codex":0.00023273111,"about_ca_topic_score_gemma":0.000035117577,"teacher_disagreement_score":0.7583623,"about_ca_system_score_codex":0.000094429015,"about_ca_system_score_gemma":0.0002540982,"threshold_uncertainty_score":0.9997043},"labels":[],"label_agreement":null},{"id":"W2119045235","doi":"10.1038/clpt.2009.194","title":"Selective Antagonism of Opioid-Induced Ventilatory Depression by an Ampakine Molecule in Humans Without Loss of Opioid Analgesia","year":2009,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Neuroscience of respiration and sleep","field":"Neuroscience","cited_by":132,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Alfentanil; Opioid; Anesthesia; (+)-Naloxone; Medicine; Placebo; Depression (economics); Clinical pharmacology; Ventilation (architecture); Ketamine; Pharmacology; Propofol; Internal medicine; Receptor","score_opus":0.08222327603796387,"score_gpt":0.42837084720153984,"score_spread":0.346147571163576,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2119045235","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979928,0.00010238847,0.00021360973,0.00045711768,0.000629998,0.00038797205,0.000013449535,0.000040958308,0.0001616824],"genre_scores_gemma":[0.97551304,0.00032914832,0.000058156445,0.023968114,0.00007487284,0.0000076045417,0.000002826626,0.00001736912,0.000028852739],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9971942,0.00063775445,0.00086628983,0.00062313274,0.0003220386,0.00035663284],"domain_scores_gemma":[0.99874014,0.00025324905,0.000459256,0.000301265,0.000092029615,0.00015406637],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005133539,0.00020573157,0.0004840968,0.00016040979,0.00010187359,0.00001384445,0.0005928399,0.00021256634,0.000033308017],"category_scores_gemma":[0.000054280335,0.00019057882,0.00013410038,0.00046308216,0.00055740325,0.00020019812,0.000055798868,0.0005605659,0.0000043391324],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004113889,0.0014910641,0.02534945,0.00000795541,0.000010117077,0.000019423554,0.00016247541,0.00004225126,0.97041506,0.000031885433,0.00013066076,0.0019282646],"study_design_scores_gemma":[0.0018461928,0.0015430273,0.054703414,0.000012035305,0.000058420097,0.0000034502705,0.000015492476,0.0019815112,0.93868697,0.00024116773,0.0007437544,0.00016455699],"about_ca_topic_score_codex":0.000003605364,"about_ca_topic_score_gemma":0.000002778984,"teacher_disagreement_score":0.03172809,"about_ca_system_score_codex":0.000030038116,"about_ca_system_score_gemma":0.00014638221,"threshold_uncertainty_score":0.77715784},"labels":[],"label_agreement":null},{"id":"W2119389223","doi":"10.1038/sj.clpt.6100377","title":"Pharmacokinetic Studies in Pregnant Women","year":2007,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pregnancy and Medication Impact","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto","funders":"Canadian Institutes of Health Research","keywords":"Miller; Pharmacy; Anger; Citation; Medicine; Clinical pharmacology; Library science; Psychology; Family medicine; Pharmacology; Psychiatry; Computer science","score_opus":0.263882189193164,"score_gpt":0.5560746804986478,"score_spread":0.29219249130548386,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2119389223","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97141635,0.013912921,0.00018298002,0.008320612,0.0040463973,0.00073906285,0.00000301731,0.000118610034,0.0012600569],"genre_scores_gemma":[0.87358224,0.017834542,0.0002496962,0.1062439,0.00085120194,0.000059969065,0.0000036302101,0.000026496235,0.001148347],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9976775,0.00016909388,0.00092698506,0.00035197075,0.00020745679,0.0006669653],"domain_scores_gemma":[0.9980955,0.0009980062,0.00017030077,0.00023621364,0.00012283071,0.00037715334],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021906227,0.0001962571,0.0005770038,0.00016042069,0.000049463993,0.0000029885546,0.00017377714,0.00020725957,0.00034282694],"category_scores_gemma":[0.000091590984,0.00015561747,0.00012310818,0.00030451702,0.0007084222,0.0000547177,0.000066146175,0.00077765266,0.00010341949],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009486864,0.011098906,0.2953438,0.0007715793,0.0071655624,0.002504828,0.013524724,0.000021959391,0.11009828,0.00007211774,0.03917009,0.5107413],"study_design_scores_gemma":[0.042204306,0.004758698,0.38260424,0.0011184624,0.0027403603,0.00025435633,0.0026198362,0.0005942968,0.04410103,0.0010048717,0.5171218,0.0008777244],"about_ca_topic_score_codex":7.2029695e-7,"about_ca_topic_score_gemma":0.0000012332107,"teacher_disagreement_score":0.50986356,"about_ca_system_score_codex":0.0002078269,"about_ca_system_score_gemma":0.0001997695,"threshold_uncertainty_score":0.6345896},"labels":[],"label_agreement":null},{"id":"W2119478252","doi":"10.1016/j.clpt.2003.11.278","title":"Neurodevelopment in children exposed in utero to cyclosporine and azathioprine following maternal renal transplant: preliminary results","year":2004,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pregnancy and Medication Impact","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; Toronto General Hospital; SickKids Foundation","funders":"","keywords":"Azathioprine; Wechsler Adult Intelligence Scale; Wechsler Preschool and Primary Scale of Intelligence; Medicine; Pregnancy; Neuropsychology; In utero; Transplantation; Pediatrics; Wechsler Intelligence Scale for Children; Cohort; Fetus; Internal medicine; Psychiatry; Cognition","score_opus":0.0509365811838767,"score_gpt":0.38739739547548346,"score_spread":0.3364608142916068,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2119478252","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9821958,0.00032607687,0.00013504934,0.015816446,0.0006109807,0.0007574907,0.000012812666,0.000045941077,0.00009941913],"genre_scores_gemma":[0.9700772,0.001644764,0.0014019944,0.02652878,0.00018463552,0.00003816597,0.000025309111,0.00002212138,0.00007701659],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979715,0.000111017514,0.0009185096,0.00043988327,0.00018087494,0.0003782674],"domain_scores_gemma":[0.9992384,0.00016210461,0.0000979894,0.00018515842,0.000020334326,0.0002960332],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00071844005,0.00019445238,0.0004396697,0.00016438807,0.000034923294,0.000005950879,0.00015276336,0.00017866174,0.000019769961],"category_scores_gemma":[0.00003359403,0.00017216674,0.000080462196,0.00019819246,0.00009598482,0.00006089213,0.00005792704,0.00062141486,0.000013728667],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016912125,0.0035044283,0.8840482,0.00006545992,0.00072403776,0.003512861,0.003837775,0.00023968631,0.052767083,0.000014445298,0.00022677293,0.034147087],"study_design_scores_gemma":[0.020879012,0.0014809311,0.9655884,0.0003794958,0.00022447563,0.00022846468,0.000010215085,0.000053312186,0.009885207,0.000055039392,0.0010500558,0.00016542336],"about_ca_topic_score_codex":0.000014095404,"about_ca_topic_score_gemma":0.0000068858885,"teacher_disagreement_score":0.08154013,"about_ca_system_score_codex":0.00007796782,"about_ca_system_score_gemma":0.00017337983,"threshold_uncertainty_score":0.70207554},"labels":[],"label_agreement":null},{"id":"W2121718651","doi":"10.1038/clpt.2010.133","title":"Deep Brain Stimulation in Clinical Practice and in Animal Models","year":2010,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Neurological disorders and treatments","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Addiction and Mental Health; Toronto Western Hospital","funders":"","keywords":"Deep brain stimulation; Neuroscience; Medicine; Movement disorders; Stimulation; Therapeutic window; Clinical pharmacology; Neurosurgery; Psychology; Pharmacology; Psychiatry; Internal medicine","score_opus":0.2707123432835973,"score_gpt":0.5559429947071708,"score_spread":0.2852306514235735,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2121718651","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.010502664,0.9805196,0.000041997806,0.0055434466,0.00092681736,0.0020587305,0.000007848455,0.00004376465,0.00035514717],"genre_scores_gemma":[0.001660239,0.92855924,0.0007533717,0.068427026,0.00037500876,0.000081358994,0.000044796336,0.000058126996,0.000040837396],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9946975,0.0014835863,0.0022987013,0.00089797244,0.00018459513,0.0004376209],"domain_scores_gemma":[0.9895431,0.009266819,0.0005706339,0.00030206342,0.000070175505,0.00024724085],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0018316711,0.00045583522,0.002541562,0.00018024787,0.00003902699,0.000013776095,0.00018893876,0.0017816419,0.00007101406],"category_scores_gemma":[0.00041488424,0.00034297458,0.00047281806,0.00029850393,0.00046394378,0.0001078386,0.0001465063,0.004001165,0.000041408508],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016495186,0.0048884535,0.0045818617,0.0005717499,0.0005548276,0.0008217383,0.000025056637,0.000009993575,0.0000016801008,0.000029135328,0.0003882912,0.9864777],"study_design_scores_gemma":[0.009978304,0.002968333,0.007019288,0.00054408587,0.006789611,0.00008454912,0.000009279145,0.0072468626,1.2490449e-7,0.0016535074,0.9632847,0.00042136328],"about_ca_topic_score_codex":0.0000036946185,"about_ca_topic_score_gemma":0.00001810019,"teacher_disagreement_score":0.9860563,"about_ca_system_score_codex":0.000049373863,"about_ca_system_score_gemma":0.00027944613,"threshold_uncertainty_score":0.99990225},"labels":[],"label_agreement":null},{"id":"W2123304989","doi":"10.1038/sj.clpt.6100492","title":"Assessing Abuse Liability During Drug Development: Changing Standards and Expectations","year":2008,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Opioid Use Disorder Treatment","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Abuse liability; Clinical pharmacology; Recreational Drug; Stimulant; Liability; Mood; Pharmacology; Medicine; Hallucinogen; Drugs of abuse; Substance abuse; Drug; Psychology; Psychiatry; Business","score_opus":0.13923717806136543,"score_gpt":0.5067391924256456,"score_spread":0.36750201436428015,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2123304989","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.05116259,0.94554484,0.000028746024,0.00029863403,0.0010977291,0.0015313622,0.000029048882,0.00017307028,0.00013396665],"genre_scores_gemma":[0.0004343495,0.9950009,0.0016767993,0.001607835,0.0005265468,0.0002514194,0.0001136636,0.00011927807,0.0002692163],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99601525,0.00063394516,0.0015329481,0.0008452052,0.00036506593,0.0006076136],"domain_scores_gemma":[0.99739367,0.00117517,0.0005024914,0.00039395364,0.0002350436,0.00029964515],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00057123613,0.0006148561,0.0023025132,0.00031013347,0.00047020754,0.000045840152,0.00018389567,0.0004923285,0.00009790796],"category_scores_gemma":[0.000042102358,0.00050942384,0.0005255038,0.00039494928,0.00047323067,0.00011708138,0.00013835213,0.0011935233,0.000039824405],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011191307,0.0020643722,0.0019848456,0.01010615,0.005517658,0.0003115027,0.007777767,5.013499e-7,0.0000047747253,0.0000016113172,0.00052090624,0.97159797],"study_design_scores_gemma":[0.0026368436,0.000093893286,0.001068498,0.0025777984,0.006583766,0.00016312585,0.00045685348,0.000014122702,0.00002628503,0.000003647539,0.9859211,0.00045405203],"about_ca_topic_score_codex":7.0690663e-7,"about_ca_topic_score_gemma":9.714063e-7,"teacher_disagreement_score":0.9854002,"about_ca_system_score_codex":0.0005856911,"about_ca_system_score_gemma":0.002082971,"threshold_uncertainty_score":0.9997357},"labels":[],"label_agreement":null},{"id":"W2124154653","doi":"10.1016/j.clpt.2005.12.304","title":"A therapeutic substitution policy for proton pump inhibitors: Clinical and economic consequences","year":2006,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Gastroesophageal reflux and treatments","field":"Medicine","cited_by":52,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Victoria","funders":"National Institute on Aging; Agency for Healthcare Research and Quality","keywords":"Medicine; Lansoprazole; Rabeprazole; Discontinuation; Omeprazole; Proton-pump inhibitor; Medical prescription; Drug; Esomeprazole; Internal medicine; Pharmacy; Intensive care medicine; Emergency medicine; Pharmacology; Family medicine","score_opus":0.09484999997130361,"score_gpt":0.4614651855137237,"score_spread":0.36661518554242006,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2124154653","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9856726,0.0006445319,0.0002096693,0.009534299,0.001143667,0.0024331613,0.000034553843,0.00010359981,0.00022391636],"genre_scores_gemma":[0.9755571,0.000893923,0.00058088684,0.019433336,0.0028773996,0.00027502087,0.000042619937,0.000035082485,0.000304615],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975231,0.00028178384,0.0010769983,0.0005575003,0.00010763516,0.00045293267],"domain_scores_gemma":[0.9984185,0.00078139163,0.00026728102,0.00021008434,0.000097611395,0.00022512182],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00076832157,0.0002759858,0.0006663162,0.00010496171,0.0001557811,0.000026580394,0.000115133575,0.00037950638,0.000050246057],"category_scores_gemma":[0.000027539103,0.00021802042,0.00032807913,0.000083005594,0.0017894114,0.000082987004,0.00004074778,0.00040914855,0.00006141086],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016505084,0.0016824562,0.97732675,0.000080223246,0.0012860692,0.00010061743,0.000021333622,0.000006926325,0.0025219107,0.0011033994,0.0010199238,0.013199859],"study_design_scores_gemma":[0.04383967,0.010459398,0.77941114,0.000075745644,0.0064173774,0.00031239088,0.000027814363,0.0018927691,0.026547663,0.018741736,0.11171607,0.0005582137],"about_ca_topic_score_codex":0.000025735959,"about_ca_topic_score_gemma":0.000005024193,"teacher_disagreement_score":0.19791563,"about_ca_system_score_codex":0.00010162171,"about_ca_system_score_gemma":0.00058991235,"threshold_uncertainty_score":0.88906145},"labels":[],"label_agreement":null},{"id":"W2125160586","doi":"10.1067/mcp.2000.107047","title":"Population pharmacokinetics of long-term oral amiodarone therapy","year":2000,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Cardiac electrophysiology and arrhythmias","field":"Medicine","cited_by":102,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; Dalhousie University","funders":"","keywords":"Pharmacokinetics; Bioavailability; Dosing; Regimen; Amiodarone; Medicine; Population; Discontinuation; NONMEM; Pharmacology; Half-life; Elimination rate constant; Internal medicine; Volume of distribution; Atrial fibrillation","score_opus":0.07404740526852116,"score_gpt":0.43506687604539046,"score_spread":0.3610194707768693,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2125160586","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9926355,0.001993694,0.0000346944,0.0033696643,0.000983418,0.0005216742,0.00001025533,0.0000905702,0.00036056142],"genre_scores_gemma":[0.9456054,0.015537591,0.00021394194,0.03673549,0.0011646731,0.000015921336,0.000076315424,0.000039467857,0.000611188],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99784446,0.00042135967,0.0007921249,0.00037699006,0.00017567504,0.0003894162],"domain_scores_gemma":[0.99892,0.000326208,0.00018381215,0.0002919961,0.0001208871,0.0001570658],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00036359797,0.0002421222,0.0007947298,0.00006975487,0.00007931865,0.0000043075406,0.00014279723,0.00033197086,0.003189287],"category_scores_gemma":[0.0000058070773,0.00020560304,0.00042192865,0.00021571948,0.00051229045,0.000051505347,0.000025337395,0.0006963755,0.00011388093],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012312286,0.002871879,0.25683627,0.000065474196,0.0035452333,0.00037461743,0.00012035627,0.00019624787,0.14665283,0.000014231872,0.0054771155,0.57153344],"study_design_scores_gemma":[0.010171336,0.002421621,0.9499394,0.000023458357,0.0016966696,0.00017534052,0.000003261136,0.00044760478,0.024846414,0.00012958815,0.009857689,0.00028757635],"about_ca_topic_score_codex":0.000004121126,"about_ca_topic_score_gemma":6.7741126e-7,"teacher_disagreement_score":0.6931032,"about_ca_system_score_codex":0.00003268247,"about_ca_system_score_gemma":0.00008354444,"threshold_uncertainty_score":0.9977219},"labels":[],"label_agreement":null},{"id":"W2125223264","doi":"10.1067/mcp.2000.104642","title":"Prediction of cyclosporine clearance in liver transplant recipients by the use of midazolam as a cytochrome P450 3A probe","year":2000,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Renal Transplantation Outcomes and Treatments","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Saint-Luc","funders":"","keywords":"Midazolam; CYP3A; Ciclosporin; Pharmacokinetics; Pharmacology; Drug interaction; Trough level; Chemistry; Oral administration; Cytochrome P450; Transplantation; Medicine; Internal medicine; Metabolism; Tacrolimus","score_opus":0.16495915294152005,"score_gpt":0.39984445039307165,"score_spread":0.2348852974515516,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2125223264","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970553,0.00045784866,0.000047198242,0.001127174,0.00019198554,0.00078153895,0.00015151392,0.000020325788,0.00016715075],"genre_scores_gemma":[0.98063505,0.012101934,0.00023702081,0.0061459434,0.0000656955,0.000029049916,0.00006186447,0.000019689936,0.0007037765],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99826944,0.00021879487,0.0008463469,0.00024603127,0.0002147513,0.00020463452],"domain_scores_gemma":[0.9990202,0.0004670693,0.00017212555,0.00019038506,0.00006899657,0.00008122036],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023373909,0.00015857907,0.0004654789,0.000048326787,0.000032333097,0.0000031308425,0.00012145465,0.0001696559,0.00047188898],"category_scores_gemma":[0.0000044756766,0.0001050964,0.00018424982,0.00019428153,0.00031795035,0.00007074895,0.000006686226,0.000358281,0.00002414472],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.029693639,0.009441749,0.8424973,0.0003795628,0.0033711547,0.00028234476,0.0016110273,0.00027605263,0.071283475,0.00003263728,0.0010021455,0.0401289],"study_design_scores_gemma":[0.009601552,0.0016566244,0.96698606,0.00026924667,0.0014120754,0.00006731515,0.000007892202,0.001024967,0.008722069,0.00003078183,0.0101267295,0.00009468495],"about_ca_topic_score_codex":0.00004357565,"about_ca_topic_score_gemma":0.000004830839,"teacher_disagreement_score":0.124488756,"about_ca_system_score_codex":0.000029050663,"about_ca_system_score_gemma":0.000058142763,"threshold_uncertainty_score":0.51668537},"labels":[],"label_agreement":null},{"id":"W2126333303","doi":"10.1038/clpt.2012.184","title":"Impact of the CYP4F2 p.V433M Polymorphism on Coumarin Dose Requirement: Systematic Review and Meta-Analysis","year":2012,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":68,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"National Center for Advancing Translational Sciences; National Center for Research Resources; National Institute of General Medical Sciences; National Institutes of Health; National Institute for Health and Care Research","keywords":"VKORC1; Confidence interval; Coumarin; Meta-analysis; Internal medicine; Clinical pharmacology; Medicine; CYP2C9; Polymorphism (computer science); Allele; Pharmacology; Oncology; Biology; Genetics","score_opus":0.617369271961051,"score_gpt":0.6106917275112662,"score_spread":0.006677544449784745,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2126333303","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000904746,0.98805,0.000005468108,0.0011909078,0.0024914471,0.006373171,0.0013831169,0.00006899155,0.00034646687],"genre_scores_gemma":[0.00066887133,0.9512541,0.00002312794,0.045426797,0.0005222427,0.0007505636,0.000091244474,0.00015833456,0.0011046681],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9789687,0.013063988,0.0048693824,0.0012355794,0.00060784037,0.0012545445],"domain_scores_gemma":[0.987809,0.005072624,0.0043020495,0.0016468472,0.00034497824,0.0008245004],"candidate_categories":["metaepi_narrow","metaepi_broad","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","metaepi_broad","research_integrity"],"category_scores_codex":[0.0067408076,0.0016998552,0.014772485,0.00047980208,0.00038524918,0.000025362107,0.0022508516,0.0017665245,0.005206245],"category_scores_gemma":[0.00010082032,0.0009439735,0.012770726,0.0016774026,0.0015283113,0.00009983206,0.0008162281,0.004121521,0.00022751225],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012325989,0.0022560093,0.00007266957,0.16313443,0.8122722,0.00001747224,0.00007897159,0.000020640939,0.00002143068,0.00005276481,0.0054393816,0.016510777],"study_design_scores_gemma":[0.0008018593,0.00017673495,0.000050408446,0.0010516891,0.6948802,0.000027180246,0.0000015526805,0.000024349994,0.000013230996,0.000022523744,0.30237517,0.00057513337],"about_ca_topic_score_codex":0.000013523424,"about_ca_topic_score_gemma":0.0000028696038,"teacher_disagreement_score":0.2969358,"about_ca_system_score_codex":0.00020003162,"about_ca_system_score_gemma":0.0006107764,"threshold_uncertainty_score":0.99985427},"labels":[],"label_agreement":null},{"id":"W2130770322","doi":"10.1016/j.clpt.2003.11.133","title":"Absence of circadian variation in the pharmacokinetics (PK) of lopinavir/ritonavir (LPV/R) in a once-daily (QD) dosing regimen in hiv-1-infected subjects","year":2004,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Dosing; Cmax; Ritonavir; Lopinavir/ritonavir; Pharmacokinetics; Lopinavir; Medicine; Pharmacology; Regimen; Human immunodeficiency virus (HIV); Geometric mean; Internal medicine; Chemistry; Gastroenterology; Viral load; Mathematics; Antiretroviral therapy; Immunology","score_opus":0.05824986706197384,"score_gpt":0.39219260239882797,"score_spread":0.33394273533685415,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2130770322","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98515123,0.000642248,0.00008453046,0.012334851,0.00037434633,0.0010170252,0.0000073309016,0.000020957339,0.00036747585],"genre_scores_gemma":[0.9916898,0.0016439436,0.0009701036,0.0053898017,0.00012401251,0.00004804939,0.00002535427,0.00002554504,0.00008337516],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99705464,0.00054437714,0.0013165431,0.00038443567,0.00028720696,0.00041280873],"domain_scores_gemma":[0.9982566,0.00093454117,0.00035768966,0.00025883023,0.00010426754,0.00008807315],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011893647,0.00024756737,0.0006938446,0.0003274345,0.000030768926,0.00000610706,0.0002709778,0.00027287254,0.000042294385],"category_scores_gemma":[0.00005215995,0.00020155935,0.0001300987,0.0009601396,0.00035096216,0.000078272926,0.000050304254,0.0007796727,0.000017895332],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027866573,0.00997328,0.87909466,0.00025335167,0.00073909253,0.0007314701,0.01839737,0.0013115063,0.07861964,0.00026357683,0.0004439931,0.007385394],"study_design_scores_gemma":[0.027031472,0.00067621656,0.9515805,0.00044445827,0.00056878163,0.00002931523,0.0003038416,0.0010409139,0.015009699,0.0006754477,0.0023473292,0.0002920136],"about_ca_topic_score_codex":0.00007770223,"about_ca_topic_score_gemma":0.00010086279,"teacher_disagreement_score":0.072485834,"about_ca_system_score_codex":0.0002618501,"about_ca_system_score_gemma":0.00053419865,"threshold_uncertainty_score":0.8219352},"labels":[],"label_agreement":null},{"id":"W2133049351","doi":"10.1016/j.clpt.2003.11.097","title":"Time-dependent toxicity of sulfonamide reactive metabolites in cells of patients with sulfonamide hypersensitivity","year":2004,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Drug-Induced Adverse Reactions","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Sulfonamide; Peripheral blood mononuclear cell; Toxicity; Pharmacology; Programmed cell death; Viability assay; Necrosis; Drug; Apoptosis; Hydroxylamine; Medicine; Chemistry; Immunology; In vitro; Biochemistry; Internal medicine; Stereochemistry","score_opus":0.033758052400297264,"score_gpt":0.34993151975444997,"score_spread":0.3161734673541527,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2133049351","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965582,0.00006707222,0.000050650655,0.00079073367,0.00045135315,0.0007420234,0.000101349346,0.000036906105,0.0012017309],"genre_scores_gemma":[0.99564564,0.00020422156,0.0006182,0.0032813372,0.00009953456,0.000009865746,0.000026028378,0.0000386381,0.000076536766],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9976491,0.00032626904,0.0008953499,0.00041803255,0.0003578441,0.00035342432],"domain_scores_gemma":[0.99754655,0.0010596465,0.0004894828,0.00032473434,0.0004120863,0.00016749359],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00058111333,0.00025195026,0.0010020668,0.00018065712,0.00003247421,0.0000022228382,0.00012919067,0.0002677762,0.000022824259],"category_scores_gemma":[0.00006327768,0.00021009172,0.00022823061,0.00034035777,0.00080763805,0.00011397881,0.000070212394,0.0007633337,0.000033140015],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019539776,0.012038647,0.06048967,0.00008033977,0.0018847241,0.00008554589,0.00041428176,0.001001956,0.9155186,0.00003644917,0.000017927634,0.006477895],"study_design_scores_gemma":[0.012700607,0.00058758294,0.5101566,0.00007115852,0.0022565387,0.000009731614,0.0001681462,0.0001098361,0.47252876,0.00012008317,0.0010583026,0.00023266848],"about_ca_topic_score_codex":0.000042437732,"about_ca_topic_score_gemma":0.000023739605,"teacher_disagreement_score":0.44966692,"about_ca_system_score_codex":0.00020546609,"about_ca_system_score_gemma":0.00043000566,"threshold_uncertainty_score":0.85672915},"labels":[],"label_agreement":null},{"id":"W2134431157","doi":"10.1038/sj.clpt.6100104","title":"Naringin is a Major and Selective Clinical Inhibitor of Organic Anion-Transporting Polypeptide 1A2 (OATP1A2) in Grapefruit Juice","year":2007,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":288,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lawson Health Research Institute; London Health Sciences Centre; Western University","funders":"National Institute of General Medical Sciences","keywords":"Grapefruit juice; Fexofenadine; Naringin; Chemistry; Bioavailability; Pharmacology; Orange juice; Hesperidin; Pharmacokinetics; Chromatography; Food science; Medicine","score_opus":0.05285124708051807,"score_gpt":0.4164629260516325,"score_spread":0.3636116789711144,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2134431157","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99267143,0.0011815721,0.0008167354,0.0030310648,0.0012496556,0.00070981146,0.000010645452,0.00007891765,0.00025015103],"genre_scores_gemma":[0.9744591,0.0015226629,0.0015883823,0.021447357,0.00064312405,0.000008218892,0.000010600352,0.00006318297,0.0002573773],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9960038,0.00018902132,0.0022277022,0.0006590041,0.0002838084,0.0006366551],"domain_scores_gemma":[0.99772894,0.0010056434,0.00046527002,0.00025179723,0.00020970443,0.00033861704],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0029323236,0.00031496058,0.0010898071,0.00020892403,0.00008180103,0.0000060982,0.0001939166,0.00061814475,0.00015062492],"category_scores_gemma":[0.000038132635,0.0002789571,0.000336265,0.0005820983,0.0006569205,0.00006944428,0.00004103414,0.001406853,0.000014374445],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0039531523,0.001847981,0.85674226,0.00015420676,0.00087055477,0.00029142544,0.00085354666,5.198436e-7,0.1283846,0.000035893172,0.00042005963,0.006445807],"study_design_scores_gemma":[0.0141302,0.0020671866,0.86728907,0.00022979091,0.002472228,0.000055569686,0.0005536303,0.000101262194,0.104142055,0.00043916504,0.008029156,0.00049068115],"about_ca_topic_score_codex":0.00001237887,"about_ca_topic_score_gemma":0.00018549513,"teacher_disagreement_score":0.02424255,"about_ca_system_score_codex":0.00005689489,"about_ca_system_score_gemma":0.00027336832,"threshold_uncertainty_score":0.99996626},"labels":[],"label_agreement":null},{"id":"W2135850268","doi":"10.1067/mcp.2000.107524","title":"Grapefruit juice–felodipine interaction in the elderly","year":2000,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Ginkgo biloba and Cashew Applications","field":"Medicine","cited_by":79,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Felodipine; Grapefruit juice; Pharmacokinetics; Bioavailability; Chemistry; Pharmacology; Metabolite; Area under the curve; Active metabolite; Blood pressure; Medicine; Endocrinology; Biochemistry","score_opus":0.12192521159463282,"score_gpt":0.47607692678771113,"score_spread":0.3541517151930783,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2135850268","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9263174,0.00037082317,0.00005426329,0.06326412,0.00056108256,0.0006550444,0.000003614849,0.000070820744,0.008702816],"genre_scores_gemma":[0.8515883,0.0016381457,0.00015648053,0.14456809,0.00066390744,0.00010954585,0.000021715481,0.00001744503,0.0012363732],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9984096,0.00029295005,0.00056934706,0.00029702685,0.00015349081,0.00027756047],"domain_scores_gemma":[0.9989132,0.0005341185,0.000075984215,0.00032648994,0.000058624355,0.00009157276],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0005577294,0.00015020752,0.00028542557,0.000056881985,0.00008896973,0.000014670494,0.0002455644,0.00019781633,0.0030484425],"category_scores_gemma":[0.000006776349,0.0001040385,0.00017603826,0.00032959055,0.00024976206,0.000052872445,0.000015128535,0.0008815895,0.0008467618],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002323114,0.0064178635,0.02868916,0.00004425713,0.0008422967,0.00015567563,0.00111971,0.000036956815,0.010930856,0.00026693597,0.12075453,0.8284186],"study_design_scores_gemma":[0.0033769612,0.0011954302,0.08297692,0.000013482386,0.0008107911,0.00011873695,0.00018521669,0.00047626352,0.0002997017,0.00047615898,0.90992814,0.00014216798],"about_ca_topic_score_codex":0.0000067810247,"about_ca_topic_score_gemma":0.00001018972,"teacher_disagreement_score":0.82827646,"about_ca_system_score_codex":0.00003474334,"about_ca_system_score_gemma":0.000072668394,"threshold_uncertainty_score":0.9999312},"labels":[],"label_agreement":null},{"id":"W2135905495","doi":"10.1038/clpt.2014.76","title":"The Ebbs and Flows in the Development of Cholesterol-Lowering Drugs: Prospects for the Future","year":2014,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Clinical pharmacology; Medicine; Cholesterol; Pharmacology; Intensive care medicine; Internal medicine","score_opus":0.09926709391705164,"score_gpt":0.46066391303830856,"score_spread":0.36139681912125693,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2135905495","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0012133634,0.98771137,0.00015424394,0.003954423,0.0018576679,0.00504888,0.0000053223275,0.000015240452,0.0000394854],"genre_scores_gemma":[0.00044549129,0.98526156,0.00022097374,0.0101489425,0.0029530334,0.0008637415,0.000009736268,0.000050451734,0.000046082263],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99674296,0.00073498,0.0014192426,0.00039190095,0.00030973632,0.00040119575],"domain_scores_gemma":[0.9957736,0.0029178776,0.00045696629,0.00066832296,0.00009874723,0.00008444665],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0071071447,0.00034006604,0.0016633214,0.00004076973,0.00032739382,0.00002573412,0.0005561059,0.00044447096,0.000004611755],"category_scores_gemma":[0.000032925716,0.00013515221,0.00075948786,0.00017703559,0.00034896604,0.000015958849,0.00012062093,0.0013384816,0.000004246148],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008882878,0.00012206334,0.000029133977,0.0036811803,0.0016153244,0.0000018028417,0.00044934175,2.6477923e-7,9.399425e-7,0.000013379933,0.0004018306,0.9935959],"study_design_scores_gemma":[0.0016962069,0.00023628319,0.0005049227,0.0008617728,0.004106425,0.000027126724,0.00017024447,0.000034905937,0.0000039461875,0.000021252683,0.9922028,0.0001340769],"about_ca_topic_score_codex":0.0000012090497,"about_ca_topic_score_gemma":0.000024886958,"teacher_disagreement_score":0.99346185,"about_ca_system_score_codex":0.000060889026,"about_ca_system_score_gemma":0.0006460751,"threshold_uncertainty_score":0.5815111},"labels":[],"label_agreement":null},{"id":"W2138509705","doi":"10.1002/cpt.269","title":"Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for <i>UGT1A1</i> and Atazanavir Prescribing","year":2015,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Neonatal Health and Biochemistry","field":"Medicine","cited_by":221,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"National Center for Advancing Translational Sciences; National Institute of Allergy and Infectious Diseases; National Institute of General Medical Sciences; National Heart, Lung, and Blood Institute; National Institutes of Health","keywords":"Guideline; Atazanavir; Medicine; Pharmacogenetics; Medical physics; Family medicine; Biology; Genotype","score_opus":0.2694700399285668,"score_gpt":0.5659185183564023,"score_spread":0.2964484784278355,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2138509705","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9600416,0.005376136,0.0018834547,0.02622004,0.0036924116,0.0022517745,0.00018469464,0.00013514282,0.00021477406],"genre_scores_gemma":[0.6012204,0.0064183716,0.018495886,0.36719397,0.005472811,0.00014579966,0.0004929195,0.00008744331,0.00047236827],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99650943,0.00025242253,0.0019067707,0.00058199576,0.00022201535,0.00052736956],"domain_scores_gemma":[0.9972306,0.0007398082,0.00036984237,0.0002489087,0.000512646,0.0008982183],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023367743,0.00025448404,0.00061844604,0.000039173687,0.000107797765,0.000014334393,0.00016729643,0.0003612565,0.00009446642],"category_scores_gemma":[0.00008161125,0.00022568674,0.0002171854,0.000103014936,0.0005259322,0.000052184416,0.00012410543,0.0006000765,0.000017776252],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00829292,0.0015976051,0.21963947,0.00036266603,0.0013337448,0.00007262405,0.00011787542,0.0000058605974,0.024053935,0.000015913227,0.46339807,0.28110933],"study_design_scores_gemma":[0.024503065,0.0026748865,0.004220523,0.000023550125,0.002525817,0.00008813824,0.00025351677,0.003216221,0.021285811,0.00017481299,0.940706,0.0003276587],"about_ca_topic_score_codex":0.0000071574495,"about_ca_topic_score_gemma":0.0000032257055,"teacher_disagreement_score":0.47730792,"about_ca_system_score_codex":0.000051600407,"about_ca_system_score_gemma":0.0006570406,"threshold_uncertainty_score":0.92032385},"labels":[],"label_agreement":null},{"id":"W2138604875","doi":"10.1038/clpt.2009.98","title":"New Antithrombotic Drugs","year":2009,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":108,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University Medical Centre","funders":"","keywords":"Antithrombotic; Hemostasis; Medicine; Thrombosis; Intensive care medicine; Fibrinolytic agent; Platelet; Pharmacology; Internal medicine","score_opus":0.15986582646157363,"score_gpt":0.4988658099130718,"score_spread":0.3389999834514982,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2138604875","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000030153064,0.9937995,0.00026468936,0.0008807529,0.0025771563,0.0013809721,0.000014935799,0.00023709038,0.00081476354],"genre_scores_gemma":[0.000006023957,0.9519701,0.00054023345,0.041120626,0.004242153,0.000019503963,0.00011885343,0.00012954742,0.0018529856],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99581003,0.00087493093,0.001474793,0.0008484999,0.00037439424,0.00061733974],"domain_scores_gemma":[0.9974317,0.000635959,0.00044215834,0.0007557872,0.00010033761,0.0006340891],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00066657766,0.00073424424,0.0046151415,0.00016454364,0.00010912984,0.000026792866,0.0004740638,0.0012108182,0.0011750464],"category_scores_gemma":[0.000012727438,0.0005628977,0.0045720995,0.00040494135,0.00036002052,0.00005108071,0.00008202987,0.0017719218,0.0010748262],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014174478,0.00051583623,0.000015570864,0.0016379977,0.010714549,0.00027748314,0.000014273908,2.8157874e-7,9.87579e-7,0.000008155389,0.03958672,0.9470864],"study_design_scores_gemma":[0.0028422768,0.00061907625,0.000057291563,0.001987784,0.057561055,0.00025503128,0.0000055089804,0.0000042224724,0.0000026079883,0.000058490987,0.9361363,0.00047035684],"about_ca_topic_score_codex":0.0000012793421,"about_ca_topic_score_gemma":1.1480617e-7,"teacher_disagreement_score":0.94661605,"about_ca_system_score_codex":0.00009438071,"about_ca_system_score_gemma":0.0016660747,"threshold_uncertainty_score":0.99973804},"labels":[],"label_agreement":null},{"id":"W2139470198","doi":"10.1038/clpt.2010.165","title":"The Development of New Therapeutics for Alzheimer's Disease","year":2010,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Alzheimer's disease research and treatments","field":"Medicine","cited_by":105,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Disease; Medicine; Biomarker; Alzheimer's disease; Intervention (counseling); Drug development; Amyloid β; Intensive care medicine; Neuroscience; Bioinformatics; Psychology; Drug; Psychiatry; Biology; Pathology","score_opus":0.36473471343936925,"score_gpt":0.553366885370989,"score_spread":0.18863217193161974,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2139470198","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000058205456,0.9915451,0.00008548697,0.0016843963,0.0018379609,0.004521746,0.00012806884,0.00006484862,0.000074188734],"genre_scores_gemma":[0.000036023604,0.99141264,0.00198918,0.003891609,0.0014116765,0.00055104424,0.00029075288,0.00016187252,0.00025521606],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.995389,0.00045263628,0.00210664,0.0007070597,0.0004910919,0.0008535679],"domain_scores_gemma":[0.99304813,0.0037080895,0.0008518612,0.0008516673,0.00037374065,0.001166501],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010335174,0.0006998055,0.0022426478,0.00011874299,0.00041084387,0.000031159827,0.00076366134,0.00076082844,0.000101342834],"category_scores_gemma":[0.00004247532,0.00041115234,0.0017663647,0.00024957373,0.0009567387,0.00003717754,0.00019640313,0.0015110895,0.0001318515],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010942863,0.0013328622,0.00013228667,0.0009784157,0.07200348,0.000021073294,0.000035030687,4.4373895e-8,0.0000011418821,0.000016193255,0.0034974886,0.9208877],"study_design_scores_gemma":[0.0027662436,0.00043778893,0.00015598263,0.0006087822,0.08077767,0.0000071768022,0.00000816987,0.000019293231,0.000023947903,0.00015463671,0.9147323,0.00030804405],"about_ca_topic_score_codex":6.980014e-7,"about_ca_topic_score_gemma":0.0000031771433,"teacher_disagreement_score":0.9205797,"about_ca_system_score_codex":0.00008502855,"about_ca_system_score_gemma":0.009274016,"threshold_uncertainty_score":0.99983406},"labels":[],"label_agreement":null},{"id":"W2139550411","doi":"10.1002/cpt.87","title":"Rational use of medicines in older adults: Can we do better during clinical development?","year":2015,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmaceutical Practices and Patient Outcomes","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Kellogg's (Canada)","funders":"","keywords":"Extrapolation; Bridging (networking); Clinical trial; Regimen; Medicine; Population; Gerontology; Intensive care medicine; Computer science; Environmental health; Internal medicine; Computer security; Statistics","score_opus":0.3811203374204423,"score_gpt":0.5203174305524702,"score_spread":0.13919709313202783,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2139550411","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96651894,0.00080161856,0.00003636156,0.029512413,0.0022802462,0.0006935985,0.00000846928,0.00003966586,0.000108688015],"genre_scores_gemma":[0.89900416,0.0015284638,0.0019980774,0.09627993,0.0008936162,0.000027304068,0.000030526833,0.00003469163,0.0002032477],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99607223,0.0006719473,0.0019760542,0.0004546652,0.0004239646,0.00040115544],"domain_scores_gemma":[0.9957907,0.0027487965,0.00042795556,0.00023816347,0.0003064138,0.00048795837],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014054002,0.0002481491,0.00082194124,0.00014146612,0.00004579284,0.0000108590675,0.00019258591,0.00034790204,0.00037199078],"category_scores_gemma":[0.0003267806,0.00019464859,0.00019772572,0.0002444986,0.0005351362,0.00017017545,0.00012676675,0.0011507627,0.000050612416],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004485665,0.0021502038,0.97408843,0.00010494571,0.00061715103,0.00010045974,0.0007090954,0.000009055709,0.0002651017,0.0000046707723,0.003845785,0.013619441],"study_design_scores_gemma":[0.0284951,0.0007854505,0.8077078,0.00027220958,0.0010344115,0.00003638145,0.0002493487,0.0013817461,0.0014301011,0.00007171015,0.15820564,0.00033010557],"about_ca_topic_score_codex":0.0000047979397,"about_ca_topic_score_gemma":0.000009709464,"teacher_disagreement_score":0.16638063,"about_ca_system_score_codex":0.000075129894,"about_ca_system_score_gemma":0.00050914095,"threshold_uncertainty_score":0.79375386},"labels":[],"label_agreement":null},{"id":"W2140042090","doi":"10.1016/j.clpt.2003.12.008","title":"Use of population modeling to define rational monitoring of amiodarone hepatic effects*1","year":2004,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Drug-Induced Hepatotoxicity and Protection","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; Queen Elizabeth II Health Sciences Centre","funders":"","keywords":"Amiodarone; Medicine; Internal medicine; Albumin; Lactate dehydrogenase; Gastroenterology; NONMEM; Population; Bilirubin; Pharmacology; Endocrinology; Pharmacokinetics; Chemistry; Enzyme; Atrial fibrillation; Biochemistry","score_opus":0.3997537084719063,"score_gpt":0.5196891367941098,"score_spread":0.1199354283222035,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2140042090","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9820482,0.00020547862,0.009451541,0.0019511969,0.005113356,0.0010751365,0.000033932298,0.00008854579,0.000032592186],"genre_scores_gemma":[0.9849977,0.0005129455,0.0054504853,0.008170061,0.0006845495,0.0000817586,0.000028796298,0.000040601055,0.000033115048],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99630934,0.001107262,0.0014510276,0.0004282475,0.00026876852,0.00043537852],"domain_scores_gemma":[0.9968787,0.0018439088,0.00047775928,0.00023842196,0.00031126663,0.00024993691],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0014288859,0.00029505955,0.0007031017,0.0002243707,0.00020764829,0.00001046048,0.00027882963,0.0006693376,0.0000868993],"category_scores_gemma":[0.0001820257,0.00030416268,0.0002614837,0.00042696728,0.00023099789,0.00021433514,0.00010677531,0.0011572174,0.000050174174],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021224527,0.0023465683,0.12632614,0.0002625044,0.0012450593,0.000014687227,0.0007016611,0.3383742,0.507202,0.0004183405,0.00013381641,0.020852564],"study_design_scores_gemma":[0.01043527,0.0026367719,0.074559204,0.00024264074,0.0029855573,0.000023265286,0.0000813198,0.08718882,0.8096416,0.005279379,0.005937977,0.0009882123],"about_ca_topic_score_codex":0.00011953473,"about_ca_topic_score_gemma":0.000013638746,"teacher_disagreement_score":0.30243957,"about_ca_system_score_codex":0.00015847417,"about_ca_system_score_gemma":0.00014150553,"threshold_uncertainty_score":0.99994105},"labels":[],"label_agreement":null},{"id":"W2140050122","doi":"10.1067/mcp.2001.119814","title":"Red wine decreases cyclosporine bioavailability","year":2001,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Alcohol Consumption and Health Effects","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences North","funders":"National Center for Research Resources","keywords":"Wine; Bioavailability; Ciclosporin; Pharmacology; CYP3A4; Chemistry; Crossover study; Pharmacokinetics; Grapefruit juice; Fluorescence polarization immunoassay; Whole blood; Medicine; Food science; Chromatography; Internal medicine; Biochemistry; Cytochrome P450; Placebo; Chemotherapy; Metabolism","score_opus":0.31722550838377744,"score_gpt":0.5350868564341703,"score_spread":0.21786134805039287,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2140050122","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9260243,0.0009862692,0.000098968274,0.06863851,0.0017634606,0.0007796651,0.000004306697,0.00026005058,0.0014444615],"genre_scores_gemma":[0.7615674,0.005731454,0.00079578266,0.228252,0.0021084452,0.0000378239,0.000033043332,0.00003784296,0.0014362135],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9976669,0.00040583938,0.00081383163,0.0004645404,0.0001906575,0.00045825745],"domain_scores_gemma":[0.9976192,0.001038757,0.00017485964,0.00039638177,0.00021499436,0.00055581477],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0009805902,0.00022028519,0.0006322424,0.00007667518,0.00012632865,0.000006646211,0.00014575732,0.00031057122,0.0037461575],"category_scores_gemma":[0.0001059761,0.00018455258,0.00024258795,0.00025436044,0.00058674853,0.000046835412,0.00006172393,0.0007151371,0.000572335],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00651957,0.003830618,0.8753745,0.00013610788,0.00087007094,0.00056462333,0.000051103456,0.0000023062794,0.014084838,0.000024898483,0.0675715,0.030969854],"study_design_scores_gemma":[0.005728502,0.0009364417,0.48291484,0.000021091797,0.00090728555,0.00016561491,0.000009926461,0.000386615,0.00064144615,0.00009056062,0.50804067,0.00015701655],"about_ca_topic_score_codex":0.000007438359,"about_ca_topic_score_gemma":0.0000032037374,"teacher_disagreement_score":0.44046918,"about_ca_system_score_codex":0.00008257352,"about_ca_system_score_gemma":0.00026544702,"threshold_uncertainty_score":0.99716455},"labels":[],"label_agreement":null},{"id":"W2140768254","doi":"10.1038/clpt.2009.151","title":"Risk to the Breast-Fed Neonate From Codeine Treatment to the Mother: A Quantitative Mechanistic Modeling Study","year":2009,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":137,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo","funders":"","keywords":"Codeine; Morphine; Medicine; Dosing; Opioid; Pharmacology; Pharmacokinetics; Clinical pharmacology; CYP2D6; Anesthesia; Breast feeding; Internal medicine; Pediatrics; Receptor; Cytochrome P450; Metabolism","score_opus":0.23207828621092713,"score_gpt":0.5160018537051443,"score_spread":0.28392356749421716,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2140768254","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.74028325,0.002003183,0.0075354325,0.24557833,0.00109171,0.003067384,0.00015040334,0.00009848948,0.00019179532],"genre_scores_gemma":[0.81380075,0.003205355,0.00083894515,0.18094711,0.0009027842,0.00012271554,0.000006235434,0.000030143445,0.00014594226],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99645627,0.001297277,0.00076376926,0.00062021194,0.00033070132,0.0005317657],"domain_scores_gemma":[0.995319,0.0034053158,0.00019747874,0.0004894102,0.00021121609,0.0003775891],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013893513,0.00036794876,0.0007072358,0.00004273461,0.0005775265,0.000043860175,0.00045028699,0.000119333185,0.00028232884],"category_scores_gemma":[0.00013147417,0.0001844068,0.00022109659,0.00033835648,0.00011714584,0.000046256246,0.00013644926,0.00082027627,0.00042598994],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.09409839,0.030994752,0.014801316,0.000018845903,0.036297657,0.00056605216,0.03484735,0.03616219,0.012665223,0.00040970702,0.020745438,0.7183931],"study_design_scores_gemma":[0.01841985,0.043101314,0.03203528,0.00004774618,0.026409032,0.000056779907,0.00669323,0.4318186,0.00033857988,0.0024517819,0.43774572,0.0008821013],"about_ca_topic_score_codex":0.0002895903,"about_ca_topic_score_gemma":0.00017089125,"teacher_disagreement_score":0.717511,"about_ca_system_score_codex":0.00012175514,"about_ca_system_score_gemma":0.000089342284,"threshold_uncertainty_score":0.75198907},"labels":[],"label_agreement":null},{"id":"W2141288222","doi":"10.1016/j.clpt.2003.11.104","title":"Natural health product use in Canada: patterns of use and the risk of interactions with pharmaceuticals","year":2004,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Complementary and Alternative Medicine Studies","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Clinical pharmacology; Population; Drug; Adverse effect; Drug interaction; Pharmacology; Environmental health","score_opus":0.17262110777362327,"score_gpt":0.4637054418829783,"score_spread":0.291084334109355,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2141288222","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9763595,0.0012343645,0.000065645145,0.020979658,0.0006056362,0.00069425546,0.00005195589,0.0000055951728,0.0000033906495],"genre_scores_gemma":[0.97655296,0.0054365178,0.00019549963,0.017610388,0.00015474012,0.000013121624,0.0000062318136,0.000009428635,0.000021126232],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982813,0.00044241763,0.0006984693,0.0002123213,0.00016137565,0.00020414093],"domain_scores_gemma":[0.99695873,0.0023417228,0.00032773352,0.00014880672,0.00014052479,0.00008246511],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005273173,0.00013496703,0.00061245647,0.00004991606,0.000055797238,0.0000025131474,0.00008376316,0.000006200964,0.00003195675],"category_scores_gemma":[0.000093684095,0.00007418534,0.00006278744,0.00011895736,0.0006663106,0.00006460061,0.000065492175,0.0006684606,1.950309e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025502497,0.00037425273,0.9915889,0.000054259213,0.0013504338,0.000018836292,0.00044299208,0.00003918369,0.0002810449,0.00002941014,0.00015546584,0.0031149609],"study_design_scores_gemma":[0.01571697,0.00055671186,0.9770387,0.00013014143,0.0010070356,0.000026082467,0.00049371895,0.00017223417,0.0016485443,0.000028761424,0.0031076018,0.000073512834],"about_ca_topic_score_codex":0.20147397,"about_ca_topic_score_gemma":0.36632428,"teacher_disagreement_score":0.16485032,"about_ca_system_score_codex":0.00011673088,"about_ca_system_score_gemma":0.00057511555,"threshold_uncertainty_score":0.8038435},"labels":[],"label_agreement":null},{"id":"W2141414647","doi":"10.1016/j.clpt.2004.08.019","title":"Bergamottin contribution to the grapefruit juice?felodipine interaction and disposition in humans","year":2004,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":89,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre","funders":"Medical Research Council; Pfizer","keywords":"Felodipine; Cmax; Grapefruit juice; Chemistry; Metabolite; Pharmacology; Pharmacokinetics; Crossover study; Bioavailability; Oral administration; Medicine; Biochemistry; Internal medicine; Placebo","score_opus":0.17119421496437587,"score_gpt":0.5234489298046765,"score_spread":0.35225471484030063,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2141414647","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9414852,0.0022514835,0.0010181312,0.046730217,0.00663145,0.0013160647,0.00006585357,0.00010194544,0.00039963072],"genre_scores_gemma":[0.873876,0.0045982925,0.00015134035,0.11968082,0.0013338554,0.00016706773,0.000043868276,0.00003927413,0.00010952522],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99595225,0.0013477948,0.0010753318,0.00066803175,0.00020417172,0.00075242197],"domain_scores_gemma":[0.9979858,0.0008798338,0.000270853,0.00026450996,0.00019105102,0.0004079967],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0022683279,0.00039402934,0.0005400475,0.00021397123,0.00046110534,0.000043313536,0.00047698073,0.0005243547,0.00039135656],"category_scores_gemma":[0.00005318787,0.00032325415,0.00018742656,0.0005097379,0.0005420515,0.00015442564,0.00022128841,0.0019665651,0.0003151671],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012429686,0.0110927615,0.08997863,0.00012875813,0.0041444413,0.0003870869,0.007817413,0.025116092,0.5607535,0.008578777,0.023582907,0.2559899],"study_design_scores_gemma":[0.013073861,0.0006922954,0.08864213,0.000031394724,0.0016008589,0.00004199056,0.0001751701,0.001790253,0.030585578,0.0026318897,0.86008,0.00065455097],"about_ca_topic_score_codex":0.00002008251,"about_ca_topic_score_gemma":0.000096315285,"teacher_disagreement_score":0.8364971,"about_ca_system_score_codex":0.00015178724,"about_ca_system_score_gemma":0.0001144836,"threshold_uncertainty_score":0.999922},"labels":[],"label_agreement":null},{"id":"W2141540589","doi":"10.1016/j.clpt.2004.12.098","title":"Clopidogrel use in children","year":2005,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Central Venous Catheters and Hemodialysis","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Clopidogrel; Medicine; Aspirin; Regimen; Antithrombotic; Warfarin; Ticlopidine; Population; Internal medicine; Anesthesia; Atrial fibrillation","score_opus":0.18226745382654194,"score_gpt":0.5097639497444308,"score_spread":0.3274964959178889,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2141540589","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98518676,0.0003807601,0.00007764347,0.01168887,0.0013919778,0.0007242124,0.00001864493,0.000094373725,0.00043678257],"genre_scores_gemma":[0.79460365,0.0027602478,0.00061268185,0.19848965,0.0023070658,0.00005144638,0.000022665154,0.000036885995,0.00111574],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9966973,0.0010211813,0.001051137,0.00038068963,0.000121461366,0.0007282366],"domain_scores_gemma":[0.99794453,0.0013072211,0.00021889155,0.00026681653,0.00007304637,0.00018948958],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0009213237,0.00018290684,0.00047810376,0.00009796259,0.0002614806,0.000007075736,0.00028857036,0.00046479417,0.0013647785],"category_scores_gemma":[0.000021933909,0.00015968665,0.00022468038,0.00020215593,0.00020148547,0.00011564682,0.00011779488,0.0015232856,0.0010480691],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018920907,0.00082585163,0.95899445,0.00000504234,0.00028707407,0.000003635932,0.00052428985,0.00003274131,0.00027447284,0.00003951582,0.020069137,0.01875458],"study_design_scores_gemma":[0.004069944,0.00012440402,0.6956076,0.000014432875,0.00040034775,0.000001906914,0.00005270115,0.0011554739,0.00004410547,0.00009996752,0.29820293,0.00022614712],"about_ca_topic_score_codex":0.000046426223,"about_ca_topic_score_gemma":0.0001420411,"teacher_disagreement_score":0.2781338,"about_ca_system_score_codex":0.00014477772,"about_ca_system_score_gemma":0.00017743475,"threshold_uncertainty_score":0.99972975},"labels":[],"label_agreement":null},{"id":"W2144051898","doi":"10.1038/clpt.2011.241","title":"Clearing the Smoke Around Medical Marijuana","year":2011,"lang":"en","type":"letter","venue":"Clinical Pharmacology & Therapeutics","topic":"Cannabis and Cannabinoid Research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Pfizer; Amgen","keywords":"Clinical pharmacology; Oxycodone; Chronic pain; Medicine; Opioid; Cannabis; Clinical Practice; Pharmacology; Clearing; Psychology; Psychiatry; Family medicine; Internal medicine; Business","score_opus":0.19313804329592957,"score_gpt":0.4637556231135128,"score_spread":0.2706175798175833,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2144051898","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.008921276,0.0022433426,0.000022954975,0.97601956,0.0058917208,0.0010004719,0.000017898103,0.0001322417,0.0057505216],"genre_scores_gemma":[0.001245739,0.004909782,0.000032138458,0.9367875,0.020401645,0.0001194158,0.000082925675,0.00016455793,0.036256302],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99420637,0.001105847,0.0012856376,0.00090559607,0.0013264494,0.0011701288],"domain_scores_gemma":[0.99710846,0.0007214475,0.00033137784,0.0010191527,0.0003484213,0.00047111657],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0024171113,0.0005445453,0.0011939405,0.00015712535,0.00028050857,0.000053341068,0.0013082819,0.0031992889,0.010663006],"category_scores_gemma":[0.00012164587,0.00034701597,0.000935813,0.0002862655,0.0026387111,0.000038751667,0.0005672885,0.015276989,0.0005355075],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004682899,0.00036737192,0.0022524777,0.00012879031,0.002121729,0.0020605172,0.0000635912,1.5755165e-7,0.000028632388,0.000007939069,0.9740948,0.018405674],"study_design_scores_gemma":[0.002409291,0.000761144,0.0062578283,0.00006389598,0.0025039224,0.00028575383,0.000029803432,0.00027106918,0.000045922356,0.0001750008,0.98685294,0.00034341472],"about_ca_topic_score_codex":0.00007425491,"about_ca_topic_score_gemma":0.000008691442,"teacher_disagreement_score":0.039232083,"about_ca_system_score_codex":0.00015737148,"about_ca_system_score_gemma":0.0016128267,"threshold_uncertainty_score":0.9998982},"labels":[],"label_agreement":null},{"id":"W2146907829","doi":"10.1038/sj.clpt.6100074","title":"Tackling Corruption in the Pharmaceutical Systems Worldwide with Courage and Conviction","year":2007,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"World Bank Group","keywords":"Language change; Poverty; Counterfeit; Conviction; Business; Pharmaceutical industry; Economics; Economic growth; Law; Medicine; Political science; Pharmacology","score_opus":0.33285393291899273,"score_gpt":0.4837387517086571,"score_spread":0.15088481878966437,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2146907829","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00064645824,0.99020743,0.0005203808,0.002063182,0.002899424,0.00161364,0.00015969817,0.000049424118,0.0018403399],"genre_scores_gemma":[0.0021415579,0.9666013,0.00004917535,0.029476693,0.0012984351,0.00015333416,0.000053824002,0.00009214159,0.00013352696],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9950653,0.00053258886,0.0026375214,0.00091138924,0.00007574662,0.0007774968],"domain_scores_gemma":[0.99545723,0.0027379033,0.0011044971,0.00039477093,0.00005279262,0.00025281424],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0045447955,0.0005970682,0.0023712304,0.00041226775,0.00016752136,0.00015909906,0.0006474714,0.00079553714,0.000146625],"category_scores_gemma":[0.00002966497,0.00046260154,0.00034337278,0.0006006317,0.00066668406,0.00017661335,0.000115282375,0.0025885398,0.000298744],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00087799836,0.002743795,0.007410705,0.010042801,0.0058552898,0.00045473,0.00087592046,0.00019580948,0.000002001815,0.044732176,0.010658548,0.9161502],"study_design_scores_gemma":[0.0015741332,0.0001692439,0.00013964828,0.00037645566,0.0009896725,0.00011742187,0.000032077718,0.0036583473,2.4184286e-7,0.00031282663,0.992107,0.0005229321],"about_ca_topic_score_codex":0.00001969685,"about_ca_topic_score_gemma":0.000008211848,"teacher_disagreement_score":0.9814485,"about_ca_system_score_codex":0.00022374919,"about_ca_system_score_gemma":0.00014078392,"threshold_uncertainty_score":0.99978256},"labels":[],"label_agreement":null},{"id":"W2148553478","doi":"10.1016/s0009-9236(03)00227-3","title":"Clinical and economic consequences of reference pricing for dihydropyridine calcium channel blockers","year":2003,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Medication Adherence and Compliance","field":"Medicine","cited_by":62,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Victoria","funders":"Agency for Healthcare Research and Quality","keywords":"Dihydropyridine; Medicine; Odds ratio; Confidence interval; Drug class; Drug; Demography; Internal medicine; Calcium; Pharmacology","score_opus":0.28652901146753074,"score_gpt":0.49971780329760757,"score_spread":0.21318879183007683,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2148553478","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98182464,0.0011668573,0.001460138,0.012103201,0.0015052841,0.0010602841,0.000017220953,0.000041201874,0.00082117337],"genre_scores_gemma":[0.96704006,0.0034471566,0.0021473933,0.026373213,0.00029870414,0.00007609744,0.0000075385565,0.00001700835,0.00059284107],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9979373,0.00025690914,0.0010513187,0.00040430532,0.00008825189,0.00026191305],"domain_scores_gemma":[0.99769473,0.0013480787,0.00036451864,0.0002213824,0.00013375239,0.00023755583],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012500839,0.00015594136,0.00064309884,0.000044998793,0.00006757269,0.0000046687737,0.00014543021,0.00024580376,0.00031672703],"category_scores_gemma":[0.000112479436,0.00013132025,0.00014436406,0.00006761357,0.001562461,0.000034112603,0.000027377624,0.0003995724,0.000056057903],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00479919,0.0032616719,0.80873054,0.0007655848,0.004254215,0.000042358348,0.00035909342,0.000024448782,0.07256795,0.004793661,0.07616626,0.024235042],"study_design_scores_gemma":[0.041476503,0.011685257,0.08203707,0.0004987425,0.0068147033,0.00026309048,0.00089002127,0.017276749,0.13314393,0.009213701,0.6953189,0.0013813676],"about_ca_topic_score_codex":0.0000037581804,"about_ca_topic_score_gemma":8.369847e-7,"teacher_disagreement_score":0.72669345,"about_ca_system_score_codex":0.000019759344,"about_ca_system_score_gemma":0.00043727993,"threshold_uncertainty_score":0.5756953},"labels":[],"label_agreement":null},{"id":"W2149041141","doi":"10.1038/sj.clpt.6100125","title":"Identification and Characterization of CYP2D6*56B, an Allele Associated with the Poor Metabolizer Phenotype","year":2007,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"","keywords":"CYP2D6; Genotype; Allele; Phenotype; Dextromethorphan; Pharmacogenetics; Genetics; Genotype-phenotype distinction; Biology; Allele frequency; Pharmacology; Gene","score_opus":0.15461644015628376,"score_gpt":0.4811678891458,"score_spread":0.32655144898951627,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2149041141","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9893791,0.0012427191,0.0013804318,0.0047162035,0.0020307808,0.00079790247,0.000103302234,0.000090435955,0.00025912098],"genre_scores_gemma":[0.954794,0.002519101,0.00009008934,0.041214403,0.0007717084,0.00003524962,0.00013031997,0.000059563103,0.0003855961],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9958737,0.0015955622,0.0010937987,0.00054219435,0.0002824743,0.00061229884],"domain_scores_gemma":[0.9967333,0.0013226826,0.000819225,0.0003008605,0.00048006335,0.0003438868],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0048454492,0.00035527596,0.0005925943,0.00012645502,0.00036741322,0.000028064607,0.00054357754,0.0005445583,0.00043145538],"category_scores_gemma":[0.00003867602,0.00025799664,0.00013723086,0.00043131041,0.0012523569,0.0001865277,0.000116042684,0.0011476993,0.000025470134],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017569682,0.0015233251,0.009414766,0.000015915979,0.001792686,0.000013353611,0.00089982245,0.000044961358,0.94791245,0.0002594082,0.00092053803,0.035445783],"study_design_scores_gemma":[0.0086138155,0.00075442967,0.30129823,0.000008955118,0.0065011433,0.000017193268,0.00025756643,0.0063112625,0.3296074,0.00034198366,0.34558326,0.0007047719],"about_ca_topic_score_codex":0.0000034359507,"about_ca_topic_score_gemma":0.000017287713,"teacher_disagreement_score":0.6183051,"about_ca_system_score_codex":0.000029094397,"about_ca_system_score_gemma":0.00012504618,"threshold_uncertainty_score":0.99998724},"labels":[],"label_agreement":null},{"id":"W2149799880","doi":"10.1038/clpt.2010.242","title":"Demonstrating Utility of Pharmacogenetics in Pediatric Populations: Methodological Considerations","year":2010,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Child and Family Research Institute; BC Children's Hospital; University of British Columbia","funders":"","keywords":"Pharmacogenetics; Clinical pharmacology; Quality (philosophy); Medicine; Computer science; Psychology; Intensive care medicine; Pharmacology; Biology; Genetics","score_opus":0.8109777463779481,"score_gpt":0.6636165452362309,"score_spread":0.14736120114171714,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2149799880","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.005114395,0.97511137,0.0002129707,0.000511225,0.01414845,0.0027523083,0.0005424699,0.0001520289,0.0014547763],"genre_scores_gemma":[0.0033200916,0.9775701,0.007122896,0.008411493,0.0028497707,0.0003463744,0.00014499824,0.00016245453,0.000071801594],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.97820914,0.012555641,0.00592486,0.0015219373,0.00044732488,0.0013410739],"domain_scores_gemma":[0.9815509,0.013908262,0.0026009977,0.0007519229,0.00045645394,0.00073150336],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","research_integrity"],"category_scores_codex":[0.008503218,0.0013191142,0.0049035763,0.0008032032,0.00037656448,0.0000379527,0.0012713277,0.004256419,0.0039460636],"category_scores_gemma":[0.00061686465,0.0012070119,0.0017574403,0.0012345904,0.0016565368,0.00012162067,0.00052724883,0.009797599,0.00014394175],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019457353,0.004763008,0.009221009,0.003212164,0.0016094326,0.0001859109,0.00017789142,0.00009833015,0.0004423208,0.0003090414,0.005477353,0.97430897],"study_design_scores_gemma":[0.0030055027,0.00016770288,0.0010295709,0.00017191282,0.016617533,0.00009866682,0.000015201247,0.001716516,0.00032365447,0.0017952945,0.97397566,0.0010828123],"about_ca_topic_score_codex":0.0000054138773,"about_ca_topic_score_gemma":0.000017823153,"teacher_disagreement_score":0.97322613,"about_ca_system_score_codex":0.00007007455,"about_ca_system_score_gemma":0.0016923036,"threshold_uncertainty_score":0.999956},"labels":[],"label_agreement":null},{"id":"W2150635997","doi":"10.1038/clpt.2010.303","title":"Ethical Issues in Developing Pharmacogenetic Research Partnerships With American Indigenous Communities","year":2011,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Ethics in Clinical Research","field":"Medicine","cited_by":73,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Center for Research Resources; National Institute of General Medical Sciences; Canadian Institutes of Health Research","keywords":"Indigenous; Pharmacogenetics; Economic Justice; Social justice; Clinical pharmacology; Engineering ethics; Medicine; Political science; Pharmacology; Sociology; Criminology; Engineering; Biology; Law","score_opus":0.8997290871352671,"score_gpt":0.6985059746058667,"score_spread":0.2012231125294004,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2150635997","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9354161,0.0010016176,0.00009521289,0.060305644,0.0004009084,0.0010823101,0.0000042990255,0.000118321506,0.0015755965],"genre_scores_gemma":[0.84722084,0.020459661,0.006928262,0.124245696,0.00047907518,0.00014890426,0.000010241006,0.00008945169,0.00041787754],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9896352,0.0056098257,0.0013955227,0.0006567762,0.0013185533,0.0013840776],"domain_scores_gemma":[0.9693923,0.02762476,0.00023098296,0.0008044866,0.0013754,0.00057206734],"candidate_categories":["metaepi_narrow","sts","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.019087665,0.000336911,0.0010379666,0.00043592247,0.00034976905,0.00003078581,0.0010662656,0.0011679436,0.0005200241],"category_scores_gemma":[0.0005814631,0.00027208452,0.00016944908,0.0012288697,0.009178949,0.00005704334,0.00050735293,0.018573212,0.00022110525],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01422088,0.0049858885,0.9216096,0.00045296503,0.0023447722,0.0013613456,0.030982303,0.000005890284,0.0018442753,0.0017231083,0.002978708,0.017490255],"study_design_scores_gemma":[0.029117476,0.03290254,0.6188393,0.0016002993,0.002358777,0.00034632787,0.029397994,0.00096316764,0.035816282,0.027223006,0.21893504,0.0024997578],"about_ca_topic_score_codex":0.00037616378,"about_ca_topic_score_gemma":0.0013935326,"teacher_disagreement_score":0.3027703,"about_ca_system_score_codex":0.00023803796,"about_ca_system_score_gemma":0.0023170707,"threshold_uncertainty_score":0.9999731},"labels":[],"label_agreement":null},{"id":"W2151985832","doi":"10.1038/clpt.2011.285","title":"Neuroimaging Markers of Cellular Function in Major Depressive Disorder: Implications for Therapeutics, Personalized Medicine, and Prevention","year":2012,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Treatment of Major Depression","field":"Medicine","cited_by":63,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Addiction and Mental Health; University of Toronto","funders":"","keywords":"Neuroimaging; Monoamine neurotransmitter; Anterior cingulate cortex; Neuroscience; Psychology; Prefrontal cortex; Psychiatry; Major depressive disorder; Dopamine; Anxiety; Clinical trial; Medicine; Serotonin; Internal medicine; Receptor; Mood","score_opus":0.2268093899742329,"score_gpt":0.49264736164671563,"score_spread":0.26583797167248274,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2151985832","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0007692052,0.9882484,0.0021238034,0.0035570897,0.0011328115,0.0039971163,0.0000493435,0.000057475125,0.00006477609],"genre_scores_gemma":[0.0011963594,0.99336463,0.0005578825,0.0029878488,0.0005923977,0.00057711435,0.00033594677,0.00012157883,0.0002662617],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9961987,0.0008855808,0.0015971378,0.00070526445,0.0001784862,0.00043481035],"domain_scores_gemma":[0.995617,0.002537346,0.0010639732,0.00043706238,0.00016298106,0.0001816494],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00087547937,0.00052059744,0.002203467,0.0003160867,0.00010512303,0.000007131251,0.00021264897,0.00064249244,0.000104252504],"category_scores_gemma":[0.000039033803,0.0003950199,0.00065265293,0.00025922,0.000728737,0.00008473421,0.00009528252,0.00079453323,0.000004951211],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00116506,0.0011648103,0.008875027,0.005096494,0.0027404749,0.0000036566616,0.00007298082,2.2887859e-7,0.0005041573,0.000036651756,0.0005868843,0.97975355],"study_design_scores_gemma":[0.011332215,0.0015076328,0.00743701,0.0025772178,0.05468091,0.000029061433,0.000040380506,0.00005994002,0.000013792379,0.00042403996,0.92156374,0.00033406977],"about_ca_topic_score_codex":0.0000052497653,"about_ca_topic_score_gemma":0.0000029158168,"teacher_disagreement_score":0.9794195,"about_ca_system_score_codex":0.000094889925,"about_ca_system_score_gemma":0.00022990149,"threshold_uncertainty_score":0.99985015},"labels":[],"label_agreement":null},{"id":"W2153126387","doi":"10.1067/mcp.2000.108023","title":"Pharmacokinetic and pharmacodynamic interaction between mexiletine and propafenone in human beings*1","year":2000,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Mexiletine; Propafenone; Pharmacokinetics; Pharmacology; CYP2D6; Medicine; Pharmacodynamics; Drug interaction; Oral administration; Active metabolite; Antiarrhythmic agent; Anesthesia; Cytochrome P450; Internal medicine; Metabolism; Atrial fibrillation","score_opus":0.1979069222556447,"score_gpt":0.5324100385057167,"score_spread":0.33450311625007195,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2153126387","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9840058,0.0039706766,0.000022977125,0.0056622596,0.0019333631,0.001182201,0.000078887046,0.00018950376,0.0029542993],"genre_scores_gemma":[0.9392138,0.023214782,0.00018115313,0.034615073,0.0016943117,0.00012169962,0.000051904357,0.000103237755,0.0008040133],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99373144,0.0020721112,0.0016749464,0.0011518657,0.00026512478,0.00110449],"domain_scores_gemma":[0.9972735,0.0012443918,0.00034937004,0.00026473834,0.00011595291,0.0007520642],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0023056709,0.00070306833,0.0010840439,0.000354172,0.00043611336,0.000051060364,0.0005284184,0.00071145303,0.004583297],"category_scores_gemma":[0.000016550628,0.0007076756,0.00018884255,0.00046778153,0.00134545,0.00025277064,0.0002573862,0.0031010618,0.0001490307],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016497129,0.0017130056,0.16583458,0.00012924553,0.0014921504,0.00020129875,0.0008336613,0.00036035647,0.267144,0.00005411199,0.0024789171,0.558109],"study_design_scores_gemma":[0.027841372,0.00095209887,0.11581592,0.00006334427,0.0052390355,0.00017039894,0.00012942191,0.022027165,0.043840747,0.0013292385,0.78080654,0.001784718],"about_ca_topic_score_codex":0.000033999873,"about_ca_topic_score_gemma":0.000009516707,"teacher_disagreement_score":0.77832764,"about_ca_system_score_codex":0.00008085639,"about_ca_system_score_gemma":0.000084633844,"threshold_uncertainty_score":0.9995374},"labels":[],"label_agreement":null},{"id":"W2153902825","doi":"10.1038/sj.clpt.6100448","title":"Drug Safety in Pregnant Women and Their Babies: Ignorance Not Bliss","year":2007,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pregnancy and Medication Impact","field":"Medicine","cited_by":82,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"BLISS; Clinical pharmacology; Ignorance; Medicine; Pregnancy; Population; Alternative medicine; Drug; Clinical trial; Family medicine; Intensive care medicine; Psychiatry; Pharmacology; Environmental health; Internal medicine; Computer science; Pathology; Political science; Law","score_opus":0.06821664335244795,"score_gpt":0.4213123777783116,"score_spread":0.3530957344258636,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2153902825","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9735135,0.0046292013,0.0006917864,0.017959425,0.0014158692,0.0006954639,0.000015699072,0.00008642317,0.0009926191],"genre_scores_gemma":[0.89496064,0.008943732,0.00016175298,0.09465275,0.00043156132,0.00002899338,0.0000060667585,0.00002354016,0.00079093187],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99782676,0.00023390904,0.00084322644,0.0003831403,0.00014005598,0.00057291857],"domain_scores_gemma":[0.9974051,0.001665675,0.00017123387,0.00027118524,0.0000743809,0.00041240937],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002593106,0.00020508422,0.00055188703,0.000108813336,0.00007178233,0.000006494483,0.00017331332,0.00024128232,0.00020500223],"category_scores_gemma":[0.000093480536,0.00015144935,0.0000909137,0.00022286475,0.00063056045,0.00007847074,0.00006568741,0.00080336706,0.000024823674],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014893076,0.0052227173,0.23704223,0.0004112921,0.0016917946,0.00032713177,0.022459768,0.000009673151,0.05640735,0.00016179784,0.008087543,0.6532856],"study_design_scores_gemma":[0.022426846,0.0014750556,0.5288178,0.00057845865,0.00039591914,0.00008938396,0.0016270237,0.0007323863,0.021551697,0.0009307315,0.42081848,0.0005562691],"about_ca_topic_score_codex":0.0000030985798,"about_ca_topic_score_gemma":0.00000851884,"teacher_disagreement_score":0.65272933,"about_ca_system_score_codex":0.000111443085,"about_ca_system_score_gemma":0.00021317994,"threshold_uncertainty_score":0.6175925},"labels":[],"label_agreement":null},{"id":"W2157100678","doi":"10.1038/sj.clpt.6100145","title":"Clinical Pharmacology: A Discipline Called to Action for Maternal and Child Health","year":2007,"lang":"en","type":"editorial","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Action (physics); Clinical pharmacology; Theme (computing); Medicine; Diligence; Engineering ethics; Psychology; Pharmacology; Social psychology","score_opus":0.22771736900203712,"score_gpt":0.6035752243865298,"score_spread":0.3758578553844927,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2157100678","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.008586501,0.00641532,0.0011040822,0.11342709,0.8653797,0.004172712,0.00044077783,0.00020954576,0.00026427233],"genre_scores_gemma":[0.00077148643,0.07959544,0.0022504355,0.19515571,0.7208199,0.00023561921,0.00020437788,0.00015708889,0.00080996804],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9922547,0.0011071734,0.0029441447,0.0015723777,0.00074308383,0.0013785674],"domain_scores_gemma":[0.9821531,0.013957136,0.0012006605,0.0003666025,0.0006843709,0.0016380943],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0070869145,0.0008293354,0.0027933556,0.00020906398,0.00062698295,0.00005415706,0.00047445818,0.0021459805,0.0003168682],"category_scores_gemma":[0.00053771154,0.00068572233,0.0007932602,0.00027158236,0.0009398901,0.000104075865,0.00054028956,0.0061187595,0.000099494384],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.019767016,0.0015787377,0.0011573345,0.000697728,0.00496128,0.00006514234,0.0000686318,0.0000015664652,0.00006383397,0.0000017681498,0.9158082,0.05582874],"study_design_scores_gemma":[0.0150959445,0.005880795,0.0030313265,0.00015550046,0.006800394,0.00003231799,0.000042322303,0.00042153022,0.00012712054,0.00002577967,0.9678392,0.0005477672],"about_ca_topic_score_codex":0.000018932027,"about_ca_topic_score_gemma":0.00003522655,"teacher_disagreement_score":0.14455982,"about_ca_system_score_codex":0.00029182745,"about_ca_system_score_gemma":0.00083420065,"threshold_uncertainty_score":0.9995594},"labels":[],"label_agreement":null},{"id":"W2159542081","doi":"10.1038/clpt.2008.157","title":"Pharmacogenetics of Neonatal Opioid Toxicity Following Maternal Use of Codeine During Breastfeeding: A Case–Control Study","year":2008,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Maternal Mental Health During Pregnancy and Postpartum","field":"Medicine","cited_by":306,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of British Columbia; SickKids Foundation; Pacific Centre for Reproductive Medicine; Western University","funders":"Genome British Columbia","keywords":"Medicine; Breastfeeding; Codeine; Opiate; Opioid; Depression (economics); Pediatrics; Asymptomatic; Anesthesia; Obstetrics; Internal medicine; Morphine","score_opus":0.11082312515559271,"score_gpt":0.41462047369216576,"score_spread":0.30379734853657303,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2159542081","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99557865,0.0009290916,0.00010041431,0.0004378004,0.0016340556,0.0011432846,0.00011314972,0.000051668623,0.000011903553],"genre_scores_gemma":[0.99453133,0.00079953746,0.00043672987,0.0036048624,0.0003962746,0.00002569698,0.000002949613,0.00004303788,0.00015958173],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99697286,0.00039929326,0.001465626,0.0003727232,0.0003422023,0.00044730015],"domain_scores_gemma":[0.9982137,0.0005897907,0.00047233413,0.00026521308,0.00015565554,0.00030327358],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00049450767,0.00027842214,0.0009350047,0.00011386576,0.00015187799,0.0000047476237,0.00018782006,0.0001825724,0.00021874455],"category_scores_gemma":[0.000019132915,0.0002503217,0.00030894502,0.00014558136,0.00033411683,0.00009279803,0.000114998125,0.0005656885,0.0000073274164],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0064191907,0.0025185882,0.94658697,0.0007528166,0.002159995,0.007313783,0.0006707755,0.000055647026,0.032039464,7.134539e-7,0.000032981134,0.0014490952],"study_design_scores_gemma":[0.02042714,0.003958785,0.8357015,0.00044222857,0.0033935152,0.00587553,0.00007399898,0.0010785499,0.12852125,0.000005246185,0.00024374506,0.0002784612],"about_ca_topic_score_codex":0.00003912531,"about_ca_topic_score_gemma":0.0000034310403,"teacher_disagreement_score":0.110885404,"about_ca_system_score_codex":0.000040139952,"about_ca_system_score_gemma":0.00013062112,"threshold_uncertainty_score":0.9999949},"labels":[],"label_agreement":null},{"id":"W2161620765","doi":"10.1002/cpt.147","title":"Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for <i>CYP2D6</i> and <i>CYP2C19</i> Genotypes and Dosing of Selective Serotonin Reuptake Inhibitors","year":2015,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":975,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"National Institute of General Medical Sciences; National Institute of Mental Health; National Heart, Lung, and Blood Institute","keywords":"Fluvoxamine; Escitalopram; Citalopram; CYP2C19; Paroxetine; Pharmacogenetics; Sertraline; Dosing; Medicine; Pharmacology; CYP2D6; Fluoxetine; Psychiatry; Anxiety; Serotonin; Internal medicine; Genotype; Antidepressant; Biology","score_opus":0.294731120690238,"score_gpt":0.567269353284168,"score_spread":0.27253823259393006,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2161620765","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96729636,0.014255148,0.0013213259,0.005628859,0.007798996,0.0027716062,0.0004655329,0.00012669107,0.000335463],"genre_scores_gemma":[0.8777315,0.022861347,0.010054307,0.08552342,0.0031857784,0.0002358772,0.00012186957,0.00015124372,0.00013467977],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99223787,0.0021667879,0.0032663096,0.0010658535,0.0003264328,0.00093672663],"domain_scores_gemma":[0.9937359,0.0025791677,0.0012366496,0.0002974693,0.0011128357,0.0010379445],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.006587692,0.00063449563,0.0013127226,0.00019575036,0.00032577923,0.000036996535,0.0004532022,0.00088828785,0.00013300325],"category_scores_gemma":[0.00014545229,0.0006249586,0.0003514998,0.00034919707,0.0017986282,0.00016204698,0.0003736239,0.0014446918,0.000012810674],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00837423,0.0026753552,0.26882976,0.00022909885,0.005837528,0.00004021956,0.0022733714,0.0004694693,0.23720703,0.00025787012,0.15961765,0.31418842],"study_design_scores_gemma":[0.022838846,0.001601697,0.0044578686,0.000014688391,0.005531495,0.000044917022,0.0005062493,0.0075472887,0.16707994,0.001218958,0.7883738,0.0007841996],"about_ca_topic_score_codex":0.000015607518,"about_ca_topic_score_gemma":0.000013951189,"teacher_disagreement_score":0.62875617,"about_ca_system_score_codex":0.00006332676,"about_ca_system_score_gemma":0.00062004273,"threshold_uncertainty_score":0.9996202},"labels":[],"label_agreement":null},{"id":"W2163924971","doi":"10.1016/j.clpt.2004.12.004","title":"The reproductive effects of beta interferon therapy for multiple sclerosis","year":2005,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Reproductive System and Pregnancy","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Pregnancy; Multiple sclerosis; Reproductive medicine; Cohort study; Obstetrics; Fetus; Prospective cohort study; Observational study; Live birth; Interferon beta-1b; Cohort; Physiology; Pediatrics; Internal medicine; Interferon beta; Immunology","score_opus":0.1112040781430695,"score_gpt":0.38106014438539076,"score_spread":0.2698560662423213,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2163924971","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8570428,0.114873886,0.00068720756,0.012750238,0.011538434,0.002840264,0.00002996768,0.00010135946,0.00013582456],"genre_scores_gemma":[0.98672706,0.006486333,0.0001745187,0.004255052,0.00093855563,0.0002725505,0.0000135548435,0.000036813828,0.0010955831],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99683535,0.001174844,0.0008581656,0.0006529544,0.000040541454,0.00043816655],"domain_scores_gemma":[0.9934549,0.005140656,0.0004374243,0.0006442841,0.00029435536,0.000028380478],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014245082,0.0002455325,0.0005555541,0.000042817363,0.00032902884,0.000009074967,0.0005427,0.00034736114,0.000050894912],"category_scores_gemma":[0.00012535448,0.00016020137,0.00037310793,0.00011039549,0.0011398231,0.00007358702,0.00009458521,0.00045756972,0.00009887967],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003072091,0.0010551708,0.008381384,0.00004517263,0.003237112,4.6928233e-7,0.0009801567,0.000008799048,0.81393623,0.00009641417,0.022064438,0.14712253],"study_design_scores_gemma":[0.0058564427,0.0019129749,0.01905532,0.000039904644,0.00035310467,0.0000053337503,0.000096539814,0.0000070007372,0.7201675,0.0001679567,0.25215125,0.00018666862],"about_ca_topic_score_codex":0.0000051435013,"about_ca_topic_score_gemma":0.000004044913,"teacher_disagreement_score":0.2300868,"about_ca_system_score_codex":0.000030466337,"about_ca_system_score_gemma":0.00006828896,"threshold_uncertainty_score":0.6532822},"labels":[],"label_agreement":null},{"id":"W2164985616","doi":"10.1016/s0009-9236(03)90554-6","title":"Frequency of adverse drug reactions (ADRS) in SLE","year":2003,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Analytical Methods in Pharmaceuticals","field":"Chemistry","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Drug reaction; Clinical pharmacology; Pharmacology; Drug; Medicine; Adverse effect; Adverse drug reaction","score_opus":0.1481425757128565,"score_gpt":0.4903538507634385,"score_spread":0.342211275050582,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2164985616","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9199302,0.001452245,0.0014136636,0.0039243856,0.004071613,0.0003949654,0.00004398734,0.00019902752,0.06856987],"genre_scores_gemma":[0.96333283,0.0015740551,0.016899863,0.014948668,0.0003585405,0.000046916262,0.000005352666,0.000069962705,0.002763788],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9962773,0.00087971083,0.0015620922,0.000514353,0.0002273847,0.00053918693],"domain_scores_gemma":[0.99455506,0.0042474503,0.00034136782,0.0004554311,0.00014241243,0.00025828878],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0018811043,0.0002676783,0.0006633309,0.00009893315,0.000064657186,0.0000033775739,0.000456436,0.00041013528,0.007817664],"category_scores_gemma":[0.00043275647,0.00026128357,0.00033644593,0.00037293928,0.0009539415,0.00008791569,0.00007425465,0.0014800626,0.00012442691],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039684074,0.0063568647,0.3170385,0.00032737223,0.0020028418,0.00017981739,0.00034916654,0.00023164137,0.6519786,0.009492742,0.00568654,0.005959057],"study_design_scores_gemma":[0.010769416,0.00014754699,0.00489816,0.00012226052,0.0028917687,0.000041869418,0.0006676477,0.0035206843,0.61222553,0.042792678,0.32069743,0.0012250395],"about_ca_topic_score_codex":0.000008925528,"about_ca_topic_score_gemma":0.0000038219246,"teacher_disagreement_score":0.31501088,"about_ca_system_score_codex":0.00010670767,"about_ca_system_score_gemma":0.00019028553,"threshold_uncertainty_score":0.99998397},"labels":[],"label_agreement":null},{"id":"W2165021451","doi":"10.1038/clpt.2014.88","title":"Association of CHRNA5-A3-B4 SNP rs2036527 With Smoking Cessation Therapy Response in African-American Smokers","year":2014,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Smoking Behavior and Cessation","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Addiction and Mental Health; University of Toronto","funders":"National Cancer Institute; National Institute on Drug Abuse; National Institute on Minority Health and Health Disparities; Canadian Institutes of Health Research; National Institutes of Health","keywords":"Abstinence; Smoking cessation; Medicine; Bupropion; Nicotine; Internal medicine; Odds ratio; Pharmacotherapy; SNP; Genotype; Psychiatry; Single-nucleotide polymorphism; Genetics; Biology; Pathology","score_opus":0.08890473931006727,"score_gpt":0.42910344538360223,"score_spread":0.340198706073535,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2165021451","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98850703,0.00006757671,0.0002911706,0.009808913,0.000597672,0.00041527642,0.0000045345064,0.0000674832,0.00024031848],"genre_scores_gemma":[0.9858517,0.000524248,0.0001413804,0.012973738,0.00028330248,0.000040015933,0.000018622797,0.000039791525,0.000127186],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99683976,0.0012387821,0.00076927565,0.0003662154,0.00044362078,0.00034237382],"domain_scores_gemma":[0.99672735,0.0019044883,0.0007433334,0.00026224955,0.0002557195,0.00010689133],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031133632,0.00020547133,0.00060429383,0.00021289643,0.00006406994,0.000011576654,0.00015858296,0.00027813163,0.000125134],"category_scores_gemma":[0.00011813903,0.00017166884,0.00013707882,0.0005644563,0.00035167558,0.00007969051,0.000022007474,0.0006932515,0.000002813905],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008378314,0.0007613675,0.9540938,0.000011580567,0.0004281075,0.0000068111717,0.00072929414,0.000058800215,0.012774764,0.0000054403395,0.00042985813,0.022321835],"study_design_scores_gemma":[0.0080967415,0.002938003,0.97110814,0.000041209598,0.0007713186,0.0000042806946,0.0002756339,0.00045455477,0.0072125434,0.00005172642,0.008862043,0.00018380399],"about_ca_topic_score_codex":0.000040841547,"about_ca_topic_score_gemma":0.000011516053,"teacher_disagreement_score":0.022138031,"about_ca_system_score_codex":0.00029426493,"about_ca_system_score_gemma":0.0001955753,"threshold_uncertainty_score":0.7000452},"labels":[],"label_agreement":null},{"id":"W2166210552","doi":"10.1002/cpt.280","title":"Pharmacogenetic allele nomenclature: International workgroup recommendations for test result reporting","year":2015,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":180,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Institute of General Medical Sciences; National Institutes of Health; National Cancer Institute; National Human Genome Research Institute; National Institute on Drug Abuse; Wellcome Trust","keywords":"Workgroup; Standardization; Confusion; Pharmacogenetics; Nomenclature; Chemical nomenclature; Transparency (behavior); Computer science; Computational biology; Medicine; Biology; Genetics; Psychology; Gene; Taxonomy (biology); Genotype","score_opus":0.7130136977464977,"score_gpt":0.6624251810135845,"score_spread":0.0505885167329132,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2166210552","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000049571532,0.94263655,0.00032420995,0.008199697,0.039715666,0.004230896,0.0023136993,0.00037103007,0.0021587021],"genre_scores_gemma":[0.000023064265,0.92802256,0.0035182037,0.048920814,0.01167749,0.0016144167,0.0024443932,0.0003642593,0.00341477],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.98494387,0.002802541,0.007855088,0.0020792778,0.0005627231,0.0017564875],"domain_scores_gemma":[0.9821507,0.0073367604,0.007162268,0.00083754846,0.0011937754,0.0013189776],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","research_integrity"],"category_scores_codex":[0.009809626,0.0016086632,0.0042498275,0.0005695795,0.0006781565,0.00012974383,0.0026784332,0.0030035295,0.0023401727],"category_scores_gemma":[0.0007784889,0.0015000642,0.0023845527,0.0008527177,0.0008958586,0.00018613788,0.0008098893,0.0057497257,0.0005914902],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000267554,0.0015839398,0.00006952116,0.0007152391,0.004761472,0.00006612197,0.0001173798,0.000020952852,0.00015044675,0.000018983304,0.34735715,0.64487123],"study_design_scores_gemma":[0.005643948,0.00032887913,0.0000048111197,0.00031222173,0.02015956,0.00013456876,0.00003092187,0.0010981644,0.000118684875,0.00040657452,0.97036463,0.0013970556],"about_ca_topic_score_codex":0.0000020502064,"about_ca_topic_score_gemma":0.0000022515728,"teacher_disagreement_score":0.6434742,"about_ca_system_score_codex":0.00045490157,"about_ca_system_score_gemma":0.0018605435,"threshold_uncertainty_score":0.9996661},"labels":[],"label_agreement":null},{"id":"W2167566912","doi":"10.1016/j.clpt.2004.12.198","title":"Renal ontogeny of ifosfamide nephrotoxicity","year":2005,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Chemotherapy-induced organ toxicity mitigation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Nephrotoxicity; CYP3A; Ontogeny; Kidney; Internal medicine; Ifosfamide; Endocrinology; Biology; Microsome; Metabolism; Cytochrome P450; Medicine; Enzyme; Biochemistry; Chemotherapy; Cisplatin","score_opus":0.09245326862491451,"score_gpt":0.4327089877712129,"score_spread":0.3402557191462984,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2167566912","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97473514,0.00035340703,0.000476961,0.022213934,0.00062664656,0.0006827129,0.000010464992,0.00012142099,0.0007792951],"genre_scores_gemma":[0.87994105,0.00058971293,0.0043018903,0.11239385,0.0022487154,0.00001528875,0.000012977131,0.00004929118,0.00044720317],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9976209,0.00025836143,0.0010755609,0.00039421537,0.00028341397,0.00036754037],"domain_scores_gemma":[0.9982088,0.00052586664,0.00034454325,0.0003735438,0.00030264028,0.0002445931],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007243918,0.00023305694,0.00064741215,0.00009686909,0.0000631901,0.0000057683546,0.00022592543,0.0004274944,0.0012039047],"category_scores_gemma":[0.000064064196,0.00021602484,0.00033556655,0.00023886461,0.00057750085,0.00008015429,0.00005849163,0.0007760449,0.0001465995],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009820625,0.0014850282,0.013865038,0.000028123617,0.0008203574,0.000012009082,0.00021437148,0.000018512377,0.9423484,0.000016844617,0.013076072,0.027133148],"study_design_scores_gemma":[0.0059418604,0.000764368,0.03989667,0.00002808152,0.00088988635,0.00003495996,0.0000234021,0.001069196,0.8635231,0.00013616306,0.08749228,0.00019997724],"about_ca_topic_score_codex":0.0000048291818,"about_ca_topic_score_gemma":0.000009609309,"teacher_disagreement_score":0.09479409,"about_ca_system_score_codex":0.00013726405,"about_ca_system_score_gemma":0.0002707829,"threshold_uncertainty_score":0.9997091},"labels":[],"label_agreement":null},{"id":"W2167742437","doi":"10.1038/clpt.2013.235","title":"Progress in Pharmacogenomics: Bridging the Gap From Research to Practice","year":2014,"lang":"en","type":"editorial","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Institute on Drug Abuse; Canadian Institutes of Health Research","keywords":"Pharmacogenomics; Clinical pharmacology; Pharmacogenetics; Viewpoints; Drug response; Epigenetics; Clinical Practice; Computational biology; Medicine; Pharmacology; Bioinformatics; Drug; Biology; Gene; Genetics; Genotype","score_opus":0.356520977217391,"score_gpt":0.6184123225768028,"score_spread":0.2618913453594118,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2167742437","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.013731139,0.0276696,0.00019177745,0.04641797,0.90550554,0.0037321544,0.0010341138,0.00024246617,0.0014752415],"genre_scores_gemma":[0.0060101836,0.031244775,0.0010259718,0.15343302,0.80515426,0.0011468082,0.00040101167,0.0004325769,0.0011513687],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9661878,0.022611946,0.0034172852,0.0027263467,0.0019339891,0.0031226699],"domain_scores_gemma":[0.9420042,0.05181961,0.0012419965,0.0014432122,0.0020899384,0.0014010418],"candidate_categories":["metaepi_narrow","sts","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"category_scores_codex":[0.027868332,0.0014763365,0.0023390201,0.0008215249,0.001105474,0.00026275235,0.005159721,0.0045749126,0.0014415844],"category_scores_gemma":[0.0015630982,0.0012621483,0.0007712011,0.0015906817,0.0029600775,0.00022736438,0.0020668986,0.023511693,0.0028643461],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004196947,0.002046087,0.0007627141,0.00006484191,0.0028317005,0.00025824658,0.0011814521,0.00042115457,0.0021490194,0.00001719082,0.8956122,0.090458475],"study_design_scores_gemma":[0.0075505343,0.00047152996,0.00017010527,0.00007436122,0.0041593006,0.000009071333,0.00018017938,0.0028979066,0.0017640234,0.00039111052,0.9810588,0.0012730901],"about_ca_topic_score_codex":0.00011309971,"about_ca_topic_score_gemma":0.000062011226,"teacher_disagreement_score":0.10701505,"about_ca_system_score_codex":0.0005871999,"about_ca_system_score_gemma":0.0019807587,"threshold_uncertainty_score":0.9997986},"labels":[],"label_agreement":null},{"id":"W2168040447","doi":"10.1002/cpt.98","title":"Cannabinoids suppress acute and anticipatory nausea in preclinical rat models of conditioned gaping","year":2015,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Cannabis and Cannabinoid Research","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research","keywords":"Nausea; Vomiting; Antiemetic; Medicine; Anesthesia; Pharmacology; Psychology","score_opus":0.2642276612433556,"score_gpt":0.5072025898914954,"score_spread":0.24297492864813974,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2168040447","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97029805,0.002337744,0.00006615694,0.025145784,0.0010101792,0.0007416569,0.000031399308,0.000040675117,0.00032833137],"genre_scores_gemma":[0.9782308,0.0020270052,0.000159092,0.01793949,0.00028810027,0.00007221458,0.00002469151,0.00004043219,0.001218191],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99692416,0.0006008499,0.0011111478,0.00048678444,0.0003732082,0.0005038189],"domain_scores_gemma":[0.9982667,0.00023019972,0.00018900198,0.0003146317,0.00044003615,0.0005594515],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018060323,0.00021804599,0.0008735973,0.00017963644,0.000048324175,0.000013116514,0.00020944935,0.00042116505,0.00012237369],"category_scores_gemma":[0.00008080545,0.00019173365,0.00017844484,0.00025480997,0.0012793554,0.00012241573,0.00018719409,0.0010121778,0.000008135504],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.026140014,0.011283557,0.27671465,0.0008938362,0.0055644345,0.0016462315,0.0047486853,0.0009186085,0.14044356,0.00060192053,0.51241064,0.01863383],"study_design_scores_gemma":[0.15292384,0.022948459,0.35410428,0.0006786209,0.012033456,0.000744743,0.0029250304,0.16744825,0.07348145,0.010567502,0.19936688,0.0027774698],"about_ca_topic_score_codex":0.000020749469,"about_ca_topic_score_gemma":0.000010036236,"teacher_disagreement_score":0.31304377,"about_ca_system_score_codex":0.000083245286,"about_ca_system_score_gemma":0.0008033809,"threshold_uncertainty_score":0.7818671},"labels":[],"label_agreement":null},{"id":"W2168285948","doi":"10.1038/clpt.2011.325","title":"Current Understanding of Rheumatoid Arthritis Therapy","year":2012,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":99,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; McGill University; McGill University Health Centre","funders":"","keywords":"Rheumatoid arthritis; Medicine; Intensive care medicine; Current (fluid); Arthritis; Internal medicine; Engineering","score_opus":0.41308115145794067,"score_gpt":0.5159239256736493,"score_spread":0.10284277421570864,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2168285948","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00017423769,0.993254,0.00014229181,0.0004339268,0.0038080153,0.0017797699,0.000065524735,0.00010991894,0.00023231535],"genre_scores_gemma":[0.00046144583,0.9964294,0.00010562571,0.0016426349,0.00093198364,0.00013428829,0.00010631781,0.00015941223,0.000028900236],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99429286,0.0012920798,0.0023381808,0.0006107661,0.00052279705,0.0009433082],"domain_scores_gemma":[0.9958927,0.0018502275,0.0009059121,0.00059565675,0.0001877832,0.0005677303],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0015388094,0.0006847523,0.004084408,0.00035489068,0.00015682347,0.00002513513,0.0004829085,0.00075565866,0.0012474017],"category_scores_gemma":[0.000028044753,0.00052533066,0.0017521298,0.00042963668,0.0014419104,0.00010060468,0.00016081275,0.0022965523,0.00024535353],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024909488,0.001469897,0.00028099975,0.001663091,0.0036664626,0.000023088633,0.00008347691,3.152947e-8,0.000008931867,0.00015341573,0.0038985917,0.9885029],"study_design_scores_gemma":[0.0038902706,0.00079393544,0.000025241327,0.0071464223,0.0003512426,0.00017284045,0.000028753413,0.0000046442615,0.000015745069,0.00022958443,0.9869444,0.00039693428],"about_ca_topic_score_codex":0.0000020959696,"about_ca_topic_score_gemma":0.0000012824754,"teacher_disagreement_score":0.988106,"about_ca_system_score_codex":0.00019516158,"about_ca_system_score_gemma":0.0010125248,"threshold_uncertainty_score":0.9997198},"labels":[],"label_agreement":null},{"id":"W2168739582","doi":"10.1016/s0009-9236(01)90120-1","title":"Deficient C‐oxidation of nicotine continued","year":2001,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Nicotinic Acetylcholine Receptors Study","field":"Biochemistry, Genetics and Molecular Biology","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Nicotine; Pharmacology; Chemistry; Medicine; Internal medicine","score_opus":0.053980509274,"score_gpt":0.41097425320951797,"score_spread":0.35699374393551797,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2168739582","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9935532,0.0009658914,0.0016015541,0.0014252656,0.0013887907,0.00032360735,0.0000075213698,0.000023682704,0.0007104839],"genre_scores_gemma":[0.98482406,0.002780563,0.0005733931,0.010251159,0.0007688687,0.000015664062,0.00005685423,0.0000307087,0.0006987034],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981197,0.0003192257,0.0007362497,0.00039282878,0.00013413459,0.00029784697],"domain_scores_gemma":[0.99891806,0.00013137293,0.00031965622,0.0003233078,0.00021275178,0.00009486102],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006514443,0.00017873124,0.0003320834,0.00003686384,0.0000542574,0.0000051913717,0.00032731367,0.00027487573,0.00017442928],"category_scores_gemma":[0.000048774746,0.0001664883,0.00021052058,0.00014619235,0.0003336699,0.000003057306,0.00016001408,0.00024014573,0.000043081007],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048437805,0.0010011722,0.05716297,0.000006233773,0.00042014965,5.45359e-7,0.0000315104,0.00003010533,0.9233325,0.000010933859,0.01222155,0.005297944],"study_design_scores_gemma":[0.003730279,0.0011376605,0.006379022,0.0000060829684,0.00040117992,0.000014085174,0.0000621714,0.00016519683,0.6161387,0.000022211045,0.3716983,0.00024511776],"about_ca_topic_score_codex":0.0000022131076,"about_ca_topic_score_gemma":0.000004511511,"teacher_disagreement_score":0.35947675,"about_ca_system_score_codex":0.000012257237,"about_ca_system_score_gemma":0.000091142596,"threshold_uncertainty_score":0.6789196},"labels":[],"label_agreement":null},{"id":"W2168886412","doi":"10.1038/clpt.2014.150","title":"Inflammation: The Dynamic Force of Health and Disease","year":2014,"lang":"en","type":"editorial","venue":"Clinical Pharmacology & Therapeutics","topic":"Adipokines, Inflammation, and Metabolic Diseases","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Inflammation; Clinical pharmacology; Disease; Medicine; Drug development; Happiness; Balance (ability); Immune system; Drug; Clinical disease; Intensive care medicine; Immunology; Pharmacology; Psychology; Internal medicine; Physical therapy; Psychotherapist","score_opus":0.04048254774790951,"score_gpt":0.4185567842207609,"score_spread":0.37807423647285143,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2168886412","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.020635448,0.031344384,0.0005778992,0.040659618,0.90416455,0.0020869416,0.00022146886,0.00013332849,0.00017633331],"genre_scores_gemma":[0.008561625,0.050014727,0.00014475778,0.035230838,0.9008185,0.00012410793,0.0011067617,0.00011810967,0.0038805506],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99646455,0.000813092,0.0014878103,0.00042708623,0.0004780007,0.0003294596],"domain_scores_gemma":[0.9942731,0.0030810947,0.0010695453,0.0005158057,0.00046656438,0.0005938645],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014977241,0.00033385787,0.0011184824,0.0000868817,0.00016557118,0.000014264922,0.00028505464,0.00051111035,0.000080203914],"category_scores_gemma":[0.00073846785,0.00022804941,0.00032023608,0.000120958575,0.0010078715,0.000047608937,0.00009626132,0.0009271119,0.000017230344],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012862629,0.00024309862,0.0013579543,0.00088990974,0.001190308,0.000004906053,0.00018030014,0.000007507264,0.000046512614,0.000047147947,0.96209025,0.03265583],"study_design_scores_gemma":[0.0030571904,0.0004221219,0.0044602337,0.00013186653,0.0037897285,0.0000019297993,0.000028470276,0.00078031723,0.0000066274465,0.00053186173,0.9866095,0.00018011237],"about_ca_topic_score_codex":0.000003837727,"about_ca_topic_score_gemma":0.000002931267,"teacher_disagreement_score":0.032475717,"about_ca_system_score_codex":0.000047298,"about_ca_system_score_gemma":0.00254518,"threshold_uncertainty_score":0.9299585},"labels":[],"label_agreement":null},{"id":"W2169510951","doi":"10.1002/cpt.186","title":"Targeting the gastrointestinal tract to develop novel therapies for HIV","year":2015,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"HIV-related health complications and treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Public Health Agency of Canada","funders":"","keywords":"Human immunodeficiency virus (HIV); Gastrointestinal tract; Antiretroviral therapy; Medicine; Pathogenesis; Immunology; Intensive care medicine; Viral load; Internal medicine","score_opus":0.31660872934648343,"score_gpt":0.5375770974254633,"score_spread":0.2209683680789799,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2169510951","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00004192391,0.96991074,0.0048135254,0.01861521,0.0009894528,0.005181672,0.00018240127,0.000116759795,0.00014830605],"genre_scores_gemma":[0.000014036675,0.94649404,0.020104017,0.029381966,0.0014447785,0.0011231423,0.0003508117,0.0001304339,0.000956785],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9964488,0.00039042826,0.0016833782,0.0006347446,0.00020657788,0.0006360809],"domain_scores_gemma":[0.9943339,0.003275137,0.00061773637,0.0004526891,0.0008833458,0.00043718953],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0017069684,0.000519204,0.0018983544,0.00011836303,0.00031371939,0.000021157803,0.00047170222,0.00040087636,0.0000827986],"category_scores_gemma":[0.00018075039,0.00030794923,0.00049581425,0.0005265635,0.00025608874,0.000025629879,0.000101723825,0.0013575401,0.0004492026],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035854362,0.002625155,0.0005744556,0.0020762032,0.0019864624,0.000026924476,0.00025564033,0.000005230391,0.000010999797,0.0000434792,0.1197318,0.8723051],"study_design_scores_gemma":[0.002114737,0.00096452376,0.00013223692,0.0014266423,0.0073469654,0.0002857371,0.000033206386,0.00013350803,3.2743546e-7,0.000026682592,0.9872973,0.00023814279],"about_ca_topic_score_codex":0.0000011483802,"about_ca_topic_score_gemma":4.5233136e-7,"teacher_disagreement_score":0.872067,"about_ca_system_score_codex":0.00024869383,"about_ca_system_score_gemma":0.0022447857,"threshold_uncertainty_score":0.99993724},"labels":[],"label_agreement":null},{"id":"W2169845877","doi":"10.1038/clpt.2014.144","title":"Adjusted Indirect Treatment Comparison of the Bioavailability of WHO-Prequalified First-Line Generic Antituberculosis Medicines","year":2014,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Canada","funders":"World Health Organization","keywords":"Bioequivalence; Interchangeability; Medicine; Confidence interval; Pharmacology; Bioavailability; Innovator; Clinical pharmacology; Isoniazid; Ethambutol; Pyrazinamide; Internal medicine; Tuberculosis; Computer science","score_opus":0.2971360709396938,"score_gpt":0.4304960972344246,"score_spread":0.13336002629473082,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2169845877","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9793091,0.0024389233,0.0002055084,0.013198138,0.0019813643,0.00044631044,0.00019854163,0.000024755445,0.0021973562],"genre_scores_gemma":[0.9805212,0.0037795084,0.00010145806,0.015057291,0.00039521363,0.000020439653,0.000008073249,0.00002572463,0.000091090755],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99679786,0.00027603112,0.002103971,0.00044194242,0.000048304508,0.00033190908],"domain_scores_gemma":[0.99686086,0.0012653499,0.0011149276,0.00054013875,0.0000761758,0.00014255458],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012279721,0.0002471634,0.0013582209,0.000108466076,0.000100249476,0.000007850175,0.0005445356,0.00027452022,0.00045370884],"category_scores_gemma":[0.00010555023,0.00019265841,0.00046025022,0.0003143917,0.0008753675,0.000047831723,0.0001265882,0.00030013683,0.000061817795],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003086128,0.0023209641,0.9744973,0.0001239184,0.0016562379,3.3632404e-7,0.00058075006,0.0006714933,0.0010299087,0.0035057564,0.0039752456,0.011329478],"study_design_scores_gemma":[0.0083905,0.0021149344,0.34185332,0.000038521157,0.001183926,0.0000020629882,0.000040093062,0.091849975,0.036288306,0.007821752,0.5097827,0.00063393876],"about_ca_topic_score_codex":0.00007568697,"about_ca_topic_score_gemma":0.00006702463,"teacher_disagreement_score":0.632644,"about_ca_system_score_codex":0.000082497776,"about_ca_system_score_gemma":0.00005406303,"threshold_uncertainty_score":0.7856382},"labels":[],"label_agreement":null},{"id":"W2292946704","doi":"10.1002/cpt.364","title":"Disease–drug database for pharmacogenomic‐based prescribing","year":2016,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Public Health Ontario; National Institute of General Medical Sciences; National Heart, Lung, and Blood Institute; National Institutes of Health","keywords":"Pharmacogenomics; Drug; Disease; Medicine; Database; Pharmacology; Computer science; Internal medicine","score_opus":0.3552165596201565,"score_gpt":0.5361870192128482,"score_spread":0.18097045959269165,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2292946704","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8207426,0.015121182,0.026538419,0.0850265,0.038407106,0.0060446793,0.0057311566,0.0010747616,0.0013135702],"genre_scores_gemma":[0.74277735,0.007723805,0.0023631752,0.23736376,0.005869095,0.00086639595,0.00016917774,0.0002486964,0.0026185326],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9927416,0.0020518077,0.0017174796,0.0014441508,0.00036881756,0.0016761783],"domain_scores_gemma":[0.9906462,0.0059542432,0.0006037757,0.0007034173,0.0004692744,0.001623105],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0034412271,0.00081516424,0.00096244237,0.0002628354,0.0006501977,0.000043026583,0.0014481329,0.0004933511,0.0037848756],"category_scores_gemma":[0.00014391435,0.000630934,0.0008904813,0.000316953,0.0012960219,0.0002694474,0.00034218866,0.0012101834,0.0005664401],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00870327,0.0029933283,0.015292151,0.00014354182,0.0024440533,0.000110526424,0.000108992,0.0003192054,0.6230169,0.0002893455,0.26583293,0.080745734],"study_design_scores_gemma":[0.016786426,0.00016242238,0.0011331494,0.000031802396,0.004065063,0.0000057301063,0.000013200868,0.010417029,0.13265958,0.0006885044,0.8331892,0.00084792153],"about_ca_topic_score_codex":0.0000025544412,"about_ca_topic_score_gemma":0.0000021118017,"teacher_disagreement_score":0.5673562,"about_ca_system_score_codex":0.00014160754,"about_ca_system_score_gemma":0.00070695946,"threshold_uncertainty_score":0.9996142},"labels":[],"label_agreement":null},{"id":"W2295757311","doi":"10.1002/cpt.366","title":"The complex interplay of diet, xenobiotics, and microbial metabolism in the gut: Implications for clinical outcomes","year":2016,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Diet and metabolism studies","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Bill and Melinda Gates Foundation","keywords":"Xenobiotic; Drug metabolism; Metabolism; Microbial metabolism; Physiology; Medicine; Biology; Internal medicine; Biochemistry; Bacteria; Genetics","score_opus":0.31136748687768595,"score_gpt":0.5701217997395129,"score_spread":0.258754312861827,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2295757311","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0002894953,0.96869546,0.00004626419,0.023525802,0.0040125847,0.0029564865,0.0003062363,0.00002313762,0.00014451971],"genre_scores_gemma":[0.00026145822,0.97765464,0.00027437112,0.019638816,0.0015664744,0.00022959716,0.00003843504,0.00005662835,0.00027956557],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9948092,0.0012396973,0.0027829532,0.0005491043,0.00012388514,0.0004951232],"domain_scores_gemma":[0.9797108,0.018330231,0.0009514892,0.0006398709,0.00024731847,0.00012025744],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0033768197,0.00047853985,0.0035396838,0.00009350437,0.00021732853,0.000021136771,0.0007653206,0.0005655776,0.000017251354],"category_scores_gemma":[0.00036490362,0.0002061382,0.0015841103,0.00017384654,0.0024499174,0.000026444663,0.00029191328,0.001044638,0.000014646601],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00054647314,0.0010430297,0.0036567582,0.0011015756,0.005953837,0.0000023229074,0.00014999884,7.0402573e-9,0.000017587112,0.0008550518,0.058053132,0.9286202],"study_design_scores_gemma":[0.0027255132,0.0003641496,0.043102857,0.00038650824,0.012585805,0.000008227951,0.000034905454,9.735425e-7,3.8794207e-7,0.00031845697,0.94028056,0.00019164321],"about_ca_topic_score_codex":0.0000015778339,"about_ca_topic_score_gemma":0.000010041851,"teacher_disagreement_score":0.9284286,"about_ca_system_score_codex":0.000023723858,"about_ca_system_score_gemma":0.00031549486,"threshold_uncertainty_score":0.9026823},"labels":[],"label_agreement":null},{"id":"W2316038236","doi":"10.1002/cpt.376","title":"Maternal use of selective serotonin‐reuptake inhibitors and risk of persistent pulmonary hypertension of the newborn","year":2016,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Maternal Mental Health During Pregnancy and Postpartum","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Persistent pulmonary hypertension; Medicine; Pregnancy; Pulmonary hypertension; Population; Prenatal exposure; Pediatrics; Intensive care medicine; Internal medicine; Gestation; Environmental health; Biology","score_opus":0.0875578418309108,"score_gpt":0.36197586267468057,"score_spread":0.27441802084376976,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2316038236","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99572235,0.00081909314,0.0000056569675,0.001955458,0.00088850054,0.0005227757,0.000047719113,0.000009639904,0.000028829425],"genre_scores_gemma":[0.9912902,0.005734507,0.00018892167,0.0024218902,0.00010373713,0.000008015326,6.0150256e-7,0.0000152394405,0.00023687143],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983461,0.00038215562,0.0007249733,0.00019677744,0.0001657539,0.00018422167],"domain_scores_gemma":[0.99831533,0.00071350264,0.00050428585,0.00019411885,0.00016883828,0.00010394386],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003422686,0.00012735801,0.00044534006,0.00003868837,0.000046495537,0.0000012063041,0.00010218789,0.00016011883,0.000037592177],"category_scores_gemma":[0.000029513127,0.00006722838,0.00025489618,0.00007353185,0.00062172377,0.000041621468,0.00009928271,0.00026450588,0.0000019726465],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032131262,0.0005377463,0.9326101,0.00043194593,0.0006920995,0.000008803569,0.0001003078,0.000003245296,0.05461607,0.0000031046613,0.00008656986,0.00769688],"study_design_scores_gemma":[0.0019698828,0.0012157563,0.808415,0.0010896244,0.0013228268,0.00006741815,0.000017281374,0.00015550059,0.18407789,0.00003220616,0.0015734589,0.000063161264],"about_ca_topic_score_codex":0.000046424473,"about_ca_topic_score_gemma":0.0000019495794,"teacher_disagreement_score":0.12946181,"about_ca_system_score_codex":0.000023521226,"about_ca_system_score_gemma":0.00007897764,"threshold_uncertainty_score":0.2741494},"labels":[],"label_agreement":null},{"id":"W2316079417","doi":"10.1016/j.clpt.2005.12.020","title":"OII-C-3Prenatal multivitamin supplementation and the rates of leukemia and two common pediatric tumours: A meta-analysis","year":2006,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Multivitamin; Meta-analysis; Odds ratio; Pediatrics; Pregnancy; MEDLINE; Confidence interval; Neuroblastoma; Internal medicine; Vitamin","score_opus":0.13519955733451736,"score_gpt":0.47635645515316544,"score_spread":0.3411568978186481,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2316079417","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9733867,0.008099247,0.00013832349,0.017387453,0.00018935761,0.0006292403,0.00008195166,0.000027579961,0.00006016601],"genre_scores_gemma":[0.98180556,0.0015215274,0.00050897116,0.015451609,0.00048381035,0.000041205338,0.00007316399,0.000019894058,0.00009424064],"study_design_codex":"observational","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9967504,0.0012428333,0.0011260079,0.00038021096,0.00026656722,0.00023395535],"domain_scores_gemma":[0.9947137,0.004317815,0.0005019237,0.0002526322,0.00011525161,0.000098632045],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022453244,0.00022243091,0.0014387124,0.00013617158,0.000096738055,0.000016841319,0.00013477838,0.00011778211,0.00017848263],"category_scores_gemma":[0.00003192916,0.00014811006,0.00062240026,0.00036135572,0.000948245,0.00006160182,0.00010223293,0.00043950664,0.0000029154546],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003377023,0.0012670464,0.8701781,0.00019790455,0.115107715,0.000025516696,0.0016056289,0.00015230017,0.0013308417,0.0002653306,0.00530794,0.0011846676],"study_design_scores_gemma":[0.0258086,0.0006046416,0.320242,0.000003802593,0.6425746,0.0000209343,0.00038808878,0.0042293007,0.0040324624,0.0008995601,0.00090277044,0.00029323148],"about_ca_topic_score_codex":0.00056415,"about_ca_topic_score_gemma":0.0003805669,"teacher_disagreement_score":0.5499361,"about_ca_system_score_codex":0.0000325638,"about_ca_system_score_gemma":0.00010285609,"threshold_uncertainty_score":0.6039753},"labels":[],"label_agreement":null},{"id":"W2317752050","doi":"10.1016/j.clpt.2005.12.064","title":"PI-43Gene expression in human mononuclear cells in response to reactive sulfonamide metabolites","year":2006,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Medical Imaging and Pathology Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Peripheral blood mononuclear cell; Gene expression; Apoptosis; Molecular biology; Gene; Jurkat cells; RNA; Metabolite; Chemistry; Biology; Pharmacology; Immune system; Biochemistry; Immunology; T cell; In vitro","score_opus":0.08365145022968416,"score_gpt":0.44767528110079063,"score_spread":0.36402383087110646,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2317752050","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98153996,0.0010659869,0.00006830169,0.0154298,0.0007531938,0.00051627407,0.000009251355,0.000065752225,0.0005514695],"genre_scores_gemma":[0.94568723,0.00037712473,0.0016382862,0.0508075,0.00049015105,0.000052825933,0.0000094713105,0.000037191843,0.00090023567],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9965279,0.0013128222,0.00091943407,0.00054297573,0.00018818694,0.00050865137],"domain_scores_gemma":[0.9974747,0.0018469406,0.00013124262,0.0002707941,0.00008637182,0.00018997243],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002094399,0.00023839071,0.00078282115,0.0002669022,0.00007869503,0.000006352321,0.00017997745,0.0003056118,0.000110372304],"category_scores_gemma":[0.00013180985,0.00020129215,0.00013631859,0.0003314173,0.00052939734,0.000041782398,0.00013031827,0.0010537775,0.00008755202],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00432506,0.0014069214,0.07173592,0.000012960626,0.00008724382,0.00044800076,0.0004700273,0.000040277802,0.91185856,0.000004873834,0.008511492,0.0010986868],"study_design_scores_gemma":[0.009262874,0.0010723589,0.707298,0.00011711151,0.0004805863,0.00001975398,0.00025089076,0.00019248656,0.19059926,0.00061427854,0.08974128,0.00035113058],"about_ca_topic_score_codex":0.000038280275,"about_ca_topic_score_gemma":0.000018777191,"teacher_disagreement_score":0.7212593,"about_ca_system_score_codex":0.00008431646,"about_ca_system_score_gemma":0.00009398024,"threshold_uncertainty_score":0.82084554},"labels":[],"label_agreement":null},{"id":"W2318253638","doi":"10.1016/j.clpt.2005.12.033","title":"PI-12Amantadine acetylation as a biomarker for malignancy","year":2006,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Sputum; Medicine; Internal medicine; Gastroenterology; Urine; Biomarker; Cancer; Bladder cancer; Amantadine; Lung cancer; Malignancy; Pharmacology; Pathology; Tuberculosis; Biology","score_opus":0.05670395556665674,"score_gpt":0.4073980869101964,"score_spread":0.35069413134353966,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2318253638","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96574813,0.011592953,0.0056402036,0.004660506,0.0096216425,0.0010057181,0.00008026247,0.000062153886,0.001588453],"genre_scores_gemma":[0.9169663,0.00738227,0.001795868,0.05126575,0.01526977,0.00021914228,0.00046179356,0.00009816435,0.0065409015],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9983646,0.00014859442,0.0005333505,0.00047981722,0.00009226462,0.0003813657],"domain_scores_gemma":[0.99920386,0.00010864503,0.0001831885,0.00025555847,0.00015504398,0.0000936739],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004290934,0.00021248918,0.0002926165,0.000041354535,0.00011416569,0.00001567222,0.00022492297,0.00038436285,0.00012591998],"category_scores_gemma":[0.000018148303,0.00020240013,0.00029974367,0.00009309634,0.00024250893,0.00000541203,0.00006935391,0.00014871507,0.000036973655],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009718944,0.00043105797,0.0016548495,0.00001602425,0.00039393065,0.0000012566154,0.000010554192,0.000019406601,0.81545955,0.000094096875,0.16498911,0.01595825],"study_design_scores_gemma":[0.0036344433,0.0004333742,0.007835643,0.0000040788855,0.00047526698,0.000011478247,0.0000075198827,0.00029773006,0.07933786,0.0006066271,0.9071097,0.00024628435],"about_ca_topic_score_codex":0.000009904838,"about_ca_topic_score_gemma":0.00001520368,"teacher_disagreement_score":0.74212056,"about_ca_system_score_codex":0.000013456442,"about_ca_system_score_gemma":0.00013568653,"threshold_uncertainty_score":0.82536376},"labels":[],"label_agreement":null},{"id":"W2318810481","doi":"10.1016/j.clpt.2005.12.223","title":"PIII-15Prioritizing treatment preferences in patients with type 2 diabetes","year":2006,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacology and Obesity Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Pill; Autonomy; Type 2 diabetes; Statement (logic); Diabetes management; Diabetes mellitus; Scale (ratio); Family medicine; Visual analogue scale; Set (abstract data type); Clinical pharmacology; Diabetes treatment; Alternative medicine; Physical therapy; Nursing; Pharmacology; Endocrinology","score_opus":0.05789577721439459,"score_gpt":0.3886293507942092,"score_spread":0.3307335735798146,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2318810481","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99544907,0.00086527615,0.0000020283157,0.0014272593,0.0007781606,0.0007004073,0.000007918596,0.00007483255,0.00069506664],"genre_scores_gemma":[0.9876846,0.00055179367,0.00031062667,0.01067229,0.00034655206,0.00004227609,0.00006758017,0.00002391795,0.00030037496],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99830455,0.00023984053,0.00048552925,0.00039296,0.00013939197,0.00043771556],"domain_scores_gemma":[0.99906325,0.00041250567,0.00011904708,0.00016397626,0.00011894982,0.00012228898],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017905692,0.00025339646,0.0005528511,0.00009326409,0.0000842087,0.000007768494,0.0001020189,0.00022870829,0.00022885608],"category_scores_gemma":[0.0000033747626,0.00017576001,0.000100017394,0.00020171053,0.0003238553,0.000058354475,0.000030199004,0.00035595088,0.00008280602],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015643989,0.0059840847,0.9831153,0.000012189669,0.0007033528,0.000052471823,0.00003847069,0.00001336117,0.0006363721,0.0000047880217,0.0009346578,0.006940515],"study_design_scores_gemma":[0.015040772,0.005400854,0.9648259,0.00002392328,0.0016282552,0.0000021493759,0.000009273913,0.0000818547,0.0032378808,0.000106118954,0.009463149,0.0001798621],"about_ca_topic_score_codex":0.0000127439625,"about_ca_topic_score_gemma":0.000021475094,"teacher_disagreement_score":0.018289432,"about_ca_system_score_codex":0.00018048187,"about_ca_system_score_gemma":0.00017245546,"threshold_uncertainty_score":0.7167285},"labels":[],"label_agreement":null},{"id":"W2319955874","doi":"10.1016/j.clpt.2005.12.052","title":"PI-31Genotype frequencies for ten polymorphisms of the renin-angiotensin-aldosterone system between healthy French-Canadians and other ethnic groups","year":2006,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Hormonal Regulation and Hypertension","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"","keywords":"Genotype; Internal medicine; Population; Bradykinin; Endocrinology; Polymorphism (computer science); Angiotensin-converting enzyme; Aldosterone synthase; Gene polymorphism; Biology; Genetics; Medicine; Renin–angiotensin system; Gene; Receptor; Blood pressure","score_opus":0.12038914565371191,"score_gpt":0.38840558561240823,"score_spread":0.26801643995869634,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2319955874","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9486875,0.005536667,0.00029043353,0.043387346,0.0008012559,0.00096857536,0.00008220341,0.0000545777,0.00019147099],"genre_scores_gemma":[0.9610986,0.00009206768,0.0007454775,0.036491074,0.0009012596,0.000013785822,0.000014925638,0.000040124956,0.00060264743],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998157,0.0002382671,0.00077421387,0.000304359,0.00019129635,0.0003348123],"domain_scores_gemma":[0.9983506,0.00070180756,0.00028597514,0.0002801048,0.00020397235,0.00017753048],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005543733,0.00018848956,0.00063784193,0.00007649368,0.00014596667,0.0000058799283,0.00014937964,0.0003413841,0.000029728935],"category_scores_gemma":[0.000020120662,0.00012738576,0.00022424424,0.0001756217,0.00061840256,0.00002454058,0.00004416895,0.00032956942,0.00000788604],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025177738,0.0009554568,0.69672847,0.0002715164,0.0029174283,0.00004976854,0.00093861995,0.000026803738,0.1931306,0.0015417119,0.06049707,0.0404248],"study_design_scores_gemma":[0.004165353,0.0011403764,0.91993,0.00006611237,0.002079095,0.000058590074,0.000053204218,0.0007653914,0.0017541851,0.00028538282,0.06951822,0.00018411844],"about_ca_topic_score_codex":0.0005015907,"about_ca_topic_score_gemma":0.00024312257,"teacher_disagreement_score":0.22320151,"about_ca_system_score_codex":0.000084454034,"about_ca_system_score_gemma":0.00023392327,"threshold_uncertainty_score":0.5194641},"labels":[],"label_agreement":null},{"id":"W2321773228","doi":"10.1016/j.clpt.2005.12.063","title":"PI-42Methamphetamine detection in maternal and neonatal hair","year":2006,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Prenatal Substance Exposure Effects","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Methamphetamine; Transplacental; Pregnancy; Medicine; Hair analysis; Fetus; Polysubstance dependence; Obstetrics; Placenta; Pharmacokinetics; Drug; Physiology; Pharmacology; Substance abuse; Psychiatry; Biology","score_opus":0.03366169745112063,"score_gpt":0.3708012681566218,"score_spread":0.33713957070550116,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2321773228","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9931746,0.002250945,0.0008597295,0.001667697,0.0013764888,0.0004229698,0.000004341174,0.00009464618,0.00014858817],"genre_scores_gemma":[0.9883259,0.0003999917,0.00056829734,0.00962382,0.00082971493,0.000025333726,0.000007889339,0.000029002307,0.0001900369],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983609,0.0002528696,0.00054986385,0.0003583458,0.0001490544,0.000328965],"domain_scores_gemma":[0.99905795,0.0005141197,0.00011376068,0.00015136471,0.000048758146,0.00011402941],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005536177,0.00018431211,0.00041302678,0.00009751386,0.00004138162,0.000009598968,0.00009265552,0.00026796004,0.00007348304],"category_scores_gemma":[0.00001756749,0.00016392532,0.000093856,0.00017404727,0.0003304574,0.0000764462,0.00005860871,0.0006295011,0.000037389484],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024891857,0.00055614265,0.5253694,0.000071599025,0.00028355393,0.0005805332,0.00006041349,0.000017550952,0.18950346,0.000013971451,0.00069990876,0.28035426],"study_design_scores_gemma":[0.007929541,0.00074959773,0.8483443,0.00003064213,0.00034052515,0.00019558375,0.000006974554,0.0024214,0.12602752,0.00037855544,0.013384445,0.00019091331],"about_ca_topic_score_codex":0.000029319757,"about_ca_topic_score_gemma":0.00008543629,"teacher_disagreement_score":0.3229749,"about_ca_system_score_codex":0.00006909133,"about_ca_system_score_gemma":0.0000419274,"threshold_uncertainty_score":0.66846806},"labels":[],"label_agreement":null},{"id":"W2322128527","doi":"10.1016/j.clpt.2005.12.074","title":"PI-53Effects of propafenone on the pharmacokinetics of caffeine","year":2006,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Anesthesia and Sedative Agents","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Propafenone; Caffeine; Pharmacokinetics; Pharmacology; CYP1A2; CYP2D6; Medicine; Drug; Drug interaction; Internal medicine; Metabolism; Cytochrome P450","score_opus":0.09898817495081592,"score_gpt":0.4184030477813123,"score_spread":0.3194148728304964,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2322128527","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9866896,0.00044436255,0.000116867945,0.009950269,0.0004119577,0.00081165665,0.000008251513,0.000027926335,0.0015390547],"genre_scores_gemma":[0.969405,0.0004064325,0.00015956709,0.02885017,0.000474244,0.000017156653,0.000011737003,0.000028509177,0.00064719823],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980172,0.00047188404,0.00075431826,0.00024064833,0.00026626978,0.00024968272],"domain_scores_gemma":[0.997604,0.0014701866,0.00035581473,0.00028146393,0.0002124965,0.000076000375],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000561449,0.00019240871,0.00059278734,0.0000617632,0.00004871393,0.0000020536816,0.0002239851,0.00016040305,0.00047386988],"category_scores_gemma":[0.000026723574,0.000117749034,0.00024264587,0.00021266122,0.00083299336,0.000017079754,0.000042767253,0.00045782689,0.000051059167],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005222472,0.008768204,0.14472963,0.00026886657,0.0018902874,0.0001756203,0.00017348594,0.00010168329,0.77456474,0.0009584799,0.055316217,0.007830308],"study_design_scores_gemma":[0.011485914,0.007071511,0.20158665,0.000119163924,0.004510332,0.00003986909,0.00007176508,0.0018094754,0.69041014,0.00047237825,0.08210287,0.00031996446],"about_ca_topic_score_codex":0.000007191445,"about_ca_topic_score_gemma":5.714223e-7,"teacher_disagreement_score":0.084154636,"about_ca_system_score_codex":0.000019663483,"about_ca_system_score_gemma":0.000097082455,"threshold_uncertainty_score":0.5188543},"labels":[],"label_agreement":null},{"id":"W2324734459","doi":"10.1016/j.clpt.2005.12.254","title":"PIII-46Generation of reactive oxygen species by sulfonamide reactive intermediates","year":2006,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Drug-Induced Adverse Reactions","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Reactive oxygen species; Chemistry; Hydroxylamine; Reactive intermediate; Sulfonamide; Metabolite; Reactive nitrogen species; Pharmacology; Oxidative stress; Biochemistry; Stereochemistry; Biology","score_opus":0.056764183530258236,"score_gpt":0.3943139702117567,"score_spread":0.33754978668149843,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2324734459","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9749729,0.00033788764,0.0002526069,0.0069982023,0.0020171413,0.0006205437,0.000091665774,0.000114117014,0.014594906],"genre_scores_gemma":[0.986088,0.00069730316,0.0003770905,0.008304319,0.0014603506,0.00003381962,0.00026411616,0.00004900879,0.002725985],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99777365,0.00027462584,0.0009154119,0.0004380773,0.00025113797,0.00034711938],"domain_scores_gemma":[0.997627,0.0011367741,0.00046626548,0.0002823831,0.00034558083,0.00014195629],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004021463,0.00025929188,0.0006434711,0.00013025221,0.000091430775,0.000009158095,0.00015733173,0.0003437067,0.00007837463],"category_scores_gemma":[0.000059503276,0.00023439302,0.00028645876,0.00023801508,0.00070861663,0.00014555326,0.000061114224,0.0007717515,0.0000697958],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030696904,0.0019849779,0.010831575,0.000018417699,0.0009995721,0.000024734461,0.00013570412,0.000015399864,0.96704507,0.00012214511,0.013389617,0.0051258397],"study_design_scores_gemma":[0.005106988,0.00046604924,0.21377154,0.0000408263,0.002482303,0.000044210858,0.00040191787,0.00054529123,0.45291984,0.00055820396,0.32330808,0.0003547606],"about_ca_topic_score_codex":0.00005024048,"about_ca_topic_score_gemma":0.00001616848,"teacher_disagreement_score":0.5141252,"about_ca_system_score_codex":0.00021582746,"about_ca_system_score_gemma":0.00023629909,"threshold_uncertainty_score":0.95582706},"labels":[],"label_agreement":null},{"id":"W2325591307","doi":"10.1016/j.clpt.2005.12.259","title":"PIII-51In utero exposure to HMG-CoA reductase inhibitors; effects on fetal and neonatal outcome","year":2006,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Pregnancy; HMG-CoA reductase; Abortion; Fetus; In utero; Hyperlipidemia; Obstetrics; Therapeutic abortion; Clinical pharmacology; Gestational age; Reductase; Endocrinology; Pharmacology; Biology","score_opus":0.04301270185536927,"score_gpt":0.39303096523366216,"score_spread":0.3500182633782929,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2325591307","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97653085,0.0025810245,0.00015366098,0.0161621,0.002879136,0.0013532286,0.000017028102,0.00011955917,0.00020340976],"genre_scores_gemma":[0.9028897,0.00030488317,0.0007014627,0.090614274,0.0048744446,0.0000680435,0.000026610545,0.00005541855,0.0004651542],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99715996,0.00046013205,0.0008214616,0.0006281447,0.00040523967,0.0005250391],"domain_scores_gemma":[0.99841213,0.00043864344,0.00012465639,0.00047389854,0.00010320958,0.00044744438],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011214522,0.00031882068,0.00083047186,0.00010806482,0.00013889294,0.000020175812,0.00014030689,0.00040454202,0.00006428063],"category_scores_gemma":[0.000038758375,0.00025814126,0.00040978836,0.00018497203,0.00023673843,0.000047369143,0.000107946275,0.00094263296,0.00012120902],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0065379385,0.0032960598,0.123851195,0.00075285113,0.0032381488,0.0031417303,0.00035199226,0.000050932358,0.047609027,0.00011853016,0.06761182,0.7434398],"study_design_scores_gemma":[0.032718323,0.015382918,0.24997714,0.00020388204,0.004482771,0.0007184442,0.00008693997,0.00018840714,0.08848756,0.00027835803,0.6063387,0.0011365819],"about_ca_topic_score_codex":0.000033108183,"about_ca_topic_score_gemma":0.0000060703137,"teacher_disagreement_score":0.7423032,"about_ca_system_score_codex":0.00007943129,"about_ca_system_score_gemma":0.00012351779,"threshold_uncertainty_score":0.99998707},"labels":[],"label_agreement":null},{"id":"W2326875227","doi":"10.1016/j.clpt.2005.12.237","title":"PIII-29Genotype frequencies for ten polymorphisms of the renin-angiotensin-aldosterone system between healthy and heart failure patients in the French-Canadian population","year":2006,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"","keywords":"Genotype; Internal medicine; Bradykinin; Population; Enos; Aldosterone; Medicine; Heart failure; Allele frequency; Angiotensin-converting enzyme; Gene polymorphism; Gastroenterology; Endocrinology; Genotype frequency; Biology; Genetics; Receptor; Gene","score_opus":0.05062803313372751,"score_gpt":0.34856484111864433,"score_spread":0.29793680798491684,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2326875227","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8856241,0.00027484403,0.00001571702,0.11185104,0.00041688056,0.0017257425,0.000038316313,0.000019029518,0.00003431911],"genre_scores_gemma":[0.9808371,0.000018404175,0.0010353605,0.017525697,0.0003706053,0.00003915661,0.00008590693,0.000018557042,0.000069191396],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99826604,0.00033196897,0.0006460819,0.0002493812,0.0001721196,0.00033442164],"domain_scores_gemma":[0.99896103,0.00042358838,0.00016613984,0.00025061416,0.000098174154,0.00010045637],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006022643,0.00016376674,0.00043681785,0.000099550816,0.00015255803,0.000010309353,0.00013449886,0.00019647543,0.0000090051435],"category_scores_gemma":[0.000013365224,0.00009775579,0.00013896832,0.00018795492,0.00020370318,0.00003559997,0.000032332322,0.00024476345,0.0000047488957],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009599204,0.00018713399,0.9693727,0.000031752777,0.00017821987,0.0000023928162,0.00011599268,0.000002481791,0.00015599771,0.000053409156,0.028321901,0.0014820596],"study_design_scores_gemma":[0.002875119,0.0007351901,0.9534164,0.00003383895,0.0008100673,0.0000029949003,0.00003767934,0.000053967917,0.000084939726,0.00009224182,0.04177593,0.00008164401],"about_ca_topic_score_codex":0.01198491,"about_ca_topic_score_gemma":0.014343046,"teacher_disagreement_score":0.095213,"about_ca_system_score_codex":0.0001271789,"about_ca_system_score_gemma":0.00011533472,"threshold_uncertainty_score":0.9945944},"labels":[],"label_agreement":null},{"id":"W2378259067","doi":"10.1002/cpt.390","title":"The effect of an abuse‐deterrent opioid formulation (OxyContin) on opioid abuse‐related outcomes in the postmarketing setting","year":2016,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Opioid Use Disorder Treatment","field":"Medicine","cited_by":72,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Purdue Pharma; University of Kentucky; Purdue University","keywords":"Medicine; Substance abuse; Medical prescription; Opioid; Psychiatry; Chronic pain; Psychological intervention; Postmarketing surveillance; Opioid abuse; Adverse effect; Pharmacology; Internal medicine","score_opus":0.027591232814806355,"score_gpt":0.40215247584193026,"score_spread":0.3745612430271239,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2378259067","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9882034,0.00040967192,0.000011635,0.008091908,0.0012876538,0.001774613,0.000010117055,0.00006555519,0.00014542381],"genre_scores_gemma":[0.9907618,0.001252671,0.00006744781,0.0074677845,0.00018138767,0.00011629074,0.000018560277,0.00004602272,0.00008799355],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9956481,0.0018372717,0.001220145,0.0004308967,0.00035181595,0.00051176216],"domain_scores_gemma":[0.98775953,0.011035298,0.00045626552,0.00055880356,0.000087950124,0.0001021539],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031731126,0.00033434114,0.00064992724,0.00009433615,0.00019200634,0.000018803494,0.00040914523,0.0002733372,0.00004638687],"category_scores_gemma":[0.00016081004,0.00014396232,0.00034012314,0.00018291567,0.00027992835,0.00008968193,0.000040460167,0.0006068487,0.00003737228],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0060046907,0.0018454092,0.79981583,0.0000731824,0.0014840565,0.000044291508,0.0042326977,0.000018158338,0.009171244,0.000029803565,0.00022904944,0.17705157],"study_design_scores_gemma":[0.020937378,0.010581971,0.9485713,0.00024145999,0.0018390922,0.000018825865,0.00035578726,0.0016466876,0.008458762,0.00019274643,0.0068509113,0.00030502572],"about_ca_topic_score_codex":0.0000055502173,"about_ca_topic_score_gemma":0.000009030966,"teacher_disagreement_score":0.17674655,"about_ca_system_score_codex":0.00010397408,"about_ca_system_score_gemma":0.0000720414,"threshold_uncertainty_score":0.5870613},"labels":[],"label_agreement":null},{"id":"W2382331551","doi":"10.1002/cpt.371","title":"The Bugs Within Our Body: The Human Microbiota","year":2016,"lang":"en","type":"editorial","venue":"Clinical Pharmacology & Therapeutics","topic":"Gut microbiota and health","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Human microbiome; Biology; Human health; Microbiome; Dysbiosis; Medicine; Bioinformatics; Environmental health","score_opus":0.03909348001864643,"score_gpt":0.44652651274041183,"score_spread":0.4074330327217654,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2382331551","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.012584885,0.0048572947,0.000026083708,0.023811137,0.95722187,0.00088779605,0.00033106035,0.000047676556,0.00023221973],"genre_scores_gemma":[0.0067373426,0.01651779,0.000036060683,0.032989655,0.92861927,0.000074174335,0.0004190578,0.00016993994,0.014436695],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.995316,0.0013249342,0.0012691822,0.0009487235,0.0002628129,0.0008783221],"domain_scores_gemma":[0.9964881,0.00092371664,0.0008385844,0.0011449663,0.00041159306,0.0001930342],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0024239465,0.00059060176,0.00061963726,0.000032905817,0.0011035834,0.00009211854,0.0020362507,0.0024936749,0.000032255954],"category_scores_gemma":[0.00011290252,0.00030755982,0.00056346995,0.00008589015,0.001051801,0.0000031371394,0.000601023,0.002399129,0.00019467126],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020714344,0.00012279957,0.000054045675,0.00001651342,0.0008507544,0.0000038434773,0.000019910209,2.7475633e-7,0.2779729,0.000007916488,0.72038376,0.0003601458],"study_design_scores_gemma":[0.0018102429,0.000631099,0.00015169481,0.000026245023,0.00071849854,0.0000063255334,0.000036443318,0.0000013461778,0.0064532952,0.000081871876,0.9896709,0.00041205809],"about_ca_topic_score_codex":0.000009280049,"about_ca_topic_score_gemma":0.00005609202,"teacher_disagreement_score":0.2715196,"about_ca_system_score_codex":0.000064375075,"about_ca_system_score_gemma":0.0011278279,"threshold_uncertainty_score":0.99993765},"labels":[],"label_agreement":null},{"id":"W2413113571","doi":"10.1002/cpt.383","title":"Mother and Child: Medication Use in Pregnancy and Lactation","year":2016,"lang":"en","type":"editorial","venue":"Clinical Pharmacology & Therapeutics","topic":"Maternal Mental Health During Pregnancy and Postpartum","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Breastfeeding; Pregnancy; In utero; Medicine; Drug; Lactation; Obstetrics; Fetus; Pharmacokinetics; Breast feeding; Pediatrics; Pharmacology; Biology","score_opus":0.061487130839002084,"score_gpt":0.44224379232295086,"score_spread":0.38075666148394877,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2413113571","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.07208992,0.019806005,0.00002740815,0.015226973,0.8904356,0.0018433555,0.00013990817,0.00009200835,0.0003388661],"genre_scores_gemma":[0.042893544,0.2740299,0.00029233564,0.029068131,0.6484026,0.00025402982,0.0002509073,0.00018487332,0.0046237297],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99793357,0.00035371774,0.0007196184,0.00047359936,0.00023196099,0.00028755947],"domain_scores_gemma":[0.99730647,0.0019501022,0.00030177098,0.00017783944,0.00006130857,0.00020250732],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004454733,0.00024276701,0.00054735393,0.000105433195,0.000059922622,0.000013650077,0.00008609406,0.0009833281,0.00009100709],"category_scores_gemma":[0.000078416735,0.00018426811,0.000054164833,0.000045670222,0.00033378266,0.00009035807,0.00006337373,0.0010849005,0.000019997236],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013463347,0.0031988416,0.25316426,0.01674769,0.0021732717,0.00046572494,0.0013606929,4.2428312e-7,0.00023106232,0.00009559583,0.5885571,0.12054196],"study_design_scores_gemma":[0.0103009865,0.0011500284,0.08211231,0.015257003,0.001058277,0.000024953843,0.0000079299025,0.00006981731,0.00013717575,0.00022333102,0.8893085,0.00034967862],"about_ca_topic_score_codex":0.000010266833,"about_ca_topic_score_gemma":0.000011359715,"teacher_disagreement_score":0.3007514,"about_ca_system_score_codex":0.0000596041,"about_ca_system_score_gemma":0.0001426725,"threshold_uncertainty_score":0.7584327},"labels":[],"label_agreement":null},{"id":"W2473575438","doi":"10.1002/cpt.421","title":"Understanding the Link Between Cannabinoids and Psychosis","year":2016,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Cannabis and Cannabinoid Research","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"","keywords":"Cannabis; Psychosis; Synthetic cannabinoids; Psychiatry; Public health; Effects of cannabis; Medicine; Psychology; Environmental health; Cannabinoid; Cannabidiol","score_opus":0.2782695212036547,"score_gpt":0.4703346766586735,"score_spread":0.1920651554550188,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2473575438","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.23704588,0.0008884088,0.0016810094,0.75802356,0.0008959124,0.0005533233,0.00001757361,0.000067998495,0.0008263594],"genre_scores_gemma":[0.9256438,0.003933009,0.000048532303,0.05821166,0.0040774536,0.00005614879,0.0000028168058,0.0000458652,0.0079807015],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.998017,0.0003294415,0.0005014221,0.00040016914,0.00026405248,0.00048788785],"domain_scores_gemma":[0.9986649,0.00045736265,0.0000994679,0.00032391938,0.00011986385,0.00033445598],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011397514,0.00018531947,0.0003998387,0.00007408248,0.00023179562,0.000023645729,0.00022085337,0.00027356518,0.00048214305],"category_scores_gemma":[0.000039839437,0.00009255282,0.00018878894,0.00019772298,0.001423683,0.00004590891,0.00012088872,0.0006544343,0.00004693529],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00080904487,0.00015686806,0.28700814,0.000047451664,0.0016134592,0.000036098296,0.00024077967,2.7958907e-7,0.013390394,0.00032142174,0.42729938,0.2690767],"study_design_scores_gemma":[0.004618262,0.0010097552,0.15768814,0.000036687437,0.0010554587,0.00002828608,0.00010891324,0.000046614183,0.001213454,0.001665729,0.8323374,0.00019132944],"about_ca_topic_score_codex":0.000005790705,"about_ca_topic_score_gemma":0.000003996592,"teacher_disagreement_score":0.6998119,"about_ca_system_score_codex":0.00013740135,"about_ca_system_score_gemma":0.00017836642,"threshold_uncertainty_score":0.52791286},"labels":[],"label_agreement":null},{"id":"W2495375730","doi":"10.1002/cpt.438","title":"The Effects of Different Aspirin Dosing Frequencies and the Timing of Aspirin Intake in Primary and Secondary Prevention of Cardiovascular Disease: A Systematic Review","year":2016,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"Universidade de Vigo; Leids Universitair Medisch Centrum; Karolinska Institutet; Universiteit Leiden","keywords":"Aspirin; Dosing; Medicine; Chronotherapy (sleep phase); Primary prevention; Intensive care medicine; Disease; Low dose aspirin; Internal medicine; Blood pressure","score_opus":0.05694217177846646,"score_gpt":0.3829627969252457,"score_spread":0.32602062514677926,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2495375730","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0035286825,0.9907988,0.000062986786,0.00013113683,0.0002942643,0.00513826,0.000018583956,0.0000101664455,0.000017173661],"genre_scores_gemma":[0.0022150802,0.9965143,0.000010489785,0.00080516894,0.00009272309,0.00028350335,0.000016005155,0.000039377486,0.000023352293],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9927455,0.0041625975,0.002109106,0.00037884587,0.00037623788,0.00022766675],"domain_scores_gemma":[0.9927634,0.0052027693,0.0010957586,0.00071524485,0.00011609568,0.00010670785],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0034531192,0.00038817243,0.00538645,0.00008463273,0.000064771026,0.0000067465453,0.00027753253,0.00024191411,0.000007765526],"category_scores_gemma":[0.00020126643,0.00017614657,0.0026719915,0.00015985999,0.0016789192,0.000037314334,0.00016232794,0.00055107847,6.4938484e-7],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024135067,0.00015193615,0.000037809776,0.6119231,0.01607245,0.000018372004,0.00002410747,9.342269e-8,0.000010452003,0.00001657947,0.00001150152,0.37149227],"study_design_scores_gemma":[0.007354218,0.00050852785,0.00067206164,0.8014529,0.15196517,0.000073060066,0.000018695593,0.000010669529,0.000037210764,0.00015353602,0.03746821,0.0002857578],"about_ca_topic_score_codex":0.0000014541018,"about_ca_topic_score_gemma":3.1281934e-7,"teacher_disagreement_score":0.3712065,"about_ca_system_score_codex":0.00004938826,"about_ca_system_score_gemma":0.00034511555,"threshold_uncertainty_score":0.7183048},"labels":[],"label_agreement":null},{"id":"W2512011249","doi":"10.1002/cpt.460","title":"An International Asset Map of Clinicians, Educators, and Researchers Pursuing Better Medicine Use in Children: Initial Findings","year":2016,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Regional Municipality of Waterloo; University of Waterloo; Western University; Robarts Clinical Trials; Child and Family Research Institute; Children's Hospital of Western Ontario; University of Toronto; BC Children's Hospital; Hospital for Sick Children; University of British Columbia","funders":"American College of Clinical Pharmacy; European Society of Clinical Pharmacy; Hospital for Sick Children; AGE-WELL; World Bank Group","keywords":"Economic shortage; Medicine; Asset (computer security); Medical education; Clinical pharmacology; Latin Americans; Family medicine; Political science; Pharmacology","score_opus":0.2908080334891536,"score_gpt":0.5650958529598014,"score_spread":0.2742878194706478,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2512011249","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8736301,0.0005681821,0.000022817123,0.12404434,0.001247513,0.00032387296,0.000028091587,0.00002133838,0.00011372531],"genre_scores_gemma":[0.9283281,0.0068405913,0.0003403074,0.06293468,0.0014304478,0.000013389339,0.000016805458,0.000024806706,0.00007085142],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973711,0.00061611866,0.0008944087,0.00043316814,0.00030178757,0.00038344305],"domain_scores_gemma":[0.9954615,0.0036908083,0.00020010515,0.0002004017,0.00015271103,0.00029444922],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021603906,0.00018528382,0.0005416857,0.00015324917,0.000060137016,0.00001310566,0.0002698532,0.00024245949,0.00083350023],"category_scores_gemma":[0.00033903855,0.000121154655,0.00008948799,0.00012687781,0.0013340993,0.00032900224,0.00013815933,0.0008074891,0.00001887241],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001854652,0.0007690375,0.9377562,0.000015260608,0.0008622805,0.000025874091,0.00015588084,1.2570196e-7,0.007887236,0.000023096158,0.006444524,0.044205833],"study_design_scores_gemma":[0.0090457415,0.0016160313,0.847222,0.00011848363,0.00071620825,0.000026490425,0.0001405172,0.00007869838,0.0013295859,0.00019304834,0.1393349,0.00017830558],"about_ca_topic_score_codex":0.000032388594,"about_ca_topic_score_gemma":0.00000820635,"teacher_disagreement_score":0.13289037,"about_ca_system_score_codex":0.00005785553,"about_ca_system_score_gemma":0.00010120998,"threshold_uncertainty_score":0.9126243},"labels":[],"label_agreement":null},{"id":"W2514206116","doi":"10.1002/cpt.462","title":"Deconstructing Designer Drugs","year":2016,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Treatment of Major Depression","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Headline; Designer drug; Stimulant; Medicine; Sedative; Pharmacology; Business; Drug; Advertising","score_opus":0.11479067319973531,"score_gpt":0.45846096209010506,"score_spread":0.34367028889036977,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2514206116","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96805924,0.00055090024,0.00081734674,0.025971461,0.0021548136,0.000398529,0.000004294885,0.00021731737,0.0018261058],"genre_scores_gemma":[0.94459236,0.0008408312,0.0039129998,0.047789916,0.0009738828,0.000023338838,0.0000023446985,0.000043774253,0.0018205455],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99828464,0.00026969664,0.0005379588,0.00038878145,0.00016612696,0.0003528075],"domain_scores_gemma":[0.99767923,0.0015614779,0.00015765706,0.0002774179,0.00009309622,0.00023112225],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004414294,0.00018552848,0.00039422043,0.000059824826,0.00008385395,0.0000059432464,0.00014199056,0.00025625055,0.0011717832],"category_scores_gemma":[0.000036311194,0.00010705595,0.00021113582,0.00008302227,0.00046369713,0.000067348126,0.000072909665,0.00028757247,0.0004852289],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001262962,0.00096135354,0.31238487,0.000015424332,0.001250266,0.0001180362,0.00008239477,3.4594032e-7,0.17644003,0.000028652606,0.017484415,0.48997122],"study_design_scores_gemma":[0.059752136,0.0037030233,0.23180565,0.00035760255,0.008477699,0.0004926242,0.00015906179,0.00022253678,0.25070363,0.002018613,0.44131586,0.000991544],"about_ca_topic_score_codex":6.102458e-7,"about_ca_topic_score_gemma":2.1199122e-7,"teacher_disagreement_score":0.4889797,"about_ca_system_score_codex":0.00006952158,"about_ca_system_score_gemma":0.00012404523,"threshold_uncertainty_score":0.99974126},"labels":[],"label_agreement":null},{"id":"W2517953645","doi":"10.1002/cpt.461","title":"Harmonizing Global Biospecimen Consent Practices to Advance Translational Research: A Call to Action","year":2016,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Ethics in Clinical Research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Informed consent; Biobank; Call to action; Translational research; Translational medicine; Action (physics); Biorepository; Ethical standards; Medical research; Engineering ethics; Medicine; Alternative medicine; Medical education; Business; Bioinformatics; Pathology; Engineering; Biology","score_opus":0.924173956648261,"score_gpt":0.7454248348351911,"score_spread":0.1787491218130699,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2517953645","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.3751894,0.00039450053,0.003429949,0.61525035,0.0019013113,0.0015230894,0.000054836568,0.00011741687,0.0021391262],"genre_scores_gemma":[0.789716,0.0054255393,0.013213541,0.18371972,0.0027118318,0.00016568837,0.0000060330644,0.00006138871,0.0049802274],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99408364,0.0014588567,0.0011408261,0.000990722,0.0014231168,0.0009028486],"domain_scores_gemma":[0.944457,0.051626667,0.00029146302,0.0006125667,0.0017966238,0.0012156577],"candidate_categories":["metaresearch","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.010351935,0.00022860563,0.0005271415,0.00015803149,0.00025899633,0.000035737714,0.0005507886,0.0006448087,0.0007208911],"category_scores_gemma":[0.010260481,0.00016591391,0.00021756324,0.00073326135,0.0010999031,0.00013945141,0.00029077902,0.0025714173,0.0017053356],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.030349355,0.00546848,0.157463,0.00026157053,0.0026813464,0.0004323716,0.00070991815,0.00002713609,0.46016365,0.004179252,0.12934013,0.20892379],"study_design_scores_gemma":[0.00785421,0.0049748505,0.08807363,0.0003770368,0.0005489445,0.00005336902,0.00019548558,0.00010808334,0.014263144,0.013404753,0.86970365,0.00044285718],"about_ca_topic_score_codex":0.000020004538,"about_ca_topic_score_gemma":0.00018748992,"teacher_disagreement_score":0.7403635,"about_ca_system_score_codex":0.0004183068,"about_ca_system_score_gemma":0.0017947301,"threshold_uncertainty_score":0.9997297},"labels":[{"model":"gemma","categories":["research_integrity"],"domain":null,"study_design":"theoretical_or_conceptual","genre":"commentary","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"gpt","categories":[],"domain":null,"study_design":"theoretical_or_conceptual","genre":"commentary","about_ca_system":false,"about_ca_topic":false,"confidence":"low"}],"label_agreement":"split"},{"id":"W2519711882","doi":"10.1002/cpt.509","title":"Adaptive Biomedical Innovation: Evolving Our Global System to Sustainably and Safely Bring New Medicines to Patients in Need","year":2016,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Biomedical and Engineering Education","field":"Engineering","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Canada","funders":"Alfred P. Sloan Foundation; Ewing Marion Kauffman Foundation","keywords":"Process management; Pace; Knowledge management; Business; Business process reengineering; Structuring; Maturity (psychological); Sustainability; Process (computing); Product (mathematics); Risk analysis (engineering); New product development; Computer science; Marketing","score_opus":0.036100106016181896,"score_gpt":0.35400336371243146,"score_spread":0.31790325769624955,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2519711882","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.942009,0.00020497906,0.025817364,0.026047137,0.0050860597,0.00045349667,0.000012466946,0.00026698044,0.000102551036],"genre_scores_gemma":[0.991044,0.00007536167,0.0012436687,0.0064904005,0.0010416093,0.000020054022,0.0000043335062,0.000024838633,0.000055772867],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99841297,0.000057362482,0.0006525811,0.00028138608,0.00018582176,0.00040985926],"domain_scores_gemma":[0.9991176,0.00019738288,0.00004164005,0.000117140415,0.00013959598,0.00038662553],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040603834,0.00018976902,0.00031408333,0.00020508957,0.000030678304,0.000012222005,0.00018781854,0.00022526963,0.0000148449635],"category_scores_gemma":[0.0000921595,0.00014481168,0.000030025974,0.00094964623,0.000060336984,0.000080989994,0.00008339046,0.00021578795,0.000045507524],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007397372,0.00074741925,0.24849771,0.0007144123,0.0009190465,0.00007111836,0.0018459191,0.0008619847,0.012457702,0.00055424985,0.23080507,0.50178564],"study_design_scores_gemma":[0.010013697,0.0017166049,0.8775156,0.0009824596,0.00033342783,0.000020223086,0.0015527919,0.024519034,0.0005244188,0.00034125792,0.08134029,0.0011402057],"about_ca_topic_score_codex":0.000025228952,"about_ca_topic_score_gemma":0.0000065074346,"teacher_disagreement_score":0.6290179,"about_ca_system_score_codex":0.0003521083,"about_ca_system_score_gemma":0.000098222605,"threshold_uncertainty_score":0.5905249},"labels":[],"label_agreement":null},{"id":"W2521539014","doi":"10.1002/cpt.515","title":"“Threshold‐crossing”: A Useful Way to Establish the Counterfactual in Clinical Trials?","year":2016,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Statistical Methods in Clinical Trials","field":"Mathematics","cited_by":77,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Canada","funders":"Medical Research Council","keywords":"Counterfactual thinking; Harm; Outcome (game theory); Randomized controlled trial; Clinical trial; Counterfactual conditional; Computer science; Randomized experiment; Actuarial science; Econometrics; Medicine; Psychology; Economics; Social psychology; Microeconomics","score_opus":0.8085835664795291,"score_gpt":0.6822660510648504,"score_spread":0.12631751541467873,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2521539014","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8205868,0.00025168815,0.070286825,0.07866784,0.024428708,0.004161401,0.0003075482,0.00039734377,0.000911824],"genre_scores_gemma":[0.60961515,0.0019712518,0.13115959,0.24285638,0.011727219,0.0005346018,0.0000029271416,0.00035410753,0.0017787725],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9680453,0.020090673,0.008499589,0.0014014607,0.00071528764,0.0012476692],"domain_scores_gemma":[0.53085774,0.46509704,0.0015114938,0.0014024241,0.00041289037,0.00071839645],"candidate_categories":["metaresearch","metaepi_narrow","sts","insufficient_payload"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.08901188,0.00063016993,0.0032292823,0.00016012757,0.0002923594,0.00020043463,0.0019172222,0.0011819336,0.0018950843],"category_scores_gemma":[0.12380791,0.0003325144,0.0011280818,0.0006175171,0.003427092,0.00016638968,0.0006428541,0.0022525592,0.0006349345],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013456223,0.007684753,0.07028135,0.000097373464,0.0034132048,0.00025203227,0.0009215652,0.000008781391,0.004253296,0.008082651,0.35768867,0.53386015],"study_design_scores_gemma":[0.025698869,0.0031129532,0.04155818,0.0003540379,0.0030688618,0.000023943394,0.00017320906,0.00048805677,0.0020555756,0.5648133,0.3572365,0.0014164832],"about_ca_topic_score_codex":0.0000040891186,"about_ca_topic_score_gemma":0.000033149543,"teacher_disagreement_score":0.5567307,"about_ca_system_score_codex":0.00017227317,"about_ca_system_score_gemma":0.00043519607,"threshold_uncertainty_score":0.9999127},"labels":[],"label_agreement":null},{"id":"W2523823607","doi":"10.1002/cpt.512","title":"Real World Data in Adaptive Biomedical Innovation: A Framework for Generating Evidence Fit for Decision‐Making","year":2016,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":65,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Canada","funders":"","keywords":"Real world evidence; Clinical decision making; Computer science; Data science; MEDLINE; Medical decision making; Management science; Medicine; Intensive care medicine; Engineering; Internal medicine; Political science; Medical emergency","score_opus":0.5963858748892129,"score_gpt":0.5456894304575541,"score_spread":0.05069644443165877,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2523823607","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.21848184,0.0016630952,0.7013025,0.068281464,0.0059928885,0.001879215,0.0020743154,0.000085489795,0.00023914366],"genre_scores_gemma":[0.7426407,0.003363071,0.15473346,0.095029965,0.0036979658,0.00030786006,0.000026639202,0.00007662917,0.00012374314],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.99624044,0.00007845212,0.0020931666,0.0009289969,0.00004407083,0.0006148495],"domain_scores_gemma":[0.9815576,0.01688016,0.0007502485,0.00056998216,0.00010744978,0.00013454906],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0037987602,0.00023305377,0.00073789136,0.00037496712,0.00014055269,0.00004782637,0.0010030047,0.0002809942,0.0002701259],"category_scores_gemma":[0.001557288,0.00021070076,0.00015582975,0.00062251394,0.0004583805,0.00030415528,0.00033012938,0.00041763674,0.000091364185],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004469935,0.0013722901,0.07467407,0.00008434376,0.0012376404,0.000010371684,0.00026061852,0.00009023143,0.00067255367,0.466554,0.057423834,0.39315012],"study_design_scores_gemma":[0.0043063597,0.0006870984,0.0065490683,0.0003041464,0.00012871472,0.0000019716108,0.000016597736,0.17797771,0.00008208898,0.38111094,0.42817235,0.000662959],"about_ca_topic_score_codex":0.0000075195753,"about_ca_topic_score_gemma":0.00004073136,"teacher_disagreement_score":0.5465691,"about_ca_system_score_codex":0.00018170325,"about_ca_system_score_gemma":0.0001654041,"threshold_uncertainty_score":0.85921276},"labels":[],"label_agreement":null},{"id":"W2528414212","doi":"10.1002/cpt.526","title":"Development and Validation of Algorithms for the Detection of Statin Myopathy Signals From Electronic Medical Records","year":2016,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Myopathy; Statin; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Algorithm; Medical record; Computer science; Medicine; Internal medicine","score_opus":0.21957639952806643,"score_gpt":0.5056059265231236,"score_spread":0.28602952699505724,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2528414212","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96652,0.0016206598,0.023164911,0.0048956336,0.0027525795,0.00077352044,0.00017916356,0.00005068116,0.00004284687],"genre_scores_gemma":[0.9809669,0.009080527,0.00048052557,0.008526764,0.00061792316,0.00016230416,0.000018221563,0.000028811517,0.000118023905],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9971877,0.0006743426,0.0011000233,0.00037128612,0.00023104758,0.00043564485],"domain_scores_gemma":[0.9905012,0.008356046,0.00057427736,0.00015922693,0.00022623525,0.00018300439],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023913502,0.00022553936,0.00046281854,0.00007714595,0.00021564786,0.000004592126,0.00035178696,0.0004401693,0.0006473012],"category_scores_gemma":[0.00012019423,0.00014548429,0.00017610479,0.00015837725,0.0007402895,0.00010689769,0.00008357333,0.0006638878,0.00001637985],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014740436,0.00063404336,0.0040562623,0.000027940629,0.0018235969,0.0000026129994,0.00038761273,0.00003281036,0.55270123,0.00004390395,0.00079593813,0.43802002],"study_design_scores_gemma":[0.004621588,0.00031628626,0.0018659056,0.000021221773,0.001101605,0.00000450518,0.00012204858,0.0029758539,0.7011704,0.0005631942,0.28706005,0.00017737778],"about_ca_topic_score_codex":0.000008562203,"about_ca_topic_score_gemma":0.000012875694,"teacher_disagreement_score":0.43784264,"about_ca_system_score_codex":0.00006912726,"about_ca_system_score_gemma":0.0004448329,"threshold_uncertainty_score":0.7087494},"labels":[],"label_agreement":null},{"id":"W2529901602","doi":"10.1002/cpt.533","title":"Exercise Mimetics: Running Without a Road Map","year":2016,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Adipose Tissue and Metabolism","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Mitochondrial biogenesis; Regulator; Skeletal muscle; Peroxisome proliferator-activated receptor; Peroxisome; Oxidative phosphorylation; Chemistry; Biogenesis; Receptor; Pharmacology; Mitochondrion; Cell biology; Endocrinology; Internal medicine; Biochemistry; Biology; Medicine; Gene","score_opus":0.09634437818454925,"score_gpt":0.441387316113056,"score_spread":0.3450429379285067,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2529901602","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9156329,0.016631987,0.00107022,0.056337874,0.007193786,0.0012196583,0.000013312873,0.00040637917,0.0014938905],"genre_scores_gemma":[0.8650293,0.011396462,0.0034452775,0.099658966,0.0033576428,0.00005852634,0.000007402519,0.00010851955,0.016937943],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9979367,0.00015498402,0.00071551424,0.00046302457,0.00020749787,0.0005222594],"domain_scores_gemma":[0.99857515,0.00031667858,0.00018464359,0.00039621582,0.00014188263,0.00038545014],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0005988246,0.0002575155,0.0007560207,0.0000847102,0.000088601904,0.000007881661,0.00022268694,0.00034943598,0.0011986196],"category_scores_gemma":[0.000024369088,0.00016384624,0.00027875535,0.000113828,0.0005771486,0.00006995845,0.00009579444,0.0004736113,0.0012636951],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00338328,0.001818839,0.0697807,0.00007994544,0.0024287114,0.00030571982,0.00045480873,6.3563505e-7,0.18085049,0.00008260411,0.06323101,0.6775832],"study_design_scores_gemma":[0.010659249,0.00070584094,0.03378223,0.00019621907,0.005414955,0.000044720433,0.0000367208,0.00007747672,0.022265855,0.00033669444,0.9261355,0.0003445633],"about_ca_topic_score_codex":0.000003181628,"about_ca_topic_score_gemma":5.239038e-7,"teacher_disagreement_score":0.8629045,"about_ca_system_score_codex":0.000032445427,"about_ca_system_score_gemma":0.00016547095,"threshold_uncertainty_score":0.99971443},"labels":[],"label_agreement":null},{"id":"W2535831098","doi":"10.1002/cpt.538","title":"Novel psychoactive substances: What educators need to know","year":2016,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Forensic Toxicology and Drug Analysis","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph; Carleton University; Canadian Centre on Substance Use and Addiction","funders":"","keywords":"Medicine; Pharmacology; Psychology","score_opus":0.17150211717467698,"score_gpt":0.5101212911496056,"score_spread":0.3386191739749286,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2535831098","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.77305615,0.0046736393,0.0046532676,0.17575078,0.037265383,0.0014320561,0.00014658051,0.000520149,0.0025019988],"genre_scores_gemma":[0.6643757,0.011214738,0.0011337333,0.31552717,0.0028236494,0.00023289758,0.000016170645,0.00011230168,0.004563586],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9939683,0.001579603,0.0014456349,0.0012948412,0.00029701734,0.0014146238],"domain_scores_gemma":[0.9924778,0.0048432443,0.00048123568,0.00064522045,0.00040598423,0.0011465292],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.002247692,0.00069048075,0.0011004471,0.00037463952,0.00050652685,0.00005192625,0.0011166971,0.001450803,0.0064165816],"category_scores_gemma":[0.00012433669,0.0005086644,0.000659638,0.0009175647,0.0020178729,0.00053674314,0.0002269209,0.0017595046,0.0030069505],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0065393914,0.0058572325,0.028979948,0.00002681361,0.007418303,0.00008531978,0.0016837977,0.0001546147,0.26593333,0.0009453806,0.3697464,0.31262946],"study_design_scores_gemma":[0.007682786,0.00093843765,0.004516331,0.00005426207,0.002800687,0.000040674902,0.0010036945,0.00019091489,0.040454984,0.00092769257,0.9404613,0.0009282765],"about_ca_topic_score_codex":0.0000052767205,"about_ca_topic_score_gemma":0.000046943962,"teacher_disagreement_score":0.5707149,"about_ca_system_score_codex":0.0002475227,"about_ca_system_score_gemma":0.00039251603,"threshold_uncertainty_score":0.9998455},"labels":[],"label_agreement":null},{"id":"W2561831579","doi":"10.1002/cpt.597","title":"Clinical pharmacogenetics implementation consortium guideline (CPIC) for <i>CYP2D6</i> and <i>CYP2C19</i> genotypes and dosing of tricyclic antidepressants: 2016 update","year":2016,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":678,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"National Institute on Drug Abuse; Canadian Institutes of Health Research; National Institute of General Medical Sciences; National Institute of Mental Health; Agency for Healthcare Research and Quality; National Institutes of Health","keywords":"Dosing; Pharmacogenetics; Guideline; CYP2C19; CYP2D6; Tricyclic; Medicine; Pharmacology; Internal medicine; Genotype; Biology; Genetics","score_opus":0.19379102528921807,"score_gpt":0.5511572408294994,"score_spread":0.35736621554028125,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2561831579","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95039356,0.021630809,0.0057778494,0.011696309,0.006960765,0.0020856427,0.0011621672,0.0001313431,0.00016152966],"genre_scores_gemma":[0.7508969,0.16289638,0.0047330833,0.07867754,0.0022687465,0.00013524131,0.000059106806,0.00013102997,0.00020199447],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9921231,0.0019953689,0.003418731,0.0011568929,0.00027197477,0.0010339168],"domain_scores_gemma":[0.9922064,0.004767883,0.0013010392,0.000384808,0.0006040597,0.00073583],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0047805626,0.0006450521,0.0013641411,0.00021482678,0.00036292148,0.000030816707,0.0005761834,0.0008013642,0.0006058803],"category_scores_gemma":[0.0001165436,0.00050495676,0.00042076097,0.00025200113,0.0022033362,0.00020389135,0.0004179172,0.0008344682,0.000029359866],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027301472,0.0009459031,0.09348923,0.00009274479,0.0024832992,0.000016141246,0.00012764275,0.000014885334,0.35957816,0.00013791256,0.045653667,0.49473026],"study_design_scores_gemma":[0.025069758,0.00070628943,0.00983905,0.00002887297,0.0053841136,0.00003338652,0.000066931716,0.0014196996,0.15759946,0.0012571317,0.7978602,0.00073510606],"about_ca_topic_score_codex":0.0000069693447,"about_ca_topic_score_gemma":0.0000050902695,"teacher_disagreement_score":0.7522065,"about_ca_system_score_codex":0.00003381041,"about_ca_system_score_gemma":0.00031426142,"threshold_uncertainty_score":0.9997402},"labels":[],"label_agreement":null},{"id":"W2562778159","doi":"10.1002/cpt.583","title":"Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for <i>CYP2C19</i> and Voriconazole Therapy","year":2016,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Antifungal resistance and susceptibility","field":"Medicine","cited_by":393,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institute of General Medical Sciences; National Human Genome Research Institute; National Cancer Institute; Children's Mercy Hospital; National Institutes of Health; Sick Kids Foundation; Instituto de Salud Carlos III; Federación Española de Enfermedades Raras","keywords":"CYP2C19; Pharmacogenetics; Voriconazole; Medicine; Medical physics; Internal medicine; Biology; Genotype","score_opus":0.3670090222705866,"score_gpt":0.582856070294495,"score_spread":0.21584704802390842,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2562778159","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9452974,0.0037586032,0.0043890523,0.042421352,0.0023361917,0.0015180012,0.0000973728,0.00010160685,0.00008039925],"genre_scores_gemma":[0.7665041,0.05223503,0.003534174,0.17441174,0.002383937,0.00009245159,0.000023125394,0.00005571568,0.00075971044],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9963878,0.0003901955,0.0017887142,0.00071236974,0.00021804978,0.0005028671],"domain_scores_gemma":[0.9957146,0.002329953,0.0003551358,0.00033381066,0.00091610645,0.00035040436],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002146236,0.00029440425,0.0007581331,0.00005039683,0.00014774608,0.0000146601315,0.00018112658,0.0003304738,0.00054232567],"category_scores_gemma":[0.00015165181,0.00019189809,0.00041429934,0.00010294474,0.00090887974,0.00008005611,0.00006896941,0.00031117292,0.00004093764],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003043964,0.0005983165,0.56485415,0.000028923456,0.0008366126,0.000008170625,0.000025082827,1.447375e-7,0.06212907,0.000027796208,0.066009514,0.3024383],"study_design_scores_gemma":[0.026392391,0.0027163709,0.30709425,0.000031443935,0.001621371,0.000015951608,0.00011785541,0.00017599006,0.022762472,0.00058027136,0.63810194,0.00038972078],"about_ca_topic_score_codex":0.0000021760038,"about_ca_topic_score_gemma":0.00000654004,"teacher_disagreement_score":0.5720924,"about_ca_system_score_codex":0.00004053504,"about_ca_system_score_gemma":0.00032838594,"threshold_uncertainty_score":0.7825377},"labels":[],"label_agreement":null},{"id":"W2574948240","doi":"10.1002/cpt.575","title":"Designer Drugs 2.0","year":2017,"lang":"en","type":"editorial","venue":"Clinical Pharmacology & Therapeutics","topic":"Cannabis and Cannabinoid Research","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"National Institutes of Health","keywords":"Synthetic cannabinoids; Hallucinogen; Pharmacology; Psilocybin; Designer drug; Medicine; Repurposing; Psychosis; Cannabinoid Receptor Agonists; Lysergic acid diethylamide; Neuropharmacology; Cannabinoid; Drug; Psychology; Psychiatry; Cannabinoid receptor; Receptor; Serotonin","score_opus":0.09317065327596848,"score_gpt":0.4980223541213104,"score_spread":0.40485170084534194,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2574948240","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0006322546,0.0031850657,0.000020411442,0.036746804,0.9522967,0.0010116296,0.00011682378,0.00013528859,0.00585504],"genre_scores_gemma":[0.0001290975,0.009699224,0.00008445308,0.02269435,0.81861305,0.00012607158,0.00022611536,0.00016031416,0.14826733],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99525803,0.000585733,0.0010861488,0.0010105192,0.001139796,0.0009197839],"domain_scores_gemma":[0.99561477,0.00090198097,0.0005649544,0.0012146742,0.0010618885,0.00064173155],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.002193773,0.0005579947,0.001571486,0.0001695321,0.00035789504,0.00009660194,0.0010097837,0.0031317638,0.002018567],"category_scores_gemma":[0.0003635066,0.00045583452,0.0009352363,0.00010575729,0.0016787635,0.00005941897,0.0003572171,0.0056733857,0.00066388387],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015968109,0.0007739299,0.000114803035,0.0001643177,0.0017839146,0.00026463304,0.00004999505,2.7394748e-7,0.00047658695,0.0000013460127,0.9729353,0.021838078],"study_design_scores_gemma":[0.0054522655,0.0013490305,0.00029742235,0.00007624321,0.0034681347,0.00000896617,0.000013246374,0.000051716514,0.00028194554,0.000059168382,0.98852545,0.00041643158],"about_ca_topic_score_codex":0.000015312104,"about_ca_topic_score_gemma":0.0000031246616,"teacher_disagreement_score":0.14241228,"about_ca_system_score_codex":0.000216908,"about_ca_system_score_gemma":0.0037585162,"threshold_uncertainty_score":0.99978936},"labels":[],"label_agreement":null},{"id":"W2581158237","doi":"10.1002/cpt.635","title":"Improving Medicine Use for Children: A Global Imperative","year":2017,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital; University of British Columbia","funders":"","keywords":"Medicine; Low and middle income countries; Medical education; Family medicine; Intensive care medicine; Developing country; Economic growth","score_opus":0.29269317816025386,"score_gpt":0.5600611820816216,"score_spread":0.2673680039213677,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2581158237","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.79493517,0.0033026366,0.0019906508,0.18978895,0.0057607605,0.002518639,0.00021542325,0.00016574816,0.0013220472],"genre_scores_gemma":[0.8047905,0.0046855523,0.0015128191,0.18446547,0.0040613045,0.000079555975,0.000025572752,0.000034749963,0.00034450056],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99793607,0.0001873093,0.0006574151,0.0005154176,0.00018427781,0.0005195084],"domain_scores_gemma":[0.99670804,0.0017123311,0.00048673555,0.00044636373,0.00029565676,0.00035087718],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009165599,0.00027476388,0.00072481844,0.00002046997,0.0008733289,0.00006409593,0.00036542566,0.00025690338,0.00027170288],"category_scores_gemma":[0.00066894194,0.00019718739,0.0002770117,0.000055455446,0.0013897569,0.00025751445,0.00022287072,0.0006309325,0.000025954016],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011316961,0.0019983994,0.5926333,0.00011503723,0.009034234,0.000107275824,0.0002444448,0.0000023559394,0.012334936,0.00046973367,0.10341568,0.26832762],"study_design_scores_gemma":[0.021500522,0.0037870558,0.5617369,0.000045481513,0.008226095,0.00009377825,0.000073230745,0.0024797316,0.0010052213,0.00048732272,0.40014058,0.00042411243],"about_ca_topic_score_codex":0.000053786185,"about_ca_topic_score_gemma":0.000010352508,"teacher_disagreement_score":0.29672492,"about_ca_system_score_codex":0.00007775139,"about_ca_system_score_gemma":0.00012953716,"threshold_uncertainty_score":0.80410683},"labels":[],"label_agreement":null},{"id":"W2591531144","doi":"10.1002/cpt.673","title":"Response to “PPARδ Modulation by GW501516: An Unsuccessful Exercise Mimetic”","year":2017,"lang":"en","type":"letter","venue":"Clinical Pharmacology & Therapeutics","topic":"Adipose Tissue and Metabolism","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Beijing; Citation; China; Library science; Sports medicine; Peroxisome proliferator; Medicine; Psychology; Computer science; Political science; Internal medicine; Physical therapy; Peroxisome proliferator-activated receptor","score_opus":0.11218188674188513,"score_gpt":0.4648383322771874,"score_spread":0.3526564455353023,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2591531144","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.15190129,0.0034383426,0.00017243825,0.83504033,0.0068335165,0.0019279842,0.00015697979,0.00021731106,0.000311785],"genre_scores_gemma":[0.014824318,0.0022139023,0.0006164323,0.94688886,0.011410857,0.0001277974,0.0006150623,0.00021736657,0.023085408],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99466383,0.0013232649,0.0012939284,0.0012482426,0.00055780995,0.00091289316],"domain_scores_gemma":[0.9956248,0.0010485566,0.0006633196,0.001604337,0.000410194,0.0006487865],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0017721741,0.00070735987,0.0018265157,0.00026534134,0.00029503048,0.00006848665,0.00096433744,0.0026932538,0.0009772667],"category_scores_gemma":[0.00012396388,0.00064328685,0.0004731359,0.00015999192,0.0006676634,0.0001603124,0.00019201187,0.0038508067,0.0007528536],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005439301,0.00058293855,0.00035756984,0.00005116034,0.00093522563,0.0008249322,0.00016958154,0.0000027025892,0.014743667,4.5774394e-7,0.95183176,0.02506072],"study_design_scores_gemma":[0.004021507,0.0013792303,0.0032773307,0.00010279931,0.006708089,0.000051915627,0.000008264366,0.00018305657,0.0022651698,0.00010233355,0.9812879,0.00061238644],"about_ca_topic_score_codex":0.00001635237,"about_ca_topic_score_gemma":9.622771e-7,"teacher_disagreement_score":0.13707697,"about_ca_system_score_codex":0.000096532145,"about_ca_system_score_gemma":0.00046716657,"threshold_uncertainty_score":0.999936},"labels":[],"label_agreement":null},{"id":"W2605398561","doi":"","title":"St Johns wort reduces oral bioavailability of talinolol in healthy volunteers","year":2002,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Natural Products and Biological Research","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Bioavailability; Medicine; Pharmacology; Traditional medicine","score_opus":0.2927404578473435,"score_gpt":0.49873534345682036,"score_spread":0.20599488560947687,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2605398561","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9507954,0.0029532076,0.0000022544475,0.044278115,0.00083371456,0.00066246104,0.000018084052,0.000041989133,0.0004147403],"genre_scores_gemma":[0.9623208,0.0093699545,0.00029558863,0.02715395,0.00039062268,0.000010741678,0.000010832542,0.000013621135,0.00043386768],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99725014,0.00043764827,0.0009962666,0.00053733255,0.0002503395,0.0005282939],"domain_scores_gemma":[0.99832445,0.0007745747,0.00014313386,0.0002801341,0.00023807438,0.00023965476],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0015317774,0.0001815315,0.0007052835,0.00012660907,0.000048302056,0.000004750584,0.0002696879,0.00041004183,0.0022757938],"category_scores_gemma":[0.0002732893,0.00012016905,0.00019903555,0.0005265242,0.0014249154,0.000040993775,0.00011277008,0.0013581762,0.000083081664],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015630249,0.0146286925,0.4710323,0.00029098775,0.001270022,0.00020215072,0.00026105272,0.000009013274,0.111028984,0.00005532387,0.06610305,0.3194882],"study_design_scores_gemma":[0.026740395,0.031899363,0.40516508,0.00015087936,0.0012960932,0.00006869385,0.0003166706,0.0081184665,0.036876913,0.0008875371,0.4873955,0.0010844223],"about_ca_topic_score_codex":0.000029730027,"about_ca_topic_score_gemma":0.000012304885,"teacher_disagreement_score":0.42129245,"about_ca_system_score_codex":0.000080402875,"about_ca_system_score_gemma":0.000112987604,"threshold_uncertainty_score":0.99863625},"labels":[],"label_agreement":null},{"id":"W2608178729","doi":"10.1002/cpt.677","title":"Adverse Drug Reactions in Children: The Double‐Edged Sword of Therapeutics","year":2017,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":106,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Drug reaction; Epidemiology; Drug; Intensive care medicine; Population; Incidence (geometry); Pediatrics; Pharmacology; Internal medicine; Environmental health","score_opus":0.4612497991793427,"score_gpt":0.5873537751746787,"score_spread":0.12610397599533596,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2608178729","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0006169896,0.9828328,0.0000033987883,0.008343195,0.0028292635,0.0030142644,0.00005231555,0.000060897382,0.0022468797],"genre_scores_gemma":[0.0007319694,0.9798551,0.00006194882,0.016422834,0.0015503563,0.0001816507,0.000046646524,0.000101097896,0.0010483742],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.994172,0.0014618566,0.0025353802,0.0007485323,0.000381993,0.00070024235],"domain_scores_gemma":[0.9918463,0.004489689,0.0020845,0.001127171,0.00021069335,0.00024162626],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0027208042,0.00071408745,0.0034138816,0.00017107581,0.00041301877,0.000025621905,0.0011283957,0.0008281633,0.0003250001],"category_scores_gemma":[0.0000736197,0.00043772414,0.0015706684,0.0003994066,0.0018090272,0.000115691066,0.00039909183,0.004495304,0.00015666065],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012868536,0.0023922543,0.0033347427,0.0023685985,0.013522119,0.000054707853,0.00014032311,0.0000016339122,0.000009675053,0.000042543696,0.004475731,0.9723708],"study_design_scores_gemma":[0.0043886653,0.00024624396,0.0016738981,0.0012578621,0.026300952,0.00010000505,0.000036561196,0.000022794899,0.000009314575,0.00003752882,0.9655567,0.00036948553],"about_ca_topic_score_codex":0.000033849283,"about_ca_topic_score_gemma":0.000013268226,"teacher_disagreement_score":0.9720013,"about_ca_system_score_codex":0.00014092437,"about_ca_system_score_gemma":0.0007058472,"threshold_uncertainty_score":0.9998075},"labels":[],"label_agreement":null},{"id":"W2614410056","doi":"10.1002/cpt.675","title":"Drugs for Children","year":2017,"lang":"en","type":"editorial","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Clinical pharmacology; Medicine; Orphan drug; SAFER; Global health; Drug; Population; Intensive care medicine; Pharmacology; Environmental health; Public health; Bioinformatics; Biology; Pathology","score_opus":0.15219260213663838,"score_gpt":0.5431166467122077,"score_spread":0.39092404457556934,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2614410056","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00057349843,0.0075827967,0.000056190012,0.024894,0.96195537,0.0019830144,0.0005289916,0.00014409616,0.0022820232],"genre_scores_gemma":[0.00035266613,0.041961692,0.00034970726,0.04892206,0.90266967,0.00018585245,0.0005300649,0.00013397253,0.0048943367],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99638015,0.00032136697,0.0010613088,0.00092670147,0.0005271629,0.0007832944],"domain_scores_gemma":[0.9869863,0.010375164,0.0009325611,0.000666416,0.00060924725,0.00043033084],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0018099891,0.000569452,0.001666134,0.00006320104,0.00057398644,0.00006903321,0.00077403075,0.0021072002,0.00036637767],"category_scores_gemma":[0.00073742616,0.00046220183,0.00095350284,0.000056772576,0.000989923,0.000091006994,0.00031262994,0.0035970628,0.00021749007],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034178416,0.0007967189,0.0005003806,0.00014713244,0.0069302157,0.00001951438,0.00003464284,1.6639618e-7,0.00004514053,0.0000020849725,0.95453,0.033576157],"study_design_scores_gemma":[0.00928194,0.0011896923,0.00058510154,0.000060511684,0.015533178,0.000005698441,0.000007625077,0.00007910318,0.00009108818,0.00012568684,0.97260344,0.00043694966],"about_ca_topic_score_codex":0.000007939966,"about_ca_topic_score_gemma":0.0000018637372,"teacher_disagreement_score":0.05928574,"about_ca_system_score_codex":0.00010082748,"about_ca_system_score_gemma":0.0007761887,"threshold_uncertainty_score":0.999783},"labels":[],"label_agreement":null},{"id":"W2614636769","doi":"10.1002/cpt.676","title":"Evaluation of the Safety of Drugs and Biological Products Used During Lactation: Workshop Summary","year":2017,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Breastfeeding Practices and Influences","field":"Medicine","cited_by":96,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"National Institutes of Health","keywords":"Lactation; Food and drug administration; Medicine; Breastfeeding; Environmental health; Pregnancy; Pediatrics; Biology","score_opus":0.5132854166828362,"score_gpt":0.5604566358928957,"score_spread":0.04717121921005951,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2614636769","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.01317398,0.9775333,3.5949876e-7,0.006118688,0.0014184887,0.001453758,0.00001754923,0.00001420697,0.00026967828],"genre_scores_gemma":[0.0123925945,0.9859054,0.000061911225,0.00077505014,0.0006751167,0.00003246566,0.000013690534,0.000020284919,0.0001234927],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99608094,0.001630804,0.0012704355,0.00040117244,0.00043384655,0.00018279138],"domain_scores_gemma":[0.9949726,0.0018876048,0.001993066,0.00044912568,0.00062797277,0.00006964452],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004438619,0.00024711335,0.0015534052,0.00005699953,0.00013879436,0.000010100521,0.00035630536,0.00056639774,0.00007639279],"category_scores_gemma":[0.0006121695,0.00013865052,0.00037249987,0.00015762381,0.0011956121,0.00008268899,0.00018328232,0.00093286764,0.00000321133],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003390173,0.00033290207,0.0011419947,0.0030002557,0.0020023498,0.0000015519719,0.00013720119,9.948934e-7,0.00008802876,0.0000047383087,0.0002595012,0.99269146],"study_design_scores_gemma":[0.0032133048,0.00032195103,0.022383092,0.0052800234,0.034783807,0.000063254454,0.000050719587,0.0000624247,0.00008760148,0.000043358243,0.9334737,0.00023673238],"about_ca_topic_score_codex":0.0000017904958,"about_ca_topic_score_gemma":4.876573e-7,"teacher_disagreement_score":0.9924547,"about_ca_system_score_codex":0.000051729163,"about_ca_system_score_gemma":0.00084452983,"threshold_uncertainty_score":0.56540036},"labels":[],"label_agreement":null},{"id":"W2614866669","doi":"10.1016/j.clpt.2005.12.016","title":"OII-B-3Effect of maternal inflammation on the expression of ABCB1 and ABCG2 in placenta","year":2006,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pregnancy and Medication Impact","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Transplacental; Placenta; Abcg2; Fetus; P-glycoprotein; Inflammation; Internal medicine; Endocrinology; Pharmacology; Efflux; Transporter; Andrology; Medicine; Biology; ATP-binding cassette transporter; Pregnancy; Drug resistance; Multiple drug resistance; Biochemistry","score_opus":0.0623512798074885,"score_gpt":0.42085504127187257,"score_spread":0.35850376146438406,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2614866669","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99316835,0.00045000986,0.000056587203,0.005133599,0.00033924798,0.00038270061,0.0000053096223,0.000011032073,0.00045313485],"genre_scores_gemma":[0.99507535,0.00082266505,0.0000638518,0.0037306368,0.00020032878,0.00001389285,0.000005098003,0.000008102846,0.00008009126],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99875796,0.00029646873,0.00055681384,0.00012696089,0.00013839839,0.00012341728],"domain_scores_gemma":[0.9984077,0.00110979,0.0002497534,0.00014544072,0.00004096327,0.000046301328],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007129522,0.000086563174,0.00026852856,0.000057732337,0.000020868121,0.0000016793009,0.00008508834,0.00013498992,0.00010853836],"category_scores_gemma":[0.000042756747,0.00005392697,0.000060163253,0.00007474342,0.00030209564,0.00002765865,0.000025407204,0.0002911227,0.0000046574655],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022091647,0.0006469886,0.33616403,0.0001367596,0.00011006867,0.000009908709,0.00019527781,0.000025238838,0.6464972,0.0001408337,0.0018729754,0.01199155],"study_design_scores_gemma":[0.0037806858,0.00054806756,0.50976866,0.0003042151,0.00018768883,0.000005676277,0.000019663923,0.00034934483,0.48251158,0.00028844742,0.0021864183,0.0000495528],"about_ca_topic_score_codex":0.0000072623643,"about_ca_topic_score_gemma":0.0000014713331,"teacher_disagreement_score":0.17360465,"about_ca_system_score_codex":0.000015932872,"about_ca_system_score_gemma":0.00005680493,"threshold_uncertainty_score":0.21990782},"labels":[],"label_agreement":null},{"id":"W2619242792","doi":"10.1002/cpt.697","title":"Psilocybin: Good Trip or Bad Trip","year":2017,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Psychedelics and Drug Studies","field":"Psychology","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Psilocybin; Clinical pharmacology; Medicine; Hallucinogen; Pharmacology; Psychology","score_opus":0.34652269791209483,"score_gpt":0.5706991515937575,"score_spread":0.22417645368166267,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2619242792","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.59485966,0.0069135935,0.00047807244,0.1008442,0.07083227,0.001620333,0.00012019945,0.0005011295,0.22383052],"genre_scores_gemma":[0.851305,0.0029353003,0.00026537123,0.10988214,0.003938558,0.00014390402,0.000007542659,0.000085512955,0.03143669],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.996635,0.00056168524,0.0010241509,0.0007870216,0.00019714092,0.00079499086],"domain_scores_gemma":[0.9963798,0.0013897339,0.0006133993,0.0011926447,0.00015854694,0.00026590074],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0013237349,0.000380948,0.00082393445,0.0000747409,0.00086681504,0.00007913127,0.0013585144,0.0005685847,0.0037740453],"category_scores_gemma":[0.00007768385,0.00029139797,0.00040251136,0.000099951976,0.0012497668,0.00009287797,0.0003038665,0.0009781916,0.0017741793],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007665021,0.0053364467,0.086234935,0.000028271148,0.008184533,0.0003958929,0.0014695989,0.0000025214508,0.0011371339,0.0026383554,0.7027202,0.18418704],"study_design_scores_gemma":[0.009308431,0.0009691868,0.11443881,0.0000095706555,0.000934555,0.000017885312,0.0001789814,0.00006750979,0.00021849762,0.0008121121,0.8726178,0.00042671183],"about_ca_topic_score_codex":0.000022708624,"about_ca_topic_score_gemma":0.000031998276,"teacher_disagreement_score":0.2564453,"about_ca_system_score_codex":0.000036351743,"about_ca_system_score_gemma":0.00012139496,"threshold_uncertainty_score":0.9999538},"labels":[],"label_agreement":null},{"id":"W2624697901","doi":"10.1002/cpt.708","title":"Within Our Skin","year":2017,"lang":"en","type":"editorial","venue":"Clinical Pharmacology & Therapeutics","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Dermatology","score_opus":0.09090138755619306,"score_gpt":0.4903581688068058,"score_spread":0.3994567812506128,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2624697901","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0018891436,0.0034578424,0.000010253834,0.010889458,0.9802302,0.0006359283,0.00014983278,0.00019339847,0.0025439567],"genre_scores_gemma":[0.0058411057,0.00488784,0.00017474269,0.043374028,0.9332204,0.00006946516,0.00046961286,0.00013604095,0.011826756],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9960501,0.0006453156,0.0012804687,0.00088326674,0.0005286221,0.00061221054],"domain_scores_gemma":[0.99506843,0.0019468601,0.0009628427,0.0010586102,0.00048143763,0.0004818465],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0009951094,0.0005785539,0.0017648684,0.00012544953,0.00030904813,0.000042856944,0.0008885535,0.0037664922,0.00026899128],"category_scores_gemma":[0.00057172665,0.0004915834,0.0008141595,0.000063495,0.0008720125,0.000068771405,0.00023975076,0.0043504946,0.0009833957],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019630608,0.0011499518,0.0028233035,0.00016074217,0.0033211873,0.0010456601,0.00004068109,6.240936e-7,0.000030411149,0.0000012618094,0.9881719,0.0012912204],"study_design_scores_gemma":[0.005894224,0.00042657065,0.0015186154,0.000113438706,0.008474589,0.000048549933,0.000024639256,0.000052330895,0.00015558297,0.00017087843,0.98269665,0.00042394383],"about_ca_topic_score_codex":0.000003052901,"about_ca_topic_score_gemma":0.000004283773,"teacher_disagreement_score":0.047009777,"about_ca_system_score_codex":0.000068002984,"about_ca_system_score_gemma":0.0020814752,"threshold_uncertainty_score":0.9997945},"labels":[],"label_agreement":null},{"id":"W2734427898","doi":"10.1002/cpt.747","title":"Fecal Microbial Transplantation in Inflammatory Bowel Disease: A Movement Too Big to Be Ignored","year":2017,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Clostridium difficile and Clostridium perfringens research","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity; University of Alberta","funders":"","keywords":"Inflammatory bowel disease; Fecal bacteriotherapy; Medicine; Feces; Disease; Transplantation; Ulcerative colitis; Intensive care medicine; Clinical trial; Immunology; Internal medicine; Biology; Antibiotics; Microbiology","score_opus":0.1205949463531807,"score_gpt":0.43800236333091347,"score_spread":0.3174074169777328,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2734427898","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9429072,0.000197889,0.000038032307,0.05410147,0.0013363973,0.0010603237,0.0000715447,0.00004736058,0.00023975824],"genre_scores_gemma":[0.9322101,0.0019666776,0.00007803761,0.06375442,0.0012174747,0.00009750094,0.00005261543,0.000041723342,0.0005814587],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9975262,0.00022407918,0.0007720922,0.0005440508,0.00034810847,0.00058542995],"domain_scores_gemma":[0.9983311,0.00024469872,0.00014622606,0.0005614352,0.00013907124,0.00057742937],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00068783865,0.00025057537,0.00043491303,0.0001584014,0.00023516317,0.00006409939,0.0004340971,0.00025447525,0.00021470449],"category_scores_gemma":[0.00007234143,0.00023517395,0.00024587318,0.000093805895,0.00041412978,0.000059810103,0.00014458352,0.00077953533,0.00010936254],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.019029746,0.0042656,0.26516184,0.000372404,0.0009632586,0.0023537646,0.00074883486,0.00009382455,0.6416752,0.000033352957,0.024374822,0.040927336],"study_design_scores_gemma":[0.017070387,0.0012640797,0.8412292,0.000117808784,0.0012066686,0.000014797847,0.00010897866,0.00097569,0.08240986,0.000055715853,0.055047702,0.00049912045],"about_ca_topic_score_codex":0.00003885816,"about_ca_topic_score_gemma":0.000089401925,"teacher_disagreement_score":0.5760673,"about_ca_system_score_codex":0.00017144895,"about_ca_system_score_gemma":0.0005196566,"threshold_uncertainty_score":0.95901155},"labels":[],"label_agreement":null},{"id":"W2745723818","doi":"10.1002/cpt.776","title":"Psychedelic Drugs as Therapeutics: No Illusions About the Challenges","year":2017,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Psychedelics and Drug Studies","field":"Psychology","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Institute on Drug Abuse; Uniformed Services University of the Health Sciences; University of Michigan","keywords":"Psilocybin; Psychotomimetic; Hallucinogen; Illusion; Variety (cybernetics); Pharmacology; Medicine; Psychology; Neuroscience; Computer science; Artificial intelligence","score_opus":0.2882514157639476,"score_gpt":0.5342440168939404,"score_spread":0.24599260112999283,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2745723818","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.24060592,0.044827476,0.0000654047,0.3190671,0.040808674,0.0013081164,0.00004433388,0.00034356926,0.3529294],"genre_scores_gemma":[0.7508639,0.049048178,0.00009096205,0.18857856,0.004372455,0.0002384605,0.0000041888584,0.00010768091,0.006695602],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9956526,0.0009269916,0.0010796338,0.0009914527,0.00034539588,0.0010039357],"domain_scores_gemma":[0.9944401,0.0019701927,0.0007536532,0.0022006764,0.00039152105,0.00024390563],"candidate_categories":["metaepi_narrow","sts","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0019726465,0.00054061686,0.000761327,0.00007276202,0.0022548046,0.00012635729,0.002512518,0.00063315214,0.0018884015],"category_scores_gemma":[0.000053040647,0.00036702253,0.0005915465,0.00008836269,0.0026889727,0.000106600586,0.0005834117,0.0014602626,0.0059362366],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003330891,0.0075538964,0.012119383,0.000061446895,0.02137785,0.00015278962,0.029266397,0.000006776358,0.002372479,0.040330973,0.32956886,0.5538583],"study_design_scores_gemma":[0.0034781613,0.0005794013,0.05387999,0.000020554915,0.0010903897,0.00001822233,0.001693281,0.0001256133,0.000048549908,0.006006485,0.9325538,0.0005055034],"about_ca_topic_score_codex":0.000043983215,"about_ca_topic_score_gemma":0.00002981942,"teacher_disagreement_score":0.60298496,"about_ca_system_score_codex":0.000039127328,"about_ca_system_score_gemma":0.00012079183,"threshold_uncertainty_score":0.99987817},"labels":[],"label_agreement":null},{"id":"W2751834855","doi":"10.1002/cpt.860","title":"Safety and Ergogenic Properties of Combined Aminophylline and Ambrisentan in Hypoxia","year":2017,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"High Altitude and Hypoxia","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"National Center for Advancing Translational Sciences; Defense Advanced Research Projects Agency; National Institutes of Health; Office of Naval Research; Gilead Sciences","keywords":"Aminophylline; Ambrisentan; Medicine; Hypoxia (environmental); Placebo; Pharmacology; Anesthesia; Internal medicine; Endothelin receptor; Bosentan; Oxygen; Chemistry","score_opus":0.05968574799120665,"score_gpt":0.36452549010356194,"score_spread":0.3048397421123553,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2751834855","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944605,0.003231206,0.000015736334,0.00165073,0.0003090234,0.00020729162,0.000009740072,0.0000051478714,0.0001106131],"genre_scores_gemma":[0.98415774,0.011452548,0.000119568016,0.003830786,0.00018869813,0.0000060840857,0.000007284041,0.0000151755785,0.0002221161],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9988763,0.00013538737,0.00043715487,0.0003019249,0.000057209334,0.00019206884],"domain_scores_gemma":[0.99934876,0.00003768706,0.0001864988,0.00028936085,0.000053240055,0.000084473526],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003360938,0.00013805203,0.00031396947,0.000026188987,0.000119377175,0.000015045299,0.00023030576,0.00021826294,0.000008908902],"category_scores_gemma":[0.000025907499,0.00011901216,0.00006040644,0.00001974531,0.00087511964,0.0000058475102,0.00023212198,0.00018990437,0.0000020889017],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016868963,0.00028653358,0.089564994,0.0000313003,0.00030962014,0.000007895326,0.000045441087,0.0000022228357,0.90418947,0.00002282536,0.00024618822,0.003606645],"study_design_scores_gemma":[0.00917034,0.0016816051,0.7729052,0.000030760377,0.00040863533,0.000015292359,0.000047665482,0.00036341604,0.18211652,0.00010355387,0.0327851,0.00037191392],"about_ca_topic_score_codex":0.000011215514,"about_ca_topic_score_gemma":0.000049785747,"teacher_disagreement_score":0.7220729,"about_ca_system_score_codex":0.000004602987,"about_ca_system_score_gemma":0.00005120273,"threshold_uncertainty_score":0.4853175},"labels":[],"label_agreement":null},{"id":"W2754167240","doi":"10.1002/cpt.885","title":"Note of Republication: A Prospective International Study on Adherence to Treatment in 305 Patients With Flaring SLE: Assessment by Drug Levels and Self‐Administered Questionnaires","year":2017,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":71,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal General Hospital","funders":"National Institute of Arthritis and Musculoskeletal and Skin Diseases; National Institutes of Health","keywords":"Drug; Medicine; Pharmacology; Internal medicine; Family medicine","score_opus":0.11355134187311544,"score_gpt":0.5072650220054349,"score_spread":0.39371368013231944,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2754167240","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99179924,0.00002778851,0.00004798765,0.004619432,0.0005152859,0.002602264,0.000021789592,0.000025496847,0.00034074846],"genre_scores_gemma":[0.99759656,0.000043272114,0.00047827302,0.0010330022,0.00009696946,0.00031085534,0.000007366725,0.000018900071,0.00041481675],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99810284,0.00028045033,0.00058219995,0.00047313023,0.0003685875,0.00019280055],"domain_scores_gemma":[0.99824876,0.00046594473,0.00032894698,0.00043977334,0.00037117465,0.00014538759],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006478455,0.00016603823,0.000437901,0.0000990722,0.0001012617,0.000035845453,0.00026632202,0.000082931925,0.000027174252],"category_scores_gemma":[0.00009030278,0.00011961526,0.00004127222,0.00007373065,0.00018910112,0.000080946586,0.00012958933,0.00027554878,0.000005036007],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013304651,0.0069075483,0.98425555,0.000025097803,0.00064275024,0.000014687932,0.0023983305,9.665337e-7,0.0003285893,0.000007954502,0.00025419806,0.0038338662],"study_design_scores_gemma":[0.013499944,0.0076883053,0.9764408,0.00015980029,0.0002063238,0.000011733503,0.0002639931,0.00020823386,0.00072348636,0.000016363334,0.0006753022,0.00010574976],"about_ca_topic_score_codex":0.000036874917,"about_ca_topic_score_gemma":0.000046768077,"teacher_disagreement_score":0.012169478,"about_ca_system_score_codex":0.00037114247,"about_ca_system_score_gemma":0.0002779838,"threshold_uncertainty_score":0.48777688},"labels":[],"label_agreement":null},{"id":"W2761667289","doi":"10.1002/cpt.807","title":"Effect of Chronic Kidney Disease on Nonrenal Elimination Pathways: A Systematic Assessment of CYP1A2, CYP2C8, CYP2C9, CYP2C19, and OATP","year":2017,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":86,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Institute of General Medical Sciences; U.S. Food and Drug Administration; National Institutes of Health","keywords":"CYP2C8; CYP2C9; CYP2C19; CYP1A2; Pharmacology; CYP3A4; Cytochrome P450; Tolbutamide; Pharmacokinetics; CYP2D6; Chemistry; Kidney disease; Medicine; Biochemistry; Metabolism; Internal medicine","score_opus":0.1731719731352774,"score_gpt":0.537432668628869,"score_spread":0.3642606954935915,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2761667289","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9803479,0.0053935302,0.00018930771,0.0033300188,0.0067317677,0.0025053981,0.0004236098,0.00007503805,0.001003457],"genre_scores_gemma":[0.9789782,0.010149654,0.0001042991,0.009380663,0.0009310637,0.00023113313,0.00004023626,0.0000730412,0.000111678324],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9919769,0.0041478756,0.0018738242,0.00079498393,0.0004899498,0.0007164519],"domain_scores_gemma":[0.9917428,0.0041032396,0.001971281,0.000890377,0.0003385584,0.00095374853],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.005595492,0.0006328334,0.0017152388,0.00023193855,0.0005715478,0.00004345537,0.0011448329,0.0005458527,0.0004340949],"category_scores_gemma":[0.00042581648,0.00052566844,0.0005418398,0.00013747688,0.0018258091,0.0001590916,0.00041779465,0.0015072417,0.000035831214],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016852818,0.014238019,0.09387684,0.044067647,0.014753782,0.0005397041,0.0009426035,0.001861355,0.6845308,0.0032229978,0.008881265,0.116232194],"study_design_scores_gemma":[0.06855482,0.018156758,0.10541116,0.0045584063,0.044988796,0.000071161485,0.00007837771,0.22465198,0.48212612,0.0013387853,0.04720386,0.002859803],"about_ca_topic_score_codex":0.000004535408,"about_ca_topic_score_gemma":0.000001284699,"teacher_disagreement_score":0.22279061,"about_ca_system_score_codex":0.00010953674,"about_ca_system_score_gemma":0.0006021519,"threshold_uncertainty_score":0.9997195},"labels":[],"label_agreement":null},{"id":"W2767469906","doi":"10.1002/cpt.890","title":"Research Directions in Genetic Predispositions to Stevens–Johnson Syndrome / Toxic Epidermal Necrolysis","year":2017,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Drug-Induced Adverse Reactions","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Human Genome Research Institute; National Institutes of Health; National Cancer Institute; National Institute of General Medical Sciences; Medical Research Council; National Institute for Health and Care Research","keywords":"Toxic epidermal necrolysis; Drug reaction; Medicine; Incidence (geometry); Drug; Dermatology; Genetic predisposition; Complication; Intensive care medicine; Allele; Surgery; Pharmacology; Internal medicine; Genetics; Disease; Biology","score_opus":0.4810342900692436,"score_gpt":0.6054057728166243,"score_spread":0.12437148274738075,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767469906","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0019108532,0.9801156,0.00002862319,0.005353634,0.0045958594,0.0045480286,0.00017388829,0.00019054233,0.0030829906],"genre_scores_gemma":[0.0008818568,0.9885861,0.0005045113,0.003838517,0.0014401223,0.0011111683,0.000100851474,0.00019004122,0.0033468285],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9918974,0.0027581854,0.002213588,0.0013301466,0.0005606157,0.0012400674],"domain_scores_gemma":[0.9926889,0.004006137,0.0005417384,0.0015208246,0.0003845467,0.00085784105],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0023881264,0.00066387246,0.0035047205,0.0015762858,0.00064418546,0.00006488342,0.00085456047,0.0014571552,0.00016427196],"category_scores_gemma":[0.00028184557,0.00061132835,0.0014019404,0.00137755,0.0007963584,0.000112174734,0.00041793747,0.0052566472,0.0017120758],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003585716,0.0020692954,0.00009429978,0.0012543726,0.0025788108,0.001220616,0.000048369937,0.000010648093,0.000035015324,0.0000035734197,0.0023146218,0.9903345],"study_design_scores_gemma":[0.0011980172,0.0003610202,0.0060768896,0.0029559801,0.009649707,0.0012562276,0.000029992632,0.000040498195,0.000003175714,0.000018973687,0.97796625,0.00044327023],"about_ca_topic_score_codex":0.000045055618,"about_ca_topic_score_gemma":0.00006240211,"teacher_disagreement_score":0.98989123,"about_ca_system_score_codex":0.00096965866,"about_ca_system_score_gemma":0.0019983326,"threshold_uncertainty_score":0.9998392},"labels":[],"label_agreement":null},{"id":"W2770199471","doi":"10.1002/cpt.921","title":"Commentary on “The Universally Unrecognized Assumption in Predicting Drug Clearance and Organ Extraction Ratio”","year":2017,"lang":"en","type":"letter","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Clinical pharmacology; Pharmacokinetics; Clearance; Drug; Metabolic clearance rate; Drug development; Subject (documents); Pharmacology; Medicine; Intensive care medicine; Nothing; Computer science; Epistemology; Philosophy; Urology","score_opus":0.2219440488571743,"score_gpt":0.4991478039572035,"score_spread":0.27720375510002915,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2770199471","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.21358773,0.0019515128,0.000027327487,0.7685141,0.013457549,0.001472944,0.00018241607,0.00012226886,0.0006841741],"genre_scores_gemma":[0.070125714,0.015946168,0.000049275073,0.9009443,0.010857562,0.00011376335,0.00017946005,0.00013804853,0.0016457272],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99037725,0.005673032,0.0014000741,0.0011448556,0.00038927532,0.0010155092],"domain_scores_gemma":[0.99048966,0.0071901763,0.0012399676,0.000626474,0.00019424176,0.00025949941],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0039213737,0.00081492565,0.001092805,0.00027062686,0.000983029,0.000107339394,0.0012247514,0.0022339877,0.0011178206],"category_scores_gemma":[0.00011658518,0.00070896844,0.00033183073,0.00018664515,0.001485895,0.00020586382,0.000319112,0.013028154,0.0002073993],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015110731,0.00058892387,0.005639463,0.000068875524,0.0014115864,0.00051845884,0.00040322353,0.00011076301,0.0037137205,0.000007419206,0.9692607,0.016765775],"study_design_scores_gemma":[0.0063026315,0.00017224523,0.003821518,0.00006887973,0.0023106032,0.000028443057,0.00005576453,0.006682572,0.0029220947,0.00028453037,0.9766844,0.0006663297],"about_ca_topic_score_codex":0.000029901974,"about_ca_topic_score_gemma":0.000048558297,"teacher_disagreement_score":0.14346202,"about_ca_system_score_codex":0.00018442373,"about_ca_system_score_gemma":0.00023095838,"threshold_uncertainty_score":0.9997953},"labels":[],"label_agreement":null},{"id":"W2773691289","doi":"10.1002/cpt.973","title":"Food Effect on Rosuvastatin Disposition and Low‐Density Lipoprotein Cholesterol","year":2017,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"Canadian Institutes of Health Research","keywords":"Rosuvastatin; Medicine; Rosuvastatin Calcium; Internal medicine; Endocrinology; Cholesterol; Low-density lipoprotein; Pharmacology","score_opus":0.05393566413035072,"score_gpt":0.4060748040629718,"score_spread":0.3521391399326211,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2773691289","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9884972,0.0003458069,0.00016391613,0.008243213,0.0010925692,0.0013267855,0.00001103253,0.00006855354,0.0002509069],"genre_scores_gemma":[0.96371895,0.0005635302,0.00011276745,0.03401087,0.0014113395,0.0000630093,0.000010611042,0.00003651755,0.000072433235],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99793696,0.0005178834,0.00043154054,0.0004913082,0.00027412138,0.00034819354],"domain_scores_gemma":[0.99835235,0.00026459986,0.0002359154,0.00076333963,0.000084891195,0.00029892306],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014911749,0.0002373182,0.0006756321,0.00004215483,0.0004529532,0.00005313724,0.00017123442,0.00029923063,0.00003831744],"category_scores_gemma":[0.0000568707,0.00018496804,0.0003205416,0.000033441396,0.00048280024,0.000074090734,0.00010851352,0.00080546417,0.00005760732],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005940624,0.0014015951,0.045913357,0.00042875516,0.0028414703,0.00017784741,0.00014301088,0.000002737664,0.017064499,0.000040254068,0.0009171698,0.9251287],"study_design_scores_gemma":[0.014269669,0.016483959,0.9249394,0.00016529267,0.0019945402,0.00009466977,0.000010433005,0.00034457864,0.034746394,0.0001488789,0.006509453,0.00029275732],"about_ca_topic_score_codex":0.00003215174,"about_ca_topic_score_gemma":0.000013382049,"teacher_disagreement_score":0.9248359,"about_ca_system_score_codex":0.000045721947,"about_ca_system_score_gemma":0.00007465116,"threshold_uncertainty_score":0.7542778},"labels":[],"label_agreement":null},{"id":"W2792603962","doi":"10.1002/cpt.1078","title":"Dosing of Ceftriaxone and Metronidazole for Children With Severe Acute Malnutrition","year":2018,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Antibiotics Pharmacokinetics and Efficacy","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"Medical Research Council; Department for International Development; University College London; Great Ormond Street Hospital for Children; Wellcome Trust; National Institute for Health and Care Research; NIHR Biomedical Research Centre, Royal Marsden NHS Foundation Trust/Institute of Cancer Research; Bill and Melinda Gates Foundation","keywords":"Ceftriaxone; Metronidazole; Pharmacokinetics; Medicine; Dosing; Antibiotics; Volume of distribution; Pharmacology; Antibacterial agent; Cmax; Population; Internal medicine; Gastroenterology; Microbiology; Biology","score_opus":0.06454998006914155,"score_gpt":0.42406018583241323,"score_spread":0.3595102057632717,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2792603962","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9914247,0.00048177742,0.002179762,0.004435632,0.00038504048,0.0008719134,0.0000453379,0.000036466015,0.00013937043],"genre_scores_gemma":[0.97789335,0.0015431904,0.007410482,0.011967118,0.0010204678,0.000006041473,0.000034252775,0.000035070087,0.00009003537],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99878174,0.00006841901,0.00045293063,0.00030181158,0.00011718954,0.00027790983],"domain_scores_gemma":[0.99895716,0.00028492796,0.00018711349,0.00015121639,0.0002721416,0.00014741598],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035177267,0.00016397238,0.00046029582,0.00007368455,0.000094258656,0.000008067044,0.00009414958,0.00017063422,0.000071860326],"category_scores_gemma":[0.00000813021,0.00012845077,0.00011285188,0.00013952624,0.0007704294,0.00003558838,0.00004948807,0.00026892315,0.000005928646],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.029729955,0.0060145007,0.48339596,0.00034539544,0.01897225,0.000029902534,0.00042889375,0.000015088348,0.38409644,0.00026113473,0.02828553,0.048424955],"study_design_scores_gemma":[0.07651768,0.023608278,0.54998976,0.00021338595,0.029612266,0.0005162929,0.00009096058,0.0061041485,0.27649316,0.0004218,0.035556845,0.00087540003],"about_ca_topic_score_codex":0.0000011867803,"about_ca_topic_score_gemma":5.0859893e-7,"teacher_disagreement_score":0.10760327,"about_ca_system_score_codex":0.000016251357,"about_ca_system_score_gemma":0.00007517133,"threshold_uncertainty_score":0.52380705},"labels":[],"label_agreement":null},{"id":"W2793349513","doi":"10.1002/cpt.1048","title":"Research Directions in the Clinical Implementation of Pharmacogenomics: An Overview of US Programs and Projects","year":2018,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":130,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"U.S. National Library of Medicine; National Institute of General Medical Sciences; National Cancer Institute; National Human Genome Research Institute","keywords":"Pharmacogenomics; Harm; Precision medicine; Matching (statistics); Dosing; Medicine; Pharmacogenetics; Intensive care medicine; Computer science; Data science; Pharmacology; Psychology; Biology","score_opus":0.8349589273527223,"score_gpt":0.7219242324363636,"score_spread":0.11303469491635865,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2793349513","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.055743095,0.9340473,0.0000029520509,0.00033867513,0.004661556,0.0046858657,0.00025178125,0.00004180996,0.00022697424],"genre_scores_gemma":[0.0034547537,0.9879349,0.00019390197,0.0051226807,0.0023586797,0.00063096546,0.00014700806,0.000117245385,0.000039893934],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9686973,0.023817908,0.0046135257,0.0012326397,0.00054127834,0.0010973093],"domain_scores_gemma":[0.989994,0.0062531144,0.0018925371,0.00074222696,0.0006877409,0.0004303918],"candidate_categories":["metaepi_narrow","sts","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.022548836,0.0007646093,0.003147151,0.00065340893,0.00033146632,0.000036954134,0.0018472216,0.001634902,0.000453335],"category_scores_gemma":[0.000056493274,0.0005741475,0.000995554,0.001556161,0.00399352,0.00014375246,0.0005416172,0.0049753524,0.000043189757],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035500003,0.003823221,0.0039973413,0.0026300645,0.0024686132,0.00002906028,0.000946135,8.755968e-7,0.000093364535,0.000094564566,0.0022954769,0.9832663],"study_design_scores_gemma":[0.0034661253,0.0016980176,0.0007016873,0.00037969276,0.008734415,0.00004913925,0.0004418757,0.00012719365,0.00016215083,0.00019333327,0.9835719,0.0004744735],"about_ca_topic_score_codex":0.00006710717,"about_ca_topic_score_gemma":0.00010715968,"teacher_disagreement_score":0.9827918,"about_ca_system_score_codex":0.00008499358,"about_ca_system_score_gemma":0.0014675865,"threshold_uncertainty_score":0.999671},"labels":[],"label_agreement":null},{"id":"W2794417831","doi":"10.1002/cpt.1004","title":"Clinical Pharmacogenetics Implementation Consortium Guideline for <i>HLA</i> Genotype and Use of Carbamazepine and Oxcarbazepine: 2017 Update","year":2018,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Drug-Induced Adverse Reactions","field":"Medicine","cited_by":302,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Children's Hospital; University of Toronto; Centre for Addiction and Mental Health","funders":"National Institute of Arthritis and Musculoskeletal and Skin Diseases; National Institute of General Medical Sciences; Medical Research Council; National Institute for Health and Care Research; Canadian Institutes of Health Research; National Institutes of Health; Canada Foundation for Innovation; National Institute of Allergy and Infectious Diseases; Australian Centre for HIV and Hepatitis Virology Research","keywords":"Oxcarbazepine; Carbamazepine; Toxic epidermal necrolysis; Pharmacogenetics; Medicine; Genotype; Allele; Eosinophilia; Pharmacology; Guideline; Human leukocyte antigen; Epilepsy; Immunology; Dermatology; Genetics; Psychiatry; Biology; Pathology; Gene","score_opus":0.18471971328602335,"score_gpt":0.5213460437019938,"score_spread":0.33662633041597045,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2794417831","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9785134,0.0011436908,0.0023195292,0.012286073,0.003373118,0.0018383432,0.0002903905,0.00008710201,0.00014833674],"genre_scores_gemma":[0.84327745,0.021235159,0.02596026,0.105519675,0.0034122316,0.000059974536,0.00023396449,0.0001019019,0.00019938553],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99656796,0.00030701963,0.0019422536,0.0005932823,0.00017323304,0.00041621737],"domain_scores_gemma":[0.9965687,0.0012532789,0.0006238024,0.0003382744,0.00084335235,0.00037258482],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0012954861,0.00028260134,0.00081292714,0.00010797256,0.00013713811,0.000015869184,0.00012367919,0.00032797447,0.00007299955],"category_scores_gemma":[0.0001254049,0.00026173762,0.00021733015,0.00014858649,0.0014348138,0.00011132807,0.00014256909,0.00046899883,0.00001494932],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025359383,0.0021224543,0.14172141,0.00021424357,0.0060373796,0.00004101776,0.00022048318,0.000007264832,0.33883873,0.00011518318,0.10037481,0.40777108],"study_design_scores_gemma":[0.012843473,0.0012060557,0.057463277,0.000021625623,0.0058698053,0.00007487086,0.00007431907,0.003987157,0.01327439,0.000097600205,0.90479016,0.00029725663],"about_ca_topic_score_codex":0.000013532879,"about_ca_topic_score_gemma":0.00001548339,"teacher_disagreement_score":0.80441535,"about_ca_system_score_codex":0.000032857333,"about_ca_system_score_gemma":0.00030284355,"threshold_uncertainty_score":0.9999835},"labels":[],"label_agreement":null},{"id":"W2794951931","doi":"10.1002/cpt.1061","title":"Critiquing the CDC Opioid Guideline: Some Light From the Heat","year":2018,"lang":"en","type":"letter","venue":"Clinical Pharmacology & Therapeutics","topic":"Opioid Use Disorder Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University of Toronto","funders":"","keywords":"Guideline; Medicine; SAFER; Praise; Opioid; Disease control; Family medicine; Harm; Intensive care medicine; Psychology; Internal medicine; Environmental health; Computer science; Pathology","score_opus":0.08100730503199681,"score_gpt":0.4311709022143147,"score_spread":0.3501635971823179,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2794951931","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.010137877,0.01826126,0.000038692797,0.95557797,0.013234111,0.0019132779,0.00019788566,0.00021872003,0.0004201862],"genre_scores_gemma":[0.0005493165,0.011091494,0.0003616397,0.91844386,0.06651391,0.00020646634,0.0007846076,0.00021581181,0.001832882],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99375534,0.001430477,0.0019733815,0.0011577867,0.0006690601,0.0010139425],"domain_scores_gemma":[0.9923357,0.004877651,0.00039053863,0.0017485115,0.00046736482,0.00018023363],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity","insufficient_payload"],"category_scores_codex":[0.0010889524,0.0008672173,0.0013918079,0.000071226495,0.00048218726,0.000078270605,0.0014181245,0.001993096,0.002109923],"category_scores_gemma":[0.00008829307,0.00045826635,0.0010283195,0.0002065406,0.0014827779,0.000071684124,0.0004297841,0.006070281,0.001272831],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030395619,0.00048450002,0.0009371143,0.000038658305,0.0043842914,0.00036045216,0.0004901735,7.4361554e-7,0.0004105935,0.0000028977022,0.9909536,0.0016330093],"study_design_scores_gemma":[0.0034448348,0.00084160035,0.000863528,0.00011500831,0.010449224,0.00003511315,0.00011624552,0.00017878762,0.00058821816,0.0008759463,0.9820591,0.0004323896],"about_ca_topic_score_codex":0.00006845675,"about_ca_topic_score_gemma":0.0000052830774,"teacher_disagreement_score":0.053279802,"about_ca_system_score_codex":0.00019212735,"about_ca_system_score_gemma":0.00070108194,"threshold_uncertainty_score":0.9997869},"labels":[],"label_agreement":null},{"id":"W2799695746","doi":"10.1002/cpt.1098","title":"Influence of Transporter Polymorphisms on Drug Disposition and Response: A Perspective From the International Transporter Consortium","year":2018,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":137,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Innovation Cluster (Canada)","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; National Institute of General Medical Sciences; National Human Genome Research Institute; National Institutes of Health","keywords":"SLCO1B1; Transporter; Pharmacogenomics; Solute carrier family; Drug; Biology; Abcg2; Disposition; Pharmacology; Pharmacogenetics; Computational biology; ATP-binding cassette transporter; Genetics; Gene; Genotype; Psychology","score_opus":0.07482595988161794,"score_gpt":0.4273965982165845,"score_spread":0.35257063833496655,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2799695746","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.22029714,0.76636904,0.00005388565,0.009328635,0.0016260798,0.0014498205,0.00072178507,0.000056369416,0.000097223885],"genre_scores_gemma":[0.028676378,0.9504226,0.0000916255,0.019195698,0.0009047481,0.00006987117,0.00018600347,0.00007216021,0.00038092863],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99669254,0.0004945664,0.0014019903,0.0007366885,0.00037927783,0.00029492623],"domain_scores_gemma":[0.99689436,0.0016658449,0.0005921006,0.00042483493,0.0002561635,0.0001666795],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009438424,0.00048555984,0.001685863,0.000117323194,0.000097058815,0.0000115865905,0.00046607302,0.0005520094,0.00028988894],"category_scores_gemma":[0.000012959644,0.000298723,0.00081244827,0.00016539465,0.0014751792,0.000052082036,0.000020560332,0.0011625512,0.0000279775],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.24791242,0.020391708,0.01448857,0.010299332,0.10610934,0.0040488825,0.030441018,0.00002449383,0.010559762,0.0016856942,0.028282225,0.52575654],"study_design_scores_gemma":[0.0039711837,0.0012028265,0.01788346,0.0049759974,0.021773385,0.000042373456,0.00018679241,0.000010465393,0.00033784506,0.00024443856,0.9488796,0.0004916401],"about_ca_topic_score_codex":0.000013645289,"about_ca_topic_score_gemma":0.000015344755,"teacher_disagreement_score":0.9205974,"about_ca_system_score_codex":0.00011037842,"about_ca_system_score_gemma":0.0004833815,"threshold_uncertainty_score":0.9999465},"labels":[],"label_agreement":null},{"id":"W2800492785","doi":"10.1002/cpt.1110","title":"Therapeutic Agents Targeting Cardiometabolic Risk for Preventing and Treating Atherosclerotic Cardiovascular Diseases","year":2018,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Institut universitaire de cardiologie et de pneumologie de Québec","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Ezetimibe; PCSK9; Statin; Atherosclerotic cardiovascular disease; Pharmacology; Canakinumab; Type 2 diabetes; Diabetes mellitus; Internal medicine; Lipoprotein; Endocrinology; Disease; Cholesterol; LDL receptor","score_opus":0.14605455818238083,"score_gpt":0.45191468108929117,"score_spread":0.30586012290691034,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2800492785","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0018631588,0.9879979,0.0010019112,0.00008094397,0.0022858991,0.0063668927,0.00018448789,0.00018121563,0.00003761109],"genre_scores_gemma":[0.00041783412,0.9858176,0.0010619573,0.0029725682,0.008198509,0.0009169887,0.00016017881,0.0003153808,0.00013895056],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99193406,0.0028273168,0.0020942958,0.0015152093,0.0005737715,0.0010553482],"domain_scores_gemma":[0.9955112,0.0014772337,0.0010219696,0.0011179186,0.00030980827,0.00056187715],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.004632243,0.00095721503,0.0064390614,0.00023871059,0.00058051787,0.00006576192,0.00038171132,0.00096643454,0.000047098805],"category_scores_gemma":[0.00020122954,0.0007344486,0.007420618,0.00045756059,0.00061093713,0.000075059164,0.00024053095,0.0013343774,0.00003637755],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000082489576,0.00032451557,0.0007302111,0.0110556865,0.04041446,0.000024076442,0.000055057022,0.0000022638176,0.0000013616464,0.0000014243984,0.0006492077,0.94665927],"study_design_scores_gemma":[0.0032630577,0.00058029994,0.0005475413,0.0018276793,0.13904725,0.00008102523,0.000028252587,0.00020133349,0.0000025532825,0.000032178894,0.8538434,0.00054545497],"about_ca_topic_score_codex":0.000015373065,"about_ca_topic_score_gemma":5.2733606e-7,"teacher_disagreement_score":0.94611377,"about_ca_system_score_codex":0.00016586758,"about_ca_system_score_gemma":0.0006649821,"threshold_uncertainty_score":0.99951065},"labels":[],"label_agreement":null},{"id":"W2800824879","doi":"","title":"An open trial of nifedipine-herb interactions Nifedipine with St Johns wort, Ginseng or Ginkgo biloba","year":2001,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Ginkgo biloba and Cashew Applications","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Ginkgo biloba; Nifedipine; Ginseng; Traditional medicine; Herb; Medicine; SAGE; Pharmacology; Pharmacognosy; Ginkgo; Medicinal herbs; Chemistry; Internal medicine; Alternative medicine; Calcium; Biochemistry; Biological activity","score_opus":0.20409685353656296,"score_gpt":0.5211432356594783,"score_spread":0.31704638212291536,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2800824879","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95958424,0.00013070727,0.0013741591,0.028388644,0.0021268318,0.0032422547,0.00006645404,0.00020024176,0.004886457],"genre_scores_gemma":[0.94408536,0.002629048,0.0032337438,0.043767136,0.0030216693,0.00036795082,0.00014421818,0.00009697453,0.002653904],"study_design_codex":"randomized_trial","study_design_gemma":"not_applicable","domain_scores_codex":[0.99695116,0.00036447597,0.0012368528,0.00066141365,0.00030466545,0.00048141554],"domain_scores_gemma":[0.9971129,0.0007245524,0.00046278152,0.0008233245,0.00040347216,0.0004729764],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007843817,0.00034052946,0.00093041285,0.00016517936,0.00018778547,0.00004279513,0.00072883104,0.00028818866,0.0025014693],"category_scores_gemma":[0.000035743058,0.00024053322,0.00019216951,0.0007495477,0.000699231,0.00022820848,0.00015251785,0.00097188324,0.00007609587],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.55494094,0.058775526,0.06638018,0.00017836071,0.009651599,0.00077603816,0.0008305457,0.00013403312,0.07404372,0.00051097665,0.13882384,0.09495423],"study_design_scores_gemma":[0.10476954,0.018117253,0.016613793,0.00008303885,0.0043375962,0.00040434618,0.00036474215,0.0009599463,0.001204113,0.000146271,0.852514,0.0004853036],"about_ca_topic_score_codex":0.00004188866,"about_ca_topic_score_gemma":0.00015889482,"teacher_disagreement_score":0.7136902,"about_ca_system_score_codex":0.00008137193,"about_ca_system_score_gemma":0.0006754047,"threshold_uncertainty_score":0.9984104},"labels":[],"label_agreement":null},{"id":"W2802614347","doi":"10.1002/cpt.1086","title":"Real‐World Evidence: What It Is and What It Can Tell Us According to the International Society for Pharmacoepidemiology (ISPE) Comparative Effectiveness Research (CER) Special Interest Group (SIG)","year":2018,"lang":"en","type":"letter","venue":"Clinical Pharmacology & Therapeutics","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Agency for Drugs and Technologies in Health","funders":"","keywords":"Observational study; Pharmacoepidemiology; Medicine; Food and drug administration; Real world evidence; Confounding; Comparative effectiveness research; Quality (philosophy); Alternative medicine; Family medicine; Medical education; Pharmacology; Internal medicine; Pathology","score_opus":0.8657431941736702,"score_gpt":0.6546872114441983,"score_spread":0.2110559827294719,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2802614347","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.057335235,0.004307589,0.00039731181,0.90733874,0.025832048,0.004111122,0.0004120851,0.000041024443,0.00022487473],"genre_scores_gemma":[0.0036108634,0.044712316,0.000558373,0.8959565,0.053010166,0.0008712242,0.00017385249,0.00010393122,0.0010027664],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.98574615,0.004902179,0.0056928922,0.002090398,0.00026567737,0.0013027177],"domain_scores_gemma":[0.9291699,0.06634916,0.0027523262,0.0007309268,0.0006803084,0.0003173879],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity","insufficient_payload"],"category_scores_codex":[0.06316372,0.00067118043,0.002962749,0.00049407134,0.0008119888,0.00083647395,0.0021549717,0.0013002523,0.001066431],"category_scores_gemma":[0.0012838385,0.0006621853,0.00085584307,0.00040149095,0.0016576072,0.0012602314,0.0008100722,0.0040516364,0.0010611042],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005767862,0.00013572062,0.0068588615,0.00033204796,0.0024034348,0.000004563131,0.002612131,0.0000136780955,0.000018957535,0.00013312497,0.9863058,0.00060492224],"study_design_scores_gemma":[0.0015650454,0.0006365463,0.0017237128,0.0006429289,0.00027770744,0.0000064075766,0.0022629173,0.0031824992,0.00003266581,0.0019079533,0.9871593,0.000602275],"about_ca_topic_score_codex":0.0002620253,"about_ca_topic_score_gemma":0.000557626,"teacher_disagreement_score":0.06187988,"about_ca_system_score_codex":0.0018499627,"about_ca_system_score_gemma":0.00054799195,"threshold_uncertainty_score":0.99999624},"labels":[],"label_agreement":null},{"id":"W2803768334","doi":"10.1002/cpt.1074","title":"Opioids: The Painful Public Health Reality","year":2018,"lang":"en","type":"editorial","venue":"Clinical Pharmacology & Therapeutics","topic":"Opioid Use Disorder Treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"Canadian Institutes of Health Research; Canada Research Chairs; Centre for Addiction and Mental Health","keywords":"Surprise; Opium; Public health; Analgesic; Addiction; Medicine; Antidepressant; Psychiatry; Political science; Psychology; Anxiety; Law; Social psychology; Nursing","score_opus":0.18047064376481972,"score_gpt":0.5008985782838596,"score_spread":0.32042793451903995,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2803768334","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0010052642,0.005766484,0.000073326635,0.19270086,0.7972993,0.0019815865,0.0002939191,0.00027842927,0.00060082553],"genre_scores_gemma":[0.00054599845,0.030540343,0.00019560201,0.15903535,0.80584615,0.00022117945,0.0012586849,0.00017341966,0.0021832755],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99183947,0.002727872,0.0019872452,0.0012161821,0.0009992758,0.0012299273],"domain_scores_gemma":[0.9893161,0.006360698,0.0010838384,0.0015815261,0.0009346868,0.00072313513],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0051000435,0.00075925695,0.0018400493,0.00012433232,0.0004445822,0.00006670464,0.0009694526,0.0020800799,0.00075278454],"category_scores_gemma":[0.00048658875,0.00049672014,0.00083666696,0.0003536061,0.0018702236,0.000056735214,0.00034462204,0.004042013,0.0006433994],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048452342,0.0024871042,0.00084101286,0.000189229,0.0039947834,0.000031382937,0.0004932075,1.5548302e-7,0.0000052630476,0.0000063254624,0.9806999,0.010767118],"study_design_scores_gemma":[0.005135987,0.0031765585,0.0016551054,0.000069697206,0.0026809508,0.00000582129,0.00012782894,0.000054114058,0.000009058133,0.00014597365,0.98657864,0.00036025647],"about_ca_topic_score_codex":0.00006613781,"about_ca_topic_score_gemma":0.00002714922,"teacher_disagreement_score":0.033665508,"about_ca_system_score_codex":0.00062429573,"about_ca_system_score_gemma":0.006644402,"threshold_uncertainty_score":0.99974847},"labels":[],"label_agreement":null},{"id":"W2804552830","doi":"10.1002/cpt.1115","title":"Disease‐Associated Changes in Drug Transporters May Impact the Pharmacokinetics and/or Toxicity of Drugs: A White Paper From the International Transporter Consortium","year":2018,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":120,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Institute of General Medical Sciences; National Institute of Environmental Health Sciences; Canadian Institutes of Health Research; National Institutes of Health","keywords":"ADME; Transporter; Pharmacokinetics; Pharmacology; Drug; Disease; Toxicity; Drug development; Distribution (mathematics); Medicine; Drug metabolism; Biology; Internal medicine; Genetics; Gene","score_opus":0.049590659468452467,"score_gpt":0.3878315960804222,"score_spread":0.33824093661196974,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2804552830","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.932771,0.0005707069,0.000058967897,0.06390054,0.0014765027,0.00069598935,0.00035571863,0.000040667703,0.00012989563],"genre_scores_gemma":[0.92454106,0.003385771,0.000053126616,0.07085108,0.0006803738,0.00003212846,0.00008480134,0.000034939694,0.000336746],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99777675,0.000259406,0.00082481344,0.00040576537,0.0003516453,0.0003816481],"domain_scores_gemma":[0.9983445,0.00074461906,0.00026526343,0.00027874619,0.00016454888,0.00020233051],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0009226077,0.00028664205,0.00056957215,0.00005662475,0.00009825818,0.000012540527,0.000432139,0.00017233705,0.0018191477],"category_scores_gemma":[0.000011231579,0.00014682622,0.0002885026,0.00022158977,0.0013982365,0.00005651682,0.000023808852,0.00063874485,0.0000050968024],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.023670143,0.002756739,0.8936395,0.00005800443,0.004522467,0.00018292796,0.011271966,0.000014318714,0.04853579,0.00001918345,0.008497719,0.0068312106],"study_design_scores_gemma":[0.010110956,0.00064752967,0.9407304,0.00015554328,0.0040192893,0.0000040303407,0.0010410403,0.0008380036,0.00892156,0.00016707084,0.03305986,0.00030474298],"about_ca_topic_score_codex":0.000030802017,"about_ca_topic_score_gemma":0.0008056624,"teacher_disagreement_score":0.04709084,"about_ca_system_score_codex":0.00004785486,"about_ca_system_score_gemma":0.00020590753,"threshold_uncertainty_score":0.99909335},"labels":[],"label_agreement":null},{"id":"W2804866893","doi":"10.1002/cpt.1114","title":"Lipids, Apolipoproteins, and Inflammatory Biomarkers of Cardiovascular Risk: What Have We Learned?","year":2018,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Diabetes, Cardiovascular Risks, and Lipoproteins","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"","keywords":"Surrogate endpoint; Trimethylamine N-oxide; Medicine; Biomarker; Cholesterol; Apolipoprotein B; Residual risk; Internal medicine; Lipoprotein; Clinical endpoint; Bioinformatics; Endocrinology; Biology; Genetics; Biochemistry; Clinical trial; Trimethylamine","score_opus":0.1278205173086226,"score_gpt":0.4186626093528992,"score_spread":0.2908420920442766,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2804866893","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0010445899,0.9905605,0.000061307386,0.00030996324,0.0038822182,0.0037536325,0.00008376552,0.0001404876,0.00016359249],"genre_scores_gemma":[0.000052873165,0.9917936,0.00045322356,0.0018018365,0.005079289,0.00025315446,0.00009196504,0.0002611072,0.00021296786],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99097586,0.0032893869,0.0025814292,0.0014930062,0.00077614794,0.0008841905],"domain_scores_gemma":[0.99465084,0.0011205586,0.0013024,0.0019132805,0.00039567126,0.00061724504],"candidate_categories":["metaepi_narrow","sts","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.00516414,0.0010727377,0.007244903,0.00043168897,0.00018675523,0.00006755632,0.0006364286,0.0021288292,0.00014907126],"category_scores_gemma":[0.0001713963,0.0008713193,0.006769543,0.00037166916,0.0028672551,0.00019336416,0.00044798982,0.0024106833,0.00016112589],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019482554,0.00033048724,0.000077887154,0.010334429,0.0705762,0.0000714683,0.000073332914,9.52678e-7,0.0000012199584,0.0000012131613,0.0026860908,0.9156519],"study_design_scores_gemma":[0.0033148683,0.0008061984,0.00017604002,0.006046972,0.085421465,0.000096267715,0.00007949845,0.000020452298,0.000047132136,0.00004538903,0.90328574,0.00065996824],"about_ca_topic_score_codex":0.00018246828,"about_ca_topic_score_gemma":0.00001573807,"teacher_disagreement_score":0.9149919,"about_ca_system_score_codex":0.00013820978,"about_ca_system_score_gemma":0.0009159861,"threshold_uncertainty_score":0.9998908},"labels":[],"label_agreement":null},{"id":"W2809978686","doi":"10.1002/cpt.1166","title":"A Novel Method to Estimate Long‐Term Chronological Changes From Fragmented Observations in Disease Progression","year":2018,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Statistical Methods and Inference","field":"Mathematics","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institute of Biomedical Imaging and Bioengineering; Canadian Institutes of Health Research; Genentech; Servier; Eisai; Ministry of Health, Labour and Welfare; Alzheimer's Disease Neuroimaging Initiative; GE Healthcare; Pfizer; BioClinica; Eli Lilly and Company; U.S. Department of Defense; Johnson and Johnson; Meso Scale Diagnostics; Novartis Pharmaceuticals Corporation; Bristol-Myers Squibb; Roche; Alzheimer's Drug Discovery Foundation; Takeda Pharmaceutical Company; AbbVie; National Institute on Aging; Fujirebio Europe; Alzheimer's Association; Foundation for the National Institutes of Health","keywords":"Disease; Covariate; Clinical trial; Medicine; Time point; Apolipoprotein E; Chronic disease; Internal medicine; Oncology; Bioinformatics; Biology; Statistics","score_opus":0.45493917138774165,"score_gpt":0.6065675190215114,"score_spread":0.15162834763376976,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2809978686","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.3900667,0.0000882197,0.5977609,0.010269843,0.00088429486,0.00068050297,0.000093815564,0.000117454496,0.000038260274],"genre_scores_gemma":[0.058132872,0.000062900675,0.9077379,0.032900486,0.00082652655,0.00022628235,0.00002273676,0.000040801297,0.000049464186],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99705726,0.0008309293,0.0007794045,0.0006274636,0.00020721497,0.00049772527],"domain_scores_gemma":[0.9930018,0.005844162,0.00021092255,0.00035205495,0.0001949445,0.00039609332],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011464393,0.00027294326,0.000569022,0.000081451384,0.0001258856,0.000029176012,0.00044434585,0.00027377083,0.00076284044],"category_scores_gemma":[0.00076169736,0.00021356967,0.000096289274,0.00031440865,0.0004668692,0.00004417337,0.00028021538,0.0005401108,0.000071686525],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004129962,0.011499324,0.29295507,0.00015252574,0.0010946873,0.0001867051,0.0014253109,0.000016589647,0.14391443,0.010186177,0.0052475254,0.5291917],"study_design_scores_gemma":[0.0033284572,0.0015095067,0.8992576,0.00019136608,0.00079926505,0.0000028724717,0.000017975308,0.01951148,0.0025188935,0.06706499,0.005281599,0.0005160137],"about_ca_topic_score_codex":0.0000063146163,"about_ca_topic_score_gemma":0.00003921078,"teacher_disagreement_score":0.6063025,"about_ca_system_score_codex":0.00006645379,"about_ca_system_score_gemma":0.00010501697,"threshold_uncertainty_score":0.87091184},"labels":[],"label_agreement":null},{"id":"W2810329335","doi":"10.1002/cpt.1162","title":"Cinnamon and Cassia Nomenclature Confusion: A Challenge to the Applicability of Clinical Data","year":2018,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Phytochemistry and biological activity of medicinal plants","field":"Agricultural and Biological Sciences","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Canada","funders":"United States Pharmacopeia","keywords":"Cinnamomum; Cassia; Confusion; Traditional medicine; Cinnamomum zeylanicum; Medicine; Lauraceae; Cinnamaldehyde; Biology; Botany; Psychology; Alternative medicine; Essential oil; Traditional Chinese medicine; Biochemistry","score_opus":0.5505821327320457,"score_gpt":0.5383740406933131,"score_spread":0.012208092038732632,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2810329335","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.017857207,0.96467423,0.0000031023635,0.013048034,0.0014089404,0.0016573587,0.0010266006,0.00004832169,0.00027622186],"genre_scores_gemma":[0.0038126442,0.98072326,0.000052818483,0.010136757,0.004878402,0.00004250424,0.0002938957,0.0000030416015,0.00005668147],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.994864,0.0014728274,0.0017362204,0.0012542399,0.0002549905,0.00041774998],"domain_scores_gemma":[0.99111056,0.0070905373,0.0008597876,0.00046425097,0.000114821196,0.00036004878],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0042711142,0.00044863432,0.0023889923,0.000008882111,0.00020534128,0.000018387298,0.0021536388,0.0013501223,0.00029294385],"category_scores_gemma":[0.00021031508,0.00013203244,0.0004609072,0.00026570138,0.0014541217,0.000043495696,0.0014392536,0.0017363171,0.00005365592],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019111315,0.0007209741,0.00012047468,0.000427272,0.00039707168,0.000008083533,0.000009594617,6.7837806e-9,0.000085272964,0.0000016662045,0.013850945,0.98418754],"study_design_scores_gemma":[0.00023081833,0.0013782041,0.0011039588,0.00041352326,0.0012848368,0.000020933623,0.00001787721,0.000015701275,0.0000047231247,0.00007968708,0.9951859,0.00026383915],"about_ca_topic_score_codex":0.0000070633205,"about_ca_topic_score_gemma":0.000032857497,"teacher_disagreement_score":0.9839237,"about_ca_system_score_codex":0.0000130872595,"about_ca_system_score_gemma":0.00008198167,"threshold_uncertainty_score":0.99994636},"labels":[],"label_agreement":null},{"id":"W2834973095","doi":"10.1002/cpt.1179","title":"Pharmacogenomics of Vincristine‐Induced Peripheral Neuropathy Implicates Pharmacokinetic and Inherited Neuropathy Genes","year":2018,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":70,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital; University of British Columbia","funders":"Canadian Institutes of Health Research; Hospital for Sick Children; BC Children’s Hospital Foundation; BC Children's Hospital; Children's Hospital Foundation; London Health Sciences Centre","keywords":"Pharmacogenomics; Peripheral neuropathy; Pharmacokinetics; Medicine; Pharmacogenetics; Pharmacology; Vincristine; Gene; Bioinformatics; Internal medicine; Genetics; Biology; Chemotherapy; Genotype; Endocrinology","score_opus":0.24322484068939612,"score_gpt":0.5059146346413825,"score_spread":0.26268979395198644,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2834973095","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.055563435,0.93542457,0.000009218918,0.0007774013,0.0048722355,0.002747333,0.00023062654,0.00018770847,0.00018745918],"genre_scores_gemma":[0.0018057849,0.97606915,0.00018606761,0.016591644,0.0042580673,0.00025689663,0.00018802755,0.00032298092,0.00032140673],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99276847,0.0016659714,0.0028124177,0.0015256439,0.0002959053,0.00093159877],"domain_scores_gemma":[0.99538726,0.0014425886,0.0014595714,0.00062981975,0.00041443395,0.0006663282],"candidate_categories":["metaepi_narrow"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.00072969816,0.0012852929,0.0045173666,0.00037399514,0.00018479677,0.000029740562,0.00065555796,0.0009078182,0.00083180156],"category_scores_gemma":[0.000026501335,0.00108316,0.0013434268,0.00064378226,0.0014871127,0.000072454626,0.00047906424,0.0018709267,0.000090713445],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020019661,0.0029033392,0.00097529584,0.0075844796,0.0071363556,0.00047835705,0.00012342402,7.03406e-7,0.02025038,0.0000022964068,0.009876439,0.948667],"study_design_scores_gemma":[0.006518679,0.0036027795,0.0002956828,0.00053024426,0.040618096,0.0007503845,0.0000081949065,0.000287795,0.0008444624,0.00000833715,0.9457983,0.00073705503],"about_ca_topic_score_codex":0.000010232791,"about_ca_topic_score_gemma":0.0000011818017,"teacher_disagreement_score":0.9479299,"about_ca_system_score_codex":0.00017001822,"about_ca_system_score_gemma":0.0008473336,"threshold_uncertainty_score":0.99998987},"labels":[],"label_agreement":null},{"id":"W2885748302","doi":"10.1002/cpt.1183","title":"Advancing Predictions of Tissue and Intracellular Drug Concentrations Using <i>In Vitro</i>, Imaging and Physiologically Based Pharmacokinetic Modeling Approaches","year":2018,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":116,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Innovation Cluster (Canada)","funders":"National Institute of General Medical Sciences; National Institute on Drug Abuse; National Institutes of Health","keywords":"Physiologically based pharmacokinetic modelling; Pharmacokinetics; Drug; Pharmacology; Drug development; In vivo; Disposition; In vitro; Medicine; Computational biology; Computer science; Chemistry; Biology; Biotechnology; Psychology","score_opus":0.07653526175492847,"score_gpt":0.37466407569362564,"score_spread":0.29812881393869717,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2885748302","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94686073,0.0018096125,0.04767647,0.0025829754,0.00043821748,0.000524146,0.000014042395,0.000044248573,0.000049575243],"genre_scores_gemma":[0.9825544,0.00071732834,0.010904349,0.0054235514,0.00033939336,0.000012473162,0.000013508371,0.000022116597,0.000012899395],"study_design_codex":"bench_or_experimental","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9984218,0.00016496031,0.0006323918,0.00036625285,0.0001106744,0.00030391957],"domain_scores_gemma":[0.99925804,0.00023806053,0.00012979095,0.00011884878,0.0001069696,0.00014829985],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00049130106,0.00017387103,0.00045146304,0.00007819323,0.00011622452,0.000007135936,0.00007450178,0.0001036142,0.000036833768],"category_scores_gemma":[0.000010385677,0.00014969434,0.00006447322,0.00015213009,0.00076583395,0.00006454821,0.000027448123,0.000378411,6.97371e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007541175,0.00040769068,0.0032716633,0.00008700422,0.0001229405,0.000019853227,0.00025292343,0.002172893,0.98966604,0.000010880641,0.000020612935,0.003213376],"study_design_scores_gemma":[0.0032432827,0.0001661167,0.00082740246,0.000059160153,0.00094020815,0.000010816919,0.00019156287,0.8499772,0.143704,0.0001357911,0.00060875196,0.00013571158],"about_ca_topic_score_codex":0.0000035953292,"about_ca_topic_score_gemma":0.0000023788814,"teacher_disagreement_score":0.8478043,"about_ca_system_score_codex":0.000025355572,"about_ca_system_score_gemma":0.0001129598,"threshold_uncertainty_score":0.61043584},"labels":[],"label_agreement":null},{"id":"W2887240487","doi":"10.1002/cpt.1212","title":"Current State of Microbicide Development","year":2018,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Reproductive tract infections research","field":"Immunology and Microbiology","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo","funders":"Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research","keywords":"Microbicide; Microbicides for sexually transmitted diseases; Medicine; Human immunodeficiency virus (HIV); Condom; Immunology; Developing country; Virology; Transmission (telecommunications); Vaginal microbicide; Sexual transmission; Population; Intensive care medicine; Biology; Environmental health; Health services; Syphilis; Computer science","score_opus":0.28995171830574307,"score_gpt":0.5407717705448669,"score_spread":0.25082005223912385,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2887240487","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0010600551,0.98717004,0.00009278391,0.00006934209,0.009970569,0.0013869368,0.000074359166,0.000080913844,0.00009497019],"genre_scores_gemma":[0.000021112473,0.997335,0.00015357562,0.0004343229,0.00040667542,0.00015246542,0.0001943889,0.000085431384,0.0012169938],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9930404,0.00269474,0.0024823062,0.0009814783,0.0000755406,0.0007255518],"domain_scores_gemma":[0.99560523,0.0019945707,0.0011118867,0.0007097757,0.00051370886,0.00006480437],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0021321878,0.00058600627,0.0024989038,0.00038957698,0.00019482168,0.000010234498,0.00095405115,0.0006621285,0.0008335149],"category_scores_gemma":[0.00006943576,0.00046360452,0.00085355056,0.00044238623,0.0022799294,0.000048317048,0.00043764643,0.0026273087,0.00478858],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009068711,0.0013689187,0.00004507769,0.0019874074,0.0052377256,0.0000035142627,0.000060734357,2.3162684e-7,0.00066271983,0.0000012323919,0.017905574,0.97263616],"study_design_scores_gemma":[0.0006979436,0.00035536152,0.00012505593,0.0009382283,0.0023164232,0.000054238026,0.0000014746452,1.4063745e-7,0.0031620732,0.000021493945,0.991947,0.00038056957],"about_ca_topic_score_codex":0.0000016686151,"about_ca_topic_score_gemma":0.0000019931163,"teacher_disagreement_score":0.9740414,"about_ca_system_score_codex":0.00018478232,"about_ca_system_score_gemma":0.0018482778,"threshold_uncertainty_score":0.99978155},"labels":[],"label_agreement":null},{"id":"W2887652885","doi":"10.1002/cpt.1101","title":"Safety Surveillance of Dietary Supplements: Importance, Challenges, and New Horizons","year":2018,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Complementary and Alternative Medicine Studies","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Canada","funders":"","keywords":"Pharmacovigilance; Medicine; Medical prescription; Postmarketing surveillance; Environmental health; Adverse effect; Pharmacology; Risk analysis (engineering)","score_opus":0.24888158128334328,"score_gpt":0.47494564000962536,"score_spread":0.22606405872628207,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2887652885","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94185716,0.020601967,0.00011532753,0.032244194,0.0022917574,0.00058326434,0.000059646074,0.000050189596,0.0021964784],"genre_scores_gemma":[0.904955,0.07456323,0.00071307074,0.016391208,0.0030636226,0.0000065182257,0.00003275915,0.00001964065,0.00025491297],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983278,0.00016718701,0.0007207075,0.00034924067,0.00015750868,0.00027756035],"domain_scores_gemma":[0.99859035,0.00066524476,0.00019784491,0.00021310677,0.00014978515,0.00018365771],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00055253605,0.00018027697,0.00061969104,0.000048029207,0.000081641585,0.000001379469,0.0001229835,0.00003887785,0.0008523303],"category_scores_gemma":[0.0000314947,0.00014160968,0.00010275174,0.00008470098,0.0009970431,0.000033468517,0.00014264049,0.000284747,0.00000976262],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025897045,0.00082013913,0.75243634,0.000089927045,0.003698052,0.000042145773,0.00075032096,8.484586e-8,0.0034331672,0.000166631,0.033258542,0.20271493],"study_design_scores_gemma":[0.00597232,0.005180341,0.59370524,0.000029250543,0.00062954775,0.000013288027,0.00027271968,0.000029872233,0.00045067695,0.00032119418,0.3932723,0.00012324158],"about_ca_topic_score_codex":0.000008656508,"about_ca_topic_score_gemma":0.000066035245,"teacher_disagreement_score":0.36001378,"about_ca_system_score_codex":0.000019457424,"about_ca_system_score_gemma":0.000085097825,"threshold_uncertainty_score":0.9332419},"labels":[],"label_agreement":null},{"id":"W2887655204","doi":"10.1002/cpt.1112","title":"Transporters in Drug Development: 2018 ITC Recommendations for Transporters of Emerging Clinical Importance","year":2018,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":229,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"National Institute on Drug Abuse","keywords":"Transporter; Organic anion transporter 1; Organic cation transport proteins; Drug; Pharmacology; Organic anion-transporting polypeptide; Drug development; Disposition; Chemistry; Medicine; Biochemistry; Psychology","score_opus":0.2865857439642586,"score_gpt":0.5248841825983547,"score_spread":0.23829843863409605,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2887655204","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0027752726,0.97854817,0.0020382646,0.0029597823,0.008609092,0.0045066522,0.00028588958,0.00011837547,0.00015851988],"genre_scores_gemma":[0.0002512931,0.9820894,0.0072054127,0.0071446868,0.0011014772,0.0003124602,0.0010485228,0.00017214705,0.00067460694],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9910448,0.00039800428,0.006344645,0.0011386405,0.00029366623,0.00078023865],"domain_scores_gemma":[0.99607164,0.0011986183,0.0016004056,0.0005515189,0.00021658663,0.00036123002],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0034439757,0.0007503538,0.0045106164,0.00036462702,0.0001224835,0.0000065963545,0.00060688006,0.0011178951,0.00034279225],"category_scores_gemma":[0.000013989617,0.00063143845,0.0022081195,0.0005275518,0.0008446322,0.00007695573,0.000019220854,0.0015414705,0.00002172737],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018011724,0.0042589735,0.005413321,0.018562328,0.007725084,0.00017097223,0.0009976535,7.860384e-7,0.000017419123,0.000030200034,0.023364687,0.9376574],"study_design_scores_gemma":[0.0047241733,0.00038223932,0.0003369344,0.0047206976,0.010510034,0.000008637968,0.000103814076,0.000014716755,0.000045568075,0.000042137035,0.97855777,0.00055327534],"about_ca_topic_score_codex":0.000002677566,"about_ca_topic_score_gemma":0.00008931325,"teacher_disagreement_score":0.9551931,"about_ca_system_score_codex":0.0001404802,"about_ca_system_score_gemma":0.0015960722,"threshold_uncertainty_score":0.9996137},"labels":[],"label_agreement":null},{"id":"W2890573975","doi":"10.1002/cpt.1238","title":"Effects of Nicotine Metabolic Rate on Withdrawal Symptoms and Response to Cigarette Smoking After Abstinence","year":2018,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Smoking Behavior and Cessation","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"National Center for Research Resources; Canadian Institutes of Health Research; National Institute on Drug Abuse; Canada Research Chairs; Campbell Family Mental Health Research Institute; University of Pennsylvania; Pfizer","keywords":"Nicotine; Abstinence; Cotinine; Craving; CYP2A6; Smoking cessation; Nicotine withdrawal; Metabolite; Medicine; Cigarette smoking; Anesthesia; Saliva; Internal medicine; Pharmacology; Metabolism; Psychiatry; Addiction","score_opus":0.03246406918592148,"score_gpt":0.39480707592511677,"score_spread":0.3623430067391953,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2890573975","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99416226,0.00023765732,0.00008776443,0.003532717,0.0014045528,0.00048773002,0.0000040368923,0.0000530509,0.000030202793],"genre_scores_gemma":[0.94347656,0.00012197068,0.00005487541,0.055513564,0.00064195984,0.00004192659,0.0000019326167,0.000029270746,0.00011793661],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998192,0.00048801946,0.00048536505,0.0003727631,0.00019593794,0.00026589146],"domain_scores_gemma":[0.9977939,0.0014588622,0.00015093734,0.00022381362,0.0001892497,0.00018320518],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011277571,0.00018662491,0.0004522562,0.0001212183,0.000061786,0.000008546968,0.00010960595,0.00021133371,0.00010760784],"category_scores_gemma":[0.000118213175,0.00015237561,0.00009381845,0.00021603698,0.0005180236,0.000034399764,0.000063423526,0.0004203261,0.000010284315],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03775861,0.0010942795,0.5836148,0.00007486016,0.0010197252,0.000082954866,0.0010552816,0.0000026663604,0.34775576,0.000014013906,0.00097080687,0.026556207],"study_design_scores_gemma":[0.0037662876,0.0027474833,0.82067144,0.00008408026,0.0019425408,0.000008810954,0.000008231294,0.00004415313,0.1659999,0.0000144540645,0.0045877686,0.00012486438],"about_ca_topic_score_codex":0.0000021038063,"about_ca_topic_score_gemma":4.7074775e-7,"teacher_disagreement_score":0.23705658,"about_ca_system_score_codex":0.000026268228,"about_ca_system_score_gemma":0.000077019606,"threshold_uncertainty_score":0.6213697},"labels":[],"label_agreement":null},{"id":"W2891332020","doi":"10.1002/cpt.1182","title":"Treating a Child With Mental Illness","year":2018,"lang":"en","type":"editorial","venue":"Clinical Pharmacology & Therapeutics","topic":"Attention Deficit Hyperactivity Disorder","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Methylphenidate; Druggability; Autism spectrum disorder; Psychiatry; Attention deficit hyperactivity disorder; Medicine; Mental illness; Autism; Drug; Psychology; Mental health; Genetics","score_opus":0.06558694036130114,"score_gpt":0.4586917552477939,"score_spread":0.39310481488649274,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2891332020","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.08819292,0.0008223245,0.000080208854,0.007464294,0.8991329,0.0012784759,0.00014925854,0.00027233482,0.0026072578],"genre_scores_gemma":[0.013740049,0.0025409458,0.0003560522,0.018980414,0.9591105,0.00010848372,0.0007617504,0.0002632127,0.004138604],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.996279,0.00047184562,0.00093887176,0.0009691152,0.0007498992,0.0005912517],"domain_scores_gemma":[0.99610746,0.0018982985,0.00062752713,0.00052523956,0.00056866556,0.0002727845],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0006461576,0.00060348335,0.0013546032,0.00013513917,0.00032830072,0.00003310581,0.00031914143,0.00172242,0.0014047163],"category_scores_gemma":[0.000117015625,0.00047113982,0.00044225837,0.00024309587,0.0011056908,0.000086267675,0.00014688504,0.003290525,0.00043451085],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002852975,0.001976185,0.0021776687,0.00010022046,0.0039560525,0.00015062117,0.00020193451,0.0000010164487,0.00016703719,5.470473e-7,0.9844753,0.0039404193],"study_design_scores_gemma":[0.009435484,0.0023491785,0.0004299566,0.00019237558,0.006670622,0.00008827137,0.00028117155,0.00013357904,0.000061715094,0.0000041739413,0.9798271,0.0005263615],"about_ca_topic_score_codex":0.0000066669745,"about_ca_topic_score_gemma":0.000009732802,"teacher_disagreement_score":0.07445287,"about_ca_system_score_codex":0.00016600275,"about_ca_system_score_gemma":0.0006568877,"threshold_uncertainty_score":0.99977404},"labels":[],"label_agreement":null},{"id":"W2897647360","doi":"10.1002/cpt.1255","title":"Innovation in Pharmacovigilance: Use of Artificial Intelligence in Adverse Event Case Processing","year":2018,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":86,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pfizer (Canada); Artificial Intelligence in Medicine (Canada)","funders":"Pfizer","keywords":"Pharmacovigilance; Adverse effect; Event (particle physics); Complex event processing; Adverse Event Reporting System; Artificial intelligence; Computer science; Medicine; Pharmacology","score_opus":0.4092247310207464,"score_gpt":0.5705374598262889,"score_spread":0.16131272880554248,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2897647360","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9910942,0.0002607972,0.0012700327,0.0018333104,0.004112194,0.0009239522,0.00007084478,0.000098189135,0.00033649613],"genre_scores_gemma":[0.9671858,0.0011241048,0.0006101811,0.029756406,0.0010567796,0.00009494869,0.00002409599,0.000047138816,0.000100547564],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9942319,0.0012219528,0.0027434537,0.0007255774,0.00022518271,0.0008519745],"domain_scores_gemma":[0.9968628,0.0013851912,0.00081420003,0.0002630981,0.00047232473,0.00020236424],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0026126124,0.0004205566,0.0007307272,0.0007619443,0.00021443234,0.00001642928,0.00042095134,0.0006344102,0.00095305464],"category_scores_gemma":[0.00012615128,0.00043828026,0.00018934575,0.0023414786,0.0014489116,0.00057774765,0.0001547386,0.0022960792,0.00014637425],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009540849,0.0119251115,0.17507802,0.00028800732,0.000986275,0.0046759043,0.0044896035,0.016542481,0.3228589,0.0009214235,0.005242953,0.4474505],"study_design_scores_gemma":[0.009153518,0.001260014,0.011904856,0.0002307585,0.0016471687,0.0007731207,0.0018723994,0.44761112,0.25802493,0.0023760793,0.26328817,0.0018578552],"about_ca_topic_score_codex":0.000038781607,"about_ca_topic_score_gemma":0.00009809379,"teacher_disagreement_score":0.44559264,"about_ca_system_score_codex":0.00020955359,"about_ca_system_score_gemma":0.00044577723,"threshold_uncertainty_score":0.9999602},"labels":[],"label_agreement":null},{"id":"W2899206436","doi":"10.1002/cpt.1270","title":"Opportunities and Challenges Related to the Implementation of Model‐Based Bioequivalence Criteria","year":2018,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Statistical Methods in Clinical Trials","field":"Mathematics","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"American Association of Pharmaceutical Scientists","keywords":"Bioequivalence; Strengths and weaknesses; Computer science; Management science; Econometrics; Mathematics; Medicine; Economics; Pharmacology; Psychology; Pharmacokinetics","score_opus":0.8623221871967739,"score_gpt":0.6812235939164175,"score_spread":0.18109859328035638,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2899206436","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.73725927,0.0015522325,0.09338955,0.15849067,0.00497155,0.0025049727,0.00033848287,0.00024424685,0.0012490463],"genre_scores_gemma":[0.5433017,0.009646515,0.4035391,0.04254316,0.00067901146,0.00009860737,0.0000021660796,0.0000716198,0.00011813549],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9956954,0.0019867183,0.0014149074,0.00037639018,0.00021053418,0.0003160517],"domain_scores_gemma":[0.97467625,0.024033599,0.00038548958,0.00037478542,0.00036079623,0.00016905837],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00558632,0.00019276231,0.0005676269,0.000059584425,0.00014408576,0.00001356611,0.00039979062,0.00021969064,0.00061802735],"category_scores_gemma":[0.0015025005,0.00013703557,0.00012092881,0.00013082898,0.0021994987,0.000046556488,0.00017626892,0.0002925085,0.000014435047],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025259757,0.0019396289,0.0015125347,0.00078931276,0.0024602024,0.000022615872,0.00739701,0.00001806608,0.014594632,0.10056018,0.028242696,0.83993715],"study_design_scores_gemma":[0.0041050706,0.003604465,0.0033065868,0.00007978888,0.0020587698,0.000005632411,0.0014953489,0.015943285,0.010726522,0.9463523,0.011885997,0.0004362408],"about_ca_topic_score_codex":0.0000019273828,"about_ca_topic_score_gemma":0.000006457978,"teacher_disagreement_score":0.8457921,"about_ca_system_score_codex":0.000019473335,"about_ca_system_score_gemma":0.00012043352,"threshold_uncertainty_score":0.8104145},"labels":[],"label_agreement":null},{"id":"W2899872209","doi":"10.1002/cpt.1202","title":"Battling the <scp>HIV</scp>/<scp>AIDS</scp> Epidemic: Triumphs and Barriers","year":2018,"lang":"en","type":"editorial","venue":"Clinical Pharmacology & Therapeutics","topic":"HIV/AIDS Research and Interventions","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Life expectancy; Human immunodeficiency virus (HIV); Disease; Medicine; Intensive care medicine; Antiretroviral therapy; Immunology; Virology; Environmental health; Viral load; Population; Pathology","score_opus":0.07434085570788461,"score_gpt":0.4580666668073135,"score_spread":0.3837258110994289,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2899872209","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.04861059,0.018231722,0.0008140642,0.00852262,0.91038895,0.00334918,0.0011288531,0.00045301547,0.008501033],"genre_scores_gemma":[0.0011277492,0.032974273,0.00045535446,0.023257954,0.86178243,0.00025551484,0.0005222369,0.0003023887,0.07932209],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9909277,0.0027142344,0.0022530328,0.0013757979,0.0011136913,0.0016155409],"domain_scores_gemma":[0.9350609,0.059572596,0.000984646,0.0012103607,0.0013789437,0.0017925077],"candidate_categories":["metaresearch","metaepi_narrow","sts","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0066026608,0.00084618764,0.0019564761,0.00035201572,0.00070659135,0.00012782228,0.0012435857,0.0028860923,0.00050084246],"category_scores_gemma":[0.0181842,0.00060501316,0.0013078487,0.00049423083,0.003968997,0.00014090203,0.0006088106,0.0076337745,0.00079660077],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013017528,0.00041580744,0.0016498612,0.00019876176,0.0039946954,0.000080206875,0.0004368832,9.067107e-7,0.0008126004,0.000008591475,0.9890947,0.0031768105],"study_design_scores_gemma":[0.005871865,0.0058638034,0.00017679775,0.00024607618,0.0046919025,0.00002963578,0.0006219962,0.0009937702,0.00043561458,0.00029067314,0.98066473,0.000113117465],"about_ca_topic_score_codex":0.00001413209,"about_ca_topic_score_gemma":0.000011743154,"teacher_disagreement_score":0.07082106,"about_ca_system_score_codex":0.00019649377,"about_ca_system_score_gemma":0.0017641988,"threshold_uncertainty_score":0.9999814},"labels":[],"label_agreement":null},{"id":"W2901716698","doi":"10.1002/cpt.1317","title":"Recognizing that Evidence is Made, not Born","year":2018,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Arthritis Patient Alliance; Canadian Agency for Drugs and Technologies in Health; Health Canada","funders":"Health Canada","keywords":"Reimbursement; Context (archaeology); Quality (philosophy); Business; Risk analysis (engineering); Product (mathematics); Process (computing); Process management; Evidence-based practice; Operations management; Marketing; Medicine; Economics; Computer science; Health care; Economic growth","score_opus":0.8440868573545443,"score_gpt":0.6056367973435256,"score_spread":0.23845006001101865,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2901716698","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5215338,0.006596989,0.003728255,0.45141935,0.012113282,0.0011407944,0.00018834008,0.00021958315,0.0030595944],"genre_scores_gemma":[0.3434916,0.0031461192,0.0024259863,0.6462489,0.0031597817,0.00005561068,0.0000058448904,0.000053569267,0.00141259],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9926939,0.0010006443,0.0045002885,0.0009844685,0.00011461697,0.00070607406],"domain_scores_gemma":[0.9909011,0.005682536,0.0022742904,0.0006408098,0.00018025986,0.00032099284],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.01944409,0.00029161625,0.0012146404,0.00019123392,0.00034901887,0.000072143994,0.00072286295,0.00047292613,0.0042591747],"category_scores_gemma":[0.0009282397,0.00035214212,0.00030354067,0.00023268236,0.0007202586,0.00048518178,0.00015924398,0.0006555087,0.01527359],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003744035,0.0005495011,0.22669575,0.00018343188,0.0012107498,0.000006456832,0.0028658577,0.0000050177996,0.00031768886,0.001428658,0.76130176,0.0050607645],"study_design_scores_gemma":[0.0020945733,0.00066166214,0.06153564,0.000111240515,0.00018780687,0.000009982388,0.00030023372,0.00554612,0.0009866476,0.006179151,0.92166746,0.0007195134],"about_ca_topic_score_codex":0.000055743712,"about_ca_topic_score_gemma":0.000014842217,"teacher_disagreement_score":0.19482954,"about_ca_system_score_codex":0.0002697303,"about_ca_system_score_gemma":0.00022467122,"threshold_uncertainty_score":0.99989307},"labels":[],"label_agreement":null},{"id":"W2902167120","doi":"10.1002/cpt.1323","title":"Effect of <i> <scp>CYP</scp> 4F2 </i> , <i> <scp>VKORC</scp> 1 </i> , and <i> <scp>CYP</scp> 2C9 </i> in Influencing Coumarin Dose: A Single‐Patient Data Meta‐Analysis in More Than 15,000 Individuals","year":2018,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa; Western University","funders":"National Cancer Institute; National Heart, Lung, and Blood Institute; Queen's University Belfast; Queen's University; British Heart Foundation; National Institute of General Medical Sciences; Medical Research Council; National Institute for Health and Care Research","keywords":"Dosing; Coumarin; Pharmacology; Acenocoumarol; Confidence interval; Meta-analysis; Medicine; Cytochrome P450; Internal medicine; Chemistry; Metabolism","score_opus":0.30353908317061196,"score_gpt":0.5164399306452812,"score_spread":0.2129008474746692,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2902167120","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.1773952,0.8080168,0.000023426324,0.00015998345,0.004359571,0.005067488,0.0038787813,0.00020739633,0.000891368],"genre_scores_gemma":[0.010168902,0.95969343,0.00037004775,0.024802802,0.0015696652,0.0009914099,0.0013978183,0.0005044823,0.0005014501],"study_design_codex":"meta_analysis","study_design_gemma":"not_applicable","domain_scores_codex":[0.96386755,0.01868486,0.008034247,0.0044197636,0.0014080737,0.0035855325],"domain_scores_gemma":[0.9399329,0.04982931,0.0051643383,0.0028247798,0.0005617856,0.001686921],"candidate_categories":["metaepi_narrow","sts","open_science","research_integrity"],"consensus_categories":["metaepi_narrow","research_integrity"],"category_scores_codex":[0.016661836,0.0035592064,0.014011979,0.0025745155,0.00055095804,0.00020379276,0.005554685,0.005241983,0.00021661435],"category_scores_gemma":[0.0015850167,0.003119233,0.0038075268,0.0051536825,0.003957377,0.00058860483,0.0044679423,0.009250644,0.00019143484],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005016478,0.017087167,0.03856657,0.020288132,0.5192034,0.0016935488,0.007928375,0.0014631784,0.005771616,0.000049974828,0.09177356,0.2956728],"study_design_scores_gemma":[0.0067448313,0.0012228806,0.00023740217,0.00036442946,0.28339925,0.000072443996,0.00014088728,0.0012656337,0.003546708,0.000060326533,0.7025284,0.00041679005],"about_ca_topic_score_codex":0.00011912844,"about_ca_topic_score_gemma":0.00013862945,"teacher_disagreement_score":0.61075485,"about_ca_system_score_codex":0.00038008636,"about_ca_system_score_gemma":0.00139642,"threshold_uncertainty_score":0.9998257},"labels":[],"label_agreement":null},{"id":"W2908525626","doi":"10.1002/cpt.1375","title":"Drug‐Induced Liver Injury due to Flucloxacillin: Relevance of Multiple Human Leukocyte Antigen Alleles","year":2019,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Drug-Induced Hepatotoxicity and Protection","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":89,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"NIHR Nottingham Biomedical Research Centre; European Regional Development Fund; Medical Research Council; Svenska Läkaresällskapet; Uppsala Universitet; Radboud Universitair Medisch Centrum; Karolinska Institutet; University of Nottingham; King's College London; Daiichi-Sankyo; Abbott Laboratories; National Institute for Health and Care Research; Biotechnology and Biological Sciences Research Council; Wellcome Trust; Nottingham University Hospitals NHS Trust; King’s College London; Roche; Instituto de Salud Carlos III; Amgen; Radboud Universiteit; Newcastle University; Novartis; AstraZeneca; Vetenskapsrådet; University of Warwick; Pfizer; Merck; Directorate for Biological Sciences; GlaxoSmithKline; Sanofi; Wellcome; Universiteit Utrecht","keywords":"Flucloxacillin; Human leukocyte antigen; Odds ratio; Allele; Medicine; Immunology; Penicillin; HLA-B; Genotype; Internal medicine; Biology; Antigen; Antibiotics; Gene; Genetics; Staphylococcus aureus","score_opus":0.22223027141294577,"score_gpt":0.4858570597651821,"score_spread":0.26362678835223635,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2908525626","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9855313,0.00048163204,0.0001208716,0.0024536285,0.007758039,0.0022367788,0.000086687214,0.0002368648,0.0010942442],"genre_scores_gemma":[0.95376104,0.0016086308,0.00040989995,0.04180075,0.0011218624,0.00011985278,0.00002869869,0.000092028036,0.0010572625],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9937172,0.0022935905,0.0016775451,0.0009954215,0.0003402876,0.0009759822],"domain_scores_gemma":[0.99534726,0.0024886054,0.00064643484,0.0005999317,0.0003970376,0.0005207397],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0026469058,0.0005735497,0.0011877031,0.00026595275,0.00042190883,0.000020988877,0.00096963916,0.0012267818,0.0022905245],"category_scores_gemma":[0.000094021154,0.000584979,0.0004887909,0.0005295268,0.00051479833,0.00021170033,0.00033907226,0.0028267964,0.0017347597],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027289232,0.0017514102,0.035256185,0.0001442407,0.0012763253,0.00006388099,0.0011537804,0.00043853297,0.9082081,0.00011645879,0.009260171,0.039602038],"study_design_scores_gemma":[0.0042809495,0.0011881934,0.012387863,0.000038093138,0.0004576659,0.000017269553,0.00011122213,0.0030454616,0.6008505,0.00027402674,0.37665418,0.00069455715],"about_ca_topic_score_codex":0.000057860536,"about_ca_topic_score_gemma":0.0000651764,"teacher_disagreement_score":0.367394,"about_ca_system_score_codex":0.00015621954,"about_ca_system_score_gemma":0.00024747965,"threshold_uncertainty_score":0.99966013},"labels":[],"label_agreement":null},{"id":"W2912908908","doi":"10.1002/cpt.1385","title":"Human Cardiac Ventricular‐Like Organoid Chambers and Tissue Strips From Pluripotent Stem Cells as a Two‐Tiered Assay for Inotropic Responses","year":2019,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pluripotent Stem Cells Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":55,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Novelis (Canada)","funders":"Innovation and Technology Commission; Pfizer","keywords":"Inotrope; Organoid; Induced pluripotent stem cell; False positive paradox; Drug discovery; Drug; Pharmacology; Stem cell; Assay sensitivity; Biology; Medicine; Internal medicine; Bioinformatics; Pathology; Cell biology; Computer science; Embryonic stem cell","score_opus":0.043833239253223785,"score_gpt":0.3851340446593681,"score_spread":0.3413008054061443,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2912908908","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9910334,0.003716753,0.00019079525,0.00098656,0.0021371867,0.0016051827,0.0002342781,0.00003415131,0.000061708044],"genre_scores_gemma":[0.9840706,0.0015781558,0.00045461254,0.007624299,0.00081037375,0.000103372324,0.00024261468,0.00007500551,0.0050409767],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99599963,0.0014262405,0.0006796308,0.0009607953,0.00027848943,0.0006552235],"domain_scores_gemma":[0.9980806,0.0005910032,0.00024348823,0.0005793956,0.00020615483,0.0002993762],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010923767,0.00035823722,0.0006122018,0.000065199376,0.00024106055,0.000058474725,0.00047074418,0.0005330839,0.00012037449],"category_scores_gemma":[0.000020766076,0.00034045882,0.00027823535,0.00012053984,0.0004133032,0.000008985645,0.00038074033,0.00055189617,0.000065747714],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010662971,0.00029426694,0.008194555,0.000036276506,0.0012386309,0.000033654178,0.000053409658,0.000044217035,0.9807647,0.000004211503,0.006089618,0.002180175],"study_design_scores_gemma":[0.006052751,0.002141243,0.003252352,0.000014020702,0.00059974386,0.000009273806,0.00009579195,0.0003234111,0.6033486,0.000046921596,0.38363785,0.00047804217],"about_ca_topic_score_codex":0.000022896042,"about_ca_topic_score_gemma":0.0000040108125,"teacher_disagreement_score":0.37754825,"about_ca_system_score_codex":0.00005679158,"about_ca_system_score_gemma":0.000267438,"threshold_uncertainty_score":0.99990475},"labels":[],"label_agreement":null},{"id":"W2914208687","doi":"10.1002/cpt.1392","title":"No Clinically Relevant Interactions of St. John's Wort Extract Ze 117 Low in Hyperforin With Cytochrome P450 Enzymes and P‐glycoprotein","year":2019,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Natural Compound Pharmacology Studies","field":"Agricultural and Biological Sciences","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Dextromethorphan; Hypericum perforatum; Hyperforin; Pharmacokinetics; Pharmacology; CYP3A4; CYP2D6; Cytochrome P450; Chemistry; P-glycoprotein; Hypericum; CYP2C9; Enzyme; Medicine; Biochemistry; Traditional medicine; Antibiotics","score_opus":0.045489493036994795,"score_gpt":0.35762090363204346,"score_spread":0.3121314105950487,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2914208687","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99163944,0.0008977513,0.000001162344,0.004852598,0.001062089,0.0009046373,0.000037450955,0.00005901382,0.00054584845],"genre_scores_gemma":[0.9875089,0.0021358223,0.00041078296,0.008645453,0.0005149689,0.000050268234,0.000016833083,0.000005918181,0.00071105856],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99690396,0.0005885098,0.0011344996,0.0006633087,0.00021661649,0.00049312913],"domain_scores_gemma":[0.9946979,0.004332654,0.0004590397,0.00012490801,0.00023191686,0.00015354446],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010172395,0.00032496447,0.00082081504,0.000042949465,0.00013034012,0.000020798481,0.00045091045,0.00029949594,0.0010930275],"category_scores_gemma":[0.000051462306,0.00014224439,0.00017898994,0.000350573,0.00072744087,0.00017986502,0.00023758032,0.0013531403,0.00009910298],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0045533767,0.0017576208,0.2505361,0.0000524033,0.000836074,0.00006365816,0.00009545402,0.000024312169,0.7157216,0.00002439738,0.0021130787,0.024221918],"study_design_scores_gemma":[0.004563994,0.0063632373,0.8393806,0.00013746216,0.00051047344,0.000051763283,0.00019447917,0.0007321948,0.006526848,0.00022715903,0.1405958,0.00071599806],"about_ca_topic_score_codex":0.00003176476,"about_ca_topic_score_gemma":0.00014568555,"teacher_disagreement_score":0.7091947,"about_ca_system_score_codex":0.00004527861,"about_ca_system_score_gemma":0.000053070384,"threshold_uncertainty_score":0.9998201},"labels":[],"label_agreement":null},{"id":"W2917080169","doi":"10.1002/cpt.1409","title":"Clinical Pharmacogenetics Implementation Consortium Guideline for <scp>Cytochrome P450 (<i>CYP</i>)</scp><i>2D6</i> Genotype and Atomoxetine Therapy","year":2019,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Attention Deficit Hyperactivity Disorder","field":"Medicine","cited_by":197,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Institute of General Medical Sciences; National Human Genome Research Institute; National Institutes of Health","keywords":"Atomoxetine; CYP2D6; Pharmacogenetics; Pharmacology; Medicine; Cytochrome P450; Guideline; Genotype; Atomoxetine hydrochloride; Pharmacokinetics; Attention deficit hyperactivity disorder; Internal medicine; Psychiatry; Metabolism; Biology; Genetics; Methylphenidate","score_opus":0.1334353888882253,"score_gpt":0.5070233472240556,"score_spread":0.37358795833583036,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2917080169","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9788212,0.003196733,0.0019714697,0.009591698,0.0022451067,0.0036755472,0.00010850754,0.00018546887,0.00020425892],"genre_scores_gemma":[0.7883943,0.013679387,0.0059827096,0.18821369,0.0019017747,0.00016558231,0.00030833104,0.00018422103,0.0011700506],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99466145,0.00065479975,0.0024843824,0.0010449818,0.0003824852,0.0007718804],"domain_scores_gemma":[0.99410605,0.0033558514,0.00079029874,0.00051234756,0.00077341567,0.0004620533],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0024000776,0.0005077586,0.0012423884,0.00013684793,0.00017304883,0.000038182643,0.00028022673,0.00055883167,0.0009312397],"category_scores_gemma":[0.00012028722,0.00046627581,0.00057159906,0.00026720358,0.00058260234,0.00013442578,0.00015479901,0.0009734983,0.00026508622],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022334715,0.0034726905,0.5576475,0.00014982502,0.0041410043,0.00003483852,0.00020333074,0.000024112816,0.3129159,0.000040040602,0.070951305,0.04818594],"study_design_scores_gemma":[0.03789001,0.0038906315,0.12136593,0.000019667841,0.002951332,0.000087344284,0.00054410327,0.0032487735,0.0055413903,0.000120443874,0.8240077,0.00033267544],"about_ca_topic_score_codex":0.0000044003896,"about_ca_topic_score_gemma":0.0000036493493,"teacher_disagreement_score":0.7530564,"about_ca_system_score_codex":0.00005571408,"about_ca_system_score_gemma":0.00042574175,"threshold_uncertainty_score":0.99998206},"labels":[],"label_agreement":null},{"id":"W2933349877","doi":"10.1002/cpt.1446","title":"Variability in the Analgesic Response to Ibuprofen Is Associated With Cyclooxygenase Activation in Inflammatory Pain","year":2019,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Montreal Neurological Institute and Hospital","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; National Heart, Lung, and Blood Institute; National Institute of Biomedical Imaging and Bioengineering; University of Pennsylvania; Pfizer; Pharmaceutical Research and Manufacturers of America Foundation","keywords":"Ibuprofen; Medicine; Analgesic; Cyclooxygenase; Pharmacodynamics; Pharmacokinetics; Prostaglandin E2; Inflammation; Pharmacology; Dosing; Anesthesia; Placebo; Internal medicine; Pathology; Biology","score_opus":0.034840341964970316,"score_gpt":0.3726062647159205,"score_spread":0.3377659227509502,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2933349877","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98300326,0.000019042356,0.000053832053,0.014434012,0.000381836,0.0019784363,0.000003940908,0.000040975665,0.000084649546],"genre_scores_gemma":[0.8866059,0.000015278725,0.000036014007,0.11295687,0.00016760253,0.00010722198,0.000010847019,0.000026056246,0.000074202784],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9911149,0.007025553,0.00070763094,0.0004254088,0.00029995752,0.0004265063],"domain_scores_gemma":[0.9899038,0.009219088,0.00018632913,0.00043040994,0.000116583,0.00014380604],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.019392531,0.00022269481,0.0005220946,0.00017700721,0.000046759513,0.000011400594,0.00023572311,0.00035786047,0.00017971473],"category_scores_gemma":[0.0007780127,0.00015024887,0.00010179148,0.0005840509,0.00015593864,0.00006888707,0.000042930144,0.0010831768,0.00008633315],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016321873,0.0012018086,0.9429663,0.000054169595,0.00028025405,0.0001420888,0.00214476,0.000042716634,0.032048315,0.000007735596,0.0023668502,0.0024231693],"study_design_scores_gemma":[0.007079912,0.0017326645,0.9807383,0.00011574022,0.00018757666,0.0000032567661,0.00019565753,0.0016621089,0.002406173,0.0000713139,0.005597866,0.00020946194],"about_ca_topic_score_codex":0.0000067490273,"about_ca_topic_score_gemma":0.000017270058,"teacher_disagreement_score":0.09852286,"about_ca_system_score_codex":0.0002401527,"about_ca_system_score_gemma":0.0004133576,"threshold_uncertainty_score":0.6721103},"labels":[],"label_agreement":null},{"id":"W2937367049","doi":"10.1002/cpt.1477","title":"Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for <i>CYP2B6</i> and Efavirenz‐Containing Antiretroviral Therapy","year":2019,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":179,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"European and Developing Countries Clinical Trials Partnership; National Center for Advancing Translational Sciences; National Institute of Allergy and Infectious Diseases; National Institute of General Medical Sciences; National Human Genome Research Institute; National Institute on Minority Health and Health Disparities; Canadian Institutes of Health Research; National Institutes of Health; Partnership for Advanced Computing in Europe AISBL","keywords":"Efavirenz; CYP2B6; Discontinuation; Medicine; Reverse-transcriptase inhibitor; Pharmacogenetics; Adverse effect; Guideline; Pharmacology; Internal medicine; Oncology; Antiretroviral therapy; Human immunodeficiency virus (HIV); Virology; Genotype; Cytochrome P450; Biology; CYP1A2; Viral load; Pathology; Genetics","score_opus":0.10445328640151225,"score_gpt":0.4935270597406963,"score_spread":0.389073773339184,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2937367049","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.976752,0.0021293894,0.00056311674,0.014682435,0.002775147,0.0026929993,0.000050443952,0.00012616455,0.00022833058],"genre_scores_gemma":[0.8464287,0.012153264,0.01078644,0.12642013,0.0015497933,0.00013889941,0.00031384954,0.00010566923,0.0021032956],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99589133,0.00038172322,0.0020858417,0.0007773907,0.0002500097,0.000613689],"domain_scores_gemma":[0.99734825,0.0012348251,0.00047506456,0.00029411406,0.00030882438,0.0003389318],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0018248471,0.00040832374,0.001003545,0.000105442516,0.00015134367,0.000029118379,0.00018379005,0.00033778904,0.00061938894],"category_scores_gemma":[0.000020514317,0.0003421197,0.00040845343,0.00015021548,0.00037816996,0.000088974964,0.000096658,0.00053290377,0.000096447344],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033248963,0.00095318793,0.7980566,0.000035795187,0.002562932,0.00002533565,0.00017075801,0.000001869904,0.008698415,0.0000254808,0.030536702,0.15560801],"study_design_scores_gemma":[0.0554689,0.006739206,0.05325948,0.000031875887,0.0031980497,0.00003973983,0.00036012506,0.0024540515,0.010055827,0.00012443373,0.86765397,0.000614336],"about_ca_topic_score_codex":0.0000028702427,"about_ca_topic_score_gemma":0.000002259975,"teacher_disagreement_score":0.83711725,"about_ca_system_score_codex":0.00006186255,"about_ca_system_score_gemma":0.0003961722,"threshold_uncertainty_score":0.9999031},"labels":[],"label_agreement":null},{"id":"W2939463022","doi":"10.1002/cpt.1472","title":"Use of 4β‐Hydroxycholesterol Plasma Concentrations as an Endogenous Biomarker of CYP3A Activity: Clinical Validation in Individuals With Type 2 Diabetes","year":2019,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier de l’Université de Montréal","funders":"Canadian Institutes of Health Research","keywords":"CYP3A; Type 2 diabetes; Biomarker; Endocrinology; Internal medicine; Diabetes mellitus; Midazolam; Endogeny; Population; Cholesterol; Pharmacology; Medicine; Chemistry; Biology; Cytochrome P450; Metabolism; Biochemistry","score_opus":0.37673199915207994,"score_gpt":0.5106181238650749,"score_spread":0.13388612471299494,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2939463022","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99327785,0.00037587128,0.000018052215,0.0005675057,0.0037348918,0.0014218288,0.00016191407,0.000051854364,0.00039023982],"genre_scores_gemma":[0.98602194,0.0031385003,0.0003576631,0.009945026,0.00026372707,0.000041923715,0.000076633936,0.00006605344,0.0000885491],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9923679,0.0039933515,0.0018370551,0.0007609328,0.0003371415,0.00070362433],"domain_scores_gemma":[0.9936982,0.0039267777,0.0010590921,0.0005096668,0.00040500483,0.00040130856],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.002845911,0.00043579112,0.0012116351,0.0002592901,0.00009463354,0.000028273214,0.0006104676,0.0009042013,0.0011558625],"category_scores_gemma":[0.000071233364,0.00039541067,0.00025917808,0.0006017041,0.001160411,0.00043313368,0.00015771986,0.0015210563,0.000131456],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018613617,0.004370269,0.6352308,0.000047320947,0.0018332411,0.000014070519,0.00036078916,0.0011375097,0.33225793,0.000045391924,0.0002686412,0.0225727],"study_design_scores_gemma":[0.021052575,0.004221414,0.2294147,0.000058353642,0.004152228,0.000031904336,0.000121862366,0.019384243,0.6351189,0.00025896923,0.08522903,0.0009558396],"about_ca_topic_score_codex":0.000012082702,"about_ca_topic_score_gemma":0.0000069302037,"teacher_disagreement_score":0.40581608,"about_ca_system_score_codex":0.000038880335,"about_ca_system_score_gemma":0.0004890374,"threshold_uncertainty_score":0.9998498},"labels":[],"label_agreement":null},{"id":"W2941831619","doi":"10.1002/cpt.1483","title":"Pharmacogenomics of Cisplatin‐Induced Ototoxicity: Successes, Shortcomings, and Future Avenues of Research","year":2019,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Hearing, Cochlea, Tinnitus, Genetics","field":"Neuroscience","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; BC Children's Hospital; University of British Columbia","funders":"Canadian Institutes of Health Research","keywords":"Pharmacogenomics; Ototoxicity; Cisplatin; Medicine; Consistency (knowledge bases); Intensive care medicine; Pharmacology; Computer science; Internal medicine; Chemotherapy; Artificial intelligence","score_opus":0.5535828575587237,"score_gpt":0.5868099747994561,"score_spread":0.03322711724073235,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2941831619","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.06619496,0.92551315,0.000006959361,0.00050222786,0.0042451774,0.002835073,0.00026530615,0.000061249,0.0003758831],"genre_scores_gemma":[0.004368025,0.9904269,0.0002018271,0.0026745964,0.0019211998,0.00005291721,0.000014588661,0.00017343009,0.00016652257],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9903456,0.003836846,0.0028109562,0.0013331214,0.0007410845,0.00093237223],"domain_scores_gemma":[0.9878924,0.008870489,0.0016084441,0.0009081716,0.00040243397,0.00031809282],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0036015243,0.00067983,0.0033418545,0.00051253854,0.00018086073,0.000040460513,0.0017535664,0.0014076727,0.00016053015],"category_scores_gemma":[0.00030119222,0.0006245033,0.00066182076,0.0009919602,0.0018649183,0.00008465592,0.0010517323,0.003713741,0.000070514274],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036247744,0.0012558579,0.0005008258,0.019759305,0.0011169767,0.0000862514,0.00036759966,0.0000032442806,0.06752164,0.00013829325,0.0019433954,0.90694416],"study_design_scores_gemma":[0.0010360747,0.0006470363,0.000048624333,0.0009248882,0.002579505,0.000049586637,0.000021091219,0.000102638456,0.024376867,0.00006157474,0.9696683,0.0004838078],"about_ca_topic_score_codex":0.000008746374,"about_ca_topic_score_gemma":0.000002121542,"teacher_disagreement_score":0.9677249,"about_ca_system_score_codex":0.00010608273,"about_ca_system_score_gemma":0.0013334934,"threshold_uncertainty_score":0.9998887},"labels":[],"label_agreement":null},{"id":"W2944279315","doi":"10.1002/cpt.1493","title":"Shared Genetic Risk Factors Across Carbamazepine‐Induced Hypersensitivity Reactions","year":2019,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Drug-Induced Adverse Reactions","field":"Medicine","cited_by":70,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"Daiichi Sankyo Europe; European Regional Development Fund; National Institute of Allergy and Infectious Diseases; Medical Research Council; Svenska Läkaresällskapet; National Institutes of Health; Pfizer; Vetenskapsrådet; National Institute of General Medical Sciences; National Institute for Health and Care Research; University of Nottingham; Nottingham University Hospitals NHS Trust; AstraZeneca; National Institute of Diabetes and Digestive and Kidney Diseases; Instituto de Salud Carlos III; Amgen; Wellcome Trust; GlaxoSmithKline","keywords":"Carbamazepine; Hypersensitivity reaction; Delayed hypersensitivity; Medicine; Pharmacology; Epilepsy; Immunology; Psychiatry; Antigen","score_opus":0.3573320228502688,"score_gpt":0.5316509958784539,"score_spread":0.17431897302818505,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2944279315","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.024581663,0.945789,0.000031827753,0.0006985188,0.019094257,0.0052085444,0.0013817026,0.00066700525,0.0025474865],"genre_scores_gemma":[0.0021047178,0.9893911,0.0002555236,0.0035283756,0.0025123863,0.000120866025,0.00040964372,0.000313242,0.0013641382],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9926043,0.001816587,0.0024493942,0.0015638263,0.00045130163,0.001114564],"domain_scores_gemma":[0.9913816,0.0044274945,0.001699691,0.0014214026,0.00036619455,0.0007036386],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0009396868,0.0011611923,0.0047291843,0.00027900134,0.00037378748,0.000047527064,0.00047439587,0.0023631724,0.00010525298],"category_scores_gemma":[0.0002441614,0.0009654067,0.002958332,0.0007282096,0.00053192844,0.00012341396,0.00028467225,0.005898556,0.0018368675],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000040942843,0.0016704175,0.00049234065,0.0029556262,0.009995157,0.00021845153,0.00012354317,0.000006734901,0.0004111989,0.0000017102157,0.0007197541,0.9833641],"study_design_scores_gemma":[0.0019320782,0.00022005547,0.0053442074,0.0011705396,0.03548464,0.00032637393,0.000109737644,0.00009250261,0.000022151804,0.000004804429,0.95453304,0.0007598557],"about_ca_topic_score_codex":0.00007397442,"about_ca_topic_score_gemma":0.000010037812,"teacher_disagreement_score":0.98260427,"about_ca_system_score_codex":0.00069666165,"about_ca_system_score_gemma":0.0015935403,"threshold_uncertainty_score":0.9992796},"labels":[],"label_agreement":null},{"id":"W2944956458","doi":"10.1002/cpt.1496","title":"Modulation of <scp>CYP</scp>450 Activities in Patients With Type 2 Diabetes","year":2019,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":83,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier de l’Université de Montréal","funders":"Fonds de Recherche du Québec - Santé; Canadian Institutes of Health Research","keywords":"Tolbutamide; CYP2B6; CYP2C19; CYP1A2; Chlorzoxazone; Type 2 diabetes; Pharmacology; CYP3A; CYP2D6; CYP2C9; Medicine; Diabetes mellitus; CYP2E1; Internal medicine; Dextromethorphan; Cytochrome P450; Endocrinology; Metabolism","score_opus":0.09800917757700978,"score_gpt":0.4363264046354054,"score_spread":0.3383172270583956,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2944956458","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99086624,0.001021962,0.000011450246,0.00026075786,0.005261615,0.0010176423,0.00006400791,0.00006735394,0.0014289492],"genre_scores_gemma":[0.98402566,0.0011625505,0.00018225289,0.013657885,0.00036947656,0.00003276265,0.000057441568,0.000068938774,0.00044306507],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.996094,0.0012018966,0.001032655,0.0005909737,0.0003073518,0.00077315234],"domain_scores_gemma":[0.99628204,0.002304821,0.00053614867,0.0003265216,0.00029920036,0.00025123922],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011811081,0.00041537252,0.0008711079,0.0002505065,0.00009045581,0.000013191572,0.0005183363,0.00064293295,0.00062167906],"category_scores_gemma":[0.000033374225,0.00036671147,0.0001816137,0.0005337138,0.00058254716,0.00018427004,0.00016125997,0.0014354287,0.00016015285],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007537919,0.0022485526,0.925004,0.00006538332,0.0010266366,0.0000041220387,0.00038417112,0.0019101568,0.055782553,0.00003933702,0.0017904394,0.010990832],"study_design_scores_gemma":[0.01770201,0.0016106612,0.7850313,0.00002945473,0.0013165218,0.0000012307864,0.00011645925,0.0107415095,0.05876317,0.0003084013,0.12400367,0.00037557207],"about_ca_topic_score_codex":0.0000023743391,"about_ca_topic_score_gemma":0.0000023944808,"teacher_disagreement_score":0.13997269,"about_ca_system_score_codex":0.00005582481,"about_ca_system_score_gemma":0.0001868956,"threshold_uncertainty_score":0.99987847},"labels":[],"label_agreement":null},{"id":"W2949245773","doi":"10.1002/cpt.1550","title":"An Update on Repetitive Transcranial Magnetic Stimulation for the Treatment of Major Depressive Disorder","year":2019,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Transcranial Magnetic Stimulation Studies","field":"Neuroscience","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"","keywords":"Transcranial magnetic stimulation; Depression (economics); Dorsolateral prefrontal cortex; Stimulation; Neuroscience; Prefrontal cortex; Medicine; Major depressive disorder; Psychology; Treatment-resistant depression; Brain stimulation; Deep transcranial magnetic stimulation; Physical medicine and rehabilitation; Cognition","score_opus":0.25466970509798215,"score_gpt":0.5031502682251587,"score_spread":0.2484805631271766,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2949245773","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.001347131,0.98314434,0.0018727261,0.0009588761,0.0038848624,0.00786108,0.0007854921,0.00008748401,0.000058031517],"genre_scores_gemma":[0.004114952,0.99014175,0.00011853265,0.003946028,0.0007146668,0.00066105725,0.000036553825,0.00010503135,0.00016141287],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9954363,0.0013731031,0.0014668892,0.0010218049,0.00028235273,0.00041951952],"domain_scores_gemma":[0.9823247,0.016126202,0.00069378276,0.00062271283,0.00013966356,0.00009289832],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002756218,0.0006222437,0.0019281969,0.000118414726,0.00026807387,0.00002571882,0.0006365881,0.00047277054,0.00031969414],"category_scores_gemma":[0.00005157903,0.00038886795,0.0010977836,0.00027000785,0.00084794365,0.000055560784,0.000020685222,0.00039984615,0.00008209921],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014468058,0.002539743,0.000030406703,0.0006913643,0.00062156614,0.0000055932883,0.0002312845,0.0005050425,0.00040929136,0.00011274895,0.00007958962,0.99332654],"study_design_scores_gemma":[0.0079880785,0.009868964,0.00036463834,0.00021846933,0.01739567,0.000003827422,0.000010495435,0.002272956,0.00008683866,0.00011360708,0.96126366,0.00041280268],"about_ca_topic_score_codex":0.0000031670795,"about_ca_topic_score_gemma":0.0000036654994,"teacher_disagreement_score":0.9929138,"about_ca_system_score_codex":0.00006283287,"about_ca_system_score_gemma":0.00018041341,"threshold_uncertainty_score":0.9998563},"labels":[],"label_agreement":null},{"id":"W2949442333","doi":"10.1002/cpt.1541","title":"The Current and Future Potential of Transcranial Magnetic Stimulation With Electroencephalography in Psychiatry","year":2019,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Functional Brain Connectivity Studies","field":"Neuroscience","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Ottawa Mental Health Centre; University of Ottawa; University of Toronto; Centre for Addiction and Mental Health","funders":"National Institute of Mental Health; Canadian Institutes of Health Research; Ontario Mental Health Foundation; Campbell Institute","keywords":"Transcranial magnetic stimulation; Electroencephalography; Neuroscience; Dorsolateral prefrontal cortex; Schizophrenia (object-oriented programming); Prefrontal cortex; Psychology; Major depressive disorder; Medicine; Psychiatry; Stimulation; Cognition","score_opus":0.08977580616819512,"score_gpt":0.41961425132900865,"score_spread":0.3298384451608135,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2949442333","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0015864243,0.9860044,0.0000327097,0.0039659305,0.007055225,0.0012835229,0.000026849204,0.000023578412,0.000021349017],"genre_scores_gemma":[0.0013225842,0.99422926,0.000034633842,0.0032421092,0.0010583256,0.00006503981,0.0000036364627,0.00003514665,0.000009245985],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9965321,0.0013374258,0.0008573551,0.0006745344,0.0002492184,0.00034937053],"domain_scores_gemma":[0.99221736,0.007010051,0.00043033395,0.00023269534,0.000057644927,0.000051924726],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005155146,0.00035882057,0.0010937055,0.00014760431,0.0001604253,0.000019229225,0.0003718002,0.0002494465,0.000014129832],"category_scores_gemma":[0.000041617477,0.00021990182,0.0003629522,0.000532392,0.0010037706,0.000052561518,0.000057179877,0.0014362554,0.000005755254],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004626619,0.00040468905,0.00037293334,0.0011448071,0.00019307659,0.0000036087142,0.000022916163,0.000009777413,0.000041222236,0.00010005978,0.00047870373,0.99676555],"study_design_scores_gemma":[0.0017400178,0.0016491459,0.002053077,0.00033233096,0.0028209062,0.000023004277,0.000008297828,0.00014762975,0.000002834873,0.00036041313,0.9905915,0.00027079554],"about_ca_topic_score_codex":5.087467e-7,"about_ca_topic_score_gemma":0.000009487894,"teacher_disagreement_score":0.99649477,"about_ca_system_score_codex":0.000025495407,"about_ca_system_score_gemma":0.00034626294,"threshold_uncertainty_score":0.8967336},"labels":[],"label_agreement":null},{"id":"W2949540323","doi":"10.1002/cpt.1539","title":"Investigation on the Existence of Sex‐By‐Formulation Interaction in Bioequivalence Trials","year":2019,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Sex and Gender in Healthcare","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Canada","funders":"","keywords":"Bioequivalence; Confidence interval; Demography; Medicine; Sex ratio; Food and drug administration; Statistics; Internal medicine; Mathematics; Pharmacokinetics; Population; Environmental health","score_opus":0.578268039446847,"score_gpt":0.5455355756224989,"score_spread":0.032732463824348135,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2949540323","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97770214,0.00022172056,0.000021005031,0.019267477,0.0015303746,0.0009121959,0.0000058102864,0.000019733641,0.0003195487],"genre_scores_gemma":[0.94997126,0.0006291795,0.00006789213,0.04890854,0.0002120151,0.000020603542,0.000016055148,0.000010429943,0.00016401823],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9973852,0.0010412713,0.00097471534,0.00026120717,0.00017676761,0.00016081972],"domain_scores_gemma":[0.99510634,0.004142934,0.00034924623,0.00024147175,0.00009950028,0.000060506558],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030587327,0.00010819224,0.00043250638,0.000066769564,0.000029354038,0.000004030569,0.00011776798,0.00019794828,0.00024258261],"category_scores_gemma":[0.00016466195,0.00007158797,0.00011687061,0.00018619356,0.00014531489,0.000052534484,0.00002127919,0.00053595664,0.000055586006],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00404069,0.00073874526,0.66491574,0.00027588988,0.0005066007,0.0000053835956,0.002540299,0.0000856048,0.2527051,0.00039179318,0.005143493,0.068650655],"study_design_scores_gemma":[0.019269539,0.010622888,0.32651532,0.0006791591,0.0014988959,0.000032458818,0.004855516,0.028642595,0.5305675,0.007155237,0.0694569,0.00070400443],"about_ca_topic_score_codex":0.000011583035,"about_ca_topic_score_gemma":0.0000016722452,"teacher_disagreement_score":0.33840045,"about_ca_system_score_codex":0.000059154714,"about_ca_system_score_gemma":0.000106962005,"threshold_uncertainty_score":0.29192728},"labels":[],"label_agreement":null},{"id":"W2950225668","doi":"10.1002/cpt.1542","title":"Invasive and Noninvasive Brain Stimulation in Parkinson's Disease: Clinical Effects and Future Perspectives","year":2019,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Neurological disorders and treatments","field":"Medicine","cited_by":78,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"Canadian Institutes of Health Research","keywords":"Transcranial magnetic stimulation; Deep brain stimulation; Transcranial alternating current stimulation; Neuroscience; Parkinson's disease; Transcranial direct-current stimulation; Motor cortex; Stimulation; Brain stimulation; Deep transcranial magnetic stimulation; Medicine; Neuroplasticity; Psychology; Physical medicine and rehabilitation; Disease; Internal medicine","score_opus":0.1264158307223851,"score_gpt":0.4791668057454216,"score_spread":0.3527509750230365,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2950225668","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.028314808,0.9593868,0.0000025017566,0.007857723,0.0011725874,0.003147399,0.000033356668,0.000043194563,0.000041587333],"genre_scores_gemma":[0.0025389707,0.96425617,0.000079431,0.0316707,0.0010935037,0.00011843985,0.00007364264,0.00006595035,0.0001031966],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9953261,0.0018202066,0.0010909319,0.0011945408,0.00017000112,0.00039823464],"domain_scores_gemma":[0.98919475,0.009537625,0.0004524817,0.0003120922,0.00007889572,0.00042415372],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005329768,0.0005821312,0.0028048777,0.00015108996,0.00006603484,0.000021370042,0.00014378439,0.0009876434,0.00005751097],"category_scores_gemma":[0.0002098212,0.0004130181,0.0005874144,0.00020812135,0.0007477689,0.000055711214,0.00017037723,0.0017114417,0.00004200963],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011500468,0.0026436287,0.094177455,0.0069440007,0.002585352,0.001304093,0.000147653,3.6138496e-7,0.0000010259417,0.000028977782,0.0018455619,0.88917184],"study_design_scores_gemma":[0.008445129,0.0028781646,0.11051118,0.0012889631,0.012462349,0.000029106217,0.00005222259,0.00004998352,2.1043306e-7,0.00031857187,0.8635467,0.00041740134],"about_ca_topic_score_codex":9.982635e-7,"about_ca_topic_score_gemma":0.000002075807,"teacher_disagreement_score":0.8887544,"about_ca_system_score_codex":0.000060456758,"about_ca_system_score_gemma":0.00043614622,"threshold_uncertainty_score":0.99983215},"labels":[],"label_agreement":null},{"id":"W2954818509","doi":"10.1002/cpt.1471","title":"Educating the Next Generation of Pharmacogenomics Experts: Global Educational Needs and Concepts","year":2019,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Horizon 2020 Framework Programme; Medical Research Council; National Institute for Health and Care Research; European Commission; Bundesinstitut für Arzneimittel und Medizinprodukte","keywords":"Pharmacogenomics; Agency (philosophy); Harmonization; Regulatory science; Specialty; Precision medicine; Medical education; Medicine; Family medicine; Pharmacology; Sociology","score_opus":0.3948679866942507,"score_gpt":0.55277601827374,"score_spread":0.1579080315794893,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2954818509","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9526241,0.013987241,0.000056348013,0.015640108,0.014197204,0.0010168673,0.00010107146,0.000045927685,0.0023311276],"genre_scores_gemma":[0.8938619,0.008935531,0.0003617724,0.09352329,0.0026515562,0.00008233582,0.00004233234,0.000043735625,0.0004975503],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9956663,0.0015648457,0.0012798652,0.0005744,0.00025834443,0.0006562064],"domain_scores_gemma":[0.9962523,0.0020708477,0.00061476364,0.00035763564,0.00032697385,0.00037750087],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0017233418,0.00043552706,0.0006769829,0.00010031689,0.0003488589,0.00004409613,0.0007502428,0.0004937202,0.0028374214],"category_scores_gemma":[0.00004351162,0.00035502162,0.000279195,0.00044982982,0.0011733585,0.00017881821,0.00028596225,0.001017358,0.00015440886],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007638009,0.0017983324,0.119647086,0.00008075542,0.002385457,0.0000043375303,0.0024588127,0.0008187392,0.75050795,0.0020638178,0.045551192,0.07391971],"study_design_scores_gemma":[0.008996167,0.00045375226,0.010353313,0.000018429459,0.003095478,0.0001017996,0.0014415334,0.03350058,0.06332933,0.0011946074,0.87659043,0.00092457555],"about_ca_topic_score_codex":0.000010523975,"about_ca_topic_score_gemma":0.0000028198444,"teacher_disagreement_score":0.83103925,"about_ca_system_score_codex":0.000084584695,"about_ca_system_score_gemma":0.00055535306,"threshold_uncertainty_score":0.99989015},"labels":[],"label_agreement":null},{"id":"W2964240041","doi":"10.1002/cpt.1574","title":"Transcranial Magnetic and Electrical Stimulation in Alzheimer's Disease and Mild Cognitive Impairment: A Review of Randomized Controlled Trials","year":2019,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Transcranial Magnetic Stimulation Studies","field":"Neuroscience","cited_by":65,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"Canadian Institutes of Health Research","keywords":"Transcranial magnetic stimulation; Randomized controlled trial; Transcranial direct-current stimulation; Dementia; Brain stimulation; Stimulation; Physical medicine and rehabilitation; Alzheimer's disease; Psychological intervention; Deep transcranial magnetic stimulation; Medicine; Psychology; Neuroscience; Disease; Psychiatry; Internal medicine","score_opus":0.27803764855153024,"score_gpt":0.5043927439523119,"score_spread":0.2263550954007817,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2964240041","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005157785,0.9773854,0.00004530843,0.00060948724,0.0007415715,0.020473652,0.0001517845,0.0000367515,0.0000402916],"genre_scores_gemma":[0.0033097342,0.9864703,0.00003825965,0.008924352,0.00022041296,0.0009449388,0.000015059629,0.000057930403,0.000019011984],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9752589,0.017226681,0.0057148454,0.000969969,0.00041426872,0.00041534973],"domain_scores_gemma":[0.9097489,0.08783835,0.0018493783,0.0001960096,0.00014891899,0.00021842773],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.0071981754,0.0007241406,0.016534405,0.00033531673,0.00007187715,0.000024052466,0.0002459423,0.00043690056,0.00025948233],"category_scores_gemma":[0.0034755294,0.00049244554,0.002276509,0.0004910811,0.0013809736,0.00006375274,0.00006755397,0.0008488392,0.000013607184],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.27243128,0.0019956934,0.00009228448,0.030397633,0.005732584,0.00005396444,0.00017213529,0.0000046872124,0.000081072365,0.00007467197,0.0001740135,0.68878996],"study_design_scores_gemma":[0.68951076,0.0017114064,0.00054406957,0.02812954,0.25154126,0.000014849688,0.0000033186557,0.0023660453,0.0000031892594,0.00027653945,0.025025377,0.0008736269],"about_ca_topic_score_codex":0.0000017722585,"about_ca_topic_score_gemma":3.543301e-7,"teacher_disagreement_score":0.68791634,"about_ca_system_score_codex":0.000023955949,"about_ca_system_score_gemma":0.00037008588,"threshold_uncertainty_score":0.9997527},"labels":[],"label_agreement":null},{"id":"W2967546963","doi":"10.1002/cpt.1532","title":"The Age of Omics‐Driven Precision Medicine","year":2019,"lang":"en","type":"editorial","venue":"Clinical Pharmacology & Therapeutics","topic":"Genetics, Bioinformatics, and Biomedical Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Omics; Precision medicine; Medicine; Computational biology; Computer science; Bioinformatics; Biology; Pathology","score_opus":0.06096806224417636,"score_gpt":0.44244562694052586,"score_spread":0.3814775646963495,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2967546963","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004697875,0.0057658223,0.00046314124,0.0038796505,0.98265535,0.0011098353,0.00024789595,0.00002080377,0.0011596335],"genre_scores_gemma":[0.002075166,0.17300078,0.00038176958,0.0075200535,0.8065517,0.00004166573,0.0021372526,0.0001195834,0.008172059],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99543273,0.00065347855,0.0017009806,0.0006078127,0.00095246703,0.00065251667],"domain_scores_gemma":[0.9937308,0.0036292865,0.0007094919,0.00094032456,0.0007705023,0.00021963092],"candidate_categories":["metaepi_narrow","sts","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0026490667,0.00042703093,0.0008750313,0.00008095052,0.00016011797,0.000026032065,0.0018520007,0.0023733673,0.00006236523],"category_scores_gemma":[0.0011871185,0.0002696315,0.00043279803,0.00013064407,0.0029486062,0.000003103419,0.00077450665,0.0016536125,0.00008776081],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007994597,0.00017293307,0.00009718618,0.000101265025,0.0009272766,0.000004455205,0.000041607625,0.000005499367,0.02884902,0.000001500307,0.9572491,0.011750712],"study_design_scores_gemma":[0.0023759755,0.0028387906,0.00011016607,0.000049986575,0.00049200666,0.0000011911959,0.000043204593,0.00019622812,0.0033367232,0.00008997732,0.99019283,0.00027293936],"about_ca_topic_score_codex":0.000006736849,"about_ca_topic_score_gemma":0.000014606454,"teacher_disagreement_score":0.17610367,"about_ca_system_score_codex":0.000038889033,"about_ca_system_score_gemma":0.000877857,"threshold_uncertainty_score":0.99997556},"labels":[],"label_agreement":null},{"id":"W2972681847","doi":"10.1002/cpt.1611","title":"Precision Medicine: Lessons Learned From Implementation of a Pharmacogenetics‐Based Patient Care Program in a Real‐World Setting","year":2019,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Citation; Associate editor; Precision medicine; Library science; Medicine; Psychology; Computer science","score_opus":0.2889980624840852,"score_gpt":0.5879891898422483,"score_spread":0.29899112735816313,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2972681847","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9771775,0.0040232413,0.000039278162,0.0071716886,0.0063095195,0.0029686766,0.00033461986,0.00016577807,0.0018096694],"genre_scores_gemma":[0.96474904,0.007595068,0.0013387646,0.024820436,0.0007613685,0.0002924386,0.0002544945,0.00010193838,0.00008645816],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9918732,0.0031151073,0.0023906808,0.0011129787,0.0005152262,0.0009927958],"domain_scores_gemma":[0.99475986,0.0027910552,0.0010597823,0.00050264545,0.0004403964,0.00044628477],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0017547566,0.0006138313,0.0011972084,0.0004935195,0.00015791478,0.000017761533,0.0008164836,0.000603324,0.005660534],"category_scores_gemma":[0.000028007591,0.000580175,0.00038460144,0.00085070863,0.00064186135,0.00011514712,0.00028621082,0.0019107207,0.00012984344],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017102553,0.0019403647,0.1638342,0.00010899003,0.0008450101,0.00003832522,0.002860623,0.0022349323,0.19309083,0.00002696814,0.0028831707,0.63042635],"study_design_scores_gemma":[0.03526165,0.0028993208,0.06650985,0.00013196935,0.003457582,0.0000024137146,0.0029373406,0.02412493,0.3255236,0.0008143086,0.5371269,0.0012101041],"about_ca_topic_score_codex":0.00018723801,"about_ca_topic_score_gemma":0.00013224942,"teacher_disagreement_score":0.62921625,"about_ca_system_score_codex":0.00016371031,"about_ca_system_score_gemma":0.0005079678,"threshold_uncertainty_score":0.99966496},"labels":[],"label_agreement":null},{"id":"W2972702245","doi":"10.1002/cpt.1625","title":"Secondary Stroke Prevention: A Population‐Based Cohort Study on Anticoagulation and Antiplatelet Treatments, and the Risk of Death or Recurrence","year":2019,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Acute Ischemic Stroke Management","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Hazard ratio; Stroke (engine); Cohort; Internal medicine; Confidence interval; Cohort study; Proportional hazards model; Clinical trial; Surgery","score_opus":0.06890834805972829,"score_gpt":0.4178344151945049,"score_spread":0.34892606713477664,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2972702245","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948716,0.0002563238,0.0000932514,0.0011012392,0.00038271403,0.002898779,0.000020451915,0.000024065952,0.00035155655],"genre_scores_gemma":[0.99441,0.0009051284,0.0003530841,0.0034627826,0.00008734069,0.000040132494,0.000025818676,0.000015496127,0.0007002621],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99818426,0.00052307267,0.0005763167,0.00036519027,0.00020195945,0.0001491958],"domain_scores_gemma":[0.998052,0.0011788905,0.0003561753,0.00028860694,0.000063478044,0.00006083732],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009523553,0.00017073093,0.00055798807,0.00006566307,0.00007119797,0.00000877257,0.000085901236,0.00010776217,0.00018366743],"category_scores_gemma":[0.000033058255,0.00010260075,0.00009812341,0.000094217365,0.00020267672,0.00004074316,0.00006655382,0.0003582915,0.000007731954],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004295625,0.0009670981,0.9843953,0.000029959063,0.0022569364,0.0000073591254,0.00007778344,0.000011252586,0.00015964164,0.00000763475,0.00027938382,0.007511994],"study_design_scores_gemma":[0.020284675,0.0026821927,0.96827435,0.000031673106,0.004863678,0.00000571713,0.00009139898,0.0026716015,0.00023061683,0.000025678446,0.000750766,0.00008765267],"about_ca_topic_score_codex":0.000011852745,"about_ca_topic_score_gemma":0.0000014504047,"teacher_disagreement_score":0.016120983,"about_ca_system_score_codex":0.000029962623,"about_ca_system_score_gemma":0.000058324902,"threshold_uncertainty_score":0.41839373},"labels":[],"label_agreement":null},{"id":"W2972996415","doi":"10.1002/cpt.1572","title":"Deep Brain Stimulation in Depression: Even if Successful, Will It Ever Be Scalable?","year":2019,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Neurological disorders and treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Library science; Mental health; Citation; Psychology; Medicine; Psychiatry; Computer science","score_opus":0.06912674434156954,"score_gpt":0.42471037554815094,"score_spread":0.35558363120658143,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2972996415","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95851046,0.0005300744,0.00008681982,0.03777916,0.0009533984,0.0009233573,0.000004276504,0.0000621696,0.0011502625],"genre_scores_gemma":[0.77070963,0.00041234138,0.00010597215,0.22777362,0.00014409854,0.000025685686,0.000025251042,0.000025186113,0.00077823614],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977966,0.0003828236,0.00064677704,0.00054811436,0.00022057591,0.00040512584],"domain_scores_gemma":[0.9980042,0.0013157442,0.00014591913,0.00028315562,0.0000692794,0.00018170978],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00035527904,0.00023166236,0.0005559428,0.00007704293,0.000053952146,0.000009981282,0.00017818008,0.0003966212,0.0027469725],"category_scores_gemma":[0.000042263513,0.00017570874,0.00018199914,0.00022419999,0.00017430304,0.000119835575,0.000098054945,0.0006723897,0.00024467515],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018322049,0.0022459526,0.9765079,0.000024466364,0.00032132582,0.00012817772,0.00007067226,0.0005626028,0.0017550078,0.000006755233,0.007346154,0.00919879],"study_design_scores_gemma":[0.020366695,0.0021116426,0.88591206,0.000039708015,0.0007857024,0.000011527137,0.000042282794,0.027369298,0.00032054714,0.0015036307,0.061227504,0.00030937648],"about_ca_topic_score_codex":0.0000059050158,"about_ca_topic_score_gemma":0.0000082523775,"teacher_disagreement_score":0.18999445,"about_ca_system_score_codex":0.000045888173,"about_ca_system_score_gemma":0.00007048618,"threshold_uncertainty_score":0.99816465},"labels":[],"label_agreement":null},{"id":"W2976816195","doi":"10.1002/cpt.2166","title":"PharmVar GeneFocus: <i>CYP2B6</i>","year":2021,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":239,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"National Institute of General Medical Sciences; National Human Genome Research Institute; Medical Research Council; National Institutes of Health; Canada Research Chairs; Robert Bosch Stiftung; Horizon 2020 Framework Programme; European Federation of Pharmaceutical Industries and Associations; National Research Foundation; Canadian Institutes of Health Research; Australian Centre for HIV and Hepatitis Virology Research; European Commission; Vetenskapsrådet; Centre for Addiction and Mental Health; McGill University","keywords":"Medicine; Pharmacology","score_opus":0.5691523363200172,"score_gpt":0.6343200664153339,"score_spread":0.06516773009531673,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2976816195","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00008944722,0.953438,0.00008320921,0.0012892369,0.037760153,0.0023526226,0.0008082735,0.00048444653,0.0036946333],"genre_scores_gemma":[0.000009286534,0.8895588,0.0004331197,0.095075704,0.010379275,0.0005547403,0.0005340551,0.00047671646,0.002978308],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.97974795,0.009950183,0.0046122707,0.0026194155,0.0006498699,0.0024202948],"domain_scores_gemma":[0.98930323,0.00507206,0.0019935782,0.0013314853,0.000592236,0.0017074029],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"category_scores_codex":[0.0041086073,0.0023030813,0.0071886634,0.0005076202,0.00071906194,0.00012440904,0.0029635606,0.0048273546,0.010378644],"category_scores_gemma":[0.000083909006,0.0020876564,0.0042780265,0.0014050595,0.0016890455,0.00017242624,0.0012700073,0.00962592,0.0037559674],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011052294,0.002095104,0.000030567917,0.0019463763,0.01016023,0.00066272373,0.00008251596,0.000017887762,0.00013638621,0.00006301099,0.13484852,0.8498461],"study_design_scores_gemma":[0.0035977399,0.00019664114,0.0000027282956,0.0006143333,0.041573543,0.00028095004,0.000019859808,0.00016690961,0.00037350465,0.00007785618,0.95119035,0.0019055838],"about_ca_topic_score_codex":0.0000037334914,"about_ca_topic_score_gemma":0.0000018745741,"teacher_disagreement_score":0.84794056,"about_ca_system_score_codex":0.0002948664,"about_ca_system_score_gemma":0.002414423,"threshold_uncertainty_score":0.9989708},"labels":[],"label_agreement":null},{"id":"W2977861177","doi":"10.1002/cpt.1622","title":"The Future of Precision Medicine","year":2019,"lang":"en","type":"editorial","venue":"Clinical Pharmacology & Therapeutics","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Hospital for Sick Children","funders":"","keywords":"Pharmacogenomics; Precision medicine; Therapeutic drug monitoring; Personalized medicine; Medicine; Intensive care medicine; Key (lock); Clinical pharmacology; Drug; Medical physics; Pharmacology; Bioinformatics; Computer science; Biology; Pathology","score_opus":0.05672421129191929,"score_gpt":0.4516181753745289,"score_spread":0.3948939640826096,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2977861177","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00010830527,0.06706346,0.000048405815,0.015221933,0.9162613,0.0004901693,0.00013071224,0.00003880655,0.00063692353],"genre_scores_gemma":[0.00015738988,0.10566321,0.00015560767,0.012849993,0.8644699,0.000020199806,0.00016714189,0.00007431804,0.016442271],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99437445,0.002543465,0.0016771976,0.0006570005,0.00018485631,0.00056299753],"domain_scores_gemma":[0.9711976,0.026511915,0.000941506,0.0007293989,0.0005651723,0.000054386077],"candidate_categories":["sts","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0038081144,0.0004618417,0.001466861,0.00007358418,0.00022143102,0.000009067097,0.001428815,0.0046552243,0.0012354251],"category_scores_gemma":[0.00034959443,0.00024378831,0.0005405284,0.00019992892,0.0031634879,0.00002401125,0.00032964753,0.0041349363,0.00022532622],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012131599,0.00021319327,0.000050607203,0.000040018356,0.002248,0.0000022812192,0.000023799454,1.7544085e-7,0.004409153,0.00003246679,0.94107467,0.050692454],"study_design_scores_gemma":[0.0027343114,0.0015638599,0.00008856449,0.00006216191,0.002575739,0.0000023259133,0.000046319903,0.0000060271855,0.0013593831,0.0004185239,0.9908949,0.00024785474],"about_ca_topic_score_codex":0.000003281012,"about_ca_topic_score_gemma":0.0000046072428,"teacher_disagreement_score":0.051791415,"about_ca_system_score_codex":0.00004365227,"about_ca_system_score_gemma":0.00039167012,"threshold_uncertainty_score":0.9996776},"labels":[],"label_agreement":null},{"id":"W2980883791","doi":"10.1002/cpt.1698","title":"Reproducing Protocol‐Based Studies Using Parameterizable Tools—Comparison of Analytic Approaches Used by Two Medical Product Surveillance Networks","year":2019,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Advanced Causal Inference Techniques","field":"Mathematics","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Canadian Society of Nephrology; Institut universitaire en santé mentale de Montréal; Jewish General Hospital; McGill University","funders":"Canadian Institutes of Health Research; U.S. Food and Drug Administration","keywords":"Protocol (science); Medicine; Observational study; Hazard; Acute pancreatitis; Emergency medicine; Pharmacology; Computer science; Internal medicine; Pathology; Alternative medicine","score_opus":0.7218767300534139,"score_gpt":0.6223373168771107,"score_spread":0.09953941317630322,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980883791","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.87542593,0.00082613365,0.076602176,0.0020155434,0.0013376322,0.04296837,0.00001845388,0.0006546961,0.00015104315],"genre_scores_gemma":[0.9558219,0.000055937388,0.036455125,0.0022479256,0.00043739963,0.00478056,0.000014033553,0.00010702936,0.00008012955],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9942008,0.0013768129,0.0021472871,0.0010849574,0.000543113,0.000647025],"domain_scores_gemma":[0.9908715,0.0063187657,0.0012755312,0.0010591759,0.00031295465,0.0001620753],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0048748655,0.00044561416,0.0017913489,0.00009124795,0.00010101897,0.00002620893,0.0006934214,0.00034675805,0.00015467171],"category_scores_gemma":[0.0010284636,0.00037311882,0.00026120292,0.00047115155,0.00092609756,0.00018475603,0.0002523658,0.0011754198,0.000006583374],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00465493,0.015134899,0.7404344,0.0037155987,0.00948135,0.00004857138,0.0017252958,0.037388805,0.1131882,0.0010469942,0.020004027,0.053176947],"study_design_scores_gemma":[0.008931776,0.002709807,0.0006281814,0.00054718356,0.0014722664,0.000014576376,0.0004435981,0.8253336,0.14146426,0.011162648,0.00561908,0.0016730492],"about_ca_topic_score_codex":0.0000048689703,"about_ca_topic_score_gemma":0.000005814567,"teacher_disagreement_score":0.7879448,"about_ca_system_score_codex":0.00012687365,"about_ca_system_score_gemma":0.00028469396,"threshold_uncertainty_score":0.9998721},"labels":[],"label_agreement":null},{"id":"W2986767939","doi":"10.1002/cpt.1715","title":"Proposed Therapeutic Range of Treosulfan in Reduced Toxicity Pediatric Allogeneic Hematopoietic Stem Cell Transplant Conditioning: Results From a Prospective Trial","year":2019,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"Medical Research Council; University College London","keywords":"Treosulfan; Medicine; Hazard ratio; Hematopoietic stem cell transplantation; Confidence interval; Internal medicine; Cumulative incidence; Transplantation; Oncology; Surgery; Busulfan","score_opus":0.06178584043855033,"score_gpt":0.36371784059020607,"score_spread":0.3019320001516557,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2986767939","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99078566,0.00061776914,0.00012333521,0.0013269061,0.0016339413,0.004596582,0.00021752244,0.00009721309,0.000601054],"genre_scores_gemma":[0.9944519,0.0010775008,0.00021832038,0.0032815188,0.00045086473,0.000089728055,0.00012589559,0.00006893866,0.0002353497],"study_design_codex":"bench_or_experimental","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9948905,0.00094978145,0.002250547,0.00089805893,0.00047818906,0.0005328998],"domain_scores_gemma":[0.9960808,0.0023460365,0.0006783141,0.0004979094,0.00017854605,0.00021837457],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0012020129,0.00041870357,0.0013788395,0.0002342366,0.00005433318,0.000012146801,0.00030606994,0.0006057851,0.00031802309],"category_scores_gemma":[0.000009301027,0.00036577467,0.0004140313,0.00048910995,0.0002831377,0.000079706035,0.000024655763,0.00091090554,0.00010697897],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.24860296,0.009555169,0.35612324,0.0008943016,0.0015344126,0.0002859652,0.011502537,0.00007129514,0.3704272,0.000042056818,0.00021049251,0.0007503896],"study_design_scores_gemma":[0.41929612,0.008811781,0.21318392,0.00029033833,0.007217179,0.00006242316,0.0008266613,0.0008386983,0.34785601,0.0004770241,0.00022068481,0.0009191655],"about_ca_topic_score_codex":0.000016954073,"about_ca_topic_score_gemma":0.0000073425017,"teacher_disagreement_score":0.17069316,"about_ca_system_score_codex":0.00012904947,"about_ca_system_score_gemma":0.0005256547,"threshold_uncertainty_score":0.9998794},"labels":[],"label_agreement":null},{"id":"W3001449808","doi":"10.1002/cpt.1795","title":"Will Artificial Intelligence for Drug Discovery Impact Clinical Pharmacology?","year":2020,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Computational Drug Discovery Methods","field":"Computer Science","cited_by":149,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Artificial Intelligence in Medicine (Canada)","funders":"National Center for Advancing Translational Sciences; National Cancer Institute; National Institutes of Health","keywords":"Context (archaeology); Drug discovery; Clinical pharmacology; Identification (biology); Clinical trial; Clinical Practice; Generative grammar; Drug; Pharmacology; Medicine; Data science; Artificial intelligence; Computer science; Bioinformatics; Internal medicine; Biology","score_opus":0.35856944796641615,"score_gpt":0.5906098123856323,"score_spread":0.2320403644192161,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3001449808","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000021170159,0.56439734,0.4060276,0.0053644483,0.021346748,0.0023283933,0.00022074071,0.00026780585,0.00002577152],"genre_scores_gemma":[0.000033753513,0.9316645,0.025324443,0.031732365,0.010453889,0.0003969095,0.00012025608,0.00016158912,0.00011224897],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.98285544,0.0072231903,0.0053852373,0.0027078332,0.00056301005,0.0012652795],"domain_scores_gemma":[0.9613384,0.03441991,0.00212777,0.0009740379,0.00038274803,0.0007571086],"candidate_categories":["metaepi_narrow","open_science","research_integrity"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.006156322,0.0013421213,0.004995372,0.0003164634,0.00032859342,0.00039256553,0.0054437662,0.0011925756,0.00012868816],"category_scores_gemma":[0.0003277218,0.0011099149,0.0051000966,0.0012359639,0.0012691105,0.0012023799,0.0018297185,0.0036758194,0.0003647393],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023200914,0.0011717989,0.000007862667,0.00085762615,0.0037932512,0.00008888463,0.000065721215,0.00042048632,0.0000024409105,0.0014509677,0.028006254,0.9639027],"study_design_scores_gemma":[0.0005639051,0.0008491087,0.000008678711,0.00030256886,0.0051034433,0.000044106975,0.0000061792643,0.051332843,0.000014891751,0.011219126,0.92951554,0.0010396333],"about_ca_topic_score_codex":0.000002087391,"about_ca_topic_score_gemma":0.0000010639815,"teacher_disagreement_score":0.9628631,"about_ca_system_score_codex":0.00036973075,"about_ca_system_score_gemma":0.0040720734,"threshold_uncertainty_score":0.99993724},"labels":[],"label_agreement":null},{"id":"W3016766421","doi":"10.1002/cpt.1852","title":"Response to Inhibition of Receptor‐Interacting Protein Kinase 1 (RIPK1) in Active Plaque Psoriasis: A Randomized Placebo‐Controlled Study","year":2020,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":73,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Innovaderm (Canada); Probity Medical Research","funders":"GlaxoSmithKline","keywords":"Placebo; Medicine; Psoriasis; Tolerability; Pharmacology; Pharmacodynamics; Internal medicine; Adverse effect; Randomized controlled trial; Pharmacokinetics; Gastroenterology; Pathology; Immunology","score_opus":0.06489494980480552,"score_gpt":0.37355454547704975,"score_spread":0.3086595956722442,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3016766421","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98086643,0.0004153192,0.00006562979,0.010487972,0.0015091279,0.00645827,0.000049575658,0.000084255225,0.00006344022],"genre_scores_gemma":[0.99040216,0.0001226582,0.00018237015,0.007603356,0.00017562092,0.0012415488,0.000027719167,0.00003848321,0.00020605733],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9857273,0.011454214,0.0016327841,0.00066012493,0.000078181714,0.0004474003],"domain_scores_gemma":[0.99127257,0.0076058237,0.0006344553,0.0002288823,0.0001570088,0.000101253776],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0034385873,0.00038993906,0.0019606824,0.00021329612,0.00011163235,0.00001011559,0.0002735954,0.00045687333,0.0005842456],"category_scores_gemma":[0.0009985891,0.00032294396,0.00042875615,0.00037230403,0.00029871883,0.000096619755,0.00014183098,0.000761123,0.00027699632],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5857744,0.0018759248,0.00030263315,0.000007881443,0.0025221216,0.000030475656,0.0036173598,0.000024518858,0.40118918,0.0000031617815,0.00049659977,0.004155701],"study_design_scores_gemma":[0.7525193,0.004717061,0.0008294513,0.00007670314,0.0021986815,0.0000036319514,0.0024097136,0.000079680925,0.23283403,0.000024223153,0.0039234753,0.0003840643],"about_ca_topic_score_codex":0.0000160263,"about_ca_topic_score_gemma":0.000013209873,"teacher_disagreement_score":0.16835517,"about_ca_system_score_codex":0.00008838402,"about_ca_system_score_gemma":0.00018909694,"threshold_uncertainty_score":0.9999223},"labels":[],"label_agreement":null},{"id":"W3023705814","doi":"10.1002/cpt.1882","title":"The Implausibility of Neonatal Opioid Toxicity from Breastfeeding","year":2020,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Prenatal Substance Exposure Effects","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; Sunnybrook Hospital; University of Toronto; Institute for Clinical Evaluative Sciences; Sunnybrook Health Science Centre","funders":"","keywords":"Breastfeeding; Opioid; Toxicity; Medicine; Pediatrics; Internal medicine; Receptor","score_opus":0.12008092285021382,"score_gpt":0.4605603057464848,"score_spread":0.340479382896271,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3023705814","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0009895973,0.99043065,0.00013009034,0.0017406954,0.004370179,0.0018421304,0.00030611717,0.00011313617,0.000077427],"genre_scores_gemma":[0.0011165226,0.989623,0.00028559932,0.0060434374,0.0026075963,0.000073284566,0.00012736101,0.0000912991,0.000031860356],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99466753,0.0013024744,0.0021928712,0.00087929924,0.00041331607,0.0005445335],"domain_scores_gemma":[0.9880112,0.0095740445,0.0011034342,0.0007467585,0.00017413971,0.00039043318],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0013683923,0.0006167185,0.0035488873,0.000048167418,0.00014817361,0.000018122395,0.0009018955,0.0009818763,0.00019867961],"category_scores_gemma":[0.000242723,0.00039212505,0.0015365643,0.00038214322,0.0011355618,0.000054420307,0.00045055032,0.0027998285,0.0001136301],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005596545,0.00025201563,0.00023667027,0.0018719153,0.0035611978,0.000116273324,0.00006176089,5.104608e-8,0.0001747884,0.000005397447,0.0031794275,0.9899809],"study_design_scores_gemma":[0.0015540781,0.0005699957,0.0003801939,0.0013818836,0.0101769,0.00006405969,0.0000106926145,0.00004895157,0.00030515497,0.00009179406,0.9851175,0.0002988106],"about_ca_topic_score_codex":0.0000076404085,"about_ca_topic_score_gemma":0.0000069472057,"teacher_disagreement_score":0.989682,"about_ca_system_score_codex":0.00016904486,"about_ca_system_score_gemma":0.00096763147,"threshold_uncertainty_score":0.9998531},"labels":[],"label_agreement":null},{"id":"W3038651714","doi":"10.1002/cpt.1981","title":"Comparing Onset of Biosimilar Versus Generic Competition in the United States","year":2020,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Novo Nordisk Fonden","keywords":"Biosimilar; Statutory law; Competition (biology); Medicine; Generic drug; Business; Pharmacology; Drug; Internal medicine; Law; Political science","score_opus":0.40271137957245057,"score_gpt":0.4240386167015656,"score_spread":0.02132723712911505,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3038651714","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94120705,0.0007787431,0.00022539425,0.055346504,0.000867384,0.00022571834,0.00013414495,0.000022222626,0.0011928537],"genre_scores_gemma":[0.8154889,0.003560462,0.00008202631,0.18055524,0.00023064714,0.000009769814,0.000055628385,0.000014770822,0.0000026057385],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99815834,0.00018612287,0.0010509667,0.0002917514,0.000027748887,0.00028508174],"domain_scores_gemma":[0.9984891,0.00086347613,0.00034409433,0.00016458811,0.000025392257,0.00011337913],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00077820395,0.00014727173,0.00050741434,0.0001112062,0.00005409466,0.000019415613,0.0004888057,0.00012670158,0.00027934264],"category_scores_gemma":[0.000028137676,0.00014074187,0.00015262883,0.00041181047,0.00032045043,0.00005343423,0.000083248764,0.00049992424,0.00017966254],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007798483,0.005549202,0.7319812,0.0003534078,0.0041902564,0.000099116645,0.010524081,0.030823823,0.0011817612,0.09944703,0.1056435,0.0024080907],"study_design_scores_gemma":[0.0075814305,0.0007077862,0.031169273,0.0000069022653,0.00015971906,0.0000023846646,0.00022854091,0.2889323,0.00048611267,0.0051106396,0.6652296,0.00038530416],"about_ca_topic_score_codex":0.000030653737,"about_ca_topic_score_gemma":0.0000072255843,"teacher_disagreement_score":0.700812,"about_ca_system_score_codex":0.00003546677,"about_ca_system_score_gemma":0.000025656249,"threshold_uncertainty_score":0.5739287},"labels":[],"label_agreement":null},{"id":"W3044445445","doi":"10.1002/cpt.1990","title":"Physiologically‐Based Pharmacokinetic Modeling Characterizes the CYP3A‐Mediated Drug‐Drug Interaction Between Fluconazole and Sildenafil in Infants","year":2020,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo","funders":"National Institute of Child Health and Human Development; National Institute of General Medical Sciences; National Heart, Lung, and Blood Institute; U.S. Food and Drug Administration; National Institutes of Health; Eunice Kennedy Shriver National Institute of Child Health and Human Development; United Therapeutics Corporation","keywords":"Sildenafil; Fluconazole; Drug; Pharmacokinetics; Pharmacology; Drug interaction; Pharmacokinetic interaction; Medicine; Internal medicine; Antifungal","score_opus":0.22670036944470984,"score_gpt":0.46322307438537763,"score_spread":0.2365227049406678,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3044445445","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8537161,0.0014144612,0.0000822828,0.14318262,0.00061169674,0.00073567126,0.000024572313,0.00010438322,0.00012823298],"genre_scores_gemma":[0.798802,0.005884139,0.00008315922,0.19392538,0.0011761581,0.000048663802,0.00003538708,0.000029731049,0.000015357678],"study_design_codex":"bench_or_experimental","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99669737,0.0008882362,0.0010144728,0.00061524194,0.0002493213,0.0005353493],"domain_scores_gemma":[0.9950532,0.0039761537,0.00028172374,0.00017013548,0.0001206735,0.00039813964],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00088136,0.00035559403,0.0008226083,0.000055954908,0.00019250855,0.000034189732,0.0002943222,0.00018334236,0.00037685927],"category_scores_gemma":[0.00017699297,0.00023834918,0.00019175633,0.00033243658,0.00047278003,0.00016522608,0.00023490563,0.0019501621,0.00008650541],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.029892081,0.004159703,0.3985248,0.00068333786,0.006247823,0.00044489134,0.0039912863,0.0021915152,0.41970825,0.000011848237,0.014279135,0.119865336],"study_design_scores_gemma":[0.019220069,0.0010784769,0.15122819,0.000117780495,0.0040145065,0.000015584848,0.0005781538,0.6295787,0.007919422,0.00008789151,0.18536285,0.0007983591],"about_ca_topic_score_codex":0.000012298415,"about_ca_topic_score_gemma":0.000002061814,"teacher_disagreement_score":0.6273872,"about_ca_system_score_codex":0.00004224807,"about_ca_system_score_gemma":0.00008827584,"threshold_uncertainty_score":0.97195977},"labels":[],"label_agreement":null},{"id":"W3047711333","doi":"10.1002/cpt.2010","title":"Postmarket Safety Communication for Protection of Public Health: A Comparison of Regulatory Policy in Australia, Canada, the European Union, and the United States","year":2020,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmaceutical industry and healthcare","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"York University","funders":"National Health and Medical Research Council; Medical Research Council; Australian Government; Canadian Institutes of Health Research; Arnold Ventures; Harvard University","keywords":"European union; Public health; Environmental health; Public administration; Business; Political science; International trade; Medicine","score_opus":0.694770904423468,"score_gpt":0.5987181050380871,"score_spread":0.09605279938538092,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3047711333","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.473497,0.002214059,0.0002882661,0.5210485,0.00044390507,0.0021566772,0.00022901468,0.000029011486,0.00009358856],"genre_scores_gemma":[0.8960331,0.0030143647,0.00003988909,0.10042559,0.0002738408,0.0000599609,0.00008027144,0.000023645684,0.00004933451],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9765386,0.020737493,0.0017255518,0.00029937865,0.00017432806,0.00052464637],"domain_scores_gemma":[0.9928914,0.005214162,0.0008896976,0.00028618463,0.00031730402,0.00040130387],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.011335228,0.00023337106,0.0006864616,0.000089939174,0.00040749836,0.000009886741,0.0006866014,0.00034688975,0.0000760937],"category_scores_gemma":[0.00031881983,0.00016393939,0.00012280345,0.0006789377,0.002301732,0.000060067847,0.00019564196,0.002553723,0.0000015577102],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03731024,0.0071135554,0.26548934,0.003589174,0.00819012,0.000017465223,0.06818212,0.013482598,0.008638247,0.013948477,0.1421111,0.43192756],"study_design_scores_gemma":[0.0158391,0.0009769337,0.081211425,0.00005018286,0.00058279856,0.0000075874855,0.003285392,0.060128324,0.0017950342,0.0010441085,0.8347349,0.0003442026],"about_ca_topic_score_codex":0.020463679,"about_ca_topic_score_gemma":0.01078737,"teacher_disagreement_score":0.6926238,"about_ca_system_score_codex":0.00013956049,"about_ca_system_score_gemma":0.00086368463,"threshold_uncertainty_score":0.99974746},"labels":[],"label_agreement":null},{"id":"W3048301534","doi":"10.1002/cpt.2012","title":"Use of Real‐World Data to Emulate a Clinical Trial and Support Regulatory Decision Making: Assessing the Impact of Temporality, Comparator Choice, and Method of Adjustment","year":2020,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Statistical Methods in Clinical Trials","field":"Mathematics","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Liraglutide; Hazard ratio; Propensity score matching; Confidence interval; Clinical trial; Internal medicine; Comparator; Type 2 diabetes; Diabetes mellitus; Endocrinology","score_opus":0.9099604995971161,"score_gpt":0.7418507534591007,"score_spread":0.16810974613801544,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3048301534","genre_codex":"empirical","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96281075,0.00010729349,0.031642947,0.001740717,0.0011798914,0.0020189688,0.00043721034,0.000037186855,0.00002502468],"genre_scores_gemma":[0.43653655,0.0004916638,0.55720115,0.004970198,0.00072691555,0.000011146049,0.000004806698,0.000049674065,0.000007921848],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9848485,0.007960622,0.0054255105,0.00090078043,0.0005049775,0.00035963603],"domain_scores_gemma":[0.7726097,0.22257808,0.0027349533,0.0012612371,0.00036821133,0.00044784072],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.017937662,0.00036124772,0.0028218573,0.00009440839,0.000067413726,0.000032257012,0.0009479207,0.00034526087,0.0001114892],"category_scores_gemma":[0.02403508,0.00024002136,0.00044818953,0.00048756666,0.0018334559,0.00014351835,0.0014152864,0.0009077383,0.0000017659489],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.10427307,0.009771997,0.41191456,0.000845197,0.012445666,0.00003374195,0.00071595993,0.00017403692,0.007941008,0.0030193916,0.103655025,0.34521034],"study_design_scores_gemma":[0.054408483,0.013809921,0.8298587,0.0003498106,0.009307312,0.0000093191875,0.000088414505,0.031701215,0.00091801264,0.055238184,0.003492601,0.00081799313],"about_ca_topic_score_codex":0.000026398515,"about_ca_topic_score_gemma":0.000008505236,"teacher_disagreement_score":0.5262742,"about_ca_system_score_codex":0.000028294593,"about_ca_system_score_gemma":0.00035377257,"threshold_uncertainty_score":0.9841859},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"simulation_or_modeling","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"gpt","categories":[],"domain":null,"study_design":"design_other","genre":"methods","about_ca_system":false,"about_ca_topic":false,"confidence":"low"}],"label_agreement":"split"},{"id":"W3084337600","doi":"10.1002/cpt.2042","title":"Potential Cost Implications of Mandatory Non‐Medical Switching Policies for Biologics for Rheumatic Conditions and Inflammatory Bowel Disease in Canada","year":2020,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"St. Michael's Hospital; Institute for Clinical Evaluative Sciences; Women's College Hospital; University of Toronto","funders":"","keywords":"Biosimilar; Infliximab; Etanercept; Adalimumab; Medicine; Medical prescription; Market share; Business; Disease; Marketing; Pharmacology; Rheumatoid arthritis; Internal medicine","score_opus":0.0712620760253613,"score_gpt":0.40832476443640914,"score_spread":0.3370626884110478,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3084337600","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9221973,0.0013447049,0.01079217,0.061971582,0.0011001722,0.0015448406,0.0010065761,0.000026909322,0.00001576523],"genre_scores_gemma":[0.94536805,0.0008307777,0.0004222798,0.053041812,0.000098941666,0.00013853615,0.00007350862,0.000013618996,0.000012470263],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99827886,0.00027147363,0.0007911205,0.00029659836,0.00003439096,0.00032757103],"domain_scores_gemma":[0.997253,0.002158026,0.00020632337,0.00011970381,0.00009679555,0.00016612813],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00051717303,0.00015755944,0.00043613632,0.000039891274,0.00013492204,0.0000047266262,0.00026343085,0.00029770218,0.00012870607],"category_scores_gemma":[0.00021839418,0.00013140711,0.00013935808,0.00007424229,0.00058771635,0.000027310542,0.00009665367,0.0003952575,0.0000015860862],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0054816795,0.001794699,0.67902386,0.0011431545,0.0040404396,0.000021792668,0.00049568224,0.00018893472,0.20415632,0.0028015347,0.066716135,0.034135744],"study_design_scores_gemma":[0.015428269,0.0012740556,0.87861425,0.00010777089,0.0024827137,0.000014100246,0.0004902219,0.01973467,0.0066398196,0.004336976,0.07008709,0.0007900353],"about_ca_topic_score_codex":0.0008952727,"about_ca_topic_score_gemma":0.0035944434,"teacher_disagreement_score":0.1995904,"about_ca_system_score_codex":0.00004607224,"about_ca_system_score_gemma":0.0009800637,"threshold_uncertainty_score":0.5358626},"labels":[],"label_agreement":null},{"id":"W3092948288","doi":"10.1002/cpt.2082","title":"Inosine 5'‐Monophosphate to Raise Serum Uric Acid Level in Multiple System Atrophy (IMPROVE‐MSA study)","year":2020,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Parkinson's Disease Mechanisms and Treatments","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Tolerability; Placebo; Internal medicine; Medicine; Montreal Cognitive Assessment; Uric acid; Adverse effect; Atrophy; Hyperuricemia; Gastroenterology; Cognitive impairment; Pathology; Disease","score_opus":0.1794911471958729,"score_gpt":0.40261411148438553,"score_spread":0.22312296428851264,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3092948288","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9846856,0.0009828609,0.0003407274,0.009516662,0.001545181,0.0025401085,0.0001367443,0.00019817565,0.00005394308],"genre_scores_gemma":[0.93266714,0.00016919836,0.00067820953,0.06549515,0.00060364825,0.00020533236,0.000017606906,0.000069434325,0.00009426492],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9968395,0.0004007846,0.0009882698,0.0008795653,0.0002912548,0.0006005953],"domain_scores_gemma":[0.99818236,0.00026572213,0.00019739653,0.0003607656,0.00013429181,0.0008594761],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00038796532,0.0004104534,0.000971939,0.000116256335,0.000110403984,0.000019478191,0.00030295862,0.00024173177,0.00013174202],"category_scores_gemma":[0.000047808582,0.00035188376,0.0002364271,0.0005100388,0.000101428865,0.00006672453,0.00021497993,0.00061742205,0.0005369394],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017985448,0.01589269,0.81725055,0.00038377856,0.0051058526,0.0048723132,0.0015594914,0.00013497917,0.09307025,0.00001852769,0.004344458,0.039381668],"study_design_scores_gemma":[0.06769491,0.016500851,0.8057304,0.00011231741,0.0056013935,0.000023886088,0.0008320118,0.0097792605,0.028547933,0.000025457857,0.06421734,0.00093422265],"about_ca_topic_score_codex":0.000014071579,"about_ca_topic_score_gemma":0.000007033285,"teacher_disagreement_score":0.06452231,"about_ca_system_score_codex":0.00018642892,"about_ca_system_score_gemma":0.00021468742,"threshold_uncertainty_score":0.9998933},"labels":[],"label_agreement":null},{"id":"W3111115779","doi":"10.1002/cpt.2135","title":"Transferability of Ancestry‐Specific and Cross‐Ancestry CYP2A6 Activity Genetic Risk Scores in African and European Populations","year":2020,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Smoking Behavior and Cessation","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"National Institute of General Medical Sciences; National Institute on Drug Abuse; Campbell Family Mental Health Research Institute; University of Pennsylvania; Centre for Addiction and Mental Health; RIKEN; Canadian Institutes of Health Research; Centre for Addiction and Mental Health Foundation; University of Toronto; National Cancer Institute; National Institutes of Health; University of Southern California","keywords":"Cotinine; CYP2A6; Pharmacogenetics; Medicine; Nicotine; Biology; Demography; Genetics; Internal medicine; Genotype","score_opus":0.32005411119911287,"score_gpt":0.4748715624802107,"score_spread":0.1548174512810978,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3111115779","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962171,0.0005174851,0.0002338315,0.0023685526,0.00024369344,0.0002959908,0.00002523816,0.000030070385,0.000068063826],"genre_scores_gemma":[0.9955467,0.0022800842,0.00022573434,0.0017185354,0.00019916733,0.0000062219165,0.0000045242023,0.000016001104,0.0000030300039],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998411,0.0004870828,0.00048659305,0.00034986335,0.000110786874,0.00015466825],"domain_scores_gemma":[0.9992645,0.00027520198,0.00013288711,0.00012936725,0.000054298478,0.0001437588],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004257303,0.00012538584,0.000354014,0.000032814336,0.00006404166,0.000010780753,0.000074132404,0.00012211289,0.000044905657],"category_scores_gemma":[0.000027065415,0.00011519657,0.00006376908,0.00016580205,0.0007218425,0.000051932457,0.00002928275,0.00056781195,7.479895e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005890101,0.00032676442,0.96200085,0.000038857943,0.000044526,0.000011665299,0.00041559475,0.00002840139,0.008944034,0.0000025476627,0.000022256678,0.027575523],"study_design_scores_gemma":[0.0026228651,0.00044038662,0.99407655,0.000012776291,0.0003883618,0.0000052644486,0.000042651554,0.00045141554,0.0014163917,0.00007844807,0.00037215467,0.0000927147],"about_ca_topic_score_codex":0.000013689546,"about_ca_topic_score_gemma":0.0000053458452,"teacher_disagreement_score":0.032075748,"about_ca_system_score_codex":0.00001730267,"about_ca_system_score_gemma":0.000044099736,"threshold_uncertainty_score":0.46975797},"labels":[],"label_agreement":null},{"id":"W3111851331","doi":"10.1002/cpt.2143","title":"Individual Atrasentan Exposure is Associated With Long‐term Kidney and Heart Failure Outcomes in Patients With Type 2 Diabetes and Chronic Kidney Disease","year":2020,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Blood Pressure and Hypertension Studies","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"NOSM University; Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"Novo Nordisk Fonden; Nederlandse Organisatie voor Wetenschappelijk Onderzoek; AbbVie","keywords":"Medicine; Kidney disease; Type 2 diabetes; Heart failure; Diabetes mellitus; Term (time); Internal medicine; Kidney; Disease; Renal function; Cardiology; Intensive care medicine; Endocrinology","score_opus":0.05209039457128074,"score_gpt":0.34278787985949494,"score_spread":0.2906974852882142,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3111851331","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9386202,0.0027814487,4.6912265e-7,0.057775326,0.00014374657,0.00051740743,0.00011097138,0.000046282574,0.0000041661597],"genre_scores_gemma":[0.70961374,0.00028638635,0.00003639961,0.28982788,0.00011641295,0.000009081203,0.00007103424,0.000024144505,0.000014929815],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99847776,0.00018036197,0.00035858352,0.00043236781,0.00022872785,0.00032221785],"domain_scores_gemma":[0.9985145,0.0003223181,0.00011136735,0.0001299171,0.00014383826,0.0007780907],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001434234,0.00025422077,0.0008128936,0.000042987842,0.00008950682,0.000018569963,0.000076954755,0.0001692043,0.000096744676],"category_scores_gemma":[0.00006810085,0.00016780432,0.000056232962,0.00016255115,0.0004707813,0.00006586133,0.000105606385,0.0005470995,0.000004795133],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009951576,0.0006703381,0.96833444,0.000072535775,0.0033528036,0.00004602794,0.00027209223,1.6898122e-7,0.00013830428,2.4006695e-7,0.025787765,0.00033013837],"study_design_scores_gemma":[0.014268181,0.0032919443,0.97080636,0.00009963184,0.0060753725,0.0000011389128,0.000024061243,0.000020646828,0.00008623048,0.0000029925498,0.0051227002,0.00020075418],"about_ca_topic_score_codex":8.091929e-7,"about_ca_topic_score_gemma":0.000005343035,"teacher_disagreement_score":0.23205255,"about_ca_system_score_codex":0.000011705733,"about_ca_system_score_gemma":0.00023288166,"threshold_uncertainty_score":0.6842862},"labels":[],"label_agreement":null},{"id":"W3114326816","doi":"10.1002/cpt.2149","title":"Clinical Pharmacogenetics Implementation Consortium Guideline for <i>CYP2D6</i>, <i>OPRM1</i>, and <i>COMT</i> Genotypes and Select Opioid Therapy","year":2021,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":399,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mental Health Research Canada; University of Toronto","funders":"National Center for Advancing Translational Sciences; National Human Genome Research Institute; National Institute on Drug Abuse; National Health and Medical Research Council; National Institute of General Medical Sciences; Medical Research Council; National Institutes of Health","keywords":"Pharmacogenetics; CYP2D6; Guideline; Opioid; Medicine; Pharmacology; Genotype; Internal medicine; Biology; Genetics; Gene; Cytochrome P450","score_opus":0.24691550981230617,"score_gpt":0.5716757893882056,"score_spread":0.3247602795758995,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3114326816","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.89894444,0.06881089,0.001992554,0.014977757,0.011440655,0.0024609182,0.00072522025,0.0002393479,0.0004082122],"genre_scores_gemma":[0.27824736,0.30210835,0.010899897,0.4022786,0.0050991825,0.00033861716,0.00037121636,0.00021228146,0.00044451028],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.991086,0.0027899821,0.0030071686,0.001534876,0.00031311417,0.0012688788],"domain_scores_gemma":[0.9929993,0.0037811634,0.0007992917,0.00043058887,0.000992772,0.0009968415],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.004569361,0.0008017036,0.0013799701,0.00014128446,0.0006910145,0.00009414027,0.0005364245,0.0010121507,0.0011562366],"category_scores_gemma":[0.00008971478,0.00079360674,0.0005182908,0.00038139801,0.0014561405,0.00015691233,0.00042001443,0.0018479294,0.000039089064],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002780423,0.002200779,0.08549385,0.00011016892,0.0048968513,0.00010212188,0.0005170659,0.00008363484,0.26921377,0.00021133413,0.12420361,0.5101864],"study_design_scores_gemma":[0.017949741,0.00067026966,0.005000585,0.0000066271837,0.0030552542,0.00009454004,0.00014945977,0.0037134164,0.10823847,0.0009789019,0.85936666,0.0007760694],"about_ca_topic_score_codex":0.00000646132,"about_ca_topic_score_gemma":0.000014537488,"teacher_disagreement_score":0.73516303,"about_ca_system_score_codex":0.000042454838,"about_ca_system_score_gemma":0.0007246626,"threshold_uncertainty_score":0.9997568},"labels":[],"label_agreement":null},{"id":"W3125345026","doi":"10.1002/cpt.2173","title":"StellarPGx: A Nextflow Pipeline for Calling Star Alleles in Cytochrome P450 Genes","year":2021,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":66,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Manitoba","funders":"GlaxoSmithKline foundation; National Research Foundation","keywords":"Genotyping; Genetics; Computational biology; 1000 Genomes Project; Biology; Haplotype; Pharmacogenomics; Genome; Gene; Allele; Genotype; Single-nucleotide polymorphism","score_opus":0.342208073002502,"score_gpt":0.5455487412779744,"score_spread":0.20334066827547237,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3125345026","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9287555,0.04029784,0.0038188924,0.014610615,0.009039628,0.0019578596,0.0004321866,0.00025083462,0.0008366005],"genre_scores_gemma":[0.6694984,0.07677455,0.008193184,0.23452955,0.0071723037,0.0005783321,0.00034527094,0.0003004155,0.0026079798],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9926559,0.00221033,0.0020662816,0.0012508875,0.0003090659,0.0015075695],"domain_scores_gemma":[0.99410695,0.0036702272,0.00043588353,0.0004898608,0.0006252734,0.00067183294],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.002981636,0.0006909639,0.0013273782,0.00023363777,0.00037920705,0.00005243083,0.0008554095,0.0012061114,0.0019805597],"category_scores_gemma":[0.00011409721,0.0007127888,0.0006647115,0.0006122803,0.0006977146,0.00013782039,0.00034269888,0.0022445377,0.00016763496],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031896587,0.005078762,0.007376092,0.00020973143,0.0023711447,0.00070956646,0.0007080818,0.005443091,0.80774695,0.00030370592,0.024062224,0.142801],"study_design_scores_gemma":[0.012130268,0.00022351979,0.0019498322,0.000018459059,0.0017913952,0.00004794361,0.00015565348,0.061484337,0.09636354,0.0011608761,0.82389355,0.0007806113],"about_ca_topic_score_codex":0.000006883164,"about_ca_topic_score_gemma":0.000052018342,"teacher_disagreement_score":0.79983133,"about_ca_system_score_codex":0.00011903111,"about_ca_system_score_gemma":0.0007544252,"threshold_uncertainty_score":0.99953234},"labels":[],"label_agreement":null},{"id":"W3126174921","doi":"10.1002/cpt.2180","title":"Variation in Target Attainment of Beta‐Lactam Antibiotic Dosing Between International Pediatric Formularies","year":2021,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Antibiotics Pharmacokinetics and Efficacy","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"University College London; Medical Research Council; National Institute for Health and Care Research; King’s College London","keywords":"Dosing; Medicine; Meropenem; Piperacillin; Intensive care medicine; Antibiotics; Pharmacology; Antibiotic resistance; Biology; Microbiology","score_opus":0.16263676581859351,"score_gpt":0.49171027780818555,"score_spread":0.329073511989592,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3126174921","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0037947244,0.9893963,0.0005845242,0.0013255399,0.0033750106,0.0011922775,0.00009832525,0.000038189777,0.0001951541],"genre_scores_gemma":[0.007915698,0.9852379,0.0016635788,0.0019178655,0.0026480288,0.0000054695133,0.00043968702,0.00008666283,0.00008509718],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9954575,0.00057547004,0.0024628863,0.0006481963,0.00040115457,0.00045484162],"domain_scores_gemma":[0.9966569,0.0014983265,0.0010721263,0.00033222948,0.000251269,0.0001891647],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0012058046,0.00048344737,0.002882504,0.00040993057,0.000053743057,0.000024343779,0.00041264604,0.0008273097,0.0002513797],"category_scores_gemma":[0.000058830046,0.0004267156,0.00089695235,0.00054265634,0.00024539212,0.000055876528,0.0002708236,0.0015416202,0.00003081723],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032990455,0.006705346,0.08740414,0.018280216,0.014390102,0.00044379086,0.00034207656,0.000057952613,0.00017114916,0.00017572237,0.0027110109,0.8689886],"study_design_scores_gemma":[0.004003674,0.00049006124,0.013690335,0.002118295,0.025119511,0.000025856321,0.000012434378,0.00039958686,0.00008736491,0.000031814627,0.95348436,0.00053669576],"about_ca_topic_score_codex":0.0000026044863,"about_ca_topic_score_gemma":2.5105828e-7,"teacher_disagreement_score":0.95077336,"about_ca_system_score_codex":0.00019064064,"about_ca_system_score_gemma":0.0007732502,"threshold_uncertainty_score":0.99981844},"labels":[],"label_agreement":null},{"id":"W3126879320","doi":"10.1002/cpt.2198","title":"Model‐Informed Drug Development for Anti‐Infectives: State of the Art and Future","year":2021,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Antibiotics Pharmacokinetics and Efficacy","field":"Medicine","cited_by":75,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Drug development; Medicine; Drug; Resistance (ecology); Drug resistance; Intensive care medicine; Pharmacology; Biology","score_opus":0.15549309197528785,"score_gpt":0.4835599761925407,"score_spread":0.32806688421725283,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3126879320","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0015240696,0.9912607,0.00029791903,0.0018766287,0.0022610875,0.0024764033,0.00008376083,0.000030904102,0.00018849869],"genre_scores_gemma":[0.00013035026,0.9869754,0.0018889165,0.008887625,0.00079413067,0.000039158967,0.00009071719,0.000083132676,0.0011106153],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99705976,0.0002523612,0.0015440693,0.00051254523,0.00021839171,0.00041289],"domain_scores_gemma":[0.9971976,0.0011931916,0.00072312023,0.00035980053,0.00032498053,0.00020125603],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007031457,0.00048023983,0.0023899397,0.00008746803,0.0001318659,0.0000146914335,0.00029970094,0.0004009897,0.00004294798],"category_scores_gemma":[0.00002919381,0.00030046,0.00089815736,0.00023426059,0.0005327823,0.000024939498,0.00025618996,0.0011039386,0.0000090964595],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010447718,0.00075869507,0.000110581146,0.0082698725,0.0042633293,0.000007820033,0.0002249617,0.000015395235,0.0000246667,0.000023465154,0.017397275,0.9687995],"study_design_scores_gemma":[0.0020810287,0.00012507057,0.00016426289,0.0014930872,0.008878814,0.000024872448,0.000013944328,0.00087262277,0.00013771367,0.000018556657,0.9859077,0.00028233646],"about_ca_topic_score_codex":1.2707143e-7,"about_ca_topic_score_gemma":7.618686e-7,"teacher_disagreement_score":0.9685171,"about_ca_system_score_codex":0.00007112538,"about_ca_system_score_gemma":0.0021524404,"threshold_uncertainty_score":0.99994475},"labels":[],"label_agreement":null},{"id":"W3129971886","doi":"10.1002/cpt.2213","title":"Defining Clinically Relevant Target Populations Using Real‐World Data to Guide the Design of Representative Antidiabetic Drug Trials","year":2021,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"Canadian Institutes of Health Research","keywords":"Liraglutide; Medicine; Clinical trial; Type 2 diabetes; Population; Representativeness heuristic; Diabetes mellitus; Disease; Internal medicine; Endocrinology; Environmental health; Psychology","score_opus":0.5210139882154484,"score_gpt":0.5680565267547004,"score_spread":0.047042538539252,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3129971886","genre_codex":"empirical","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.858203,0.004569797,0.027461907,0.092655234,0.0073761516,0.0068428745,0.00034213482,0.00027099793,0.002277936],"genre_scores_gemma":[0.36362657,0.007520154,0.5039658,0.11696974,0.0014391178,0.00011357024,0.0005288117,0.00015240154,0.0056838198],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99290943,0.003232857,0.002424643,0.00071594975,0.0003075245,0.0004096011],"domain_scores_gemma":[0.98773664,0.009592841,0.0008355418,0.0012741709,0.00035613732,0.00020466106],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0077504846,0.00023097926,0.0013195123,0.00010090564,0.00016296621,0.00003093975,0.0005061489,0.00009131834,0.0002531514],"category_scores_gemma":[0.0013672126,0.00017245793,0.0003073523,0.00062504405,0.00043190044,0.00008030335,0.0006252681,0.00042942818,0.000040868068],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035009596,0.006104519,0.56927264,0.00013610086,0.016800933,0.00042960173,0.0011593057,0.0043442473,0.023007968,0.0005795418,0.33825722,0.036406986],"study_design_scores_gemma":[0.040770836,0.0059731794,0.32449058,0.0011063804,0.09909547,0.000033790355,0.0034038026,0.10403746,0.033450197,0.00882471,0.37670228,0.0021113087],"about_ca_topic_score_codex":0.000069239526,"about_ca_topic_score_gemma":0.000047119553,"teacher_disagreement_score":0.4945764,"about_ca_system_score_codex":0.000067535024,"about_ca_system_score_gemma":0.00046843023,"threshold_uncertainty_score":0.70326304},"labels":[],"label_agreement":null},{"id":"W3134241111","doi":"10.1002/cpt.2223","title":"Systematic Review and Patient‐Level Meta‐Analysis of SARS‐CoV‐2 Viral Dynamics to Model Response to Antiviral Therapies","year":2021,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"SARS-CoV-2 and COVID-19 Research","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"Medical Research Council; University College London Hospitals NHS Foundation Trust; Rosetrees Trust; Action Medical Research; National Institute for Health and Care Research; NIHR Biomedical Research Centre, Royal Marsden NHS Foundation Trust/Institute of Cancer Research; University College London; Great Ormond Street Hospital for Children; Wellcome Trust","keywords":"Viral load; Medicine; Proportional hazards model; Hazard ratio; Meta-analysis; Ribavirin; Internal medicine; Respiratory system; Confidence interval; Immunology; Virus","score_opus":0.3737928707146751,"score_gpt":0.5548009881660153,"score_spread":0.1810081174513402,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3134241111","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0012385995,0.9894439,0.00047622857,0.0029804893,0.00023126259,0.0051317443,0.0004217069,0.000048362315,0.000027713884],"genre_scores_gemma":[0.000112414345,0.6846304,0.00051292113,0.3140764,0.00004232199,0.00044954204,0.000026452231,0.00008511722,0.00006443902],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.98928976,0.0048552505,0.003397524,0.0011346271,0.00066657463,0.0006562423],"domain_scores_gemma":[0.9921726,0.004874735,0.00088952965,0.0012084974,0.0006864289,0.00016821091],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0036508287,0.0008335235,0.01388272,0.00091151247,0.00009032181,0.00003571868,0.0007023809,0.00071017595,0.000023349543],"category_scores_gemma":[0.00050239824,0.00058625697,0.004400107,0.0022013339,0.0004051029,0.000055754183,0.0005431216,0.0012755964,0.00004793623],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010893393,0.0012675084,0.000024921952,0.35861084,0.6063003,0.00017291737,0.0003392695,0.0000025389231,0.00046268333,0.000030049507,0.00096993067,0.03072973],"study_design_scores_gemma":[0.00057847286,0.0009842822,0.0000035122528,0.01866747,0.81893295,0.000022272054,0.000034093344,0.0010501968,0.000077329896,0.000009939748,0.159139,0.0005004936],"about_ca_topic_score_codex":0.000008024786,"about_ca_topic_score_gemma":0.000017172684,"teacher_disagreement_score":0.33994335,"about_ca_system_score_codex":0.00021959105,"about_ca_system_score_gemma":0.0014009213,"threshold_uncertainty_score":0.9996589},"labels":[],"label_agreement":null},{"id":"W3155322721","doi":"10.1002/cpt.2269","title":"Rational Clinical Dose Selection of Adeno‐Associated Virus‐Mediated Gene Therapy Based on Allometric Principles","year":2021,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Adeno-associated virus; Genetic enhancement; In vivo; Computational biology; Gene transfer; Vector (molecular biology); Biology; Gene; Allometry; Medicine; Bioinformatics; Recombinant DNA; Genetics","score_opus":0.15284503367886842,"score_gpt":0.4556251334500514,"score_spread":0.302780099771183,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3155322721","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99416584,0.0016941209,0.00029507224,0.002042076,0.0010346678,0.0004845172,0.000105877596,0.0000461585,0.00013169361],"genre_scores_gemma":[0.9442552,0.012291521,0.00045397892,0.040661965,0.0010655418,0.000059687125,0.0007143233,0.00008209314,0.00041570293],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9940744,0.0027326585,0.0013343123,0.0008403879,0.00049459806,0.0005236434],"domain_scores_gemma":[0.99657136,0.0013878411,0.00047922516,0.00047654047,0.000839584,0.00024545353],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0025130145,0.00032775663,0.00060356804,0.00018507245,0.00015042812,0.000021561038,0.00047177324,0.00082317705,0.0007271877],"category_scores_gemma":[0.0004621703,0.00031341452,0.0005292606,0.0008738622,0.0005423678,0.0000068750887,0.00011754512,0.0008251147,0.000051405023],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01117033,0.0049831276,0.034033574,0.000008281218,0.0018082556,0.000018607614,0.000012638311,0.0011216792,0.9367508,0.000003350603,0.00342355,0.0066657797],"study_design_scores_gemma":[0.011832558,0.013360425,0.059910443,0.000010958278,0.00023929302,0.0000053453036,0.000010200035,0.0090551255,0.85496736,0.00002869022,0.050132185,0.00044740166],"about_ca_topic_score_codex":0.0000021958513,"about_ca_topic_score_gemma":0.00003697355,"teacher_disagreement_score":0.08178345,"about_ca_system_score_codex":0.00006029811,"about_ca_system_score_gemma":0.0013536933,"threshold_uncertainty_score":0.9999318},"labels":[],"label_agreement":null},{"id":"W3164768471","doi":"10.1002/cpt.2311","title":"Interaction Between SNP Genotype and Efficacy of Anastrozole and Exemestane in Early‐Stage Breast Cancer","year":2021,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Cancer Society","funders":"National Institute of General Medical Sciences; National Cancer Institute; Canadian Cancer Society","keywords":"Exemestane; Anastrozole; Oncology; Breast cancer; Single-nucleotide polymorphism; Medicine; Aromatase inhibitor; Internal medicine; Aromatase; SNP; Tamoxifen; Genotype; Cancer; Bioinformatics; Biology; Genetics; Gene","score_opus":0.04359414938016718,"score_gpt":0.4054828458177262,"score_spread":0.361888696437559,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3164768471","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99495935,0.003656546,0.000030215975,0.00087108096,0.0002860106,0.00012626842,0.000026276186,0.0000056925273,0.00003855141],"genre_scores_gemma":[0.9885395,0.009488539,0.000102582875,0.0015093002,0.00022793085,0.0000053218364,0.000026662714,0.000015751784,0.00008436999],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9989397,0.00022850305,0.00032048457,0.00028762722,0.000049215174,0.00017447647],"domain_scores_gemma":[0.9995038,0.00012805212,0.0001046126,0.000113701586,0.00006367615,0.00008615377],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018551505,0.00011833714,0.00024062014,0.000028860542,0.00003066209,0.0000068943264,0.000065862856,0.00026376836,0.000022715087],"category_scores_gemma":[0.000007981283,0.00011059592,0.000056890978,0.00008114753,0.00022921813,0.0000047750823,0.000104056126,0.00031443723,0.0000014070275],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00065587484,0.0002616724,0.4368148,0.00002550578,0.00056520675,0.000024666946,0.000072079034,0.000024353978,0.54150754,0.0000037051645,0.00017160473,0.019872997],"study_design_scores_gemma":[0.003966578,0.00057607394,0.82906646,0.000026196152,0.0004222119,0.000031746993,0.000050965686,0.00014644585,0.15788789,0.000011030247,0.0076238182,0.00019058168],"about_ca_topic_score_codex":0.000016266418,"about_ca_topic_score_gemma":0.000008195917,"teacher_disagreement_score":0.39225164,"about_ca_system_score_codex":0.000008779686,"about_ca_system_score_gemma":0.000074373034,"threshold_uncertainty_score":0.45099708},"labels":[],"label_agreement":null},{"id":"W3164819010","doi":"10.1002/cpt.2307","title":"Trends in Postpartum Opioid Prescribing: A Time Series Analysis","year":2021,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Prenatal Substance Exposure Effects","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"St. Michael's Hospital; Health Sciences Centre; Sunnybrook Hospital; University of Toronto; Institute for Clinical Evaluative Sciences; Sunnybrook Health Science Centre","funders":"Canadian Institutes of Health Research","keywords":"Codeine; Medicine; Hydromorphone; Medical prescription; Oxycodone; Opioid; Breastfeeding; Hydrocodone; Interrupted Time Series Analysis; Morphine; Postpartum period; Obstetrics; Anesthesia; Pregnancy; Pediatrics; Internal medicine; Pharmacology","score_opus":0.056725964097367666,"score_gpt":0.3995204168444509,"score_spread":0.3427944527470832,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3164819010","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97614586,0.0035052598,0.0000935998,0.017063327,0.0012287836,0.00026258573,0.000023065364,0.000154209,0.0015232941],"genre_scores_gemma":[0.9517219,0.0010298177,0.000943016,0.04050499,0.0005881348,0.000036497528,0.00019606708,0.000043357006,0.0049362066],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99730897,0.0006439445,0.00076297106,0.0005808167,0.00022648428,0.00047679956],"domain_scores_gemma":[0.99837,0.0006641418,0.00014093496,0.0004306759,0.00015876992,0.00023547656],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00062408653,0.00024201607,0.00093143043,0.000296468,0.000049818213,0.000016973345,0.00018531203,0.0003254377,0.0018654127],"category_scores_gemma":[0.00006295729,0.00022546753,0.00050932204,0.0016965935,0.00030308953,0.000111566515,0.00012478791,0.00080519187,0.00013752507],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005106955,0.0043758648,0.69864124,0.00009887488,0.015492883,0.00423837,0.00086100475,0.00012017308,0.20909327,0.000042674314,0.027306005,0.034622654],"study_design_scores_gemma":[0.009405347,0.0014782152,0.823337,0.00006849567,0.014296544,0.00013830786,0.000070229784,0.005366959,0.06485447,0.00017928806,0.08019061,0.0006145402],"about_ca_topic_score_codex":0.0000026853647,"about_ca_topic_score_gemma":0.000027617789,"teacher_disagreement_score":0.1442388,"about_ca_system_score_codex":0.00008787945,"about_ca_system_score_gemma":0.00019659406,"threshold_uncertainty_score":0.99904704},"labels":[],"label_agreement":null},{"id":"W3168682140","doi":"10.1002/cpt.2339","title":"Pharmacogenetics‐Guided Advances in Antipsychotic Treatment","year":2021,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"","keywords":"Pharmacogenetics; Antipsychotic; Tardive dyskinesia; Medicine; Clozapine; Adverse effect; Tolerability; CYP2D6; Dosing; Pharmacology; Schizophrenia (object-oriented programming); Psychiatry; Genotype; Internal medicine; Genetics; Gene; Biology","score_opus":0.3489785414320632,"score_gpt":0.5963113076902017,"score_spread":0.2473327662581385,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3168682140","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00060153054,0.99294513,0.0000066231264,0.0011866182,0.0023859264,0.0024754873,0.00005104957,0.00007438032,0.0002732576],"genre_scores_gemma":[0.000043229546,0.9912563,0.0008073858,0.005095153,0.0013408854,0.00048067214,0.0002401131,0.000125637,0.0006106337],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9944202,0.0014147199,0.0018421235,0.0011221342,0.00034289673,0.0008579282],"domain_scores_gemma":[0.99664074,0.0016423528,0.00038458477,0.0006212329,0.00015100584,0.0005600725],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004935538,0.00080726796,0.0040389434,0.00033651243,0.00007545425,0.000024678528,0.0003296509,0.00069476216,0.0009383865],"category_scores_gemma":[0.000024684643,0.0005761502,0.0016098501,0.00066288013,0.00041605585,0.000050302468,0.00010425287,0.0013047017,0.000389995],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010274464,0.0040103323,0.0007681014,0.0016096226,0.0043277233,0.0022874589,0.000013434136,0.0000011622304,0.0000032095238,0.0000066225325,0.0015873358,0.98435754],"study_design_scores_gemma":[0.011327721,0.0015356776,0.00016747758,0.0021245608,0.014021717,0.00031501884,0.0000064200085,0.00002948814,0.000027150361,0.000030747757,0.97002727,0.00038672987],"about_ca_topic_score_codex":0.0000030237097,"about_ca_topic_score_gemma":0.0000143144025,"teacher_disagreement_score":0.9839708,"about_ca_system_score_codex":0.00054299226,"about_ca_system_score_gemma":0.002307968,"threshold_uncertainty_score":0.9999749},"labels":[],"label_agreement":null},{"id":"W3174118295","doi":"10.1002/cpt.2345","title":"The Role of Pharmacogenetics in Smoking","year":2021,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Smoking Behavior and Cessation","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"Canadian Institutes of Health Research","keywords":"Genome-wide association study; Nicotine; Varenicline; Candidate gene; Smoking cessation; CYP2A6; Nicotinic agonist; Heritability; Twin study; Pharmacogenetics; Genetic association; Nicotine replacement therapy; Single-nucleotide polymorphism; Medicine; Genetics; Bioinformatics; Biology; Gene; Genotype; Psychiatry; Receptor","score_opus":0.20673550538778504,"score_gpt":0.5280580195504998,"score_spread":0.32132251416271473,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3174118295","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.002381408,0.99399453,0.00000357635,0.00024294753,0.0023624997,0.00070665276,0.000012567841,0.000025041814,0.00027075113],"genre_scores_gemma":[0.001390125,0.9952306,0.000023074197,0.0023711196,0.0006784789,0.000077352095,0.00005625934,0.00006550921,0.00010746402],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9963817,0.0009280148,0.001654563,0.00040051,0.0002813856,0.0003538193],"domain_scores_gemma":[0.99675614,0.001961292,0.00061578344,0.00039227313,0.00017109243,0.00010341933],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012202952,0.0003213605,0.0018182247,0.00011241388,0.000077427074,0.000013326553,0.00034792532,0.00071247586,0.00017858444],"category_scores_gemma":[0.00003297878,0.00022158062,0.00081124814,0.00043929744,0.00041081413,0.000016238635,0.00012379578,0.0017087256,0.0000049970395],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003579188,0.0005990492,0.008236375,0.0006294834,0.0011066723,0.00004245793,0.00003472441,5.567186e-7,0.000024098803,0.000010082188,0.00039308617,0.9888876],"study_design_scores_gemma":[0.0010612069,0.00014020994,0.0007258965,0.0015011715,0.011864856,0.000041804822,0.00004336043,0.000018259014,0.0001564416,0.000024488678,0.9842478,0.0001745165],"about_ca_topic_score_codex":0.0000018488694,"about_ca_topic_score_gemma":7.8487545e-7,"teacher_disagreement_score":0.9887131,"about_ca_system_score_codex":0.00011381256,"about_ca_system_score_gemma":0.0007368128,"threshold_uncertainty_score":0.90357953},"labels":[],"label_agreement":null},{"id":"W3181496761","doi":"10.1002/cpt.2355","title":"Adverse Cardiovascular Outcomes and Antihypertensive Treatment: A Genome‐Wide Interaction Meta‐Analysis in the International Consortium for Antihypertensive Pharmacogenomics Studies","year":2021,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Hormonal Regulation and Hypertension","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Center for Advancing Translational Sciences; National Center for Research Resources; National Institute of Neurological Disorders and Stroke; Barts Charity; National Institute of General Medical Sciences; National Institute of Diabetes and Digestive and Kidney Diseases; National Heart, Lung, and Blood Institute; National Institute for Health and Care Research; National Institutes of Health","keywords":"Medicine; Pharmacogenomics; Antihypertensive drug; Internal medicine; Thiazide; Pharmacogenetics; Genome-wide association study; Blood pressure; Single-nucleotide polymorphism; Odds ratio; Pharmacology; Cardiology; Bioinformatics; Genotype; Genetics; Biology","score_opus":0.49062669163725126,"score_gpt":0.531260397962451,"score_spread":0.04063370632519969,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3181496761","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0026785065,0.9864859,0.00005087761,0.007064423,0.0012451536,0.002305156,0.00011861216,0.00002954139,0.00002185907],"genre_scores_gemma":[0.0013793112,0.9484804,0.00023219298,0.048533652,0.00041134516,0.00035364882,0.00036953637,0.00005870948,0.00018118],"study_design_codex":"meta_analysis","study_design_gemma":"not_applicable","domain_scores_codex":[0.9957701,0.0010727615,0.0015409852,0.0009143851,0.0003369137,0.00036483657],"domain_scores_gemma":[0.9927384,0.0052151335,0.0005411866,0.0004896243,0.0008751273,0.00014051411],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0012105181,0.0006630285,0.0073438734,0.0004777895,0.00015714469,0.000030304325,0.00025610064,0.00044151826,0.000067775116],"category_scores_gemma":[0.00017674285,0.00037892547,0.0072153346,0.0004822337,0.00043005127,0.000088357054,0.0001218724,0.0006581197,0.00001311716],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026156838,0.00071161013,0.00044931236,0.0004461608,0.9031873,0.0007275058,0.0002586169,0.000038425515,0.00001856125,0.000007522719,0.00042259236,0.093470864],"study_design_scores_gemma":[0.001946186,0.00015395923,0.00033000179,0.00005235263,0.45789656,0.00019225926,0.0003517263,0.0002220077,0.0000030868039,0.0000030453893,0.5386639,0.00018487033],"about_ca_topic_score_codex":0.000008395285,"about_ca_topic_score_gemma":0.00001180797,"teacher_disagreement_score":0.5382414,"about_ca_system_score_codex":0.00024882567,"about_ca_system_score_gemma":0.0003693174,"threshold_uncertainty_score":0.99986625},"labels":[],"label_agreement":null},{"id":"W3201928742","doi":"10.1002/cpt.2430","title":"Incretin‐Based Drugs and Risk of Intestinal Obstruction Among Patients With Type 2 Diabetes","year":2021,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":61,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Hazard ratio; Internal medicine; Incretin; Gastroenterology; Type 2 diabetes; Confidence interval; Adverse effect; Diabetes mellitus; Proportional hazards model; Exenatide; Vildagliptin; Glucagon-like peptide-1; Endocrinology","score_opus":0.02719847512076245,"score_gpt":0.3351393835277968,"score_spread":0.30794090840703436,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3201928742","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981135,0.00027115492,0.00001714474,0.00055282604,0.00045073612,0.0002747091,0.0000063429793,0.000032964297,0.00028062932],"genre_scores_gemma":[0.99368244,0.00038799393,0.001672926,0.0038967363,0.00009169105,0.0000098660785,0.00007428457,0.000018167108,0.00016591519],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989223,0.00018749683,0.00032003352,0.00024142202,0.00015368544,0.00017509761],"domain_scores_gemma":[0.9987073,0.00047972126,0.00019122897,0.00014558567,0.00037974268,0.00009641786],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023833658,0.00012910142,0.00033195718,0.000042890413,0.00004255915,0.0000064211763,0.000046627116,0.00008761956,0.00013077744],"category_scores_gemma":[0.000041086143,0.00009796809,0.00006433922,0.00015716297,0.00041463034,0.0000350388,0.000051776235,0.00024326895,0.0000054854145],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004212402,0.00074215,0.97647816,0.00004475856,0.0013161598,0.0000065952736,0.000032853266,0.0000048056127,0.0003192352,0.0000029043879,0.00056406535,0.020067092],"study_design_scores_gemma":[0.006392048,0.0018001517,0.9778698,0.000047357196,0.0047622514,3.8970717e-7,0.000035720626,0.0006930068,0.005140954,0.000040554987,0.0031167197,0.000101039914],"about_ca_topic_score_codex":0.0000022381773,"about_ca_topic_score_gemma":0.0000015044401,"teacher_disagreement_score":0.019966053,"about_ca_system_score_codex":0.000021271375,"about_ca_system_score_gemma":0.000063246545,"threshold_uncertainty_score":0.39950228},"labels":[],"label_agreement":null},{"id":"W3202017675","doi":"10.1002/cpt.2431","title":"Pharmacokinetics, Pharmacodynamics, and Therapeutic Drug Monitoring of Valganciclovir and Ganciclovir in Transplantation","year":2021,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Cytomegalovirus and herpesvirus research","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Valganciclovir; Ganciclovir; Pharmacokinetics; Medicine; Pharmacodynamics; Therapeutic drug monitoring; Transplantation; Pharmacology; Internal medicine; Intensive care medicine; Human cytomegalovirus; Immunology","score_opus":0.15462390531955592,"score_gpt":0.4995614486638928,"score_spread":0.3449375433443369,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3202017675","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.037574824,0.95920974,0.000017889159,0.0004787485,0.0010851282,0.0014465532,0.00008648686,0.00004221396,0.000058446672],"genre_scores_gemma":[0.005817305,0.9907054,0.000283769,0.0020043731,0.00073667703,0.00008316987,0.00005848245,0.00013370514,0.00017716568],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99495775,0.001101327,0.0019827788,0.00093272293,0.0003915187,0.000633937],"domain_scores_gemma":[0.9970131,0.001584879,0.0004986016,0.0003249356,0.00021279868,0.00036571547],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0014385278,0.0006465364,0.0032292625,0.0004638287,0.000080789156,0.000030645024,0.0002646305,0.00064952864,0.00014100697],"category_scores_gemma":[0.000019270688,0.00057227415,0.0005207498,0.0005863081,0.0008133643,0.00006497138,0.00015243246,0.002379716,0.000011073034],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003974419,0.00090554403,0.0074241385,0.014874946,0.002380338,0.0004289652,0.00033964685,0.0000018471404,0.0009047239,0.000010619293,0.0002500828,0.9720817],"study_design_scores_gemma":[0.009192929,0.0004927881,0.0047045154,0.0064913733,0.01890544,0.00040120346,0.00010618497,0.0006686912,0.00073891296,0.000032193137,0.95738286,0.0008828895],"about_ca_topic_score_codex":0.000020351643,"about_ca_topic_score_gemma":0.0000057936913,"teacher_disagreement_score":0.9711988,"about_ca_system_score_codex":0.00013702275,"about_ca_system_score_gemma":0.0006915226,"threshold_uncertainty_score":0.99992186},"labels":[],"label_agreement":null},{"id":"W3206617408","doi":"10.1002/cpt.2452","title":"Roadmap to 2030 for Drug Evaluation in Older Adults","year":2021,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":66,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Aging","funders":"National Institutes of Health; Medical Research Council; National Institute for Health and Care Research; U.S. Department of Health and Human Services","keywords":"Drug; Medicine; Gerontology; Drug development; Intensive care medicine; Pharmacology","score_opus":0.5514141914017356,"score_gpt":0.5828578909313099,"score_spread":0.031443699529574265,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3206617408","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7343826,0.0044857487,0.0027127613,0.24937508,0.0054832217,0.002719175,0.00016340986,0.000048203994,0.0006297796],"genre_scores_gemma":[0.45454705,0.00057828805,0.0044751693,0.53680795,0.0015389718,0.0009085962,0.0000989708,0.00006011123,0.0009848912],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9928834,0.0011877517,0.004464139,0.00085379987,0.00010048253,0.00051046564],"domain_scores_gemma":[0.99437255,0.0036530057,0.0010092785,0.00041583664,0.00030996162,0.00023938945],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.023343896,0.00020113365,0.0010155732,0.0002034206,0.00011559468,0.000035183308,0.00030818838,0.00026968823,0.0013589509],"category_scores_gemma":[0.0014699119,0.00026545185,0.00023026697,0.00028773703,0.000081656115,0.00017224422,0.00007593447,0.00034632746,0.0013571156],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008492006,0.003814406,0.1850327,0.0005646652,0.0010735079,0.000011155312,0.009747867,0.0021328046,0.00011258905,0.004573537,0.77484465,0.017242951],"study_design_scores_gemma":[0.018097382,0.00036166617,0.20975666,0.00015783595,0.00023171709,0.0000058632195,0.0017860691,0.07736592,0.00026785227,0.013523937,0.6774649,0.0009802184],"about_ca_topic_score_codex":0.000039093615,"about_ca_topic_score_gemma":0.0001667961,"teacher_disagreement_score":0.28743288,"about_ca_system_score_codex":0.00043622244,"about_ca_system_score_gemma":0.00045083623,"threshold_uncertainty_score":0.9999798},"labels":[],"label_agreement":null},{"id":"W3207687648","doi":"10.1002/cpt.2453","title":"The Friends of Cancer Research Real‐World Data Collaboration Pilot 2.0: Methodological Recommendations from Oncology Case Studies","year":2021,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":56,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Tellabs (Canada)","funders":"","keywords":"Real world data; Clinical trial; Medicine; Consistency (knowledge bases); Identification (biology); Oncology; Clinical Oncology; Lung cancer; MEDLINE; Internal medicine; Medical physics; Cancer; Family medicine; Data science; Computer science","score_opus":0.6741482432695717,"score_gpt":0.6587737536001147,"score_spread":0.015374489669456981,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3207687648","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9149048,0.022325348,0.00029233715,0.055632908,0.0048202476,0.0004006956,0.0012052451,0.000015100049,0.00040334242],"genre_scores_gemma":[0.5580193,0.4102056,0.008654424,0.018236808,0.0031656101,0.00016563,0.0008528093,0.000046485555,0.00065332634],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9948738,0.003189603,0.00080145395,0.0006461506,0.00014553705,0.00034345957],"domain_scores_gemma":[0.9882418,0.009284328,0.0003176626,0.0008600176,0.0011880982,0.00010809677],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0035182028,0.00015517694,0.00042901305,0.00004026166,0.0004133284,0.000028823906,0.000577848,0.00018203647,0.00008015723],"category_scores_gemma":[0.0007408002,0.000121651785,0.00008101699,0.00042902213,0.0013825633,0.000006255832,0.0010652299,0.00053452165,0.000005400264],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003807121,0.0024066227,0.012980528,0.000029898732,0.0088433735,0.00059728697,0.00049723726,0.00035311465,0.36210582,0.00085751386,0.48458844,0.12293304],"study_design_scores_gemma":[0.0016379221,0.0014025278,0.0007883011,0.00000888498,0.0008400931,0.00002429325,0.0018280102,0.00041568145,0.048087694,0.0011463057,0.9436282,0.00019209608],"about_ca_topic_score_codex":0.00024094031,"about_ca_topic_score_gemma":0.013935746,"teacher_disagreement_score":0.45903975,"about_ca_system_score_codex":0.0000838962,"about_ca_system_score_gemma":0.0010990843,"threshold_uncertainty_score":0.7776473},"labels":[],"label_agreement":null},{"id":"W3217362361","doi":"10.1002/cpt.2499","title":"Features of Inflammatory Heart Reactions Following mRNA COVID‐19 Vaccination at a Global Level","year":2021,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Viral Infections and Immunology Research","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"Genome Canada; Canadian Institutes of Health Research; University of Ottawa; World Health Organization; Heart and Stroke Foundation of Canada","keywords":"Coronavirus disease 2019 (COVID-19); Vaccination; 2019-20 coronavirus outbreak; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Medicine; Virology; Immunology; Internal medicine; Outbreak","score_opus":0.19642267703817928,"score_gpt":0.5143449396845047,"score_spread":0.3179222626463254,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3217362361","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9625896,0.0031108612,0.00016173917,0.029655972,0.001992367,0.00035161883,0.000025559902,0.00008159694,0.00203069],"genre_scores_gemma":[0.95850796,0.0021742084,0.000495093,0.03495422,0.0003343937,0.000031293606,0.00004791207,0.000020765183,0.003434148],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980248,0.0005490431,0.0006267956,0.00031664383,0.0001835705,0.0002991017],"domain_scores_gemma":[0.9984493,0.0006120182,0.00013980457,0.00028391826,0.0003005682,0.00021439254],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00070289586,0.00014224107,0.00044534268,0.00007511247,0.0002465001,0.000008557055,0.00010329955,0.00036865607,0.00069644256],"category_scores_gemma":[0.00025212616,0.00013184684,0.0004112767,0.00036615494,0.00024466205,0.00007122483,0.0001488431,0.0007010054,0.00006920376],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019243051,0.0025467833,0.52148205,0.00015947063,0.0047846967,0.00031576,0.00013139784,0.000033223852,0.38490915,0.00024712554,0.06615182,0.01731423],"study_design_scores_gemma":[0.0051666102,0.0006908162,0.6850457,0.000019835517,0.0010203767,0.00035040695,0.000106664316,0.00007867986,0.01788726,0.0002735926,0.28921586,0.00014418806],"about_ca_topic_score_codex":0.000018445617,"about_ca_topic_score_gemma":0.000036243327,"teacher_disagreement_score":0.3670219,"about_ca_system_score_codex":0.00030705563,"about_ca_system_score_gemma":0.00081972923,"threshold_uncertainty_score":0.7625557},"labels":[],"label_agreement":null},{"id":"W4200424936","doi":"10.1002/cpt.2520","title":"A Systematic Review and Analysis of the Use of Polygenic Scores in Pharmacogenomics","year":2021,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Genetic Associations and Epidemiology","field":"Biochemistry, Genetics and Molecular Biology","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CancerCare Manitoba; Health Sciences Centre; Manitoba Health; Children's Hospital Research Institute of Manitoba; University of Manitoba","funders":"Natural Environment Research Council; Medical Research Council; Mitacs; Health Sciences Centre Foundation; Health Research","keywords":"Pharmacogenomics; Precision medicine; Medicine; Trait; Demography; Pharmacology; Computer science; Sociology","score_opus":0.18662149865401398,"score_gpt":0.46797509607897086,"score_spread":0.2813535974249569,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200424936","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.001792319,0.99633956,0.0000368172,0.00022358849,0.00029010573,0.001138507,0.00017421585,0.000002104184,0.0000027891044],"genre_scores_gemma":[0.00015851147,0.99158657,0.00016085316,0.0077203885,0.000051762538,0.00006896571,0.00012981026,0.000026461012,0.00009665532],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9935308,0.0032036493,0.0024944958,0.00045002517,0.000085883425,0.00023515144],"domain_scores_gemma":[0.9963673,0.0010284829,0.0018059476,0.0005819798,0.00015682122,0.000059480466],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012726345,0.00029632877,0.004281776,0.00012926776,0.000030616713,0.0000044537883,0.00045306628,0.0005499219,0.000024057406],"category_scores_gemma":[0.0003335646,0.00020149666,0.001476339,0.00072362303,0.00046588283,0.0000018465581,0.0003477723,0.00038800316,8.2388453e-7],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007465087,0.0015686142,0.021607913,0.7655985,0.1682298,0.000010282783,0.00007777655,0.00026105417,0.0006357356,0.000022753607,0.0060707247,0.03584223],"study_design_scores_gemma":[0.0010325605,0.00028602206,0.00252292,0.04752194,0.5378529,0.000028220093,0.000013827067,0.0003632938,0.00003823931,0.000007688388,0.40960306,0.0007293663],"about_ca_topic_score_codex":0.0000061221913,"about_ca_topic_score_gemma":0.000016280095,"teacher_disagreement_score":0.7180765,"about_ca_system_score_codex":0.000023967983,"about_ca_system_score_gemma":0.00034748175,"threshold_uncertainty_score":0.82167953},"labels":[],"label_agreement":null},{"id":"W4214770147","doi":"10.1002/cpt.2563","title":"PharmVar GeneFocus: <i>CYP3A5</i>","year":2022,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Research Institute in Oncology and Hematology; Children's Hospital Research Institute of Manitoba; CancerCare Manitoba","funders":"National Human Genome Research Institute; Erzincan Üniversitesi; National Institutes of Health; Vetenskapsrådet; Ontario Institute for Cancer Research; National Institute of General Medical Sciences; European Federation of Pharmaceutical Industries and Associations; Kungliga Tekniska Högskolan; Robert Bosch Stiftung; McGill University","keywords":"Pharmacogenomics; CYP3A5; Pharmacogenetics; Allele; Locus (genetics); Tacrolimus; Biology; Genetics; Computational biology; Medicine; Gene; Bioinformatics; Transplantation; Genotype; Internal medicine","score_opus":0.6241503739757894,"score_gpt":0.6259530102670595,"score_spread":0.0018026362912700877,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4214770147","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00007623836,0.9451571,0.000035780995,0.0009811616,0.04274268,0.0030815522,0.0011851925,0.0005960415,0.0061442405],"genre_scores_gemma":[0.000007375356,0.886959,0.00021271594,0.099818066,0.0078629805,0.0012849774,0.0005393617,0.0005256988,0.0027898254],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9787068,0.01108003,0.004471429,0.002505953,0.0008022074,0.0024335834],"domain_scores_gemma":[0.98795736,0.0067623183,0.0022670627,0.0012768866,0.00020500706,0.0015313451],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"category_scores_codex":[0.005384026,0.0022312049,0.005849444,0.00067001773,0.0012528636,0.00008491896,0.003982298,0.0031315351,0.04285545],"category_scores_gemma":[0.00007045574,0.002073228,0.0038282112,0.0014509397,0.0016005195,0.00016783357,0.001833847,0.012248052,0.0034052127],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002587704,0.0022084306,0.000025272906,0.0017410167,0.007960233,0.00041836375,0.00011111205,0.00003275433,0.0000623595,0.000040299943,0.119067505,0.8680739],"study_design_scores_gemma":[0.0038349999,0.00036896093,0.000002473082,0.00014383213,0.035732623,0.0002320945,0.00002499124,0.00021584207,0.00009538543,0.0001432338,0.95728296,0.0019226109],"about_ca_topic_score_codex":0.000005250166,"about_ca_topic_score_gemma":0.0000014125809,"teacher_disagreement_score":0.8661513,"about_ca_system_score_codex":0.00046938573,"about_ca_system_score_gemma":0.0019191733,"threshold_uncertainty_score":0.99904275},"labels":[],"label_agreement":null},{"id":"W4214826920","doi":"10.1002/cpt.2525","title":"Hepatic clearance models and <i>IVIVE</i> predictions","year":2022,"lang":"en","type":"letter","venue":"Clinical Pharmacology & Therapeutics","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Library science; Citation; Pharmacy; Associate editor; Operations research; Medicine; Computer science; Mathematics; Family medicine","score_opus":0.1004050219349011,"score_gpt":0.38816384701812806,"score_spread":0.287758825083227,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4214826920","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.008423862,0.0056087067,0.0016239844,0.972995,0.007629712,0.0013815186,0.00021647608,0.00032162474,0.0017991272],"genre_scores_gemma":[0.0052000354,0.01658294,0.00044801144,0.96597415,0.004493457,0.0001519041,0.0002738758,0.00012829812,0.0067473543],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9970381,0.0003573291,0.0008848139,0.00075970555,0.0004132619,0.0005467616],"domain_scores_gemma":[0.9985081,0.00052592653,0.00026893432,0.00041780432,0.00010311549,0.00017613338],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004537735,0.00041448962,0.0010320427,0.000115960225,0.00026623375,0.000014248156,0.0002780248,0.0010622721,0.0010671171],"category_scores_gemma":[0.0000036466668,0.00037023786,0.00041890648,0.0001788561,0.00065715006,0.000057336947,0.00008837128,0.005304947,0.000031258893],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008887649,0.0004626948,0.00054198824,0.00032047406,0.0019712097,0.0011746746,0.00013145975,0.0000557225,0.0001947798,0.000014528565,0.9930501,0.0011936262],"study_design_scores_gemma":[0.0027373687,0.0009031052,0.0004455225,0.00005814703,0.0056042573,0.00008416417,0.000022750262,0.003211796,0.00004020715,0.000925567,0.9856345,0.00033259747],"about_ca_topic_score_codex":0.0000031635307,"about_ca_topic_score_gemma":0.0000017321743,"teacher_disagreement_score":0.010974234,"about_ca_system_score_codex":0.00007763285,"about_ca_system_score_gemma":0.00028060365,"threshold_uncertainty_score":0.99987495},"labels":[],"label_agreement":null},{"id":"W4214845839","doi":"10.1002/cpt.2570","title":"Sulfonylureas and the Risk of Ventricular Arrhythmias Among People with Type 2 Diabetes: A Systematic Review of Observational Studies","year":2022,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Medicine; Internal medicine; Observational study; Type 2 diabetes; Hazard ratio; Cardiology; Ventricular tachycardia; Confidence interval; Sudden cardiac death; Meta-analysis; Diabetes mellitus; Endocrinology","score_opus":0.19009107634780928,"score_gpt":0.4510741831559829,"score_spread":0.2609831068081736,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4214845839","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0006639807,0.9917094,0.000002275557,0.0016510058,0.00032866772,0.005590731,0.000019789972,0.000016762906,0.000017378994],"genre_scores_gemma":[0.00004450114,0.99418634,0.000121489735,0.0045780465,0.00012293678,0.00070674496,0.00006858148,0.000033141252,0.00013819976],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.99519765,0.0022718892,0.0016747416,0.00031150892,0.00034855417,0.00019566716],"domain_scores_gemma":[0.99164855,0.0060333023,0.0015879008,0.00041500502,0.0002461218,0.00006912377],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028997746,0.00033297425,0.0049021123,0.000076870194,0.00007993035,0.0000031937452,0.0001726465,0.00013250606,0.0001458509],"category_scores_gemma":[0.0003708062,0.00015761882,0.0006690534,0.00049781194,0.000687971,0.00002163116,0.00016091281,0.00058187643,0.0000047209687],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013732653,0.00037571648,0.0029801507,0.9544903,0.033317696,0.000045755045,0.00009540504,6.229535e-7,2.2860295e-8,0.000032139287,0.0029657756,0.0055590705],"study_design_scores_gemma":[0.0028340085,0.0009697839,0.0002821224,0.19967103,0.22841355,0.000029881416,0.00007140893,0.000023259183,3.0052263e-7,0.000018504998,0.567506,0.0001801097],"about_ca_topic_score_codex":0.0000019882625,"about_ca_topic_score_gemma":0.0000017076732,"teacher_disagreement_score":0.7548193,"about_ca_system_score_codex":0.000062449595,"about_ca_system_score_gemma":0.00027358276,"threshold_uncertainty_score":0.6427509},"labels":[],"label_agreement":null},{"id":"W4224235286","doi":"10.1002/cpt.2605","title":"Regulation of Drug Transport Proteins—From Mechanisms to Clinical Impact: A White Paper on Behalf of the International Transporter Consortium","year":2022,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":66,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Institute of General Medical Sciences; National Cancer Institute; National Institutes of Health","keywords":"Transporter; Biology; Computational biology; Pharmacology; Function (biology); Drug discovery; Transport protein; Bioinformatics; Cell biology; Gene; Genetics","score_opus":0.12546130704385555,"score_gpt":0.450526811696567,"score_spread":0.32506550465271145,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4224235286","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.063409306,0.83012855,0.0024446256,0.02071208,0.045677274,0.026827678,0.0082855,0.00038013392,0.0021348496],"genre_scores_gemma":[0.019688196,0.9588849,0.00097595,0.01662603,0.0010203158,0.00034358914,0.0008564149,0.00018473862,0.0014198571],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9931442,0.0007070134,0.003913031,0.0009059804,0.00092594646,0.00040383052],"domain_scores_gemma":[0.99619865,0.00087463943,0.0015537214,0.0008736755,0.00020483881,0.00029449753],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0019133544,0.0006317281,0.0033072,0.00019872336,0.000089013425,0.0000051443476,0.0010326715,0.00077624025,0.006396966],"category_scores_gemma":[0.000018572213,0.0004035042,0.0035176529,0.0004300518,0.00049433904,0.000049151105,0.00006489789,0.0020246056,0.000018006986],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.023930442,0.021549696,0.013009671,0.009428873,0.038332954,0.000357698,0.0022691565,0.00012979767,0.005471322,0.00058600324,0.008246459,0.87668794],"study_design_scores_gemma":[0.003542988,0.0015832062,0.011374204,0.0023157685,0.017244302,0.000012620154,0.000050277406,0.000015015781,0.0004827632,0.00027902157,0.96265835,0.00044150045],"about_ca_topic_score_codex":0.000014777465,"about_ca_topic_score_gemma":0.000033040502,"teacher_disagreement_score":0.95441186,"about_ca_system_score_codex":0.00014346118,"about_ca_system_score_gemma":0.001105205,"threshold_uncertainty_score":0.9998417},"labels":[],"label_agreement":null},{"id":"W4224291920","doi":"10.1002/cpt.2618","title":"Use of Real‐World Data and Physiologically‐Based Pharmacokinetic Modeling to Characterize Enoxaparin Disposition in Children With Obesity","year":2022,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo","funders":"National Institute of General Medical Sciences; Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Heart, Lung, and Blood Institute; U.S. Food and Drug Administration","keywords":"Physiologically based pharmacokinetic modelling; Dosing; Pharmacokinetics; Obesity; Medicine; Pharmacology; Childhood obesity; Renal function; Disposition; Internal medicine; Overweight","score_opus":0.20845782886564637,"score_gpt":0.4167351816970661,"score_spread":0.2082773528314197,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4224291920","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99431175,0.000056798202,0.00028427236,0.0037363428,0.00015102915,0.0012889948,0.000111614034,0.000040721865,0.000018468341],"genre_scores_gemma":[0.9606837,0.0010292447,0.00096650294,0.036774985,0.000126424,0.00009982134,0.00027472366,0.000026025302,0.000018575647],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99794155,0.00041457877,0.000577414,0.0005757083,0.00019857714,0.00029217216],"domain_scores_gemma":[0.9989318,0.00025656697,0.00018303482,0.00042780433,0.00005231696,0.00014844652],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006084701,0.00018982896,0.0007059728,0.00015619333,0.000096982585,0.000010105988,0.00030157674,0.000044286884,0.0001559972],"category_scores_gemma":[0.000008448753,0.0001584692,0.000057764937,0.00033829364,0.00018197429,0.00007190148,0.0005805622,0.0005011979,0.0000028245129],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0057739853,0.014550857,0.8805985,0.00008302273,0.0018632719,0.00006033956,0.00021181663,0.023217354,0.052562114,0.000033492222,0.0023998478,0.018645389],"study_design_scores_gemma":[0.0030433238,0.0018051701,0.88116544,0.000024831541,0.0011724639,0.000004108104,0.000018472883,0.11082606,0.00036202944,0.000014685956,0.0013860277,0.00017738348],"about_ca_topic_score_codex":0.00018087031,"about_ca_topic_score_gemma":0.000027501648,"teacher_disagreement_score":0.0876087,"about_ca_system_score_codex":0.000056167675,"about_ca_system_score_gemma":0.00006645624,"threshold_uncertainty_score":0.6462187},"labels":[],"label_agreement":null},{"id":"W4224657289","doi":"10.1002/cpt.2620","title":"Exposure‐Response Modeling and Simulation to Support Human Dosing of Botulism Antitoxin Heptavalent Product","year":2022,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Botulinum Toxin and Related Neurological Disorders","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Emergent BioSolutions (Canada)","funders":"","keywords":"Antitoxin; Botulism; Botulinum neurotoxin; Potency; Dosing; Neurotoxin; Serotype; Medicine; Neutralization; Toxin; Botulinum toxin; Pharmacology; Immunology; Biology; Antibody; Anesthesia; Microbiology; Internal medicine","score_opus":0.14067646145126642,"score_gpt":0.45146537200993897,"score_spread":0.3107889105586725,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4224657289","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98610735,0.0004880579,0.00027282402,0.011483528,0.00080168515,0.000712385,0.0000088931,0.000072210205,0.000053087457],"genre_scores_gemma":[0.95520157,0.00030626907,0.00028140374,0.04384682,0.00015037028,0.000020065008,0.000007508107,0.000030365822,0.00015565603],"study_design_codex":"bench_or_experimental","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9974327,0.0007830929,0.0007818591,0.00046730242,0.00024593234,0.000289126],"domain_scores_gemma":[0.9988047,0.0005548631,0.00014981558,0.0002194905,0.00008562354,0.0001855242],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012388264,0.00017314659,0.00046145657,0.00011766184,0.00023751825,0.000006068047,0.00014163085,0.00014680273,0.00039709365],"category_scores_gemma":[0.000059944978,0.00015311617,0.00015884652,0.00023030707,0.00022514065,0.000031930656,0.00020122474,0.000863693,0.000008102277],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02092433,0.003955254,0.028329264,0.00009196575,0.0009939858,0.00019332425,0.0013392344,0.2432418,0.6822142,0.000016244527,0.0018807749,0.016819637],"study_design_scores_gemma":[0.036401242,0.057252403,0.14095604,0.00007836935,0.006376354,0.00025200416,0.00086502044,0.65599597,0.018240413,0.001320226,0.080647886,0.0016140392],"about_ca_topic_score_codex":0.0000016188966,"about_ca_topic_score_gemma":2.5236375e-7,"teacher_disagreement_score":0.66397375,"about_ca_system_score_codex":0.000030849435,"about_ca_system_score_gemma":0.00008574672,"threshold_uncertainty_score":0.6243896},"labels":[],"label_agreement":null},{"id":"W4235605449","doi":"10.1016/j.clpt.2004.01.006","title":"Reply","year":2004,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children","funders":"","keywords":"Clinical pharmacology; Citation; Sick child; Psychology; Medicine; Library science; Computer science; Pharmacology; Pediatrics","score_opus":0.24167310496199226,"score_gpt":0.5310736219903486,"score_spread":0.28940051702835634,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4235605449","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.52210075,0.005009164,0.0004702987,0.452935,0.0043878783,0.0007256914,0.00000719757,0.0003025085,0.014061515],"genre_scores_gemma":[0.4045992,0.006719617,0.0011025097,0.5858738,0.0012841979,0.000015983871,0.00000385122,0.000023905284,0.00037695433],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9983724,0.00015024867,0.00055181625,0.00035691293,0.00017694508,0.0003917144],"domain_scores_gemma":[0.99853456,0.00069423654,0.00013427046,0.00022023948,0.000116339506,0.0003003288],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00061828434,0.00017387755,0.000429515,0.000032114403,0.00014728222,0.000011091863,0.00014846589,0.000158854,0.00068880577],"category_scores_gemma":[0.00005277727,0.00013538024,0.00023975264,0.00017295705,0.00047291737,0.0000698022,0.00009531508,0.0008821891,0.00056469074],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.023100076,0.0236236,0.16875236,0.00041065225,0.023847297,0.0033789242,0.0014269782,0.00018600152,0.08267251,0.0019848442,0.3800581,0.29055867],"study_design_scores_gemma":[0.0063531683,0.0009465702,0.015741527,0.000012755105,0.0018964807,0.000083630555,0.00003842492,0.00005612658,0.0039236005,0.000838285,0.96994996,0.0001594985],"about_ca_topic_score_codex":0.0000070462447,"about_ca_topic_score_gemma":8.157294e-7,"teacher_disagreement_score":0.5898918,"about_ca_system_score_codex":0.00006408242,"about_ca_system_score_gemma":0.0001489103,"threshold_uncertainty_score":0.754194},"labels":[],"label_agreement":null},{"id":"W4237242270","doi":"10.1016/s0009-9236(01)70992-7","title":"Red wine decreases cyclosporine bioavailability","year":2001,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences North","funders":"","keywords":"Wine; Ciclosporin; Pharmacology; Bioavailability; CYP3A4; Pharmacokinetics; Crossover study; Chemistry; Grapefruit juice; Whole blood; Fluorescence polarization immunoassay; Medicine; Placebo; Chromatography; Cytochrome P450; Internal medicine; Food science; Biochemistry; Chemotherapy; Metabolism","score_opus":0.14501065618878375,"score_gpt":0.4814705665912841,"score_spread":0.33645991040250034,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4237242270","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9344889,0.0016017562,0.000034367473,0.056484353,0.0027447164,0.00076382834,0.000012969142,0.0002561312,0.0036129793],"genre_scores_gemma":[0.8554168,0.008591439,0.0007076574,0.12580091,0.0042479876,0.000079045916,0.00008916552,0.00005854895,0.0050084633],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9975522,0.00032076178,0.0008212278,0.00059192884,0.00018330284,0.00053055846],"domain_scores_gemma":[0.9979858,0.0007897754,0.00018359449,0.00039163826,0.0001959444,0.00045325316],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00051779125,0.0003108929,0.0007801085,0.00008963511,0.000115180694,0.000008060363,0.00019649693,0.00031489448,0.0074104127],"category_scores_gemma":[0.000030154497,0.00025919764,0.00037558126,0.00034914495,0.0007117245,0.000061416285,0.000085323656,0.00061918766,0.0003048867],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012693404,0.010123543,0.718852,0.000050636034,0.0033446422,0.0012906445,0.000072926654,0.000006773977,0.04675365,0.000013240317,0.17905737,0.02774116],"study_design_scores_gemma":[0.0116966115,0.0023555933,0.2210973,0.000012316277,0.0035813586,0.00028950535,0.000016069433,0.00022732654,0.0046914076,0.00019940118,0.75557894,0.00025416273],"about_ca_topic_score_codex":0.000019371988,"about_ca_topic_score_gemma":0.0000078707635,"teacher_disagreement_score":0.5765216,"about_ca_system_score_codex":0.00013423346,"about_ca_system_score_gemma":0.00025827732,"threshold_uncertainty_score":0.99998605},"labels":[],"label_agreement":null},{"id":"W4240364009","doi":"10.1038/clpt.2014.133","title":"Biotransformation","year":2014,"lang":"en","type":"editorial","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; SickKids Foundation; Hospital for Sick Children","funders":"","keywords":"Clinical pharmacology; Clinical trial; Medicine; Drug development; Human immunodeficiency virus (HIV); Drug; Intensive care medicine; Pharmaceutical industry; Public health; Pharmacology; Virology; Internal medicine; Pathology","score_opus":0.13172511939189824,"score_gpt":0.5186376197035598,"score_spread":0.3869125003116616,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4240364009","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00042002552,0.0035591298,0.00024782066,0.026900312,0.96029806,0.0007212536,0.0000747091,0.0001942046,0.0075844885],"genre_scores_gemma":[0.0007483708,0.04689621,0.00021640022,0.09537878,0.8552338,0.0000422437,0.00029628348,0.00008186997,0.0011060435],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99635905,0.00063263933,0.0012233474,0.0005884192,0.0006207345,0.00057582743],"domain_scores_gemma":[0.99160296,0.00676416,0.00048617666,0.00033569144,0.00043592343,0.00037509395],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0017007126,0.00046387393,0.0012585059,0.000085392836,0.0001942863,0.00003280507,0.000326229,0.0020085995,0.0008373539],"category_scores_gemma":[0.00023215913,0.00037002203,0.00055931386,0.00017142267,0.0005786672,0.000089747526,0.00011217943,0.004100539,0.0008465171],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014983693,0.0005591166,0.00011034995,0.00025050147,0.0025531754,0.000028444252,0.000031955435,7.424691e-7,0.00019842362,0.0000038244975,0.977376,0.017389107],"study_design_scores_gemma":[0.0043911454,0.0011350673,0.00011440268,0.000056638382,0.008462215,0.0000069829434,0.000009161267,0.00032812802,0.00020720504,0.000058796846,0.98488456,0.00034569835],"about_ca_topic_score_codex":0.0000044690973,"about_ca_topic_score_gemma":0.0000018792165,"teacher_disagreement_score":0.10506426,"about_ca_system_score_codex":0.00010562646,"about_ca_system_score_gemma":0.00038302713,"threshold_uncertainty_score":0.99993145},"labels":[],"label_agreement":null},{"id":"W4244684940","doi":"10.1002/cpt.1194","title":"A Prospective International Study on Adherence to Treatment in 305 Patients With Flaring <scp>SLE</scp>: Assessment by Drug Levels and Self‐Administered Questionnaires","year":2018,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal General Hospital","funders":"National Institutes of Health; Johns Hopkins University","keywords":"Medicine; Drug; Hydroxychloroquine; Internal medicine; Systemic lupus erythematosus; Drug class; Prospective cohort study; Multivariate analysis; Drug holiday; Pharmacology; Immunology; Disease; Coronavirus disease 2019 (COVID-19)","score_opus":0.09093447510755344,"score_gpt":0.4739171374763177,"score_spread":0.38298266236876427,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4244684940","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99405074,0.00004786801,0.000048021207,0.0011040895,0.0009340089,0.0032595051,0.000021461337,0.00006453155,0.00046978059],"genre_scores_gemma":[0.99489295,0.000039526378,0.00041035537,0.003112571,0.00027961162,0.00039975293,0.000008394712,0.00003433602,0.00082247675],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974461,0.00048886164,0.0006060758,0.0006465734,0.0004590036,0.00035334093],"domain_scores_gemma":[0.997957,0.0010322975,0.00015849808,0.00025200544,0.0003553132,0.00024489147],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00063332164,0.00025423316,0.00050387107,0.00014523101,0.00008913785,0.00003275074,0.0002003504,0.000112791975,0.00003073131],"category_scores_gemma":[0.00007255426,0.00018198238,0.000048884627,0.00019168937,0.00023702375,0.00006020696,0.00012280759,0.00038974723,0.00003984279],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007292494,0.008906497,0.9803004,0.000018783277,0.0010688385,0.000038766797,0.0057329778,6.8563946e-7,0.00035295187,0.000004483036,0.0011898706,0.001656453],"study_design_scores_gemma":[0.018635103,0.02303122,0.9526466,0.00018786904,0.00032945644,0.000030534382,0.0014041853,0.00027277795,0.0009618401,0.000024121538,0.0023681032,0.000108154025],"about_ca_topic_score_codex":0.000025107991,"about_ca_topic_score_gemma":0.00006801571,"teacher_disagreement_score":0.027653808,"about_ca_system_score_codex":0.0005739322,"about_ca_system_score_gemma":0.00028195433,"threshold_uncertainty_score":0.7421026},"labels":[],"label_agreement":null},{"id":"W4252666590","doi":"10.1016/s0009-9236(03)90389-4","title":"Systemic exposure to morphine and the risk of acute chest syndrome in sickle cell disease","year":2003,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; Purdue Pharma (Canada)","funders":"","keywords":"Acute chest syndrome; Medicine; Disease; Morphine; Intensive care medicine; Anesthesia; Internal medicine; Sickle cell anemia","score_opus":0.022918215778570835,"score_gpt":0.33414970316308495,"score_spread":0.3112314873845141,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4252666590","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98331153,0.0065795844,0.000047616188,0.008321576,0.00056196976,0.00092642056,0.000019864672,0.000022199767,0.00020925605],"genre_scores_gemma":[0.97087824,0.012126089,0.00009847124,0.01652243,0.00004256016,0.000031290623,0.0000033934607,0.000023090479,0.00027443684],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980401,0.0006091292,0.0006819646,0.00027726108,0.00012645869,0.00026511977],"domain_scores_gemma":[0.9985963,0.00064396556,0.00017133435,0.00026461718,0.0000629524,0.0002608257],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010131844,0.00017037771,0.00060076994,0.00006273372,0.00005604596,0.000004466369,0.000126585,0.00020628815,0.0000685087],"category_scores_gemma":[0.00005170445,0.000104651415,0.00016889322,0.00023868366,0.0005419105,0.000020014622,0.000046502428,0.0006675063,0.000026035665],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014368768,0.0049982453,0.9466642,0.0007295945,0.005661296,0.0014457459,0.0023356269,0.0009343997,0.014304227,0.00030236138,0.004397545,0.003857978],"study_design_scores_gemma":[0.13940863,0.007561744,0.7612495,0.0005945569,0.041434687,0.0010087889,0.0018747397,0.00459619,0.0031230112,0.0019058718,0.03595189,0.0012904264],"about_ca_topic_score_codex":0.0000068944287,"about_ca_topic_score_gemma":0.0000010025325,"teacher_disagreement_score":0.18541475,"about_ca_system_score_codex":0.000021770402,"about_ca_system_score_gemma":0.00012719774,"threshold_uncertainty_score":0.42675608},"labels":[],"label_agreement":null},{"id":"W4280512618","doi":"10.1002/cpt.2652","title":"Rifampin Drug–Drug–Interaction Studies: Reflections on the Nitrosamine Impurities Issue","year":2022,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Celerion (Canada)","funders":"","keywords":"Drug; Pharmacology; Pharmacokinetics; Drug interaction; Cytochrome P450; Chemistry; Medicine; Biochemistry; Enzyme","score_opus":0.7281972667024696,"score_gpt":0.6661751620883808,"score_spread":0.06202210461408886,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4280512618","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00053886144,0.9310843,0.000004407261,0.010919728,0.04907388,0.002934055,0.00062260067,0.0003377561,0.0044844523],"genre_scores_gemma":[0.000088104134,0.86890906,0.000041713338,0.112913586,0.008654699,0.0019782917,0.00021109876,0.0002681119,0.0069353613],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.97850657,0.01435985,0.0032961904,0.0016832092,0.00063308503,0.0015210981],"domain_scores_gemma":[0.9724024,0.023816593,0.0018722471,0.0010397595,0.00030786087,0.00056115317],"candidate_categories":["metaepi_narrow","sts","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","insufficient_payload"],"category_scores_codex":[0.0058687907,0.0016478769,0.0037769855,0.00057273277,0.0022215326,0.00008393489,0.0023440889,0.0011056846,0.016552078],"category_scores_gemma":[0.0002339328,0.0012100318,0.0023791844,0.001195095,0.0019594207,0.00013268412,0.0009937868,0.011865267,0.00187249],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00056079926,0.0029556563,0.0000061253013,0.0014734125,0.013829568,0.00013879512,0.0011308353,0.0001431977,0.000065334105,0.00023912854,0.45848307,0.5209741],"study_design_scores_gemma":[0.0018133597,0.00039761548,0.0000012468576,0.00029639062,0.018696714,0.00010068924,0.0009834938,0.00014871596,0.00019268543,0.00035939823,0.97592664,0.0010830649],"about_ca_topic_score_codex":0.000009757078,"about_ca_topic_score_gemma":0.000011797997,"teacher_disagreement_score":0.519891,"about_ca_system_score_codex":0.00059265585,"about_ca_system_score_gemma":0.00083065033,"threshold_uncertainty_score":0.9996268},"labels":[],"label_agreement":null},{"id":"W4280526493","doi":"10.1002/cpt.2638","title":"Transporters and Toxicity: Insights From the International Transporter Consortium Workshop 4","year":2022,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Transporter; Toxicity; ATP-binding cassette transporter; Pharmacology; Solute carrier family; Biology; Medicine; Biochemistry; Internal medicine","score_opus":0.18589677694194875,"score_gpt":0.43870313585958853,"score_spread":0.2528063589176398,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4280526493","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0017956019,0.9828558,0.00014695592,0.0064249206,0.0066962657,0.0013329334,0.00025771654,0.00010497635,0.00038486032],"genre_scores_gemma":[0.000431086,0.94080293,0.000113856026,0.05554882,0.0013768364,0.00015100844,0.0008319582,0.000099484,0.0006440057],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99640524,0.00035509487,0.0015891967,0.00084617187,0.00043666307,0.0003676377],"domain_scores_gemma":[0.9969251,0.0018768084,0.00044871823,0.0004517295,0.000048506718,0.00024914456],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00047429456,0.0005749541,0.0021288565,0.000098264,0.0002074615,0.000025730777,0.0006917676,0.00067363173,0.003034437],"category_scores_gemma":[0.0000057849215,0.00036004308,0.001141195,0.00021893227,0.0007406991,0.000048453327,0.00004997075,0.002407521,0.000023294218],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010194406,0.001325639,0.00048806393,0.001223593,0.013128662,0.0011458202,0.000787285,7.266117e-7,0.00009771257,0.00005223092,0.0069771237,0.9737537],"study_design_scores_gemma":[0.0018940506,0.00014566419,0.00024932675,0.00068109843,0.019170715,0.00003725316,0.00011574195,0.000011519877,0.000011879665,0.000085181084,0.97724724,0.00035030313],"about_ca_topic_score_codex":0.0000032677203,"about_ca_topic_score_gemma":0.000019578727,"teacher_disagreement_score":0.9734034,"about_ca_system_score_codex":0.00008537095,"about_ca_system_score_gemma":0.00046600742,"threshold_uncertainty_score":0.99989396},"labels":[],"label_agreement":null},{"id":"W4280575162","doi":"10.1002/cpt.2644","title":"Transporters in Drug Development: International Transporter Consortium Update on Emerging Transporters of Clinical Importance","year":2022,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":60,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Transporter; Drug; Pharmacology; Multidrug resistance-associated protein 2; Drug development; Drug interaction; Medicine; Antifolate; Organic anion transporter 1; ATP-binding cassette transporter; Biology; Toxicity; Biochemistry; Internal medicine; Antimetabolite","score_opus":0.18934579634714893,"score_gpt":0.4877991353196528,"score_spread":0.29845333897250387,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4280575162","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.029062426,0.9451852,0.00025489792,0.0025837726,0.016962856,0.0038705543,0.00047727334,0.00021984735,0.0013831661],"genre_scores_gemma":[0.0035962064,0.979258,0.000697127,0.013348826,0.0006503746,0.00022166938,0.001540206,0.00019733176,0.0004902508],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9885095,0.00060845574,0.0077642007,0.0014694899,0.0008482284,0.00080017396],"domain_scores_gemma":[0.9961145,0.00084402855,0.0019004437,0.0006284057,0.00009916122,0.0004134403],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.003310981,0.0009613547,0.0053902683,0.00059753185,0.00010473103,0.00000799993,0.0010077875,0.000895921,0.0035554648],"category_scores_gemma":[0.000009237768,0.0008284319,0.0026801021,0.0005953187,0.00072863256,0.0000870534,0.000026689728,0.0037623076,0.000029065717],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037182125,0.0055311183,0.017384041,0.00618012,0.0083219465,0.0030747564,0.00074793387,0.000013386963,0.000011458839,0.00004973527,0.0012899544,0.95367736],"study_design_scores_gemma":[0.0058509037,0.0002957331,0.0021709704,0.002128389,0.0071324017,0.000023930459,0.0001345266,0.000017166703,0.000032525866,0.000014448696,0.98150736,0.00069166435],"about_ca_topic_score_codex":0.0000032989872,"about_ca_topic_score_gemma":0.000047285343,"teacher_disagreement_score":0.9802174,"about_ca_system_score_codex":0.0001942319,"about_ca_system_score_gemma":0.0016807413,"threshold_uncertainty_score":0.99941665},"labels":[],"label_agreement":null},{"id":"W4283785081","doi":"10.1002/cpt.2700","title":"Sotrovimab Lowers the Risk of <scp>COVID</scp>‐19 Related Hospitalization or Death in a Large Population Cohort in the United Arab Emirates","year":2022,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"SARS-CoV-2 and COVID-19 Research","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre","funders":"Deanship of Scientific Research, King Saud University","keywords":"Favipiravir; Medicine; Odds ratio; Hazard ratio; Internal medicine; Confidence interval; Retrospective cohort study; Population; Coronavirus disease 2019 (COVID-19); Disease","score_opus":0.0921600825197258,"score_gpt":0.44593573757270755,"score_spread":0.35377565505298175,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283785081","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99543214,0.0005189218,0.00007731261,0.0018221318,0.00042631972,0.001512251,0.00002538315,0.00004528031,0.00014028342],"genre_scores_gemma":[0.84070253,0.0003019143,0.000014331128,0.15865448,0.00006855544,0.00013436521,0.000059575457,0.000026625516,0.000037606853],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99496347,0.002767883,0.0009665884,0.000383094,0.00048180198,0.00043713767],"domain_scores_gemma":[0.9944869,0.004613189,0.00036048368,0.00038014172,0.00011727818,0.0000419875],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004743795,0.00018981948,0.0004467394,0.00030864542,0.00023771221,0.0000135297305,0.0004883821,0.00022906472,0.0000573632],"category_scores_gemma":[0.0007499022,0.000117100506,0.00017176408,0.0017877182,0.00026927982,0.000054174874,0.00015729286,0.0016902522,0.000009226507],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008911535,0.0014232037,0.9932558,0.000024245124,0.00039311522,0.00009125026,0.0018564465,0.00033285317,0.0006893859,0.00009914959,0.00071820646,0.00022520054],"study_design_scores_gemma":[0.009039866,0.0014693914,0.8938628,0.000014416443,0.0008962618,0.000024838591,0.0019054243,0.029313726,0.00025266668,0.00077426754,0.062352724,0.00009363589],"about_ca_topic_score_codex":0.00035044897,"about_ca_topic_score_gemma":0.00009226806,"teacher_disagreement_score":0.15683235,"about_ca_system_score_codex":0.00024382437,"about_ca_system_score_gemma":0.0005257311,"threshold_uncertainty_score":0.73433983},"labels":[],"label_agreement":null},{"id":"W4285593302","doi":"10.1002/cpt.2712","title":"Population Pharmacokinetics of Vericiguat in Patients With Heart Failure With Reduced Ejection Fraction: An Integrated Analysis","year":2022,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Heart failure; Ejection fraction; Volume of distribution; Medicine; Pharmacokinetics; Population; Internal medicine; Renal function; Cardiology; Endocrinology","score_opus":0.03919895872102991,"score_gpt":0.38041107143812253,"score_spread":0.3412121127170926,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4285593302","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947301,0.000018944285,0.0002628983,0.0038301735,0.00025007775,0.00081846287,0.000011038883,0.000054119224,0.00002415728],"genre_scores_gemma":[0.9911857,0.000022705979,0.002455749,0.0056596636,0.00008002168,0.00006732243,0.00044298673,0.00002506348,0.000060784118],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980724,0.0004934118,0.0005267536,0.00036255657,0.00033108683,0.00021378566],"domain_scores_gemma":[0.9991876,0.000105762345,0.00021663711,0.00022344395,0.00016460432,0.000101992446],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036891925,0.00018011057,0.0005649736,0.00033848645,0.00009779487,0.000006142957,0.00007840057,0.00008054264,0.00074406376],"category_scores_gemma":[0.0000034772575,0.00013768215,0.000112255795,0.0012959188,0.00009865332,0.000093776995,0.000036041856,0.00053192716,0.0000034762015],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005224856,0.0035886732,0.98241377,0.000012741638,0.0023750977,0.000009645965,0.00006239622,0.0026232759,0.00066793076,0.0000014041497,0.0014233355,0.0015968815],"study_design_scores_gemma":[0.009926268,0.0060187657,0.9365673,0.000008716041,0.007873589,0.0000022922757,0.00026094294,0.0030974706,0.00042767543,0.0000036882402,0.035644867,0.00016838961],"about_ca_topic_score_codex":0.000055836776,"about_ca_topic_score_gemma":0.000037672664,"teacher_disagreement_score":0.04584643,"about_ca_system_score_codex":0.00019244335,"about_ca_system_score_gemma":0.000075012525,"threshold_uncertainty_score":0.8146977},"labels":[],"label_agreement":null},{"id":"W4288067911","doi":"10.1002/cpt.2721","title":"Organic Anion Transporter Gene Variants Associated With Plasma Exposure and Long‐Term Response to Atrasentan in Patients With Diabetic Kidney Disease","year":2022,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Neonatal Health and Biochemistry","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"NOSM University; Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"Horizon 2020 Framework Programme; Innovative Medicines Initiative; European Commission; Steno Diabetes Center Copenhagen; European Federation of Pharmaceutical Industries and Associations","keywords":"Transporter; Diabetes mellitus; Organic anion transporter 1; Kidney disease; Kidney; Pharmacology; Medicine; Plasma concentration; Gene; Chemistry; Internal medicine; Endocrinology; Biochemistry","score_opus":0.022962206097100573,"score_gpt":0.3322508767920141,"score_spread":0.3092886706949135,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4288067911","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9932751,0.00011714952,0.000007249266,0.0051932875,0.00023871879,0.0008725416,0.00025573274,0.000037438458,0.0000027663075],"genre_scores_gemma":[0.94811225,0.000045773515,0.000036320536,0.051224187,0.000077246,0.00005153568,0.00030819108,0.000038744696,0.00010573024],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99796647,0.00041119603,0.00045905967,0.000464406,0.0002909813,0.00040789307],"domain_scores_gemma":[0.9984331,0.00028764582,0.0001223231,0.00019496442,0.000074415424,0.00088752364],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005067975,0.0002072821,0.00038360202,0.0000674822,0.00012302144,0.000005818142,0.0001195785,0.00011824381,0.00036043406],"category_scores_gemma":[0.000028513423,0.00016385344,0.000045551955,0.00029178098,0.0001694934,0.000029487206,0.00004992824,0.00064878544,0.0000034761476],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06444322,0.0022663663,0.9237999,0.000055272198,0.00024955135,0.0004957873,0.00012778041,0.000001836914,0.007392886,4.7955698e-8,0.0002182679,0.0009491078],"study_design_scores_gemma":[0.018713988,0.005314887,0.9737172,0.000055365912,0.00071473385,0.000010921351,0.000016120563,0.00002919332,0.0009311106,0.0000020794075,0.00030123958,0.00019315172],"about_ca_topic_score_codex":8.908857e-7,"about_ca_topic_score_gemma":0.000003654629,"teacher_disagreement_score":0.04991734,"about_ca_system_score_codex":0.00015130934,"about_ca_system_score_gemma":0.0005206004,"threshold_uncertainty_score":0.668175},"labels":[],"label_agreement":null},{"id":"W4294281525","doi":"10.1002/cpt.2737","title":"The Effect of Tobacco Use on the Expression of Placental Transporters in Alaska Native Women","year":2022,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Birth, Development, and Health","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Addiction and Mental Health; University of Toronto","funders":"Canadian Institutes of Health Research; University of Toronto; National Institute on Drug Abuse; Canada Research Chairs; National Cancer Institute; Centre for Addiction and Mental Health","keywords":"Placenta; Transporter; Fetus; Pregnancy; Medicine; Abcg2; Physiology; Nicotine; Genotype; Tobacco smoke; Biology; Andrology; Internal medicine; ATP-binding cassette transporter; Environmental health; Genetics; Gene","score_opus":0.07405333240630581,"score_gpt":0.4121692863026753,"score_spread":0.3381159538963695,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4294281525","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.992133,0.00014936243,0.0000025873696,0.0058316514,0.00082018244,0.0008540555,0.00001984007,0.000011379486,0.0001778969],"genre_scores_gemma":[0.9741623,0.005938355,0.000012373412,0.019634983,0.00006865027,0.00011962242,0.0000062449462,0.000016098185,0.000041378913],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99737304,0.0011967457,0.0006735055,0.00020254852,0.00026790402,0.00028623693],"domain_scores_gemma":[0.99502176,0.0044044796,0.00027139226,0.00018845712,0.000034361055,0.000079562924],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022002745,0.00013247997,0.0004311916,0.00005456544,0.00016940001,0.0000022561999,0.0002284155,0.00009138959,0.00018083387],"category_scores_gemma":[0.00003109027,0.00007167284,0.00012714435,0.00018293064,0.00043521525,0.00002126608,0.000057501406,0.0009315112,0.0000020424297],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.035254743,0.0020794685,0.9014765,0.00011134005,0.0009307007,0.000049719456,0.009728193,0.00009101797,0.03161519,0.00032712726,0.0077734343,0.01056259],"study_design_scores_gemma":[0.03457352,0.024720127,0.68890625,0.00018818972,0.00079423544,0.000017629194,0.00869152,0.00034827014,0.21262892,0.00075191975,0.0279377,0.0004417495],"about_ca_topic_score_codex":0.000003918959,"about_ca_topic_score_gemma":0.000003403222,"teacher_disagreement_score":0.21257025,"about_ca_system_score_codex":0.00014506171,"about_ca_system_score_gemma":0.00019592159,"threshold_uncertainty_score":0.40470046},"labels":[],"label_agreement":null},{"id":"W4296028961","doi":"10.1002/cpt.2749","title":"Characterization of <scp><i>CYP2D6</i></scp> Pharmacogenetic Variation in <scp>Sub‐Saharan</scp> African Populations","year":2022,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Manitoba","funders":"National Institute of Allergy and Infectious Diseases; National Institutes of Health; University of the Witwatersrand, Johannesburg; South African Medical Research Council; National Research Foundation; Wellcome Trust; National Human Genome Research Institute; GlaxoSmithKline","keywords":"Genotyping; CYP2D6; Genetics; Allele; Biology; Context (archaeology); Pharmacogenetics; Haplotype; Population; Genotype; Gene; Computational biology; Medicine","score_opus":0.18229329636119448,"score_gpt":0.45458766997590283,"score_spread":0.2722943736147083,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296028961","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9768093,0.004421444,0.0005475376,0.0017724532,0.012377358,0.0018792766,0.00083885744,0.00019539698,0.0011583727],"genre_scores_gemma":[0.94750357,0.0095827365,0.0002749979,0.039593257,0.0013639624,0.0006260035,0.0003342124,0.00015754254,0.0005637433],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.98876804,0.005208524,0.0027655598,0.0011774803,0.0006980461,0.0013823782],"domain_scores_gemma":[0.9932101,0.0037310857,0.0015423638,0.00052699,0.00038105212,0.000608438],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00379601,0.0007456331,0.0012744983,0.0007504828,0.00072407903,0.000035539484,0.0013278142,0.0005933635,0.00072461047],"category_scores_gemma":[0.00021521517,0.0008608964,0.00056930626,0.0017683844,0.000681933,0.00023381616,0.0006499974,0.003247939,0.00012425437],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021838227,0.0037297718,0.018335968,0.000055980654,0.0011410611,0.00006671146,0.0023622625,0.0049245046,0.9533674,0.00013475923,0.007858819,0.0078043635],"study_design_scores_gemma":[0.00989002,0.0005201269,0.10262276,0.000012226624,0.003041703,0.000045442393,0.00034945537,0.023765966,0.22263202,0.0009592283,0.635863,0.00029802977],"about_ca_topic_score_codex":0.000015428126,"about_ca_topic_score_gemma":0.000009677976,"teacher_disagreement_score":0.7307354,"about_ca_system_score_codex":0.00022949674,"about_ca_system_score_gemma":0.00053164223,"threshold_uncertainty_score":0.99938416},"labels":[],"label_agreement":null},{"id":"W4296034623","doi":"10.1002/cpt.2748","title":"Pharmacogenomic Testing and Depressive Symptom Remission: A Systematic Review and <scp>Meta‐Analysis</scp> of Prospective, Controlled Clinical Trials","year":2022,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":115,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Alberta Children's Hospital; Centre for Addiction and Mental Health; University of Manitoba; Children's Hospital Research Institute of Manitoba; University of Calgary","funders":"","keywords":"Meta-analysis; Pharmacogenomics; Clinical trial; Medicine; MEDLINE; Internal medicine; Pharmacology","score_opus":0.6450440072230488,"score_gpt":0.6158629572286234,"score_spread":0.02918104999442539,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296034623","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0003358613,0.97849065,0.00002998971,0.0003033906,0.0032368845,0.016034843,0.0009388724,0.00016164858,0.0004678438],"genre_scores_gemma":[0.00017511817,0.96821254,0.00023824051,0.025525559,0.0010329552,0.0038564121,0.00009564037,0.00022342027,0.0006400964],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.927877,0.055436194,0.012498433,0.0023393629,0.0006162502,0.0012327789],"domain_scores_gemma":[0.8468499,0.13855194,0.011584682,0.001023595,0.0005971419,0.0013927334],"candidate_categories":["metaresearch","metaepi_narrow","metaepi_broad","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","research_integrity"],"category_scores_codex":[0.04436901,0.0020026516,0.035446916,0.00078615686,0.00068779103,0.000071385424,0.0017549397,0.002058778,0.0017726783],"category_scores_gemma":[0.00747543,0.001463541,0.009035685,0.0018815129,0.0019114336,0.00012752933,0.0014065052,0.0067682187,0.000035231405],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035182416,0.002052051,0.00050351175,0.25326735,0.7000101,0.0001569898,0.00011403246,0.000016143438,0.00009779937,0.000015766504,0.0035940295,0.039820354],"study_design_scores_gemma":[0.007059356,0.0002955065,0.000011960276,0.0022084464,0.6317824,0.00010624102,0.000015270813,0.00041885785,0.000021124439,0.000062177154,0.35759026,0.00042840396],"about_ca_topic_score_codex":0.0000038158164,"about_ca_topic_score_gemma":6.393471e-7,"teacher_disagreement_score":0.35399625,"about_ca_system_score_codex":0.00011412126,"about_ca_system_score_gemma":0.0011508499,"threshold_uncertainty_score":0.99927163},"labels":[],"label_agreement":null},{"id":"W4306803289","doi":"10.1002/cpt.2768","title":"Impact of Drug Exposure on Resistance Selection Following Artemether‐Lumefantrine Treatment for Malaria in Children With and Without <scp>HIV</scp> in Uganda","year":2022,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Malaria Research and Control","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Center for Advancing Translational Sciences; University of California, San Francisco; National Institute of Child Health and Human Development; National Institute of General Medical Sciences; International Development Research Centre","keywords":"Artemether/lumefantrine; Nevirapine; Lumefantrine; Efavirenz; Lopinavir; Medicine; Malaria; Population; Lopinavir/ritonavir; Ritonavir; Pharmacology; Virology; Internal medicine; Immunology; Viral load; Plasmodium falciparum; Artemisinin; Human immunodeficiency virus (HIV); Antiretroviral therapy; Environmental health","score_opus":0.0429054703106308,"score_gpt":0.4118038061710506,"score_spread":0.3688983358604198,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4306803289","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945033,0.0007005947,0.000058591042,0.0025557473,0.00010609065,0.0019611951,0.000027726574,0.000019132342,0.00006762464],"genre_scores_gemma":[0.99665934,0.00027688395,0.00022500337,0.0014707951,0.00012874791,0.000355464,0.000024308278,0.000031002673,0.00082846434],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99796915,0.0005524727,0.00049871637,0.00037677595,0.00021076738,0.0003921462],"domain_scores_gemma":[0.9986466,0.0008637131,0.00015393988,0.00015416218,0.000052789746,0.00012878471],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010214546,0.00019209548,0.00063287275,0.0001793587,0.00008781142,0.000007392411,0.00010054068,0.00009206717,0.000039351282],"category_scores_gemma":[0.00004911925,0.00014200169,0.00019045208,0.00029036807,0.00010257504,0.000034631143,0.000030882016,0.0005773723,7.861899e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009233732,0.0017934062,0.9802233,0.000014079626,0.0017835498,0.000017568545,0.00023338581,0.00023638202,0.0041363114,0.00001922397,0.00033452714,0.001974528],"study_design_scores_gemma":[0.042291064,0.010689538,0.94203,0.000026392157,0.0006810987,0.000016324359,0.00009970909,0.0018262259,0.00077347434,0.00007546751,0.0014146095,0.00007607147],"about_ca_topic_score_codex":0.000043110816,"about_ca_topic_score_gemma":0.00013439656,"teacher_disagreement_score":0.038193278,"about_ca_system_score_codex":0.00023398617,"about_ca_system_score_gemma":0.0003459857,"threshold_uncertainty_score":0.5790661},"labels":[],"label_agreement":null},{"id":"W4306803572","doi":"10.1002/cpt.2767","title":"Signal and Noise: Proton Pump Inhibitors and the Risk of Dementia?","year":2022,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Gastroesophageal reflux and treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland; Ministry of Health; University of Manitoba","funders":"","keywords":"Dementia; Medicine; Hazard ratio; Proportional hazards model; Internal medicine; Confidence interval; Cohort; Cohort study; Population; Disease; Environmental health","score_opus":0.04035446280081602,"score_gpt":0.3802120723772229,"score_spread":0.33985760957640687,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4306803572","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940383,0.0015980097,0.000015994465,0.0027041552,0.00033099897,0.0011703884,0.00001761122,0.000017009246,0.00010755208],"genre_scores_gemma":[0.98825324,0.0012928485,0.000107297514,0.00990256,0.00014832102,0.0001602138,0.000005850765,0.00001473067,0.00011493962],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983553,0.000627107,0.0004307209,0.0002291326,0.00017648704,0.00018123616],"domain_scores_gemma":[0.9988094,0.0007123566,0.0002100469,0.00012311114,0.00004262606,0.00010247615],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008978782,0.0001245943,0.00037271352,0.00003554776,0.00021073605,0.0000049099153,0.00007919808,0.000061206025,0.00031713254],"category_scores_gemma":[0.000015246091,0.00007776555,0.00011718576,0.00008206384,0.00079435814,0.00001962745,0.00018184038,0.0005448711,0.0000031263612],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025675576,0.0009839445,0.98109525,0.00003942095,0.0033228996,0.00007615019,0.00026725564,0.000009297987,0.0014167887,0.000020834363,0.0005537693,0.0096468115],"study_design_scores_gemma":[0.07560344,0.009420922,0.8422277,0.00001840222,0.0240351,0.00016678803,0.00030283138,0.0031311798,0.016295139,0.0015943899,0.026978549,0.00022555607],"about_ca_topic_score_codex":0.000004729183,"about_ca_topic_score_gemma":2.339405e-7,"teacher_disagreement_score":0.13886757,"about_ca_system_score_codex":0.000015762325,"about_ca_system_score_gemma":0.000059781163,"threshold_uncertainty_score":0.3472379},"labels":[],"label_agreement":null},{"id":"W4312114408","doi":"10.1002/cpt.2782","title":"Advancing Innovations in Biosimilars","year":2022,"lang":"en","type":"editorial","venue":"Clinical Pharmacology & Therapeutics","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Biosimilar; Medicine; Pharmacology; Business; Internal medicine","score_opus":0.06304985624685244,"score_gpt":0.44777936023714354,"score_spread":0.3847295039902911,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4312114408","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0007077519,0.0058086035,0.00006522059,0.011801081,0.9797366,0.0005588259,0.00049305434,0.00013119007,0.000697632],"genre_scores_gemma":[0.0007294072,0.025330156,0.0025984237,0.20196268,0.75665265,0.00042490332,0.0021117819,0.00033738115,0.0098525975],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99357903,0.0023901865,0.0018456678,0.001055675,0.00015556012,0.00097388256],"domain_scores_gemma":[0.99098563,0.0075754765,0.00058981625,0.0005281469,0.00025395598,0.00006696157],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.003431332,0.0005554603,0.0013573852,0.00039550534,0.000287002,0.00001911837,0.0010731657,0.003311186,0.0088660745],"category_scores_gemma":[0.00048659713,0.0005194861,0.00044363656,0.00085979025,0.0010065134,0.00006204448,0.0006169632,0.007889473,0.0001519751],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003981177,0.00090668973,0.0006337837,0.000029909866,0.0011306048,0.00004130544,0.00003459164,0.000004827086,0.0045445827,0.000011283003,0.98739785,0.0048664724],"study_design_scores_gemma":[0.002887564,0.0006074957,0.00026632345,0.000024956416,0.0010423452,0.0000044211984,0.000052644544,0.000016106218,0.0007769816,0.00024928153,0.9935442,0.0005276501],"about_ca_topic_score_codex":0.000011406308,"about_ca_topic_score_gemma":0.000026918418,"teacher_disagreement_score":0.22308397,"about_ca_system_score_codex":0.0002683777,"about_ca_system_score_gemma":0.0008038574,"threshold_uncertainty_score":0.9997257},"labels":[],"label_agreement":null},{"id":"W4313827968","doi":"10.1002/cpt.2842","title":"Predicting Treatment Responses in Patients With Osteoarthritis: Results From Two Phase III Tanezumab Randomized Clinical Trials","year":2023,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Osteoarthritis Treatment and Mechanisms","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Institute of Dental and Craniofacial Research; Pfizer; Eli Lilly and Company","keywords":"WOMAC; Placebo; Osteoarthritis; Physical therapy; Medicine; Clinical trial; Placebo response; Randomized controlled trial; Internal medicine; Pathology","score_opus":0.1540398353393806,"score_gpt":0.4839731938438626,"score_spread":0.329933358504482,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4313827968","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9867134,0.0007196804,0.000017391061,0.003210426,0.0030577148,0.0051501514,0.000586499,0.0003632469,0.0001815037],"genre_scores_gemma":[0.98475736,0.0033887078,0.0005405228,0.0068144947,0.0017421835,0.0003813674,0.0013468815,0.000095102114,0.000933376],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9853949,0.008212681,0.0041819294,0.001053934,0.00044426773,0.0007122702],"domain_scores_gemma":[0.96987283,0.02791564,0.0009842828,0.0005455819,0.00024029036,0.00044136815],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0107062375,0.0005229754,0.0035671415,0.0002721314,0.0001502333,0.000038852064,0.00019314478,0.00051324227,0.00018425565],"category_scores_gemma":[0.0017756145,0.0003620992,0.00087738776,0.0004420964,0.0006936376,0.00013456428,0.000084876454,0.00079233706,0.00017279184],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.72737545,0.004015233,0.04848824,0.0000044789513,0.0018806116,0.0006459617,0.00036196568,0.0000052471514,0.00035460034,0.000004082802,0.00038326855,0.21648088],"study_design_scores_gemma":[0.9546041,0.025652848,0.0068644383,0.00018773733,0.0056222593,0.0000064632195,0.00014028697,0.0006481838,0.0009669681,0.00014031617,0.004842588,0.00032383963],"about_ca_topic_score_codex":0.000035248802,"about_ca_topic_score_gemma":0.000061509694,"teacher_disagreement_score":0.22722864,"about_ca_system_score_codex":0.0001495079,"about_ca_system_score_gemma":0.00044906783,"threshold_uncertainty_score":0.9998831},"labels":[],"label_agreement":null},{"id":"W4317698015","doi":"10.1002/cpt.2854","title":"<scp><i>ABCB1</i></scp> Gene Variants and Antidepressant Treatment Outcomes: A Systematic Review and Meta‐Analysis Including Results from the <scp>CAN‐BIND</scp>‐1 Study","year":2023,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"St. Michael's Hospital; Douglas Mental Health University Institute; McGill University; Simon Fraser University; St. Joseph’s Healthcare Hamilton; Royal Ottawa Mental Health Centre; McMaster University; Queen's University; University of British Columbia; Centre for Addiction and Mental Health; University of Guelph; University of Calgary; University Health Network; University of Toronto","funders":"Janssen Canada; H. Lundbeck A/S; Pfizer Canada; Michael Smith Health Research BC; Mitacs; Eisai; Allergan; Canadian Network for Mood and Anxiety Treatments; Canadian Institutes of Health Research; Sunovion; Servier; Natural Sciences and Engineering Research Council of Canada; Fondation Brain Canada; Pfizer; Government of Ontario; Bristol-Myers Squibb","keywords":"Antidepressant; Single-nucleotide polymorphism; Meta-analysis; Major depressive disorder; Odds ratio; Medicine; Internal medicine; Tolerability; Oncology; Confidence interval; Genotyping; Pharmacogenetics; Pharmacology; Bioinformatics; Psychiatry; Genotype; Genetics; Biology; Gene; Adverse effect","score_opus":0.32817147146877756,"score_gpt":0.4800795561691877,"score_spread":0.15190808470041012,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4317698015","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0010493079,0.98485655,0.000034427125,0.0010877453,0.0006490972,0.0107076615,0.0013842807,0.00018756154,0.000043384072],"genre_scores_gemma":[0.00023797886,0.9825152,0.00016154679,0.012460268,0.00033598673,0.0011638507,0.0003896162,0.00018482322,0.0025507053],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.98879486,0.0034334888,0.004443355,0.0018428378,0.0006488655,0.0008365713],"domain_scores_gemma":[0.9730734,0.022510871,0.002166459,0.0015376176,0.00020302247,0.00050862104],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0046924073,0.0014162033,0.015824707,0.00029000462,0.0004189049,0.000081153165,0.0007587781,0.00078079995,0.000019294159],"category_scores_gemma":[0.00050861854,0.0007186351,0.0029788255,0.0012189316,0.0004891232,0.00005714182,0.00032100294,0.0014068575,0.000047088008],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000022124343,0.0020608285,0.00088711636,0.12576915,0.8676694,0.0009233219,0.000977482,0.0000016157774,0.0000044860503,0.0000031298484,0.0006918646,0.0009894442],"study_design_scores_gemma":[0.0032416885,0.00065725914,0.0008271435,0.009060184,0.9354747,0.00003179249,0.00034112285,0.000021957452,0.0000023579537,0.000023401682,0.05016573,0.00015265075],"about_ca_topic_score_codex":0.00005074356,"about_ca_topic_score_gemma":0.00008857129,"teacher_disagreement_score":0.11670898,"about_ca_system_score_codex":0.0001348345,"about_ca_system_score_gemma":0.00042458964,"threshold_uncertainty_score":0.9998588},"labels":[],"label_agreement":null},{"id":"W4327753841","doi":"10.1002/cpt.2894","title":"Thiopurine Methyltransferase Intermediate Metabolizer Status and Thiopurine‐Associated Toxicity During Maintenance Therapy in Childhood Acute Lymphoblastic Leukemia","year":2023,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"Children's Health Foundation","keywords":"Thiopurine methyltransferase; Maintenance therapy; Medicine; Lymphoblastic Leukemia; Oncology; Toxicity; Pharmacology; Internal medicine; Chemotherapy; Leukemia; Azathioprine","score_opus":0.04033367827705326,"score_gpt":0.37899921285048216,"score_spread":0.3386655345734289,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4327753841","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99142396,0.0010931587,0.000049485796,0.004223806,0.0011939211,0.0013831271,0.00009347841,0.00043030767,0.000108776636],"genre_scores_gemma":[0.9174694,0.062290065,0.00011908475,0.018657994,0.00050245674,0.0001579507,0.00007406231,0.0001409275,0.00058809115],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9940284,0.0009176028,0.0014990731,0.001111433,0.0006294396,0.0018140788],"domain_scores_gemma":[0.9960322,0.0021998803,0.00024955807,0.0005170808,0.00026742596,0.00073390163],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001630809,0.0006346875,0.0015142078,0.00055338006,0.00018708155,0.000038814625,0.00046353918,0.0006547214,0.00025331814],"category_scores_gemma":[0.0003156434,0.0005212586,0.00036344994,0.0013854058,0.0010161832,0.00017931416,0.0003623341,0.0018901121,0.00016639824],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.032089226,0.007992133,0.3644953,0.0004969164,0.022610983,0.0093902135,0.006090169,0.0004075125,0.49580953,0.000088822766,0.008473765,0.052055433],"study_design_scores_gemma":[0.046553947,0.0015295196,0.9251945,0.00013073515,0.0012097709,0.00012235565,0.00014002286,0.0050440715,0.017653316,0.00029131965,0.0015604193,0.00057001546],"about_ca_topic_score_codex":0.000037921178,"about_ca_topic_score_gemma":0.00002417864,"teacher_disagreement_score":0.5606992,"about_ca_system_score_codex":0.0011180995,"about_ca_system_score_gemma":0.0013699635,"threshold_uncertainty_score":0.9997239},"labels":[],"label_agreement":null},{"id":"W4362735831","doi":"10.1002/cpt.2903","title":"Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for <i>CYP2D6</i>, <i>CYP2C19</i>, <i>CYP2B6</i>, <i>SLC6A4</i>, and <i>HTR2A</i> Genotypes and Serotonin Reuptake Inhibitor Antidepressants","year":2023,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":403,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health; Alberta Children's Hospital; University of Calgary","funders":"Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Center for Advancing Translational Sciences; National Institute of Child Health and Human Development; National Institute of General Medical Sciences; National Human Genome Research Institute; National Institutes of Health; Patient-Centered Outcomes Research Institute","keywords":"CYP2C19; Pharmacogenetics; Serotonin reuptake inhibitor; Medicine; CYP2B6; CYP2D6; Guideline; Internal medicine; Genotype; Serotonin; CYP3A4; Biology; Genetics; Cytochrome P450","score_opus":0.260799143689104,"score_gpt":0.5708299925254577,"score_spread":0.31003084883635373,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362735831","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94851613,0.013446378,0.000696018,0.0148301935,0.01511685,0.004602026,0.001651451,0.00073272124,0.00040825614],"genre_scores_gemma":[0.5453092,0.16619845,0.0058427164,0.27104867,0.008424581,0.0010038937,0.00077872805,0.00046673254,0.0009270321],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9881504,0.0026784362,0.004376078,0.0021496213,0.00055630255,0.0020891214],"domain_scores_gemma":[0.9909659,0.0046638744,0.0012786676,0.00067061454,0.0009446402,0.0014763116],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.008320654,0.0011768707,0.0018794336,0.00039157414,0.0010329301,0.00013361953,0.00095358875,0.0014543647,0.0005420597],"category_scores_gemma":[0.00019508539,0.0011828222,0.00059221225,0.0009481951,0.0022692324,0.00029834142,0.0009199998,0.0023943018,0.00018249635],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003543274,0.0014958446,0.1462594,0.00027466574,0.003985549,0.00015355599,0.0006385595,0.00025858113,0.2164234,0.00014642696,0.40586504,0.2209557],"study_design_scores_gemma":[0.019419566,0.00083871116,0.012112369,0.000021503703,0.004607944,0.00006439245,0.00027290793,0.008978627,0.059389513,0.0007241533,0.8923309,0.0012394025],"about_ca_topic_score_codex":0.000014775565,"about_ca_topic_score_gemma":0.000021412721,"teacher_disagreement_score":0.48646587,"about_ca_system_score_codex":0.00005743818,"about_ca_system_score_gemma":0.00051164173,"threshold_uncertainty_score":0.9999072},"labels":[],"label_agreement":null},{"id":"W4377565617","doi":"10.1002/cpt.2956","title":"Response‐Based Dosing for Ponatinib: Model‐Based Analyses of the Dose‐Ranging OPTIC Study","year":2023,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Espace pour la vie","funders":"","keywords":"Ponatinib; Medicine; Neutropenia; Confidence interval; Internal medicine; Hazard ratio; Odds ratio; Dosing; Myeloid leukemia; Toxicity; Nilotinib; Imatinib","score_opus":0.30421762609624836,"score_gpt":0.533092272215992,"score_spread":0.22887464611974362,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4377565617","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98566455,0.00016233351,0.0011556597,0.009919762,0.00067004503,0.0021847312,0.00003756525,0.00016017497,0.000045154145],"genre_scores_gemma":[0.9786606,0.00002178291,0.0021219915,0.018441364,0.00015953236,0.00016935288,0.000020687627,0.00006674867,0.00033793715],"study_design_codex":"bench_or_experimental","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9969208,0.00082089123,0.000952528,0.00047814235,0.00035843812,0.0004692057],"domain_scores_gemma":[0.99305284,0.005679265,0.00033897214,0.0005799866,0.0002204538,0.00012846611],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020902997,0.0002680394,0.00071353774,0.00020664545,0.0001986729,0.000009395606,0.00034897053,0.00020641605,0.000059252914],"category_scores_gemma":[0.00021850971,0.00018720436,0.00049723487,0.0007278465,0.00037345692,0.000030101095,0.00009147033,0.00045287854,0.000016852811],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06490211,0.0141825685,0.08590832,0.00042189215,0.012115102,0.00027466158,0.0014641588,0.1701668,0.6286979,0.000020213045,0.009297064,0.012549258],"study_design_scores_gemma":[0.031294398,0.00246744,0.033273995,0.00007467523,0.0065939357,0.0000037378181,0.00017382983,0.8979142,0.026616536,0.000056783465,0.0013191813,0.00021128765],"about_ca_topic_score_codex":0.000005099214,"about_ca_topic_score_gemma":0.0000017761122,"teacher_disagreement_score":0.7277474,"about_ca_system_score_codex":0.00029468254,"about_ca_system_score_gemma":0.0013700463,"threshold_uncertainty_score":0.7633973},"labels":[],"label_agreement":null},{"id":"W4380871434","doi":"10.1002/cpt.2975","title":"Pharmacologic Heterogeneity and Risk of Severe Hypoglycemia with Concomitant Use of Sulfonylureas and <scp>DPP</scp>‐4 Inhibitors: Population‐Based Cohort Study","year":2023,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; McGill University","funders":"Fonds de Recherche du Québec - Santé; Canadian Institutes of Health Research; McGill University; American Diabetes Association","keywords":"Medicine; Concomitant; Hypoglycemia; Internal medicine; Gliclazide; Sitagliptin; Pharmacology; Population; Saxagliptin; Sulfonylurea; Alogliptin; Hazard ratio; Endocrinology; Insulin; Metformin; Confidence interval","score_opus":0.07703914487866334,"score_gpt":0.379905066417467,"score_spread":0.30286592153880365,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380871434","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968921,0.0002824351,0.000007829442,0.00027365712,0.0002686314,0.002093482,0.000053165742,0.00009399617,0.000034684068],"genre_scores_gemma":[0.9952131,0.0017399115,0.00033272174,0.0023457007,0.00009566085,0.00007339249,0.000054310716,0.00003203997,0.0001131649],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977643,0.00048409076,0.0007417319,0.00046154225,0.00025109228,0.0002972525],"domain_scores_gemma":[0.99675536,0.0022032051,0.00045773102,0.00024627082,0.00015545398,0.0001819538],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00080393674,0.00026477728,0.0008489681,0.00015499024,0.00007857625,0.000011599054,0.000089210196,0.00016361866,0.00001641632],"category_scores_gemma":[0.00006608932,0.00019569018,0.00010501008,0.0003235669,0.00043306279,0.00007704546,0.00013036795,0.0003115056,0.000004236271],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007627459,0.0017758666,0.9877516,0.000086106775,0.0048475917,0.000054768767,0.00007800851,0.00013962037,0.0015936806,0.0000018976868,0.001449486,0.0014585967],"study_design_scores_gemma":[0.012176647,0.004434286,0.9685524,0.000029997027,0.00996486,0.0000038684484,0.000113302995,0.0014104893,0.0017431269,0.000019050905,0.0014605992,0.000091334994],"about_ca_topic_score_codex":0.000042645905,"about_ca_topic_score_gemma":0.000024048073,"teacher_disagreement_score":0.019199194,"about_ca_system_score_codex":0.000038210303,"about_ca_system_score_gemma":0.00006539811,"threshold_uncertainty_score":0.7980014},"labels":[],"label_agreement":null},{"id":"W4385230989","doi":"10.1002/cpt.3009","title":"Design and Execution of Sustainable Decentralized Clinical Trials","year":2023,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Institutes of Health; Defense Threat Reduction Agency; Eidgenössische Technische Hochschule Zürich; European Commission; AstraZeneca; Eli Lilly and Company","keywords":"Sustainability; Process management; Health care; Clinical trial; Carbon footprint; Product (mathematics); Computer science; Business; Risk analysis (engineering); Knowledge management; Medicine; Political science","score_opus":0.9191579949922717,"score_gpt":0.6967284397073333,"score_spread":0.22242955528493835,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385230989","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00009878457,0.9775862,0.006195901,0.0064934087,0.004223269,0.0050296155,0.00019402373,0.00010978564,0.00006898517],"genre_scores_gemma":[0.0000069694174,0.9724778,0.0018838224,0.022989847,0.0011861669,0.00035297763,0.00007387225,0.00012694152,0.00090162084],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.95158243,0.021176023,0.025163148,0.0011752779,0.00011004678,0.00079304684],"domain_scores_gemma":[0.9125559,0.07027437,0.015817726,0.00070477003,0.00020406597,0.0004431998],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.19790955,0.0005514914,0.011644486,0.00049260195,0.00017596525,0.000054985434,0.0006713733,0.0017004997,0.00038446556],"category_scores_gemma":[0.009323515,0.00057188707,0.0015341169,0.00044899914,0.0007216341,0.00017792097,0.00022681995,0.0012233208,0.0010875356],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00087963656,0.0030236265,0.0019619972,0.064778775,0.026242975,0.00007614589,0.0008701316,0.0000672594,5.581946e-7,0.024779683,0.62169373,0.2556255],"study_design_scores_gemma":[0.002271455,0.00034532123,0.00008103787,0.0007426337,0.002239418,0.0000055747846,0.00011304017,0.0005749394,2.3760232e-7,0.004441494,0.9887287,0.0004561656],"about_ca_topic_score_codex":0.000029222954,"about_ca_topic_score_gemma":0.0000012691913,"teacher_disagreement_score":0.36703494,"about_ca_system_score_codex":0.00033681208,"about_ca_system_score_gemma":0.001158834,"threshold_uncertainty_score":0.99969023},"labels":[],"label_agreement":null},{"id":"W4385514873","doi":"10.1002/cpt.3006","title":"Model‐Informed Drug Development: Steps Toward Harmonized Guidance","year":2023,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Canada","funders":"","keywords":"Harmonization; Drug development; Context (archaeology); Viewpoints; Consistency (knowledge bases); Guideline; Population; Medicine; Regulatory science; Risk analysis (engineering); Drug; Computer science; Pharmacology; Environmental health","score_opus":0.7476456105265453,"score_gpt":0.5707018036775844,"score_spread":0.17694380684896094,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385514873","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7142292,0.0036938263,0.007823675,0.25856718,0.008134951,0.001985606,0.00025965212,0.0009078814,0.004398],"genre_scores_gemma":[0.37126628,0.0043942444,0.01512804,0.5971338,0.0015503918,0.0005088631,0.00015088182,0.00016079443,0.009706679],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9910936,0.00056540914,0.0065189344,0.00081332127,0.00013794181,0.000870804],"domain_scores_gemma":[0.9936897,0.0033232332,0.0020118835,0.0004899716,0.00012909778,0.0003561109],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.017621197,0.00033225602,0.001382576,0.00032048128,0.00032607195,0.000060244925,0.00077611464,0.00035846044,0.0006166291],"category_scores_gemma":[0.0006457579,0.0004039973,0.00028213905,0.00044784183,0.00029448426,0.0003487533,0.00020227056,0.0006083851,0.013375595],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028462277,0.0005769477,0.04972582,0.00046527604,0.0016426622,0.000012612375,0.008621458,0.0028516124,0.000078505465,0.0039813556,0.9284283,0.0033308112],"study_design_scores_gemma":[0.0043085613,0.000078079436,0.017940124,0.000038933842,0.00007784583,0.0000025627216,0.00045279117,0.15604654,0.00011330346,0.006727277,0.8134967,0.0007172658],"about_ca_topic_score_codex":0.000014272423,"about_ca_topic_score_gemma":0.000016580538,"teacher_disagreement_score":0.34296295,"about_ca_system_score_codex":0.0004407358,"about_ca_system_score_gemma":0.00079316314,"threshold_uncertainty_score":0.9998412},"labels":[],"label_agreement":null},{"id":"W4386462042","doi":"10.1002/cpt.3044","title":"PharmVar Tutorial on <i>CYP2D6</i> Structural Variation Testing and Recommendations on Reporting","year":2023,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":51,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"MD Precision (Canada); University of Calgary","funders":"National Human Genome Research Institute; National Institute on Drug Abuse; National Institutes of Health","keywords":"Variation (astronomy); CYP2D6; Medical physics; Medicine; Internal medicine; Physics","score_opus":0.6853737617081412,"score_gpt":0.635492340409372,"score_spread":0.04988142129876927,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386462042","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.003253311,0.90632206,0.000022831437,0.0036623369,0.07841417,0.0042423736,0.0010264626,0.0009887797,0.0020676602],"genre_scores_gemma":[0.00021724786,0.95301455,0.00046789116,0.032515485,0.012229124,0.0003666448,0.00024301076,0.0003044959,0.0006415483],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.98661524,0.004684247,0.0052147144,0.0017777246,0.0004445865,0.0012634827],"domain_scores_gemma":[0.9762844,0.016950909,0.005120131,0.0005853931,0.00032902585,0.00073015195],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["metaepi_narrow","research_integrity"],"category_scores_codex":[0.0058986647,0.0013208378,0.0032813605,0.0005170564,0.001089161,0.00010561654,0.0008904052,0.0021659585,0.00059070386],"category_scores_gemma":[0.0012063417,0.0011649968,0.00092819904,0.0009806801,0.0006228632,0.00011426333,0.00045071426,0.0064712595,0.0007565782],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003651297,0.00056521205,0.0000774156,0.0012396774,0.0040302505,0.00017177023,0.00016510244,0.00011206751,0.00020785209,0.0001724524,0.017949663,0.9749434],"study_design_scores_gemma":[0.002950225,0.0005472787,0.00008617197,0.0007160977,0.011816492,0.000072788636,0.000011374024,0.0017511871,0.00008391423,0.000699397,0.9802267,0.0010383817],"about_ca_topic_score_codex":0.0000074914883,"about_ca_topic_score_gemma":0.000001440831,"teacher_disagreement_score":0.973905,"about_ca_system_score_codex":0.000226375,"about_ca_system_score_gemma":0.00070991775,"threshold_uncertainty_score":0.9999543},"labels":[],"label_agreement":null},{"id":"W4387297227","doi":"10.1002/cpt.3068","title":"Nicotine Metabolite Ratio Decreases After Switching Off Efavirenz‐Based Therapy in People With <scp>HIV</scp> Who Smoke","year":2023,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"HIV/AIDS Research and Interventions","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"National Institute of Allergy and Infectious Diseases; National Institute of General Medical Sciences; National Heart, Lung, and Blood Institute; National Institute of Mental Health; Center for AIDS Research, University of Washington; Canada Research Chairs; University of Washington; Canadian Institutes of Health Research; Penn Mental Health AIDS Research Center; Cambia Health Foundation; National Institute on Alcohol Abuse and Alcoholism; University of Pennsylvania","keywords":"Efavirenz; CYP2A6; Cotinine; Regimen; Chemistry; Metabolite; Human immunodeficiency virus (HIV); Nicotine; Emtricitabine; Antiretroviral therapy; Pharmacology; Medicine; Internal medicine; Viral load; CYP3A4; Virology; Metabolism; Biochemistry","score_opus":0.08329523741160537,"score_gpt":0.43707824951528446,"score_spread":0.3537830121036791,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387297227","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9849665,0.0029033988,0.0005629788,0.0096562635,0.00024952533,0.0009949534,0.00004752965,0.0002084179,0.00041042804],"genre_scores_gemma":[0.94067323,0.0075426684,0.00028004512,0.044620596,0.0006618206,0.00041571658,0.00019426714,0.00010334522,0.005508327],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9962806,0.0008697555,0.0009681049,0.00060657255,0.00042763047,0.0008472984],"domain_scores_gemma":[0.99621856,0.0024282197,0.00017721501,0.00045079645,0.00025508212,0.0004701326],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0013516339,0.0003418717,0.000860951,0.00042387587,0.00013328243,0.00004653498,0.0003105976,0.0002580325,0.00047066621],"category_scores_gemma":[0.00021622232,0.00025641633,0.00044063322,0.0010970637,0.00033823133,0.00014652249,0.00009250464,0.0012079417,0.00033490575],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035787602,0.0040326547,0.87467176,0.00011846292,0.0021974042,0.00030194796,0.0007458051,0.00009709842,0.01883372,0.000026922642,0.051838208,0.04355724],"study_design_scores_gemma":[0.0197766,0.007115224,0.7221879,0.0002346235,0.0010139302,0.000023601362,0.00027057546,0.027311565,0.012803392,0.00009769849,0.2089119,0.000253003],"about_ca_topic_score_codex":0.00004273262,"about_ca_topic_score_gemma":0.00015685122,"teacher_disagreement_score":0.15707369,"about_ca_system_score_codex":0.00006150903,"about_ca_system_score_gemma":0.0004957308,"threshold_uncertainty_score":0.9999888},"labels":[],"label_agreement":null},{"id":"W4387691682","doi":"10.1002/cpt.3078","title":"Treosulfan Exposure Predicts Thalassemia‐Free Survival in Patients with Beta Thalassemia Major Undergoing Allogeneic Hematopoietic Cell Transplantation","year":2023,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"Medical Research Council; The Wellcome Trust DBT India Alliance; Department of Biotechnology, Ministry of Science and Technology, India; Wellcome Trust","keywords":"Treosulfan; Medicine; Hematopoietic stem cell transplantation; Internal medicine; Transplantation; ThioTEPA; Hazard ratio; Thalassemia; Oncology; Confidence interval; Busulfan; Chemotherapy","score_opus":0.04065219798733664,"score_gpt":0.3372681177469051,"score_spread":0.29661591975956847,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387691682","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99279475,0.00016543047,0.00036171294,0.0027441308,0.0012684584,0.001425538,0.0000787675,0.0003056045,0.00085558224],"genre_scores_gemma":[0.9928285,0.0016626738,0.00045719484,0.0038014469,0.00024872448,0.00008920646,0.0005048337,0.000120583,0.0002868496],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.995892,0.0006095869,0.0012484123,0.0007831043,0.00069151993,0.00077537197],"domain_scores_gemma":[0.9964627,0.002228973,0.00029459936,0.00053293403,0.00016727248,0.0003134907],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00097000785,0.00045608214,0.00086966314,0.00029751676,0.000117948475,0.000022878197,0.0003832177,0.00055810285,0.0001416097],"category_scores_gemma":[0.000018179482,0.00039028787,0.00021371078,0.00077062414,0.00027842086,0.00012991061,0.000048592992,0.00085867534,0.00014211451],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022826775,0.0011919909,0.98798054,0.00078870903,0.00053616206,0.00037809744,0.0009475525,0.00012423433,0.004512212,0.000012809813,0.0008251846,0.00041984566],"study_design_scores_gemma":[0.02790471,0.0017426783,0.95771366,0.0002908412,0.002432335,0.00003383583,0.00024368848,0.00018734839,0.008680012,0.00008657117,0.00027415666,0.00041015897],"about_ca_topic_score_codex":0.0000052372875,"about_ca_topic_score_gemma":0.00005309083,"teacher_disagreement_score":0.03026686,"about_ca_system_score_codex":0.0001115092,"about_ca_system_score_gemma":0.00036624525,"threshold_uncertainty_score":0.9998549},"labels":[],"label_agreement":null},{"id":"W4389069801","doi":"10.1002/cpt.3112","title":"Pharmacogenetics of Biochemically Verified Abstinence in an Opioid Agonist Therapy Randomized Clinical Trial of Methadone and Buprenorphine/Naloxone","year":2023,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Opioid Use Disorder Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Waypoint Centre for Mental Health Care; British Columbia Centre on Substance Use; Université de Montréal; Public Health Ontario; University of British Columbia; Centre for Family Medicine; Centre Hospitalier de l’Université de Montréal; University of Toronto; Centre for Addiction and Mental Health","funders":"Health Canada; University of Toronto; Michael Smith Health Research BC; Department of Psychiatry, University of Toronto; Pfizer; Canadian Institutes of Health Research; GW Pharmaceuticals; Centre for Addiction and Mental Health Foundation; BrainsWay; Indivior; National Institutes of Health; Centre for Addiction and Mental Health","keywords":"Methadone; Buprenorphine; Medicine; Opioid use disorder; Opioid; (+)-Naloxone; Pharmacology; Pharmacogenetics; Randomized controlled trial; Internal medicine; Anesthesia; Genotype; Biology","score_opus":0.14027334896993393,"score_gpt":0.47521284732280694,"score_spread":0.334939498352873,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389069801","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.989722,0.0033394855,0.00007955738,0.002695892,0.0014401439,0.002561462,0.000039453687,0.00008380044,0.000038190745],"genre_scores_gemma":[0.9055748,0.08516127,0.0030825278,0.0053521395,0.00046597872,0.0001446752,0.00010505214,0.00006280001,0.000050770377],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9940189,0.001637581,0.0028763379,0.00068252924,0.0003535903,0.0004310574],"domain_scores_gemma":[0.9935812,0.004628209,0.00071996346,0.00049053045,0.00028443962,0.00029566817],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0042107543,0.00036837894,0.0022926896,0.00023217767,0.000040055802,0.000007880174,0.0003323599,0.0004670908,0.00011470133],"category_scores_gemma":[0.00027464912,0.0002990205,0.0005363986,0.0005730746,0.0019333923,0.000046258818,0.00013432222,0.000720703,0.000012659255],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7496218,0.009429336,0.03883681,0.00014041051,0.0025097702,0.000050906743,0.0005814798,0.00001437895,0.1667849,0.0000130059225,0.00030344925,0.031713754],"study_design_scores_gemma":[0.9039983,0.005799324,0.038929194,0.00006952306,0.002698839,0.0000062400236,0.00009336679,0.003080555,0.043049417,0.0003654192,0.001588494,0.0003213049],"about_ca_topic_score_codex":0.00001909452,"about_ca_topic_score_gemma":0.0000020234693,"teacher_disagreement_score":0.15437652,"about_ca_system_score_codex":0.000024167108,"about_ca_system_score_gemma":0.00039964152,"threshold_uncertainty_score":0.9999462},"labels":[],"label_agreement":null},{"id":"W4389322814","doi":"10.1002/cpt.3124","title":"Characterization of <i>CYP2B6</i> and <i>CYP2A6</i> Pharmacogenetic Variation in <scp>Sub‐Saharan</scp> African Populations","year":2023,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Manitoba","funders":"National Institutes of Health; Medical Research Council; South African Medical Research Council; National Research Foundation; Wellcome Trust; National Human Genome Research Institute; GlaxoSmithKline; National Institute of Allergy and Infectious Diseases; Bill and Melinda Gates Foundation","keywords":"1000 Genomes Project; Allele; Pharmacogenetics; Haplotype; CYP2A6; Genetics; Biology; Allele frequency; Genotype; Evolutionary biology; Gene; Single-nucleotide polymorphism","score_opus":0.21288528920082814,"score_gpt":0.4750250815627104,"score_spread":0.26213979236188223,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389322814","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9861809,0.0022682426,0.0002490106,0.003000719,0.006080806,0.0011739697,0.00030297638,0.00023921927,0.00050415925],"genre_scores_gemma":[0.93982357,0.032554027,0.00017072198,0.025790213,0.0009504207,0.00018028382,0.00018765948,0.00009956456,0.00024356485],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9939765,0.0019799918,0.0018869648,0.0008430811,0.0003386427,0.0009748555],"domain_scores_gemma":[0.99607104,0.002142454,0.0007358279,0.0003191182,0.00026016397,0.0004714215],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0025864393,0.00052057364,0.0009256893,0.0006073283,0.00026690742,0.000028922046,0.0005594238,0.00063145364,0.00014272348],"category_scores_gemma":[0.00011657663,0.00055503007,0.00026386022,0.0016018174,0.00068813516,0.00020277803,0.00028358883,0.0014092567,0.00017164192],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002109539,0.0009056939,0.024006154,0.00007250525,0.0005594966,0.00003899477,0.0010627132,0.00062827097,0.95361423,0.00008970978,0.0040819743,0.014729277],"study_design_scores_gemma":[0.009702567,0.00027719006,0.34256765,0.00003203409,0.0024059166,0.000024576962,0.00013021853,0.031232052,0.29992193,0.0012627856,0.31197304,0.0004700646],"about_ca_topic_score_codex":0.000008940934,"about_ca_topic_score_gemma":0.000010085244,"teacher_disagreement_score":0.6536923,"about_ca_system_score_codex":0.000054399312,"about_ca_system_score_gemma":0.00020758063,"threshold_uncertainty_score":0.9996901},"labels":[],"label_agreement":null},{"id":"W4389508203","doi":"10.1002/cpt.3133","title":"Challenging the Norm: A Multidisciplinary Perspective on Intravenous to Subcutaneous Bridging Strategies for Biologics","year":2023,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Canada","funders":"","keywords":"Dosing; Medicine; Bridging (networking); Comparability; Pharmacology; Patient safety; Intensive care medicine; Risk analysis (engineering); Computer science","score_opus":0.33356432890633997,"score_gpt":0.539773575557006,"score_spread":0.20620924665066603,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389508203","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00008865399,0.9779503,0.0011749166,0.009461656,0.0069939024,0.0034227327,0.00038625882,0.00029189565,0.00022969459],"genre_scores_gemma":[0.00018478862,0.9838054,0.0003379339,0.013054417,0.0011463731,0.00041234714,0.00006380507,0.00013144923,0.0008634966],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99418217,0.0020485807,0.0014266307,0.0012031986,0.00006657792,0.0010728596],"domain_scores_gemma":[0.98730206,0.011284788,0.00052405574,0.0005654135,0.00022251694,0.00010115268],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0021216404,0.0008130638,0.0025267852,0.00022272921,0.00067890325,0.000051143947,0.0012283721,0.0018394487,0.00010247775],"category_scores_gemma":[0.00016215023,0.00047910083,0.0013995732,0.00046774992,0.0011155087,0.000026922831,0.00045981383,0.002636678,0.00051394996],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001145312,0.0010931885,0.0000025868642,0.0015388444,0.010517321,0.00013877318,0.00063933193,0.00003114845,0.00017913054,0.0023834393,0.011387008,0.9709439],"study_design_scores_gemma":[0.0008018809,0.0036086242,0.000008501288,0.0008690458,0.006260714,0.00013527455,0.00086040155,0.00007254294,0.000023592296,0.0014899324,0.9851598,0.0007096558],"about_ca_topic_score_codex":0.000008277344,"about_ca_topic_score_gemma":0.000010519296,"teacher_disagreement_score":0.9737728,"about_ca_system_score_codex":0.00023663127,"about_ca_system_score_gemma":0.00045900748,"threshold_uncertainty_score":0.99976605},"labels":[],"label_agreement":null},{"id":"W4389628350","doi":"10.1002/cpt.3097","title":"Animal‐to‐Human Dose Translation of ANTHRASIL for Treatment of Inhalational Anthrax in Healthy Adults, Obese Adults, and Pediatric Subjects","year":2023,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Bacillus and Francisella bacterial research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Emergent BioSolutions (Canada); Centre for Drug Research and Development","funders":"","keywords":"Medicine; Pediatrics; Intensive care medicine","score_opus":0.10329842705157029,"score_gpt":0.45367051999075125,"score_spread":0.350372092939181,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389628350","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960432,0.0017672351,0.000039302762,0.00094585406,0.00023980493,0.00080573827,0.00013908856,0.000007735155,0.000012060109],"genre_scores_gemma":[0.9845062,0.014241408,0.00020573405,0.00040870777,0.00039780096,0.000063808686,0.00014656712,0.000019288498,0.00001051739],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9985336,0.00015602063,0.00059565675,0.0003450078,0.00009925781,0.00027045814],"domain_scores_gemma":[0.9991913,0.00029249996,0.0001277084,0.0001288993,0.00014901954,0.00011059935],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040554086,0.00013430208,0.00033363086,0.00011939564,0.00005150704,0.0000034037716,0.00010476842,0.00023411828,0.00001953233],"category_scores_gemma":[0.000024407333,0.00012350647,0.00010861682,0.00022692309,0.00018544581,0.000004207762,0.000032531127,0.00006673286,0.000002398806],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04296095,0.0024444289,0.17032646,0.00043588132,0.0002870961,0.000005860659,0.00080844265,0.000046499335,0.71417,0.00002887968,0.0004125925,0.06807293],"study_design_scores_gemma":[0.038154073,0.049136184,0.81197965,0.000048612357,0.0003555322,0.0000039262873,0.00019741627,0.0027347086,0.08507468,0.00016032689,0.01163337,0.00052149413],"about_ca_topic_score_codex":0.000017290831,"about_ca_topic_score_gemma":0.00006153868,"teacher_disagreement_score":0.64165324,"about_ca_system_score_codex":0.000014523171,"about_ca_system_score_gemma":0.00013709905,"threshold_uncertainty_score":0.50364476},"labels":[],"label_agreement":null},{"id":"W4389681401","doi":"10.1002/cpt.3115","title":"Current Perspectives on Data Sharing and Open Science in Pharmacogenomics","year":2023,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Genetic Associations and Epidemiology","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Research Institute in Oncology and Hematology; Children's Hospital Research Institute of Manitoba; Health Sciences Centre; CancerCare Manitoba; Research Manitoba; University of Manitoba","funders":"","keywords":"Genome-wide association study; Pharmacogenomics; Data science; Pooling; Data sharing; Genomics; Statistical power; Computer science; Data mining; Computational biology; Biology; Bioinformatics; Statistics; Genome; Medicine; Genetics; Artificial intelligence","score_opus":0.2853482510302646,"score_gpt":0.5334135100286765,"score_spread":0.24806525899841192,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389681401","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99264705,0.0012906421,0.000057818528,0.004344785,0.0010679024,0.0003191067,0.00003334247,0.000016094933,0.00022324122],"genre_scores_gemma":[0.96717656,0.024051543,0.00036068808,0.0077450774,0.0004495614,0.000025446638,0.00008424274,0.000019775387,0.000087134715],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99792016,0.00021342002,0.0004001961,0.0009924236,0.00007927875,0.00039450589],"domain_scores_gemma":[0.99898744,0.00015865362,0.00012122909,0.0005525622,0.00006722864,0.00011287278],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0032266825,0.00013647723,0.0002453915,0.00010005722,0.00016121031,0.000038005008,0.0020628646,0.00012660159,0.00001858996],"category_scores_gemma":[0.00015499984,0.00013031103,0.000035339504,0.00030827342,0.00074570446,0.000010192981,0.0032321487,0.00031519958,0.000031837008],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005633177,0.001067644,0.7853959,0.000017106946,0.00041374195,0.000013137228,0.000605984,0.00065691443,0.119209215,0.00021314624,0.034209352,0.057634547],"study_design_scores_gemma":[0.0061316025,0.0009899458,0.6996244,0.000022175442,0.00029718905,0.000010180953,0.0013241129,0.044797957,0.0025460187,0.0013939111,0.24212669,0.0007357913],"about_ca_topic_score_codex":0.000005220723,"about_ca_topic_score_gemma":0.000008485515,"teacher_disagreement_score":0.20791735,"about_ca_system_score_codex":0.000031262774,"about_ca_system_score_gemma":0.00020962549,"threshold_uncertainty_score":0.531393},"labels":[],"label_agreement":null},{"id":"W4391322849","doi":"10.1002/cpt.3162","title":"<scp>CYP2D6</scp> Phenotype Influences Pharmacokinetic Parameters of Venlafaxine: Results from a Population Pharmacokinetic Model in Older Adults with Depression","year":2024,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Treatment of Major Depression","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"Taylor Family Institute for Innovative Psychiatric Research, Washington University School of Medicine in St. Louis; National Center for Advancing Translational Sciences; National Institute of Mental Health; Campbell Family Mental Health Research Institute","keywords":"Ven; CYP2D6; Pharmacokinetics; Medicine; Pharmacology; NONMEM; Population; Pharmacogenetics; Active metabolite; Internal medicine; Chemistry; Cytochrome P450; Genotype","score_opus":0.05019779129283248,"score_gpt":0.3910578229988767,"score_spread":0.34086003170604423,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391322849","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98837113,0.007038683,0.00026250392,0.0011859764,0.0011783158,0.0014157848,0.000118078446,0.00022223487,0.00020730578],"genre_scores_gemma":[0.9892017,0.0021392715,0.0031138463,0.004658393,0.00033060653,0.00010200277,0.00020887631,0.00009410169,0.00015120005],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9960046,0.00041078764,0.0014625362,0.0010476981,0.0005479436,0.0005264266],"domain_scores_gemma":[0.9962473,0.0025098466,0.00039755172,0.00042079066,0.00015315546,0.00027134182],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00048663476,0.00047758938,0.00085874635,0.00032393393,0.000054531283,0.000023642597,0.00030292966,0.00039385978,0.0000588981],"category_scores_gemma":[0.00008472987,0.00035576898,0.00023288006,0.000559079,0.00034817462,0.00020114082,0.00011345979,0.0010594116,0.000036843256],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.034144133,0.011068453,0.46851256,0.00120744,0.006215671,0.0016193145,0.0071160644,0.06003378,0.19373544,0.0000064320543,0.014991856,0.20134887],"study_design_scores_gemma":[0.039690837,0.0016444696,0.46916348,0.0024118405,0.0064342646,0.000031526935,0.0001430796,0.44495037,0.033536196,0.0002398879,0.0014155288,0.00033853922],"about_ca_topic_score_codex":0.0001080979,"about_ca_topic_score_gemma":0.000010983123,"teacher_disagreement_score":0.3849166,"about_ca_system_score_codex":0.00011440557,"about_ca_system_score_gemma":0.00018947688,"threshold_uncertainty_score":0.99988943},"labels":[],"label_agreement":null},{"id":"W4391931994","doi":"10.1002/cpt.3210","title":"Genetic Prediction of Smoking Cessation Medication Side Effects: A Genome‐Wide Investigation of Abnormal Dreams on Varenicline","year":2024,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Smoking Behavior and Cessation","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"National Cancer Institute; National Institute on Drug Abuse; Canadian Institutes of Health Research; National Institutes of Health","keywords":"Varenicline; Smoking cessation; Medicine; Genome-wide association study; Odds ratio; Bupropion; Internal medicine; Nicotine replacement therapy; Allele; Nicotine; Placebo; Genotype; Genetics; Single-nucleotide polymorphism; Biology; Pathology","score_opus":0.07445360903375202,"score_gpt":0.39481104279617507,"score_spread":0.32035743376242304,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391931994","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99163944,0.0005567223,0.0029735805,0.0017419193,0.0022623485,0.0005685666,0.000022188033,0.00012507844,0.000110133675],"genre_scores_gemma":[0.993788,0.0008036626,0.00019452059,0.0042762547,0.00067103596,0.000048467784,0.00015565984,0.00003472649,0.000027686041],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976035,0.00034313355,0.0010984129,0.0003518332,0.0004178813,0.00018524128],"domain_scores_gemma":[0.9978155,0.0012743762,0.0003553492,0.00023529575,0.00020849318,0.00011102413],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009933303,0.00017483841,0.00039835786,0.00024012642,0.000049190592,0.000008642254,0.000116626594,0.0003596741,0.000074360476],"category_scores_gemma":[0.00007481646,0.00015610545,0.0001783249,0.00036275154,0.00035147415,0.00009175236,0.00002616355,0.0005436953,0.0000048556635],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006029619,0.00062073173,0.8253889,0.0006961966,0.0010333505,0.000028303222,0.0008436495,0.00037141418,0.13938607,0.000042548945,0.00052686513,0.030459002],"study_design_scores_gemma":[0.0021161332,0.0014780674,0.947667,0.00025866006,0.0030793888,0.000015765614,0.000032992837,0.005208065,0.039096124,0.00028564048,0.0006641999,0.00009796651],"about_ca_topic_score_codex":0.000008817567,"about_ca_topic_score_gemma":7.002691e-7,"teacher_disagreement_score":0.122278094,"about_ca_system_score_codex":0.00011249867,"about_ca_system_score_gemma":0.0002200835,"threshold_uncertainty_score":0.6365796},"labels":[],"label_agreement":null},{"id":"W4392885091","doi":"10.1002/cpt.3235","title":"Combination Therapy With Guselkumab and Golimumab in Patients With Moderately to Severely Active Ulcerative Colitis: Pharmacokinetics, Immunogenicity and Drug–Drug Interactions","year":2024,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"Janssen Research and Development","keywords":"Golimumab; Medicine; Immunogenicity; Combination therapy; Pharmacokinetics; Pharmacology; Internal medicine; Immunology; Antibody; Adalimumab; Rheumatoid arthritis","score_opus":0.019850049621665703,"score_gpt":0.33769454991885833,"score_spread":0.31784450029719263,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392885091","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965262,0.0003963512,0.00011033901,0.0013229164,0.0003917375,0.0010306055,0.00009667907,0.00003457065,0.000090613656],"genre_scores_gemma":[0.9903033,0.0009819785,0.00015525031,0.008010054,0.00013410312,0.00011692491,0.000077779114,0.000050866154,0.00016975531],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99810815,0.0004749271,0.000377524,0.00060347497,0.00013723018,0.00029869584],"domain_scores_gemma":[0.99915874,0.00016342668,0.00009197596,0.00016651134,0.00024730654,0.00017201621],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025044425,0.00028873322,0.00026078767,0.00009521911,0.0001189282,0.000065471686,0.0001376301,0.00009290188,0.000030717678],"category_scores_gemma":[0.000007863324,0.00023847923,0.000051555508,0.00013525049,0.0003525456,0.000033200115,0.00009996249,0.0004306834,0.000006945138],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6065114,0.011141476,0.21149203,0.0003703304,0.01674076,0.00063241686,0.011553362,0.0019021926,0.021992514,0.00039538066,0.014851444,0.10241667],"study_design_scores_gemma":[0.009340828,0.0010756954,0.96965736,0.000051759394,0.00035526472,0.000009552815,0.00014070324,0.0012719859,0.009078809,0.000086899076,0.008491678,0.00043946574],"about_ca_topic_score_codex":0.000010445788,"about_ca_topic_score_gemma":0.00011665824,"teacher_disagreement_score":0.7581653,"about_ca_system_score_codex":0.000060684884,"about_ca_system_score_gemma":0.00018872364,"threshold_uncertainty_score":0.9724901},"labels":[],"label_agreement":null},{"id":"W4396623478","doi":"10.1002/cpt.3284","title":"Should You Run a Dedicated TQT Study? Sponsor and Regulatory Considerations on Substitution Pathways to Assess QT Liability","year":2024,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Cardiac electrophysiology and arrhythmias","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Celerion (Canada)","funders":"","keywords":"Drug; Medicine; Substitution (logic); Pharmacology; Business; Actuarial science; Computer science","score_opus":0.36415714434018903,"score_gpt":0.5161278685460166,"score_spread":0.15197072420582752,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396623478","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.106222436,0.88095814,0.00001544194,0.0032045427,0.0042198803,0.004801578,0.00012155616,0.0003205959,0.00013581672],"genre_scores_gemma":[0.022179054,0.94899315,0.0000866877,0.025738075,0.0020795187,0.0004759257,0.000104179824,0.00009912446,0.0002442709],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9942037,0.0021905787,0.0015242551,0.0012952603,0.00027544776,0.0005107809],"domain_scores_gemma":[0.9952083,0.0031592248,0.00028549263,0.0007084055,0.00019826095,0.00044031802],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0019074646,0.00067268667,0.0029073542,0.0002743858,0.00026384156,0.000033024346,0.00015488623,0.0012085265,0.00015993195],"category_scores_gemma":[0.00027148327,0.0005035258,0.00086468365,0.00042439153,0.00088364515,0.00003903318,0.00017874497,0.0031209728,0.00033518393],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006960651,0.018620225,0.0011152319,0.01809714,0.047519498,0.01427566,0.0012435317,0.00004330102,0.0017356541,0.0030601008,0.079526104,0.8078029],"study_design_scores_gemma":[0.0020272231,0.003914999,0.0016817285,0.0014285288,0.039177947,0.0006142206,0.000032798947,0.000042689866,0.000042400417,0.00035112022,0.9500468,0.00063958624],"about_ca_topic_score_codex":0.000001152598,"about_ca_topic_score_gemma":0.0000018785618,"teacher_disagreement_score":0.87052065,"about_ca_system_score_codex":0.0002307132,"about_ca_system_score_gemma":0.0014629614,"threshold_uncertainty_score":0.9997416},"labels":[],"label_agreement":null},{"id":"W4399590993","doi":"10.1002/cpt.3338","title":"Clinical Pharmacogenetics Implementation Consortium Guideline for <i>CYP2B6</i> Genotype and Methadone Therapy","year":2024,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"National Institutes of Health; National Human Genome Research Institute; Universidad Autónoma de Madrid; National Institute of General Medical Sciences; Canada Research Chairs","keywords":"Methadone; CYP2B6; Pharmacogenetics; Pharmacology; Medicine; Opioid; Context (archaeology); Opioid use disorder; Pharmacokinetics; Anesthesia; Genotype; Internal medicine; Chemistry; Metabolism; CYP3A4; Receptor; Biology; Cytochrome P450","score_opus":0.5190700035271528,"score_gpt":0.6601642049216446,"score_spread":0.1410942013944918,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399590993","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0006312364,0.95465475,0.000521033,0.002600448,0.032074444,0.0065898676,0.0023219995,0.00039222522,0.00021401435],"genre_scores_gemma":[0.00004993162,0.8954041,0.0027095182,0.088487394,0.010170603,0.001126669,0.0008840315,0.00050825736,0.00065949635],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9816448,0.0058822185,0.007526785,0.0026173857,0.0004659243,0.0018628894],"domain_scores_gemma":[0.9887651,0.0061891414,0.0022054228,0.00078984915,0.00070746755,0.0013429796],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","research_integrity"],"category_scores_codex":[0.010082673,0.002046621,0.0053768815,0.00053922867,0.0005714242,0.00014254708,0.001575501,0.0033628314,0.0016501929],"category_scores_gemma":[0.00007498752,0.0017132853,0.002908376,0.0007589771,0.0019296447,0.00013174885,0.00076326507,0.005564731,0.00051048],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00056957384,0.00096130156,0.00010488986,0.001933344,0.0114170695,0.00006313971,0.000087133754,0.0000047215667,0.0003138385,0.00005393476,0.1855967,0.79889435],"study_design_scores_gemma":[0.008365378,0.00082052127,0.000009229189,0.00019303864,0.054034572,0.00008664306,0.00003507728,0.0007991925,0.00040825433,0.00038741835,0.93331456,0.0015461426],"about_ca_topic_score_codex":0.000005529443,"about_ca_topic_score_gemma":0.00000480289,"teacher_disagreement_score":0.7973482,"about_ca_system_score_codex":0.00014233463,"about_ca_system_score_gemma":0.0016840425,"threshold_uncertainty_score":0.99926245},"labels":[],"label_agreement":null},{"id":"W4400745688","doi":"10.1002/cpt.3370","title":"Integrated Population Exposure–Response of Dolutegravir in HIV‐1 Supports Bridging of Clinical Response Influenced by Relevant Intrinsic and Extrinsic Patient Characteristics","year":2024,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"GlaxoSmithKline (Canada)","funders":"","keywords":"Dolutegravir; Bridging (networking); Human immunodeficiency virus (HIV); Population; Medicine; Antiretroviral therapy; Virology; Environmental health; Viral load; Computer science","score_opus":0.041195131179588805,"score_gpt":0.3980079425941253,"score_spread":0.3568128114145365,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400745688","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99201214,0.001311361,0.00005331555,0.004774646,0.0009917691,0.00070341397,0.0000851713,0.000063047395,0.000005152262],"genre_scores_gemma":[0.99473166,0.0019042668,0.0006710864,0.002125051,0.00008989807,0.000024469606,0.00013465527,0.000039749055,0.00027915504],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9945443,0.0016306973,0.0027001114,0.0005334534,0.00027146906,0.0003199389],"domain_scores_gemma":[0.99543756,0.003467644,0.00045535126,0.0002593495,0.00017427752,0.0002058205],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031557356,0.0002935478,0.0011214602,0.0003337493,0.000034966637,0.000012428336,0.00010513486,0.00036910313,0.00007016991],"category_scores_gemma":[0.00040461763,0.00023791313,0.00021780175,0.00043780723,0.0003949971,0.000082369625,0.00008900673,0.00079001754,0.000012595704],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.046680983,0.0018864119,0.7282882,0.0001323205,0.0009639945,0.00056279293,0.0010575138,0.000001619529,0.041490708,0.00001012332,0.002325509,0.17659985],"study_design_scores_gemma":[0.005490093,0.0020906946,0.9706289,0.0004057498,0.0009698602,0.000045388224,0.00013597163,0.0009370862,0.0061378498,0.00003778532,0.012876683,0.00024393694],"about_ca_topic_score_codex":0.000009934127,"about_ca_topic_score_gemma":0.0000025686627,"teacher_disagreement_score":0.24234071,"about_ca_system_score_codex":0.00011133326,"about_ca_system_score_gemma":0.0005566204,"threshold_uncertainty_score":0.97018164},"labels":[],"label_agreement":null},{"id":"W4400930961","doi":"10.1002/cpt.3380","title":"Solanidine Metabolites as Diet‐Derived Biomarkers of <scp>CYP2D6</scp>‐Mediated Tamoxifen Metabolism in Breast Cancer Patients","year":2024,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lawson Health Research Institute; London Health Sciences Centre; Western University","funders":"","keywords":"Tamoxifen; Internal medicine; Endocrinology; Metabolite; CYP2D6; Medicine; Chemistry; Breast cancer; Metabolism; Cancer; Cytochrome P450","score_opus":0.1032164564343435,"score_gpt":0.46476276253494675,"score_spread":0.36154630610060323,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400930961","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.931137,0.045390915,0.000015345477,0.004355674,0.0153722055,0.0011975722,0.001313212,0.00025667372,0.00096137647],"genre_scores_gemma":[0.9052541,0.055700608,0.000116363146,0.036509566,0.0015530022,0.00025785362,0.0001406429,0.00016541584,0.000302437],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9919631,0.002490201,0.0023390185,0.0012350348,0.00051437126,0.0014583025],"domain_scores_gemma":[0.9928849,0.004826469,0.0005887237,0.00039348193,0.00053000625,0.0007764727],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.002423967,0.00087424315,0.0016273513,0.00064529775,0.00019441573,0.000053935986,0.0010925352,0.0012126688,0.0015259414],"category_scores_gemma":[0.00014482158,0.00079010555,0.00072317943,0.0014226938,0.0013801767,0.00028162284,0.00042389217,0.00263921,0.00031683923],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002702589,0.00595879,0.13244317,0.00032790288,0.012298374,0.0002353059,0.0022754741,0.00026334953,0.7816513,0.00029776167,0.035849,0.025696993],"study_design_scores_gemma":[0.012223335,0.0004302328,0.16098118,0.00007775526,0.007241601,0.000023036815,0.00018271749,0.009954632,0.15853794,0.0008795922,0.64881706,0.00065092475],"about_ca_topic_score_codex":0.000065568966,"about_ca_topic_score_gemma":0.000011333479,"teacher_disagreement_score":0.62311333,"about_ca_system_score_codex":0.00011710791,"about_ca_system_score_gemma":0.00065744214,"threshold_uncertainty_score":0.99966174},"labels":[],"label_agreement":null},{"id":"W4400982324","doi":"10.1002/cpt.3387","title":"PharmVar GeneFocus: <i>CYP2A6</i>","year":2024,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"National Human Genome Research Institute; National Institute on Drug Abuse; Canadian Institutes of Health Research; National Institutes of Health","keywords":"CYP2A6; Allele; Genetics; Biology; Genetic variation; Gene; Phenotype; Genotype; Locus (genetics); Computational biology; Genotype-phenotype distinction; Bioinformatics","score_opus":0.5594046779091968,"score_gpt":0.6417700626406821,"score_spread":0.08236538473148536,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400982324","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00005858697,0.9332068,0.000039959956,0.0017292881,0.055867482,0.0027058194,0.0011151875,0.0008838994,0.0043929773],"genre_scores_gemma":[0.000014199554,0.9051451,0.00022162568,0.073876925,0.013973619,0.000686715,0.0002986345,0.0006231879,0.0051599625],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9842603,0.005715067,0.004447909,0.0026352936,0.00061215484,0.002329265],"domain_scores_gemma":[0.9925136,0.003124014,0.0013608531,0.0011195263,0.00031631635,0.0015656991],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"category_scores_codex":[0.0040923087,0.0024575857,0.0057833362,0.0007457063,0.00053835934,0.0001545886,0.0030129422,0.0046345475,0.005238939],"category_scores_gemma":[0.00004313331,0.0019936538,0.004155255,0.0014476972,0.0017478986,0.00016160341,0.0012577921,0.011396106,0.016540466],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001350268,0.0011246838,0.000008016907,0.004385939,0.010592427,0.00054055994,0.00009671501,0.000008326576,0.00009827349,0.000075468655,0.24731472,0.73561984],"study_design_scores_gemma":[0.002202522,0.00022971568,0.0000010121372,0.00070664915,0.0826648,0.0002267274,0.000012345465,0.00035290723,0.00015867491,0.00032671532,0.91135806,0.0017598472],"about_ca_topic_score_codex":0.0000037290486,"about_ca_topic_score_gemma":0.0000017928703,"teacher_disagreement_score":0.73386,"about_ca_system_score_codex":0.00032015351,"about_ca_system_score_gemma":0.0017549382,"threshold_uncertainty_score":0.9988161},"labels":[],"label_agreement":null},{"id":"W4400984543","doi":"10.1002/cpt.3360","title":"Racial and Ethnic Disparities in Antihypertensive Medication Prescribing Patterns and Effectiveness","year":2024,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Blood Pressure and Hypertension Studies","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"The Scarborough Hospital; University of Toronto","funders":"National Institutes of Health; University of South Dakota","keywords":"Medicine; Blood pressure; Antihypertensive drug; Ethnic group; Guideline; Internal medicine; Cohort; Demography; Gerontology; Pathology","score_opus":0.145234474189237,"score_gpt":0.45128188639284156,"score_spread":0.30604741220360454,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400984543","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9312062,0.05309694,0.000071352326,0.014055605,0.001103649,0.0003707889,0.0000079346455,0.00006143591,0.00002606025],"genre_scores_gemma":[0.938313,0.026326872,0.00003124784,0.03481479,0.00044017067,0.000029717574,0.0000061955243,0.000017583288,0.00002039253],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99870855,0.00031311542,0.00033413907,0.0003477062,0.00010157227,0.00019494032],"domain_scores_gemma":[0.9979547,0.0017614781,0.000034420867,0.000087175,0.00007287677,0.0000893357],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006270851,0.00013814765,0.0005333808,0.00008522757,0.00005947592,0.000015106112,0.00004004402,0.00020245463,0.000017766297],"category_scores_gemma":[0.000030149615,0.00010602947,0.000056204295,0.000091237314,0.00040386707,0.00006243611,0.00009188997,0.0005693372,0.0000045325514],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023875865,0.0011726706,0.69464934,0.0013237983,0.005203743,0.0009250958,0.0027189103,0.0000010792435,0.033050727,0.00014819694,0.0064869593,0.2519319],"study_design_scores_gemma":[0.0045541404,0.0006979644,0.97552675,0.00033272596,0.0037986173,0.000094225215,0.00015953284,0.001978068,0.0010079044,0.0001869164,0.011505707,0.00015742244],"about_ca_topic_score_codex":0.000027893027,"about_ca_topic_score_gemma":0.000019632995,"teacher_disagreement_score":0.28087744,"about_ca_system_score_codex":0.0000073977267,"about_ca_system_score_gemma":0.000047459467,"threshold_uncertainty_score":0.43237564},"labels":[],"label_agreement":null},{"id":"W4401522897","doi":"10.1002/cpt.3406","title":"Item Response Theory Quantifies the Relationship Between Improvements in Serum Phosphate and Patient‐Reported Outcomes in Adults With X‐Linked Hypophosphatemia","year":2024,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Parathyroid Disorders and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Hypophosphatemia; Biomarker; Population; Medicine; Internal medicine; Phosphate; Endocrinology; Chemistry; Biochemistry; Environmental health","score_opus":0.09063046115921253,"score_gpt":0.41930822129331213,"score_spread":0.3286777601340996,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401522897","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9770884,0.012723228,0.000008327855,0.008424018,0.00047428574,0.0011560374,0.000021344518,0.00006788672,0.00003649725],"genre_scores_gemma":[0.99059594,0.0008399143,0.000047233174,0.007965636,0.000035968216,0.00010841244,0.000016900285,0.00003755675,0.000352448],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99731445,0.0007468671,0.0009113905,0.0004899742,0.00018284746,0.0003544428],"domain_scores_gemma":[0.9920093,0.0074120555,0.00016030467,0.00025941132,0.000047896196,0.000111032845],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012334292,0.0002627625,0.0005212979,0.00014195406,0.00009079731,0.000026843869,0.0001071944,0.0002326025,0.00001795124],"category_scores_gemma":[0.00016603046,0.00015658376,0.000100870064,0.00038469318,0.00039135566,0.00009907085,0.000061779996,0.0007686759,0.00002107888],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009145256,0.00052966014,0.9821405,0.000024787243,0.0008232425,0.0003933556,0.0013523995,0.0000028358684,0.00011793824,0.0000404671,0.00021417685,0.005215379],"study_design_scores_gemma":[0.009527655,0.0011728836,0.9853817,0.000097966506,0.0007237265,0.000010187339,0.00048823975,0.00023592322,0.00024264242,0.0011118675,0.0008492656,0.00015794512],"about_ca_topic_score_codex":0.00001865604,"about_ca_topic_score_gemma":0.00002091626,"teacher_disagreement_score":0.013507556,"about_ca_system_score_codex":0.00007151141,"about_ca_system_score_gemma":0.00019181626,"threshold_uncertainty_score":0.63853},"labels":[],"label_agreement":null},{"id":"W4401553233","doi":"10.1002/cpt.3405","title":"<scp>PharmVar GeneFocus</scp>: <i>CYP4F2</i>","year":2024,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"National Institutes of Health; National Institute on Drug Abuse; National Institute of General Medical Sciences; Österreichische Forschungsförderungsgesellschaft; National Human Genome Research Institute; Universidad Autónoma de Madrid","keywords":"Chemistry","score_opus":0.44551167257493557,"score_gpt":0.5966109123631308,"score_spread":0.15109923978819523,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401553233","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0002295297,0.93005043,0.000049515616,0.00093286653,0.055597145,0.0031443709,0.0014329907,0.0010009338,0.007562202],"genre_scores_gemma":[0.000019923005,0.90216964,0.0002480034,0.07104529,0.013937727,0.00080856617,0.0003877072,0.00074577145,0.010637397],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.98150575,0.0067110853,0.0049957135,0.0030659286,0.00076381874,0.0029576914],"domain_scores_gemma":[0.98717004,0.0073553952,0.0017460181,0.0013024963,0.00042176034,0.0020043165],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"category_scores_codex":[0.0049486645,0.0028976293,0.0064656753,0.00089445565,0.0006777129,0.00020332143,0.0035990009,0.005608844,0.0020323533],"category_scores_gemma":[0.00013004204,0.0024176138,0.004598053,0.0017673827,0.002075276,0.00019577908,0.0015846814,0.013274276,0.016294006],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004801768,0.0013259146,0.0000164976,0.0044033127,0.011455246,0.00086114637,0.00016266035,0.000015315321,0.0001252669,0.00008961036,0.39375424,0.58774275],"study_design_scores_gemma":[0.00251018,0.00028452565,0.000002890574,0.000651315,0.07857206,0.0003557865,0.000026342079,0.00041140994,0.00029120402,0.00041935808,0.9155287,0.00094624696],"about_ca_topic_score_codex":0.0000041032445,"about_ca_topic_score_gemma":0.0000021625035,"teacher_disagreement_score":0.5867965,"about_ca_system_score_codex":0.0003414073,"about_ca_system_score_gemma":0.0020300383,"threshold_uncertainty_score":0.9988799},"labels":[],"label_agreement":null},{"id":"W4401648132","doi":"10.1002/cpt.3407","title":"Getting the Dose Right in Drug Development for Rare Diseases: Barriers and Enablers","year":2024,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Genomics and Rare Diseases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"AstraZeneca (Canada)","funders":"","keywords":"Modalities; Medicine; Intensive care medicine; Drug development; Clinical trial; Disease; Population; Orphan drug; Drug; Bioinformatics; Pharmacology; Pathology; Biology","score_opus":0.026236344515111473,"score_gpt":0.3615465485684599,"score_spread":0.33531020405334844,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401648132","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9758005,0.01755546,0.0001405879,0.004588738,0.0012544392,0.00050949276,0.000056063323,0.000020583253,0.00007414078],"genre_scores_gemma":[0.97377527,0.0021631855,0.00023521078,0.022653252,0.0005477255,0.00012264369,0.000070324335,0.000030955598,0.00040143647],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99878055,0.00014143014,0.00034847893,0.00039715483,0.000053673626,0.00027872185],"domain_scores_gemma":[0.9993662,0.00026303524,0.00004581888,0.00013707961,0.000037624297,0.0001502407],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041682538,0.0001538091,0.00015969451,0.00003201162,0.00016160014,0.000041380375,0.00020791758,0.000121368736,0.00003165594],"category_scores_gemma":[0.000025472853,0.00010716183,0.000121200515,0.0000623504,0.00025138198,0.0000037733275,0.00011918692,0.00017288224,0.000004048266],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0061466284,0.0020360462,0.07303174,0.0014727446,0.011129488,0.0007407466,0.006280225,0.0010242378,0.29554886,0.0008922307,0.38134733,0.22034974],"study_design_scores_gemma":[0.0013216357,0.00010818189,0.0043535014,0.000019797577,0.0003296678,0.000007717018,0.00032173327,0.0009736201,0.0048496383,0.0003402261,0.9871284,0.00024590254],"about_ca_topic_score_codex":0.0000014761773,"about_ca_topic_score_gemma":0.000010411286,"teacher_disagreement_score":0.6057811,"about_ca_system_score_codex":0.000018091785,"about_ca_system_score_gemma":0.00034648174,"threshold_uncertainty_score":0.43699327},"labels":[],"label_agreement":null},{"id":"W4402567628","doi":"10.1002/cpt.3404","title":"Is Pharmacogenetic Testing a Vital Tool for Enhancing Therapeutic Management of Patients Worldwide?","year":2024,"lang":"en","type":"editorial","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pharmacogenetics; Medicine; Intensive care medicine; Pharmacology; Biology; Genotype; Genetics","score_opus":0.17465712181962192,"score_gpt":0.5086332172790551,"score_spread":0.3339760954594332,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402567628","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.02320904,0.024040285,0.0005838712,0.0014596111,0.9394227,0.004825442,0.005209896,0.00037609247,0.00087306],"genre_scores_gemma":[0.04321816,0.044403132,0.0043245982,0.071179606,0.8231004,0.0024964467,0.0016002618,0.0013591365,0.008318242],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9886987,0.0016276398,0.004133811,0.0023299388,0.0011696008,0.0020403115],"domain_scores_gemma":[0.9842511,0.010779238,0.0017535929,0.0008314121,0.0017434828,0.00064116553],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","research_integrity"],"category_scores_codex":[0.0041311225,0.0017250425,0.0025426107,0.00054474507,0.00047623581,0.00009977628,0.002191227,0.0032781707,0.0011695053],"category_scores_gemma":[0.0001333584,0.0017001202,0.0017054686,0.0010084794,0.0011546732,0.00014052447,0.0009377064,0.0055099283,0.00042472628],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002354565,0.0026683502,0.00083461375,0.0025636202,0.014886055,0.000075131175,0.0003368743,0.0001085929,0.012014562,0.000017744904,0.87385625,0.090283655],"study_design_scores_gemma":[0.010616383,0.0008265057,0.00019745812,0.00024585973,0.027081927,0.0000025631396,0.00003696285,0.0023443238,0.021375954,0.0009462321,0.93481064,0.0015151999],"about_ca_topic_score_codex":0.000002831687,"about_ca_topic_score_gemma":0.0000025527265,"teacher_disagreement_score":0.11632229,"about_ca_system_score_codex":0.00026209548,"about_ca_system_score_gemma":0.0009556265,"threshold_uncertainty_score":0.9997436},"labels":[],"label_agreement":null},{"id":"W4402929046","doi":"10.1002/cpt.3445","title":"A Novel Step‐Up Dosage Regimen for Enhancing the Benefit‐to‐Risk Ratio of Mosunetuzumab in Relapsed or Refractory Follicular Lymphoma","year":2024,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada)","funders":"Genentech; Roche","keywords":"Medicine; Regimen; Follicular lymphoma; Neutropenia; Dosing; Internal medicine; Adverse effect; Refractory (planetary science); Population; Pharmacokinetics; Oncology; Lymphoma; Gastroenterology; Pharmacology; Toxicity; Biology","score_opus":0.10287831559075052,"score_gpt":0.4523550682450669,"score_spread":0.3494767526543164,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402929046","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96901816,0.0040700114,0.0074384566,0.012199003,0.0029355448,0.003928523,0.000081299106,0.00012768197,0.00020131854],"genre_scores_gemma":[0.94140345,0.0052952156,0.0032558849,0.032066137,0.0015905355,0.0007133435,0.000036006248,0.00022820082,0.015411226],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99648076,0.00041867053,0.0013658854,0.0006912565,0.00041951306,0.0006239233],"domain_scores_gemma":[0.99227786,0.006408539,0.00021421963,0.0006332528,0.00024047647,0.00022564235],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0033322533,0.00030884176,0.0008439311,0.0002402723,0.000115265255,0.000030831787,0.00045723587,0.00043339847,0.0007131645],"category_scores_gemma":[0.00022918796,0.00020489824,0.00046346558,0.0007371418,0.00040351058,0.00005682789,0.00014599318,0.00093993073,0.00003952142],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017890375,0.0015412694,0.00058613834,0.00027609224,0.0029223734,0.00011952169,0.0021346777,0.00014315586,0.7796213,0.00010273113,0.0073929396,0.18726942],"study_design_scores_gemma":[0.03772449,0.0105683,0.006229645,0.0005417088,0.0038501918,0.00011573475,0.0009913396,0.06457292,0.112456724,0.00043531577,0.76179725,0.0007163491],"about_ca_topic_score_codex":0.00004496503,"about_ca_topic_score_gemma":0.00014820314,"teacher_disagreement_score":0.7544043,"about_ca_system_score_codex":0.00033990503,"about_ca_system_score_gemma":0.00093566906,"threshold_uncertainty_score":0.8355508},"labels":[],"label_agreement":null},{"id":"W4403434151","doi":"10.1002/cpt.3466","title":"Longitudinal Analysis of Natural History Progression of Rare and Ultra‐Rare Cerebellar Ataxias Using Item Response Theory","year":2024,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Genetic Neurodegenerative Diseases","field":"Neuroscience","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Vetenskapsrådet; Uppsala Multidisciplinary Center for Advanced Computational Science; Else Kröner-Fresenius-Stiftung","keywords":"Ataxia; Cohort; Natural history study; Medicine; Cerebellar ataxia; Cohort study; Pediatrics; Natural history; Internal medicine; Psychology; Psychiatry","score_opus":0.160688855391447,"score_gpt":0.4464478865971174,"score_spread":0.2857590312056704,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403434151","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9860918,0.01143067,0.00012168774,0.0003674053,0.0015337027,0.00028692567,0.00009653468,0.000052020183,0.000019247369],"genre_scores_gemma":[0.99593383,0.00078123726,0.00016179531,0.002859834,0.000097413984,0.0000074621303,0.0000054053985,0.000031024778,0.00012198942],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9952431,0.0027632315,0.0007434682,0.0006988995,0.0002859964,0.00026534562],"domain_scores_gemma":[0.9934186,0.0057438924,0.00028178337,0.00029743311,0.0001311444,0.00012719621],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008672437,0.00023281426,0.00056686025,0.0003247732,0.000079124206,0.000013551345,0.00031881532,0.00014727148,0.0002231049],"category_scores_gemma":[0.00032093722,0.00019314252,0.00035249445,0.00062933174,0.0014806147,0.00008323368,0.00012248184,0.00043275396,0.000003011605],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026622752,0.0003270952,0.018373976,0.00008523767,0.0008127932,0.00009030071,0.00036506416,0.0001897197,0.97431886,0.000058063622,0.00032566817,0.0023909472],"study_design_scores_gemma":[0.00084929424,0.00062853366,0.058455262,0.00006400139,0.0073707514,0.000019974575,0.00007109839,0.018015174,0.9109427,0.000109604254,0.003191875,0.0002817348],"about_ca_topic_score_codex":9.711043e-7,"about_ca_topic_score_gemma":7.398422e-7,"teacher_disagreement_score":0.063376166,"about_ca_system_score_codex":0.000076539596,"about_ca_system_score_gemma":0.0002801118,"threshold_uncertainty_score":0.7876123},"labels":[],"label_agreement":null},{"id":"W4403658439","doi":"10.1002/cpt.3457","title":"Collaborative Real‐World Evidence Among Regulators: Lessons and Perspectives","year":2024,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Canada","funders":"","keywords":"Timeline; Public relations; Transparency (behavior); Preparedness; Working group; Outreach; Business; Global health; Repurposing; Observational study; Pandemic; Public health; Political science; Coronavirus disease 2019 (COVID-19); Medicine; Engineering; Nursing; Infectious disease (medical specialty); Geography","score_opus":0.5045551526292459,"score_gpt":0.6237966433062814,"score_spread":0.11924149067703549,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403658439","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00065592694,0.97854066,0.00000521526,0.0053513497,0.00960657,0.0023223804,0.00054558343,0.0005625302,0.0024098044],"genre_scores_gemma":[0.0008901484,0.9792256,0.00006254822,0.008312308,0.0039405436,0.0006210113,0.00007349259,0.00024434732,0.0066300053],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99046606,0.0036401425,0.0022343432,0.002080049,0.00034320404,0.0012361878],"domain_scores_gemma":[0.98990685,0.007071678,0.0011222889,0.0006305507,0.0003793252,0.00088928355],"candidate_categories":["metaepi_narrow","sts","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"category_scores_codex":[0.0025194366,0.0014680248,0.003513739,0.0007365285,0.0006803003,0.00013942474,0.0010664825,0.0020446486,0.0010439121],"category_scores_gemma":[0.00009372244,0.0012248596,0.0012928941,0.0018785656,0.0036000707,0.00047171564,0.000620139,0.007819883,0.0009963652],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005412386,0.0019650778,0.0007886686,0.008855362,0.022854913,0.0008958725,0.002222371,0.00002181301,0.00017592502,0.0011947977,0.2548396,0.70564437],"study_design_scores_gemma":[0.00096379436,0.00019011527,0.00011149316,0.0028083373,0.038770385,0.00005394501,0.0003814179,0.00019928536,0.000040003695,0.00020336894,0.9551768,0.0011010793],"about_ca_topic_score_codex":0.00001599045,"about_ca_topic_score_gemma":0.000039932285,"teacher_disagreement_score":0.7045433,"about_ca_system_score_codex":0.0005438024,"about_ca_system_score_gemma":0.0016961406,"threshold_uncertainty_score":0.9998693},"labels":[],"label_agreement":null},{"id":"W4404387167","doi":"10.1002/cpt.3484","title":"Hyponatremia Associated with the Use of Common Antidepressants in the <i>All of Us</i> Research Program","year":2024,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Electrolyte and hormonal disorders","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Human Genome Research Institute; Centers for Disease Control and Prevention; National Institutes of Health","keywords":"Venlafaxine; Sertraline; Escitalopram; Duloxetine; Hyponatremia; Citalopram; Bupropion; Medicine; Mirtazapine; Internal medicine; Reuptake inhibitor; Fluoxetine; Serotonin reuptake inhibitor; Antidepressant; Serotonin","score_opus":0.3985958998572817,"score_gpt":0.540353734815298,"score_spread":0.1417578349580163,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404387167","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97212315,0.0029144483,0.0000025547354,0.023193194,0.0000811279,0.0009988409,0.000011842179,0.000034240216,0.0006406346],"genre_scores_gemma":[0.97484446,0.0026886482,0.000031155396,0.022161951,0.000077481396,0.00004996515,0.000017149074,0.000024241806,0.000104932915],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971816,0.0012526806,0.0005285428,0.00023151803,0.00044043304,0.0003652414],"domain_scores_gemma":[0.99298,0.006411194,0.00010319451,0.00025557115,0.000203907,0.00004611499],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023359982,0.00012711887,0.00040279215,0.00009535702,0.000051470444,0.000017026374,0.00033611327,0.00019595349,0.000024052146],"category_scores_gemma":[0.00005588518,0.00006286721,0.00015161755,0.0006957668,0.0012076203,0.000048077116,0.00005680036,0.0016313144,0.00000421438],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01060125,0.019509092,0.422307,0.0004198046,0.010417198,0.0007023736,0.0033606964,0.00013435117,0.1279613,0.00046624037,0.22436301,0.17975767],"study_design_scores_gemma":[0.004544777,0.0065899254,0.7260359,0.00023772317,0.0024994768,0.000026606662,0.00022058241,0.0047853044,0.004048992,0.00046134827,0.25036845,0.00018095363],"about_ca_topic_score_codex":0.00003845287,"about_ca_topic_score_gemma":0.00010914255,"teacher_disagreement_score":0.30372885,"about_ca_system_score_codex":0.000025071413,"about_ca_system_score_gemma":0.00022796217,"threshold_uncertainty_score":0.708734},"labels":[],"label_agreement":null},{"id":"W4405025489","doi":"10.1002/cpt.3498","title":"Quantitative Systems Pharmacology‐Based Digital Twins Approach Supplements Clinical Trial Data for Enzyme Replacement Therapies in Pompe Disease","year":2024,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Lysosomal Storage Disorders Research","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sanofi (Canada)","funders":"Sanofi","keywords":"Medicine; Population; Enzyme replacement therapy; Pharmacodynamics; Disease; Clinical trial; Biomarker; Cohort; Glycogen storage disease; Internal medicine; Pharmacology; Pharmacokinetics; Biology; Genetics","score_opus":0.40785404046999735,"score_gpt":0.5612350576010974,"score_spread":0.15338101713110003,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405025489","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.88041055,0.027818998,0.012827246,0.03352958,0.019660896,0.02069048,0.0041414043,0.0005582243,0.00036262677],"genre_scores_gemma":[0.9651337,0.002560638,0.0013560434,0.022039888,0.0032335557,0.0014277959,0.0032523803,0.0001784117,0.00081757177],"study_design_codex":"randomized_trial","study_design_gemma":"not_applicable","domain_scores_codex":[0.99273103,0.0015172097,0.0023535108,0.0017584256,0.0006513343,0.0009884972],"domain_scores_gemma":[0.9916924,0.006183322,0.00027184567,0.0009620373,0.00027114426,0.00061922875],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0047229384,0.00049493846,0.0012687262,0.0003185617,0.00014838061,0.00017499531,0.0010569001,0.00043612145,0.0003491278],"category_scores_gemma":[0.00036585523,0.00040766702,0.00054945744,0.00052192475,0.0010585726,0.00033509912,0.00045258302,0.0015327492,0.0000964798],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5772634,0.02935043,0.04381492,0.0016895278,0.012784261,0.0008313329,0.00047294158,0.00025591478,0.0012663921,0.0002874899,0.3212678,0.010715578],"study_design_scores_gemma":[0.14439206,0.009851561,0.0014955614,0.0001140937,0.0030445673,0.00000882212,0.000549395,0.38394326,0.00005386345,0.00010991936,0.4558777,0.00055920554],"about_ca_topic_score_codex":0.000010099246,"about_ca_topic_score_gemma":0.0000027668225,"teacher_disagreement_score":0.43287134,"about_ca_system_score_codex":0.00024362993,"about_ca_system_score_gemma":0.0016661007,"threshold_uncertainty_score":0.9998375},"labels":[],"label_agreement":null},{"id":"W4405248118","doi":"10.1002/cpt.3512","title":"Mapping the Clinical Development Trajectory of Cell and Gene Therapy Products","year":2024,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Cancer Institute","keywords":"Medicine; Chimeric antigen receptor; Clinical trial; Internal medicine; Oncology; Immunotherapy","score_opus":0.2873189533852471,"score_gpt":0.4787642868699958,"score_spread":0.19144533348474868,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405248118","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95785713,0.022755923,0.000098701625,0.01501019,0.002374239,0.0012071587,0.000004409607,0.00010403742,0.00058823195],"genre_scores_gemma":[0.90622336,0.049669713,0.0026292768,0.033224206,0.0027514796,0.00008201495,0.000013775526,0.00011097435,0.005295228],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9964747,0.00081669475,0.0012654226,0.00064495474,0.00035720482,0.00044101872],"domain_scores_gemma":[0.9966122,0.0024151262,0.00013894284,0.0004173258,0.00021570531,0.0002007221],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003852476,0.00025619668,0.00065991096,0.00013102755,0.0001132638,0.000025147576,0.00030264686,0.00031371435,0.0008012384],"category_scores_gemma":[0.00003365189,0.00016456883,0.00026480816,0.00041707497,0.0012583442,0.00004082382,0.00013267228,0.0014491245,0.00005653921],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001567854,0.001373555,0.012013803,0.0002530426,0.002562176,0.00009986289,0.0016836821,0.0000014681359,0.646531,0.000007534905,0.008251415,0.32565463],"study_design_scores_gemma":[0.004218733,0.0012738514,0.047649067,0.000057270212,0.0003965515,0.00006114346,0.00016098308,0.00046490997,0.18299651,0.000073099545,0.762411,0.00023688133],"about_ca_topic_score_codex":0.000001759204,"about_ca_topic_score_gemma":7.369907e-7,"teacher_disagreement_score":0.75415957,"about_ca_system_score_codex":0.000053500113,"about_ca_system_score_gemma":0.0010148847,"threshold_uncertainty_score":0.87729985},"labels":[],"label_agreement":null},{"id":"W4405476348","doi":"10.1002/cpt.3534","title":"Prevalence Estimates of Cytochrome <scp>P450</scp> Phenoconversion in Youth Receiving Pharmacotherapy for Mental Health Conditions","year":2024,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Children's Hospital; University of Manitoba; Children's Hospital Research Institute of Manitoba; University of Calgary","funders":"","keywords":"CYP2C19; Pharmacogenetics; Medicine; Pharmacotherapy; CYP2D6; CYP2B6; Pharmacology; CYP3A4; Internal medicine; Cytochrome P450; Genotype; Biology; Genetics; Gene","score_opus":0.21507940728317868,"score_gpt":0.5323083967818297,"score_spread":0.3172289894986511,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405476348","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91664964,0.056328066,0.0010902289,0.0060940953,0.012499995,0.0034581074,0.0030982783,0.00034861444,0.00043296497],"genre_scores_gemma":[0.86899126,0.082067385,0.0013220533,0.044904448,0.0014411389,0.00030776154,0.00030163844,0.0001641718,0.00050013437],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99427706,0.0013621774,0.0018884997,0.0010002196,0.0002951169,0.0011769439],"domain_scores_gemma":[0.99354917,0.0049220137,0.0005135914,0.00028903215,0.00019745367,0.0005287638],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0033633295,0.00059401436,0.0010598004,0.00043760618,0.00036651615,0.000041331277,0.0007915332,0.00059968745,0.0007752462],"category_scores_gemma":[0.00006686571,0.00058986514,0.0005548042,0.00063113647,0.0010028653,0.00024178179,0.00017345654,0.0016947115,0.00008808155],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013353191,0.0051487256,0.020868754,0.0020774212,0.004907365,0.00006288871,0.015378192,0.001501156,0.7709991,0.00045253415,0.09637766,0.08089093],"study_design_scores_gemma":[0.019832056,0.0017968576,0.009103809,0.00043846786,0.003737372,0.000048112586,0.0010820494,0.08000112,0.1999332,0.002761233,0.68049634,0.00076935923],"about_ca_topic_score_codex":0.000011552523,"about_ca_topic_score_gemma":0.000003627814,"teacher_disagreement_score":0.5841187,"about_ca_system_score_codex":0.00018718293,"about_ca_system_score_gemma":0.00063715753,"threshold_uncertainty_score":0.99965525},"labels":[],"label_agreement":null},{"id":"W4407686581","doi":"10.1002/cpt.3551","title":"<scp>ASCPT</scp> News","year":2025,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Diverse Scientific and Economic Studies","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"School of Medicine, Indiana University; University at Buffalo; Bristol-Myers Squibb; Universiti Sains Malaysia; University of Toronto; Seoul National University; Genentech; Seoul National University Hospital; SK Life Science; Istanbul Üniversitesi-Cerrahpasa; Vertex Pharmaceuticals; University of Minnesota; Brown University; Pfizer","keywords":"Chemistry","score_opus":0.13730371267469865,"score_gpt":0.369158236514969,"score_spread":0.23185452384027033,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407686581","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.16269058,0.008694859,0.0009093441,0.0090781385,0.041380297,0.00050078135,0.00022024922,0.0001900378,0.7763357],"genre_scores_gemma":[0.14072852,0.010581903,0.0006183862,0.22310147,0.0011350429,0.000067601606,0.000016238535,0.000046515917,0.6237043],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9977724,0.00005569144,0.0010388694,0.0006548268,0.00002296155,0.0004552705],"domain_scores_gemma":[0.9984713,0.0007399619,0.00031294278,0.00032821848,0.000045199587,0.00010237744],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00095794717,0.00019337787,0.00062820816,0.00017778002,0.0002003427,0.000055600554,0.00050683913,0.00022531878,0.001959254],"category_scores_gemma":[0.000076132455,0.00021292812,0.00029904526,0.00028372993,0.0005171755,0.00010712951,0.00023351349,0.00037144785,0.014429783],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000012003877,0.0002591481,0.050073966,0.00000938711,0.0008654743,0.0000036063227,0.00022409076,0.000015236657,0.000019619069,0.008672223,0.93849826,0.0013470157],"study_design_scores_gemma":[0.0012993973,0.00005231705,0.0073828152,0.000003808827,0.0001130045,5.36557e-7,0.0002398085,0.00080130075,0.00006994876,0.008877114,0.98107964,0.0000802822],"about_ca_topic_score_codex":0.00001294685,"about_ca_topic_score_gemma":0.0000039440274,"teacher_disagreement_score":0.21402332,"about_ca_system_score_codex":0.000069405,"about_ca_system_score_gemma":0.0000506952,"threshold_uncertainty_score":0.9989531},"labels":[],"label_agreement":null},{"id":"W4408287379","doi":"10.1002/cpt.3628","title":"Evolving Recommendations for Patient Populations Among Oncology Medicines: A Quantitative and Qualitative Analysis","year":2025,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Guideline; Authorization; Medicine; Confidence interval; Family medicine; Regulatory science; Oncology; Exploratory analysis; Internal medicine; Marketing authorization; Bioinformatics; Pathology; Computer science","score_opus":0.700022351571417,"score_gpt":0.6620894597513208,"score_spread":0.03793289182009618,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408287379","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.2734307,0.0055696093,0.1592482,0.55287576,0.0043562856,0.0023394516,0.0006818168,0.00009699378,0.0014011906],"genre_scores_gemma":[0.5492315,0.0012326995,0.05063172,0.3968609,0.000335222,0.00083408906,0.00027327833,0.000039766997,0.00056079973],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9924811,0.0019201164,0.004569752,0.0006368458,0.000047424164,0.00034477076],"domain_scores_gemma":[0.9819348,0.015279619,0.0020860236,0.00026294173,0.00027299792,0.0001636336],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.013328203,0.0001985313,0.0013794281,0.00064019696,0.0003964812,0.000032580214,0.00019766479,0.0002985434,0.0002967131],"category_scores_gemma":[0.0021363408,0.00023070716,0.0002901837,0.0006348738,0.0004887463,0.00023206715,0.00007280435,0.00035250842,0.00004862464],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036394742,0.0016979674,0.29827264,0.000299222,0.0156156225,0.0000017062391,0.06298751,0.0005918173,0.000018695848,0.14307825,0.4734013,0.003671321],"study_design_scores_gemma":[0.0068534478,0.0018720721,0.1469852,0.000109343215,0.0046212967,0.0000012899563,0.05736369,0.1724819,0.000009359188,0.13147971,0.4773366,0.00088609],"about_ca_topic_score_codex":0.0001521961,"about_ca_topic_score_gemma":0.00031016138,"teacher_disagreement_score":0.27580082,"about_ca_system_score_codex":0.00036443525,"about_ca_system_score_gemma":0.00021666699,"threshold_uncertainty_score":0.94079643},"labels":[],"label_agreement":null},{"id":"W4409566964","doi":"10.1002/cpt.3658","title":"Oncology Dose Optimization: Tailored Approaches to Different Molecular Classes","year":2025,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada)","funders":"Genentech; F. Hoffmann-La Roche","keywords":"Medicine; Clinical trial; Drug; Drug development; Clinical pharmacology; Immunotherapy; Pharmacology; Oncology; Cancer; Medical physics; Computational biology; Bioinformatics; Internal medicine; Biology","score_opus":0.4881619744201073,"score_gpt":0.5448352007766311,"score_spread":0.056673226356523776,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409566964","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000045394114,0.9742663,0.0025418585,0.010369113,0.002989999,0.0055776215,0.000038930677,0.000198005,0.003972781],"genre_scores_gemma":[0.000010112093,0.9509794,0.0021752415,0.03630347,0.0014367286,0.00093451573,0.0003084845,0.00017182853,0.0076802033],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.992244,0.0027406747,0.0021649753,0.0013968926,0.00050344854,0.0009500096],"domain_scores_gemma":[0.99345136,0.0040312596,0.00048675272,0.0010469309,0.0002498361,0.0007338618],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.001092421,0.00093803793,0.004943878,0.0005946167,0.00013176317,0.00004557082,0.0009605434,0.0019829234,0.0038125305],"category_scores_gemma":[0.00011805069,0.0007273931,0.0017659102,0.0009942345,0.0007057242,0.00003316235,0.00063895766,0.003068675,0.00020627372],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010443203,0.0026069116,0.000023111797,0.006177538,0.006748184,0.00033863963,0.000044802582,0.00021478397,0.00006794483,0.00003768599,0.010189996,0.9725061],"study_design_scores_gemma":[0.0030506104,0.0020496633,0.000007852816,0.0014978222,0.013558815,0.00006852313,0.000017391552,0.00061293977,0.00004987183,0.000028082808,0.97854066,0.0005177653],"about_ca_topic_score_codex":0.0000012737431,"about_ca_topic_score_gemma":0.0000014393099,"teacher_disagreement_score":0.9719883,"about_ca_system_score_codex":0.00071378663,"about_ca_system_score_gemma":0.0026849722,"threshold_uncertainty_score":0.99951774},"labels":[],"label_agreement":null},{"id":"W4409661637","doi":"10.1002/cpt.3673","title":"The Drug Titration Paradox Updated and Reinterpreted: With Perfect Titration, Dose and Effect Will Be Uncorrelated","year":2025,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Anesthesia and Sedative Agents","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia, Okanagan Campus; University of British Columbia","funders":"","keywords":"Titration; Uncorrelated; Correlation coefficient; Population; Drug; Statistics; Correlation; Metric (unit); Medicine; Mathematics; Pharmacology; Chemistry; Operations management; Economics","score_opus":0.020176439710911733,"score_gpt":0.38002330853783933,"score_spread":0.3598468688269276,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409661637","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9753857,0.0010429149,0.00019945363,0.0217146,0.00033206755,0.00074113696,0.0000018178869,0.00005828591,0.0005239924],"genre_scores_gemma":[0.9576354,0.0016635541,0.000056102086,0.039198622,0.00007753612,0.000025618448,0.00003060434,0.000015140805,0.0012973987],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984433,0.0005921648,0.00036506838,0.0003066014,0.00010358691,0.00018924402],"domain_scores_gemma":[0.9982043,0.0013208706,0.00010462471,0.00016642605,0.00011092757,0.000092832975],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006640403,0.00017810587,0.00032558446,0.000041333435,0.00024533833,0.000028574734,0.000080791106,0.0001635173,0.000042078624],"category_scores_gemma":[0.000030001876,0.00010270269,0.00005557277,0.00016638351,0.0006306241,0.00007374688,0.0000296046,0.00050071446,0.000007152969],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018989297,0.00071089965,0.8753462,0.00012473395,0.005115086,0.00018257114,0.0011115938,0.000016326556,0.015233527,0.00046972028,0.048912004,0.033788037],"study_design_scores_gemma":[0.022468152,0.0072112917,0.6796748,0.00021067426,0.008960404,0.00018131791,0.00027808506,0.02565851,0.006223837,0.00046055354,0.24811955,0.0005528556],"about_ca_topic_score_codex":0.000004584174,"about_ca_topic_score_gemma":0.0000089919995,"teacher_disagreement_score":0.19920754,"about_ca_system_score_codex":0.00002421444,"about_ca_system_score_gemma":0.00011119891,"threshold_uncertainty_score":0.4188094},"labels":[],"label_agreement":null},{"id":"W4409852902","doi":"10.1002/cpt.3697","title":"Estimating the Frequency of False‐Negative Pharmacogenetic Test Results by Self‐Reported Ancestry","year":2025,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Children's Hospital; University of Manitoba; Children's Hospital Research Institute of Manitoba; University of Calgary","funders":"Alberta Innovates; Alberta Children's Hospital Foundation; American College Health Foundation; Children's Hospital Foundation","keywords":"Pharmacogenetics; Statistics; Test (biology); Medicine; Genetics; Biology; Mathematics; Genotype; Gene","score_opus":0.2090136641616907,"score_gpt":0.5244458290443401,"score_spread":0.3154321648826494,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409852902","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92668986,0.01721528,0.0009063446,0.022976886,0.019713761,0.002452266,0.0014892523,0.00045488786,0.008101433],"genre_scores_gemma":[0.88851434,0.006548857,0.0030359838,0.09924637,0.0013308399,0.0002202037,0.00008119043,0.00008405641,0.0009381491],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9917123,0.0025957697,0.0030646273,0.00110076,0.00040918394,0.0011173685],"domain_scores_gemma":[0.9872307,0.009481961,0.0014805162,0.0007202779,0.00066834886,0.00041818377],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0040582493,0.0007308248,0.0011333736,0.00019978854,0.0006924943,0.00003843274,0.0016841613,0.0008968197,0.00052347453],"category_scores_gemma":[0.00045041938,0.0005877676,0.00051991316,0.0011388757,0.00206679,0.00012864215,0.00040865244,0.0029739458,0.000087428925],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017545293,0.00701401,0.06089989,0.00021416093,0.0116754025,0.00010697581,0.001256402,0.0023855877,0.6275396,0.00011556853,0.22956823,0.057469673],"study_design_scores_gemma":[0.020596636,0.0006245903,0.010790098,0.00007470957,0.013776987,0.000044049,0.00017787497,0.053133596,0.4473849,0.0042124153,0.44798827,0.0011958637],"about_ca_topic_score_codex":0.000016286842,"about_ca_topic_score_gemma":0.00000410144,"teacher_disagreement_score":0.21842004,"about_ca_system_score_codex":0.00009712035,"about_ca_system_score_gemma":0.00076456595,"threshold_uncertainty_score":0.9996574},"labels":[],"label_agreement":null},{"id":"W4409956483","doi":"10.1002/cpt.3693","title":"Impaired Drug Metabolism Caused by Compound Heterozygous Loss‐of‐Function Variants in <i>CYP3A4</i>: A Case Report","year":2025,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Institute for Clinical Evaluative Sciences; Public Health Ontario; University of Toronto; Hospital for Sick Children","funders":"Hospital for Sick Children; University of Toronto","keywords":"CYP3A4; Pharmacogenetics; Medicine; Drug; Pharmacology; Population; Drug metabolism; Internal medicine; Metabolism; Biology; Genetics; Genotype; Gene","score_opus":0.11761001336131921,"score_gpt":0.47329417444472477,"score_spread":0.35568416108340556,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409956483","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96287477,0.011132306,0.0006070674,0.0051077884,0.017107252,0.001391356,0.0002575922,0.00017853282,0.001343331],"genre_scores_gemma":[0.9322463,0.0041364995,0.00015660396,0.061121624,0.000649269,0.00015974556,0.00008416885,0.000077498094,0.0013682919],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99106765,0.003376079,0.002933904,0.0011620964,0.00031330078,0.0011469512],"domain_scores_gemma":[0.9951313,0.0024038472,0.0009184343,0.00065693166,0.00040125655,0.0004882328],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.003942029,0.00072042784,0.0015971132,0.00047306583,0.0003535438,0.000032953878,0.00078811264,0.0010449812,0.000735675],"category_scores_gemma":[0.00008333086,0.00072503166,0.00054969714,0.0010590104,0.001289887,0.00018214197,0.000360601,0.0026756593,0.00006143039],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011641413,0.01901449,0.090484664,0.0004552291,0.014577011,0.07484237,0.0019795755,0.0018276076,0.4616948,0.0006501557,0.27499774,0.04783494],"study_design_scores_gemma":[0.026925344,0.00031376196,0.012272789,0.00004364972,0.008224629,0.003271042,0.00020421422,0.007816891,0.06687334,0.0023288666,0.8704904,0.0012351238],"about_ca_topic_score_codex":0.000092533264,"about_ca_topic_score_gemma":0.000055066266,"teacher_disagreement_score":0.5954926,"about_ca_system_score_codex":0.00011528549,"about_ca_system_score_gemma":0.00054649013,"threshold_uncertainty_score":0.9996252},"labels":[],"label_agreement":null},{"id":"W4409980303","doi":"10.1002/cpt.3616","title":"Modeling and Simulation to Inform Apixaban Dosing in Pediatrics With Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma Treated With Asparaginase","year":2025,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Pfizer; Bristol-Myers Squibb","keywords":"Lymphoblastic lymphoma; Lymphoblastic Leukemia; Dosing; Asparaginase; Medicine; Lymphoma; Acute lymphocytic leukemia; Oncology; Pediatrics; Internal medicine; Leukemia; Immunology","score_opus":0.08085524973616941,"score_gpt":0.43625565781602776,"score_spread":0.35540040807985834,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409980303","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98653823,0.0005558986,0.0062934537,0.005033834,0.00025509426,0.0009177843,0.000008135082,0.00009952683,0.00029804313],"genre_scores_gemma":[0.96254665,0.0018503682,0.0010380128,0.03407743,0.00018691564,0.000054602293,0.000009320911,0.00003738357,0.00019934028],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9977576,0.00016330232,0.00069991837,0.000557202,0.0002528074,0.00056915276],"domain_scores_gemma":[0.9965673,0.002514676,0.00014765558,0.00020466157,0.00022751593,0.00033815944],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00044224292,0.00037741903,0.0007353787,0.00025892883,0.00023747551,0.00004840314,0.00014252806,0.00024337403,0.000031831914],"category_scores_gemma":[0.00009407902,0.00024899832,0.00006433569,0.0011306038,0.00027646756,0.00018644743,0.00013006208,0.00039979484,0.000014553599],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.19185679,0.0030069347,0.14972284,0.0007773025,0.007165371,0.0028664714,0.0011819925,0.5357407,0.0016686706,0.000051261795,0.0006723569,0.105289355],"study_design_scores_gemma":[0.02575501,0.0029610558,0.016592866,0.00019662874,0.007128103,0.00012063354,0.00016829961,0.9395385,0.00027189308,0.00002832884,0.0068092286,0.00042947844],"about_ca_topic_score_codex":0.000034666344,"about_ca_topic_score_gemma":0.000038781953,"teacher_disagreement_score":0.40379784,"about_ca_system_score_codex":0.00058929983,"about_ca_system_score_gemma":0.0009165919,"threshold_uncertainty_score":0.99999624},"labels":[],"label_agreement":null},{"id":"W4409984050","doi":"10.1002/cpt.3702","title":"Prevalence of Actionable Pharmacogenetic Genotype Frequencies, Cautionary Medication Use, and Polypharmacy in Community‐Dwelling Older Adults","year":2025,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Children's Hospital; University of Calgary","funders":"National Institute on Aging; National Health and Medical Research Council; Monash University; National Cancer Institute; National Institutes of Health; Australian Government; Commonwealth Scientific and Industrial Research Organisation; Medical Research Council","keywords":"Polypharmacy; Pharmacogenetics; Medicine; Genotype; Pharmacogenomics; Internal medicine; Pharmacology; Genetics; Biology; Gene","score_opus":0.15653193806827218,"score_gpt":0.4792447535376588,"score_spread":0.32271281546938657,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409984050","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96408886,0.025495842,0.0003251928,0.0032018686,0.0048916196,0.0012565546,0.00014765473,0.00010033054,0.00049208896],"genre_scores_gemma":[0.90365785,0.052900143,0.0004800823,0.04189567,0.00032035974,0.00013510465,0.0000392787,0.00004496223,0.00052651984],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99277055,0.0037249303,0.0017381571,0.00069558294,0.00029048577,0.00078030553],"domain_scores_gemma":[0.9944374,0.003828338,0.00054208597,0.0004248605,0.00040765462,0.00035966304],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0030322582,0.0004949527,0.00075862405,0.00048859196,0.00046593838,0.000025190295,0.0008480244,0.0007108357,0.00092455914],"category_scores_gemma":[0.00010759583,0.0005194334,0.00020947885,0.0007315559,0.0014609816,0.0002834611,0.00037402732,0.0030365095,0.000029273719],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005727615,0.006574042,0.59268224,0.0017887154,0.0027305246,0.00006385003,0.0028468936,0.0017102652,0.2931302,0.00037563895,0.011135239,0.0812348],"study_design_scores_gemma":[0.02530256,0.0004959961,0.5742708,0.00035301424,0.006144799,0.000051016148,0.000535443,0.04092873,0.16576084,0.0016593558,0.18322824,0.0012692416],"about_ca_topic_score_codex":0.00011473144,"about_ca_topic_score_gemma":0.000015099006,"teacher_disagreement_score":0.172093,"about_ca_system_score_codex":0.00012235924,"about_ca_system_score_gemma":0.0005624784,"threshold_uncertainty_score":0.99998873},"labels":[],"label_agreement":null},{"id":"W4410136343","doi":"10.1002/cpt.3694","title":"Populations Addressed in Vaccines Approved via the European Medicines Agency","year":2025,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Vaccine Coverage and Hesitancy","field":"Social Sciences","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Marketing authorization; European union; Authorization; Family medicine; Agency (philosophy); Breastfeeding; Clinical trial; Randomized controlled trial; Inclusion (mineral); Environmental health; Pediatrics; Business; Internal medicine; Bioinformatics","score_opus":0.14306822477042724,"score_gpt":0.4754522399186983,"score_spread":0.33238401514827104,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410136343","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.54592246,0.0047472827,0.002113012,0.3696202,0.009930371,0.0014458941,0.0000053635135,0.00025248202,0.065962896],"genre_scores_gemma":[0.9172515,0.0019667516,0.00008150929,0.07737317,0.0013861207,0.000023658642,0.000004840603,0.000014739932,0.0018976995],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99627614,0.002270173,0.0006771836,0.00028637,0.00013938053,0.00035078079],"domain_scores_gemma":[0.99825466,0.0011585904,0.00014616275,0.00023974922,0.00012595931,0.00007489287],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023988022,0.0001412347,0.00027795677,0.0000943886,0.0005030685,0.000027310743,0.0006313255,0.0001431103,0.00033195014],"category_scores_gemma":[0.00014031606,0.000102630635,0.0001374578,0.00059310644,0.000145175,0.00009046189,0.00009279657,0.00050757785,0.00005620866],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026203392,0.0013322254,0.60547,0.000032205364,0.0005310539,0.00006976075,0.008649643,0.00007227545,0.0024671801,0.003992692,0.23018345,0.14693749],"study_design_scores_gemma":[0.0019045222,0.000063795385,0.66665024,0.00002260563,0.00041828866,4.8795226e-7,0.0005327689,0.00037863696,0.000040156665,0.0094993375,0.32032105,0.00016813444],"about_ca_topic_score_codex":0.00010273488,"about_ca_topic_score_gemma":0.001216724,"teacher_disagreement_score":0.37132904,"about_ca_system_score_codex":0.000041712105,"about_ca_system_score_gemma":0.00018975152,"threshold_uncertainty_score":0.41851556},"labels":[],"label_agreement":null},{"id":"W4410483842","doi":"10.1002/cpt.3619","title":"Deciphering the Relative Contribution of <scp>CYP3A4</scp> Versus P‐Glycoprotein for the Shared Substrate Cyclosporine—Commentary on Lown <i>et al</i>.","year":2025,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"P-glycoprotein; CYP3A4; Bioavailability; Pharmacokinetics; Glycoprotein; Substrate (aquarium); Pharmacology; Chemistry; Function (biology); Medicine; Internal medicine; Endocrinology; Biology; Biochemistry; Cell biology; Metabolism","score_opus":0.06248814900051441,"score_gpt":0.41263315606313505,"score_spread":0.35014500706262064,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410483842","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.69061095,0.0036107567,0.016287426,0.27587983,0.007686372,0.0045761154,0.0001471287,0.00012959693,0.0010718172],"genre_scores_gemma":[0.75404674,0.0025128275,0.00048195972,0.2416607,0.00031836936,0.00022948955,0.000090155365,0.00003381553,0.0006259559],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99805313,0.00022995185,0.00077287457,0.00035607247,0.00021081352,0.0003771341],"domain_scores_gemma":[0.9927776,0.0062682335,0.0002852017,0.00035981723,0.00022887501,0.00008027852],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013777117,0.0002458903,0.00051268225,0.00004231821,0.00024054265,0.000011401492,0.0003374067,0.00019769659,0.00004137004],"category_scores_gemma":[0.000089211964,0.00014321112,0.00041348243,0.00024779837,0.00048186118,0.000053567153,0.000043866345,0.0008377061,0.0000069500707],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.08229268,0.009664879,0.03495109,0.00048442412,0.038249984,0.00022170659,0.0026111263,0.0014613568,0.20545797,0.02386157,0.56659096,0.03415225],"study_design_scores_gemma":[0.02543527,0.0023399475,0.02404438,0.00022432998,0.005189113,0.0000022907032,0.0005008871,0.0019078596,0.08175035,0.0026224747,0.8558391,0.00014404742],"about_ca_topic_score_codex":0.000006719611,"about_ca_topic_score_gemma":0.000021673653,"teacher_disagreement_score":0.28924808,"about_ca_system_score_codex":0.00007279363,"about_ca_system_score_gemma":0.0001591322,"threshold_uncertainty_score":0.58399796},"labels":[],"label_agreement":null},{"id":"W4413115464","doi":"10.1002/cpt.70021","title":"Rules of Thumb for Estimating Drug Levels in Breast Milk: How Well Do They Work?","year":2025,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Breastfeeding Practices and Influences","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; Hospital for Sick Children; University of Toronto","funders":"Canadian Institutes of Health Research; Hospital for Sick Children","keywords":"Rule of thumb; Work (physics); Breast milk; Drug; Medicine; Statistics; Computer science; Pharmacology; Mathematics; Biology; Engineering","score_opus":0.10350450613318889,"score_gpt":0.4536804243410876,"score_spread":0.3501759182078987,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413115464","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8176511,0.0013736746,0.000673907,0.17490837,0.0027149802,0.00088230445,0.000039529255,0.00006265458,0.0016934884],"genre_scores_gemma":[0.9633542,0.00035971322,0.010257355,0.024869498,0.00047579777,0.00004042626,0.000005507186,0.000022047176,0.0006154812],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99823993,0.00022304812,0.00072961027,0.00034389092,0.00012855435,0.0003349328],"domain_scores_gemma":[0.99621624,0.0029402003,0.00034932233,0.00020952009,0.00020008178,0.00008466275],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001467411,0.00018994654,0.0006201135,0.000117703115,0.00007491715,0.000022174212,0.00027063073,0.00022985398,0.00009520553],"category_scores_gemma":[0.000082250335,0.00015119373,0.00022348228,0.00018115492,0.00037999704,0.000111551315,0.0000824766,0.00060624396,0.000010794287],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007543956,0.0039113,0.50776404,0.00090255495,0.003340374,0.00003125558,0.0014429883,0.00034052847,0.012646077,0.0009176515,0.037009846,0.4241494],"study_design_scores_gemma":[0.025601003,0.001142533,0.8192007,0.0017074121,0.006234346,0.000087596876,0.0009067181,0.020916797,0.004868616,0.010891935,0.10763605,0.0008062747],"about_ca_topic_score_codex":0.0000129609525,"about_ca_topic_score_gemma":0.0000031377479,"teacher_disagreement_score":0.42334312,"about_ca_system_score_codex":0.000034506327,"about_ca_system_score_gemma":0.00021132446,"threshold_uncertainty_score":0.61655015},"labels":[],"label_agreement":null},{"id":"W4413140803","doi":"10.1002/cpt.70018","title":"Safety and Efficacy of the NMDA‐2b‐Selective Negative Allosteric Modulator BI 1569912: A Phase Ib Randomized Trial in Major Depressive Disorder","year":2025,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Treatment of Major Depression","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Allergan; Bausch Health; H. Lundbeck A/S; National Natural Science Foundation of China; Janssen Pharmaceuticals; Gilead Sciences; Yale University; Usona Institute; Eisai; Purdue University; Novo Nordisk; Teva Pharmaceutical Industries; Biogen; Canadian Institutes of Health Research; Sunovion; Sanofi; Pfizer","keywords":"Allosteric modulator; Allosteric regulation; NMDA receptor; Randomized controlled trial; Major depressive disorder; Pharmacology; Medicine; Psychology; Psychiatry; Internal medicine; Receptor; Cognition","score_opus":0.038910241321284435,"score_gpt":0.4279431943816881,"score_spread":0.38903295306040364,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413140803","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9816649,0.0018232474,0.0003003097,0.008709412,0.0013942483,0.0057129096,0.000022960989,0.00004342761,0.00032857727],"genre_scores_gemma":[0.98825544,0.0014211732,0.00021107885,0.009240557,0.00018319221,0.00020266714,0.000009354614,0.000030358373,0.00044618075],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99553573,0.0020620557,0.0012854922,0.00056230184,0.00022142165,0.0003330073],"domain_scores_gemma":[0.9914023,0.007460324,0.00049668667,0.00037131968,0.00015436145,0.00011495682],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000871503,0.00032342027,0.0015230159,0.00015570567,0.00012090529,0.000008957896,0.00024457884,0.00036053616,0.00008211054],"category_scores_gemma":[0.0004789892,0.00019977528,0.00044992694,0.00046911038,0.0012178862,0.000058602207,0.0002323491,0.0008031066,0.0000036955591],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9592474,0.0058305515,0.009542263,0.00003805188,0.0035772957,0.00001435541,0.00042500906,0.00002499409,0.005657647,0.000026677631,0.00032556496,0.015290181],"study_design_scores_gemma":[0.95264965,0.001256354,0.029057363,0.0001345851,0.0049470677,0.0000038172366,0.000045105087,0.0016711237,0.008482982,0.00053029176,0.0010669418,0.00015472312],"about_ca_topic_score_codex":0.000020286398,"about_ca_topic_score_gemma":0.000010075981,"teacher_disagreement_score":0.0195151,"about_ca_system_score_codex":0.00009343072,"about_ca_system_score_gemma":0.00030490154,"threshold_uncertainty_score":0.81466},"labels":[],"label_agreement":null},{"id":"W4414024538","doi":"10.1002/cpt.70059","title":"<scp>GenoStaR</scp> : An R Package for Genotype to Star Allele Conversion for Major Cytochrome <scp>P450</scp> Family of Genes","year":2025,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Public Health Ontario; University of Toronto; Centre for Addiction and Mental Health","funders":"Canadian Institutes of Health Research; Myriad Genetics; Assurex Health","keywords":"Pharmacogenomics; Genotyping; Genotype; CYP2D6; Genetics; Allele; CYP2C19; Pharmacogenetics; Biology; CYP2C9; Haplotype; Computational biology; Gene","score_opus":0.1804791213810116,"score_gpt":0.4970048930810093,"score_spread":0.31652577169999774,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414024538","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9611212,0.011148112,0.008802126,0.0021338619,0.0085465815,0.0052645644,0.0017726321,0.00022815737,0.0009827383],"genre_scores_gemma":[0.6913668,0.015156147,0.013633769,0.26645327,0.003914496,0.0015904948,0.0007686332,0.00037079162,0.0067455918],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99302846,0.0014614969,0.0020764486,0.0013922452,0.00033667547,0.0017046842],"domain_scores_gemma":[0.9872641,0.009191887,0.0007127663,0.00071689865,0.0011328076,0.0009815391],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0033189962,0.0008512036,0.0016189687,0.00047267735,0.00066351774,0.00004589395,0.0016513021,0.0014061545,0.00014448361],"category_scores_gemma":[0.00035489292,0.00086242263,0.0008345883,0.0006814692,0.00087971665,0.00017538064,0.00046060156,0.0012917328,0.00011738064],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012701286,0.0025162068,0.0024458033,0.0003361705,0.0034838438,0.000017422286,0.0008662844,0.00047973613,0.8225046,0.00042745276,0.1502427,0.01540969],"study_design_scores_gemma":[0.009355138,0.00143418,0.00427991,0.000012207532,0.0035533325,0.000002965164,0.00038070747,0.003469912,0.29449463,0.0011570484,0.6816782,0.00018182423],"about_ca_topic_score_codex":0.0000124215685,"about_ca_topic_score_gemma":0.000012535076,"teacher_disagreement_score":0.53143543,"about_ca_system_score_codex":0.00012399752,"about_ca_system_score_gemma":0.00079142,"threshold_uncertainty_score":0.9998902},"labels":[],"label_agreement":null},{"id":"W4414618336","doi":"10.1002/cpt.70066","title":"Pharmacomicrobiomics","year":2025,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Gut microbiota and health","field":"Biochemistry, Genetics and Molecular Biology","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Institute for Advanced Research","funders":"","keywords":"Microbiome; Drug; Leverage (statistics); Gut microbiome; Drug development; Standardization; Drug response; Affect (linguistics)","score_opus":0.1323773628249725,"score_gpt":0.5281699447942727,"score_spread":0.39579258196930023,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414618336","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000052410513,0.99123764,0.00009897841,0.00046342105,0.006158645,0.0011275187,0.00023597275,0.000050902836,0.00057450845],"genre_scores_gemma":[0.0000027757683,0.94810605,0.00028368167,0.04500595,0.0021587738,0.000078202385,0.0007118981,0.000096201395,0.0035564702],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99573416,0.0010100021,0.001483905,0.0010267916,0.00007483885,0.00067029835],"domain_scores_gemma":[0.99814475,0.00033259354,0.0005548481,0.0006354017,0.00011926823,0.00021312296],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00068685785,0.00068717083,0.0019245134,0.00015163537,0.00016511738,0.00002755413,0.0010188238,0.0016700015,0.00017038971],"category_scores_gemma":[0.000015981124,0.0006145472,0.0013369375,0.00025436087,0.000432344,0.0000022674003,0.0005128424,0.0012242537,0.00023899732],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011054358,0.0005992524,0.000014836053,0.0067505552,0.003187866,0.000014930138,0.000006439217,6.2950454e-7,0.003113354,0.0000061450796,0.3548705,0.63132495],"study_design_scores_gemma":[0.0010291459,0.00021984064,0.0000027445737,0.0006860325,0.0042975284,0.000030451998,0.0000020721566,0.000001522201,0.00020095233,0.000006043802,0.9930086,0.0005150721],"about_ca_topic_score_codex":8.932441e-7,"about_ca_topic_score_gemma":0.0000013574548,"teacher_disagreement_score":0.6381381,"about_ca_system_score_codex":0.00006528945,"about_ca_system_score_gemma":0.0018188877,"threshold_uncertainty_score":0.9996306},"labels":[],"label_agreement":null},{"id":"W4414982739","doi":"10.1002/cpt.70082","title":"Application of Physiologically Based Pharmacokinetic Modeling to Inform Dose Selection of Mezigdomide in a Phase I Drug–Drug Interaction Study","year":2025,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Fungal Plant Pathogen Control","field":"Agricultural and Biological Sciences","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Bristol-Myers Squibb Canada","keywords":"Physiologically based pharmacokinetic modelling; Pharmacokinetics; CYP3A; Pharmacokinetic interaction; Drug interaction; Dosing; Clinical pharmacology; P-glycoprotein; Clinical trial","score_opus":0.06323606875511817,"score_gpt":0.412159567254321,"score_spread":0.34892349849920284,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414982739","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99531746,0.000053854536,0.00058427476,0.0020630814,0.00036000618,0.0014884296,0.000027746702,0.00004279448,0.00006233212],"genre_scores_gemma":[0.99290895,0.000034710152,0.00016013552,0.006577291,0.0001259339,0.00014408251,0.000024487008,0.0000018226305,0.000022554215],"study_design_codex":"bench_or_experimental","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9975296,0.00050923554,0.0011632262,0.00039118523,0.00016365766,0.00024306198],"domain_scores_gemma":[0.997863,0.0014376584,0.00032024548,0.000074322554,0.00023101627,0.00007374386],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001034039,0.00018776147,0.0005343655,0.00008183305,0.000070325084,0.000008811194,0.00035977858,0.000112949034,0.00012959233],"category_scores_gemma":[0.000045024197,0.00009518994,0.00014113661,0.0008838403,0.00007089201,0.0000825452,0.00007794457,0.0003946931,0.000009422329],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037506346,0.0034417105,0.010289797,0.000016257178,0.00012694036,0.0000012948211,0.00007062689,0.014254122,0.921372,0.0000032620137,0.00014914991,0.046524234],"study_design_scores_gemma":[0.008904199,0.002518483,0.03288844,0.00005229733,0.00060739066,9.0544756e-7,0.00037637568,0.8771347,0.07454899,0.0001070491,0.0025511875,0.0003099895],"about_ca_topic_score_codex":0.000057212605,"about_ca_topic_score_gemma":0.00015418611,"teacher_disagreement_score":0.8628806,"about_ca_system_score_codex":0.000051657087,"about_ca_system_score_gemma":0.000040330695,"threshold_uncertainty_score":0.38817334},"labels":[],"label_agreement":null},{"id":"W4415617558","doi":"10.1002/cpt.70095","title":"Transforming Pharmacovigilance With Pharmacogenomics: Toward Personalized Risk Management","year":2025,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SNC-Lavalin (Canada)","funders":"National Institute of General Medical Sciences","keywords":"Pharmacovigilance; Pharmacogenomics; Adverse effect; Patient safety; Pharmacogenetics; Population; Health care; Drug reaction","score_opus":0.2948564498869957,"score_gpt":0.5553377293727445,"score_spread":0.2604812794857488,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415617558","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00011178305,0.9665297,0.00084934745,0.0007987245,0.01137346,0.005799458,0.0018530424,0.00079859747,0.011885837],"genre_scores_gemma":[0.00007527007,0.9507016,0.00063586264,0.037442047,0.0026735528,0.0017834207,0.00044898252,0.0003160149,0.0059232423],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.98682725,0.0044367802,0.0032963955,0.0025269322,0.00059449946,0.0023181092],"domain_scores_gemma":[0.9909083,0.004865958,0.0020061058,0.00084532984,0.0003000243,0.0010742325],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"category_scores_codex":[0.0026371214,0.002384352,0.0051010884,0.00088947796,0.0011316543,0.00010194011,0.0025397816,0.0021465393,0.002543639],"category_scores_gemma":[0.000020682373,0.0020071787,0.00276878,0.0016394549,0.0019650022,0.0003927129,0.0004473461,0.009432729,0.0011322536],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019164989,0.0021821545,0.00019408953,0.014819247,0.028092856,0.00089033647,0.00025800598,0.00015548372,0.0000541359,0.0001304009,0.03328418,0.91802263],"study_design_scores_gemma":[0.009272995,0.0002497459,0.0000023215762,0.0022124378,0.0748991,0.00015235804,0.00011105963,0.00024327847,0.00019549645,0.00006335923,0.91075814,0.0018397202],"about_ca_topic_score_codex":0.0000057459993,"about_ca_topic_score_gemma":0.0000022474205,"teacher_disagreement_score":0.9161829,"about_ca_system_score_codex":0.0006739383,"about_ca_system_score_gemma":0.0016368461,"threshold_uncertainty_score":0.9996455},"labels":[],"label_agreement":null},{"id":"W4415949485","doi":"10.1002/cpt.70120","title":"Evolving Standards: Good Clinical Practice Insights from US <scp>FDA</scp> , <scp>MHRA UK</scp> , and Health Canada","year":2025,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Ethics in Clinical Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Canada","funders":"","keywords":"Safeguarding; Clinical trial; Harmonization; Good clinical practice; Flexibility (engineering); Guideline; Quality (philosophy); Regulatory affairs; Best practice; Clinical Practice","score_opus":0.43095583600692045,"score_gpt":0.6335834548259027,"score_spread":0.20262761881898228,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415949485","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":"methods","model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0004781524,0.9644469,0.000118342716,0.011930338,0.01117129,0.00406982,0.00085368,0.00020226096,0.0067291902],"genre_scores_gemma":[0.00008700185,0.8183417,0.0021438156,0.17055112,0.004489429,0.00016951465,0.00032087817,0.00023826286,0.003658314],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.97182643,0.0102042835,0.0089681605,0.003409642,0.0034611004,0.0021303897],"domain_scores_gemma":[0.3752651,0.6083031,0.0049847206,0.0030173974,0.004649974,0.0037796844],"candidate_categories":["metaresearch","metaepi_narrow","sts","research_integrity"],"consensus_categories":["metaepi_narrow","research_integrity"],"category_scores_codex":[0.025476918,0.0016207718,0.009305689,0.0004106918,0.00075614767,0.00019276804,0.0020672036,0.0059503443,0.00015700146],"category_scores_gemma":[0.09345776,0.0013548812,0.0018353264,0.0012382778,0.0029802332,0.00019606264,0.0018986639,0.028025633,0.00009200286],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001839966,0.003147015,0.0036590553,0.019494357,0.017124511,0.0016609029,0.00025451081,0.0000010545721,0.0000015379277,0.0004242015,0.5457109,0.40833792],"study_design_scores_gemma":[0.00490267,0.002190852,0.0010188859,0.010509431,0.014147661,0.0000735605,0.00028013665,0.000069454494,0.0000025690983,0.0013003646,0.9652474,0.00025705088],"about_ca_topic_score_codex":0.013084285,"about_ca_topic_score_gemma":0.038612347,"teacher_disagreement_score":0.5980989,"about_ca_system_score_codex":0.0020840596,"about_ca_system_score_gemma":0.082120605,"threshold_uncertainty_score":0.9997331},"labels":[],"label_agreement":null},{"id":"W4416850271","doi":"10.1002/cpt.70153","title":"An Update to the Clinical Pharmacogenetics Implementation Consortium ( <scp>CPIC</scp> ) <i>SLCO1B1</i> Allele Functionality Table Leveraging Evidence from Participants of Predominantly Sub‐Saharan African Ancestry","year":2025,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Pharmacogenetics; Pharmacogenomics; Allele; Table (database); 1000 Genomes Project; Perspective (graphical); MEDLINE; Precision medicine","score_opus":0.3652053681126602,"score_gpt":0.5602017774771113,"score_spread":0.19499640936445112,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416850271","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96260417,0.01160096,0.0029728818,0.00762343,0.011988864,0.002010049,0.0008408184,0.00014903072,0.00020979221],"genre_scores_gemma":[0.8757632,0.023120172,0.0007979453,0.097676285,0.0019591008,0.00031526643,0.00013801384,0.00007064313,0.0001593719],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.98674977,0.0061934856,0.0034281581,0.0015193125,0.0005626297,0.00154662],"domain_scores_gemma":[0.9886591,0.007445184,0.0011846623,0.00095783244,0.0007861474,0.0009670733],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0076719318,0.00074162026,0.0013902516,0.00019792389,0.00072292227,0.0000829851,0.001997861,0.00074131275,0.00083428586],"category_scores_gemma":[0.00029543927,0.00064739527,0.0005364231,0.0010324545,0.001492633,0.00031004957,0.00057266315,0.002364762,0.00015875297],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026695193,0.0038461937,0.35669628,0.00008676147,0.005319019,0.000043631135,0.0011570733,0.00614184,0.38030097,0.000054467273,0.15287964,0.0908046],"study_design_scores_gemma":[0.0066464455,0.0004967929,0.096918724,0.000034839344,0.0058951173,0.0000043301725,0.00051537267,0.0095930975,0.2930265,0.00051084196,0.5860011,0.00035685417],"about_ca_topic_score_codex":0.00008867036,"about_ca_topic_score_gemma":0.00008820383,"teacher_disagreement_score":0.4331214,"about_ca_system_score_codex":0.00010514629,"about_ca_system_score_gemma":0.0011831381,"threshold_uncertainty_score":0.9999368},"labels":[],"label_agreement":null},{"id":"W4416910333","doi":"10.1002/cpt.70135","title":"Pathway‐Informed Machine Learning Identifies Genetic Predictors of High‐Dose Methotrexate‐Induced Mucositis in Pediatric Acute Lymphoblastic Leukemia","year":2025,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; BC Children's Hospital; University of British Columbia","funders":"Natural Sciences and Engineering Research Council of Canada; Health Canada; Centers for Disease Control and Prevention; Genome British Columbia; BC Children’s Hospital Foundation; BC Children's Hospital; Michael Smith Health Research BC; Illumina; Provincial Health Services Authority; Thermo Fisher Scientific; Canadian Institutes of Health Research; Genome Canada","keywords":"Mucositis; Single-nucleotide polymorphism; Lymphoblastic Leukemia; Methotrexate; Genetic variation; Area under the curve; Acute lymphocytic leukemia; Risk assessment","score_opus":0.04262106986820542,"score_gpt":0.39241830252540616,"score_spread":0.34979723265720075,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416910333","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9924929,0.0012014604,0.00057203224,0.0015393945,0.0025191365,0.0010582398,0.000034908273,0.00015173212,0.0004301569],"genre_scores_gemma":[0.9819199,0.008477479,0.00086997304,0.006512083,0.000563548,0.000096731994,0.00006353747,0.000076085875,0.0014206803],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9946579,0.0009764662,0.0020842825,0.00077282183,0.0005962437,0.0009123081],"domain_scores_gemma":[0.99337125,0.0048906654,0.000499427,0.00050808484,0.0003939864,0.00033656793],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001196637,0.00047821752,0.0013780297,0.000852707,0.00013514629,0.0000254714,0.00061464077,0.00073896366,0.00025497767],"category_scores_gemma":[0.0005216746,0.00042862087,0.00037567638,0.0014717393,0.0006128127,0.00011627317,0.00044249196,0.0016671641,0.00007362653],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012930713,0.002893574,0.7886112,0.0015916846,0.009344427,0.0021664845,0.0011974728,0.0016033745,0.13589337,0.000066579,0.008145852,0.035555266],"study_design_scores_gemma":[0.04181597,0.0033277255,0.8568191,0.00024396,0.0088856025,0.00013761315,0.00014369086,0.045317553,0.038953595,0.0003486546,0.0033045888,0.0007019559],"about_ca_topic_score_codex":0.00012360574,"about_ca_topic_score_gemma":0.000039809453,"teacher_disagreement_score":0.09693978,"about_ca_system_score_codex":0.0013090273,"about_ca_system_score_gemma":0.005295852,"threshold_uncertainty_score":0.99981654},"labels":[],"label_agreement":null},{"id":"W4417029509","doi":"10.1002/cpt.70160","title":"Navigating the Genetic Risk of Chemotherapy‐Induced Hearing Loss in the Stria Vascularis","year":2025,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Hearing, Cochlea, Tinnitus, Genetics","field":"Neuroscience","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Research Institute in Oncology and Hematology; Children's Hospital of Winnipeg; Sunnybrook Hospital; CancerCare Manitoba; Children's Hospital Research Institute of Manitoba; University of Manitoba; University of Toronto","funders":"Canadian Institutes of Health Research; University of Toronto","keywords":"Ototoxicity; Hearing loss; Transcriptome; Genetic testing; Incidence (geometry); Inner ear; Risk assessment","score_opus":0.1281005476965739,"score_gpt":0.45693423455989707,"score_spread":0.32883368686332315,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417029509","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.985706,0.00042818332,0.0005322806,0.01085386,0.001290516,0.00090850436,0.0000061437268,0.00004907931,0.00022546899],"genre_scores_gemma":[0.9358884,0.0025298672,0.0004167293,0.060787316,0.00027187765,0.00003824216,5.614182e-7,0.00003409602,0.00003291602],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9938497,0.0032671427,0.0012839292,0.00062821736,0.00037421845,0.0005967754],"domain_scores_gemma":[0.99241126,0.006154424,0.00044050085,0.00083425565,0.000091113965,0.00006842767],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0031203933,0.0002825399,0.00049740676,0.00005466871,0.00032805174,0.0000493162,0.0015306821,0.0003201397,0.000052988315],"category_scores_gemma":[0.0004865056,0.0001904327,0.0003089199,0.00094475364,0.0008971834,0.000041747422,0.00028395868,0.002754486,0.000023995628],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005638242,0.0018841979,0.38921297,0.00008775965,0.0007623323,0.00007084515,0.0048774057,0.0025049571,0.4469008,0.00021161164,0.0011978172,0.15172546],"study_design_scores_gemma":[0.007969036,0.0007319478,0.6227566,0.00014326806,0.0013037369,0.00003159411,0.0006183752,0.020969097,0.3161476,0.0029948053,0.025696184,0.00063773105],"about_ca_topic_score_codex":0.00008076478,"about_ca_topic_score_gemma":0.00002181925,"teacher_disagreement_score":0.23354365,"about_ca_system_score_codex":0.000052649673,"about_ca_system_score_gemma":0.00026424788,"threshold_uncertainty_score":0.9995462},"labels":[],"label_agreement":null},{"id":"W4417304124","doi":"10.1002/cpt.70154","title":"Prognostic Implication of <i>CYP2C19</i> Genotype According to Clinical Risk Stratification After Drug‐Eluting Stent Implantation","year":2025,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Daiichi Sankyo Europe; Idorsia Pharmaceuticals; Chung-Ang University; Yuhan; Daewoong Pharmaceutical Company; Bayer HealthCare; Medicure; Sanofi; Amgen","keywords":"CYP2C19; Confidence interval; Risk stratification; Clinical endpoint; Genotype; Genotyping; Clopidogrel; Coronary stent","score_opus":0.04887897696284085,"score_gpt":0.4250951989225361,"score_spread":0.3762162219596953,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417304124","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9854734,0.0025765027,0.0066018575,0.002338921,0.0013481203,0.0013913795,0.000029134348,0.00009140105,0.00014928207],"genre_scores_gemma":[0.9783574,0.0044308593,0.0009413767,0.015467197,0.0005329945,0.00011896721,0.00005203323,0.00002660333,0.00007258018],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967805,0.0007697502,0.0013899761,0.00053849234,0.00021636987,0.0003048967],"domain_scores_gemma":[0.99746156,0.0011577246,0.00039088438,0.0004330194,0.00037449627,0.00018234074],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017072625,0.0002127504,0.0006650376,0.00012480184,0.000117481206,0.000016481714,0.00019470601,0.00025116358,0.000044935718],"category_scores_gemma":[0.00012203338,0.00019094236,0.00057713425,0.00038643804,0.00023344,0.00006625565,0.00006981995,0.00052530074,0.00004883076],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035185805,0.00095942745,0.78622735,0.00010191374,0.0025002554,0.000011427058,0.00010344559,0.000052233107,0.0076728687,0.000032338983,0.00065559853,0.19816454],"study_design_scores_gemma":[0.0040992033,0.00061254465,0.9706635,0.00011575253,0.0068815663,0.000012313253,0.0002553616,0.00054226076,0.006597268,0.0002741409,0.009721454,0.00022463073],"about_ca_topic_score_codex":0.000006705293,"about_ca_topic_score_gemma":0.0000026852167,"teacher_disagreement_score":0.19793992,"about_ca_system_score_codex":0.000043960077,"about_ca_system_score_gemma":0.00029880155,"threshold_uncertainty_score":0.77864033},"labels":[],"label_agreement":null},{"id":"W7117119520","doi":"10.1002/cpt.70156","title":"Verekitug, a Novel Antibody Antagonist to the <scp>TSLP</scp> Receptor in Adults with Asthma: A 32‐Week Randomized Phase 1b Multiple Ascending‐Dose Trial","year":2025,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Iron Ore Company (Canada)","funders":"Manchester Biomedical Research Centre; National Institute for Health and Care Research","keywords":"Clinical endpoint; Dosing; Pharmacodynamics; Pharmacokinetics; Adverse effect; Biomarker; Thymic stromal lymphopoietin; Asthma","score_opus":0.050554718821735414,"score_gpt":0.432808475411597,"score_spread":0.3822537565898616,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7117119520","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9692764,0.0015769161,0.0011684732,0.017309777,0.004282498,0.005398054,0.00009347456,0.00014391892,0.0007504731],"genre_scores_gemma":[0.9226188,0.0011354863,0.0006238853,0.07349724,0.00077067333,0.00049100147,0.00014021274,0.00004833442,0.00067435735],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9954306,0.0013176765,0.0014499533,0.0007870487,0.0002837067,0.0007310265],"domain_scores_gemma":[0.98942167,0.009167561,0.0003359114,0.0005187939,0.00021162444,0.00034446135],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0017087942,0.00045442922,0.0017422003,0.00025912607,0.00025823803,0.000035242232,0.00050615106,0.00046657107,0.000105487554],"category_scores_gemma":[0.0011741103,0.00029392942,0.0005194526,0.00070092204,0.0013116426,0.0000786025,0.00015487488,0.001263969,0.00012950205],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.90446734,0.022288073,0.012006682,0.00011538656,0.0027358183,0.00026942792,0.0007534379,0.000015324875,0.0032063772,0.000050700124,0.051620346,0.0024710596],"study_design_scores_gemma":[0.85129184,0.0018968288,0.0037080168,0.00022292299,0.0018977553,0.0000388222,0.00030794225,0.0021755907,0.0009721321,0.000037324793,0.13731502,0.00013579115],"about_ca_topic_score_codex":0.00001496698,"about_ca_topic_score_gemma":0.000028158285,"teacher_disagreement_score":0.08569468,"about_ca_system_score_codex":0.00007520803,"about_ca_system_score_gemma":0.0005918457,"threshold_uncertainty_score":0.9999513},"labels":[],"label_agreement":null},{"id":"W7117768419","doi":"10.1002/cpt.70189","title":"Major Adverse Cardiac Events with Ondansetron: A Systematic Review","year":2025,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Nausea and vomiting management","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; McMaster University Medical Centre; St. Joseph’s Healthcare Hamilton; Impact; Hamilton Medical Research Group; Ontario Clinical Oncology Group; University of Toronto","funders":"","keywords":"Ondansetron; Adverse effect; Torsades de pointes; Randomized controlled trial; Mace; Placebo; QT interval","score_opus":0.048872275969037746,"score_gpt":0.4353023206791349,"score_spread":0.3864300447100971,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7117768419","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4322936,0.22690748,0.0027201492,0.2664993,0.0147485575,0.033730794,0.000068227375,0.0012965825,0.021735318],"genre_scores_gemma":[0.22019194,0.045059804,0.0010222672,0.7133632,0.0006106732,0.0006354003,0.000040492112,0.00007818904,0.018998045],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.99766666,0.00056950934,0.0008601115,0.0003683334,0.00021651576,0.00031889125],"domain_scores_gemma":[0.998474,0.00056552555,0.00022522241,0.00045325296,0.00014786811,0.00013413485],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011794851,0.00021990373,0.001186885,0.000082930805,0.00008361138,0.0000042784795,0.00020850905,0.00013027836,0.000136394],"category_scores_gemma":[0.000049783695,0.00015279163,0.0003359218,0.00032631904,0.00016852288,0.000029857503,0.00008393393,0.0004932498,0.0001585395],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033338503,0.00427234,0.10716785,0.61326766,0.03931696,0.00048390497,0.00013169847,0.0000045533466,0.0011678338,0.00042519358,0.22808208,0.0023461024],"study_design_scores_gemma":[0.03809159,0.005521369,0.07205116,0.24509764,0.29100832,0.00007438509,0.00040626316,0.000277232,0.0012482058,0.0003762336,0.3443126,0.0015349991],"about_ca_topic_score_codex":0.0000015363934,"about_ca_topic_score_gemma":6.1689957e-7,"teacher_disagreement_score":0.44686386,"about_ca_system_score_codex":0.00008904022,"about_ca_system_score_gemma":0.00020789237,"threshold_uncertainty_score":0.6230662},"labels":[],"label_agreement":null}]}